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ABSTRACT
The psychobiological effects of the menstrual cycle on both self reported food 
intake and subjective experiences of appetite were assessed in a series of studies. A 
significant premenstrual increase in both sugar intake (determined by semi weighed 
method) and carbohydrate preference was observed. In addition, although not 
significant, total calorific intake peaked premenstually. Subjective appetite rating 
scores also significantly altered during the cycle, with maximum appetite noted in 
the luteal stage. Altered perception of hunger and satiety were observed 
premenstrually. Significant correlations between food intake and subjective 
experiences of appetite were observed, with percentage protein intake being related 
to the degree of satiation experienced, and food cravings to absolute and percentage 
fat intake.
The role of serotonin (involved in the inhibition of eating and the control of 
macronutrient intake) was investigated to identify its putative mediation of eating 
control during the menstrual cycle. Initially, the metabolism of its precursor, 
tryptophan was clarified during the menstrual cycle, and led to the development of 
a salivary assay to measure tryptophan and a wide range of its metabolites. 
Correlational studies did not identify a role for serotonin in affecting either the 
inhibition of eating nor macronutrient choice during the menstrual cycle. However, 
a premenstrual association between the subjective overconsumption of food and 
increased serotonin production (relative to kynurenine metabolites) was identified. 
The role of mood in affecting eating control was also investigated. No effects were 
noted on self-reported food intake. However, mood did significantly modulate
subjective experiences of eating with positive moods in the follicular and luteal 
stages predictive of the degree of satiety; whereas negative moods (specifically 
depression and hostility) were predictive of low satiation premenstrually. 
Comments regarding methodological issues, and areas for further research are 
highlighted.
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CHAPTER ONE
INTRODUCTION
1
1.0 Overview of Thesis
This research study is aimed at investigating the control of eating across the 
menstrual cycle, from a psycho-biological approach. In particular the role of 
serotonin, a neurotransmitter involved in the inhibitory processes of food intake, 
and in the pathogenesis of a variety of behavioural and psychiatric disorders, will 
be investigated. In addition, mood states during the period of assessment will also 
be investigated with particular emphasis on the role of depression, anger and 
anxiety in affecting food intake. A physiological index of stress ie the measurement 
of cortisol will also be performed to assess coping strategies and their impact on 
eating in women. A final aim of the thesis is the development of a novel method to 
assay tryptophan and its metabolites in saliva. Previous studies investigating 
tryptophan metabolism in behavioural and psychiatric disorders have been based on 
levels assayed in cerebrospinal fluid (CSF), whole blood, plasma, blood platelets 
and urine collections. Therefore the possible development of a non invasive 
salivary assay to measure these metabolites has far reaching consequences for the 
range of disorders and biological processes in which serotonin has been implicated. 
The literature that has led to the hypothesis of the thesis is reviewed and discussed 
in the subsequent five chapters. The following overview highlights those areas of 
research of particular interest in the study.
Numerous factors have been shown to influence the synthesis and metabolism of 
serotonin. However, the effect of the female gonadal hormones on its synthesis has 
not been clarified to any great extent in humans. The research that has been carried
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out to date (as will be discussed) appears to be conflicting. Therefore in view of 
possible implications of a putative role for serotonin in a wide range of disorders it 
seems apparent that the metabolism of tryptophan (the dietary essential precursor 
for serotonin) and its many metabolites (including serotonin) needs to be 
elucidated.
A multitude of studies have demonstrated that serotonin plays an inhibitory role in 
the control of food intake as well as playing a role in the expression of appetite for 
certain macronutrients. From a biological view, a considerable number of 
transmitters and hormones have been shown to control and mediate eating 
behaviour. Research into the control of eating requires a multidisciplinary approach. 
Eating behaviour is not simply a survival process to ensure the body has enough 
nutrients for adequate maintenance and development. Eating is a biological 
process, and a behaviour too, its expression being dependent upon the environment 
in which it is carried out ie it needs to be put into a context. For example, feeding 
can be seen to be an expression of emotions; it can be used as a weapon, to 
express anger, hatred, independence, control. It can also be used to express love, 
care and sharing. The actual process of eating is also context dependent. That is, 
what we eat can be a result of the food that is available (less of a problem in our 
food abundant Western society) and what society and religious convictions dictate 
we eat. In Western society perhaps one of the major overriding influences, 
especially for women, is that of an acceptable body image. Current media images 
of women encourage a thin, androgenous body type. The pervading issue from
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these media images it that to be thin is to be beautiful, successful and by inference 
to be acceptable to our society and the extent of these messages can be seen with 
the increasing prevalence of dieting in Western societies. So perhaps one of the 
main cultural pressures on food intake in women (and to a lesser extent in men) 
can be seen to be the "normal” behaviour of weight reducing dieting. In addition, 
women frequently recount that their appetite and food intake depends on other 
factors, for example their moods, their self esteem and their menstrual cycle. 
However, these observations are anecdotal, and little attention has been paid in the 
scientific literature, specifically to the role of the menstrual cycle on eating 
behaviour and food intake.
Therefore, to investigate eating behaviour per se necessitates a biopsychosocial 
approach. With the ever growing incidence of eating disorders (ie anorexia, 
bulimia and binge eating) in women, it is important that a clearer understanding is 
made to comprehend the control of food intake and eating behaviour in "healthy" 
eating women. The main areas in this study will address the relationship between 
food intake and female hormones, and the controversial area of how mood and 
emotional states may mediate the intake of food, if at all. The whole emphasis will 
revolve around the neurotransmitter serotonin, a neurotransmitter involved in the 
control of eating, and the mediation of mood states such as depression, anxiety and 
anger.
The subsequent introductory chapters will discuss the following areas which are
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pertinent to this study. The changes in female hormones across the menstrual cycle; 
the metabolism of tryptophan with a review of studies that have assessed the effect 
of female hormones on tryptophan metabolism; the biological control of eating 
behaviour and a review of studies investigating how eating changes during the 
cycle; mood changes during the menstrual cycle and finally a review of the 
literature assessing the relationship between mood states and food intake. From 
these areas, hypotheses are presented to investigate the relationships between 
tryptophan metabolism, female hormones and mood on eating behaviour in women. 
A series of seven studies to test these hypothesis are described and the results 
interpreted and discussed.
1.1 Hormonal Changes During The Menstrual Cycle
The reproductive years of the female are characterised by monthly rhythmic 
changes in the rates of secretion of female hormones and corresponding changes in 
the ovaries. This rhythm is known as the female sexual cycle, but is more 
commonly referred to as the menstrual cycle. The duration of this cycle is 28 days 
on average, although the length varies with each individual and can range from 23 
to 35 days in healthy women. (See section 1.2 for a discussion on these 
assumptions and the inherent problems associated with cycle phase defining in 
menstrual cycle based research). The cycle can be arbitrarily divided into two 
phases by the occurrence of ovulation, the follicular phase (days 1 - 1 4 )  and the 
luteal phase (days 15 - 28). The normal luteal phase is considered to be of a 
constant length (14 ± 2 days) but the follicular phase is of variable duration (Bailey
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and Marshall, 1970; Lachelin, 1991).
The cycle commences with the first day of menstruation (day 1) and in the case of 
a "regular" 28 day cycle, ovulation is assumed to occur at day 14. Two ovarian 
hormones oestrogen and progesterone are secreted by the ovaries throughout the 
cycle in response to hormones from the anterior pituitary ie follicle stimulating 
hormone (FSH) and luteinising hormone (LuH). Both of these anterior pituitary 
hormones are secreted in response to the release of luteinising hormone releasing 
hormone (LHRH) from the hypothalamus. All these various hormones are not 
secreted in a constant steady amount but are released at different rates during the 
different phases of the cycle (as shown in Figure 1).
At approximately the onset of menstruation, the release of FSH and LuH is 
increased (although the FSH increase precedes that of LuH), causing accelerated 
growth of the granulosa cells of the ovaries in the ovarian follicles (and theca cells, 
but to a lesser extent). These cells secrete follicular fluid that contains high 
concentrations of oestrogen and both the granulosa and theca cells continue to 
proliferate. After one week with the rising levels of FSH and LuH, one follicle 
outgrows the others and the remainder become atretic. Shortly before ovulation, the 
follicle loses its fluid and ruptures releasing its ovum. Two days prior to ovulation 
there is a two fold rise in FSH and a 6 - 10 fold rise in LuH. The LuH causes the 
theca cells to change to lutein cells that secrete less oestrogens but progressively 
increasing amounts of progesterone. These changes cause the rapid growth of the
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Figure 1. A Diagram Showing the Hormonal Changes During the Menstrual Cycle
follicle so that it ruptures releasing its ovum. Once the ovum is expelled the 
remaining granulosa cells undergo luteinisation, becoming a corpus luteum. The 
theca cells, now incorporated into the corpus luteum, continue to secrete oestrogen 
but the lutein cells secrete considerable amounts of progesterone. Seven to eight 
days after ovulation, if fertilisation does not occur, the luteum involutes and looses 
its secretory function. FSH and LuH now have no feedback from the ovarian 
hormones so that the anterior pituitary secretes several times as much FSH, 
followed by increasing quantities of LuH. The FSH and LuH initiate the growth of 
a new follicle to begin a new ovarian cycle. The cessation of secretion of 
progesterone and oestrogen result in menstruation and a new cycle commences.
1.2 Methodological Issues in Defining the Stages of the Menstrual Cycle in 
Research
The role of the hormones responsible for the continuing cycle have been shown to 
have other effects than as purely reproductive triggers. Research has implicated a 
role for progesterone and oestrogen in a variety of physiological, endocrinological, 
psychological and behavioural changes that have been found to vary with the 
menstrual cycle. Most menstrual cycle research is based on the assumption that it is 
the fluctuating hormonal levels that cause changes or alterations in behaviour and 
therefore identifying the different cyclic phases is essential to the design of the 
study. Studies that have investigated the covariance of behaviours, for example, 
with hormones, have divided the menstrual cycle into several phases and compare 
the behaviour across these phases. However, there are inherent problems associated 
with this. Menstrual cycle length varies between and within individuals, and
therefore this division into phases may not be accurate for the women studied.
However, the most obvious choice of hormonal assaying is not frequently used 
since it is both expensive and time consuming; alternatively the stage under interest 
is identified indirectly; generally by trying to "fix" the time of ovulation (since this 
event leads to the changes in hormonal levels). Once ovulation has been fixed it is 
assumed that pre ovulation, oestrogen levels are high, and progesterone low; and 
for post ovulation vice versa. However, again there are problems identifying 
ovulation. Frequently it is identified by using the date of the last menses, the 
normal length of the cycle, and the predicted date of the next menses; with 
ovulation assumed to occur 14 days prior to the onset of menses. However, it has 
been shown that this method was successful in only 50% of cases (reviewed by 
Gannon, 1981). Frequently, one method of coping with this is to "fix" the primary 
phase of interest, and leave the phase of least interest as variable. For example, if 
the primary stage of interest was around menses, the cycle has been divided into 
pre - menses, post menses and intermenses, which would cover the period from 4 
days after the onset of menses until the four days preceding menses. No standard 
procedure exists for defining the different phases, and as a result there is a huge 
variation in how studies assess different stages which hinders comparative work. 
Sommer (1992) has identified that menstrual cycle research studies have defined 
between 1 to 7 different stages; and in addition that the definition of the same 
phase varies between studies.
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The problems associated with menstrual cycle research have been reviewed by 
Richardson (1992). Subjects participating in research studies are asked to provide 
details of their menstrual history and on this basis assumptions are made 
concerning their cycles. This automatically poses one potential problem ie that the 
information recalled may not be accurate and valid. Studies investigating this 
potential problem have though concluded that women in Western countries are 
relatively accurate at remembering information concerning their menstrual cycles 
(World Health Organisation, 1981).
Many studies have used the onset of menses as the cycle marker and assume an 
arbitrary cycle length of 28 days. However this does not take into account 
differing cycle lengths, nor inter or intra cycle variances. Hormonal levels may not 
follow a regimented pattern but the studies are based on the premise that hormonal 
events are directly proportional to the length of the cycle. Problems are therefore 
encountered with these theoretical assumptions in those women who have either 
short or long cycles. Knaus (1929) originally suggested that in healthy women with 
a regular 28 day cycle, the day of ovulation fell between days 14 and 16. Since 
that time, studies on the menstrual cycle have based their methods on this 
assumption despite the criticism by Ogino (1930) that there is no causal 
connection between the date of ovulation and the previous menses. Again no 
single standardised method of assessment has been employed to deal with this. 
However to accommodate different cycle lengths authors have assumed either of 
the following arguments.
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Firstly, that irregularities in cycle length occur before ovulation; that is, the 
follicular phase is variable but the luteal phase is relatively constant (ie the time 
between ovulation to the onset of menses is a standard 13 or 14 days) (Genuine, 
1981; Guillebaud, 1984). This view is currently the most popular despite a lack of 
supportive evidence. This assumption is based on indirect evidence such as basal 
body temperature, intermenstrual pain and cervical mucorrhea (Bailey & Marshall, 
1970; Vollman, 1977). However these measurements are not considered good 
predictors of ovulation and a more direct measurement of the timing of ovulation is 
considered to be the midcycle peak of plasma FSH or LuH levels. However even 
studies using these more accurate methods of determination have shown that the 
length of the luteal phase still shows considerable signs of variation (Cargille, Ross 
and Yoshimi, 1969).
The alternative view suggested is that irregularities occur after ovulation and that 
the time from the onset of menses to ovulation is standard ie that the follicular 
phase length remains constant. Work by Cutler and Garcia (1980) indicated that the 
follicular phase is generally constant.
1.3 Methodological Issues with Menstrual Cycle Research on Mood and 
Behaviour
Finally other aspects should be considered when evaluating research findings from 
menstrual cycle based research (as discussed by Sommer, 1992). The menstrual 
cycle in research is generally considered a physiological processes that has the 
potential to effect a behaviour, emotions and performance. However, it is both a
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physiological and psychological process and both factors are present and capable of 
varying in the same study. For example, both personal and societal beliefs, attitudes 
and feelings concerning the menstrual cycle are intertwined with the role of women 
in the society but yet are rarely addressed in the research design. In addition, 
findings from a study are not usually put into a context; ie a statistically significant 
result is considered important but the actual level of the finding is rarely compared 
against findings from other behavioural or cognitive variables. Therefore the 
relative importance of the finding is rarely addressed.
In addition, problems are encountered with the interpretation of mood changes 
during the cycle. A range of diverse methods of assessments are used in studies 
hindering standardisation. In addition, the nature of the assessment is questionable 
since it depends on self reporting by the subject who is aware of the objective of 
the study which could influence reporting. However the greatest difficulties arise in 
the interpretation of results and stems from the inadequate methods of interpretation 
of the phases of the cycle.
The design of the research study should also be considered. The two methods used 
include a within-subjects (ie a repeated measures) design and a between- subjects 
design ( ie the comparison of groups of women in different phase of their cycles). 
In addition, some studies mix both designs. The within-subjects design is obviously 
the more statistically sensitive design, since each subject is used as her own 
control. There are disadvantages though to this design such as the problem of
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subject commitment and the potential of carryover effects of treatments. The 
between-subjects design involves a single measurement and so does not have the 
disadvantages above. However, one major problem is that of individual differences 
which may confound any results.
This chapter has reviewed a crucial and basic understanding for the research 
design of this study. It has highlighted the potential problems of menstrual cycle 
related research ie the importance and necessity for the correct interpretation of the 
cyclical phase(s) of interest, and the importance of interpreting any statistically 
significant results in a meaningful manner.
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CHAPTER TWO
THE CONTROL OF FOOD INTAKE
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2.0 Introduction
Adequate food intake is essential for survival and as such feeding behaviour and 
appetite are controlled. To maintain a stable body weight requires a precise 
regulation of energy intake versus energy expenditure; a 1% change in either intake 
or expenditure results in an appreciable change in body weight, ultimately the 
excess storage of energy (ie obesity) or energy loss (ie starvation) if not rectified. 
Short term influences affect and modify individual meal patterns particularly their 
nutrient content, meal selection and short term satiety. Longer term adaptations to 
food intake are reflective of the body's nutrient stores to ensure that a homeostatic 
energy balance is met. In spite of the multiple levels of interaction, the regulatory 
processes generate a drive to eat ie to protect the body against underconsumption. 
Therefore undereating is a deliberate disciplined act whereas overeating can occur 
passively leading to obesity, a major health problem in developed societies.
Eating behaviour and the control of food intake is a complex area requiring a 
multidisciplinary approach to its study. The actual process of eating is an 
expression of the interaction of biological (ie physiological, metabolic and neural) 
control mechanisms, psychological factors (motivational and other cognitive 
aspects; emotional states) and environmental cues (eg cultural norms and food 
availability). Changes in eating behaviour and food intake could therefore be a 
result of alterations to either physiological and/or neural control systems, to 
cognitive control or to the environment. The main area of interest in this study is to 
ascertain if and how the menstrual cycle can exert changes on food intake, and 
whether cyclical changes are a result of hormonally mediated changes in
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neurochemistry or mood, or an interaction of both.
Therefore the following sections will review those aspects pertinent to affecting 
eating control across the menstrual cycle. Firstly, a review of the biological 
processes that affect eating and appetite will be discussed (with particular emphasis 
on the role of the neurotransmitter serotonin) followed by a review of the research 
investigating eating behaviour and food intake during the menstrual cycle.
2.1 The Biology of Eating
The biological control of eating behaviour is a highly complex process and is 
controlled at three levels (Blundell, 1991). Firstly, at a psychological and 
behavioural level ie the process of eating is mediated by how we perceive hunger; 
by factors that affect and effect our desire for food (eg emotional states, food 
characteristics, levels of arousal) expressed through our appetite and cravings for 
certain food types; as well as our psychological need to fulfil our hedonistic 
desires. Secondly, peripherally, eating is controlled by multiple physiological 
processes that monitor the intake of food and how food is metabolised. Finally, the 
central nervous system mediates and monitors food intake via complex interactions 
between different neurotransmitter systems and actual metabolic interactions within 
the central nervous system (CNS). Of particular relevance to this study is the role 
of serotonin.
The neurobiological processes involved in eating are not just switched on or off but
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consists of the four distinct consecutive stages, hunger, appetite, satiation and 
satiety (see Table 1). Hunger and appetite are considered excitatory processes, and 
satiation and satiety as inhibitory processes. Food is sensed neuronally and 
humorally through these four stages and ultimately results in satiation ie the 
process bringing a period of eating to a halt (cf satiety = inhibition of hunger and 
eating as a consequence of food consumption). These processes are reflected in an 
individual's subjective feelings resulting in an observable behavioural pattern of 
food intake and appetite control.
Stage Process Description
1 Hunger Process which stimulates the onset of eating
2 Appetite Process which directs and guides eating 
once feeding has commenced
3 Satiation Process which brings eating to a halt
4 Satiety State of inhibition over further eating
Table 1: The Distinct Stages of Appetite Control
The drive to eat is controlled in part by the satiating power of food ie "the capacity 
of consumed food to suppress hunger and to inhibit the onset of a further period of 
eating", and is mediated by four processes, sensory, cognitive, postingestive and 
post absorptive, collectively referred to as the satiety cascade (Blundell, 1991)(see 
Figure 2).
The metabolism of food can be divided into two phases; the absorptive phase, 
concerned with the storage of nutrients; and the postabsorptive phase concerned 
with the breakdown and utilisation of stored nutrients. Physiological signals are
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figure 2. The Satiety Cascade 
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believed to monitor these phases since it is during the postabsorptive phase that 
hunger begins; and during the absorptive phase that satiety starts. Throughout the 
various stages of eating there are a considerable number of satiety signals that will 
trigger the satiety cascade (Norton, Falciglia and Gist, 1993) ( refer to Table 2).
The major signals affecting satiety in the post ingestive phase are briefly discussed. 
The cephalic phase of hunger and appetite anticipates the ingestion of food in the 
gut by the sight and smell of food, and during and immediately after eating, the 
major control of eating is via afferent innervation. Although food in the mouth 
provides positive feedback for eating, it is the distention of the stomach that is the 
primary mechanism that determines the size of a meal via the vagal and splanchnic 
nerves (which convey information concerning the nutritional content of the 
stomach).
Hunger Satiety
Neural Neural
Lateral hypothalamus Nucleus solitarius tract
Limbic system Paraventricular nucleus
Nigrostriatal tract Ventromedial hypothalamus
Nucleus of Solitarius tract
Paraventricular nucleus
Chemical Chemical
P - endorphin Anorectin
Dopamine Bombesin
Dynoiphin Cholecystolon in
Galanin Corticotrophin -releasing hormone
Growth Hormone - releasing hormone Enterostatin
Insulin (plasma) Glucagon
Neuropeptide Y Hepatic glucose concentration
Noradrenaline Neuromedia P
Oxytocin
Serotonin
Somatostatin
Table 2: The Principal Neural and Chemical Stimulators of Hunger and Satiety 
(From Norton, Falciglia and Gist, 1993; and Kushner and Pendarvis (1995)
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The macronutrient content of food also plays a role in the experience of satiation 
and satiety. Human and rat preload studies have shown that carbohydrate-rich foods 
are efficient appetite suppressants, effecting satiation and having a potent effect on 
satiety (reviewed by Blundell, 1991). Dietary fats on the otherhand stimulate 
calorific intake, increasing the attractiveness of food (by altering texture and 
palatability) and therefore have a minimal effect on satiation but do affect satiety. 
Protein though has been claimed to have the greatest satiating efficiency of all the 
macronutrients. Once nutrients are digested the degree of oxidative metabolism of 
glucose and free fatty acids in the liver is monitored by the CNS to trigger the 
neurobiological processes involved in the satiety cascade.
2.2 The Neurobiological Control of Eating
The majority of studies investigating the neurobiological control of food intake 
were developed from investigations of two syndromes that resulted in abnormal 
feeding behaviour ie ventromedial hypothalamic hyperphagia (Brobeck et al 1943 
in Sullivan and Chang, 1978) and lateral hypothalamic aphagia (Anand and 
Brobeck, 1951). These studies showed that lesions in the ventromedial area of the 
hypothalamus resulted in hyperphagia and obesity; whereas lesions in the lateral 
area resulted in aphagia and adipsia and eventual death. Subsequently, the effect of 
electrical stimulation of these two regions was investigated; stimulation of the 
lateral hypothalamus led to eating; stimulation of the ventromedial hypothalamus to 
cessation or inhibition of eating. It was from these observations that the dual centre 
theory of eating was proposed. The lateral hypothalamus (LH) became known as 
the excitatory "feeding" centre and the ventromedial hypothalamus (VMH) as the
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inhibitory "satiety" centre.
Subsequently lesion studies were performed to further define this theory but 
findings indicated that this dual centre concept was too simplistic. It was suggested 
that the behavioural effects observed after the lesions were a result of destruction 
of the neuronal pathways which passed through this region and not due solely to 
the destruction of the hypothalamic areas. Therefore subsequent research focused 
away from the hypothalamus as the centre for the control of food intake but 
concentrated on the pathways that innervated the VMH and LH (Rolls, 1981).
2.3 Neurotransmitters Involved in the Control of Eating
The neuronal pathways that innervate the hypothalamus include the ventral and 
dorsal noradrenergic pathways, and the dopaminergic nigrostriatal pathway (which 
is part of the putative reward system, affecting feeding by mediating motivation). 
The LH is innervated by the ascending nigrostriatal fibres (Ungerstedt, 1971) and 
injections of the dopaminergic neurotoxin (6 hydroxy dopamine) in this region 
resulted in the same effects noted after the lesion studies ie aphagia and adipsia. 
Ungerstedt and Ljungberg (1974) suggested that the resultant aphagia and adipsia 
observed after lesioning was due to sensory neglect, a reflection of the disruption 
of the dopamine reward function, so that the rats were unable to orientate and 
initiate an appropriate behavioural response to environmental stimuli (ie in this 
case, food), since food had lost its "reward value". As such dopaminergic neurones 
are considered to be concerned more with general arousal and the reward values of
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various food signals, and therefore involved in the initiation of food intake (unlike 
noradrenaline, and serotonin which are involved in the inhibition of eating, as will 
be discussed).
2.4 Neural Centres Involved in the Control of Eating
Traditionally the neural control of appetite was based on the hunger and satiety 
centres in the hypothalamus and although the hypothalamus does play a major role, 
further studies have indicated other regions of the brain are involved in eating. The 
brain stem for example, is involved in the actual mechanism of feeding ie 
salivation, chewing and swallowing. The higher brain areas, which are anatomically 
coupled with the hypothalamus, have been shown to be more involved in the 
higher levels of eating control. The hindbrain (particularly the nucleus of the 
solitary tract, NST and area postrema, AP) and the forebrain having distinct roles. 
They receive innervation from the vagus nerve concerning sensory and visceral 
information, transcribed onto the aminergic neurones which are transmitted to the 
forebrain (particularly the paraventricular nucleus).
The limbic system (amygdala and cortical areas) has also been implicated. Lesion 
studies on the amygdala (involved in learned fear and also a major part of the 
olfactory nervous system) have not provided consistent findings. However, the 
bilateral destruction of the amygdala, have led to psychic blindness in food choice 
ie the loss of appetite for the types and quantity of food. The cortical areas of the 
limbic system, ie the infraorbital, hippocampal gyrus and the cingulate gyrus, also
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all appear to be implicated. It is suggested that these areas act in association with 
the amygdala and the hypothalamus to determine the quality of food eaten. 
Therefore other areas of the brain are involved in eating.
2.5 The Role of Serotonin in the Control of Eating
The following section will concentrate specifically on the role of serotonin (5HT) 
in the control of eating. The involvement of serotonin in the control and expression 
of appetite has been noted for the last twenty years and suggest that 5HT has an 
inhibitory effect on eating behaviour.
2.5.1 Serotonin and Feeding Sites
The majority of 5HT is found in the periphery within the enteric nervous system 
where it interacts with other neuromodulators to exert its effects; namely in the 
control of gut muscles and in gut secretion and absorption. However, the actual 
serotonergic control of food intake occurs within the CNS; with studies identifying 
the active involvement of 5HT terminals at those sites in the brain controlling 
feeding eg the PVN (Liebowitz and Shor Posner, 1986).
Serotonin is found concentrated within the limbic structures and the hypothalamus, 
(where it is innervated by the dorsal raphe and the medial raphe forebrain tracts) 
and it is here that it critically mediates feeding behaviour, occupying a strategic 
anatomical location, projecting to and through the hypothalamus. It has been 
demonstrated that lesions of the paraventricular nuclei (PVN), ventromedial nuclei
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(VMN) and the suprachiasmatic nuclei (SCN) result in the dysregulation of 
feeding; lesions of the midbrain raphe nuclei however, had no effect on feeding 
(Samanin et al, 1972).
2.5.2 The Role of Serotonin in Satiety
Considerable evidence exists that increased serotonergic activity leads to an 
identifiable reduction in food intake (reviewed by Blundell, 1984; Liebowitz and 
Shur Posner, 1986). Numerous studies have shown that agents that enhance 
serotonergic transmission are frequently associated with a reduction in food intake; 
and that this effect can be reversed by a number of serotonin antagonists (or other 
manipulations that reduce 5HT availability presynaptically). In addition, 
microinjections studies have identified that administration of serotonin within the 
medial hypothalamus led to an alteration of meal patterns (Leibowitz & Shor 
Posner, 1986); with a decrease in both the size and the duration of a meal 
(Blundell and Hill, 1987). Hill and Blundell (1990) argued that increased serotonin 
synthesis leads to an increase in post prandial satiety. The latency of the onset of a 
meal was not affected at all. Conversely decreased 5HT synthesis (or decreased 
activation of 5HT receptors) has been shown to increase food consumption with a 
subsequent increase in weight gain, although the evidence is certainly less 
convincing than those studies investigating the reverse situation (see review by 
Blundell and Hill, 1991).
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Therefore studies do support the view that central serotonin acts primarily in the 
termination of food intake (ie induces satiety) rather than affecting the initiation of 
eating by suppressing hunger. Serotonin acts centrally by inducing satiety; its 
mechanism being mediated within the PVN in the medial hypothalamus via post- 
synaptic receptors and terminal autoreceptors.
Serotonin therefore mediates feeding behaviour via specific receptors, and to date 
the 5HTla, 5HTlb and 5HT2c receptors have been implicated as playing a major role 
in the inhibition of food intake (Garatinni et al, 1988; Garatinni et al, 1989; 
Dourish, 1995) (refer to Figure 3). The role of the 5HTla autoreceptors 
(postsynaptic, located on the soma and dendrites of the 5HT neurones found in the 
raphe nuclei) has been largely investigated in rat studies using the specific agonist 
8-hydroxy-2-(di-n-propylamino)tetralin (80HDPAT). The results of these studies 
(reviewed by Dourish, 1995) identified a hyperphagic effect; a contradiction in 
view of serotonin’s inhibitory effect on food intake. Subsequent studies showed that 
80HDPAT stimulated the 5HT]a autoreceptors in the raphe, leading to a decrease 
in 5HT neuronal firing and hence a decrease in synthesis and release of 5HT; 
thereby explaining the removal of the inhibitory effect of serotonin in the PVN 
(this is discussed further in section 2.7).
The role of the 5HTlb receptors has been investigated by both agonist and 
antagonist studies (reviewed by Dourish, 1995) which suggest that the inhibition of 
feeding by 5HT is mediated by the postsynpatic 5HTlb receptors located in the
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PVN. The role of the 5HT2c receptors (exclusively found postsynaptically) in the 
satiety process, is believed to be mediated in the ventromedial nucleus. A recent 
study has identified increased postsynaptic sensitivity of these receptors after short 
term dieting (three week period; Clifford et al, 1995), and may explain why 
previous investigations have had difficulty in (a) demonstrating anorexia by 
injecting 5HT into various brain regions, and (b) why 5HT is better at treating 
overeating than catecholamines (as demonstrated by Silverstone and Goodall,
1992).
2.6 Other Neurotransmitters Involved in the Control of Eating
Dopamine is involved, like serotonin, in the inhibition of feeding (reviewed in 
Leibowitz and Shor Posner, 1986) acting via the LH (specifically the perifomical 
region) which contains a high concentration of D2 receptors and terminals. The 
action of dopamine at this specific site is unique, since dopamine has a general 
activating effect on influencing motivated behaviours (including feeding) in other 
areas of the brain. The anorectic effect of amphetamines is believed to be mediated 
partially via activation of dopaminergic neurones in this region of the LH. 
Adrenergic pathways have a dual role in feeding, dependent on their position 
within the hypothalamus. Activation of adrenergic a 2receptors in the medial 
hypothalamus result in the stimulation of feeding. Activation of P-adrenergic (and 
noradrenergic and dopaminergic receptors) located in the LH however inhibit 
feeding (Liebowitz, 1990). The inhibitory feeding action of these catecholamines 
(ie dopamine, adrenaline and noradrenaline) act by delaying the onset of a meal,
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rather than altering the point of the meal termination; unlike 5HT, which acts to 
inhibit feeding by decreasing meal size, activating the satiety mechanism to 
terminate the meal.
2.7 The Interaction of Serotonin with other Neuro transmitters
Neurochemically the control of eating is complex. Both the LH and PVN receive 
innervation from the vagal nerve via the NST, from different afferent tracts of 
dopaminergic, noradrenergic and serotonergic tracts that transcend to the 
hypothalamus, which interact to control food intake.
The satiety mechanism is mediated by the interaction of the different serotonin 
receptors in both the raphe nuclei and the PVN. Deactivation of the 
somatodendritic 5HTla autoreceptors increases neuronal firing in the raphe nuclei, 
resulting in decreased food intake which is mediated by several interactions.
(1) The increased release of serotonin in the raphe nuclei leads to decreased DA 
release from the D2 receptors in the LH.
(2) The increased serotonin release in the raphe nuclei stimulates the 5HTlb 
receptors thereby inhibiting (a) the a 2 noradrenergic receptors in the PVN 
(Liebowitz, 1978); (b) the P2 adrenergic receptors in the LH; and (c) the D2 
receptors in the LH, so leading to a decrease in food intake.
(3) The increased 5HT release from the raphe nuclei increases the stimulation of 
the 5HT2c postsynaptic receptors in the VMN hence inhibiting food intake.
[A small number of peptides also increase food intake eg p endorphins (Sanger,
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1981), dynorphin, neuropeptide Y, peptide YY and galanin; acting in conjunction 
with 5HT, noradrenaline and dopamine in the expression of appetite].
2.8 Serotonin and Its Role in the Control of Appetite for Specific 
Macronutrients
In the past decade, research has focused on the role of neurotransmitter precursors 
in the control of appetite for specific macronutrients (eg Anderson, Li and 
Glanville, 1984). In addition to its postulated anorectic action and its role in the 
structure of feeding, 5HT has also been implicated in the control of macronutrient 
intake, in particular protein and carbohydrate (Wurtman, 1983). Increased central 
serotonin synthesis has been associated with a decrease in consumption of 
carbohydrate foods (Wurtman et al, 1985) compared to protein or fat intake 
(Wurtman & Wurtman, 1979). Conversely when brain 5HT levels have been 
pharmacologically reduced, the opposite effect occurs, with a severe reduction in 
protein intake (reviewed by Wurtman, 1987). Serotonin is therefore believed to 
affect appetite for carbohydrate and protein macronutrients; by the effect of 
circulating levels of amino acids that determine the ratio of tryptophan to the large 
neutral amino acids which influences central serotonergic synthesis. Two theories 
have been proposed for the role of serotonin in both the short term and long term 
control of macronutrient selection. Firstly that the acute selection of carbohydrate 
will depend on the diet's effect on brain 5HT synthesis (Wurtman & Wurtman, 
1988). Secondly that the chronic selection of dietary protein is related to the dietary 
effects on 5HT synthesis (Woodger et al 1979 as cited in Femstrom, 1987).
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Both Femstom and Wurtman (1973) and Yokogoshi & Wurtman (1986) have 
suggested that serotonergic neurones are 'ratio sensors' of food induced changes in 
plasma amino acid composition and that they produce more or less 5HT dependent 
on the food digested. They suggest the existence of a bio-behavioural loop ie that 
food consumption affects brain biochemistry, which in turn affects food 
consumption as the brain makes choices about what specific portions of 
carbohydrate/protein should be consumed next.
Numerous studies have shown that pharmacologically adjusting serotonin levels can 
provide an effective tool in the management of hunger and eating patterns. Studies 
have identified that serotonergic indirect agonists eg fenfluramine, do reduce 
carbohydrate snacking between meals in healthy subjects, obese "carbohydrate 
cravers" (Wurtman, 1988; Wurtman et al, 1981 and Wurtman & Wurtman, 1988) 
and in patients with seasonal affective disorder (SAD; O'Rourke et al, 1989). These 
studies have received criticism for their methodology (eg see Blundell and Hill, 
1987); for example in the study performed by Wurtman et al (1981) the subjects, 
carbohydrate cravers, received fenfluramine and although the results did show 
reduced intake of carbohydrate snacks, the study did not demonstrate a truly 
selective effect on carbohydrate cravings. All the snacks available were not only 
high in protein or carbohydrate but were also high in fat, a variable not measured 
in their study. In addition their criteria for identifying carbohydrate cravers was not 
defined and the subjects participating in the study responded to an advert (ie a 
biased population) so that it could not be certain that all subjects were specifically
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carbohydrate cravers.
Although the majority of fenfluramine studies do indicate that carbohydrate 
consumption and cravings were altered, it still does not provide definitive evidence 
that this is mediated via central serotonin metabolism. If this were the case, then a 
rise in the plasma ratio of tryptophan to the large neutral amino acids (T/LNAA) 
would be expected after a carbohydrate rich meal. However, Wurtman et al (1989) 
and Rosenthal et al (1989) did not find any difference between the clinical and 
control groups. The catecholamines, and certain peptides have also been implicated 
as playing a role in the selection of macronutrients (refer to Table 3)
Effect on Mainly Carbohydrate > Carbohydrate = Mainly Fat
Feeding Carbohydrate Fat Fat
Increase Neuropeptide Y Noradrenaline Galanin Dynorphin 
(opiod) agonist
Decrease " Serotonin
?CRF
*
Table 3 : Neurotransmitters and Neuromodulators Involved in the Selection of 
Macronutrients [From Morley, 1989]
Injections of catecholamines both peripherally and in the LH, in free feeding and 
deprived animals, resulted in a dramatic reduction in protein consumption (no 
change in either carbohydrate or fat intake was observed; Blundell and McArthur, 
1979). Human studies such as that by Blundell and Rogers (1980) subsequently 
supported this finding. It is suggested that the catecholamines in the LH, therefore 
actively potentiate carbohydrate intake but inhibit the hunger mechanism for protein 
intake. And that serotonin acts in opposition (a) directly with the a 2noradrenergic
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system of the PVN to control carbohydrate intake, but (b) indirectly with the 
catecholamines generally regarding protein intake.
Therefore although the evidence does support a role for 5HT in macronutrient 
selection, it is suggested that both serotonin (in the medial hypothalamus) and the 
catecholamines (in the lateral hypothalamus) potentially act together to control 
carbohydrate and protein intake and the ratio between these macronutrients. The 
initial theory for a sole role for serotonin has therefore been disputed (Femstrom, 
1987). Criticisms of this theory include the following (Blundell and Hill, 1987)
(1) According to Femstrom, in rat and humans, there is no known requirement for 
carbohydrate (unlike protein) so there is no physiological need for carbohydrate 
regulation. And it is suggested that protein intake is controlled by many factors.
(2) This theory has been supported by pharmacological manipulation studies. 
However, in studies using carbohydrate cravers no consistent definition has been 
used.
(3) In those studies where the protein and carbohydrate content have been 
manipulated, no account has been taken of the changes in fat content. Blundell et 
al (1992) have demonstrated that fat has a low satiating effect (ie its consumption 
does not suppress the later intake of food) and also has a weak effect on satiation, 
as demonstrated by the relative increased energy intake obtained from fat 
(compared to the control meal). As such therefore, the changing fat content will 
affect food intake.
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(4) Finally, that the majority of studies described have been carried out in the rat; 
in view of the cognitive aspects of food control, it may be difficult to therefore 
extrapolate these findings from animal studies to the human experience of eating.
2.9 Summary of the Role of Serotonin in the Control of Eating behaviour.
If serotonin does have a role in the control of eating, Blundell and Hill (1991) 
suggest that it must meet certain criteria. That is, that manipulating serotonin 
should affect food intake; that serotonergic systems must be anatomically linked to 
those areas of the brain involved in eating; and finally that there should be a link 
between nutritional status and brain activity. [Serotonin has been shown to interact 
with certain nutritional factors eg glucose, plasma amino acids and cholecystokinin; 
for example, 5HT, receptors have been shown to inhibit the activity of glucose 
sensitive neurones in the LH].
Empirical evidence, as described previously, does support a role for 5HT in the 
control of feeding at all stages of eating from ingestion, to pre and post absorptive 
operations. However, no single neurochemical is thought to be critical for the 
maintenance of all functions of appetite control, rather that a complex network of 
amines, peptides and other neuromodulators act together to achieve the balance.
The control of eating can become dysregulated at various sites (as suggested by 
Blundell, 1991) eg internally due to a defect in physiology or neurochemistry (eg 
altered enzyme regulation of changes in receptor responsivity) which could affect
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the satiety cascade, or by external factors eg changes in taste or dieting, which 
could dysregulate appetite control systems, and severe dysregulation would result 
from conditions such as chronic dieting or the behaviour seen in eating disorders, 
where the deliberate conscious alterations in food intake provide conflicting 
information to the control centres. The interaction of other factors that may mediate 
eating control could also be involved in the modulation of food intake. Pertinent to 
this study is the potential effect of the female gonadal hormones on food intake 
and eating behaviour, and will be discussed in sections 2.12 and 2.13.
2.10 Eating Behaviour in Women
The control of food intake and eating behaviour is not solely controlled 
biologically; other factors such as psychological states and environmental cues play 
a role (Chapter Six reviews the putative link between mood states and their effect 
on food intake). This following section will briefly review environmental effects on 
eating particularly the effect of Western culture on women’s relationship to food.
Since the 1960's Western Society has shown a pronounced shift towards a 
preference for a thin physique and to achieve and maintain this perceived ideal 
shape, women are more likely to control their food intake consciously through 
dieting and/or restrained eating for aesthetic reasons (Polivy and Herman, 1987). 
Indeed studies have shown that in young females and adolescent girls, dieting is 
more prevalent than not dieting and as such is now a "normal" behaviour (Polivy, 
Garner and Garfinkel, 1986). This dysregulation of eating becomes further
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perpetuated because of the action of dieting, dieters become less responsive to their 
internal physiological cues of hunger and satiety (Herman and Polivy, 1980).
The effect of dieting has been shown to have deleterious effects (reviewed by 
French and Jeffrey, 1994; Brownell and Rodin, 1994). In particular it has been 
suggested that dieting could contribute to the development of eating disorders 
(Polivy and Herman, 1985; Striegal- Moore et al, 1986; reviewed by French and 
Jeffrey, 1994), particularly binge eating or bulimia nervosa. Indeed Laessle et al 
(1989) have reviewed the literature to provide firm evidence for this link. For 
example, approximately 50% of patients with anorexia have bulimic symptoms; 
strict dieting precedes bingeing on average by 1.5 years; that approximately 80% of 
bulimics had attempted to loose weight by dieting prior to the onset of binge eating 
(Pyle et al, 1981); and that severe food restriction leads to long term bingeing even 
after weight loss has been rectified (Keys et al, 1950 as cited in Laessle et al,
1989; Polivy et al, 1994).
The relationship between dieting and overeating has been investigated using 
"restrained eaters", a concept which describes the state of chronic dietary concern 
that characterises people who believe that they should regulate their body weight 
and shape (as reviewed by Rudeman, 1986). Restrained eaters show great variations 
in energy intake indicating periods of alternate short term semistarvation (Laessle et 
al, 1989) and overeating (similar to that of a bulimic type behaviour, Schweiger et 
al, 1988). However this type of eater does not exhibit any evidence of
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psychological disturbance (ie depression, low self esteem and fears regarding 
interpersonal relationships) that characterise those with clinical eating disorders.
2.11 The Effect of Dieting on Serotonergic Function
Women are more susceptible neurochemically to the actions of dieting; with studies 
indicating a reduction in brain serotonergic functioning. Indeed, short term dieting 
has been seen to lead to a significant reduction in tryptophan available for 5HT 
synthesis in women when compared to males (Goodwin, Fairbum and Co wen,
1987; Anderson et al, 1990). Additionally, women also respond to dieting with an 
upregulation of 5HT2c receptors, which is reflected in an increased desire to eat, so 
making dieting more difficult for females. As such these results indicate that 
women may be more vulnerable to men to diet induced changes in brain 5HT 
function, an interesting finding considering the preponderance of women with 
eating disorders. (This finding could be important since women frequently become 
bulimic after a period of successful dieting). Supporting this study it has been 
shown that females do have a higher CSF basal metabolism of 5HT than men 
(Young et al, 1985) which may be reflected in the differential gender effects of 
dieting. These results indicate reduced availability of circulating tryptophan for 
brain 5-HT synthesis. Fasting and starvation have been reported to increase brain 
tryptophan and serotonin production (Schwarchz, 1991); both these activities (found 
in bulimia) are known to raise non esterified fatty acid (NEFA) levels (NEFA 
displaces tryptophan from albumin binding sites) so elevating serum tryptophan 
levels.
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2.12 Hie Effect of Female Gonadal Hormones on Eating Behaviour
Changes in food intake during the oestrous cycle have been repeatedly documented 
in non human species (Blaustein and Wade, 1976) and are thought to be mediated 
by the ovarian hormones, oestrogen and progesterone. The majority of studies have 
been carried out in laboratory rats and the important findings are > (1) that 
oestrogen appears to be the principal hormone for regulating body weight (Wade, 
1972; McCaffrey and Czaja, 1989) since food intake and body weight are reduced 
at proestrus when oestrogen levels are at their peak, and (2) that during dioestrus 
(when progesterone levels are high and oestrogen are low) food intake and body 
weight increases.
These findings suggest a causal , relationship between sex steroid levels and the 
pattern of eating, and it is logical to suspect that a similar pattern exists in human 
females. Indeed studies investigating the effects of oestrogen on food intake in the 
rhesus monkey (whose menstrual cycles resemble that of the human female with 
respect to cycle length and pattern of circulating ovarian and pituitary hormones) 
have been confirmed (Kemnitz et al 1989); however the sole effects of 
progesterone were not conclusive (Czaja, 1978) although progesterone has been 
shown to attenuate the effects of oestrogen when both hormones were administered 
at the same time (Kemnitz et al, 1989). Therefore it is suggested that oestrogen has 
an inhibitory effect on appetite; and that progesterone has a less clear effect, 
indirectly stimulating appetite by its antagonising effect on oestrogen.
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2.13 Eating Behaviour During the Menstrual Cycle
Studies assessing menstrual cycle changes in appetite are hampered by certain 
methodological problems eg incorrect phase designation, method of food intake 
assessment (especially those methods that rely on 24 hour recall or estimated 
methods, see Appendix 1) and environmental factors (weekend intake differs from 
weekday; many subjects are selected from hostels or university halls of residence 
which restrict lifestyle and eating patterns), all of which may result in skewed 
findings. However the major problem is that frequently subjects are not blind to the 
aims of the studies, which therefore could bias food intake details. In spite of these 
problems, it does appear that the menstrual cycle does modulate food intake.The 
following sections will review those studies that have investigated menstrually 
linked changes in overall energy intake and macronutrient intake.
2.13.1 Menstrual Cycle Changes in Energy Intake
Changes in energy intake during different phases of the cycle have been
documented (Dalvit, 1981; Pliner and Fleming, 1983; Manoucha et al, 1986;
Lissner et al, 1988; Lyons et al, 1989; Tarasuk and Beaton, 1991; Fong and 
Ketsch, 1993; Johnson et al, 1994). The majority of studies have consistently found 
that food intake is greater in the pre menses period compared to the post menses 
phase (see Table 4 for a summary of studies investigating energy intake during the 
cycle). The actual degree of difference intake has been reported to vary from about 
100 Kcal (Lissner et al, 1988; Tarasuk and Beaton, 1991, Fong and Ketsch, 1993) 
to 500 Kcal (Dalvit, 1981). Differences in this quantification could be due to the 
actual method of assessment employed. As can be seen from Table 4, those studies
using the accurate method of food intake ie weighed or semi weighed methods 
provide the much more conservative changes than those (Pliner and Fleming, 1983; 
Manocha et al, 1986, Dalvit, 1981) using the 24 hour recall method. In addition, it 
has been noted that menstrual cycle length changes with age (Treolar et al, 1967) 
and as the age range in studies is not standardised, this could explain, in part, the 
differences between the actual amount of energy intake noted between the different 
studies.
2.13.2 Menstrual Cycle Changes in Macronutrient Intake
Changes in macronutrient intake have been assessed quantitatively and
qualitatively.
a. Quantitative Changes in Macronutrient Intake During the Menstrual Cycle 
Several authors have examined qualitative changes in nutrient intake during the 
cycle, and the findings are presented below.
(i) Fat Intake.
Five studies to date have investigated changes in dietary fat intake during the cycle. 
No significant alterations were noted by Dalvit McPhillips (1983), Lyons et al 
(1989) nor Fong and Ketsch (1993). However, both Galiant et al (1987) and
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Author N Age
Range
No
Cycles
Cycle
Definition
Period of 
Assessment
Dietary
Method
Bias Energy
Difference
Noted
Dalvit, 1981 8 18-22 Two Menstrual
History
10 days pre menses, 
10 days post menses
24 hr recall No Post>Pre 
oviiation approx 
500 Kcal
Pliner & 
Fleming, 
1983
34 18 -41 One Menstrual
History
Preoviiation 
Postoviiation - one 
day
24 hr recall Yes Post> Pre 
ovulation 223 
Kcal
Manocha et 
al, 1986
11 22-30 Two Menstrual
History
10 days pre menses, 
10 post menses
Semi-weighed No Pre>Post menses 
by 320 cycle 
one, 305 cycle 
two
Lissner et al, 
1988
23 22- 41 One Menstrual
History
10 days pre menses, 
10 post menses
Weighed
intake
No Pre>Post menses 
by 87 Kcal
Lyons et al, 
1989
18 17-35 One [LH] for 
ovulation
For 28d cycle 
Menses 1-4 
Post menses 
Oviiation ie 4 days 
around ov.
Post ovii 
Premen
Semi-weighed No Post >Pre 
Oviiation 
186 Kcal
Tarasuk & 
Beaton, 1991
13 20-47 Mainly 4 Menstrual
History
10 day pre menses 
and 10 days post 
menses
Weighed
Method
No Pre>Post menses 
by 90Kcal
Fong & 
Ketsch, 1993
9 23-35 One Menstrual 
History +Oral 
temp
Menses 1-4 
Folliciiar 4-12 
Peri Ovriat 12 -1 5 
Luteal 16-28 
Premenstrual
Weighed
Intake
(Metabolic
Unit)
No Luteal >Foll by 
141 Kcal
Johnson et al, 
1994
26 22-39 One Serum
hormonal
levels
Perimenstrual
Follicular/
Ovulatory
Luteal
Estimated food 
weights
Yes? Luteal>Foll by 
686 Kjoties
Table 4: Summary of Studies Investigating Energy Intake During the Menstrual 
Cycle
Tarasuk and Beaton (1991) found a significant increase pre menstrually compared 
to the post menstrual stage, and Johnson et al (1994) showed a significant increase 
in the luteal stage, compared to the peri menstrual and follicular phases. Tarasuk
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and Beaton suggest that this change in actual fat intake (ie grammes/day) 
corresponds to the change in total energy intake, and as such plays an important 
role in the regulation of energy intake.
(ii) Protein Intake
The intake of protein during the menstrual cycle has been investigated, with 
inconsistent findings. Some studies have identified cyclical variations; a 
postovulatory increase (to ovulation) has been noted by Lyons et al (1989); and a 
pre menses increase (to post menses) by Galiant et al, 1987. However, others have 
not (Dalvit McPhillips, 1983; Tarasuk and Beaton, 1991; and Fong and Ketsch, 
1993).
(iii) Carbohydrate Intake.
The assessment of change in carbohydrate intake during the cycle is of special 
interest for two reasons. Firstly, that if carbohydrate intake is variable it could be 
indicative of a behavioural based mechanism to increase serotonin production. 
Secondly, that anecdotally women frequently recount they have increased appetite 
for carbohydrates (simple sugars) particularly at the premenstrual stage. A summary 
of findings are presented in Table 5 and as can be seen, the results are conflicting 
and are difficult to interpret because different phases of the cycle have been studied 
so hindering comparative analysis. However, three of these studies have indicated 
an increased consumption after ovulation but prior to menses. Both Snell et al
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Author N No cycles Cycle
Definition
Period of 
Assessment
Dietary
Method
Bias Finding
Dalvit-
McPhillips
1983
8 Two Menstrual
History
10 day pre 
menses and 
10 days post 
menses
24 hr recall No 50%
increase
Post>Pre
Lyons et al, 
1989
18 One [LH] for 
ovulation
Menses 
Post menses 
Ovulation 
Post ovul 
Premen
Semi­
weighed
No Increase in 
CHO post 
ovulatory 
and
premenses 
compared to 
ovulatory
Tarasuk &
Beaton,
1991
13 Mainly 4 Menstrual
History
10 day pre 
menses and 
10 days post 
menses
Weighed
Method
No No
significant
changes
noted
Fong & 
Ketsch, 
1993
9 One Menstrual 
History 
+Oral temp
Menses 
Follicular 
Peri Ovulat 
Luteal
Premenstrual
Weighed
Intake
(Metabolic
Unit)
No No Increase
in CHO
(simple
sugars)
during
menses
Johnson et 
al, 1994
26 One Serum
hormonal
levels
Perimenstrua
1
Follicular/
Ovulatory
Luteal
Estimated
weights
Yes Increased 
CHO in 
both luteal 
and
perimenstru 
al compared 
to follicular
Table 5: Summary of Studies Investigating Carbohvdrate Inta ce During the
Menstrual Cvcle
(1920) and Wakeham (1923) (both cited in Dalvit McPhillips, 1983) and Webb 
(1986) reported increased basal metabolic rate (BMR) premenstrually (which 
dropped rapidly at the onset of menstruation) and suggests that an increased
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consumption of carbohydrates might reflect an actual physiological requirement. 
Additionally, Dalvit-Mc Phillips (1983) suggested that carbohydrate consumption is 
influenced by the appetite suppressing effect of oestrogen; oestrogen levels are 
comparatively lower in the luteal phase when carbohydrate consumption was 
notably increased. The following section will provide other evidence in support of 
this (from studies assessing food preferences or cravings during the cycle).
(bl Qualitative Changes in Macronutrient Intake During the Menstrual Cycle 
The previous section has identified that quantitative studies have provided evidence 
for cycle linked changes in food choice. Qualitative studies have investigated 
preference for food types, on the basis that gonadal hormones may alter taste and 
perception, and therefore preference, for specific foods. Increased preference and a 
taste for sweet food, specifically, has been noted in the post ovulatory stage (when 
oestrogen and progesterone were both at high levels) compared to the pre ovulatory 
stage (Bowen and Grunberg, 1990). However, Tomelleri and Grunewald (1987) did 
not find any changes in high sugar or high starch preferences during the cycle.
Food cravings may provide a more accurate reflection for 'hunger' for food or for a 
particular choice of food. An increase in food cravings has been noted in the luteal 
stage (Cohen, Sherwin and Fleming, 1987) specifically for chocolate (at menses) 
(Tomelleri and Grunewald, 1987). Cravings though, may be a reaction to negative 
mood change (Bancroft and Backstom, 1985) suggesting the possibility that 
dysphoric mood may be responsible for the link between hormonal variation and 
food intake in women (see Chapter Six). However both Cohen, Sharwin and
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Fleming (1987) and Bancroft, Cook and Williamson (1988) did not find any 
significant correlates between mood and food cravings. As such it has been 
suggested that the basis for craving is of a biological nature be it hormonal (ie due 
to the effects of oestrogen on appetite) or due to hypoglycaemia (Bancroft and 
Backstrom, 1985) which is characterised premenstrually.
2.14 Disturbances in the Link Between Hormonal Changes and Eating Control
It does appear that therefore that the changing hormonal levels of the menstrual 
cycle do affect eating control but that the mechanisms require clarification.
Evidence has shown that alterations in the normal pattern of hormonal levels does 
lead to a dysregulation of eating, as discussed below.
(1) Disturbances of the menstrual cycle are common in women suffering from 
eating disorders (which are obviously characterised by grossly disturbed appetite 
regulation) and in anorexia nervosa the absence of menstrual cycles (amenhorrea) is 
indeed one of the criteria needed for its diagnosis (DSMIV). In addition, Kriepe et 
al (1989) showed that women with "subclinical eating disorders" (ie no diagnosable 
eating disorders but EAT scores >19) had increased rates of amenorrhea. Although, 
menstrual function is dependant to a certain degree on body weight (Pirke et al, 
1985), this is not the sole determining factor. In bulimia nervosa, menstrual cycles 
are frequently irregular or non existent but body weight is frequently normal.
Stewart et al (1990) identified that approximately 8% (a rate of approximately 2 -4 
times that of the general population) of infertile women met the criteria for eating
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disorders (60% from anorexia and 40% from bulimia), and another 8% had 
disturbed eating indicating that infertile women with menstrual abnormalities are at 
a much higher risk from suffering from an eating disorder
(2) In addition McClusky et al (1991) identified a link between the endocrine 
disorder polycystic ovarian disorder (PCOD, characterised by oligomenhorrea or 
amenhorrea) and binge eating. Both PCOD and binge eating are common in the 
female population of Western countries; the incidence of PCOD has been 
estimated in the region of 26% (Poison et al, 1988) and binge eating at 21% 
(Fairbum & Cooper, 1984). Of the patients with PCOD it was demonstrated that 
one third had abnormal eating patterns and 6% were suggested to have clinical 
diagnosable bulimia;
(3) The process of restrained eating seems to effect the menstrual cycle (Schweiger 
et al, 1992 demonstrated that 75% of restrained eaters had abnormal cycles), 
although the degree of dietary restraint is important: mild dieting does cause 
menstrual irregularities but does not suppress LH secretion (Pirke et al, 1985). The 
likelihood of irregularities increases with greater weight loss, the rate of weight 
loss, the younger the age when dieting starts and if women are vegetarian (Pirke et 
al, 1989). The mechanism by which dieting (or restrained eating) and menstrual 
function are linked are unclear; it could either be that the diet induced effects on 
follicular and corpus luteum development are centrally mediated or that dieting 
causes the impaired ovarian function.
The co-occurrence of eating problems and menstrual problems does therefore seem
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to suggest a relationship between female hormonal levels and eating behaviour, 
presumably controlled at the hypothalamic-pituitary-gonadal axis. However, other 
factors such as generalised emotional stress or erratic dietary intake or excessive 
exercise, may play a role in this relationship too.
2.15 Conclusion
This chapter has reviewed those aspects involved in the control of food intake. The 
neurotransmitter serotonin has been shown to have an inhibitory effect on food 
intake by causing satiety. Women are more vulnerable to changes in serotonin 
metabolism. In addition, Clifford et al (1995) has recently demonstrated that short 
term dieting leads to a reduction in tryptophan levels and in addition to an increase 
in post synaptic 5HT2c receptor sensitivity (which could indicate a compensatory 
mechanism due to decreased 5HT neurotransmission). Alterations in 5HT2c receptor 
during dieting could therefore lead to impaired satiety and could explain why some 
women show adverse psychological responses to dieting.
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CHAPTER THREE
THE METABOLISM OF TRYPTOPHAN
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3.0 Introduction
Tryptophan is a dietary essential aromatic indole amino acid, and is the precursor 
of serotonin, an established neurotransmitter in the central nervous system, first 
identified by Hopkins and Cole in 1901. As with other amino acids, tryptophan 
occurs naturally in the laevo (1) enantiomer form. It is used primarily in the body 
for protein synthesis although a small proportion is metabolised in humans by three 
catabolic pathways (refer to Figure 4). One of the minor pathways (quantitatively), 
is of great interest in behavioural and psychiatric studies since it leads to the 
production of serotonin, a neurotransmitter indicated to play a major role in the 
regulation of a variety of behaviours such as mood (Wurtman, 1988), appetite 
(Blundell, 1984), and aggression (Brain et al, 1982); and additionally has also been 
shown to be involved in normal physiological functions such as pain, sleep and 
sexual behaviour (for an overall review see Sandyk, 1992). The role of serotonin 
has therefore been described in a whole gamut of clinical conditions, in particular 
the affective disorders (Coppen, 1967; Murphy, 1990) (see Table 6), modulating 
mood states through the its numerous receptor subtypes. As such, tryptophan plays 
an important regulatory role as the precursor of serotonin. This thesis will be 
concentrating on the role of tryptophan metabolism during the menstrual cycle in 
relation to eating control and the following section will address some of the general 
methodological problems encountered with tryptophan metabolism research in the 
behavioural sciences.
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Conditions
Affective Disorders (eg Coppen, 1967; Wurtman, 1988)
Obsessive Compulsive Disorder (eg Saxena, 1995)
Suicidal Behaviour (eg Roy and Linnoila, 1988)
Aggressive Behaviour (eg Brown et al, 1979)
Eating Disorders (eg Liebowitz, 1990)
Alcoholism (eg Roy et al, 1990)
Panic Disorder (eg Ballenger et al, 1988)
Seasonal Affective Disorder (eg Rosenthal et al, 1989 )
Anxiety (eg Murphy, 1990)
Table 6.Conditions in which alterations of 5HT metabolism have been described
3.1 The Investigation of Tryptophan and its Metabolites in Behavioural and 
Psychiatric Studies
Studies investigating the role of tryptophan metabolism especially central
serotonergic activity in specific behavioural or psychiatric disorders in humans, are 
limited by certain methodological problems. The main problem that exists it that it 
is not possible to directly gain access to the brain (with the exception of post 
mortem studies although metabolic degradation limits the time available for 
investigation). In spite of this limitation, numerous studies have provided evidence 
for the role of serotonin in behaviour using certain indirect methods.
To study the role of serotonin in behaviour, several methods are commonly 
employed and include :
(1) measuring the concentration of the precursor (ie tryptophan), serotonin or its 
metabolite (5 hydroxy indole acetic acid, 5HIAA) in biological fluids [ie 
cerebrospinal fluid (CSF), blood platelets, plasma or urine] to gain some index of
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functional changes when compared to a healthy control population. Due to its close 
contact with the brain, CSF obtained from lumbar punctures, is considered the best 
reflection of central 5HT activity; the biochemical composition of this fluid reflects 
an area of the nervous system which is innervated by descending 5HT fibres. 
However the collection of CSF is obviously not commonly employed. Frequently, 
peripheral models of serotonergic cells such as blood platelets [considered a good 
reflection of synaptic uptake (Da Prada et al, 1988)] are used where differences in 
concentration, activities of the enzymes, 5HT receptor activation as well as 
imipramine binding activity, can be measured directly.
(2) Alternatively, the activity of the enzymes involved in the synthesis of 5-HT can 
be determined (using kinetic studies employing probenecid, or by dynamically 
challenging the enzymes with agonists, antagonists, receptor blockers or reuptake 
inhibitors). Until recently problems were associated with this method as the 
pharmacological compounds employed were not "clean" having uncontrollable 
effects on other neurotransmitter systems. The use of loading studies (ie the 
administration of precursors to assess dynamic changes in metabolite 
concentrations) are also not ideal. Precursors such as tryptophan or 5 hydroxy 
tryptophan (5HTP) need to be absorbed, carried into the cell, transformed into 5HT 
and released. Only 1% of orally administered tryptophan reaches the brain and 
parenteral administration is difficult. Additionally, there are well recognised links 
between 5HT and other neurotransmitter pathways and drugs that alter 5HT may 
therefore inevitably produce changes in other brain pathways. More recently the
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use of nutritional challenge studies have been carried out (eg Young et al, 1985; 
Oldman et al, 1994) in which diet is manipulated to increase or decrease the uptake 
of tryptophan.
Neuroendocrine challenge studies have also been employed to assess central 
serotonergic activity, albeit indirectly. This method is based on the fact that if a 
chemical (known to influence serotonergic activity) is administered then it will 
result in altered release of a hormone that is believed to be under serotonergic 
control (reviewed by Van Praag, 1986). However, this strategy is based on two 
assumptions; firstly that the challenge is 5HT selective, and secondly that 5HT 
plays a significant and direct role in the control of the marker hormone. Van 
Praag, Lemus and Kahn (1987) have reviewed those studies that have used 
prolactin, cortisol and growth hormone as a probe of central 5HT activity. They 
concluded that as yet no reliable hormonal probe for 5HT exists due to (1) the lack 
of selectivity of the 5HT precursors used (which influence catecholamine 
metabolism particularly in high doses); and (2) that comparison amongst studies is 
difficult due to variation in the dose and route of administration.
Therefore there are a variety of methods commonly employed to investigate the 
role of serotonin in behavioural and psychiatric disorders. A combination of both 
pre and post receptor challenges could provide the most beneficial method, 
obviously dependant on the sensitivity of the post synaptic receptor. Future 
research still needs to distinguish between presynaptic and postsynaptic indices
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(van Praag et al, 1987). At present, presynaptic 5HT function can be evaluated 
using tryptophan, 5HTP and fenfluramine; postsynaptic 5HT function, assessed 
using direct 5HT receptor agonists (eg mCPP) or agents selective for one 
subreceptor (eg 5HTla agonists such as buspirone and gepirone).
In recent years, serotonergic probes have been developed that specifically select 
target enzymes and receptor subtypes causing stimulation and inhibition within the 
CNS. One of the major advances has been the synthesis of selective serotonin 
receptor inhibitors (the group of chemicals known as SSRI's eg fluoxetine, 
setraline, paroxetine and fluoxamine; Fuller and Wong, 1990). These compounds 
act to specifically inhibit the membrane uptake carriers that transport serotonin 
from the synaptic cleft back into the nerve terminal, thereby increasing 5HT 
concentrations in the synaptic cleft (demonstrated by in vivo histochemical and 
voltametric technique^ Turnover is also decreased (as identified by a decrease in 
5HIAA levels) and is accompanied by decrease in firing rates of serotonin neurones 
and increased activation of the postsynaptic receptors. These inhibitors also effect 
serotonin uptake carrier systems present on glial cells and blood platelets; blood 
platelets cannot manufacture their own serotonin and therefore the carrier is the 
only way in which platelets can acquire serotonin. The effect of these carrier 
inhibitors on platelets leads therefore to a depletion of platelet and whole blood 
concentration of 5HT.
Once biochemical measures have been obtained there is then the subsequent
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problem in relating it to behavioural and psychopathological data. In recent years, 
specific biochemical indices have been shown to correlate with certain symptoms 
(Freyhan, 1979), independent of any clinical diagnosis and can explain why 
changes in one particular neurotransmitter can be involved in many 
psycho(patho)logical features. For example, suicidal behaviour with low levels of 
the metabolite of serotonin, 5HIAA (Nielsen et al, 1994; Asberg, Traskman and 
Thoren, 1976) delusions with high levels of the metabolite of noradrenaline, 
homovanilic acid (HVA); psychomotor inhibition with low concentrations of HVA 
and low levels of monamine oxidase (MAO) platelet activity with impulsivity and 
higher degree of sensation seeking (Von Knorring et al, 1984).
3.2 The Metabolism of Tryptophan and its Regulation
Tryptophan enters the circulatory system from two main sources, from protein 
ingestion and from efflux from the bound and free tryptophan pools in tissues. 
Tryptophan plasma levels are reduced by its uptake into tissues, by metabolism in 
the liver and to a minor extent by excretion in urine. Tryptophan, serotonin and the 
kynurenines exhibit diurnal rhythms (Femstrom & Wurtman, 1971b; Bonner and 
Brien, 1993), with tryptophan and serotonin peaking in mid-afternoon, independent 
of dietary consumption. Tryptophan is metabolised in man by three different 
catabolic pathways (see Figure 4). Generally only 20% of available peripheral 
tryptophan is available for metabolism, the majority being used for protein 
synthesis. Ninety per cent of tryptophan is bound covalently to serum albumin 
(McMenamy and Oncley, 1958) to maintain free blood tryptophan levels at a
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Figure 4. The Metabolic Pathways of Tryptophan Metabolism in Man
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constant 10% since only free tryptophan can pass across the blood-brain barrier 
(BBB; Curzon & Knott, 1974). Tryptophan can be displaced from albumin to 
increase brain uptake; factors affecting its binding to albumin include: -
a. Plasma Non Esterified Fatty Acids (NEFA) levels, which when raised (eg after 
food deprivation) displace tryptophan from its albumin binding sites (Curzon et al 
1973).
b. Insulin Insulin reduces plasma free tryptophan by reducing NEFA levels (via 
reduced cAMP) so removing the competition for albumin binding sites (Curzon and 
Knott, 1974). In addition, since insulin decreases plasma amino acid levels, 
relatively more tryptophan is available to cross the BBB (Femstrom and Wurtman, 
1972).
c. Kynurenine levels Kynurenine (KY), 3 hydroxy kynurenine (HK) and 3 hydroxy 
anthranilic acid (HA) are all extensively bound to plasma albumin under normal 
physiological conditions and can displace tryptophan (Bender, 1982) increasing 
plasma free levels. In addition, KY also competes with tryptophan for entry across 
the blood brain barrier.
d. Acid - Base effects Yuwiler et al (1977) demonstrated that binding of 
tryptophan to serum albumin is pH dependant, with maximal binding at pH 7.6. 
Decreasing the pH to 6.8 (which could occur as a result of metabolic acidosis) 
leads to a steady decrease in tryptophan binding.
The next section will review the two metabolic pathways of interest to this thesis ie 
the tryptophan pyrollase (referred to as the kynurenergic pathway) and tryptophan 
hydroxylase (ie referred to as the serotonergic pathway) pathways, with mention of
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the factors that will effect their regulation.
3.3 The Kynurenine Pathway of Tryptophan Metabolism
The metabolism of tryptophan to kynurenine (via formyl kynurenine) is, under 
normal conditions effected by the enzyme tryptophan pyrrolase, and is regulated as 
discussed in detail below (see Figure 5). This is quantitatively the most important 
metabolic pathway of tryptophan, with 90% of available tryptophan (TRY) being 
metabolised via this route. Under normal physiological conditions the end products 
include the nicotinamide nucleotides and acetyl Co A which is oxidised (via the 
Krebs cycle) to C 02 and water. Only when the Krebs cycle is saturated will denovo 
synthesis of NAD (nicotinamide adenine dinucleotide) occur, this then being the 
final product of tryptophan metabolism. However before concentrating on this 
enzyme, it is additionally important to note that an alternative enzyme, indoleamine
2.3 dioxygenase (IDO) is present in mammals that is also capable of cleaving the 
indole ring of tryptophan (Taylor and Feng, 1991).
Tryptophan is metabolised to formyl kynurenine in the presence of tryptophan 
pyrrolase (also referred to as tryptophan 2,3 oxygenase EC 1.13.11.11), the rate 
limiting step of this oxidative pathway. The enzyme is specific for the laevo form 
of tryptophan and has a very short half life (ti/2 = 2 hours). It is dependant on the 
presence of haem and molecular oxygen. This enzyme was initially identified in the 
liver but has subsequently been found within the CNS (Gal and Sherman, 1978). 
The enzyme is regulated by several mechanisms (as reviewed by Badawy, 1977) :
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Figure 5. The Kynurenine Pathway of Tryptophan Metabolism
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(11 Induction bv hormones. For example, (a) Glucocorticoids which act at both 
transcriptional and translational levels, increasing the rate of synthesis of mRNA 
and therefore the enzyme protein, (b) Glucagon acts at the translational level, 
increasing the rate of conversion of existing mRNA to protein. However glucagon 
only exerts its inducible effects when in the presence of its substrate, tryptophan.
(c) Oestrogens (including the contraceptive pill and hormone replacement therapy) 
act indirectly by increasing the uptake of glucocorticoids into the liver.
(2) Precursor stimulation. The enzyme has two tryptophan binding sites, one 
specifically for tryptophan and another with a broader specificity. Bound 
tryptophan stabilises the enzyme preventing it from catabolism by proteolytic 
enzymes and as a result increases its half life.
(3) Availability of haem. The major percentage of the enzyme is generally found 
in an inactive apo form. The presence of haem converts the enzyme from the apo 
to its active, holoenzyme form.
(4) Product Inhibition. A number of intermediate metabolites will significantly 
inhibit tryptophan being metabolised under normal physiological conditions and 
include KY, HK and HA.
Formyl kynurenine once formed is immediately decarboxylated by the highly active 
enzyme kynurenine formamidase to kynurenine. KY can then be metabolised by 
either (Bender and Me Creanor, 1982):-
(i) cleavage to anthranilic acid (AA, by the enzyme kynureninase) and pyruvate
(ii) hydroxylation to HK (by the enzyme kynurenine hydroxylase) followed by
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cleavage to HA (by the action of kynureninase) and pyruvate or
(iii) transamination and ring closure to xanthurenic acid.
Under normal conditions, the preferred route for KY catabolism is to HK and then 
to HA; (the synthesis of xanthurenic and kynurenic acid is rare unless conditions 
such as tryptophan loading, or highly increased activity of tryptophan pyrrolase are 
present).
Several enzyme reactions in this major pathway require pyridoxal phosphate as 
coenzyme, which is derived from vitamin B6. Under normal conditions, the 
production of xanthurenic acid by transamination is rare. However deficiency of 
vitamin B6 results in the production of high concentrations of xanthurenic acid 
(rather than HA) which can easily be detected in urine. Kynurenine 
aminotransferase, the enzyme responsible for the production of xanthurenic acid, is 
also pyridoxal phosphate dependant but as it is contained in the mitochondrial 
regions of the hepatocytes it is protected from cofactor depletion. (Kynureninase on 
the otherhand is found in the supernatant region of hepatocytes). Administration of 
vitamin B6 will prevent the abnormal accumulation of xanthurenic acid and hence 
will concede the metabolism of HK to HA. So under normal physiological 
conditions, HA is oxidised rapidly to acroleyl aminofumerase. This metabolite can 
then be metabolised in either of the following ways.
1. Decarboxylated to produce acroleyl aminofumerate, which is then further
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metabolised via amino muconic semialdehyde to produce carbon dioxide and water. 
Aminomuconic semialdehyde can also be non enzymatically converted to picolinic 
acid (a compound essential for the absorption of zinc in the intestines) although 
significant amounts are only produced when this pathway is overloaded.
2. Alternatively, HA can undergo nonenzymatic cyclisation to quinolinic acid (QA), 
the precursor of nicotinamide nucleotides (see Figure 5) although is only formed to 
a significant extent when the enzymatic pathway is saturated (ie the enzyme 
picolinic carboxylase is saturated). The majority of NAD is however produced from 
the dietary intake of niacin (nicotinic acid and nicotinamide). There is 
competition between these two pathways and generally the majority of acroleyl 
aminofumerate is enzymatically converted to carbon dioxide and water, rather than 
down the alternative pathway that results in the production of NAD.
3.3.1 Cerebral Sources of the Kynurenine Metabolites
In 1970, Green and Curzon first reported that kynurenines were capable of reducing 
brain serotonin concentrations by competing with tryptophan on the blood-brain 
barrier (BBB) carrier transporter. Further studies demonstrated that kynurenine and 
its metabolites exist in the brain (Gal and Sherman, 1978; Joseph and Kadam,
1979). The presence of these metabolites therefore arises from two sources and it is 
difficult to precisely separate the source from either
(a) extracerebral sources ie the flux of KY from plasma into the brain (which has 
been shown to account for 60% of cerebral concentrations of these compounds).
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Fukui et al (1991) confirmed that kynurenergic metabolites (KY, HK and AA) 
cross the BBB on the same carrier system as tryptophan, but under normal 
conditions would not inhibit tryptophan uptake, as these metabolites only occupy 
0.004% of the carrier system. Other kynurenergic metabolites ie QA, HA and 
kynurenic acid have limited crossing. Indeed cerebral HA (and therefore QA) is 
produced from AA (Baran and Schwarz, 1990; Fukui et al, 1991) by cerebral 
biosynthetic enzymes.
(b) intracerebral sources, from the metabolism of tryptophan to kynurenine 
centrally. The presence of cerebral tryptophan pyrollase was first identified in 1966 
(Gal, Armstrong and Ginsberg 1966). To date the existence of KY, HK, AA and 
QA have all been identified as being metabolised in the CNS, confirmed by the 
discovery of the key pathway enzymes in brain tissue (Fukui et al, 1991); therefore 
having implications for cerebral serotonergic synthesis.
To date the physiological and biochemical effects of cerebral kynurenine 
metabolites remain largely unknown; however, it does appear that they do interact 
with the monoamines and their precursors and as such may play an important 
neuroregulatory role within the CNS, in particular with reference to serotonin (Gal 
and Sherman, 1980). The existence of the kynurenine pathways in the brain 
therefore emphasises the importance of the interplay between the biochemical 
systems and difficulty in interpreting behavioural consequences of their 
manipulation; with the recent advances it would be of interest to assess the effects 
of the kynurenergic metabolites on serotonin metabolism. To date research has
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been limited in investigating the importance of the peripheral and endogenous 
kynurenine metabolites which interplay with the serotonin system.
3.4 The Serotonergic Pathway of Tryptophan Metabolism
The conversion of tryptophan to serotonin occurs in several tissues throughout the 
body (90% is located peripherally) including the enterochromaffin cells of the gut, 
enteric neurones, blood platelets (see Table 7 for physiological levels) and the 
CNS. In the periphery, 5HT inhibits gastric acid secretion, stimulates intestinal 
secretion of water and electrolytes, and affects gut motility and peristalsis as well 
as gut hormone release. It is the main secretory product of carcinoid tumours, 
where it may account for gut symptoms such as diarrhoea. The catabolism of 
tryptophan to serotonin is quantitatively of minor importance; however in the 
CNS, serotonin functions as a neurotransmitter and is believed to be important in
mediating several behaviours.
Bodily Fluid Mean (SD) Median Range Sample Size
Plasma 5HT (ng/ml plasma) 0.93 (0.67) 0.74 0.12 - 3.32 166
Plasma 5HIAA (ng/ml plasma) 6.8 (2.3) 6.3 2.6 - 14.1 166
Whole blood 5HT (ng/ml blood) 187 (78) 182 32 - 437 175
Platelet 5HT(ng/109 platelets) 711 (319) 649 104 - 2426 172
PUI whole blood 5HT/plasma 5HT 295 (223) 227 57 - 1442 166
PUI platelet 5HT/plasma 5HT 1128 (827) 965 208 - 4888 163
where PUI = platelet uptake index
Notes The levels show that 5HT is mainly concentrated in platelets due to high affinity uptake mechanisms on the platelet 
wall. The existence of both plasma and platelet pool of 5HT; with plasma pool having rapid turnover and affected by short 
term changes in 5HT physiology (ie synthesis, inactivation, uptake etc) whilst the platelet pool is a reserve, slow turnover 
pool effected by sustained changes. Therefore using both plasma and platelet 5HT it is possible to study the different aspects 
of 5HT physiology.
Table 7: Serotonin concentrations in Bodily Fluids (Adapted from Ortiz, Artigas 
and Gelpi, 1988)
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Tryptophan is hydroxylated to 5 hydroxytryptophan by the rate limiting enzyme, 
tryptophan hydroxylase. This enzyme is biopterin dependant, and requires the 
presence of molecular oxygen (see below) (Gal, Armstrong and Ginsberg, 1966).
In normal physiological conditions this enzyme functions below saturation, and 
indeed normally only 10 - 25% of the enzymes capacity is used. (Normal 
concentration of brain tryptophan is 5 - 25 pmol/kg, although its concentration is 
increased in localised areas of the brain such as the raphe nuclei where 
serotoninergic neurones proliferate). As a result, increased tryptophan concentration 
leads to a proportional rise in serotonin production. Tryptophan hydroxylase is 
present in neurones, melatonin producing cells and gastric mucosal cells. It is 
inhibited by excess tryptophan, catecholamines and compounds that chelate iron. 
Recent evidence has shown that a genetic element may play a role in the 
expression of this enzyme. Nielsen et al (1994) demonstrated a relationship 
between the genotype of the gene that encodes for the enzyme and low CSF 
5HIAA levels, in a group of impulsive alcoholic violent offenders. Although no 
relationship was identified with particular behaviour (eg impulsivity) or psychiatric 
disorder, the results suggest a genetic susceptibility to impaired serotonin synthesis 
and metabolism that may be expressed behaviourally providing valuable insights 
into other neuropsychiatric disorders.
5 hydroxytryptophan (5HTP) is decarboxylated to serotonin in the presence of the 
enzyme 5HTP decarboxylase (which is capable of acting on both 5HTP and 
1-dopa). Serotonin is metabolised by neuronal type A monoamineoxidase (MAO) to 
an intermediate aldehyde, 5 hydroxy indole acetaldehyde (Figure 6). Two
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isoenzymes of MAO exist in the central nervous system, type A acts on serotonin 
and is inhibited by clorgyline, and type B preferentially acts on phenylalanine and 
catecholamines, although it will oxidise serotonin but not under normal 
physiological conditions. The aldehyde intermediate is metabolised to 5 hydroxy 
indole acetic acid (5HIAA) by aldehyde reductase.
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Figure 6. The Serotonergic Pathway of Tryptophan Metabolism
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3.5 Hie Regulation of Serotonin levels
The production of CNS serotonin is affected and regulated by a number of factors, 
as described below.
(1) Precursor Availability
Brain 5HT is synthesised from the dietary essential precursor tryptophan. The 
affinity of tryptophan hydroxylase for its substrate is low and as the concentration 
present in neurones is not sufficient to saturate the enzyme, brain 5HT production 
is normally limited by availability of tryptophan, although not solely (as will be 
discussed). Brain 5HT levels do not however depend solely on plasma tryptophan 
concentration (Femstrom & Wurtman, 1971a) but on a competitive facilitated 
diffusion carrier system transporting tryptophan into the CNS.
(21 The Blood-Brain barrier facilitated carrier system
Tryptophan competes with other plasma large neutral amino acids (LNAA, which 
include tyrosine, phenylalanine, leucine, isoleucine and valine) for transport into the 
CNS (Femstrom & Wurtman 1972) to enable the synthesis of serotonin. This 
LNAA carrier system is one of seven other such systems that exist to transport 
substrates across the BBB. It is a facilitated diffusion system, having poor affinity 
for its ligands and is relatively unsaturated when LNAA levels are at their normal 
concentrations. The cerebrovascular LNAA carrier is sodium independent, 
equilibrative and facilitates the exchange of 10 or more amino acids between 
plasma and brain. Affinity is greatest for the amino acids with large neutral side 
chains, for example, leucine, tryptophan and phenylalanine (Smith et al, 1987).
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Kynurenergic uptake is also mediated by this carrier mechanism.
(3) Competition from the LNAA's
Because of the competitive nature of this uptake system, brain levels of tryptophan 
are determined therefore not only by the activity of hepatic pyrollase and insulin, 
but also by physiological variations in the concentrations of competing neutral 
amino acids (Femstrom & Faller, 1978; Gessa et al, 1974). Individual amino acids 
effect the uptake of brain tryptophan from blood to different degrees (Yuwiler et 
al, 1977), the order of inhibition being
leucine > tyrosine > threonine > phenylalanine = histidine > isoleucine = methionine > valine
Thus dietary proteins and carbohydrates will influence serotonin levels directly.
(41 Dietary Factors
A high carbohydrate diet has been shown to increase the tryptophan to LNAA ratio 
(T/LNAA), resulting in the elevation of brain tryptophan and therefore brain 5HT 
levels (Femstrom and Wurtman, 1971a). Carbohydrate consumption elicits insulin 
secretion which increases the uptake of the other LNAA into skeletal muscle for 
protein synthesis (Martin du Pon et al, 1982). Conversely a high protein diet will 
decrease the ratio leading to a decrease in brain tryptophan levels and hence a 
reduction in brain 5HT synthesis (Femstrom and Wurtman 1972). The consumption 
of a mixture of both protein and carbohydrate will alter the ratio (and therefore the 
uptake of tryptophan into the brain) and depends upon the relative amount and
type of protein in the meal. [A very small concentration of certain proteins, eg 5% 
casein can block the dietary carbohydrate mediated rise in the tryptophan ratio 
(Yokogoshi & Wurtman, 1986)]. Dietary proteins are much richer in the other 
LNAA’s than in tryptophan (which accounts for only 1 - 1.5 % of protein) in 
particular the branched chain amino acids, leucine, isoleucine and valine. So a 
high protein meal decreases the T/LNAA ratio leading to reduced 5HT 
production. Protein ingestion of 18 - 24% of energy does not modify the ratio nor 
brain tryptophan concentrations.
Brain tryptophan levels are also determined by the ratio of bound to unbound 
tryptophan concentrations. Femstrom et al (1979) suggest that total tryptophan is 
more valid since tryptophan has a higher affinity for the transport carrier than 
albumin (Yuwiler et al, 1977); bound tryptophan can be readily stripped from 
albumin binding sites as they pass through the brain capillary circulation. 
Therefore tryptophan can be transported in blood, bound or free but almost all is 
accessible for brain transport (Femstrom, 1979).
(5) Sex Differences
Plasma whole blood and platelet 5HT have been identified as being significantly 
higher in females whereas plasma 5HIAA was higher in the males (Ortiz, Artigas 
and Gelphi, 1988). This indicates enhanced 5HT synthesis and/or uptake in the 
female but decreased metabolic degradation in females as compared to males. Sex 
differences within the LNAA's have also been demonstrated (Armstrong and Stave,
68
1973 in Errikson et al, 1989)
T61 Circadian Effects
The uptake of 5HT in platelets is suggested to be effected by body, temperature and 
exercise since platelet uptake is a temperature dependant process. Circadian 
rhythms in plasma 5HT were noted with maximum values at 8pm, minimum at 4 
am. Circadian rhythms in plasma LNAA's have also been identified, irrespective of 
the diet consumed (Feigin et al, 1968). Kynurenergic metabolites additionally 
exhibit diurnal rhythms (Bonner and Brien, 1993).
It has been suggested by Wurtman, Hefti and Melamed (1981) that in order for 
nutrient intake to affect neurotransmitter synthesis physiological and biochemically 
mechanisms must exists. These have been described as follows:-
(1) The lack of significant feedback control on plasma levels
(2) That plasma levels of the precursor effect its influx into the CNS
(3) That the transport system mediating the flux between the blood and 
brain is relatively unsaturated
(4) That the enzyme converting the precursor to the neurotransmitter is not 
saturated
(5) Finally that there is a lack of a negative feedback from the 
neurotransmitter on the enzyme.
On the basis of these guidelines, it can be seen that tryptophan intake can affect
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brain serotonin synthesis. However, the rate at which serotonergic neurones 
produce and release serotonin is affected by tryptophan (Schaecter and Wurtman, 
1990) and therefore by manipulating the ingestion of tryptophan and the relative 
ratio of carbohydrate to protein, it would be possible to increase serotonergic 
synthesis and release.
3.6 The Indole Acetic Acid Pathway of Tryptophan Metabolism
The final pathway of tryptophan metabolism occurs in the liver and results in the 
production of indole acetic acid (IAA) in the presence of the rate limiting enzyme 
tryptophan decarboxylase (refer to Figure 4). The majority of indole acetic acid 
produced is however believed to be formed by bacterial fermentation in the colon. 
More recent evidence has shown that of the small percentage of tryptophan that 
enters the brain, some is metabolised to tryptamine (see Sandyk, 1992)
3.7 Serotonin Pathways and Receptors Within the Central Nervous System
Serotonin was first identified in nerve cells in 1962 following lesion studies 
performed by Heller et al (1962) and fluorescence microscopy (Anden et al, 1966). 
Jouvet (1969) demonstrated that by destroying the raphe system in the pons, brain 
serotonin was reduced to 10% of its normal content and concluded that the 
serotonin system is diffuse in its projections. From subsequent lesion and 
pharmacological studies the distribution of serotonin within the CNS was mapped.
The cell bodies of the 5HT containing neurones in the brain, are relatively few in
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number, and are situated in a narrow band of nuclei that run along the brain stem 
from the medulla to the midbrain, and are collectively referred to as the raphe 
nuclei. The neurones send axons to many of the higher regions of the brain but 
their distribution is not as widespread as dopaminergic pathways. The serotonergic 
neurones project throughout the CNS, including the hypothalamus, forebrain, limbic 
system, cerebellum and spinal cord. The 5HT fibres that project to the 
hypothalamus go primarily to the suprachiasmatic nucleus (involved in the control 
of the basic biological rhythms eg sleep and waking). They also project to the 
septum, hippocampus, cerebral cortex, basal ganglia and amygdala. The pineal 
gland has the highest concentrations of 5HT (and also receives innervations from 
noradrenergic fibres of the sympathetic part of the autonomic nervous system). This 
gland, although physically in the brain, it is not part of the brain, separated by the 
BBB. Serotonin is converted here to melatonin, and both 5HT and melatonin here 
are under the control of the day/night cycle. The sympathetic nerves fibres that 
exert their influence on the pineal, also control the female reproductive cycle in 
many animal species. Nerve terminals containing serotonin are located at both 
synaptic and non synaptic sites (Seguela et al, 1989) and suggest that serotonin acts 
as both a neurotransmitter and/or a neuromodulator within the CNS dependant on 
their location.
In the last decade rapid progress has been made in identifying serotonin receptors 
using a variety of selective techniques such as radioligand binding studies, 
autoradiography, second messenger analysis and recently molecular biological
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techniques. To date four families of serotonin receptors have been identified in the 
CNS and the periphery (as reviewed by Hoyer and Schoeffer, 1991; Saxena, 1995). 
In addition, recombinant receptors 5HT5a, 5HTSb 5HT6 5HT7 and "orphan" 
receptors ( ie those that have no structural information available and hence awaiting 
classification) have been identified but are not fully classified, nor their function 
known (Saxena, 1995). The 5HT receptors can be classified either
(1) Pharmacologically into 5HTj, 5HT2, 5HT3 and 5HT4 or
(2) Functionally into G protein coupled receptors (5HTl5 5HT2 and 5HT4) and 
ligand gated ion channels (5HT3). [There is an obvious parallel to be drawn 
between serotonin and acetylcholine receptors, which can be divided into 
muscarinic (G protein coupled) and nicotinic receptors (ligand gated channels)]. 
The localisation of these receptors in the CNS are identified in Table 8. The 5HTj 
receptor family presents a large heterogeneity. Six subtypes to date have been 
identified - 5HTla, 5HTlb, 5HTlc, 5HTld, 5HTle, 5HTlf (these last two are 
recombinant subtypes); and the 5HTld subtype also appears to be heterogeneous. In 
the 5HT2 receptors two subtypes have been proposed, although this is not 
conclusive. The 5HT3 receptor are composed of three subtypes but at present the 
characteristics of the subtypes have not been fully identified (reviewed by Hoyer, 
1990). The final family of receptors are the 5HT4 receptors (this nomenclature has 
yet to be confirmed as it is thought, at present, that these receptors may be better 
categorised with the 5HT/5HT2 family). The 5HT4 receptor was first identified in 
1990 and its characteristics have yet to be established (Hoyer & Schoeffer, 1991).
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The heterogeneity of the subtypes of receptors have been substantiated; with the 
application of molecular biological techniques five receptor subtypes have been 
cloned, sequenced and expressed. The subtypes are 5HTla, 5HTlb, 5HTlc, 5HTld 
and 5HT2. All the 5HTl5 5HT2, and 5HT4 receptors have been demonstrated to be 
metabotrophic ie slow acting and requiring energy, belonging to the G protein 
coupled receptor family. (5HTla, 5HTlb and 5HTld and 5HT4 receptor sites are 
coupled to adenylate cyclase and to potassium channels; 5HTlc and 5HT2 are 
believed to be linked to phospholipase C and calcium mobilisation). The 5HT3 
receptor sites are on the otherhand ionotrophic (ie fast acting) belonging to the 
nicotinic/GABAa/glycine ion gated channel receptor family.
3.8 TTie Role of Serotonin Receptor Subtypes in Modulating Behaviour
The different receptor subtypes have been shown to affect different aspects of
behaviour (see Table 8); some of the subtypes have not fully been investigated so
only those receptors with defined behavioural effects are described in Appendix 2.
In conclusion, it is clear therefore that the presence of the variety of 5HT receptor
subtypes in different brain regions have physiological and psychopathological
consequences. Of particular relevance to this thesis, eating control is considered
mediated via, in part, the 5HTla, 5HTlb and 5HT2.C receptors; and mood via 5HT3
receptors (with a possible involvement of 5HT2 receptors) and anxiety via the 
5HTla receptors.
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Receptor Type Localisation Behaviour Affected
5HTla Dorsal raphe
Hippocampus
Cortex
Antihypertensive
Feeding
Sexual behaviour
5HTlb Substantia Nigra 
Basal Ganglia
Motor behaviour 
Emotions ?
5HTlc
Chorios plexus 
Globus pallidus 
Substantia Nigra
CSF regulation 
Motor behaviour
5HTld 
5HT 2
Substantia Nigra 
Basal ganglia 
Subiculum
Claustram 
Olfactory tubercle 
Cortex
Motor behaviour 
Feeding Behaviour 
Anxiety
Emotions
Sleep
5HT 3 Dorsal vagal nerve 
Solitary tract nerve 
Trigemminal nerve 
Area postrema 
Spinal cord 
Limbic system
Anti emetic 
Learning deficit 
Addiction 
Anxiety
5HT 4 Colliculus
Hippocampus Feeding
Emotions
Table 8 The Identification of Serotonin Receptors in the Brain, and their Function 
in Modulating Behaviours
3.9 Conclusion
This chapter has reviewed some of the factors involved in the metabolism of 
tryptophan. In particular certain points are specifically pertinent to this study. 
Firstly, the majority of investigations of tryptophan metabolism require invasive 
methods eg the collection of blood and CSF. One study to be undertaken in the 
thesis, is the novel development of a non invasive collection method using saliva to 
analyse tryptophan metabolism.
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From the literature, it has been shown that the kynurenine pathway of tryptophan 
metabolism could play a putative role in the regulation of serotonin production both 
peripherally and cerebrally. The actual mechanism though has not been investigated 
to any degree. In this thesis therefore, one aim will be to investigate the role of this 
kynurenine pathway in the mediation on the serotonergic metabolic pathway.
Previous studies have suggested that the serotonergic pathway may be involved in 
effecting specific behaviour psychopathologically, independent of any clinical 
diagnosis. This hypothesis has been based on clinical groups. However, in this 
thesis this hypothesis will be applied to a non clinical group ie healthy women to 
ascertain if hormones may mediate changes in serotonergic linked behaviours 
throughout their menstrual cycles. This will obviously be dependant on the 
metabolic pathways of tryptophan metabolism being effected by changing levels of 
the female gonadal hormones. The following chapter will address the literature on 
this particular area of tryptophan metabolism to date.
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CHAPTER FOUR
THE EFFECT OF FEMALE GONADAL HORMONES ON 
TRYPTOPHAN METABOLISM
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4.0 Introduction
Numerous studies have indicated that steroids (which penetrate the BBB easily) are 
capable of modifying neurotransmitters and/or neuromodulators that control 
behaviours, neuroendocrine function and affective states (McEwan and Parsons, 
1982) by interacting with intracellular receptors in specific brain regions. The 
mechanism by which steroids do interact are not clear; however, it is possible that 
the modification could occur at either of the following stages:
(1) By affecting enzyme regulation (eg the oestrogen dependent decrease in type A 
MAO has been demonstrated to be due to an increase in the rate of degradation 
rather than a decrease in the rate of synthesis).
(2) By affecting the rate of neurosecretion
(3) By affecting or altering reuptake mechanisms
(4) By affecting receptor activation. For example, ovariectomized rats treated with 
oestrogen have increased levels of 5HTJ receptors in areas of the brain known to 
contain oestrogen receptors ie the hypothalamus, specifically the preoptic area and 
the ventromedial nucleus, amygdala, arcuate nucleus and the ventrolateral septum. 
(These areas also contain highest levels of oestrogen inducible progesterone 
receptors). Oestrogen can also affect in vitro binding to 5HTj receptors, by 
decreasing the number of available receptors rather than altering apparent affinity.
There are three mechanisms by which steroid hormones, especially oestrogen, could 
alter receptor activation. Firstly by direct competition, but studies have shown that 
this effect occurs at such high steroid concentration that in vivo it is unlikely to 
occur. Secondly by influencing membrane properties so altering the binding
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capacity of receptors to ligand or the coupling of receptor to adenylate cyclase; this 
is typically short acting and of brief duration. And finally, by induction of receptor 
formation at the genomic level (ie longer latency and duration of action ) as 
demonstrated by increased receptor binding in oestrogen concentrating brain 
regions after in vivo oestrogen treatment. Further studies though are needed to 
confirm this is actually occurring by using protein and RNA inhibitors.
Central to the studies in this thesis, is the effect of the menstrual cycle on the 
metabolism of tryptophan, and the following sections will review the relevant 
animal and human based studies.
4.1 The Effects of Female Gonadal Hormones on Tryptophan Metabolism: 
Summary of Findings From Animal Studies
The following section will review the findings from research studies investigating 
the effect of the female gonadal hormones in non human species.
4.1.1 The Effect of Female Gonadal Hormones on The Kynurenine Pathway of 
Tryptophan Metabolism
Progesterone is believed to increase the activity of the pyrollase enzyme indirectly 
by inducing the rate limiting synthesis of heme (the cofactor necessary for 
activation of tryptophan pyrollase). As such it would be expected that serotonin 
synthesis would decrease as tryptophan (TRY) is diverted to the liver for 
degradation. However, experimental evidence is lacking. Oestrogens (or their
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metabolites) may affect the regulation of the kynurenergic pathway by its action of 
three enzymes, however the evidence is conflicting (reviewed by Bender, 1987).
(a) Affect on tryptophan pyrollase (converting TRY to KY)
Several authors have demonstrated that oestrogens induce tryptophan pyrrolase 
indirectly via displacement of glucocorticoids (eg Braidman and Rose, 1971; Brin, 
1971) leading to increased urinary excretion of KY, xanthurenic and kynurenic 
acids. However, Bender et al (1983) found no induction in pyrollase activity after 
oestrogen administration either directly or indirectly (in a variety of conditions), 
which was corroborated by in vivo radiolabelled studies. This finding reflects that 
seen in human based studies ie that oestrogens do not appear to induce the 
pyrollase enzyme (Bender and Wynick, 1981; Bender and McCreanor 1982; Bender 
et al, 1983).
(b) Affects on kynurenine hydroxylase (converting KY to HK)
As with the enzyme kynureninase, sex differences on its activity have been noted; 
with male adults having a higher ratio (ie HK/KY) than children, postmenopausal 
and reproductive women. This therefore does seem to imply an inhibitory role of 
the endogenous oestrogens on the enzyme.
(c) Affect on kynureninase (converting HK to HA)
Numerous studies (reviewed by Bender 1987) have indicated that oestrogen inhibits 
the activity of kynureninase (Scardi et al, 1962; Mason and Gullekson, 1960). It 
has been shown that the phosphate and sulphate esters of oestradiol act to compete 
with the cofactor (pyridoxal phosphate) required for activation of kynureninase; and 
therefore prevent the activation of the holoenzyme leading to increased production
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of xanthurenic acid (the side metabolite). Sex differences in its activity have also 
been demonstrated; with male rats having greater activity than female rats, 
mediated by the concentration of oestradiol (Rose and Braidman 1971).
In summary, empirical evidence is supportive for an inhibitory role of oestrogens 
on the kynurenergic pathway (its effect on the rate limiting pyrollase enzyme being 
disputed); and as such it would be expected that tryptophan would be displaced to 
the serotonergic pathway.
4.1.2 The Effect of Female Gonadal Hormones on the Serotonergic Pathway 
The following section will discuss, firstly, the changes noted during the oestrous 
cycle and secondly the effects of exogenous administration on progesterone and 
oestrogen on the metabolism.
(a) Observations of Serotonergic Pathway Metabolism in Discrete Brain Areas 
Greengrass and Tonge (1971) studied the levels of tryptophan and serotonin in 
discrete brain areas of mice during different stages of the oestrus cycle. At 
dioestrus (low oestrogen and progesterone levels), highest concentrations of 5HT 
were noted in the midbrain area (including the hypothalamus) and forebrain (ie 
cortex). During proestrus (when oestrogen levels are rising), TRY levels decreased 
significantly (and remained low until dioestrus again). At oestrus, (high levels of 
progesterone), both 5HT and TRY concentrations increased, returning to dioestrus 
values. Therefore it does appear that the serotonergic pathway of TRY could be 
altered by the effects of the steroids. Subsequently, the effects of direct hormonal
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administration were assessed.
(b) Effects of Exogenous Hormonal Administration on Serotonergic Metabolism 
The effect of administration of gonadal hormones (oestrogen, progesterone and 
oestrogen-progesterone together) in the rat do not appear to be consistent. In the 
majority of studies performed, ovariectomized rats were used (ie to remove all the 
effects of gonadal hormones) and the effect of subsequent administration of a 
specific hormone noted. As will be discussed, the results are frequently 
conflicting.
(i) The Effects of Progesterone on Serotonergic Metabolism 
Accumulation of progesterone and its metabolites have been noted in several areas 
of the CNS including the hypothalamus (Karavolas et al, 1979). Studies have 
investigated the effect of progesterone administration on serotonergic synthesis and 
turnover (no receptor studies have been performed). It has been suggested that 
progesterone induces the synthesis of 5HT (eg Hackman et al, 1973; Cone et al, 
1981). However, other studies have not demonstrated this stimulatory effect (eg, 
Renner, Krey and Luine, 1987; Ladische, 1974; Ladische, 1977) making it difficult 
to draw any definite conclusions regarding the direct influence of progesterone on 
5HT.
More convincingly progesterone has been shown, in rats, to increase the turnover 
of 5HT (as indicated by higher levels of its metabolite, 5HIAA) by induction of the
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enzyme monoamine oxidase (MAO) (Ladische, 1974; Ladische, 1977). Renner, 
Krey and Luine (1987) also demonstrated that (in the ventromedial nucleus of rats 
pretreated with oestradiol) progesterone administration led to a significant increased 
turnover. However in both this study and a previous one by Luine and Rhodes 
(1983), the increased activation of MAO was only seen if the rats were pretreated 
with oestradiol; administration of progesterone alone did not result in its increased 
activity. It has been suggested that the ability of progesterone to rapidly increase 
MAO activity in the ventromedial nucleus was not dependant on enzyme synthesis 
(since protein synthesis inhibitor did not block the increase) nor a results of a 
genomic effect (since the response was too quick); instead it could be that the 
MAO enzyme protein was activated by progesterone directly or via a second 
messenger. In conclusion, it appears that progesterone could increase the turnover 
of 5HT by its induction of MAO. However further substantiation is required.
(ii) The Effect of Oestrogen on Serotonergic Metabolism 
The effect of oestrogen on the synthesis and turnover of serotonin, as well as on 
serotonergic receptors has also been investigated. Again, conflicting results have 
been demonstrated on the direct effect of oestrogen on serotonergic metabolism.
For example, Crowley et al (1979) showed no change in 5HT levels in any region 
of the brain after oestrogen administration. However, decreased 5HT turnover as 
indicated by decreased levels of 5HIAA, was noted by Luine and Rhodes (1983) in 
oestrogen sensitive areas of the preoptic hypothalamus.
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Pretreatment with oestrogen was seen to significantly decrease the activity of 
MAOa (not MAOb) in oestrogen sensitive areas (Luine and Rhodes, 1983); the 
mechanism though has not been clarified. Additionally, the turnover rate of MAOa 
is suggested to be enhanced by oestrogen (Luine and McEwan, 1977) as a result of 
increased degradation, and not as a result of increased synthesis.
The main effect of oestrogen on serotonergic metabolism has been demonstrated at 
the receptor level. It is suggested that by changing the microviscosity of receptor 
membranes, steroids may increase or decrease the apparent numbers of 5HT 
receptors by exposing them or submerging them in the membrane (Heron et al, 
1980). The effect on the serotonergic receptors has been shown to occur almost 
exclusively to those brain areas that contain intracellular hormone receptors; with 
changes in 5HTj noted 1-2 days after oestrogen administration. To date studies 
have concentrated on the effect of oestrogen on 513^ and 5HT2 receptors.
A biphasic effect has been noted after oestrogen administration in ovariectomized 
rats in those regions of the brain associated with oestrogen receptors (ie the 
hypothalamus, preoptic area and the amygdala) (Biegon and Me Ewan, 1982); with 
a decrease in density of 5HTj receptors (confirming previous work by Biegon et al,
1980) followed two to three days later by increased 5HTj binding, indicative of an 
up regulation of these receptor binding sites. In vitro studies have shown that the 
direct effect of physiological doses of oestrogen on these 5HI\ receptors, was a 
result of a reduction of the number of receptors available rather than altering the
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affinity via competitive action. It is suggested therefore that the increase in 5HTJ 
binding observed, was due to an oestrogen receptor mediated genomic action of the 
hormone. Indeed Elliott et al, (1980) demonstrated that oestrogen administration 
increased the capacity of 5HT receptors on rabbit blood platelets after oestrogen 
administration; and since blood platelets are anucleate, their finding can be 
considered a direct effect. 5HT2 receptor levels on the otherhand increased after 
oestrogen administration (Biegon et al, 1982). These receptors are thought to be 
dependent on circulatory levels of oestradiol in normal women since minimal 
binding activity has been reported mid cycle; and maximal binding premenstrually 
(Biegon, 1990).
To summarise, empirical evidence from the animal studies investigating the effects 
of the female gonadal hormones on serotonergic metabolism, remains conflicting in 
certain areas. In spite of this, progesterone appears to induce MAOa (resulting in 
increased conversion of serotonin to 5HIAA): and oestrogen, a reduction in MAOa 
activity. Oestrogen also appears to influence serotonin indirectly by altering 5HT 
receptors; decreasing 5HT1 receptor density but increasing 5HT2 receptor density. 
Extrapolating these findings to human metabolism, it could be hypothesised that 
increased serotonergic turnover would occur in the luteal stage as compared to the 
follicular stage. In addition it appears that oestrogen could be capable of affecting:-
(1) food intake; oestrogen has been seen to decrease MAOa activity in the 
ventromedial nucleus of the hypothalamus (where 5HT acts to inhibit eating) hence
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increasing inhibition of eating. This could account in part for the decreased food 
intake seen in the follicular phase observed in women (eg Dalvit, 1981).
(2) mood states; The mechanism by which oestrogen modulates 5HTj and 5HT2 
receptors still requires further clarification. However potentially it could contribute 
to the known emotional lability and eating changes with the premenstrual and 
postpartum periods in susceptible women. As previously described in Chapter 3, 
section 3.8, eating behaviour is suggested to be regulated by 5HTla , 5HTlb and 
5HT2c , and emotions regulated by 5HTlb and 5HTld (anxiety only). This study was 
carried out before the receptor subtypes were distinguished. However, it could be 
inferred that the modulation of 5HTj receptors during the oestrous cycle could alter 
emotional and feeding behaviour during the menstrual cycle in females. The 
following section will now review findings from human based studies investigating 
tryptophan metabolism during the menstrual cycle.
4.2 Human Studies: The Metabolism of Tryptophan During the Menstrual 
Cycle
The metabolism of tryptophan during the menstrual cycle is of interest because of 
its possible impact on eating control and mood states which are regulated via 
serotonin production. Indeed, Labrum (1983) has suggested that changes in brain 
levels of 5HT may be a basis for cycle related mood complaints. The findings from 
animal based studies point to oestrogen having an inhibitory effect and 
progesterone, a stimulatory effect on the serotonergic pathway; it could be expected 
therefore that the premenstrual phase would be characterised by increased turnover
of 5HT. Changes in serotonergic metabolism (ie turnover) in the ventromedial 
nucleus area therefore could affect eating behaviour since it is involved in the 
satiety response. Especially of interest is the effects of progesterone, since its 
marked decline before menstruation and during parturition could be one of the 
causes of PMS and postpartum depression, mediated via monoaminergic activity.
The following section will review the effect of the menstrual cycle on the 
pyrollase and serotonergic pathways of metabolism. It will be seen that findings are 
conflicting (due in part to methodological problems) making it possible to only 
generalise findings, for example, that decreasing levels of gonadal hormones are 
associated with decreases in 5HT activity, probably with increased sensitivity to 
post synaptic stimulation. However, it would be misleading to suggest a single 
causal factor for any cyclical mediated behaviour changes; rather, that any changes 
found could be viewed as a difficulty with homeostatic basis.
4.2.1 Changes in Tryptophan Levels During the Menstrual Cycle 
Cyclical variation in plasma tryptophan levels have been identified in healthy 
women in some, but not all studies eg Ashby et al, (1988) and Hrboticky et al, 
(1989) found no difference in tryptophan concentration pre or post menstruation. 
Within those studies that did find cycle variations, there was no consistent phase 
finding. For example, increased levels of plasma tryptophan have been noted 
premenstrually (Wirz Justice et al, 1975; Wirz Justice and Puhringer, 1978), 
whereas Rausch and Janowsky (1982) identified premenstrually levels were
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minimal, rising to reach maximal levels in the early luteal phase.
4.2.2 The Effects of the Menstrual Cycle on the Kynurenine Metabolic Pathway 
The literature investigating the effects of the menstrual cycle on the pyrrolase 
pathway is scant, with to date two studies (Hrboticky et al, 1989; and Brien and 
Bonner, 1996) noted. Hrboticky et al (1989) identified no significant change in KY 
levels pre ovulation versus postovulation; however they did identify that urinary 
excretion of KY was significantly higher post ovulation, following a tryptophan 
load. The actual mechanism for this cycle alteration was unclear, however it did 
suggest that during the luteal phase, serotonergic metabolism could be reduced by 
either diverting tryptophan from 5HT synthesis or, by elevating kynurenine 
metabolites across the BBB which would compete for tryptophan uptake.
A subsequent study was carried out by Brien and Bonner (1996) and was the first 
to measure a range of the pyrollase pathway metabolites during the follicular, mid 
luteal and premenstrual stages of the cycle (Chapter Nine, Study C). Cyclical 
changes in HK were noted, with a reduction in urinary excretion from the 
premenstrual to follicular stage. This metabolite has been shown to have an 
inhibitory effect on the pyrollase enzyme; and suggests that when levels are 
relatively elevated (ie in the mid luteal and premenstrual stages) a relative decrease 
in activity of the pyrollase would result, diverting tryptophan to the serotonergic 
pathway. This was borne out by the analysis of ratios of metabolites of the 
pyrollase to the serotonergic pathway. The relative changes in metabolism did
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significantly alter, with reduced serotonergic metabolism versus the pyrollase 
pathway from the premenstrual to follicular phase. This study put forward the 
suggestion, that the relative changes in metabolism across the pathways are 
important rather that levels per se.
4.2.3 The Effect of the Menstrual Cycle on the Serotonergic Pathway 
Menstrually related changes in the metabolism of serotonin has been indicated. 
Changes noted in this pathway could be due to either changes in availability of 
TRY, competition from the LNAA's, change in activity of tryptophan hydroxylase 
or MAO, change in autoreceptor sensitivity, change in reuptake mechanisms or 
change in postsynaptic 5HT receptor sensitivity; or a combination of these factors.
(a) Menstrual Cycle Variations in Serotonin levels.
Plasma 5HT concentrations (Taylor et al, 1984) and platelet levels of 5HT have 
been reported to be lower premenstrually (Ashby et al, 1988). However, no cyclical 
variation in platelet poor plasma was noted by Blum et al (1992). Conversely, 
premenstrual increases in 5HT levels were noted in plasma (Wirz Justice and 
Puhringer, 1978) as well as in platelet poor plasma (Hindberg and Naesh ,1992; a 
two month study of 20 women; single samples per phase). Therefore these plasma 
studies do not provide any consistent findings.
Cyclical changes in platelet serotonergic uptake (considered to reflect central 
serotonergic uptake; Da Prada et al, 1988) and imipramine binding have also been
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indicated. Again, contradictory findings have been reported. No cyclical changes in 
platelet 5HT uptake have been found by a number of authors (Wirz Justice and 
Arndt, 1976; Malmgen et al, 1987; Ashby et al, 1988; and Veeninga and 
Westenberg, 1992). And likewise Poirier et al (1986) found no difference in 
platelet imipramine binding during the cycle. However, Ashby et al (1988) found 
platelet uptake was reduced premenstrually. Conversely, increased uptake in the 
luteal (compared to the follicular stage) was noted by Tam, Chan & Lee (1985). 
Findings from platelet uptake studies should however be interpreted carefully; since 
platelet membrane changes are reflective of events that occurred 7 days previously, 
and not instantaneous changes (Wirz Justice 1988), a fact not frequently discussed 
in papers.
(b) Menstrual Cycle Changes in Serotonin Turnover 
Urinary excretion of 5HIAA has been shown to significantly decrease 
premenstrually, with highest values found in the mid luteal phase (Lerdo de Tejada, 
1978; Wirz Justice and Puhringer, 1978) although Rausch and Janowsky (1982) did 
not identify any cyclical alterations.
The activity of MAO has been investigated. The effect of gonadal hormones (both 
endogenous and exogenous) on MAO activity in plasma of women has been 
studied by Klaiber et al (1971) (however the type of MAO was not specified).
They noted that, similar to animal studies the activity of MAO is affected by 
changing hormonal levels, with oestrogen having an inhibitory effect, and
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progesterone a stimulatory effect. The inhibitory effect of oestrogen was further 
corroborated by Luine and Rhodes (1983) whilst the stimulatory effect of 
progesterone was confirmed by Belmaker et al (1974).
(cl Menstrual Cycle Variation in Indices of Serotonergic Metabolism 
Other methods such as neuroendocrine challenge studies (eg prolactin), have been 
used to ascertain central 5HT metabolism during the cycle. The findings indicate 
that maximum serotonin synthesis occurs mid cycle (O'Keane et al, 1991; who used 
the selective 5HT release and uptake inhibitor fenfluramine, but reduced synthesis 
premenstrually (O'Keane et al, 1991; Bancroft et al, 1991; tryptophan loading 
study) but the validity of using prolactin as a probe for serotonergic function has 
been queried (as discussed by Van Praag et al, 1987).
4 .3  Conclusion
In summary, the evidence from human based studies is conflicting and far from 
conclusive. Methodological issues, noted in chapter one, may account for some of 
the contradictory findings. The paucity of studies also does not aid clarification. 
However, on the basis of animal studies it does appear that changes in hormonal 
levels will effect tryptophan metabolism, but that the relative changes in metabolic 
pathways may be of greater importance than actual changes in levels per se.
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CHAPTER JIVE
THE MENSTRUAL CYCLE AND MOOD
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5.0 Introduction
It has been suggested that eating behaviour may be modulated by mood states, and 
as such mood may be an important factor in investigating food intake and 
macronutrient selection during the menstrual cycle. As such, this chapter will 
review the literature investigating mood changes that occur during the menstrual 
cycle. Changes in specific mood states (eg depression, anger and anxiety) have 
been attributed to changes in neurotransmitter metabolism, particularly for 
serotonin. Therefore, any cyclical changes in serotonin metabolism may be 
behaviourally expressed through mood changes which may affect or lead to altered 
eating behaviour. If there is such an interaction between serotonin metabolism, 
eating and mood, the direction of the relationships may be of interest for clinical 
groups where eating has become grossly disturbed. Therefore, particular reference 
will be made to the role of serotonin in mediating these mood states during the 
menstrual cycle.
5.1 Alterations in Mood States Associated with Hormonal Fluctuations
Changing hormonal levels have been associated with mood disturbance, for 
example in pregnancy, premenstrual syndrome (PMS), post natal depression, 
contraceptive pill users (Sheehan and Sheehan, 1976) and the menopause (Vliet and 
Davis, 1991). Women between menarche and menopause are at the highest risk for 
affective illness, and in particular one form of mood disorder, PMS, renamed 
premenstrual dysphoric disorder (American Psychiatric Association, 1994) has been 
associated with a specific phase of the menstrual cycle. This increased incidence of 
mood and behaviour symptomology during the luteal phase, might be indicative
that the process of ovulation is involved. The phase after ovulation is characterised 
by fluctuating hormonal levels, and compared with the follicular phase is a 
relatively unstable phase of the cycle. Elimination or suppression of ovulation has 
been shown to be effective in eliminating premenstrual symptoms (Halbreich, 1990; 
Crammer, 1992), and it has been suggested that luteal phase symptoms might be 
due to rapid fluctuations in hormonal levels rather that from either high or low 
levels per se (Halbreich et al, 1986). The next section will review studies 
investigating menstrual cycle related changes in mood.
5.2 Summary of Research Investigating The Menstrual Cycle and Mood
The influence of the menstrual cycle on the physical, psychological and social 
functioning of women has become a subject of considerable interest in the last four 
decades. Physiological changes occur during the cycle as a result of the changing 
patterns of hormonal release; however, the study of psychological symptoms and 
behavioural changes has led to the conclusion that they are a common 
accompaniment of the menstrual cycle, and are considered 'normal'.
Retrospective and prospective studies in both clinical and non clinical groups have 
suggested that many women do show cyclical changes in affect during their 
menstrual cycle; with a predominance of psychological symptoms in the 
premenstrual phase, and somatic symptoms during menstruation (Moos, 1968). The 
incidence and severity of negative symptoms has been shown to reach a peak 
during the premenstrual phase (Moos, 1968; Dennerstein and Burrows, 1979;
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Metcalf et al 1988; Morse and Dennerstein, 1988; Choi and Salmon, 1995a;1995b); 
with the negative changes noted including depression, anxiety, irritability, 
headaches and sleep disturbance. Positive changes such as pleasantness, increased 
vigour and elation are also often reported in the follicular or mid cycle phases 
(Gallant et al, 1991), although are rarely highlighted in studies.
In recent years more attention has focused on the premenstrual phase of the cycle - 
a phase itself not clearly defined but generally including the 3 to 4 days 
immediately preceding the onset of menses with cessation of symptoms when 
menstruation begins (Greenblatt et al 1987). A whole range of physical and 
psychological symptoms have been reported to occur or to be exacerbated during 
this phase (Moos, 1968). Wurtman et al (1989) has suggested that the cyclical 
mood changes may be limited to those women who experience PMS. Despite 
extensive investigations little progress has been made in establishing a generally 
accepted definition for what has now been recognised as PMS, nor a complete 
understanding of this multifaceted "syndrome". Cyclical patterns of symptoms are 
necessary for a diagnosis but there is still disagreement over the nature and 
duration of the symptoms (eg Choi, 1995; Richardson, 1995)
However not all women experience mood changes and not every study finds 
significant changes within the cycle (eg Abplanalp et al, 1979; Vila and Beech, 
1980, although both these studies have been criticised on methodological grounds). 
The inconsistent findings between studies may be due to a combination of factors
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eg that differences are only apparent in women who suffer from PMS; that the 
methods used to detect mood changes are of differing sensitivities; or that the aim 
of the study was not adequately disguised. In those studies monitoring phase of the 
cycle by hormone profiling, no cyclical changes in affect were identified in normal 
women (Abplanalp et al, 1979; Sanders et al, 1983; Laessle et al, 1990), nor any 
relationship between hormonal levels and symptomology. Therefore in those studies 
using correct methodology ie non biased studies with the use of hormonal profiling, 
it appears that these commonly held beliefs are not true. Physical symptoms 
though do seem to show cyclical changes and premenstrual/menstrual exacerbation 
has been reported consistently (Janowsky et al, 1973; Beumont et al, 1975; Laessle 
et al, 1990).
Multiple theories have been proposed over the years to explain the basis for these 
supposed cyclical changes, but to date no single theory has been able to account 
for the symptoms (Golub, 1992). Different theories have been presented 
(specifically referring to the pre/menstrual phases) to explain these changes in 
mood (reviewed by Dennerstein and Burrows, 1979; Bancroft and Backstom, 1985) 
as discussed below
(11 Psvchodvnamic Theory
That menstruation intensifies a woman's existing conflicts (both conscious and 
unconscious) concerning pregnancy, childbearing, their own femininity and their 
'role' as a female, and their lack of control of bodily functions. It has been
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suggested that psychological vulnerability may lead on to neurotic or psychotic 
reactions (Berry & McGuire, 1972) and it has been shown that intensity of 
premenstrual discomfort has been correlated with neuroticism (van der Ploeg, 
1987), and trait anxiety with increased premenstrual symptomology (Picone and 
Kirby, 1990).
(21 Sociological Theory
That cyclical changes in mood may be socially learned. Both women and men 
report stereotypic beliefs concerning menstruation: they expect women to 
experience negative physical and affective changes in the premenstrual and 
menstrual phases (Parlee, 1974).
(31 Biological Theories
Since alterations in mood states occur at times of changes in gonadal hormonal 
levels, a considerable body of research has aimed at clarifying the relationship 
between hormonal changes and psychological alterations. Several mechanisms have 
been proposed (as reviewed by Clare, 1985) and include
(a) high plasma oestrogens (Munday et al, 1981)
(b) decreased progesterone production (Abraham et al, 1978)
(c) elevated LuH and FSH (Backstrom et al, 1976)
(d) excessive aldosterone action (Janowsky et al, 1973) and
(e) the monoamine theory (Tam, Chan and Lee, 1985) which will be discussed in 
more detail later.
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However attempts to relate specific hormonal changes within the cycle to specific 
behaviours have encountered numerous methodological problems. Different 
methods have been used to assess cyclical mood changes eg, retrospective and 
prospective questionnaires (reviewed by Richardson, 1990), mood scales and 
interviews. There are inherent problems in investigating mood changes during the 
cycle. These issues have been addressed, in part, previously (Chapter 1 sections 1.2 
and 1.3) and include (1) the obvious drawback of self report measures; (2) the 
questionable methods used to assess cycle phase ie the value of prospective, rather 
than retrospective self report; (3) biasing of future research by the consistent 
investigation and reporting of negative mood states in the premenstrual phase, 
rather than addressing both positive and negative moods throughout the whole 
cycle; (4) the continuous citing of previous research that is scientifically poor eg 
Daltons studies in the 1960’s that do not discuss the statistical analysis employed 
and (5) the problems of societal expectation regarding the cycle (eg Parlee, 1974) 
ie that a women will experience negative affect premenstrually.
Therefore some studies do suggest that women have mood changes associated with 
their cycle; however the significance of how meaningful these changes are has 
rarely been addressed. Golub (1976) compared the significant premenstrual increase 
in depression and anxiety scores with other groups over a similar time period, and 
in addition with normative scores from clinically depressed individuals. The actual 
change in levels of anxiety and depression scores was shown to be equivalent to 
those invoked by the stress of being in an unfamiliar surrounding, and in addition
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the scores were considerably different from normative data of a clinical depressed
group.
Other factors may also account for any cyclical changes noted. For example, 
stressful life events have been shown to account for more of the psychological 
changes than cycle phase in one study (Wilcoxon, Schrader and Sherif, 1976; 
Laessle et al, 1990). In addition, the day of the week was shown to strongly affect 
moods, more so than cycle phase, with an increase in positive mood noted over the 
weekend (Rossi and Rossi, 1977). Therefore, although the changing hormonal 
levels associated with the cycle may play a role in mediating mood states, other 
factors will inevitably significantly contribute to, or outweigh mood independent of 
the stage of the cycle.
5.3 Hie Role of Serotonin in Mediating Mood States
Current attempts to ascribe menstrually related dysphoria to simple excesses or 
deficiencies of hormones involved in regulating the cycle have failed. However the 
role of changes in neurotransmitter activities, mediated by hormonal variations as a 
factor in the aetiology of menstrual cycle changes in mood has been investigated, 
with studies indicating dysfunction of the serotonergic system (Halbreich, 1990). 
Indeed, a recent study by Fink et al (1995) has shown, in rats, that oestrogen 
increased the activity of the gene that codes for serotonin receptors in the areas of 
the brain involved in mood control, and as such suggests that oestrogen may act as 
a "psychoprotectant" by boosting the production of serotonin receptors. Abnormal
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metabolism of serotonin, initially reported in depression has been identified in a 
wide range of psychiatric and behavioural disorders, and as such has been 
nicknamed a "transmitter for all seasons" (van Kammen, 1987).
Apter et al (1990) correlated a number of these psychological states and traits 
associated with serotonin dysfunction and indeed did find a high degree of 
intercorrelations between those components that are believed to be a result of 
serotonin dysregulation. The authors suggest that the underlying commonality 
between these variables (ie lowered mood, anxiety, aggression, and impulsivity) 
could therefore in fact be altered serotonin metabolism; which could explain why a 
particular biological variable can be found across different diagnostic criteria, and 
can be present in some but not all individuals with the same diagnosis. The 
over-representation of women sufferers in mental disorders (particularly depression 
and anxiety) has been noted (Blanchard et al, 1995). The brain 5HT system appears 
to be more highly expressed in females with higher levels of its precursor, 
tryptophan, its metabolite 5HIAA in a variety of brainstem and limbic forebrain 
sites, with increased 5HIAA/5HT ratios in the hypothalamus and limbic forebrain 
(Carlsson and Carlsson, 1988). In addition, since the menstrual cycle may affect 
serotonin metabolism it could be expected that cyclical changes in affect could be 
due to a predisposition to alterations in 5HT metabolism.
In this thesis, the role of particular negative mood states (ie depression, anxiety and 
anger) are investigated to assess their potential relationship to eating behaviour
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during the cycle. The neurotransmitter serotonin has been implicated in the 
mediation of these mood states and as such the following section will review 
evidence for this.
5.4 The Role of Serotonin in the Mediation of Anger
The literature on anger, hostility and aggression is frequently ambiguous and 
confusing; this is in part to the problems identifying what specifically is anger. 
Definite criteria are needed to ensure that anger, and not hostility nor aggression 
are being measured. Spielberger et al (1983) proposed the following definitions: 
"Anger is generally considered to be a simpler concept than hostility and 
aggression. The concept of anger usually refers to an emotional state that consists 
of feelings that vary in intensity, from mild irritation or annoyance to fury and 
rage. Although hostility involves angry feelings, this concept has the connotation of 
a complex set of attitudes that motivate aggressive behaviours towards destroying 
objects or injuring other people".
While anger and hostility refer to feelings and attitudes, the concept of aggression 
generally implies destructive or punitive behaviour directed towards other persons 
or objects. It should be noted, however, that aggression and hostility are often used 
interchangeably.
Research into anger is confounded by other problems, for example anger is 
frequently present with other emotions making it difficult, especially in
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physiological based research to identify what specifically relates to anger only. A 
large number of scales are available that contain a factor that measures 
anger/hostility/aggression but again rarely distinguish between the concepts of 
anger and aggression, nor are they particularly sensitive to changes in behaviour. 
However, the Spielberger State Trait Anger Inventory has been identified as being 
both sensitive to measuring changes in anger (Koning and Mak, 1991) and reliable 
(Knight, et al, 1988; Kroner and Reddon, 1992).
(a) The Neural Control of Anger
The hypothalamus, amygdala and the neocortex (concerned with symbolic thought, 
logic and reason) have been suggested to interact to mediate anger and 
violent/aggressive behaviours (reviewed by Bear, 1991). It has been suggested that 
there may be two parallel information systems in the brain, one for cognitive- 
interpretive explanations and another for feelings.
The feeling and expression of anger is controlled neurally at different levels. For 
example, the lateral hypothalamus is suggested to be involved in the physical 
expression of anger. The amygdaloid complex, part of the limbic system, is 
suggested to play a fundamental role in associating sensory experiences with 
emotions (both the amygdala and hippocampus are involved in new learning and 
memory). Anatomically this is unsurprising; the amygdaloid complex receives 
innervation from the sensory pathways eg the visual cortex which in turn innervates 
the extrapyramidal motor system and the hypothalamus (which as suggested from
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animal studies is believed to be involved in the physical expression of anger). The 
prefrontal cortex is involved in the complex nature of judgement integrating the 
state of the external and internal world, in the light of previous experiences. The 
prefrontal cortex in innervated from many areas of the neocortical areas, 
specifically from the inferior parietal lobule (the area involved in surveying 
extrapersonal space for relevant stimuli); and from the hypothalamus (via the dorsal 
medial nucleus and then the uncinate fasciculus) which informs the frontal lobes of 
both internal and external emotional stimulus. The prefrontal cortex itself 
innervates the pyramidal motor system and the neostriatum (which controls speech 
and complex learned movements).
Based on this model it could be perceived that any trigger (eg hormonal 
stimulation, hunger, fatigue etc) that alters the functioning of the hypothalamus 
could perceivably result in feelings and expression of anger. Alternatively it could 
be seen that an aggressive act could be a result of emotional association to external 
stimuli or events. Or else aggressive acts could be conceptualised as an impulsive, 
unreflective response. The expression of anger though is not considered a hard trait, 
but may be altered dependent on the situation; however women tend not to react 
differently depending on the situation, but remained steadfast in the way they dealt 
with anger (Lai and Linden, 1992).
(b) Serotonin and Anger
Animal studies have indicated that decreased 5HT activity is related to increased
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aggressive behaviour (Valzelli, 1984), and vice versa (Olivier et al, 1990). Human 
studies have also confirmed reduced serotonergic activity in the mediation of anger 
(by proxy since most of the research has focused on aggression, particularly 
impulsive aggression, rather than anger). For example, (a) low CSF 5HIAA 
concentrations have consistently been found in patients with aggressive behaviours 
however expressed eg outward directed aggression (violence) (Brown et al, 1979; 
Roy et al, 1988) or inwardly turned aggression (eg suicidal attempts) (Asberg et al, 
1976b; Traskman et al, 1981, van Praag 1982; 1983); (b) Increased 5HT2 receptor 
binding in the frontal cortex (van Praag, 1986), and (c) Blunted prolactin response 
to neuroendocrine challenges ( Rosenbaum et al, 1993).
5.5 The Role of Serotonin in Mediating Anxiety
Freud was the first to propose a critical role for anxiety in personality theory. The 
term anxiety is used to refer to two constructs ie an unpleasant emotional state (ie 
state anxiety) and a relatively stable construct (ie trait anxiety) (Cattell ,1966) .
(al Neural Control of Anxiety
The prefrontal cortex and some components of the limbic system, in particular the 
amygdala, have been demonstrated to play a role in anxiety and fear (Kalin, 
1993).The prefrontal cortex plays a role in assessing danger. The amygdala has 
been shown to have many possible roles in the expression of anxiety, mediated 
through different structures of the brain, particularly the hypothalamus eg the 
paraventricular nucleus (hypothalamus) leading to release of adrenocorticotrophin
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hormone (ACTH), which in turn leads to the release of cortisol. The limbic system 
is important in memory; long term potentiation has been demonstrated in 
amygdaloid fear pathways (LeDoux, 1994) and the amygdala has been shown to be 
important in the emotional memory mechanism associated with anxiety (McGaugh, 
1991).
(b) Serotonin and Anxiety
Neurochemical studies have implicated reduced gamma aminobutyric acid (GABA), 
the most prevalent inhibitory neurotransmitter in the nervous system in anxiety. 
However, serotonin has also been implicated in anxiety disorders [ie generalised 
anxiety disorder, panic disorder and obsessional compulsive disorder (reviewed by 
Murphy, 1990; Barrett and Vanover, 1993; Saxena, 1995)]. Pharmacological studies 
have indicated that increased activation of the 5HTla presynaptic receptors leads to 
increased anxiety, via down regulation of the 5HT la raphe cell body autoreceptors 
(Kennett, 1991), which in turn inhibits 5HT synthesis and release in both 5HT2 and 
5HT3 receptors in the frontal cortex (Murphy et al, 1993).
5.6 The Role of Serotonin in Depression
Reduced serotonergic activity has also been implicated in the aetiology of 
depression (reviewed by Meltzer, 1989). The most persuasive evidence comes from 
studies that have decreased the availability of tryptophan, and has resulted in 
lowered mood in both depressed (Smith, 1987) and non depressed patients (Young 
et al, 1985).
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Reduced T/LNAA ratios have been identified in depressed patients, indicative of 
reduced tryptophan uptake into the brain (Joseph et al, 1984; Russ et al, 1990) and 
a correlation between this ratio and the severity of depression has been 
demonstrated by De Meyer et al (1981). Furthermore, platelet 5HT2 receptor 
binding changes in correlation with changes in clinical state (Biegan et al, 1990); 
and, 5HT2 binding sites on the post synaptic membrane increase in depressed 
individuals (Stanley, Virgilio and Gershon, 1982) but after corrective anti depressant 
treatment returned to normal.
This 'up regulation' of binding sites is suggested to occur due to reduced 
presynaptic output of 5HT and/or decreased innervation of the 5HT neurones 
(Goldbloom et al, 1990). Reduced CSF levels of 5HIAA have been shown in 
depressed patients (Asberg et al, 1976a; 1976b) but not all. More consistently an 
inverse relationship has been demonstrated between suicide attempt (ie impulsive 
behaviour) in unipolar depressed patients and 5HIAA levels (Asberg et al, 1976b). 
It has been inferred from studies that 5HT deficiencies are a predisposing factor in 
depression and not a direct causal effect (Van Praag and de Haan, 1979).
5.7 Conclusion
This chapter has reviewed the evidence indicating that mood states may vary across 
the menstrual cycle. Those moods that do appear to alter have been shown to be 
mediated, in part, by serotonin. The next chapter will review the controversial 
relationship between how eating control could be mediated by mood states.
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CHAPTER SIX
THE LINK BETWEEN FOOD AND MOOD
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6.0 Introduction
Many factors are known to influence food intake. However recent research has focused 
on the mechanisms by which eating can affect mood states or emotions, and vice versa 
(reviewed by Brewerton et al, 1986; Christensen, 1993; Rissanen, 1994; and Rogers, 
1995) The response to arousal eg anger, fear and anxiety is often the loss of appetite; 
however some individuals have been shown to react by eating excessively (Plutchik, 
1976; reviewed by Rosch, 1995). It has also been shown that negative mood states 
such as anxiety and depression can breakdown dietary restraint (DR) and lead to 
overeating (Polivy and Herman, 1976; reviewed by Ruderman, 1986) whereas 
unrestrained eaters tend to respond to negative moods by undereating. However, not 
all studies have identified this increase in food intake due to negative emotional states 
(eg Steere and Cooper, 1992) .
It has been proposed that individuals may adapt their behaviour to regulate their mood 
states and that an individual's behaviour is motivated to maintain positive moods. In 
the case of food, anecdotally individuals state that they eat junk foods when feeling 
negative but prefer healthy foods during positive moods. However, research in this 
area is particularly sparse and the mechanisms to account for this supposed form of 
self medication are lacking in empirical evidence. Two approaches have been used to 
study this association (Christensen, 1993) ie by (a) investigating the use of foods in 
certain disorders to relieve negative emotions, and (b) eliminating certain foods that 
are thought to be used to ameliorate negative moods and assessing any changes in
behaviour. Whether the affects are mediated in the sensory, pre or post absorptive 
phase, or in the central nervous system of the control mechanism is unsure; however, 
ultimately all changes in mood are linked to changes in neurotransmitter activities.
Therefore this chapter will concentrate specifically on the major hypothesised 
mechanism that indicates a link between food intake and mood regulation which is 
mediated via the serotonergic system.
6.1 The Effects of Carbohydrate on Mood
The most extensive research on the putative link between mood and food has been 
based on the hypothesis proposed by Wurtman and colleagues, initially carried out in 
rats (Fernstom and Wurtman, 1971a; 1971b; 1972). This theory has been previously 
discussed in Chapter 4, and is based on the fact that an increase in carbohydrate 
consumption facilitates the cerebral uptake of tryptophan (via an increased T/LNAA 
ratio) leading to increased brain serotonin synthesis, which in turn, leads to an increase 
in serotonergic neurotransmission. In contrast, a meal high in protein has the opposite 
effect.
It has been suggested that the diet induced changes in serotonergic neurotransmission 
result in an alteration in behaviours, specifically, food choice and intake, mood, 
arousal and cognitive performance (reviewed by Spring et al, 1987;Young, 1991; 
Silverstone, 1993); with increased drowsiness, sleepiness and calmness being noted
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after a high carbohydrate versus high protein intake (Blundell, Mavjee and Hill, 1987; 
Spring et al, 1987). However, not all studies have identified such changes in mood (eg 
Diejen et al, 1989; Christensen and Redig, 1993).
In 1989, Wurtman and Wurtman developed a further hypothesis which suggested that 
in certain individuals, increased intake of carbohydrate relieved their depression. All 
forms of depressive disorders include somatic disturbances (eg insomnia), and appetite 
is frequently affected, the majority loosing their appetite (reviewed by Hopkinson, 
1981). However, a subgroup of depressed individuals show increased appetite, 
preferentially for carbohydrates (referred to as atypical depression; Moller, 1992) and 
is suggested to be associated with dysfunction of the 5HT system (Coppen, 1967; 
Anderson et al, 1984) with women more susceptible than males, the ratio of female to 
male sufferers is 5:1. Serotonergic function is decreased in the aetiology of depression 
(eg Meltzer, 1989; Moller, 1992; Maes and Meltzer, 1995) and it has been suggested 
that increased carbohydrate consumption is a self medication mechanism to relieve the 
depression in these individuals.
Three forms of atypical depression (reviewed by Wurtman, 1990) have been studied ie 
carbohydrate cravers, premenstrual syndrome (PMS) and seasonal affective disorder 
(SAD), to investigate this link between food and mood. Below is presented a summary 
of findings for the investigation of the serotonergic theory for the link between food 
intake and mood.
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6.1.1 The Use of Clinical Groups to Investigate Altered Serotonergic Metabolism
and the Relationship Between Mood and Food Intake
(a) Seasonal affective disorder (SAD) is characterised by recurrent depression at the 
same time of the year (Rosenthal et al, 1984) and differs from non seasonal affective 
disorder in that the sufferer craves or has a specific hunger for carbohydrate rich foods 
(Wurtman, 1984) and experience significantly more fatigue. Serotonergic metabolism 
may be altered in SAD since even in healthy individuals 5HT metabolism exhibits 
seasonal variation with plasma tryptophan (Swade & Coppen, 1980), platelet 5HT 
(Wirz Justice et al, 1977) and hypothalamic 5HT levels (Carlsson et al, 1980) 
reaching a nadir in the winter months when the depressive episode commences. A 
study by Rosenthal et al (1989) identified that mood and fatigue was improved 
following consumption of carbohydrate (but not a protein test meal) in SAD patients 
and as such may be indicative of the mechanism to regulate their mood.
(b) Carbohydrate cravers. 74% of obese individuals have been reported to experience 
transient episodes of depression, and cravings for carbohydrates, compulsively eating 
carbohydrate rich foods as snacks in addition to their regular calorific intake, and are 
referred to as carbohydrate cravers (Hopkinson & Bland, 1982). To study the mood 
altering effects of carbohydrate consumption in depression, Lieberman et al (1986) 
assessed mood after intake of carbohydrate in depressed cravers and a group of 
depressives who did not crave carbohydrates. Only the carbohydrate cravers showed
110
mood improvement after the carbohydrate intake.
(c) Premenstrual Dvsnhoric Disorder or Premenstrual Syndrome.
PMS is characterised by carbohydrate cravings (Wurtman et al, 1989). Calorific intake 
in sufferers increase in the luteal phase and is believed to be from increased 
carbohydrate intake and not fat or protein intake (Dalvit McPhillips, 1983; Wurtman et 
al, 1989). Both- Orthman et al (1988) demonstrated, in a 3 month study, a dramatic 
increase in appetite in the premenstrual phase of the cycle in the PMS group, and 
suggested that mood could contribute to the increase in appetite in the PMS group, 
since appetite strongly correlated with mood in this phase of the cycle only [depression 
r=0.82, anxiety r = 0.62, irritability, r=0.68 and loneliness r=0.60]. The control 
subjects showed no evidence of any relationship between appetite and mood in any of 
the phase of the cycle. Intake of carbohydrate, specifically, in the premenstrual phase 
has in addition been shown to reduce depression (Wurtman et al, 1989; Sayegh et al, 
1995) and anger (Sayegh et al, 1995).
Levels of serotonin in blood (Rapkin et al, 1987), plasma (Taylor et al, 1984) and 
platelet 5HT uptake (Ashby et al, 1988) have been shown to be significantly reduced 
premenstrually in PMS subjects; and confirmed by tryptophan loading studies (Rapkin 
et al, 1989; Bancroft et al, 1991). In addition, acute tryptophan depletion has been 
shown to aggrevate PMS symptoms. However, other studies have not found any 
cyclical changes (eg Malmgren et al, 1987). These findings do seem to implicate a
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neurochemical basis for the appetite changes, which in the case of SAD and PMS are 
a result of an interaction of neurochemical, hormonal or neuroendocrine systems with 
annual or monthly cycles respectively that affect mood and behaviour.
(d) Bulimia nervosa. In addition to these specific disorders, the eating disorder bulimia 
nervosa has been studied since both food control and mood are severely dysregulated. 
Bulimia nervosa is characterised by binge eating ie "the rapid consumption of a large 
amount of food in a discrete period of time" (American Psychiatric Association, 1994). 
A number of studies have revealed that binge episodes revolve around the 
consumption of high fat and high carbohydrate foods ie sweets and desserts (Abraham 
& Beumont, 1982; Mitchell, Pyle and Eckert, 1981; Rosen et al, 1986; Hetherington et 
al, 1994).
One of the precipitant antecedents of a binge episode in sufferers is a negative mood 
state. (Schlundt, Johnson & Jarrell , 1985; Pyle, Mitchell and Eckert, 1981; Abraham 
and Beumont, 1982). In addition, Greenberg (1986) found that mood lability was the 
best predictor of binge eating even in a non-depressed, non-eating disordered college 
population. Negative moods, therefore, seem to precipitate a binge, and as the process 
of binging leads to a removal of negative feelings (Abraham and Beumont, 1982), it is 
understandable that carbohydrate consumption has been seen as a self regulatory 
attempt to improve a dysphoric state through food ingestion. Increased bingeing has 
additionally been noted premenstrually (Gladis and Walsh, 1987; Price et al, 1987);
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which has been shown to decrease after progesterone treatment in a preliminary study 
(Price and Dimarzio, 1988).
Increasingly the connection between depression and binging has been investigated, and 
deficiency of 5HT has been implicated. Bulimia is accompanied by severe mood 
disturbances and anxiety (Russell, 1979; Fairbum and Cooper, 1984) with the onset of 
depressive symptoms has suggested to commence with the first episode of bulimia 
(Walsh et al, 1985). Reduced serotonergic metabolism has been implicated in bulimia 
in numerous studies (reviewed by Marazziti et al, 1988; Liebowitz, 1990), with 
increased platelet 5HT uptake noted (Stanley, Virgilio and Gershon, 1982) and changes 
in 5HT2 receptor binding correlating with changes in clinical states (Biegon et al,
1990). In addition, the T/LNAA ratio has been shown to increase with satiation (Kaye 
et al, 1988). Therefore, research does seem to implicate that the carbohydrate binges 
may be a mechanism to increase serotonergic function in this population.
6.1.2 Alteration of the T/LNAA Ratio as a Mechanism For the Carbohvdrate- 
Serotonin Hypothesis for the Relationship Between Food Intake and Mood
Another investigation of the carbohydrate-serotonin hypothesis is the effect on the 
T/LNAA ratio. The plasma T/LNAA ratio is required to increase for 5HT synthesis 
and its release. As expected, meals with a very high proportion of carbohydrates result 
in a significantly elevated ratio approximately 2 hours after meal consumption (eg
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Ashley et al, 1985; Christensen and Redig, 1993). However, the actual physiological 
relevance of these studies has been questioned on two points. Firstly, that the 
magnitude of this increase is thought to be too small to influence brain serotonergic 
activity (Ashley et al, 1985;Young, 1991); and secondly, that most diets will contain a 
small protein element, and even a 4% protein content has been shown to block this 
elevation in the T/LNAA ratio (Wurtman et al, 1981).
However no differences in the plasma T/LNAA ratios have been identified after a 
carbohydrate meal in either PMS subjects (Wurtman et al, 1989), SAD sufferers 
(Rosenthal et al, 1989) or obese subjects (Caballero, Finer and Wurtman, 1988) 
regardless of any improvement in mood. Therefore the proposed mechanism of 5HT is 
not definite and no conclusions can be drawn regarding the mechanism mediating the 
carbohydrate mood altering effects. This does not totally rule out the action of 5HT 
but perhaps suggests that this explanation is incomplete. More studies need to be 
replicated and extended to reach a conclusion regarding the self regulating effects of 
carbohydrate ingestion.
6.1.3 Administration of Tryptophan and its Effects on Modulating Mood and Diet 
Administration of tryptophan, with or without a high carbohydrate diet should in 
theory alter serotonergic function and behaviour. Effects on the T/LNAA ratio, mood 
and eating behaviour has been confirmed from a number of studies (reviewed by 
Young, 1986; Spring et al, 1987; Hill and Blundell, 1988). Doses of 1.5 to 5g have
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been shown to induce drowsiness, affect sleep and decrease hunger, appetite and actual 
food intake. Tryptophan is also a mild antidepressant and administration of amino acid 
mixtures devoid of tryptophan demonstrated that lowered mood resulted after 
tryptophan depletion (eg Young et al, 1985; Oldman et al, 1995). These studies 
therefore do indicate that carbohydrate and protein may exert effects on mood and 
behaviour.
The use of serotonin agonists has investigated this relationship eg using fenfluramine, 
which mediates its effects by causing a selective increase in 5HT mediated 
neurotransmission. O'Rourke et al (1989) demonstrated that 15 mg d-fenfluramine 
decreased carbohydrate cravings in SAD patients. Decreased carbohydrate cravings in 
obese carbohydrate cravers have been noted after administration of both d-fenfluramine 
(Wurtman et al, 1981 ;1985;1989; 1993) and fluoxetine (Wurtman et al, 1993). 
Fluoxetine has also been found to be beneficial in the treatment of PMS. The 5HT 
releaser and reuptake blocker d fenfluramine (15mg twice daily) was used over 6 
menstrual cycles by Brzezinski et al (1990), and showed a significant improvement in 
PMS sufferers as assessed by the Hamilton depression rating scales. The 
administration of the 5HTla antagonist buspirone along with a carbohydrate rich meal 
produced a greater reduction in depression scores than busiprone alone or placebo, 
providing further evidence for the carbohydrate mediated effect. However these studies 
cannot conclusively be taken as evidence for the role of carbohydrates in alleviating 
negative moods.
6.2 Conclusion
The research on the use of food as a means to assist in the regulation of mood, has 
focused mainly on the consumption of carbohydrates (generally simple sugars). The 
data are sparse but do appear to be consistent in demonstrating a lifting of negative 
mood. However, there are limitations in a considerable number of these studies; the 
effects of a high fat or a high protein diet were often not investigated so it could not 
be established whether findings were specific to carbohydrate. The most frequently 
proposed mechanism is the action of carbohydrates on central serotonin synthesis; 
however, the evidence for this is conflicting and therefore may be an incomplete 
explanation.
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CHAPTER SEVEN
METHODOLOGICAL TECHNIQUES USED IN THE 
RESEARCH STUDIES
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7.0 Section A. Behavioural Methods Used in the Studies
The following section contains details of the methods used in the behavioural aspects 
of the Studies discussed in the following four chapters.
7.1 The Beck Depression Inventory: The Assessment of Depressive Svmptomology
To ensure that all subjects participating in Studies One and Four were not currently 
depressed, the Beck Depression Inventory (BDI) (Beck et al, 1961; Appendix 3) was 
completed. The BDI was originally developed in 1971 and later revised in 1979 (Beck, 
Rush, Shaw and Emery, 1979). Although the BDI was not developed as a screening 
instrument for detecting the presence of depressive symptoms in adult populations, it 
has been used for such purposes for many years (Steer et al, 1986).
7.1.1 Description of the Beck Depression Inventory
The BDI is based on clinical observations and descriptions of symptoms frequently 
expressed in depressed psychiatric patients in contrast to those infrequently given by 
non depressed psychiatric patients (Beck et al, 1961). These observations were 
consolidated into 21 symptoms and attitudes questions which are rated on a four point 
scale ranging from 0 to 3 in terms of severity.
7.1.2 Administration and Scoring of the Beck Depression Inventory
The revised BDI takes 5 to 10 minutes to complete when self administered. The 
individual is instructed to circle the number that best describes how she has been
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feeling in the past week, including the day of completion, in respect of each statement. 
The BDI is scored as follows
1. Each item is rated on a four point scale from 0 to 3. The scores for all 21 items are 
added. Special attention is noted to the answer to question number 19 concerning 
weight loss. If the individual has indicated that she is consciously trying to lose 
weight, then the rating is NOT added to the score.
2. Within a normal population, a BDI total score of greater than 15 may predict 
possible depression. No individual in either of the studies scored 15 or above. If 
however this case did arise, then the subject would have been eliminated from the 
study (and in addition particular reference would be made to the subject's answer to 
item 2 ie the pessimism item which is believed to be a good predictor of eventual 
suicide). The subject would have be contacted to discuss their assessment. As all 
information is confidential no disclosure would be made to any third party.
7.2 Mood Assessment using the Profile of Mood States Questionnaire (POMS)
An abridged version of the Profile of Mood States (POMS) questionnaire (see 
Appendix 4) was used in Study Seven to assess affective states (ie anxious/composed; 
agreeable/hostile and depressed/elated). Subjects were advised to complete the 
questionnaire, two hours after their evening meal, based on their mood and feelings at 
the time of completion and were asked not to think about the answers but to give their 
immediate response.
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The Profile of Mood States Bipolar Questionnaire (POMS-BI) is a validated method 
for identifying and assessing transient affective states and was therefore applicable to 
this thesis. Originally developed for use in psychiatric outpatients to assess their needs 
for treatment and to monitor the effectiveness of the treatment, the questionnaire has 
also been validated for use in non clinical populations. The POMS-BI can be 
administered to single individuals or groups and completion time is approximately 5 
minutes or less. Assessment can be made by rating an individual's mood state either
(a) at the time of completion (ie "right now") or
(b) over the past week including the day of completion (ie "during the past week 
including today"). For the purposes of this study the subjects were asked to complete 
the form relevant to their feelings immediately at the time of sampling (Lorr & 
McNair, 1984, 1988).
7.2.1 Description of the Mood Assessment
The Bipolar form was constructed to measure 6 bipolar subjective mood scales ie to 
measure both the positive and negative aspects of the states. However, in this Study an 
abridged version was given to the subjects to complete. This therefore contained a 
total of 36 adjectives or phrases, in cyclical order with 12 adjectives for each mood 
state. For each adjective the individual completing the form marks how she feels on a 
sliding scale of 0 to 3 (where 0 = much unlike this and 3 = much like this). The 
mood states assessed are as follows
(1) Composed - Anxious scale which measures a state ranging from untroubled,
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composed, relaxed and serene to a state of being tense, uneasy, anxious, jittery and 
shaky.
(2) Agreeable - Hostile scale represents feelings that range from friendly, kindly, and 
sympathetic at one pole of the dimension to grouchy, annoyed or angry feelings at the 
opposed scale end.
(3) Elated - Depressed scale reflects cheerful, lighthearted, joyful and elated feelings at 
one pole and dejected, lonely and discouraged feelings at the other.
7.2.2 Mood Scale Scoring and Analysis
Each mood state was scored by hand using scoring stencils. As the questionnaire was 
based on a bipolar construct, each mood state has both a positive and a negative 
aspects. The raw scale score was calculated as the sum of positive (Sp) minus the sum 
of the negative items (Sn). It was also possible to assess two other dimensions; that is 
the overall positive and negative affect. Positive affect is defined as sum of the elated, 
agreeable and composed scores. Negative affect is based on the sum of the scores for 
hostile, anxious and depressed feelings.
7.3 The Assessment of Anxiety
The Spielberger State-Trait Anxiety Inventory (STAI) was used to assess both (a) the 
experience of anxiety during the menstrual cycle, and (b) trait anxiety characteristics 
(see Appendix 5 and 6 respectively). The original STAI was developed in 1970, but 
was later revised in 1980, for use in college students and adults, has been used
121
extensively in research and clinical practice; it has been validated and is considered a 
reliable measure of state and trait anxiety (Spielberger et al, 1983). The STAI has also 
been correlated with other trait and state anxiety measures (Spielberger et al, 1983). It 
is composed of self report scales for measuring state (Form Y l) and trait (Form Y2) 
anxiety .The state questionnaire consists of twenty questions that assess how the 
individual feels at that particular moment in time. It has been shown to be a sensitive 
measure of changes in transitory anxiety in both clinical and non clinical situations 
and can be completed by the individual on more than one occasion. The trait 
questionnaire consists of twenty statements that assess how individuals generally feel.
It has again been used in both clinical and non clinical populations.
Freud was the first to propose that anxiety was a distinct condition, suggesting it was 
an unpleasant specific emotional state or condition that was composed of experiential, 
physiological and behavioural components. Since Freud the concept of anxiety has 
been better defined and methods developed to measure anxiety. However, anxiety can 
be seen as two different constructs. Firstly as an unpleasant emotional state or 
condition ie state anxiety condition. And secondly as a relatively stable personality 
trait ie anxiety as a trait. Cattell (1966) was the first to introduce the concept of state 
and trait anxiety. Anxiety state refers to the emotion at a given point in time, and at a 
particular level of intensity and is characterised by subjective feelings of tension, 
apprehension and arousal of the autonomic nervous system.
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Trait anxiety on the otherhand refers to an enduring emotional reaction to anxiety that* 
is an expression of the personality type. Trait anxiety therefore refers to a stable 
individual difference in how we perceive stressful situations, and respond to them with 
increased intensity of their state anxiety. Trait anxiety also may reflect individual 
differences in the frequency and intensity which anxiety states have resulted in the 
past. The stronger the anxiety trait, the more likely the individual will experience more 
intense increase in state anxiety in a threatening situation. Therefore an individual with 
high trait anxiety will more frequently exhibit state anxiety, than compared to low trait 
anxiety individuals; and their feelings of anxiety (ie state) will also be of a greater 
intensity in situations that threaten the individuals self esteem than compared to a low 
trait anxious person.
7.3.1 Administration and Scoring of the STAI
The questionnaires were retyped to omit the title of Anxiety questionnaire. The trait 
questionnaire was administered, together with the state trait anger questionnaire before 
the subjects were given any details regarding the study. Subjects were advised that 
these questions were measures of personality type and no further information was 
given. The investigator was not in the room at the time of completion of the 
questionnaires. They completed these questionnaires on their own, in their own time. 
They were reminded that all the information would remain confidential and only be 
accessible to the experimenter. Instructions on how to complete the forms were written 
at the top of the pages, and subjects were advised that there was no right or wrong
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answers, to try to limit their desire to answer what they wished the investigator would 
want to see.
The State anxiety forms were completed whilst the subject was on her own; no time 
limits were placed on the subject. Instructions for completion were noted at the top of 
the sheets, and a few days prior to the start of the study, the investigator ascertained 
that all subjects understood how to complete the questions. Questions were answered 
according to the intensity of their feelings at that point in time, scaled from 1 to 4 
with 1 indicating not at all and 4, very much so.
Each STAI item is given a weighted score of 1 to 4. In both the state and trait 
questionnaires there are anxiety present items and anxiety absent items. For anxiety 
present items, a score of 4 indicates high anxiety. For anxiety absent questions, a score 
of 4 indicates low levels of anxiety. The scores for the state and trait scales are added 
up: total scores can range from 20 to a maximum of 80. Normative scores for healthy, 
non clinical females are shown below in Table 9.
State Anxiety 
Mean (SD)
Trait Anxiety 
Mean (SD)
Woridng adults 
College students
35.2 (10.61) 
38.76 (11.95)
34.79 (9.22) 
40.40 (10.15)
Table 9. Normative Mean scores of adult women for state and trait anxiety assessed bv 
Soielberger’s state-trait anxiety questionnaire
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7.4 The Assessment of Anger
The Spielberger State-Trait Anger Expression Inventory (STAXI) was used to assess 
both (a) the experience of anger during the menstrual cycle (Appendix 7), and (b) trait 
characteristics (Appendix 8 and 9) regarding the expression of anger. The STAXI was 
developed in 1979 to provide a validated measure for the accurate assessment of the 
concept of anger, the definition of which has frequently been ambiguous and confused 
with hostility and aggression in the literature. The STAXI was originally developed for 
use in college students, and adults and has subsequently been used extensively in 
research and clinical practise.
Anger is conceptualised as having two components ie state and trait (Spielberger,
1991) following on from the state- trait distinction applied to anxiety (Cattell, 1966). 
State anger being defined as " an emotional state marked by subjective feelings that 
vary in intensity from mild annoyance to intense fury and rage" and is associated with 
changes in the autonomic nervous system. Trait anger on the otherhand has been 
defined as "the disposition to perceive a wide range of situations as annoying or 
frustrating, and the tendency to respond to such situations with more frequently 
elevations in state anger. Individuals high in trait anger experience state anger more 
often and with greater intensity than individuals low in trait anger". Trait anger is 
therefore refers to a stable difference in the perception of anger.
The actual expression of anger has been considered to have three components.
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(1) Anger Out - ie the expression of anger towards other people or objects.
(2) Anger In - ie that anger is directed inwards ie the suppression of angry 
feelings
(3) Anger Control - ie which identified individuals differences in the extent 
to which an individual attempts to control the expression of anger.
The STAXI is composed of 44 item self report scales for measuring both trait anxiety 
(including the expression of anger) and state anger. The stat questionnaire consists of 
ten questions that assess the intensity of how angry the individual feels right now. The 
trait questionnaire consists of ten questions that assess how the individual generally 
feels  to measure individual differences in the disposition to experience anger. In 
addition, other trait aspects are assessed ie
(1) Angry temperament, which is assessed by 4 items and measures the 
general propensity to experience and express anger without specific 
provocation
(2) Angry Reaction (assessed by 4 items), which measures individual 
differences in die disposition to express anger when provoked
(3) Anger In {assessed by 8 items)
(4) AngerOut {assessed by 8 items)
(5) Anger ^ Control (assessed by 8 items)
(6) Anger Expression which is based ^ on The previous three items, and 
provides a general index of the frequency that-anger is expressed regardless
1 2 b
of the direction of the expression. It is calculated from
Anger expression = [Anger Out + Anger In] - Anger Control +16.
7.4.1 Administration and Scoring of the STAXI
All questions were retyped, omitting the title of Self Rating Questionnaire. The 
questions addressing trait characteristics were administered prior to the actual start of 
the research study (Appendix 8 and 9). Subjects were given these questions to 
complete (at the same time as the Trait anxiety) and were advised they were a measure 
of personality types; they were additionally reassures of the confidentiality of the 
information. The subjects completed the questions on their own, in their own time. 
Instructions on the completion were given at the top of the sheets, and subjects were 
told to give truthful answers and not to respond in their desire to please the 
investigator. The questions were answered according to the intensity of their feelings 
as to how they generally felt, scales from 1 to 4 with 1 indicating Not at all, and 4, 
very much so. The scores regarding each subscale were summed to give an overall 
total for each trait aspect.
The ten questions regarding state measures (Appendix 7) were completed by the 
subject on each of her 18 sampling days. Again, instructions were provided, and a few 
days prior to the start of the study the investigator ascertained that all subjects 
understood how to complete the questions. The questions were answered according to 
the intensity of their feelings at the time of completion, scaled from 1 to 4 with 1
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indicating not at all and 4, very much so. The scores for the ten questions were 
summed to give a single total value. Normative scores for both trait and state anger 
dimensions, for healthy non clinical females are presented below in Table 10.
Anger Dimensions Nonnative Data 
Mean Scores (Sd)
State Anger 12.82 (4.83)
Trait Anger (Total) 19.44 (5.11)
- Angiy Temperament 6.43 (2.55)
- Angiy Reaction 9.78 (2.71)
- Anger In 15.70 (4.24)
- AngerOut 14.92 (4.02)
- Anger Control 26.20 (4.26)
- Anger Expression 19.35 (736)
Table 10. Normative mean scores of adult women for state and trait anger scores 
assessed bv Snielberger's state-trait Anger Inventory questionnaire
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7.5 Section B: Biochemical Methods and Procedures Used in the 
Studies
The following sections contain details regarding the biochemical methods used in the 
Studies discussed in the following four chapters.
7.6. High Performance Liquid Chromatography using Electrochemical and
Ultraviolet Detection For the Analysis of Tryptophan and its Metabolites
7.6.1 Introduction
All urine samples collected in Studies Two, Three and Four were assayed for 
tryptophan metabolites by High Performance Liquid Chromatography (HPLC). The 
theoretical and practical applications of HPLC relevant to this thesis are described in 
detail in Appendix 10. Two separate assays were required to determine the 
concentrations of tryptophan and its metabolites. Tryptophan, serotonin,
5-hydroxyindoleacetic acid, indoleacetic acid and anthranilic acid concentrations were 
detected by electrochemical detection (referred to as the serotonin assay). Kynurenine,
3-hydroxykynurenine, 3-hydroxyanthranilic acid, quinolinic acid and nicotinic acid 
levels were detected by ultraviolet detection (referred to as the kynurenine assay).
Picolinic acid could not be determined at the sensitivities used by either the UV or 
electrochemical detector. Other tryptophan pathway metabolites such as kynurenic 
acid, xanthurenic acid, quinaldic acid and 5 hydroxy tryptophol were detectable in 
urine, but due to the longer run time needed for their determination, these metabolites
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were not assayed for the purposes of this study.
7.6.2 Methodological Details
The chromatographic conditions were identical to those described previously (Bonner 
and Brien, 1993), and are described fully in Appendix 10. Prior to the sample analysis, 
the HPLC was calibrated. Standards were obtained from Sigma, Poole, UK (99% pure) 
and diluted with HPLC grade water to the following final concentrations.
(a) for the serotonin assay; tryptophan and anthranilic acid, 20ng/ml; 5HT and HIAA, 
lOng/ml and IAA, 30ng/ml;
(b) for the kynurenine assay; all standards made to a final concentration of 500 ng/ml.
Prebreakfast urinary samples were centrifuged at 12000rpm (MSE Micro Centaur) for 
5 minutes and were diluted (1/8) with HPLC grade water before analysis by HPLC. 
Standards were subsequently run after every fourth urine sample. The concentrations 
obtained for each metabolite in each sample were therefore expressed as ng/ml. Inter 
and intra assay coefficients of variation for (a) the serotonin assay were 9.75% and 
7.69% respectively, and (b) the kynurenine assay were 10.07% and 6.92% 
respectively.
7.7 The Analysis of Creatinine in Urine
Creatinine concentrations were determined for each prebreakfast urine sample collected 
in the relevant studies, as a means to control for the variations in urine concentrations.
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Samples were assayed based on the Jaffe Creatinine Colorimetric method without 
deproteinization (Lustgaraten and Wenk, 1972), using the automated Gilford Impact 
400E Clinical Analyser. The analyser was calibrated prior to the analysis. The urine 
samples (already diluted 1:2 by preservative) were prepared to give a final dilution of 
1:20 (ie 50pl urine in 450pl water), and the concentration of creatinine in urine 
calculated, expressed as pmol per litre. The data obtained from both the HPLC 
analysis and hormonal levels were accordingly adjusted by the appropriate creatinine 
concentration, to standardise for the variations in urine concentration.
7.8 The Analysis of Cortisol in Urine
The enzymimmuno assay (EIA) used for the measurement of cortisol in prebreakfast 
urine samples collected in Study Four, was based on the method devised by the 
NETRIA Unit at St Bartholomews Hospital, London, developed for the quantitative 
determination of total cortisol in serum and urine. Detailed information regarding the 
assay can be found in Appendix 11.
Cortisol was extracted from the urine samples prior to the assay (see Appendix for 
details). On the day of analysis, the urine samples were reconstituted, and together 
with the cortisol tracer, were added to the prepared wells (which contained the 
immunoglobulin and antibody) for incubation for two hours. Cortisol standards 
(between 1.625 nM and 800 nM) were made fresh on the day of analysis, and also 
added to the microtitre plates. After washing a spectrophotometric end-point was
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developed using the chromogenic substrate 3,3',5,5'-tetramethylbenzidine (TMB).
The plate was then read by an Anthos II microplate spectrophotometer preprogrammed 
to read at 450 nm with a reference wavelength at 620 nm. The data was stored for 
subsequent retrieval. A report was produced of the measurement data, the standard 
curve and an evaluation of the coefficient of variation (which reflects the degree of 
accuracy of repetition of the samples, which were assayed in duplicate). The standard 
curve was calculated to fit based on a 4 parameter fit method. In the case of the 
occasion when the standards did not fit the model, they were rejected and the curve 
and results reevaluated. The sample concentrations were expressed in units of 
nmol/litre (and to take into account the urinary dilutions, the levels were adjusted for 
creatinine levels. The inter- and intra -assay coefficients of variation were calculated at 
5.44% and 4.61% respectively.
7.9 The Analysis of Female Gonadal Hormonal Levels
The principle metabolites of estradiol and progesterone ie estrone -3-glucuronide (EG) 
and pregnanediol -3- glucuronide (PG), are excreted in urine and can be used as 
marker of menstrual function. In view of the problems associated with blood analysis 
of the gonadal hormones (eg the pulsatile excretion requiring either crucial collection 
timing or serial collection, and the problems differentiating between actual levels or 
levels of their metabolites), the analysis of the metabolites of female sex hormones in 
urine samples is more appealing.
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Hormonal levels were required for Studies B, D, E, F and G to confirm that (a) 
ovulation had occurred, and (b) that correct phase designation had been made. The 
prebreakfast urinary samples collected for analysis, were stored in 0.1M HC1, and kept 
frozen at -70Oc prior to analysis. The assays, to determine the levels of EG, PG and 
luteinising hormone (LuH) was carried out at the Regional Endocrine Unit, 
Southampton General Hospital. Unfortunately, acid hydrolysis affected the 
measurement of EG and LuH; however fragmented LuH levels were determined which 
together with the PG levels, were still considered a good indication to confirm that 
ovulation had occurred. Analysis of the hormonal levels were determined by a 
competitive time resolved fluoroimmunoassay, the details of which are found in 
Kesner et al (1994). Concentrations of the hormones were expressed as nmol/1 for EG; 
pmol/1 for PG and IU/1 for fragmented LuH levels. The values were adjusted for 
creatinine levels to control for variation in urine concentrations.
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CHAPTER EIGHT
THE INFLUENCE OF THE MENSTRUAL CYCLE ON 
FOOD INTAKE AND EATING BEHAVIOUR
Study A: An Exploratory Investigation into the Subjective
Experiences of Appetite during the Menstrual Cycle
Study B: A Longitudinal Study into (a) the Qualitative Assessment
of Food Intake, and (b) the Subjective Experiences of 
Appetite Control During the Menstrual Cycle
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The Influence of ffae Menstrual Cycle on Food Intake and Eating 
Behaviour
8.0 Introduction and Review of the literature
As discussed in Chapter 2, previous studies have indicated that ovarian hormones 
may play a role in modulating eating behaviour ie food intake, food preferences 
and subjective experiences of food intake. Eating behaviour during the menstrual 
cycle has been assessed both quantitatively (ie by measurements of food intake) 
and qualitatively (ie by subjective report measures on perceptual experiences).
With regard to the quantitative methods, both human and animal studies (eg Wade 
1972; Kemnitz et al, 1989) have indicated that oestrogen has an inhibitory effect 
on food intake, and as such total calorific intake has been shown to be consistently 
lower prior to ovulation. The reported preovulatory reduction in actual intake 
quantified has been shown to vary considerably, dependant on the method of 
dietary assessment used; with the more accurate methods providing evidence for a 
more conservative cyclical change. In addition, changes in macronutrient intake (ie 
fat, protein and carbohydrate intake) during the cycle have been investigated. The 
findings are however, less consistent due in part perhaps to the sparse literature, as 
well as to the different methodological approaches applied.
The actual process of food intake is affected by numerous factors, and evidence for 
cognitive and other psychological factors has been established. To assess the 
supposed influence, qualitative studies have been carried out to ascertain if gonadal
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hormones alter taste and perception, and therefore preference for specific foods or 
quantity of food. Results from these studies are however conflicting.
Based on the existing research, the assessment of food intake and eating behaviour 
during the menstrual cycle was investigated in the following two studies. In the 
hope of gaining an insight into possible factors affecting eating control, different 
aspects were studied using both qualitative and quantitative methods. Firstly, in 
study A, subjective experiences of eating behaviour (ie food preferences and stages 
of eating) were monitored by completion of questionnaires during one complete 
menstrual cycle, on a repeated measures basis.
In study B, actual food intake (assessed by the semi weighed method) was 
monitored through two consecutive menstrual cycles to give a quantitative 
indication of the effect of hormonal influence. Subjective experiences of appetite 
(ie stages of eating, dietary restraint and cravings) were also monitored by the use 
of visual analogue scales. Finally, the relationship between subjective experiences 
and actual intake were investigated. In this study, hormonal levels were assessed to 
ensure that the results were related to hormonal changes. The results from the 
various investigations are presented below.
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8.1 STUDY A ;
An Exploratory Investigation into the Subjective Experiences of Appetite
During the Menstrual Cycle.
8.1.1 Aims of the Study
The aim of this study was to investigate if menstrual cycle variation exists in (1) 
food preferences (measured subjectively), and (2) the subjective experiences of the 
four stages of eating ie hunger, appetite, satiation and satiety. The study was 
carried out over one complete menstrual cycle; three defined phases of the cycle 
were monitored ie follicular, luteal and premenstrual. The study was a repeated 
methods design with each phase of the same cycle being tested three times, so that 
nine observations were obtained from each subject (thus minimising intra-individual 
variation). On the basis of previous research, the following hypotheses were tested 
in this study:
(1) That an increased preference for carbohydrate rich foods is noted during the 
premenstrual stage
(2) That a premenstrual increase is observed in the ratio of carbohydrate/protein 
choice, as an indication of a behavioural method to increase serotonin production at 
this stage.
(3) That the perception of both the excitatory (ie hunger and appetite) and 
inhibitory (ie satiation and satiety) processes are altered during the menstrual cycle, 
with an increase in the excitatory processes observed in the luteal and premenstrual 
stages as food intake increases
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8.1.2 Methodology
(a) Subject population
The subjects were volunteers recruited from the postgraduate population at 
Roehampton Institute, London and from advertisements in the local press. All 
subjects were initially screened to ensure they met the established criteria (see 
below) by means of postal questionnaires and subsequent interviews. Subjects were 
advised that this study was investigating factors that may influence women to 
develop an eating disorder, and no mention was made of the menstrual cycle. The 
final population participating in the study consisted of 30 women with regular 
cycles aged between 20 and 40 years (mean 31.41; SD 5.62), and within 90% to 
115% of ideal body weight (range 49-79.4 kg ; mean 61.41; SD 7.75) as 
determined using standardised life insurance tables. However, of the thirty 
subjects, only 20 fully completed all nine observations and hence cyclical analysis 
using Friedman's analysis of variance (ANOVA) was performed only on these 20 
subjects. Informed consent from the subjects was obtained in accordance with the 
regulations of the Ethical Committee of Roehampton Institute, London (RIL) 
(Appendix 12). All information obtained from the subjects was coded to ensure 
anonymity and confidentiality.
(b) Study Criteria
All subjects were screened to ensure that the following criteria were met.
(1) Regular menstrual cycles over the previous six months (ie an average cycle
length of between 26 and 32 days, with an inter cycle variability no greater
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than 4 days).
(2) Aged between 20 - 40 years of age. The lower range was given to ensure 
all participants had been regularly cycling for a few years; the upper range 
to ensure no participants were undergoing the menopause.
(3) Were within 90 % to 115 % of the average mean matched population
weight. This range was set to ensure no participants were greatly under or 
overweight.
(4) Not taking an oral contraceptive pill for the previous six months or during
the study .
(5) No current or previous history of ovarian disorders.
(6) No current or previous history of depression, eating disorders, drinking 
problems.
(7) No current or previous history of any major clinical condition.
(8) Not currently nursing babies.
(9) Not currently on a weight reducing diet or special diet because of a specific
medical condition; or had been on such a diet for the last six months. This 
criteria was set since previous studies have indicated that both acute and 
chronic dieting affects central serotonergic metabolism which may therefore 
alter appetite control.
(10) Not working unusual time schedules (eg shift work).
( i d  Free from all chronic medication.
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8.1.3 Depression Assessment of the Subjects
All subjects were initially screened to ensure that they had no current or past 
psychiatric problems, however to ensure that all subjects participating were not 
currently depressed, the Beck Depression Inventory (BDI) was completed 
(described in Chapter Seven, section 7.1). A total score was calculated on 
completion of the BDI; a score of 15 or greater indicating the presence of possible 
depression. No subject in the group scored 15 or more and thus confirmed the 
absence of depressive symptomology.
8.1.4 Menstrual Cycle Details and the Calculation of Sampling Davs
In view of the nature of the study, the following main factors were determined by 
means of an additional questionnaire (Appendix 13) ie (1) that all subjects had 
regular cycles and details for the previous six months were requested; (2) that no 
subjects were currently taking oral or depot contraception, or had been in the past 
six months; (3) the average length of the subjects cycles over the past 6 months, 
with particular reference to their current cycle; and (4) any current or previous 
history of gynaecological disorders. From this data the sampling dates for the 
collection of urine samples was calculated as described below. Of the three phases 
that were investigated, endogenous hormone levels were predicted to be as follows 
(Table 11).
Phase Days of Cycle Oestrogen Levels Progesterone Levels
Follicular 9, 10, 11 High Stable
Luteal 19, 20, 21 Rising Rising
Premenstrual 24, 25, 26 Low Reducing/Low
*for subjects whose cycle length exceeded or was less than 28 days, the collection days were determined on a pro rata basis.
Table 11. Predicted Hormonal Levels for the Sampling Dates during the Menstrual 
Cycle for Study A.
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On completion of the study, the length of each subject's menstrual cycle was 
established to ensure that it was equal to the estimated length, and that the data 
collection days reflected the appropriate menstrual cycle phase.
8.1.5 Study Design and Procedures for Study A
To assess food preferences and subjective appetite experiences during the menstrual 
cycle, all subjects were asked to complete the subjective appetite questionnaire two 
hours after breakfast on each of their sampling days (see Appendix 14). They were 
advised to answer the questions based on their feelings at the moment of its 
completion, and not to think about the answers in depth but to answer on their 
initial reactions. Question 5 consisted of a checklist of common food items and 
subjects were asked to tick off which foods that they felt like eating immediately. 
Subjects were advised that foods should not be chosen on the basis of choosing a 
meal but that each food should be considered independently. As many or as little 
food items could be chosen, and if there was a food item that the subject 
particularly felt like eating, they were advised to note it under 'Others'.
8.1.6 Questionnaire Design
The questionnaire was based on the design of Hill's questionnaire (Hill, 1986; 
Blundell and Hill, 1987) which was developed to assess short term appetite, hunger 
and satiety levels. For the purposes of this study, the questionnaire was modified to 
include a vegetarian choice of food in the protein category, and to give the subject 
an opportunity to identify a particular food that they particularly felt like eating
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but was not on the list. These amendments will be discussed in more detail in the 
following text.
The questionnaire was composed of five questions in total. Questions 1 to 4 were 
taken from Blundell and Hill (1987), with each question addressing each particular 
facet of feeding behaviour (see Chapter 2, section 2.1 for the definition of terms) ie 
see Table 12.
Question
Number
Feeding Behaviour 
Addressed
1 Hunger Rating
2 Appetite Rating
3 Satiation Rating
4 Satiety Rating
Table 12. Identification of Appetite Rating Questions
Subjects were asked to complete questions 1 to 4. All answers were based on a 
four point unipolar sliding scale rated from nil (score=0) to strong (score=3) 
feelings. The use of such a scale ie using a single construct, ensures a more reliable 
measure of each facet of eating.
The final question, number 5, consisted of a list of food items that the subjects 
chose to give a reflection of food preferences. Subjects were asked to choose as 
many or as few items from the list, that they wished to eat immediately. The 
checklist of foods identified was composed of four categories listed below. The low 
energy foods were included to give a balanced choice. In each category there is a
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total of 8 food items, and half the items are sweet and half savoury (excepting of 
course the high protein items which are all savoury). The items listed are 
considered to be readily accessible "westernised food" and were assessed for their 
macronutrient content by Compeat 4 Database to ensure that they did in fact reflect 
accurately the group to which they belonged.
Categoiy Macronutrient
1 High Carbohydrate
2 High Protein
3 High Fat |
4 Low Energy
Table 13. Identification of Food Categories in the Appetite Questionnaire
The mean macronutrient content of the three groups (ie high carbohydrate, protein 
or fat) are identified in Table 13. The macronutrient breakdown for each individual 
food item is listed in Appendix 15. An inherent problems with devising the food 
checklist was that by changing the percentage macronutrient content of a food 
automatically resulted in another macronutrient contents being altered. However, 
the means below (Table 14) indicate that all items were reflective of their category. 
[All food items except the low energy group, had a standardised calorific energy 
content of between 180 to 220 Kcal to remove one of the confounding factors that 
could invalidate the questionnaire]
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1Categoiy % Carbohydrate % Protein % Fat
High carbohydrate 76.9 12.45 10.6
(14.165) (9.407) (10.086)
High Protein 2.1 66.1 31.85
(3.869) (14.892) (13.660)
High Fat 17.5 10.5 71.77
(17.335) (8.486) (15.241)
Table 14. Mean macronutrient content of categories in the appetite questionnaire. 
(Standard deviations in parentheses).
Some of the items listed in the Blundell and Hill's questionnaire (1987) were 
included in the list. One of the problems encountered by the authors was that 
vegetarians were not catered for in the protein category, which could skew results, 
reducing reliability of the questionnaire. Therefore, food items specifically chosen 
for vegetarians (ie cottage cheese and lentil/chickpea dahl) were included on the 
list. In addition to the checklist, subjects were given the opportunity to list other 
foods that they particularly felt like eating but were not listed. [Hill (1986) showed 
reduced specificity if the subjects did not have "personal" choices available, and 
the inclusion of "Others" addressed this].
Pilgrim and Kamen (1963) showed that a disclosure of an individuals preference 
for food did correlate well with their actual food intake. Hill (1986) also 
demonstrated good correlation between food preferences chosen and actual food 
intake. The overall reliability of the questionnaire was determined at r = 0.60, 
however, correlations with individual macronutrient preference was wide, ranging 
from r = 0.215 to r = 0.881. A high protein choice significantly correlated well
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with actual protein intake, and a high carbohydrate choice with actual carbohydrate 
intake.
8.1.7 Analysis of the Appetite Questionnaire
The questionnaire was scored by hand. For questions 1 to 4 (inclusive), the rating 
scales were assessed by assigning an ordinal value of 0 to 3, with 3 representing in 
all cases, the strongest feeling ranked. For question 5, the total number of each 
macronutrient listed were totalled and the sum of all the totals was calculated. If 
subjects had noted a particular food item under 'Others', the item was analysed by 
Compeat 4 Database for analysis of its macronutrient content and assigned to the 
correct group. Therefore for each group of items listed, the range of values that 
could be determined was 0 to 8. Comparisons of the totals were made between the 
phases.
8.1.8 Statistical Analysis
The data obtained from study one was of an ordinal nature and therefore non 
parametric analysis was appropriate. The complete data set (ie based on 20 
subjects) was analysed to determine any cyclical effects, using SPSS for Windows 
by the use of Friedman's one way analysis of variance (ANOVA). Statistical 
significance was assumed to have occurred when p was equal to or less than 0.05. 
Post hoc analysis, to identify where in the cycle significant differences occurred, 
was performed using Wilcoxon rank sum test.
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8.2 Results for Study A.
8.2.1 Menstrual Cycle Related Preferences for Food Types 
Of the thirty subjects, only twenty subjects fully completed questionnaires 
throughout the three phases of one menstrual cycle regarding their preferences for 
macronutrients, two hours after breakfast. Menstrual cycle alterations in preferences 
were assessed by Friedman's ANOVA using only the data with a complete data set. 
The relative choice for each macronutrient per total choice was determined; as 
some macronutrients were not selected by the subject, the N values of these ratios 
(identified in Table 15) are therefore lower than N=20. The results are shown in 
Table 15.
Macronutrient n " Follicular Luteal Premenstrual Friedmans' 
ANOVA (df=2)
CHO 20 1.59 (1.48) 1.50 (1.41) 1.86 (1.49) X2 = 0.9000 
p = 0.638
Protein 20 0.28 (0.59) 0.37 (0.76) 0.95 (1.72) X2 = 0.3250 
p = 0.850
Fat 20 1.24 (1.27) 1.20 (1.10) 1.24 (1.61) X2 = 0.4000 
p = 0.819
Low calorie 20 1.41 (1.64) 1.13 (1.63) 1.52 (1.72) X2 = 0.4000 
p = 0.819
Total 20 4.45 (3.38) 4.23 (3.31) 5.43 (5.28) X2 =0.4750 
p = 0.789
Ratios
Protein/CHO 9 0.14 (0.31) 0.24 (0.38) 0.55 (0.83) X2 = 0.3889 
p = 0.823
CHO/Total 13 0.38 (0.28) 0.37 (0.30) 0.45 (0.25) X2 = 8.423 
p = 0.015*
Protein/Total 13 0.05 (0.10) 0.06 (0.10) 0.11 (0.13) X2 = 0.0385 
p =0.981
Fat/Total 13 0.31 (0.27) 0.27 (0.24) 0.21 (0.18) X2 = 0.4615 
p = 0.794
Low calorie/Total 13 0.29 (0.29) 0.29 (0.36) 0.28 (0.22) X2 =0.8077 
p = 0.6677
Table 15. Subjective Pre: ■erence for Macronutrients Across the Menstrual Cvcle
Assessed in Study A. Standard deviations in parentheses.
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Food choice for the three macronutrients and for low calorific foods did not alter 
significantly during the different phases of the menstrual cycle. The relative ratio of 
protein to carbohydrate intake, a possible indication of a behavioural response to 
alteration of cerebral serotonin synthesis, also did not significantly alter. However, 
a significant changes in the relative ratio of carbohydrate to total food choice was 
identified (%2 = 8.423, df=2, p= 0.015); subsequent analysis (Wilcoxon rank sum 
test) indicating that this preference was significantly higher premenstrually 
compared to the follicular phase only (z=-2.24, p=0.025).
8.2.2 Assessment of the Stages of Appetite During the Menstrual Cvcle 
The process of eating (which consists of the four stages of hunger, appetite, 
satiation and satiety) was assessed during the menstrual cycle. Subjects were asked 
to tick one of four boxes in their response to these four stages, which were 
assigned an ordinal value of 0 to 3, with a score of 3 representing in all cases the 
strongest feeling ranked. Twenty subjects fully completed the assessment during
one complete menstrual cycle. The results are presented in Table 16 below.
Appetite Score N Follicular Luteal Premenstrual Friedmans'
ANOVA
(df=2)
Hunger 20 2.03 (0.50) 2.10 (0.84) 2.14 (0.79) X2 = 0.000 
p = 1.000
Appetite 20 1.93 (0.65) 1.97 (0.89) 2.00 (0.71) X2 =0.2250 
p = 0.894
Satiation 20 1.90 (0.82) 2.00 (0.83) 2.05 (0.80) X2 =1-225 
p =  0.542
Satiety 20 1.93 (0.46) 1.93 (0.74) 2.10 (0.54) X2 =0.5250 
p = 0.769
Table 16. Mean Scores for the Subjective Assessment of the Processes of Eating 
Determined in Study A. Standard deviations in parentheses.
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No significant changes in either the excitatory nor inhibitory processes involved in 
eating were noted across the menstrual cycle. Hunger and appetite ratings increased 
during the cycle, with maximal levels noted premenstrually. The degree of satiation 
(ie "fullness") and satiety (which indicate the desire to continue food intake after a 
period of eating) also increased during the cycle, again with maximal scores noted 
premenstrually. Interestingly, these findings suggest that during the premenstrual 
stage, when the subjects felt most full, they also had the greatest desire to continue 
eating. And conversely, in the follicular stage, although the subjects did not feel as 
"full" they did not have the desire to continue eating after a period of food intake.
To further investigate these findings, cross correlations were performed on the 
whole data set (Spearmans rank), between these distinct stages of eating at each 
stage of the cycle as identified in Tables 17, 18 and 19 below. In all three stages of 
the cycle, hunger ratings, as expected, significantly correlated (a) positively with 
appetite scores; (b) negatively with satiation (ie increased hunger relating to a 
decrease in feeling of fullness); and (c) positively with satiety scores (ie increased 
hunger related to an increased desire to continue eating after a period of food 
intake). Of interest, the satiation and satiety scores correlated negatively during the 
three stages of the cycle, indicating that the greater the feeling of fullness, the less 
the desire was to eat more food after a period of food intake; however, this 
relationship was only significant in the luteal stage of the cycle only (r = -0.560, 
n=30, p=0.001) although near significance was reached in the follicular stage 
(r =-0.339, n=29, p=0.072).
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Follicular Stage Hunger
--------------------------------
Appetite Satiation Satiety
Hunger -
Appetite 1 =  0.772 
(N=29)
-
Satiation
p = 0.000
r = -0.456 r = -0.302 -
(N=29) (N= 29)
p = 0.013 p = 0.112
Satiety r = 0.788 r =  0.706 r = -0.339 -
(N= 29) (N= 29) (N=29)
p=0.000 p = 0.000 p = 0.072
Table 17. Correlations between the Stage of Eating in the Follicular phase of the 
menstrual cycle for Study A
Luteal Stage Hunger Appetite Satiation Satiety
Hunger -
Appetite
Satiation
r = 0.778 
(N=30)
p = 0.000
r = -0.536 
(N=30)
p = 0.002
r = -0.529 
(N= 30) 
p = 0.003
-
Satiety r = 0.813 
(N= 30)
p=0.000
r = 0.692 
(N= 30)
p =  0.000
r = -0.560 
(N=30)
p = 0.001
Table 18. Correlations between the Stage of Eating in the Luteal phase of the 
menstrual cycle for Study A.
Premenstrual Stage Hunger Appetite Satiation Satiety
Hunger -
Appetite r = 0.837 
(N=21)
-
Satiation
p = 0.000
r = -0.632 r  = -0.610
(N=21) (N=21)
p = 0.002 p = 0.003
Satiety r = 0.587 r = 0.517 r = -0.216 -
(N=21) (N= 21) (N=21)
p=0.005 p = 0.016 p = 0.347
Table 19. Correlations between the Stage of Eating in the Premenstrual phase of 
the menstrual cycle for Study A.
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8.3 Discussion of Study A
The assessment of food preferences for macronutrients during the menstrual cycle 
were assessed in this study. No significant cyclical changes were observed in the 
selection for any of the macronutrients. However, for each macronutrient, the 
choice of number of items peaked in the premenstrual stage (and therefore the total 
number of items selected) indicative of increased hunger and appetite for 
carbohydrate rich, protein rich and fat high foods at this stage.
Analysis of the relative preference for macronutrients however did provide support 
for the first hypothesis of this study ie that a significant relative increase (to total 
macronutrients selected) in carbohydrate rich foods occurred in the premenstrual 
stage [relative to the follicular stage (p=0.015)]. This finding has been indicated in 
previous work (eg Rogers et al, 1992; Rogers and Jas, 1994). On the basis that 
increased macronutrient preference is indicative of actual increased macronutrient 
intake, there could be several possible explanations for this increase. Firstly, that 
this increased preference may be a physiological adaptation to the increased basal 
metabolic rate noted premenstrually (Solomon et al, 1982; Webb, 1986). Secondly, 
a behavioural mechanism to increase serotonin production, as a response to 
possible dysphoric mood changes at this time (Wurtman et al, 1989; Sayegh et al, 
1995). However, the ratio of protein to carbohydrate choice preference, calculated 
to give an index of this suggested 5HT mechanism (as suggested in hypothesis 
two), did not support this suggestion since the reverse pattern was observed 
(although not significant). A third possible explanation, that women feel that they
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have a socially acceptable reason for not restraining what they eat, attributing such 
a response to being "premenstrual” (Ussher, 1993, pp 53-55). However, in this 
study the aim of the study was disguised, subjects being advised that they were the 
control group to investigate factors that predispose women to eating problems.
With regard to the influence of menstrual cycle on the subjective experiences of 
the stages of eating, the data did not support the hypothesis investigated. However, 
although non significant, as expected hunger and appetite rating did increase during 
the cycle, as the inhibitory influence of oestrogen was removed (Wade, 1972; 
McCaffrey and Czaja, 1989). What was of particular interest in this study was the 
response of the inhibitory satiety process during the menstrual cycle. As expected, 
the satiation ratings (indicating the degree of fullness) increased during the cycle 
reflecting the concomitant increased hunger and appetite ratings (which are 
predictive of increased food intake). However, the ratings for satiety (reflecting the 
desire for continued food intake after a period of eating) increased premenstrually; 
suggesting a possible dysregulation of the feeding inhibition processes at this stage 
(since maximum desire for further food occurred at a stage when the subjects felt 
most full). Although the findings were not significant, this could partially account 
for the increase in food preference (specifically carbohydrates) seen at this stage. 
The disturbance of this inhibitory process warrants further investigation, since if the 
findings were replicated it could potentially explain the supposed premenstrual 
increased hunger and appetite in "healthy eating" women to the premenstrual 
exacerbation of bulimic episodes in eating disordered population (Pirke et al, 1988;
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Stewart, 1992).
In conclusion, this study did confirm a premenstrual increase in relative 
carbohydrate preference (relative to the total food items selected). However the use 
of self reports for food preferences may not accurately reflect short term changes in 
actual consumption. In addition, the phases of the cycle were based on menstrual 
history and as such the findings could be criticised on the grounds that the stages 
investigated were not clarified. In an attempt to understand the mechanisms 
underlying this alteration, together with a further investigation into the possible 
dysregulation of satiety response premenstrually, the following areas require 
investigation in the subsequent studies. Firstly, is a premenstrual increase in 
carbohydrate intake confirmed when quantitative measures are employed ?
Secondly, what is the possible role of dietary restraint and food cravings, and how 
this may affect actual food intake during the cycle? Thirdly, an investigation of the 
premenstrual alterations of the inhibitory response to food intake in a subsequent 
study with improved methodology, is required. Finally, an investigation of the 
effectiveness of subjective measures compared to objective studies.
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8.4 STUDY B
A Longitudinal Study into (a) the Qualitative Assessment of Food Intake
and (bl the Subjective Experiences of Appetite Control During the 
Menstrual Cycle
8.4.1 Aims of the Study
Study B was carried out to investigate aspects of eating behaviour during the 
menstrual cycle in more depth. The study was redesigned to take into account 
different aims from study A, and in addition to improve the methodology by 
repeating the study over two consecutive cycles and by using hormonal profiling to 
confirm stages of the cycle. The aims for this study are (1) To quantify total 
calorific intake and intake of specific macronutrients during the menstrual cycle.
(2) Further to Study A, to clarify the subjective experiences of food intake (ie the 
different stages of eating) and in addition to assess the possible influence of dietary 
restraint and cravings on food intake, and (3) Finally to assess the relationship 
between actual and subjective experiences of eating during the cycle, and the 
potential relevance of others factors such as exercise that could account for 
observable changes in food intake. The study was investigated in a group of 32 
women over two consecutive menstrual cycles, with three hormonally defined 
stages (ie follicular, luteal and premenstrual) investigated per cycle. The experiment 
was designed on a repeated measures basis, with three observations per phase per 
cycle. The following hypotheses were tested in the study.
(1) That total calorific intake is increased after ovulation due to the removal 
of the effects of high oestrogen levels.
(2) That carbohydrate intake (specifically sugars) is increased 
premenstrually.
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(3) That dysregulation of the inhibitory processes of food intake occurs in 
the premenstrual stage of the cycle and in addition that dietary restraint is 
significantly reduced premenstrually.
(4) That relationships exist between the stages of eating and total calorific 
intake.
8.4.2 Methodology
(a) Subject Population and Study Criteria
The subjects were all volunteers who responded to a series of advertisements in 
the local press between January and April 1995. Subjects did not receive any 
financial renumeration for the study; however they were given a full dietary report 
on completion of the study as a means to aid compliance. Initially approximately 
80 subjects volunteered for the study. All subjects were initially contacted by 
telephone and brief details of the study were provided, ensuring that the aims of 
the study were not obvious. Subjects were selected by sending questionnaires 
which concerned general health (to obtain information concerning their menstrual 
cycles) and a list of criteria necessary for the study (as previously listed in Study 
A) to the subjects.
All subjects were screened to ensure they met the criteria, and thirty two women 
were chosen to take part in the study. The mean age of the subject group was 
30.13 years (SD 5.95), of mean weight 61.66 kg (SD 10.07) and mean height 1.65 
metres (SD 0.07). The mean BMI value for the group was 22.12 (SD 3.06).
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Informed consent was obtained from the subjects in accordance with the regulations 
of the Ethical Committee of RIL (Appendix 12). All information obtained from the 
subjects was coded to ensure anonymity and confidentiality.
(b) Menstrual Cycle Details and Calculation of Sampling Davs
In addition to the study criteria (previously described in Study A), subjects were
asked to provide the following additional information.
(a) To confirm that they had regular menstrual cycles.
(b) That they were not taking the oral contraceptive pill, or receiving hormonal 
depot injections.
(c) To provide details of when their menstrual cycles had been irregular.
(d) To provide details of any current or previous gynaecological disorder.
(e) To provide details (ie dates, complications etc) of any pregnancy.
(f) To confirm that they had not started the menopause, were not taking HRT nor 
experiencing any menopausal symptoms.
(g) To provide the date of the first day of their last period together with the dates 
of the first day of menstruation for the previous six months.
The study was carried out over two consecutive menstrual cycles. Sampling days 
for the three phases in both menstrual cycles were calculated (as previously 
described in Study A, section 8.1.4) according to retrospective analysis of their 
previous six months cycle lengths. All three consecutive phases of the cycle were 
investigated ie follicular, luteal and premenstrual. Subjects were assessed for three
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days in each of the three phases, across both menstrual cycles, making a total of 
18 sampling days per subject. Subsequently, urinary hormonal levels were 
determined to confirm that the sampling days were indicative of the correct 
menstrual cycle phases.
8.4.3 Study Design and Procedures for Study B
On each of the sampling days subjects were asked to complete the following 
procedures.
(1) To provide a prebreakfast urine sample, preserved in 0.1M HC1 (dilution 1:1) 
and kept frozen until assayed for levels of sex steroid hormones (see section 8.4.6) 
and cortisol levels (section 8.4.6). The samples were additionally later analysed for 
analysis of tryptophan and its metabolites for use in Studies D and E. The urine 
samples were regularly collected from the subjects during the duration of the study 
for storage at -80 Oc.
(2) To complete a food diary based on the semi weighed methods (see section 8.4.4 
below) incorporating all food and drink consumed in that 24 hour period. (See 
Appendix 16 for instructions on the completion of the questionnaire; and Appendix 
17 for a copy of the food diary sheet).
(3) To complete, two hours after the evening meal, a questionnaire regarding 
subjective experiences of appetite control. Following on from Study A, the aim of 
this study was to identify any cyclical changes in the subjective experiences of 
hunger, appetite, satiation and satiety with particular reference to the inhibitory 
influences. The questionnaire devised by Blundell and Hill (1987) was used to
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investigate this over two menstrual cycles. However, differing from Study A, a 
100mm visual analogue scale was used (considered to be a more accurate method 
of determining subjective experiences, compared to the method used in Study A; 
Appendix 18). Details of the questionnaire and its scoring are found in sections 
8.1.6 and 8.1.7. In addition, aspects of dietary restraint and food cravings were also 
assessed (by 100mm visual analogue scales; Appendix 18). Dietary restraint was 
assessed by three questions, two relating to restraint for total food intake (one to 
assess subjective experiences of restraint, the other to assess if the subjects had 
disinhibited eating when they perceived from the previous question that restraint 
had failed to control intake), and one investigating restraint for (non specified) food 
types.
(4) In addition, subjects were asked to complete a final questionnaire investigating 
certain factors that may affect eating behaviour two hours after the evening meal. A 
copy of the daily questionnaire can be found in Appendix 19. Visual analogue 
scales (100 mm) were used to assess the subjects' subjective response to (a) level 
of exercise (b) level of stress (c) their relationships with family/partners and close 
friends, (d) their physical health, and (e) how assertive they felt, on each of the 
sampling days. Each factor was scored by measuring where the subject placed the 
line that reflected their feeling.
(5) Finally, subjects were asked to take a vitamin B6 supplement (50mg) for the 
concurrent Study D in which they were also participating.
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8.4.4 Details for the Semi Weighed Method of Food Assessment 
All subjects participating in this study were free living, and an accurate assessment 
of dietary intake was determined using the semi weighed method, described in 
Appendix 1. Dietary intake was assessed on the 18 sampling days over two 
consecutive menstrual cycles. Unknown to the subjects, intake was assessed for 
three days per stage of the cycle ie at the follicular, luteal and premenstrual stages. 
For each phase of the cycle, subjects completed food diaries for a three day 
consecutive period.
Therefore, over the two month period subjects kept dietary records for 6 days per 
phase of the cycle. The days of collection of the data were calculated based on 
their menstrual cycle ie
Davs of Cycle *
Follicular 9,10,11
Luteal 18,19,20
Premenstrual 25,26,27
^assuming a 28 day cycle
However, in view of the reported difference between weekday (Monday to 
Thursday) and weekend (Friday to Sunday) intake, these days were adjusted 
slightly to ensure that of each of the six days assessed per phase, two related to 
weekend food intake.
Subjects were interviewed prior to commencement of the study to give instruction 
to complete a food diary. Summarised notes were left with the subjects (Appendix 
16) together with a copy of the dietary record sheets used (Appendix 17). Subjects
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were advised that the purpose of the study was to compare dietary intake from 
physically healthy women with a group of women with eating problems. Emphasis 
was made to try to ensure that the subjects did not change their diet. Subjects were 
advised that certain chemicals would be measured in their urine samples to 
validate their food diaries. To increase compliance and dedication, subjects were 
told they would be given a report at the end of the study on their dietary intake 
which would highlight any recommendations to optimise the nutritive balance of 
their diet. No mention was made of the real aim of the study ie to look at 
menstrually related changes in diet. The following instructions were given to 
subjects, based on the method described in Nelson and Nettleton (1980).
Procedures Used for the Assessment of Dietary Intake in Study B _
1. All food consumed should be weighed where possible to the nearest gram or ounce
2. Where it was not possible to weigh food, subjects were asked to estimate food portion sizes based on 
household measures. Subsequently, the weight of the portion was calculated.
3. All foods and drinks should be recorded on the food diary, preferably at the time of consumption. It was 
explained that the description should be as accurate and specific as possible ie noting the type of bread, fat 
content of butter or margarine, and the manufacturer if possible. If prepared meals were used, then the 
subjects were asked to keep the nutritional details with the food diary. Where home cooked meals were 
concerned, subjects were asked to write down the recipe and weigh out all constituents and estimate the 
portion sizes they consumed. For drinks such as coffee and tea, subjects were asked to record only once the 
actual amount of milk and sugar used normally ; on subsequent occasions this would be referred to.
4. For snack items such as crisps and bars of chocolate, only the size and manufacturers name was noted.
5. Subjects were also asked to keep a note of any alcohol that was consumed, noted in pub measures.
6. At the end of the day, subjects were advised to recheck their diary to ensure no food was missed out.
8.4.5 Analysis of Dietary Intake
Food intake details were analysed using Compeat 4 database. A time program was 
set up for each individual to be able to identify each day of the menstrual cycle
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completed, and in addition to take into account weekend versus week day intake. 
For each subject participating, the dietary data was analysed for each day recorded 
and for each phase of the menstrual cycle completed. Therefore from this analysis 
it was possible to analyse both daily and menstrual cycle variations in intake.
8.4.6 Analytic Methods Used in Study B
Prebreakast urine samples were assayed for the measurement of female sex 
hormones, creatinine levels and cortisol.
(a) Urinary creatinine and urinary cortisol levels
Details for both these procedures can be found in Chapter Seven, sections 7.7 and 
7.8 respectively. Both urinary levels of cortisol and creatinine are expressed in 
concentrations of pmol/1.
(b) Urinary Hormonal Determination
The hormonal levels, ie estrone glucuronide (nM/L), pregnenlione glucoronide 
(nM/L) and fragmented leutinising hormone (IU/L), were determined by 
fluoroimmunoassay (Kesner et al, 1994; see Chapter Seven, section 7.9) from each 
urine sample for each subject. The assays were performed by Dr G Barnard at the 
Regional Endocrine Unit, Southampton University. To account for the variation of 
urine concentration, the hormonal levels were adjusted by the appropriate creatinine 
values. The results for each subject were plotted to ascertain that the cycles were 
ovulatory and that the days investigated were representative of the phases 
investigated. For comparison, a hormone profile from an abnormal and normal 
menstrual cycle are shown in Appendix 20. The results from six of the subjects did
160
not follow the expected trend for hormone levels ie
Subject Number Cycle
1 Two
5 Two
6 Two
7 Two
19 One
34 One
and the data from these cycles was therefore omitted from analysis of the
respective cycles (therefore 10% of the original data was omitted from the data
set); the mean values for the mean of both cycles were therefore calculated from
the remaining data set. Both estrone and pregnenlione glucuronide are indexes of
plasma oestrogens and progestagens, and as such it was not possible to correlate
levels of these with the tryptophan data (in Study D); additionally due to the
acidification of the samples (by the acid preservative), only fragmented LuH levels
could be determined. The mean hormonal levels for the group (for the mean of
both cycles) are presented in Table 20 and the results indicate the great degree of
inter-subject variation for the hormonal levels at each stage of the cycle.
Phase of the Cycle Estrone glucoronide 
(nmol/1)
Pregnanediol 
glucoronide (fimol/1)
Fragmented 
Leutinising hormone 
(IU/L)
Follicular tN=32'>
mean
range
3.17 (2.61) 
0.369 - 11.087
0.28 (0.33) 
0.0108 - 1.8709
0.51 (0.63) 
0.0241 - 2.897
Luteal fN=32')
mean
range
4.75 (3.42) 
1.172 - 16.893
1.15 (1.27) 
0.0180 - 5.1344
1.28 (2.19) 
0.0885 - 12.5526
Premenstrual (N=32)
mean
range
3.64 (3.02) 
0.404 - 16.548
1.44 (1.22) 
0.1991 - 5.387
0.44 (0.66) 
0.0374 - 3.5827
Table 20. Mean levels, and range of concentrations of estrone glucoronide.
pregnanediol glucoronide and fragmented leutinising hormones for the mean of 
both cycles of Study B. Standard deviations in parentheses.
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8.4.7 Statistical Analysis
Mean values for the data per phase of the menstrual cycle were determined for the 
mean of both menstrual cycles, and for cycle one and cycle two seperately, prior to 
statistical analysis. Only the results for the mean values of both menstrual cycles 
are presented here.
(1) Dietary Intake Data
For the use of a parametric test (ie repeated measures analysis of variance, 
ANOVA), on this data several criteria are required to be met. These include that 
the level of measurement must be at least interval, homogeneity of variance ie that 
the variances of the three time samples are not significantly different and finally 
that the data is normally distributed. As the data obtained from the dietary records 
was interval measurement, the data was explored and confirmed that the criteria for 
use of parametric analysis were met. Therefore to assess changes in both actual and 
percentage macronutrient intake during the menstrual cycle, the data was analysed 
using repeated measures (ANOVA) on SPSS for Windows. There are 2 degrees of 
freedom for all analysis.
As a result of both missing data values, and the removal of the data points from 
the non ovulatory cycles, the total subject numbers for cycle one were n=29 (ie two 
subjects with anovulatory cycles, and one with missing data), for cycle two, n=23 
(ie four subjects with anovulatory cycles, and five with missing data). However, 
since no subject had anvoulatory cycles for both cycles one and two, subject 
numbers for the mean of both cycles one and two were n=32. Significant 
differences were assumed to have occurred when p was equal to or less than 0.05.
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Any significant main effects of cycle were then subsequently analysed by paired t 
tests, to identify where the significant differences occurred in the phases of the 
cycle.
(2\ Subjective Measurements of Appetite and General Data
As discussed in Study A, the data obtained from the visual analogue scales is of an 
ordinal nature and therefore cyclical effects were assessed by Friedman's ANOVA, 
with post hoc analysis using Wilcoxon rank sum test where appropriate.
8.5 Results For Study B.
8.5.1 Section A. The Qualitative Assessment of Food Intake During the Menstrual 
Cycle
(a) Actual Macronutrient Intake
Cyclical changes in total energy intake, macronutrient and micronutrient intake 
were assessed by repeated measures ANOVA. The results for the mean of both 
cycles are identified in Table 21.
The following results were found to be consistent across both cycles, and therefore 
for the mean of both cycles. Total energy intake (KCal) increased throughout the 
cycle (7.59% increase), maximal levels noted premenstrually. This was reflected in 
the intake of both protein (7.66 % increase), fat (8.15% increase), carbohydrate 
(8.63% increase) specifically sugar intake (14.41% increase). Indeed when the 
mean cycles were analysed sugar intake significantly altered during the cycle 
[F(2,32)= 3.27, p=0.045] (refer to Graph 1). Further analysis (paired t tests) showed
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Macro/mi cro-rmtrient (g) Follicular Luteal Premenstrual N Anova 
p value
KCalorie 2010 2090 2158 32 0.174
(485) (564) (505)
% inc rel to follicular 100% 103.98% 107.39%
Protein 70.09 71.79 75.60 32 0.195
(16.42) (19.13) (16.16)
% inc rel to follicular 100% 102.43% 107.86%
Fat 86.74 89.81 93.79 32 0.357
(28.66) (31.02) (28.41)
% inc tel to follicular 100% 103.54% 108.13%
Carbohydrate 231.52 243.17 251.51 32 0.109
(64.11) (82.59) (70.79)
% inc rel to follicular 100% 105.03% 108.63%
Starch 130.13 138.42 136.96 32 0.461
(34.67) (46.70) (39.80)
% inc rel to follicular 100% 106.37% 105.25%
Sugar 94.26 98.50 107.84 32 0.045*
(35.57) (42.74) (37.52)
% inc rel to follicular 100% 104.50% 114.41%
Table 21. Mean Energy Intake. Actual Macronutrient and Micronutrient Intake For 
the Mean of Both Menstrual Cycles in Study B . Standard deviations in 
parentheses.
Mean intake of macronutrients during the menstrual cycle
Mean of both cycles
Actual intake (grammes)
------------ I ■Follicular (mean)
aLuteal (Mean) 
FMXQ45 - ■Premenstrual (Met in)
Protein Fat Carbohydrate Starch
Macronutrient
Graph 1. Mean Macronutrient and Micronutrient Intake Putins the Menstrual Cycle
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that the intake of sugar was significantly higher premenstrually compared to both 
the follicular (t=-2.45, p=0.020) and the luteal (t=-2.13, p=0.042) stages. The intake 
of starch was however, maximal in the luteal phase (6.57 % increase).
(b) Percentage Macronutrient Intake
The intake of each macronutrient and micronutrient was expressed as a percentage 
of the total energy intake. To determine if the percentage intake altered across the 
cycle for each macronutrient or micronutrient, the data were analysed by repeated 
measures analysis of variance. The results for the mean of both cycles are 
identified in Table 22.
Percentage
Macro/micronutrient
Follicular Luteal Premenstrual N Anova 
p value
Protein 14.21 (2.19) 14.01(2.36) 14.68 (2.76) 32 0.296
Fat 38.14 (6.47) 38.64 (7.37) 38.87 (5.46) 32 0.801
Carbohydrate 43.91 (6.44) 43.50 (7.53) 43.72 (5.80) 32 0.917
Starch 24.07 (4.85) 24.05 (4.63) 25.23 (4.91) 32 0.316
Sugar 18.80 (4.56) 18.58 (4.44) 17.53 (4.39) 32 0.206
Table 22. Mean Percentage Macronutrient and Micronutrient Intake For the Mean 
of both Menstrual cycles in Study B. Standard deviations in parentheses
For the mean of both cycles, no significant cyclical alterations in the percentage 
energy obtained from either macronutrient nor micronutrient were identified (see 
Graph 2). In addition, the percentage energy intake during both the cycles was not 
consistent; the mean results from both cycles are as follows. Both protein and 
starch energy intake were maximal premenstrually, minimal in the luteal phase; fat 
energy intake maximal premenstrually, minimal in the follicular phase; 
carbohydrate maximal premenstrually, minimal luteal phase; and sugar intake
maximal follicular phase minimal premenstrually. These results differed from the 
actual levels of macronutrient intake.
Mean percentage macronutrient intake during the menstrual cycle
Graph 2. Mean percentage Macronutrient and Micronutrient intake During the 
Menstrual Cycle
Analysis of the data from cycle two identified significant cyclical effects for both 
percentage intake of starch [F(2,23)=5.17, p=0.010] and sugar [F(2,23)=4.74, 
p=0.014). Further analysis (paired t tests) identified that starch intake was 
significantly higher in the premenstrual phase compared to both the follicular (t=- 
2.50, p=0.020) and luteal stages (t=-2.10, p=0.047). The percentage intake of sugar, 
however, was significantly elevated in the follicular stage, compared to the 
premenstrual stage (t=2.70, p=0.013).
Mean of both cycles
Percentage intake
o
■Follicular (mean) 
□Luteal (Mean) 
■Premenstrual (Me in)
% Protein % Fat % Carbohydrate % Starch % Sugar
Macronutrient
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(c) Daily Variability of Macronutrient Intake and Percentage Macronutrient 
Intake
To determine if there were any significant changes in the daily intake of the 
macronutrients (both absolute and percentage) or total calorific intake, which may 
contribute to cyclical changes, the daily variability was determined for each phase 
of both cycles by repeated measures ANOVA, with post hoc analysis (paired t 
tests) where applicable. No variation in either macronutrient intake (absolute and 
percentage), nor total calorific intake, was consistently observed per phase of the 
cycle.
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8.5.2 SECTION B.The Subjective Experience of Appetite Control During the 
Menstrual Cycle
(a) The Assessment of Food Cravings and Dietary Restraint During the 
Menstrual Cycle
Dietary intake may, in part, be affected by dietary restraint or cravings for specific 
food types. These potential factors were assessed in 32 subjects by the completion 
of 100mm visual analogue scales throughout two consecutive menstrual cycles. The 
scales were scored by hand measuring (in cm) where the subject had scores the 
scale. Hence the subjects were assigned a value of between 0.0 to 10.0 for each 
factor assessed. The direction of scoring as follows.
Factor High Score Indicating
Restraint on food types Low restraint
Restraint on amount of food Low restraint
Loss of restraint (for amount) Low restraint
Cravings Craved more
Phases of the cycles were determined by hormonal levels. The data was analysed to 
determine any cycle related alterations by the non parametric test, Friedman's 
ANOVA. As a result of either or both missing data values, and the removal of the 
data points from the non ovulatory cycles, the total subject numbers for cycle one 
were n=30 (ie two subjects with anovulatory cycles), for cycle two, n=25 (ie four 
subjects with anovulatory cycles, and three with missing data). However, since no 
subject had anvoulatory cycles for both cycles one and two, subject numbers for 
the mean of both cycles one and two were n=32.
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The results are shown in Table 23 for the mean of both cycles. No significant 
changes were noted on any aspect of dietary restraint nor on feelings of food 
cravings during the phases of the cycle.
Subjective Appetite N Follicular Luteal Premenstrual Friedmans
ANOVA
(df=2)
Restraint - food types 32 6.59 (1.53) 6.89 (1.76) 6.85 (2.10) X -1-313 
p=0.519
Restrained on amount of 
food wanted
32 7.20 (1.36) 7.66 (1.35) 7.38 (1.34) X2=0.484
p=0.785
Ate more than wanted 32 4.19 (1.92) 5.02 (1.73) 4.60 (1.31) X -1-938 
p=0.380
Cravings 32 3.70 (1.90) 5.00 (5.97) 4.19 (2.30) X2=0.438
p=0.804
Table 23. Subjective Assessment of Dietary Restraint and Food Cravings During 
the Menstrual Cycle (Study BT for the Mean of both Menstrual Cycles. Standard 
deviations in parentheses.
(b) The Assessment of the Stages of Appetite During the Menstrual Cycle
The process of eating (which consists of the four stages of hunger, appetite,
satiation and satiety) was assessed during the menstrual cycle. In this study,
100mm visual analogue scales were used to assess the stages of eating. Thirty two
women initially completed the scales at each phase of the cycle, over two complete
menstrual cycles. The scales were scored by hand by measuring where the subjects
scored the scale, in cm. Hence the subjects were assigned a value of between 0.0 to
10.0 for each factor assessed. The direction of the scoring being as follows
Stage of eating High Score Indicating
Hunger Not hungry
Appetite No appetite
Satiation Not very full
Satiety No desire to continue eating
Hormonal analysis was used to identify correct phases of the cycle. The data was
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analysed by Friedmans ANOVA, and the results for both cycles investigated, 
together with the mean results of both cycles are shown in Table 31 below.
No significant effects of cycle were noted for the assessment of either hunger, 
satiation nor satiety. Appetite scores however, did significantly alter during the 
cycle (p=0.048), although subsequent analysis (Wilcoxon rank test) did not reveal 
any significant phase differences. The data for both the appetite and satiety ratings 
were identified as being consistent in their trends across both cycles assessed; the 
scores indicating that their appetite was highest in the luteal stage, lowest in the 
follicular; and that in the follicular stage, the subjects had least desire to continue 
eating, but wished to continue eating premenstrually. The direction of trends for the 
appetite and hunger ratings surprisingly did not follow the same pattern, and 
neither for the inhibitory processes of eating (ie satiation and satiety ratings). 
However, the results did indicate that in the premenstrual stage, subjects felt most 
hungry, least full and indicated that they could continue to consume more food 
after their period of food intake.
Subjective Appetite N Follicular Luteal Premenstrual Friedmans
ANOVA
(df=2)
Hunger 32 7.69 (1.69) 7.81 (1.62) 7.66 (1.78) Xi=0.578
p=0.749
Appetite 32 8.09 (1.58) 7.72 (1.62) 7.79 (1.78) X2=6.063 
p=0.048*
Satiation 32 3.34 (1.71) 3.06 (1.83) 3.40 (1.87) X -3.25
p=0.197
Satiety 32 7.36 (1.87) 7.12 (1.87) 7.01 (1.98) X2=l-563 
p =0.458
Table 24. Mean Scores for the Stages of Eating Assessed during the Menstrual 
Cycle in Study B. for the Mean of both cycles. Standard deviations in parentheses
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To ascertain that the inhibitory processes were linked to the excitatory processes, 
cross correlations were performed on the mean scores of both cycles (Spearmans 
rank) between these stages of eating as shown below in Tables 25, 26 and 27.
Follicular Stage 
(n=32)
Hunger Appetite Satiation Satiety
Hunger .
Appetite r=0.774, p =0.000 -
Satiation r=-0.489 p=0.005 r=-0.487, p=0.005 -
Satiety r=0.750 p=0.000 r=0.665, p =0.000 r=-0.719 p =0.000 -
Table 25. Correlations between the scores for the stages of eating during the 
follicular stage for the mean of both menstrual cycles
Luteal Stage 
(n=32)
Hunger Appetite Satiation Satiety
Hunger -
Appetite r=0.796, p=0.000 -
Satiation r=-0.622 p=0.000 r=-0.729, p=0.000 -
Satiety r=0.741, p =0.000 r=0.727, p=0.000 r=-0.847, p=0.000 -
Table 26. Correlations between the scores for the stages of eating during the luteal 
stage for the mean of both menstrual cycles
Premenstrual Stage 
(n=32)
Hunger Appetite Satiation Satiety
Hunger „
Appetite r=0.950, p=0.000 •
Satiation r=-0.751, p=0.000 r=-0.738, p=0.000 -
Satiety r=0.923, p=0.000 r=0.882, p=0.000 r=-0.805, p =0.000 -
Table 27. Correlations between the scores for the stages of eating during the 
premenstrual stage for the mean of both menstrual cycles
The results from this second study, confirmed the findings from the previous study. 
That is, in all three stages of the cycle, hunger ratings, as expected, significantly 
correlated (a) positively with appetite scores; (b) negatively with satiation (ie
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increased hunger relating to a decrease in feeling of fullness); and (c) positively 
with satiety scores (ie increased hunger related to an increased desire to continue 
eating after a period of food intake). The correlational coefficients in this study 
though were considerably higher than Study A. The relationship between the scores 
for satiation and satiety showed a significant inverse correlation; however, unlike 
the previous study, this relationship was significant for all three stages of the 
cycles, indicating that the more full the subject felt, the less the desire there was to 
continue eating.
(c) The Relationship between Food Intake. Stress and External Factors 
A study was performed through two consecutive menstrual cycles to assess how 
other factors may contribute to changes in food intake during the menstrual cycle. 
Stress was assessed quantitatively (from prebreakfast urinary cortisol levels, nb in 
only 19 subjects) and qualitatively (by means of a visual analogue scale). Other 
factors ie levels of exercise, relationships, physical health and assertiveness were 
also determined (in N=32 subjects) by means of visual analogue scales. Mean 
values for these factors, during the menstrual cycles are shown in Table 28 below, 
and represented graphically in Graph 3. Differences between the stages of the 
menstrual cycle were determined by Friedman’s ANOVA (df=2).
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S ta g e  o f  C y c le U rin a ry  
C o r tis o l  le v e ls
E x e rc is e S tre s s e d /
h a s s le d
R e la t io n s h ip s P h y s ic a l  H e a l th A s s e r tiv e n e s s
F o ll ic u la r  
M e a n  o f  b o th  
c y c le s  
C y c le  O n e  
C y c le  T w o
0 .4 2  (1 .3 3 )
0 .0 7  (0 .0 6 )  
0 .9 3  (2 .9 8 )
4 .6 6  (1 .3 1 )  
4 .2 7  (1 .3 1 )  
5 .0 9  (1 .9 2 )
4 .6 3  (2 .0 4 )  
4 .3 9  (2 .4 3 )  
4 .8 4  (2 .7 7 )
6 .9 5  (1 .7 9 )  
6 .6 8  (2 .0 7 )  
7 .4 8  (1 .7 1 )
5 .9 7  (1 .6 8 )  
5 .7 8  (1 .9 0 )  
6 .3 0  (2 .7 1 )
5 .7 9  (1 .3 4 )  
5 .7 7  (1 .8 3 )  
5 .8 3  (2 .3 5 )
L u te a l
M e a n  o f  b o th  
c y c le s  
C y c le  O n e  
C y c le  T w o
0 .1 8  (0 .3 4 )  
0 .0 7  (0 .0 5 )  
0 .3 3  (0 .7 2 )
4 .5 6  (1 .3 3 )  
4 .6 3  (1 .6 2 )  
4 .5 4  (1 .7 2 )
5 .4 5  (1 .5 9 )  
5 .4 4  (1 .8 9 )  
5 .6 6  (1 .7 3 )
6 .6 2  (1 .3 2 )  
6 .4 7  (1 .8 6 )  
6 .7 2  (1 .5 8 )
5 .7 5  (1 .8 2 )  
6 .1 8  (1 .8 5 )  
5 .2 4  (1 .9 3 )
5 .5 7  (1 .1 4 )  
5 .8 0  (1 .4 2 )  
5 .2 5  (1 .3 7 )
P re m e n s tru a l
M e a n  o f  b o th  
c y c le s  
C y c le  O n e  
C y c le  T w o
0 .1 9  (0 .2 9 )  
0 .2 4  (0 .5 1 )  
0 .1 5  (0 .1 3 )
4 .5 6  (1 .2 9 )  
4 .5 4  (1 .9 2 )  
4 .5 2  (1 .5 2 )
4 .9 7  (1 .6 2 )  
5 .1 8  (1 .9 0 )  
4 .4 5  (1 .9 7 )
6 .7 9  (1 .5 6 )
6 .91  (1 .6 8 )
6 .91  (1 .4 8 )
5 .7 4  (1 .5 4 )  
6 .0 0  (1 .8 4 )  
5 .71  (2 .2 5 )
5 .6 3  (1 .4 2 )  
5 .6 6  (1 .9 3 )  
5 .7 4  (1 .3 8 )
A N O V A / 
F r ie d m a n s  
A N O V A  
M e a n  o f  b o th  
c y c le s
C y c le  O n e
C y c le  T w o
X2= 0 .4 2 1 ,n = 1 9 ,
p = 0 .8 1 0
X2= 0 .8 2 4 ,n = 1 7 ,
p = 0 .6 6 3
r ^ O . 5 3 3 ^ 1 5 ,
p = 0 .7 6 6
%2= 0 .2 5 ,n = 3 2 ,p
= 0 .8 8 3
X2= 2 .9 7 ,n = 2 9 ,p
= 0 .2 2 7
X2= 0 .6 1 ^ = 2 3 ,p
= 0 .7 3 8
X2= 5 .6 9 ,n = 3 2 ,p
= 0 .0 5 8
%2= 5 .7 9 ,n = 2 9 ,p
= 0 .0 5 5
)C2= 5 .5 7 4 i= 2 3 ,p
= 0 .0 6 2
X2= 3 .8 1  ,n = 3 2 ,p  
= 0 .1 4 9
X2= 2 .8 1 ,n = 2 9 ,p
= 0 .2 4 5
%2= 3 .9 3 ,n = 2 3 ,p
= 0 .1 4 0
X2= 0 .2 5 ,n = 3 2 ,p
= 0 .8 8 3
X2= 2 .1 4 ,n = 2 9 ,p
= 0 .3 4 3
X2= 5 .3 0 ,n = 2 3 ,p
= 0 .0 7 1
%2= 3 .2 5 ,n = 3 2 ,
p = 0 .1 9 7
f = \  ,4 5 ,n = 2 9 ,
p = 0 .4 8 5
X2= 0 .6 1 ,n = 2 3 ,
p = 0 .7 3 8
Table 28. Mean values for urinary cortisol levels, and external factors during 
phases of the menstrual cycles. Standard deviations in parentheses.
Other factors during the menstrual cycle
Mean of both cycles
Mean score
■Follicular (Mean) 
oLuteal (Mean) 
■Premenstrual (Me; n)
Exercise Relationships Physical Health Assertiveness
Factors
Graph S. Assessment o f Other Factors Potentially A ffecting Food Intake and Eatins 
Behaviour
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Urinary levels of cortisol were highest in the follicular stage of the menstrual cycle; 
no cyclical effects though were noted in its excretion (NB cortisol levels were only 
measured in 19 of the subjects). Subjective levels of stress were maximal in the 
luteal stage, minimal in the follicular stage, nearing significance [F(2,32)=5.69, 
p=0.058]. The other factors assessed (ie degree of exercise, relationships, physical 
health and degree of assertiveness) in addition did not exhibit any cyclical 
variations across the stages of the menstrual cycles.
Correlations between urinaiy cortisol levels and subjective measures of stress were 
performed (Spearmans rank). A weak significant correlation was noted in the 
premenstrual phase of the cycle only (r=0.484, n=19, p=0.036).
Spearmans rank correlations were performed to assess the relationship between 
both the urinary cortisol data and the questionnaire assessed data (ie exercise, 
subjective stress, relationship, physical health and assertiveness) and food intake.
The overall results for the follicular, luteal and premenstrual stages for the mean of 
both cycles, for cycle one and cycle two are found in the Appendix 21, Tables 1 
(a,b,c), 2 (a,b,c) and 3 (a,b,c) respectively. Only the significant findings are 
identified below.
The relationship between stress and food intake was assessed by both subjective 
assessment and by cortisol levels. No consistent relationship was identified between 
subjective experiences of stress with calorific intake, nor with the macronutrient
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intake during the phases of the cycles. With regard to the cortisol measurements, a 
significant relationship was identified between urinary levels of cortisol and total 
calorific intake in the luteal stage only (r =-0.467, n=19, p=0.044) (indicative of 
increased food intake, with less stress). No consistent relationship was identified 
with macronutrient intake however during any phase of the menstrual cycle. 
Cortisol levels, in addition, were shown to correlate with satiation 
(r=-0.558,n=19,p=0.013) and satiety (r=0.595,n=19,p=0.007) in the follicular stage 
only; indicating that higher cortisol excretion levels related to less feeling of 
fullness but no desire to continue eating after a period of food consumption.
With regard to the relationships between food intake and either the degree of 
exercise, relationships, physical health and assertiveness, no significant results were 
identified.
8.5.3 Section C. The Relationship between Subjective and Actual Experiences of 
Food Intake
To investigate a putative relationship between subjective experiences of eating and 
actual food intake, appropriate correlations were carried out between the relevant 
variables between section A and section B. As the actual dietary intake data was 
correlated with ordinal data, Spearmans rank correlational tests were employed for 
cycles one, two and the mean of both cycles. The total results can be found in 
Appendix 21, Tables 4, 5 and 6. The important significant findings are as follows ;
(1) The relationship between the stages of eating and quantitative food intake 
No relationship was identified between either the excitatory processes of eating (ie
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hunger and appetite) nor the inhibitory processes with the total calorific intake. 
Each macronutrient (both the actual (g) amounts and the percentage intake) was 
correlated with the stages of eating. No relationship between both hunger and 
appetite and the macronutrients was identified.
However, consistent significant results were found between protein and starch 
intake with the inhibitory processes of eating. Both actual intake and percentage 
protein intake was seen to correlate inversely with the degree of fullness (satiation) 
indicating that the higher the protein intake, the more full the subjects felt. With 
regard to actual intake, significant relationships were identified in both the 
follicular and premenstrual phases. With regard to the percentage energy obtained 
from protein, significant relationships were identified across all three menstrual 
phases, with the highest correlation noted premenstrually.
Intake of starch was seen to positively correlate with satiety scores, suggesting that 
the high intake of starch related to a greater desire to continue eating. The 
correlation coefficients for both the actual starch intake (in the premenstrual phase 
only) and the percentage energy from starch (follicular and premenstrual stages) 
though were weak (between r=0.372 to r=0.384). The results for the mean of both 
menstrual cycles are summarised in Table 29.
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Macronutrient Intake/
Eating Process per Cycle Phase
Protein Intake 
<g) %
Starch Intake 
(8) %
Mean of both Cycles
Follicular
Satiation r=0.561, n=32, p=0.003 r=-0.362,n=32,p=0.042 NS NS
Satiety NS NS NS r=-0.380,n=32,p=0.032
Luteal
Satiation NS r=-0.388,n=32,p=0.028 NS NS
Satiety NS NS NS NS
Premenstrual
Satiation r=-0.435,n=32,p=0.013 r=-0.51 8^f=32,p=0.002 r=0384^r=32,p=0.030 r=0.372^f=32,p=0.036
Satiety NS 1=0.381^1=32,pF=0.031 NS NS
Table 29. Correlations between Protein and Starch Intake with the Inhibitory 
Processes of Eating
(2) The Relationship between Dietary Restraint Food Cravings and the 
Qualitative Intake of Food
Aspects of dietary restraint (ie for specific food types and for the amount of food)
were correlated with total energy intake and macronutrient intake. No significant
correlations were noted during either of the phases of the cycle. Levels of food
cravings were found to weakly correlate positively with fat (either actual or
percentage) intake throughout all phases of the mean cycle values. The results are
shown below. However, these results were not found in cycles one and two
separately.
Food Cravings
Mean cycles Mean cycles Mean cycles
Follicular Luteal Premenstrual
Actual fat intake (g) NS r = 0.000 r = 0.372
n = 32 n = 32
p =0.000 p =0.036
Percentage fat intake r=0.425 NS r = 0.369
n = 32 n = 32
p=0.015 p = 0.038
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8.6 Discussion of Study B
The second study was performed to (a) quantify food intake and (b) to further 
investigate subjective experiences of appetite control, during the menstrual cycle. 
Urinary hormonal levels of estrone glucoronide, pregnenlione glucoronide and 
luteinising hormone levels were determined to confirm the stages of the menstrual 
cycle investigated. The major rise in LuH values during the luteal phases confirmed 
that ovulation did in fact occur in both cycles for 26 subjects, with the remaining 
six subjects having one ovulatory cycle only; and that the rise in pregnenlione 
levels confirmed the presence of normal cycles, and hence the correct definition of 
the premenstrual stage. Two points were of interest from the hormonal data 
collected; firstly, the extremely high between-subjects variability for all three 
hormonal levels; and secondly, that six subjects had cycles that were anovulatory, 
so that in fact 10% of the overall cycles analysed had to be removed from the data 
set, which obviously would not have been identified in those studies using 
menstrual history.
Unfortunately, since both estrone and pregnenlione glucoronide are only "indexes” 
of plasma oestrogens and progestagens levels, it was not meaningful to correlate 
levels of these with the dietary data; additionally, due to the acidification of the 
samples, the fragmented actual LuH levels may provided spurious results so again 
no correlation were made with the data.
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(a) Actual Dietary Intake During the Menstrual Cvcle
The results for the mean values of both cycles will be discussed, however since the 
data was separately analysed per cycle, the inter cycle variation should be noted. In 
both cycles, with the exception of starch intake (and therefore total carbohydrate 
intake) the data was consistent, exhibiting the same trends across the phases in both 
cycles. This suggests therefore that the method of data collection was repeatable. In 
addition, any alterations noted could not have been attributable to weekday versus 
weekend intake (since this was controlled in the study), nor to levels of exercise, 
physical health, personal relationships nor assertiveness (which did not significantly 
alter during the cycle). The average total energy intake, independent of phase, for 
the subject group was slightly higher (2085 Kcal per day) than the average 
recommendation of 1940 Kcal per day (Department of Health, 1991).
Consistent with previous studies, the data showed an increased energy intake (non 
significant) post ovulation compared to preovulation, with the actual magnitude of 
the increase being 148 KCal (ie a 7.39% increase from follicular to premenstrual). 
Compared to previous studies, this change in intake was conservative but consistent 
with those studies that employed hormonal profiling and semi weighed or weighed 
food intake methods (eg Lyons et al, 1989, Johnson et al, 1994). However, 
although not significant (p=0.174), the data does suggests that dietary intake is 
responsive to the hormonal changes associated with the menstrual cycle. The 
premenstrual increase in intake could be due to either of the following factors (or 
to their combined effects)
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(1) The removal of the inhibitory effects of oestrogen;
(2) The increased circulatory levels of progesterone which increase basal 
metabolic rate by 1500 KJ/day (~375 Kcal/day) (Solomon, Kurzer and 
Calloway, 1982). (The energy increase in this study did not increase to this 
degree though).
(3) As a result of altered energy expenditure.
(4) By the influence of psychological factors eg dietary restraint or 
alterations in mood.
(5) By the effect of other factors such as stress, exercise levels, 
relationships, physical health or assertiveness. However, no significant 
correlations were observed at all during the cycle. Or
(5) Mediation of the excitatory or inhibitory processes of eating via 
alterations in the relevant neurotransmitter levels.
Analysis of the actual macronutrient intake indicated that the increased energy 
intake was attributable to a concurrent increased intake of protein, fat and sugar, 
with the patterns of intake reflecting that of total energy intake. Indeed, sugar 
intake was seen to be significantly elevated in the premenstrual stage compared to 
both the follicular and luteal stages (p=0.045) [supporting the observation of 
increased preference for relative carbohydrate intake premenstrually identified in 
Study A], and may have accounted for the decrease in starch intake. Only the 
carbohydrate intake data showed significant variations on a day to day basis 
(regardless of phase), suggestive perhaps of regulatory processes that control the
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intake of both protein and fat (there is no physiological need to regulate 
carbohydrate intake).
Analysis of the absolute intake of protein, fat and sugar reflected that of total 
energy intake. However to assess regulatory processes that may alter food selection 
and therefore alteration in macronutrient intake, the percentage energy obtained 
from each macronutrient was investigated across the menstrual cycles. No 
significant cyclical alterations in percentage energy obtained from the 
macronutrients were noted; indeed the mean scores (for both cycles) were stable 
during the cycle with the maximum changes noted; protein 0.67%, fat 0.73%, total 
carbohydrate 0.41% (starch 1.16%; sugars 1.27%). However, further analysis did 
reveal some interesting findings (albeit non significant). Only the percentage energy 
from fat data showed the same pattern as that of total energy intake, suggestive of 
factors (either physiological or behavioural) influencing the selection of fat rich 
foods which had a direct influence on energy intake [previously shown by Tarasuk 
and Beaton (1991) and Johnson et al (1994)]. Since dietary fat is a stimulator of 
calorific intake, by its alteration of texture and palatability, the parallel alteration in 
both actual and percentage fat intake with total calorific intake was not surprising.
In comparison, the pattern of energy intake from sugars mirrored that of percentage 
fat, suggestive of a compensatory mechanism. Therefore, the alteration in total 
energy intake and percentage energy from fat could be mediated by fluctuations in 
oestrogen and progesterone levels over the cycle, affecting both basal metabolic
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rate and fat metabolism. Animal studies have indicated that oestrogen has a 
lipolytic action leading to a reduction in food intake as triglycerides are increased 
for metabolic fuel; whereas in contrast progesterone promotes fat storage by 
decreasing triglyceride levels (Wade and Grey, 1979; Wade et al, 1985). Therefore 
the action of the female sex hormones on fat metabolism could be sensed centrally 
to alter preference and choice for fat rich foods, thereby altering total energy 
intake.
The percentage energy obtained from protein did not mirror that of percentage fat. 
Unlike the other macronutrients, the pattern of energy from protein intake was 
consistent across both cycles (ie maximum energy obtained premenstrually, 
minimal in the luteal stage) indicative of regulatory mechanisms that may influence 
protein selection to maintain its intake (reviewed by Millward, 1995). Indeed 
significant inverse correlations were identified with satiation scores across the three 
cycle phases, indicating that an increased intake of percentage protein corresponded 
to increased subjective feelings of fullness. [This confirmed evidence identifying 
that protein has the greatest satiating efficiency of all macronutrients (reviewed by 
Blundell, 1991)]. The level of this association, was particularly evident in the 
premenstrual stage (r= - 0.518, n=32, p=0.002), the correlation coefficients being 
weaker in the follicular (r= - 0.362, n=32, p=0.042) and luteal phases (r= - 0.388, 
n=32, p=0.028). (Significant inverse correlations were also noted between actual 
protein intake and satiation scores, however only in the follicular (r= - 0.561, n=32, 
p=0.003) and luteal (r= -0.435, n=32, p=0.013) phases).
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In conclusion, the first hypothesis (ie the existence of a postovulatory increase in 
energy intake) was not significantly supported although the data did indicate that 
energy intake was increased. The mechanism underlying this intake could be due to 
the removal of the inhibitory effects of oestrogen; alternatively, energy intake could 
be indirectly affected by the hormonal mediation of fat rich food choice. Further 
studies would be required to investigate this. The second hypothesis (ie that 
carbohydrate intake was elevated premenstrually) was supported as sugar intake 
significantly increased at that stage (p=0.015).
(b) Analysis of Subjective Experiences of Dietary Intake During the Menstrual 
cycle
The potential influence of dietary restraint and food cravings on dietary intake was 
investigated during the cycle. Although all subjects in the study were not on weight 
reducing diets (a selection criteria) it is possible that the subjects restrained their 
intake per se for specific macronutrients during the cycle. Although not reaching 
significance, the results were consistent over both cycles, indicating that they had 
highest degrees of restraint (for both the amount and types of foods), and lowest 
cravings reported in the follicular stage; with the lowest restraint, coupled with 
increased cravings noted in the luteal stage. No relationships was identified 
between dietary restraint with either total or macronutrient intake. Cravings though 
were shown to positively correlate with actual (in the luteal and premenstrual 
stages) and percentage fat intake (in the follicular and premenstrual stages) 
although the degree of association was weak, indicating that the higher actual and
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percentage intake of fat premenstrually could be accounted for by the increased 
cravings noted.
Following on from the findings of Study A, the stages of eating were assessed 
during the cycle. Of the four stages involved, only appetite rating scores were 
significantly altered during the cycle (although no significant phase differences 
were noted), with increased appetite in the luteal stage, decreasing to a minimum in 
the follicular phase (p=0.048). Surprisingly, hunger ratings did not follow the same 
cyclic pattern. Of interest, the group identified that they felt most hungry, least full 
and accordingly had an increased desire to continue eating in the premenstrual 
stage when actual food intake was at a maximum. This was not attributable to a 
dysregulation of the eating processes; indeed no dysregulation between the 
inhibitory and excitatory processes was observed at either the premenstrual nor 
other stages. Although non significant, the trend of the data was surprising, 
suggesting a premenstrual alteration in the perception of both hunger and the 
satiety mechanisms. Women anecdotally do report premenstrual changes in 
appetite; and this study indicated that although there is a real increase in food 
intake, this appears not to be perceived by the individual leaving them still hungry 
wanting more food. Therefore this finding warrants further investigation.
In conclusion, hypothesis three (ie that the inhibitory processes were dysregulated 
premenstrually) was not supported. No alteration between the processes of satiety 
and satiation were observed; however, the data was suggestive of a disturbance in
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perception of eating at the premenstrual stage. The increased energy intake 
observed at this time, was hypothesised to be due to a reduction in dietary restraint; 
however again the data did not support this. The final hypothesis was tested to 
confirm a relationship between energy intake with the stages of eating. No 
significant data was found to support this notion; however, protein intake (both 
percentage and actual) was shown to be reflective of the degree of satiation 
experienced, and indicates the presence of a hormonally adaptable "protein sensor" 
which mediates the inhibition of food intake. In addition, although rather a weak 
correlation, percentage starch intake correlated with satiety scores.
8.7 Concluding Remarks From Studies A and B
Two studies were carried out to investigate both actual and subjective experiences 
of eating during the menstrual cycle. The lack of significant cyclical effects in both 
calorific intake and perception of stages of eating, were disappointing but may 
highlight the need for more controlled studies using a repeated measures design 
over a number of cycles, together with the use of hormonal profiling.
The premenstrual increase in total calorific intake was not significant but the level 
of increase was consistent with studies using similar methodology. As expected, 
both actual sugar intake and preference for carbohydrate/(total macronutrient 
selection) were significantly higher in the premenstrual phase, and suggests a 
possible influence of the serotonergic system in the control of eating during the 
cycle.
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Control mechanisms altering macronutrient intake were indicated. In particular, the 
percentage energy obtained from fat was seen to correspond to the changes in 
calorific increase across the cycle. At a perceptual level, increased energy obtained 
from protein related to an increased feeling of fullness (indeed previous studies 
have confirmed the satiating effect of protein, reviewed by Blundell, 1991). 
Although no significant changes in how women perceived the stages of eating 
during the cycle were observed in either Study A or B, the data does indicate a 
premenstrual alteration in the control of eating; for even though food intake was 
maximal, the group felt most hungry, least full and least sated compared to any 
other stage of the cycle. This could have been due to the increase in BMR 
previously noted at this time, or to the removal of the inhibitory influence of 
oestrogen. However, since both total calorific and actual sugar intake (which is an 
effective appetite suppressant) increased at this stage, the data suggests the 
possibility of other influential factors either at a biochemical or a 
cognitive/psychological level not accounted for in this study.
As discussed in Chapter 2, the role of the neurotransmitter serotonin has been 
shown to be involved in both the inhibition of food intake (eg Blundell, 1984; 
Liebowitz and Shur Posner, 1986), and in macronutrient selection (specifically 
carbohydrate and protein, eg Wurtman, 1983). As the data has shown, an 
involvement of serotonin in the mediation of eating control is feasible. For example
(a) sugar intake was significantly elevated premenstrually, indicating a possible 
behavioural mechanism to increase serotonin levels, and (b) serotonin may also
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influence percentage protein intake (Yokogoshi & Wurtman, 1986), thereby 
indirectly altering the subjective experience of satiation during the menstrual cycle. 
Alternatively, the changes observed could be due to alterations in mood, which 
have been shown to vary across the menstrual cycle phases (eg Moos, 1968). To 
investigate this putative relationship, the metabolism of tryptophan (the precursor 
for serotonin) was investigated during the menstrual cycle (see Studies C, D and E) 
prior to investigating a link between serotonin and the control of eating during the 
menstrual cycle (Study F).
In recent years interest has been highlighted on the link between food intake and 
mood (see Chapter 6). Eating control has been shown to be influenced by 
alterations in mood (which does appear to covary with the menstrual cycle), and as 
such a further study to investigate the changes observed in this study with cyclical 
monitoring of mood will be investigated (Study G).
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CHAPTER NINE
INVESTIGATIONS INTO THE METABOLISM OF 
TRYPTOPHAN DURING THE MENSTRUAL CYCLE
STUDY C : An Exploratory Investigation into the Metabolism of 
Tryptophan During the Menstrual Cycle
STUDY D: A Longitudinal Investigation into the Metabolism of 
Tryptophan During the Menstrual Cycle
STUDY E: The Development of a High Performance Liquid 
Chromatography Assay to Determine Tryptophan 
and Tryptophan Pathway Metabolites in Saliva
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Investigations into The Metabolism of Tiyptophan During 
the Menstrual Cycle
9.0 Introduction and Review of Literature
The neurotransmitter serotonin, a metabolite of tryptophan has been implicated in 
mediating appetite control and food intake. As such, the metabolism of tryptophan 
was investigated during the menstrual cycle, to ascertain if and how changing 
metabolic status could affect eating control.
Female gonadal hormones have been shown to influence the metabolism of 
tryptophan (TRY), the precursor for the neurotransmitter serotonin. Serotonin (5HT) 
has been implicated in the pathogenesis of a variety of behaviours, in particular the 
control of food intake (Blundell, 1984; Brien, 1996) and as such, it has been 
suggested that the interaction of gonadal hormones with the serotonergic systems 
may contribute significantly to behaviour and mood changes during the menstrual 
cycle (Labrum, 1983).
Empirical evidence for the effects of female gonadal hormone on 5HT metabolism 
has come mainly from data on animal studies. The main effect of oestrogen on the 
serotonergic pathway appears to be at the receptor level, in those areas of the brain 
associated with oestrogen receptors ie the hypothalamus, preoptic area and 
amygdala. Administration of oestrogen in ovariectomized rats (Biegon and Me 
Ewan, 1982) has been shown to lead to (1) a decrease in 5HT! density, followed by 
increased 5HTJ receptor binding (indicating an up regulation of these 5HT binding 
sites, Elliott et al, 1980) and (2) increased 5HT2 receptor binding (Biegon et al,
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1980). Oestrogen has also been noted to decrease 5HT turnover (Luine and 
McEwan, 1977; Luine and Rhodes, 1983) as indicated by a decrease in levels of its 
metabolite 5 hydroxyindole acetic acid (5HIAA). Progesterone, on the otherhand 
has been suggested to have a stimulatory effect on serotonin synthesis (Hackman et 
al, 1973; Cone et al, 1981); however, not all studies have corroborated this eg 
Renner, Krey and Luine, 1987; Ladische, 1974;1977). More convincingly, 
progesterone has been noted to induce monoamine oxidase (MAOa) resulting in 
increased 5HT turnover (Ladische, 1974:1977; Renner, Krey and Luine, 1987).
The assessment of serotonergic metabolism during the menstrual cycle has not 
provided consistent findings. Increased serotonergic activity has been noted in the 
post ovulatory stage by several authors (Wirz-Justice and Puhringer, 1978; Tam et 
al. 1985; Hindberg and Naesh, 1992 ); however, an opposite change has also been 
noted ( Taylor et al. 1984; Ashby et al. 1988). Some studies even showed no 
cyclical effects (Rausch and Janowsky, 1982; Blum et al. 1992).
Approximately 90% of tryptophan is metabolised via the rate limiting enzyme 
tryptophan pyrollase (TRY Dioxygenase, E.C. 1.13.11.11) resulting in the 
production of kynurenine (KY) and its metabolites (refer to Figure 5). This enzyme 
is found in the liver and within the CNS where it could locally induce changes in 
central 5HT metabolism (Green and Curzon, 1970; Sandyk, 1992 and McEwan and 
Parsons, 1982). Therefore the kynurenergic pathway metabolites are potentially 
capable of effecting serotonin synthesis by (1) displacing tryptophan from plasma
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albumin and (2) competing for the blood brain barrier for entry into the CNS 
(Green and Curzon, 1970; Gal and Sherman, 1978; Fukui et al, 1991).
The effect of oestrogen and progesterone on the kynurenergic pathway has been 
mainly investigated in animal studies. Progesterone has not shown any consistent 
effects on the pathway. Oestrogen however, is thought to indirectly induce the 
pyrollase enzyme by elevating glucocorticoid levels (Braidman and Rose, 1971; 
reviewed by Bender, 1987); and as such the available tryptophan is directed to this 
pathway leading to a decrease in brain serotonergic production (Green and Curzon, 
1970). In addition, oestrogen has been suggested to inhibit the enzymes kynurenine 
hydroxylase (Bender, 1987) and kynureninase (Scardi et al, 1962; Bender, 1987), 
leading to an overall reduction in the activity of the kynurenergic pathway. To date, 
only one study has investigated this pathway during the menstrual cycle (Hrboticky 
et al, 1989), before and after a tryptophan load. The urinary excretion of KY was 
significantly elevated in the luteal phase, after the TRY load, suggesting a 
reduction in serotonergic metabolism at this stage; however, this cannot be 
attributed to changes in the central uptake of TRY, since the ratio of TRY to the 
large neutral amino acids does not alter during the cycle (Green et al, 1978; 
Hrboticky et al, 1989).
The effect of female gonadal hormones on the synthesis of serotonin may therefore 
be mediated/affected by the kynurenergic pathway. On the basis of previous 
experimental evidence, the following aims were investigated in a series of studies.
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(1) To obtain levels of both serotonergic and kynurenergic pathway metabolites 
during the follicular, luteal and premenstrual stages of the menstrual cycle. (These 
are the first studies to report such a range of metabolites during a whole cycle on 
a repeated measures basis). (2) To assess the regulation of the serotonergic 
pathway by the kynurenergic pathway during those phases of the cycle. (3) To 
assess the degree of daily variation which may be a confounding factor in these 
repeated measure studies, and finally (4) To develop an assay to measure 
tryptophan and its metabolites in saliva, and to assess the relationship between 
urinary and salivary levels. On this basis, two repeated measure studies were 
performed to assess (in prebreakfast urine samples) if and how tryptophan 
metabolism varied during the menstrual cycle in women with normal, regular 
cycles. Two hypotheses were tested (1) That tryptophan metabolism varies during 
the menstrual cycle, and (2) That the ratio of serotonergic to pyrollase pathways 
significantly alters during the menstrual cycle.
The first study was carried out on a group of 34 women during one complete 
menstrual cycle; hormonal levels though were not measured in this study. The 
second study, was performed in a group of 32 women throughout two consecutive 
cycles and hormonal levels were monitored. The third and final study consisted of 
a study to develop an assay to measure salivary levels of tryptophan and its 
metabolites, and to re test the hypotheses. The methods employed and the results 
for each study, together with details of the appropriate statistical methods used, are 
presented below.
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9.1 Study C
An Exploratory investigation into die Metabolism of Tryptophan During the
Menstrual Cycle
9.1.1 Aims of the Study
The metabolism of tryptophan was investigated during the one menstrual cycle, in 
prebreakfast urine samples, and the role of the kynurenergic pathway in mediating 
serotonin synthesis and metabolism, investigated. Three defined phases of one 
complete menstrual cycle were assessed: follicular, luteal and premenstrual (as 
discussed in Chapter 8, section 8.1.4). Each phase of the cycle was tested over 
three days, making a total of nine sampling days per subject.
9.1.2 Methodology
(a) Subject Population
The subjects, volunteers recruited from the postgraduate population at Roehampton 
Institute, London and from advertisements in the local press) were screened to 
ensure they met the established criteria by means of initial postal questionnaires 
and subsequent interviews. The final population completing the study consisted of 
33 women with regular cycles aged between 20 and 40 years (mean 30.61; SD 
7.27), and within 90% to 115% of ideal body weight (range 49-79.4 kg ; mean 
59.76; SD 12.13) as determined using standardised life insurance tables. Informed 
consent was obtained in accordance with the Ethical Committee of RIL (Appendix 
12). All information obtained from the subjects was coded to ensure anonymity and 
confidentiality.
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(b) Study Criteria
The criteria for the study were the same as listed in Study A, and prior to entering 
this study all subjects were screened to ensure that they met the necessary criteria.
(c) Depression Assessment of the Subjects
All subjects were initially screened to ensure that they had no current or past 
psychiatric problems, however to ensure that all subjects participating were not 
currently depressed, the Beck Depression Inventory (BDI) was completed (see 
Chapter 7, section 7.1). A total score was calculated on completion of the BDI; a 
score of 15 or greater indicative of the presence of possible depression. No subject 
in the group scored 15 or more and thus confirmed the absence of depressive 
symptomology which would invalidate the study.
(d) Menstrual Cycle Details and the Calculation of Sampling Days
Details regarding menstrual cycles were obtained, as previously discussed in Study 
A. From this data, sampling dates for the collection of urine samples were for the 
three phases of the cycle under investigation (ie follicular, luteal and premenstrual) 
were calculated. (Refer to Study A for details). On completion of the study, the 
length of each subjects menstrual cycle was established to ensure that it was equal 
to the estimated length, and that the data collection days reflected the appropriate 
menstrual cycle phase.
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9.1.3 Study Design
Urine samples were collected by each subject prior to breakfast (after overnight 
starvation, to avoid the confounding problem of dietary effects on tryptophan 
metabolism) for three days in each of the follicular, luteal and premenstrual phases 
during one menstrual cycle and were stored in 0.1M HC1 (dilution 1:1) and frozen 
at -80°c. All subjects took 50mg of vitamin B6 (a cofactor in the tryptophan 
pathway) daily before and for the complete duration of the study.
9.1.4 Procedures For Study C
Subjects were personally interviewed to advise them of the procedures involved. 
Sampling days for each phase of the cycle were calculated according to 
retrospective analysis of their previous six months cycle lengths. All three 
consecutive phases of the cycle were investigated ie follicular, luteal and 
premenstrual. Subjects were assessed on three days in each of the three phases of 
the cycle, making a total of nine sampling days in the one complete cycle tested. 
The sampling days are listed above. For each of the nine sampling days (ie three 
days per phase investigated) subjects were asked to carry out the following 
procedures .
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Procedures for Study C
1. Ensure that no food or drink, except water, was consumed after midnight prior to the day of sampling.
2. Provide a prebreakfast urine sample in a 10 ml specimen tube, which already contained 5 ml of 
preservative (5% sodium metabisulphite in 1M hydrochloric acid). Subjects were advised to collect all the 
urine flow in a plastic jug provided, and to pour 5ml of the urine collected into one tube. The remainder of 
the urine could then be discarded. The tube was labelled with the subjects name and the date of collection 
using a permanent pen. Subjects were advised to immediately store the specimen tubes (wrapped in plastic 
sample bags) in their freezer. A mutually convenient date was agreed upon when the samples could be 
collected from them.
3. Throughout the period of sampling subjects were asked to take daily, 50 mg of Vitamin B6 supplements 
to ensure that no subjects were deficient in this vitamin. Some of the enzymes involved in the hepatic 
metabolism of tryptophan are vitamin B6 dependant. Subjects were asked to start the supplements on the 
day prior to commencement of their first sampling day and to continue right through the period of sampling. 
They were advised to take the supplement with food, preferably with their evening meal. All supplements 
were given free of charge. There is no recommended daily intake of vitamin B6 but the dosage prescribed 
was within the range of advised daily doses (25 mg to 100 mg).
These procedures were to be repeated for each day of sampling. At the end of the 
period of sampling, all specimens were collected and subjects were asked to advise 
the observer of the date of their next menstruation. It was then possible to 
retrospectively calculate which days of sampling were appropriate for analysis. The 
mean values for each stage of the menstrual cycle investigated were calculated.
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Data Collection
Each subject was issued with a pack containing the following items with which to 
carry out the study
* A measuring jug
* Nine 10 ml specimen tubes which contained 5ml of preservative (5% sodium 
metabisulphite in 1M HC1).
* Specimen storage bags
* A current menstrual cycle questionnaires
* An indelible pen
* Instructions for completion of the study
* Vitamin B6 supplements (50 mg)
The urine sample tubes were transported to the Addictive Behaviour Centre at RIL 
where they were defrosted and four 1ml aliquots taken for HPLC analysis and 
creatinine testing. Further details regarding the laboratory techniques are found in 
the Chapter Seven, sections 7.6 and 7.7 respectively. The aliquots and the sample 
tubes were refrozen immediately at -75 Oc if not assayed immediately.
Anthropometric data was also collected from each subject ie age, height, weight 
and occupation. In order to determine if subjects were within 90 - 115% of mean 
matched weight for the population, the Society of Actuaries tables were employed.
9.1.5 Analytical Methods
Prebreakfast urinary samples were centrifuged at 12,000 rpm (MSE Micro Centaur)
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for 5 minutes and were diluted (1/8) before their analysis by High Performance 
Liquid Chromatography (HPLC). The chromatographic conditions are described 
previously in Chapter Seven (Bonner and Brien,1993). Inter and intra assay 
coefficients of variation for (a) the serotonin assay were 9.75% and 7.69% and (b) 
the kynurenine assay were 10.07 % and 6.92% respectively. Urinary creatinine 
levels were assayed (based on the Jaffe creatinine colorimetric method without 
deproteinisation) to standardise the tryptophan metabolite data for differences in 
urinary concentrations.
9.1.6 Statistical Analysis
To assess the appropriate statistical analytic test for the data, the data set was 
initially viewed. As described previously in Study B, three criteria need to be met 
for the use of a parametric test. This data was of a ratio measurement, and 
therefore to assess if the data was normally distributed and that the variances equal, 
the data was initially explored. A calculation of the relative variance for each 
metabolite was made by dividing the maximum value of variance by the minimum 
value of variance for each metabolite across the cycle. These results are presented 
below in Table 30.
For the basis of parametric tests an acceptable (rule of thumb) degree of variation 
is considered to be between 3 and 4. From this table it can be seen that the only 
metabolites that meet this are serotonin, indole acetic acid, and quinolinic acid. 
Subsequently, the data was investigated to ascertain if it was normally distributed 
boxplots were drawn for each metabolite per phase of the cycle (SPSS for
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Windows). Overall it appeared that the data was highly skewed, a result of both a 
high number of zero values for most metabolites, as well as being due to a large
VARIABLE VARIANCE RELATIVE VARIANCE 
maximum variance/minimum variance
AA Follicular 2732651.44 4.113
Luteal 4597869.90
Premenstrual 1117758.53
HA Follicular I.189E+10 160.36
Luteal 741422558
Premenstrual 978355542
5HIAA FoUictiar 8871329.20 5.29
Luteal 20636427.7
Premenstrual 3898944.36
HK Follicular 66178356.8 11.611
Luteal 768458454
Premenstrual 131372854
5HT Follicular 11611814.9 2.49
Luteal 11904760.8
Premenstrual 2S923753.4
IAA Follicular 84982632.5 2.28
Luteal 57187524.8
Premenstrual 37319879.4
KYN Follicular 76637726.5 11.88
Luteal 372916542
Premenstrual 910527032
NA Follicular 3145694694 4.69
Luteal 671094457
Premenstrual 791299808
QA Follicular 2.865E+10 3.73
Luteal 1.930E+10
Premenstrual 7687554172
TRY Follicular 2488489312 26.486
Luteal 4.383E+10
Premenstrual 6.591E+10
Table 30. The Relative Variance of Trvptophan and its Metabolites in Studv C
(N=33 for each metabolite)
number of outliers. From this initial overview, the raw data was seen to violate 
parametric assumptions, with non homogeneity of variance being seen as a feature 
across almost the whole data set; modification of the data was not deemed possible 
since the number of outliers (as seen in the boxplots) was too high to employ the 
use of trimming to maximum capacity. The alternative approach of Wincorising 
the data was performed, with 10% of the outliers at the upper hinges being 
Wincorised on all variables. However, when ANOVA was performed on this data,
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it was still unsymmetrical and therefore this particular approach was considered to 
not achieve its objective.The only alternative that appeared feasible was to 
transform the data. Logarithmic transformations were performed on the data [log 10 
(n+1)] but again the data still did not follow a normal distribution (not surprisingly 
since the effects of logarithmic transformations on a zero value did not remove 
their flooring effects).
Therefore, the complete data set was analysed using the non parametric test, 
Friedmans one way analysis of variance, on the complete data set using SPSS for 
Windows. Statistical significance was assumed to have occurred when p was equal 
to or less than 0.05 Post hoc analysis was performed using Wilcoxon rank sum 
test, to assess exactly where the significant differences lie within the cycle. For 
those significant results found, trend analysis using the Page Trend test for related 
samples was performed to assess if it was possible to predict trends across the 
different stages of the cycle.
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9.2 Results For Study C
9.2.1 A. The Assessment of Tryptophan Metabolism During the Menstrual Cycle
The data was initially analysed to assess if the excretion of tryptophan and its 
metabolite altered during the three stages of the menstrual cycle. Friedman's one 
way . analysis of variance was performed on the actual (jig/ pmol creatinine) levels 
for each of the ten metabolites. The results are expressed as mean values per phase
(SD in parentheses) and are presented in Table 31.
Metabolites 
pg/ nmol creat
N Follicular Luteal Prcmenstraal Friedman
ANOVA
(df=2)
TRY 33 10667.83
(49884.76)
64137.77
(209353.25)
67317.42
(256735.70)
X2=2.773
p=0.250
5HT 33 1551.86
(3407.61)
1674.21
(3450.33)
1872.53
(5378.08)
r=0.288
p=0.866
5HIAA 33 1421.11
(2978.48)
2232.69
(4542.73)
1076.95
(1974.57)
X2=0.424
p=0.809
AA 33 540.80
(1653.07)
620.09
(2144.26)
385.13
(1057.24)
y>0.924
p=0.630
IAA 33 2850.46
(9218.60)
3880.55
(7562.24)
2273.17
(6109.00)
X2=4.136
p=0.126
KY 33 5150.50
(8754.30)
9377.44
(19311.05)
13922.51
(30174.94)
X2=3.379
p=0.185
HK 33 4123.00
(8135.01)
13330.02
(27721.08)
6937.97
(11461.80)
X2=7.136
p=0.028*
HA 33 36091.47
(109031.28)
19154.85
(27229.08)
18818.21
(31278.68)
Xz=2.106
p=0.349
QA 33 86148.92
(169252.93)
84945.83
(138910.17)
60966.47
(87678.70)
Xz=2.242
p=0.326
NA 33 14415.34
(56086.49)
9259.63
(25905.49)
6929.47
(28130.05)
Xz=0.727
p=0.695
Total Metabolites 33 162961.29
(287491.05)
208613.07
(304948.07)
180499.84
(324421.61)
X2=4.061
p=0.131
Table 31. Mean concentrations of tryptophan and its metabolites during the 
menstrual cycle (concentration pg/umol creatinine). Standard deviations in 
parenthesis.
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Significant alterations in the urinary excretion of 3 hydroxy kynurenine (HK) 
(X2=7.1364, df=2, p=0.0282) were noted during the menstrual cycle. Post hoc 
Wilcoxon test was performed on to assess where the significant changes occurred 
during the cycle. The excretion of HK was shown to be significantly increased in 
both the luteal phase (z= - 2.2583, p=0.0239) and premenstrual phase (z=-2.1700, 
p=0.03) compared to the follicular phase. The remaining nine metabolites did not 
exhibit any cyclical alterations.
9.2.2 The Analysis of Relative changes in Metabolite Excretion during the 
Menstrual cycle
The relative excretion of tryptophan and its metabolites to the total sum of 
metabolites excreted was then determined to assess if any changes during the cycle 
were evident. Analysis again was performed using Friedman’s one way analysis of 
variance. The relative concentrations were calculated using the actual (ie pg/ pmol 
creatinine) values. The results are presented in Table 32. Analysis of the relative 
changes in tryptophan and tryptophan metabolites during the menstrual cycle was 
assessed by Friedman's ANOVA. No significant cyclical alteration of any 
metabolite was observed.
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Metabolites 
pniol/pmol crcat
N Follicular Luteal Premcnstnial Friedman
ANOVA
(df=2)
TRY 33 0.04 0.08 0.08 X2=0.469
(0.14) (0.22) (0.23) p=0.791
5HT 33 0.02 0.01 0.01 X2=0.470
(0.05) (0.03) (0.03) p=0.791
5HIAA 33 0.01 0.01 0.01 X2=0.562
(0.01) (0.01)) (0.01) p=0.562
AA 33 0.00 0.01 0.00 II o i/i
(0.01) (0.02) (0.01)) p=0.602
IAA 33 0.02 0.01 0.01 ll o o t/i
(0.06) (0.02) (0.01) p=0.992
KY 33 0.08 0.07 0.11 X2= 1.106
(0.10) (0.08) (0.15) p=0.575
HK 33 0.05 0.07 0.07 X:=4.409
(0.05) (0.07) (0.08) p=0.110
HA 33 0.22 0.19 0.16 X2= 1.379
(0.20) (0.18) (0.16) p=0.502
QA 33 0.07 0.07 0.07 X2=0.788
(0.06) (0.04) (0.06) p =0.674
NA 33 0.04 0.05 0.04 X2=0.182
(0.08) (0.123) (0.10) p=0.913
Table 32. Mean relative concentrations of tryptophan and its metabolites during the 
menstrual cycle. Standard deviation in parentheses.
9.2.3 The Relationship between the Different Metabolic Pathways of Tryptophan 
Previous research studies investigating the metabolism of tryptophan during the 
menstrual cycle have concentrated on the analysis of the serotonergic pathway 
during the cycle. Of the limited studies that have investigated the major degredative 
pathway ie the kynurenine pathway, no previous attempt has been made to 
ascertain the changes during the cycle, nor the effect of this pathway on the 
serotonergic pathway. The following results focus on these aspects. The sum total 
of both the serotonergic pathway (ratio A) and the kynurenine pathway (ratio B) 
were initially determined. From these values it was then possible to assess any
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relative changes in the metabolic degradation down these pathways during the 
different stages of the cycle. The mean values of these ratios are presented in Table
33. Due to zero values for certain metabolites, the N values for their corresponding 
ratios were therefore lower than N=32.
Metabolite Ratio N Follicular Luteal Premenstnial Friedman
ANOVA
(df=2)
A. 5HT+5HIAA 33 2972.97
(5662.99)
3906.89
(6489.53)
2949.48
(7016.15)
y2=0.546
p=0.761
B. KY+HK+HA+AA+QA+NA 33 146470.03
(274507.20)
136687.86
(195427.99)
107959.77
(134376.79)
Xz=2.969
p=0.227
C.5HT+5HIAA/ 33 0.06 0.03 0.04 XM.879
KY+HK+HA+AA+QA+NA (0.14) (0.04) (0.10) p=0.391
D. 5HT+5HIAA/ 31 1.17 0.34 0.39 X2=l-355
KY+HK+HA (5.69) (1.39) (1.43) p=0.508
E.. 5HT+5HIAA/ KY+HK: . 27 4280.11
(8448.72)
12226.73
(28295.92)
6069.29
(9582.83))
X2=9.407 
p=0.009 **
F. 5HT+5HIAA/ IAA 26 5.03
(12.76)
3.15
(7.18)
5.26
(16.20)
X-3.692
p=0.158
G.5HT+5HIAA/ AA 6 3.70
(4.55)
3.04
(4.23)
3.61
(4.03)
X2=6.333
p=0.042*
G.5HT/KY +HK 28 4279.45
(8448.70)
7491.20
(11890.77)
7491.17
(11890.56)
X2=10.571
p=0.005**
able 33. The Interaction of the Different Metabolic Pathways of Tryptophan
during the Menstrual Cycle. (Mean values, based on ng/umol creatinine levels with 
standard deviations in parentheses.)
Investigation of a possible metabolism of the three pathway of tryptophan 
metabolism revealed that significant changes do occur during the menstrual cycle. 
It was expected that the relative metabolism of serotonergic pathway to the total 
hepatic metabolism (as indicated by ratio C) would alter during the cycle; however 
no significant change was noted during the menstrual cycle. The ratio of the 
serotonergic pathway to the major metabolites of the hepatic pathway (ie KY, HK 
and HA) indicated by ratio D also did not demonstrate a cyclical nature. However,
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when the ratio of the serotonergic pathway to the two metabolites KY and HK 
(ratio E) was calculated significant changes were noted (%2=9.4074, df=2, 
p=0.0091). Post hoc analysis by Wilcoxon test revealed that this ratio was 
significantly elevated in both the luteal (z=-2.1177, p=0.0342) and the 
premenstrual phase (z=-2.5959, p=0.0094) as compared to the follicular stage.
When the ratio of serotonin only to KY and HK was calculated (ratio G), a 
significant cyclical change was observed (%2= l0.5714, df=2, p=0.0051). As 
expected, the ratio was significantly elevated in both the luteal (z=-2.5504, 
p=0.0108) and the premenstrual (z=-2.5504, p=0.0108) compared to the follicular 
phase.
Based on the Thompson MacMillan ratio (Thompson and MacMillan, 1987), the 
ratio of the serotonergic pathway to AA and IAA was calculated. No significant 
differences was noted for the ratio of 5HT +5HIAA to IAA (ratio F). However, a 
significant alteration in the relative metabolism of the serotonergic pathway to the 
hepatic metabolite AA (ratio G) was observed (x2=6.3333, df=2,p=0.0421); with a 
reduction from the premenstrual phase to the luteal stage (z=-2.1974, p=0.028). 
However, due to the small size (n=6), this result should be interpreted with caution.
9.2.4 Assessment of Changes in the Activity of the Enzymes involved in 
Tryptophan Metabolism During the Menstrual Cycle
Changes in the excretion rates of the metabolites during the menstrual cycle could
be due in part to changes in the activities of the enzymes involved in the
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catabolism of tryptophan. From the data collected it was possible to determine 
indirectly the activities of the following enzymes
(a) Monoamine oxidase (MAOJ which is responsible for the degradation of 
5HT to 5HIAA.
(b) Kynurenine hydroxylase, which converts KY to HK.
(c) Kynureninase, which converts HK to HA.
The calculation of the activities of these enzymes was based on the assumption that 
all the kynurenine produced was directly metabolised to 3 hydroxy kynunrenine 
and not converted to xanthurenic acid; all subjects were receiving supplemental 
doses of vitamin B6, which should ensure that both the hydroxylase and 
kynunreninase should work efficiently. In addition, changes in the activity of MAO 
to both the liver enzymes were determined. The activity of the rate limiting 
enzymes involved in the metabolism of tryptophan ie tryptophan hydroxylase and 
tryptophan pyrrolase could not be assessed since the levels of tryptophan available 
as a substrate for both these enzymes could not be determined. All ratios were 
calculated on the raw ie pg/pmol creatinine data. The results are presented in Table
34. No significant changes in either the activities or the relative activities of the 
three enzymes involved in the degradation of tryptophan, exhibited any cyclical 
alterations.
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Enzyme N Follicular Luteal Premenstrual Friedman
ANOVA
(df=2)
MAO 25 5.01 1.51 2.04 X2=2.000
(18.98) (3.47) (2.92) p=0.368
Kynurenine 27 3.15 2.13 2.19 X2=0.907
Hydroxylase (7.22) (3.50) (3.41) p=0.635
Kynureninase 18 4.10 3.55 105.21 X2=4.194
(4.70) (4.37) (534.91) p=0.123
MAO/ 12 5.47 0.88
i
12.09 X2=4.500
Kynurenine (11.85) (0.92) (37.97) p=0.105
Hydroxylase
MAO/ 13 5.85 6.93 15.72 X2=4.308
Kynureninase (22.49) (21.52) (63.86) p=0.116
Difference across the menstrual cycle were assessed by Friedman ANOVA 
MAO - calculated by the ratio of serotonin to 5HIAA ie 5HT/5HIAA
Kynurenine hydroxylase = calculated by the ratio of kynurenine to 3 hydroxy kynurenine ie Kyn/HK 
Kynureninase = calculated by the ratio of 3 hydroxy kynurenine to 3 hydroxy anthranilic acid ie 3HK/3HA
Table 34. The Activities of the Enzymes Systems involved in the Degradation of 
Tryptophan During the Menstrual Cycle
9.2.5 Analysis of daily variation
This study was a repeated measures design. Therefore to assess any degree of daily 
variability in the excretion rates of tryptophan and its metabolites, Friedman 
ANOVA was performed to check if any significant daily changes were found 
within each phase of the cycle. However, no significant changes were noted for any 
of the metabolites analysed at each of the three phases of the cycle.
9.2.6 Trend analysis
To ascertain if it is possible to predict changes in tryptophan metabolism across the 
cycle, the Page Trend test was employed on HK, that demonstrated significant 
changes during the cycle. Based on the predicted order of the total rank scores, 
neither metabolites identified any significant trend during the menstrual cycle.
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9.3 Discussion of Study C
This initial study was performed to determine prebreakfast urinary levels of 
tryptophan and its metabolites during the follicular, mid luteal and premenstrual 
phases of one complete menstrual cycle. It was hoped therefore that an assessment 
of the effects of the female gonadal hormones on the metabolism of tryptophan 
would be assessed by specifically choosing days of the cycle that reflect high 
oestrogen levels (ie follicular phase), high progesterone levels (ie mid luteal stage 
and the combined effect of oestrogen and progesterone (ie premenstrual phase). To 
date this is the first study that has investigated such a range of liver metabolites of 
tryptophan during the cycle.
The analysis of tryptophan and the nine metabolites was performed by three 
methods. Firstly by comparison of actual (pg/umol creatinine) during the cycle. 
Secondly, by analysis of relative changes in the actual levels excreted. Finally by 
assessing any changes in the three pathways of tryptophan metabolism that may 
exist during the cycle.
In the discussion of the results, any significant changes in urinary excretion and 
changes in metabolism can be viewed either as a result of changes in the overall 
availability of tryptophan necessaiy for its metabolism (as a result of dietary 
changes of changes in endogenous amino acid pool levels); or, alternatively as a 
reflection of changes in the activity of the enzymes of the pathways involved in its 
metabolism; or more likely as a combination of either of these factors.
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The majority of tryptophan is metabolised by the liver via the hepatic tryptophan 
pyrrolase enzyme that results in the production of kynurenine and its associated 
metabolites. To date only one previous study has investigated this hepatic pathway 
during the menstrual cycle (Hrboticky, 1989). However in this study no discussion 
was made as to the potential role of the liver pathway of metabolism on the 
serotonergic pathway. To interpret such a role is complicated; any changes noted 
could be a result of increased degradation of tryptophan due to induction of the rate 
limiting pyrollase enzyme which could be mediated via several mechanisms. For 
example,
(1) By increase availability of tryptophan. No cyclical changes were noted 
in this study.
(2) By stimulation by cortisol. However to date the majority of studies have 
not identified any cyclical variations in cortisol release (reviewed by 
Leibenluft, Fiero and Rubinow, 1994).
(3) By increased cerebral availability of tryptophan thereby increasing the 
activity of the rate limiting enzyme, tryptophan hydroxylase that would 
divert tryptophan from the pyrollase activity. The important factor 
determining cerebral availability is the ratio of tryptophan to the other large 
neutral amino acids. Again previous studies have indicated that this ratio is 
not altered during the menstrual cycle.
(4) By the effect of changing female gonadal hormones.
Assessment of both actual and molar concentrations of tryptophan and its
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metabolites excreted in urine during the cycle showed that only HK exhibited 
significant cyclical changes, with minimal excretion noted in the follicular phase 
compared to both the mid luteal and premenstrual phases. Animal studies (eg 
Bender et al, 1983) have suggested that oestrone sulphate and oestrone glucuronide 
have (a) an inhibitory effect on kynurenine hydroxylase (that metabolises KY to 
HK) and (b) an inhibitory effect on kynureninase (that converts HK to HA) -(sex 
differences have been noted in the activity of this enzyme) The reduced excretion 
rate seen in the follicular phase might be related to several factors. Firstly, that less 
KY is metabolised due to inhibition of kynunreine hydroxylase. However, no 
significant decrease in the activity of this enzyme was noted, nor an increase in the 
excretion of KY. Secondly, that decreased catabolism of KY is commonly related 
to dietary or functional deficiency of pyridoxine (Bender, 1987); however, dietary 
supplements were taken by the subjects for the duration of the study. Thirdly, that 
there is increased activity of kynureninase, leading to increased turnover of HK to 
HA. However, analysis of the ratio of HK/HA as an index of the activity of this 
enzyme did not reveal any significant changes during the cycle (p=0.123).
It was hypothesised that the kynurenergic pathway may mediate the activity of the 
serotonergic pathway. Unexpectedly, the ratio of 5HT+5HIAA/total kynurenine 
(and the ratios of the relevant enzymes) did not show this. However, these results 
do suggest that the kynurenergic pathway may mediate its effects on 5HT through 
HK.
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Figure 7. The Effects of Oestrogen on the Kynurenine Metabolic
Pathway
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Indeed, increased production of HK has an inhibitory effect on the activity of the 
pyrollase enzyme, and therefore in both the mid-luteal and premenstrual stage when 
HK excretion was significantly elevated, there may be a relative decrease in the 
activity of the liver pathway, which could result in tryptophan being diverted to the 
serotonergic pathway. Both the ratios 5HT +5HEAA/ KY + HK and 5HT/KY +
HK did alter during the cycle (p=0.009 and p=0.005 respectively) being 
significantly elevated in both the mid-luteal and premenstrual phases compared 
with the follicular phase.
These results could imply that the activities of the enzymes involved in both these 
pathways ie tryptophan hydroxylase and kynumine hydroxylase, could be 
significantly altered by the changing hormonal levels thereby indirectly altering 
relative rather than actual 5HT synthesis. Since the levels of serotonin and 5HIAA 
on their own were not significantly altered, it could be concluded that it is the 
relative changes in metabolism that may be important here rather than actual levels 
per se. This could corroborate the findings of Zekjeni 1971 (cited in Blum et al 
1992) that oestrogens effects brain tryptophan availability by increasing KY levels 
which competes with tryptophan for entry across the BBB.
Despite the limitations of this preliminary study the results have provoked some 
interesting thoughts. The kynurenergic pathway did not, as expected, directly affect 
the serotonergic pathway during the menstrual cycle. However, it appears that the 
kynurenergic pathway does exert an influence on the serotonergic pathway, being
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mediated by HK. Previously it has been suggested that the dysphoric changes noted 
in the literature with regard to mood and behaviour could result from reduced 
serotonin production at this stage. The results from this study contradict this; 
serotonin synthesis or metabolism were not significantly reduced premenstrually; 
rather that the kynurenergic pathway appears to modulate serotonin metabolism 
during the cycle indirectly, via HK, and suggests that the relative decrease of 
activity in the serotonin pathway in comparison with that of the kynurenergic 
pathway, between the premenses and post menses stages could account for the 
documented changes in mood and eating behaviours that may occur at this stage.
This study could be criticised since menstrual cycle phase designation were 
assessed on menstrual history, and not confirmed by hormonal assays. However, 
numerous studies investigating the metabolism of tryptophan during the cycle have 
not used hormonal profiling for phase definition; indeed most studies have used 
menstrual histories (eg Taylor et al, 1984; Ashby et al, 1988; Tam, Chan and Lee, 
1985; Odink et al, 1990; Hindberg and Naesh, 1992). Therefore a further study 
incorporating hormonal profiling was subsequently carried out to assess both the 
pyrollase and serotonergic pathways during the cycle, to hopefully confirm the 
findings from this study.
Finally one further comment may be appropriate. To date previous studies that 
have investigated the metabolism of tryptophan in urine in behavioural disorders 
have generally employed the use of parametric tests for its analysis. Parametric
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tests are generally considered robust, but it was clearly apparent from this study 
that the data did not meet the necessary criteria for the use of such tests. As such, 
the use of non parametric testing, although more conservative in their findings and 
hence liable to Type II errors, does identify those metabolites that truly do show 
cyclical variations. (Of interest, when the data was analysed using parametric 
analysis, four of the metabolites, including 5HT, did demonstrate cyclical 
variations).
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9.4 Study P
A Longitudinal Investigation into the Metabolism of Tryptophan During the
Menstrual Cycle
9.4.1 Aims of The Study
This study, developed from findings obtained from Study C, aimed to (1) replicate 
the findings from Study C ie that changes in the kynurenergic metabolic pathway 
of tryptophan exist through the menstrual cycle; and (2) to identify and clarify the 
regulatory role of the kynurenine pathway metabolites of tryptophan on 
serotonergic metabolism; and (3) to investigate if  the cyclical alteration in the 
kynurenergic pathway could be mediated by cortisol levels.
Study D was redesigned to investigate these aspects of tryptophan metabolism with 
improved methodology ie (a) the determination over two consecutive menstrual 
cycles (b) the use of hormonal profiling to ascertain that each subject did ovulate 
and that the days under investigation (based on menstrual histories), were reflective 
of the appropriate phase of the cycle. Thirty two women took part in the study. 
Prebreakast urine samples were collected, on a repeated measure basis through the 
relevant phases of two consecutive menstrual cycles for determination of 
tryptophan and its metabolites.
9.4.2 Methodology
The subjects participating in this study were all concurrently participating in Study 
B. Therefore subject population details, study criteria, and calculation of the 
sampling days can all be obtained by reference to Study B.
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9.4.3 Study Design and Procedures
The design for the experiment replicated that of Study C, with the exception that 
the study was carried over two consecutive menstrual cycles, and that the urine 
samples were assayed for levels of sex steroid hormones and cortisol (refer to 
Study B for details on these assays). Of the 32 participating subjects, six subjects 
had one anovulatory cycle, and the data from that cycle was therefore omitted from 
analysis. The urine samples were regularly collected from the subjects during the 
duration of the study.
9.4.4 Analytical Measurements
The prebreakfast urinary samples were analysed for levels of tryptophan and its 
metabolites by HPLC (refer to Chapter Seven, section 7.6) and cortisol (Chapter 
Seven, section 7.8). In addition, urine samples were also analysed for creatinine 
levels (Chapter Seven, section 7.7) and oestrone 3 glucuronide, pregnanediol 3- 
glucuronide and fragmented levels of luteinising hormone (Chapter Seven, section 
7.9).
9.4.5 Statistical Analysis
To assess the appropriate statistical analytic test for the data, the data set was 
initially viewed to see if the data was normal distributed, and that the variances 
were homogenous for each of the ten metabolites analysed in both cycles. A 
calculation of the relative variance for each metabolite was made by dividing the 
maximum variance value by the minimum variance value across the cycle.
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These results are presented below in Table 35. As can be seen, in both cycles and 
the mean of both cycles, the relative variances are generally greater than 3 or four.
Metabolite
(Ng/umol
creatinine)
Relative Variance 
Cycle One
Relative Variance 
Cycle Two
Relative Variance 
Mean cycle one 
and two
TRY 4.22 17.691 4.30
5HT 22204.94 6.443 16779.03
5HIAA 384.28 48427.54 27278.38
AA 23722.33 8744.22 117.05
IAA 24.86 2.00 3.49
KY 72964.6 1.685 790.38
HK 9.21 8.72 3.83
HA 11.84 101.804 104.08
QA 5.22 227.179 134.96
NA 22.74 15.96 10.42
Relative variance = maximum variance of three phases/minimum variance of three phases 
(N=32 for all metabolites)
Table 35. The Relative Variances of Tryptophan and Its Metabolites
From the viewing of boxplots it could be seen that the data was highly skewed, a 
result of both a high number of zero values for most metabolites, as well as being 
due to a large number of outliers. Even with the use of trimming, or 
transformations the data was still unsymmetrical and therefore was seen to violate 
parametric assumptions.
Therefore, the complete data set (excluding those subjects with "abnormal" cycles) 
was analysed using the non parametric test, Friedman's one way analysis of 
variance, using SPSS for Windows. Statistical significance was assumed to have 
occurred when p was equal to or less than 0.05. Post hoc analysis was performed
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using Wilcoxon rank sum test, to assess exactly where the significant differences 
occured within the cycle. For those significant results found, trend analysis using 
the Page Trend test for related samples was performed to assess if it was possible 
to predict trends across the different stages of the cycle.
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9.5 Results for Study D
9.5.1 The Assessment of Tryptophan Metabolism During Two Consecutive
Menstrual Cycles
To ascertain if urinary excretion altered during the three stages of the cycle, the 
actual data (pg/jimol creatinine) for the mean of both cycles investigated was 
analysed using Friedman's one way analysis of variance. The results are shown in 
Table 36.
Urinaiy Metabolites 
Hg/umol creat
N Follicular Luteal Premenstrual Friedman
ANOVA
(df=2)
TRY 32 62805.60 32404.65 40285.41 X*=0.750
(260887.72) (125756.35) (162252.53) p=0.687
5HT 32 335579.47 13042.38 19962.89 XHJ.063
(1798516.55) (13884.69) (31337.93) p=0.969
5HIAA 32 65212.25 680595.82 14816.31 X ^.169
(207256.79) (3762570.22) (22781.19) p=0.430
AA 32 4706.95 9159.13 175331.35 X-5-688
(18115.44) (27735.43) (663351.64) p=0.058
IAA 32 26606.57 24189.04 38208.33 X^=0.188
(39205.38) (37678.87) (70365.33) p=0.910
KY 32 410380.16 48508.09 63617.22 xMl.203
(1991640.31) (70842.27) (103612.28) p=0.903
HK 32 10066.57 16217.08 7989.61 X*=0.766
(23264.55) (34590.49) (17678.68) p=0682
HA 32 132350.03 602284.78 96461.51 X ^.813
(423643.20) (2918993.06) (286120.16) p=0.666
QA 32 146973.97 37648.53 36343.78 X2=0.047
(730044.27) (62842.62) (71305.40) p=0.977
NA 32 11296.32 13901.88 6003.10 X ^ - W
(30127.96) (42044.99) (13027.73) p=0.947
Total Metabolites 32 1205977.90 1477951.40 499019.52 X^=0.563
(4361455.99) (4775004.35) (1098252.95) p=0.755
Table 36. Mean Urinary Concentrations (pg/umol creatinine) of Tryptophan and 
Tryptophan metabolites for the Mean of Both Cycles. Standard deviations in 
parenthesis.
When the mean values for both cycles were analysed, no significant changes during 
the phases of the cycles were noted. When both cycle one and cycle two were 
analysed separately, only anthranilic acid showed a significant cyclical effect; post
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hoc analysis revealed that the urinary excretion was significantly higher in the 
follicular compare to luteal stage (z=-2.90,p=0.004) and significantly higher 
premenstrually, compared to the follicular phase (z=3.14, p=0.002).
9.5.2 Analysis of the Ratios of the Tryptophan Metabolic Pathways During the 
Menstrual Cycle
To test the hypothesis that the menstrual cycle may alter the relative metabolism of 
tryptophan, various ratios of the metabolites were calculated, based on the actual 
(pg/pmol creatinine) levels of urinary metabolites excreted. The results for the 
mean of both cycles are presented in Table 37. Due to zero values, the N values 
for some ratios are lower than N=32.
Metabolite Ratio N ' Follicular Luteal Premenstrual Friedman’s
ANOVA
(df=2)
5HT+5HIAA 32 400.79 (1997.52) 693.64 (3766.50) 34.78 X ^.812
(46.58) p=0.666
Total kynurerines 32 715.77 727.72 385.75 X ^.438
(2246.77) (2912.96) (986.74) p=0.804
5HT+5HIAA/Total Kyn 32 0.35 1.77 0.47 X-1-313
(0.80) (7.12) (1.33) p=0.519
5HT+5HIAA/KY+HA+HK 31 0.85 5.91 3.46 X*=0.2600
(3.13) (27.28) (16.69) p=0.272
5HT+5HIAA/KY+HK 30 2.07 6.58 4.09 X^O.483
(3.95) (27.66) (16.88) p=0.786
5HT/KY+HK 30 0.72 1.00 2.41 X-1.103
(1.18) (2.49) (10.25) p=0.576
5HT+5HIAA/AA 17 86.35 39.79 23.93 X-3.800
(272.89) (65.14) (48.96) p=0.149
5HT+5HIAA/1AA 29 4.90 9.49 3.44 X*=0.500
(8.79) (24.94) (5.74) p=0.779
Table 37. The interaction of the different metabolic pathways of tryptophan for the 
Mean of Both Cycles. Standard deviations in parentheses.
No significant alterations in the metabolic pathways were noted across the phases 
of the cycle for the mean cycle values nor for each of the two cycles investigated.
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9.5.3 Assessment of Changes in the Activities of the Enzymes Involved in the
Metabolism of Tryptophan During the Menstrual Cycle 
To further test possible influence of the menstrual cycle on the metabolic 
conversion of tryptophan, the activities of MAO, kynurenine hydroxylase and 
kynureninase were determined indirectly. These calculations were based on the 
actual levels of excretion of tryptophan metabolites (ie pg/pmol creatinine) and the 
results for the mean of both cycles are shown in Table 38.
Enzyme activity N Follicular Luteal Premenstrual Friedman's
ANOVA
(df=2)
Kynurenine Hydroxylase 30 3.32 0.37 0.30 X^l.241
(15.20) (1.38) (0.90) p=0.538
Kynureninase 17 15.79 31.32 111.64 (437.77) X*=0.350
(28.67) (62.94) p=0.839
MAO 32 1.84 20.62(110.77) 0.95 X-1.750
(4.32) (0.66) p=0.417
MAO/Kynurenine Hydroxylase 17 65.99 1168.71 51.69 X-3.200
(121.95) (4552.71) (168.76) p=0.202
MAO/Kynureninase 8 0.16 0.32 0.28 X-3.000
(0.17) (0.65) (0.49) p=0.223
Table 38. Activities of the enzyme systems involved in the degradation of 
tryptophan, for the mean of cycles one and two. Standard deviations in parentheses.
No significant changes in the activities of the enzymes was noted during the phases 
of the cycle.
9.5.4 Investigation of the Effects of Cortisol Production on the Kynurenergic 
metabolic Pathway
Previous studies have indicated that cortisol induces the pyrollase enzyme (see 
review by Badawy, 1977) and therefore may mediate cyclical changes in 
metabolism of those metabolites. Therefore urinary cortisol levels were monitored 
during the menstrual cycle and the ratios of (a) kynurenine (the main metabolite of
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pyrollase activity) and (b) the total kynurenergic metabolites to cortisol levels were 
assessed to investigate this. Previous work (Braidman and Rose, 1971; Brin, 1971) 
has additionally shown that oestrogen is capable of inducing the pyrollase enzyme 
indirectly by its elevation of glucocorticoids; therefore follicular elevation in levels 
would be expected, with the ratios to the pyrollase metabolites identifying such a 
change.
The mean urinary excretion levels of cortisol (pmol/1) are identified below in Table 
39. Changes during the cycle were assessed by Friedmans ANOVA (df=2).
Phase of cycle/Cycle N Follicular Luteal Premen Friedmans ANOVA 
(df=2)
Mean of both cycle 19 0.42 (1.33) 0.18 (0.34) 0.19 (0.29) X2=0.421
p=0.810
Cycle One 17 0.07 (0.06) 0.07 (0.05) 0.24(0.51) X2=0.824
p=0.663
Cycle Two 15 0.93 (2.98) 0.33 (0.72) 0.15 (0.13) X2=0.533
p=0.766
Table 39. Mean urinary excretion levels (umol/H of cortisol during the menstrual 
cycle. Standard deviation in parentheses
The mean levels (for both cycles) of cortisol excretion were highest in the follicular 
stage, however no significant cyclical effects were noted (p=0.810).
To ascertain if cortisol excretion affected the pyrollase enzyme during the 
menstrual cycle, the ratio of kynurenine to cortisol, and total kynurenergic 
metabolites to cortisol were investigated by Friedmans ANOVA, with a lower ratio 
indicative of increased induction of the relevant part of the pathway. The results for 
the mean of both cycles are presented in Table 40.
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Phase of cycle/ 
Metabolite ratio
N Follicular Luteal Premens Friedmans ANOVA 
(df=2)
Mean of both cycle 
KY/cortisol 19 503.69
(1140.96)
506.26
(1441.43)
1170.14
(3938.42)
X2=0-800
p=0.961
Total KY/cortisol 19 2445.36
(5328.46)
2202.43
(2534.40)
2797.87
(3850.39)
X2=0-105
p=0.949
Table 40 The Pvrollase metabolic pathway in relation to cortisol excretion during 
the menstrual cycle (for the mean of cycles one and two! Standard deviations in 
parentheses.
No significant cyclical changes were noted in the excretion of either kynurenine 
nor the total kynurenergic pathway relative to cortisol excretion. However, the 
results do suggest that cortisol may influence the pyrollase enzyme (as indicated by 
the lower ratio of KY to cortisol) only, but had no effect on the total enzymic 
pathway.
9.5.5 Analysis of Daily Variation of Tryptophan and Tryptophan Metabolites 
This study was a repeated measures design, and to check any daily variability in 
the excretion rates of tryptophan or its metabolites, Friedmans' ANOVA was 
performed in each phase of the cycle, and for both cycles monitored. No consistent 
significant change per phase were identified.
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9.6 Discussion of Study D
Study D was performed to clarify the metabolism of tryptophan during the 
menstrual cycle by repeating the study over two consecutive menstrual cycles and 
differed from Study C since urinary concentrations of estrone glucoronide, 
pregnenlione glucoronide and luteinising hormone levels were determined to 
confirm the stages of the menstrual cycle investigated. The major rise in LuH 
values during the luteal phases confirmed that ovulation did in fact occur in both 
cycles for 26 subjects, with the remaining six subjects having one ovulatory cycle 
only; and the rise in pregnenlione levels confirmed the presence of normal cycles, 
and that premenstrual stage was correctly defined. Two points were of interest from 
the hormonal data collected; firstly, the extremely high between-subjects variability 
for all three hormonal levels; however in spite of this the data did support the aim 
ie to confirm that subjects did ovulate and that the phases of the menstrual cycle 
were correctly interpreted. And secondly, that six subjects had cycles that were 
anovulatory, so that in fact 10% of the overall cycles analysed had to be removed 
from the data set, which obviously would not have been identified in those studies 
using menstrual history.
As previously discussed in Study Two, both estrone and pregnenlione glucoronide 
are "indexes” of plasma oestrogens and progestagens, so it was not possible to 
correlate levels of these with the tryptophan data; additionally, due to the 
acidification of the samples, the fragmented actual LuH levels may provided 
spurious results so again no correlation were made with the tryptophan data.
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The findings discussed below are those mean results for both menstrual cycles 
assessed. However, initially the data for each separate cycle was determined. 
Considerable inter- subject variation existed, as would be expected. However, intra 
subject variation also showed a considerable degree of variation. None of the ten 
metabolites analysed showed consistent trends during both the cycles; indeed 
urinary levels of only 5 metabolites exhibited either their maximum or minimum 
values at the same stage for both the cycles. Therefore, the non significant findings 
from this study was not unexpected. Analysis of daily variation in metabolite 
excretion rates per phase did reveal that two metabolites did alter within a phase of 
the cycle. Although the findings were significant the actual alterations were 
relatively meaningless, suggesting that the overall variability of results was not 
attributable to significant daily alterations. In spite of these factors, the following 
conclusions were drawn from the data.
(i) The assessment of tryptophan and tryptophan metabolites during the menstrual 
cycle.
Analysis of the urinary excretion of each of the individual metabolites analysed 
(actual and molar concentrations) did not reveal any significant cyclical changes; 
unlike study three which demonstrated a significant main effect for HK levels.
The urinary excretion of tryptophan altered during the cycle, with maximal 
excretion in the follicular phase, minimal value at the luteal stage; these cyclical 
changes, albeit non significant could be accounted for by alterations in either/ or a
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combination of the following
(a) the displacement of albumin bound tryptophan by oestrogen (Aylward and 
Maddock, 1973).
(b) dietary intake. Dietary tryptophan intake was monitored in these subjects 
(refer to the Results section of Study B) but no significant cyclical changes in 
intake were noted. However, the actual dietary intake of tryptophan did increase 
during the menstrual cycle, with maximal intake noted during the premenstrual 
stages. The urinary concentration of tryptophan was lowest when intake was 
highest; indicating that either increased protein synthesis or increased tryptophan 
metabolism accounted for this discrepancy. Analysis of the ratio of tryptophan to 
LNAA was determined from the dietary intake data from the subjects (Study B); 
but no significant changes were identified.
(c) protein synthesis or
(d) metabolic catabolism of tryptophan. The sum of the overall total tryptophan 
metabolites analysed gave an index of this; maximal excretion of the total 
metabolites was identified in the luteal phase when urinary tryptophan levels were 
at their lowest levels (ie indicating that the available tryptophan was being 
metabolised). Premenstrually the excretion for the total metabolites was minimal 
indicating either increased protein synthesis or down regulation of the degredative 
enzymes. As the activity of both the rate limiting enzymes ie tryptophan 
hydroxylase and pyrollase could not be directly determined, the sum of both 
pathways ie serotonergic (5HT+5HIAA) and total kynurenergic metabolites were 
investigated to give an indirect indication. However neither the sum serotonergic
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pathway, nor the sum kynurenergic metabolites exhibited this same pattern as 
tryptophan; an interesting finding since the majority of tryptophan has been shown 
to be metabolised by this pyrollase pathway. Protein synthesis therefore may be 
interfering with tryptophan metabolism during the menstrual cycle.
With regard to the pyrollase enzyme pathway metabolites, maximal excretion of 
HK, HA, nicotinic acid (NA) and the sum of the total pyrollase metabolites, was 
noted in the luteal stage. The overall increased excretion rates during the luteal 
phase could therefore be a result of the removal of the inhibitory effect of 
oestrogen on both kynurenine hydroxylase and kynureninase enzymes (progesterone 
has not been shown any direct effect on the pyrollase metabolism). However, both 
QA and KY exhibited maximal excretion in the follicular stage. This increase in 
KY excretion was not due to the inhibitory effect of oestrogen on the enzyme 
kynurenine hydroxylase (Bender, 1987) since the activity of this enzyme (identified 
by the ratio of HK/KY) was maximal at this stage; but due to the induction of the 
rate limiting enzyme pyrollase. High oestrogen levels noted at this time, have been 
shown to induce its activity via glucocorticoid release (Braidman and Rose, 1971; 
Bender, 1987); indeed cortisol levels were highest at this stage (although not 
significantly). In addition, the pyrrolase enzyme may have been induced by the 
high circulating levels of tryptophan. Therefore, although the findings are non 
significant, this study contradicts earlier work suggesting that oestrogen has an 
inhibitory effect on kynurenine hydroxylase and kynureninase. The data in the 
follicular stage, supports an indirect oestrogen induction of the pyrollase enzyme,
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via increased cortisol release. Premenstrually (with the exception of KY and AA) 
the concentration of the excreted remaining pyrollase metabolites was minimal (the 
sum of the total pyrollase metabolites additionally were at their lowest at this 
phase).
High circulating levels of oestrogen have been indicated to have an inhibitory 
effect on the enzyme MAO in both animal (Luine and McEwan, 1977; Luine and 
Rhodes, 1983) and human studies (Klaiber et al, 1971). Urinary excretion of 
serotonin was highest in the follicular stage, but lowest in the luteal phase 
confirming the data from these previous studies. The metabolic conversion of 
serotonin to 5HIAA by MAO has been demonstrated in both animal (Ladische, 
1974; 1977) and human studies (Belmaker et al, 1974) to be increased due to high 
progesterone levels. In this study (and the previous one) the excretion of 5HIAA 
levels was indeed shown to be maximal in the mid luteal stage, and lowest 
premenstrually. This was further corroborated by the indirect assessment of the 
activity of MAO; with increased activity noted in the luteal stage, declining to a 
minimal activity premenstrually. Overall the sum of the serotonergic pathway 
metabolites (ie 5HT+HIAA) changed during the cycle; like the total pyrollase 
pathway, maximal excretion was evident in the luteal phase (associated with the 
decreased excretion in tryptophan, due to its increased catabolism), decreasing to a 
minimum premenstrually.
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(ii) The mediation of the pyrollase pathway on the serotonergic pathway during the 
menstrual cycle
The hypothesis that the serotonergic pathway of metabolism was mediated by the 
pyrollase pathway was tested but no significant cyclical effects were noted in this 
study. The ratio of the total serotonergic to total kynurenergic pathways [and 
additionally the serotonergic to (a) the main arm metabolites ie KY, HK, HA and
(b) the sum of KY+HK were highest in the luteal stage, reducing to a minimum in 
the follicular phase; and what is of interest is that the most rapid relative reduction 
of serotonin metabolism was prominent between the luteal and premenstrual stages 
(being reduced by 74% for the serotonergic to total kynurenergic metabolites); an 
interesting finding considering the pronounced behavioural changes suggested at 
this time.
The alternative ratios employed by Thompson and McMillan (1987) to investigate 
the effects of the other tryptophan metabolic pathways on serotonergic pathway 
were also investigated. The use of AA as an index of the pyrollase pathway, did 
not reflect the findings above; the relative serotonergic metabolism was maximal in 
the follicular stage reducing to a minimum premenstrually. Due to the large number 
of zero values obtained for this metabolites, only 17 cases could be calculated. The 
ratio of the serotonergic pathway to the indoleamine pathway, showed that the 
maximal metabolism of serotonin occurred in the luteal stage, reducing to a 
minimum premenstrually.
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9.7 Overall Discussion From Studies C and P
In study C, significant alterations in HK levels were noted, with elevated excretion 
levels noted in both the luteal and premenstrual phases, compared to the follicular 
stage of the menstrual cycle. On this basis, it appeared that the metabolism of 
serotonin was modulated during the menstrual cycle indirectly by the pyrollase 
pathway, specifically by levels of both KY and HK; serotonin synthesis and 
metabolism was significantly increased in both the luteal and premenstrual phases, 
compared to the follicular stage.
On the basis of these initial findings, the second metabolic study was carried out, 
but with improved methodology ie hormonal profiling and the analysis over two 
consecutive menstrual cycles. With these modifications however the findings from 
study C were not replicated; indeed comparative analysis of both studies revealed 
that only the urinary excretion of 5HIAA, QA and the metabolic ratio 
5HT+5HIAA/KY+HK followed the same trends. Therefore to interpret the results, 
it is assumed that due to the improved methodology, the findings of study D are 
the more meaningful. This finding in itself is important; the limited number of 
studies investigating the effects of hormonal variation on tryptophan metabolism 
rarely employ repeated measures designs, hormonal profiling nor longitudinal 
studies; and this therefore questions the validity of the findings from such studies. 
Indeed the findings from previous research has been very conflicting, and as these 
two studies do show, the need for precise methodologies is imperative to provide 
any consistent understanding of this area of research.
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The findings from the second study indicate that maximum catabolism of 
tryptophan occurs in the luteal phase (as indicated by the increase in total 
metabolites, total pyrollase and total serotonergic pathway metabolites being 
excreted in their highest concentrations); and minimal conversion of tryptophan 
premenstrually. With regard to the pyrollase pathway, the data supports an 
oestrogen mediated induction of the pyrollase enzyme; but not an oestrogen 
mediated inhibition of the enzymes kynurenine hydroxylase and kynureninase. The 
increased metabolic conversion down the kynurenergic pathway in the luteal phase 
is unclear, but could be due either to the removal of the inhibitory effects of 
oestrogen or alternatively influenced by the high circulatory levels of progesterone 
(although no previous studies have supported this notion). The premenstrual decline 
in both the kynurenergic and serotoninergic pathways suggests that either 
tryptophan is being diverted away from degradation or that the removal of the 
hormonal influences leads to a down regulation of the catabolic enzymes. Further 
studies would be required to confirm or dispute this latter suggestion.
With regard to the serotonergic pathway, the findings suggest that the changing 
female hormones do influence serotonin metabolism. Serotonin excretion was 
highest in the follicular stage (confirming the oestrogen mediated inhibition of 
MAO) but lowest in the luteal stage when MAO activity was accentuated by 
progesterone. (The metabolite levels of 5HIAA further confirmed this with highest 
levels observed in the luteal phase).
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In conclusion, due to the lack of significant findings from study D, the results did 
not provide any firm support for the hypotheses under investigation, however the 
ratio of serotonergic to kynurenergic metabolites did exhibit a 74% decrease from 
the luteal to the premenstrual stage. In addition, the results did exhibit trends that 
were supportive of previous research.
The absence of any firm findings could be explained by a number of reasons. 
Firstly, that the menstrual cycle does not have any effect on the metabolism of 
tryptophan. Secondly, that because of the high variability (both inter and intra 
subject) in the data, no obvious findings were clear. Variation in this metabolic 
data could arise from two sources ie within and between subjects, a confounding 
factor or else by the method employed to determine actual physiological levels ie 
the HPLC (although the coefficients of variations were within acceptable ranges). 
Alternatively, other factors not accounted for might have confounded the findings 
eg the rate of protein metabolism during the menstrual cycle.
Therefore in view of the non significant findings from prebreakfast urine samples, 
one further study was undertaken to investigate the effects of the menstrual cycle 
on tryptophan metabolism. The subsequent study was employed to measure the 
metabolites using the same methodology in salivary samples; which would, unlike 
urinary samples give a more rapid reflection of immediate changes within the body.
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9.8 STUDY E
The Development of a HPLC assay to determine tryptophan and tryptophan
pathway metabolites in saliva
9.8.1 Introduction
The assessment of tryptophan, and tryptophan metabolites from prebreakfast urine 
samples collected in study C indicated that changes did occur during the menstrual 
cycle. However, when the study was repeated, with improved methodology, the 
previous findings were not replicated. Indeed, in the main study (study D) no 
significant cyclical alterations were noted. Two possible explanations could explain 
these latter findings. Firstly that when the improved methodology was employed, 
there is no cyclical alterations in either the tryptophan pathway metabolites, nor in 
the relative ratios of the degredative pathways. Alternatively, the results could 
suggest that creatinine adjusted urinary levels were not an appropriate measure to 
use. Plasma samples would be the most obvious choice for a subsequent study, but 
repetitive measuring over such a period of time was not feasible. Therefore, this 
final study was carried out to assess if cyclical changes in tryptophan metabolism 
could be identified in salivary samples.
To date, the metabolites of the hepatic and serotonergic degredative pathways of 
tryptophan have been analysed in CSF, blood, plasma and urinary samples. This 
study was therefore performed to assess the feasibility and accuracy of measuring 
these metabolites in saliva. No previous work has determined this and therefore the 
assay was developed to assess its accuracy and repeatability. The advantages of 
collection of saliva are obvious; it is economic, non invasive, painless, and can be
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collected direct by the subjects. The availability of such an assay would be 
beneficial to those multiple areas of research implicating altered tryptophan 
metabolism.
9.8.2 Methodology
The assays to measure tryptophan and its metabolites was developed from the 
method used for analysis in urine. Electrochemical detection was used for the 
analysis of TRY, 5HT, 5HIAA, AA and IAA. Ultraviolet detection was used for 
the determination of the hepatic pathway of tryptophan metabolism ie KY, HK, 
HA, QA and NA.
9.8.3 Developmental methods
The following tests were performed prior to the collection of salivary samples.
(a) To Determine the Optimum Conditions for the Collection of Saliva 
To assess whether the flow of saliva affected the composition of saliva and 
therefore determination of tryptophan and its metabolites, four consecutive saliva 
samples (A,B,C and D) were collected from three subjects. The saliva samples 
were filtered as described below prior to analysis for levels of metabolites. In the 
samples assayed, levels of both tryptophan and anthranilic acid levels were found 
in the three subjects (see Table 41 below).
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Subject/
Metabolite (ng/ml)
Sample A Sample B Sample C Sample D
1 Try 2601.46 6794.32 1817.10 2398.73
AA 86.78 125.193 129.839 132.994
2 Try 242.330 292.72 334.569 319.97
AA 121.727 109.135 110.450 156.025
3 Try 310.59 295.67 287.32 300.06
AA 132.01 120.79 118.65 110.66
Table 41. The Effect of Consecutive Sampling Collections (AJB.C. and D) on 
Salivary Levels of Tryptophan and Anthranilic acid (ng/ml) for three subjects.
The results were plotted (Graph 4) and indicated that the levels of both anthranilic
acid and tryptophan did not alter during the period of sampling. Therefore, these 
findings indicate that the first salivary collection would be a consistent measure of 
salivary levels of tryptophan and its metabolites.
(b) The Effect of Freezing and Defrosting on the Stability of Tryptophan and its 
Metabolites in Saliva
Saliva samples were collected from 5 subjects and pooled. The samples were 
analysed using HPLC, after filtration, and spiked with fresh standards to ensure that 
levels of QA, NA, KY, HK and HA were all detectable. The final concentration of 
each metabolite in the pooled sample was set to 125 ng/ml. The saliva was then 
frozen. Subsequently, this sample was defrosted and run on the HPLC to determine 
the levels of the metabolites. This was repeated a further two times so that the 
effects of three defrostings could be determined. The results are presented in Table 
42.
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Graph 4.
The Effect of Salivary Sampling Collection Times
Salivary levels of tryptophan and anthranilic acid (ng/ml) for three subjects
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M e ta b o li te F re s h  S a liv a  
M e ta b o li te  
C o n c e n tra t io n  
(n g /m l)
D e f ro s t  1 
M e ta b o li te  
C o n c e n tra t io n  
(n g /m l)
D e f ro s t  2  
M e ta b o li te  
C o n c e n tra t io n  
(n g /m l)
D e f ro s t  3 
M e ta b o li te  
C o n c e n tra t io n  
(n g /m l)
Q A 1 2 5 1 1 6 .2 8 8 1 0 1 .0 1 8 2 6 .9 3 1
-
N A 1 25 1 1 4 .7 9 8 1 1 6 .1 7 4 1 8 .5 1 3
K Y 1 2 5 1 2 0 .4 4 8 1 0 0 .5 7 5 1 4 .5 5 8
H K 1 25 1 2 4 .9 4 4 5 1 .8 9 1 4 5 .2 4 8
H A 1 25 1 1 7 .5 5 4 8 7 .7 6 8 2 0 .3 3 2
Table 42. The Effects of Defrosting on Salivary Kynurenergic Pathway Metabolites 
from Pooled Saliva of Subjects.
The results are presented in Graph 5. As can be seen, the effects of defrosting did 
affect salivary levels; the findings indicating that saliva can be defrosted once 
before levels rapidly decline.
(3) HPLC details
The conditions required for the analysis (ie column, buffer, temperature and flow 
rate) were identical to those urinary analysis (see Chapter Seven, section 7.6) 
except for the preparation of the standards for the quantification of the kynurenine 
pathway metabolites, which were prepared at a concentration of 125 ng/ml. The 
standards for the quantification of serotonergic pathway metabolites were the same 
as for the urinary analysis ie tryptophan 20 ng/ml; serotonin 10 ng/ml; 5HIAA 10 
ng/ml; AA 20 ng/ml; IAA 30 ng/ml. All pure standards (99.9%) were purchased 
from Sigma Chemical Company, Poole, UK and were prepared fresh on the day of 
analysis. 100 ul of the diluted standard was injected onto the automated Shimadzu 
system. The run time was 25 and 15 minutes respectively. The HPLC was then 
calibrated by reference to the standards for the analysis of salivary levels of the 
relevant tryptophan metabolites.
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9.8.4 The Collection of Saliva and its Preparation for HPLC Analysis
Saliva samples were collected through two consecutive menstrual cycles in 25 
subjects as previously described in Chapter Nine, section 9.4.3. Hormonal analysis 
identified those samples that were indicative of the phase of the menstrual cycle; 
the data from any subject that had abnormal cycles was rejected for analysis. Saliva 
was collected from the sub mandibular and sub lingual glands, located on the floor 
of the mouth, by the use of absorbent swabs (Salivettes from Sarstedt, UK). The 
following instructions were given to all subjects providing saliva, to ensure all 
samples were collected in a similar fashion.
Procedures for the Collection of Saliva
* Preferably, saliva should be collected prior to breakfast, before the consumption of food and drink, and 
before brushing teeth. If food has been consumed, wash mouth out with water prior to taking the sample.
*Take care never to touch the salivette roll. In all cases wash hands prior to taking the sample.
♦Open the cap of the salivette, and drop the cotton wool roll into the mouth, positioned under the front of 
the tongue. Try not to move the roll around but leave in this position for two minutes. Do not chew. Again, 
without touching, put back the roll into the salivette container.
Sample preparation
Saliva samples were filtered to remove all particles greater than 3000 Daltons ie 
specifically proteins ,polypeptides and peptides which would block the analytic 
column and therefore impair analysis. The salivettes, containing the saliva sample 
were initially spun at 40c for 20 minutes (Heraeus Instruments, Labofuge 400R).
The saliva was then transferred to Amicon YM10 filters (using Amicon 
Micropartition System MPS1 unit, Amicon Ltd, Stonehouse, UK) to remove 
proteins and peptides to 3000 Daltons by centrifuging at 4°c for 40 to 60 minutes
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(dependent on the volume to filter). Once filtered, saliva was placed in an 
Eppendorf and 100 pi injected (undiluted) on the HPLC for analysis.
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9.9 Results For Study E.
9.9.1 Salivary levels of Tryptophan and its Metabolites During the Menstrual
cycle
Mean salivary levels (concentration ng/ml) for the mean of both cycles are 
presented below in Table 43. Both tryptophan and nicotinic acid exhibited 
significant cyclical variation; levels of both metabolites increased during the cycle, 
with maximum levels noted premenstrually. Further analysis though revealed that 
tryptophan levels did not significantly alter between the phases of the cycle 
(Wilcoxon rank).
Metabolite N Fdliciiar Luteal Premenstrual Friedman's
ANOVA(df=2)
TRY 23 1487.90 (1995.63) 1582.16 (2822.52) 2462.03 (318934) X -  6 28 
p=0.043*
5HT 25 367.77 (566.33) 653.32 (944.52) 452.15 (436.98) X -  3 38 
p=0.185
SHIAA 23 218.79 (423) 247.93 (403.33) 257.09 (372.89) X^=0-152
p=0.927
AA 23 51139 (1365.68) 434.40 (1026.83) 350.39 (91433) X ^.804
p=0.669
IAA 23 820.82 (1125.81) 916.23 (1294.64) 683.04 (887.98) xMl.783
p=0.676
KY 25 920.21 (1346.67) 666.80 (897.15) 993.62 (1800.54) X^=2.16
p=0.340
HK 25 1975.09 (3314.34) 1811.38 (3783.07) 1908.50 (4452.66) X^ =2-16
p=0.340
HA 25 1176.80 (279532) 1029.80 (2551.34) 1538.12 (3746.28) X*=0.780
p=0.677
QA 25 3542.77 (3703.64) 3322.25 (3719.62) 3494.72 (3210.17) X ^-96
p=0.228
NA 25 1194.96(1517.14) 1259.99 (1638.84) 1435.99 (178735) X-7-34
p=0.026*
TOTAL 23 10865.64 (6190.12) 11710.33 (8820.05) 12699.98 (8725.66) XM.69
p=0.260
Table 43. Mean salivary levels of tryptophan and tryptophan metabolites for the 
mean of cycles one and two investigated. Standard deviations in parentheses.
Post hoc analysis of nicotinic acid levels though did identify that the premenstrual
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increase was significantly higher than both the follicular (z=-2.31, p=0.021) and 
the luteal stages (z=-2.17, p=0.030). Salivary levels of serotonin and its metabolite 
5HIAA did not show any significant cyclical changes. However serotonin levels 
were maximal in the luteal stage whilst 5HIAA was highest premenstrually.
9.9.2 The Daily Variability of Salivary levels of Tryptophan and its Metabolites 
To assess if the mean values for each phase of the cycle were representative of the 
phases of the cycle, daily variability was assessed for each metabolite during both 
both menstrual cycles. No significant variation in salivary levels of tryptophan and 
tryptophan metabolites were noted during the phases of the menstrual cycle. This 
result indicated that salivary excretion does not vary between days of collection and 
therefore that the repeated measures method of sample collections for salivary 
samples was appropriate; and that the use of the mean score for each phase was 
acceptable.
9.9.3 Analysis of the Ratios of the Tryptophan Metabolic Pathways During the 
Menstrual Cvcle
To test the hypothesis that the menstrual cycle may alter the relative metabolism of 
tryptophan, various ratios of the metabolites were calculated, based on the actual 
(ng/ml) levels of salivary metabolites. The results are presented for the mean of 
both cycles (Table 44).
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Metabolite Ratio N Follicular Luteal Premenstrual Friedman's
ANOVA(df=2)
5HT+5HIAA 23 586.56 (772.76) 949.43(1008.36) 709.24 (610.60) Y2=1.978
p=0.372
Total kynurenines 23 9321.21 (5133.57) 8618.79(7607.48) 9805.01 (8329.29) X2=1.826
p=0.401
5HT+5HIAA/Total Kyn 23 0.07 (0.09) 0.21 (0.29) 0.17 (0.26) X2=4.587
p=0.101
5HT+5HIAA/KY+HA+HK 18 1.20 (4.71) 0.78 (1.34) 0.79 (1.38) X2=1.694
p=0.429
5HT+5HIAA/KY+HK 15 1.55 (4.94) 1.23 (2.34) 1.28 (2.18) X2=0.433
p=0.805
5HT/KY+HK 17 0.91 (2.45) 0.67 (1.40) 0.81 (1.49) X2=0.206
p=0.902
5HT+5HIAA/AA 6 2.38 (2.46) 21.70 (33.42) 2.97 (4.01) X-2.333
p=0.311
5HT+5HIAA/IAA 11 1.93 (4.91) 18.50 (45.70 ) 3.05 (6.86) X2=4.546
p=0.103
Table 44.The Ratios of 1rrvptoohan Metabolic Pathways (Assessed from Salivarv
Levels) During the Menstrual Cycle. Standard deviation in parentheses.
Of interest, the serotonergic pathway metabolites (ie 5HT+5HIAA) were highest in 
the luteal stage, whilst the kynurenic pathway metabolites were maximal 
premenstrually. However, the ratio of these two pathways did not alter during the 
menstrual cycle; indeed no significant alterations was noted in any of the ratios 
investigated.
9.9.4 Assessment of Changes in the Activities of the Enzymes Involved in the 
Metabolism of Tryptophan During the Menstrual Cvcle 
To further test possible influence of the menstrual cycle on the metabolic
conversion of tryptophan, the activities of MAO, kynurenine hydroxylase and
kynureninase were determined indirectly. These calculations were based on the
actual levels of excretion of tryptophan metabolites (ie ng/ml) for the mean of both
the cycles and the results are found in Table 45.
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Enzyme activity N Follicular Luteal Premenstrual Friedman's
ANOVA(df=2)
Kynurenine
Hydroxylase
13 4.17 (10.48) 4.79 (12.34) 4.74 (7.01) X2=3.500
p=0.174
Kynureninase 9 1.03 (2.69) 0.35 (0.69) 0.18 (0.31)
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MAO 17 0.89 (1.95) 1.06 (1.85) 1.15 (2.20) 5C2=0.029
p=0.985
MAO/Kynurenine
Hydroxylase
5 0.12 (0.22) 0.37 (1.17) 0.08 (0.13) X2=2.100
p=0.350
MAO/Kynureninase 6 0.25 (0.62) 0.60 (1.41) 0.61 (1.26) 5C2=0.583
p=0.747
Table 45. The Activities of the Enzymes Involved in The Metabolism of 
Tryptophan During the Menstrual Cycle (Based on Salivary Levels).Standard 
deviation in parentheses.
No significant cyclical changes were noted in the relative activities of the enzymes; 
however, the number of cases are small to make generalised statements. The 
activity of MAO increased during the cycle, with maximal activity noted 
premenstrually (reflective of the highest levels of 5HIAA at this point).
9.9.5 The Relationship Between Urinary and Salivary Levels of Tryptophan and 
Tryptophan Metabolites During the Menstrual cycle
Prebreakfast samples of both saliva and urine were collected from each subject. To 
assess if salivary levels of tryptophan and tryptophan metabolites correlated with 
urinary levels during the phases of the menstrual cycle, Spearmans rank 
correlations were performed for each phase for the mean cycle values. No 
significant correlations were noted for tryptophan, nor its metabolites at any stage 
of the menstrual cycle. These findings were not unexpected since urinary levels 
represent changes in metabolism over a longer period of time (ie hours), whereas 
salivary levels represent a more immediate insight into metabolic changes.
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9.10 Discussion of Study E.
The analysis of tryptophan metabolism in saliva was performed to identify any 
consistent findings, which were not identified from the urinary studies C and D. In 
this study, like that of study D, salivary levels were obtained through two 
consecutive menstrual cycles, and the mean values for both cycles are discussed. 
However, again it is important to note that for the metabolites analysed, no 
consistent trends were identified across both the cycles. However in spite of this, a 
significant premenstrual increase in nicotinic acid (relative to both the follicular and 
luteal stages) was identified, as discussed later.
(a) The Assessment of tryptophan and tryptophan metabolites in saliva during the 
menstrual cycle
Tryptophan levels in saliva were shown to increase during the cycle, with highest 
levels noted in the premenstrual stage (the salivary levels reflecting the dietary 
intake of tryptophan). As would be expected, with the increase in tryptophan 
available, the level of total salivary tryptophan metabolites increased with maximal 
levels noted premenstrually. The sum of the total kynurenine pathway metabolites 
was lowest in the luteal stage, highest premenstrually. In the follicular phase, it was 
expected that KY levels would be at their highest [due to the induction of the 
pyrollase (shown in study D) and inhibition of KY hydroxylase (identified in 
previous research)]. However, although the activity of KY hydroxylase was at its 
lowest (albeit non significant), the actual levels for KY did not peak at this stage. 
Instead levels of HK were highest, indicating increased turnover of KY. This 
elevation in HK was not a result of the supposed oestrogen-mediated inhibitory
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effect on kynureninase (since the activity of this enzyme was not depressed); rather 
that more tiyptophan was diverted to the pyrollase pathway than to the serotonergic 
pathway (as indicated by the minimal excretion rates of both 5HT and 5HIAA, and 
the reduction in MAO activity).
The luteal phase, however demonstrated a reduction in levels of the main arm 
pyrollase metabolites ie KY, HK and HA suggesting (like study D) a possible 
influence of progesterone. Correspondingly 5HT levels were at their highest 
indicating a possible induction of tryptophan hydroxylase; the activity of MAO was 
surprisingly not induced as would have been expected on the basis of previous 
research.
Finally in the premenstrual phase, a significant elevation in salivary levels of 
nicotinic acid was noted (p=0.026), indicative of a major increase in kynurenergic 
metabolism (due to HA being diverted to the non enzymic, NAD forming, 
pathway). This was confirmed by the maximal levels of the sum of the total 
pyrollase pathway metabolites noted at this stage. As a result of this increase in 
kynurenergic metabolism, less tryptophan was metabolised by the serotonergic 
pathway. Indeed, serotonin levels did decrease (by 66% from the luteal stage); 
however, 5HT breakdown was shown to be maximal (as indicated by the highest 
activity of MAO and correspondingly the highest levels of 5HLAA) at this stage 
indicative of reduced serotonin availability.
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(b) The mediation of the pyrollase pathway on the serotonergic metabolic pathway 
during the menstrual cycle
The effect of the pyrollase pathway on the serotonergic pathway was investigated 
but no significant cyclical effects were noted, and again hypothesis two was not 
supported. The ratio of the serotonergic to total kynurenergic pathways was 
maximal in the luteal stage, with the major decrease noted (of 71.4%) between the 
premenstrual and follicular stages. However, the other ratios investigated (ie of the 
serotonergic to the main arm metabolites) did not show this trend; rather that the 
highest ratios were noted in the follicular stage, with the major decrement observed 
between the follicular to luteal stages. The alternative ratios employed by 
Thompson and McMillan (1987) to investigate the effects of the other tryptophan 
metabolic pathways on the serotoninergic pathway were also investigated; however, 
the small case numbers invalidates any conclusions that could be drawn from the 
results.
In conclusion, the hypotheses (1) that tryptophan metabolism is affected by the 
menstrual cycle, and (2) that the kynurenergic pathway mediates serotonin 
production and metabolism during the cycle, were not supported, when salivary 
measures were employed. However, in spite of the lack of significant findings, this 
study does indicate a possible use for future behavioural studies using saliva since 
the levels of tryptophan and its metabolites were detectable in saliva. The 
advantage of such a biological medium is obvious; collection can be carried out by 
the subject, the method of collection is both painless and economic and sample 
storage and preparation easy. No relationship was identified between salivary levels
of tryptophan and its metabolites with urinary levels, in this study. This could 
have been accounted for by the relatively small sample size for such an 
investigation. However, salivary levels are more reflective of acute metabolic 
changes, compared to urine levels which represent metabolic changes over a 
number of hours. Therefore, although the aim of this study was not met, the use of 
saliva as an index of metabolic change requires further investigation. Further 
studies would be required to validate the methodology, and an investigation into 
the correlation between plasma and saliva levels would be of immense use, 
potentially providing an alternative to the invasive techniques employed for blood 
studies.
9.11 Overall Concluding Remarks From Studies C. D and E
The metabolism of tryptophan during the menstrual cycle was investigated in three
studies. The two hypotheses tested (ie that cyclical effects occur in tryptophan 
metabolism, and that the kynurenergic pathway mediated serotonin production) 
were only supported in the initial urinary study. However, when the study was 
repeated with hormonal profiling, neither hypotheses were not supported, nor the 
expected trends identified.
In studies D (urinary samples) and E (salivary samples) the study was repeated 
over two consecutive cycles, and in both these studies no consistent trends were 
established across the two cycles for any of the ten metabolites analysed, the 
metabolite ratios, nor enzyme activities. When the mean cycle phase values were 
investigated however, the data from both studies did support (although non
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significantly) previous work indicating that oestrogen induces the activity of the 
pyrollase enzyme but leads to inhibition of MAO.
The methodology used in these studies was comparatively improved on previous 
studies. For example, subject numbers were considerably higher, repeated 
measurements were obtained from the subject (ie 6 samples per phase) and two 
cycles were investigated and hormonal levels confirmed. In addition, in these 
studies due to the high inter and intra subject variation, the data was not deemed to 
be analysed by parametric tests and limited the analysis available. Previous 
longitudinal studies only report the overall mean metabolite values with no 
comment on the consistency of findings across one or more cycles, and therefore it 
is difficult to ascertain if this finding was specific to these studies. Therefore 
although the results were disappointing in the lack of significance, these studies 
raise questions as to the validity of previous research. (Indeed, the literature 
demonstrated findings that are frequently conflicting and inconsistent which could 
be partly due to poor methodology).
On the basis of these findings, future research in this area could include the use of 
24 hour urinary collections; repetition of the methodology but monitoring levels in 
plasma, and correlating levels with hormonal concentrations; and finally tryptophan 
challenge studies which may identify any hormonally mediated metabolic changes, 
since cyclical changes may not be so overtly identifiable in non clinical groups. In 
addition, the salivary assay to measure tryptophan metabolites requires further
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investigation as a means of providing a potential non invasive correlate of plasma 
levels.
Therefore, with regard to the potential effect serotonin metabolism may exert on 
eating control during the menstrual cycle, no explicit findings could support any 
cyclical nature. However, correlational studies may provide evidence for such a 
role, and the discussion of these studies is found in Chapter Ten.
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The Relationship Between Tryptophan Metabolism, Food Intake and
Eating
Behaviour During the Menstrual Cycle
10.0 Introduction and Review of the literature
Previous research has identified that the neurotransmitter serotonin has an 
inhibitory effect on eating behaviour (eg Blundell, 1984, Liebowitz and Shur 
Posner, 1986) resulting in a decrease in meal size (Blundell and Hill, 1987b) and 
increased post prandial satiety (Hill and Blundell, 1990). In addition, research has 
implicated a role for serotonin in the selection of specific macronutrients, ie protein 
and carbohydrate (Wurtman, 1983); with increased central serotonin synthesis being 
associated with a decrease in carbohydrate foods (Wurtman et al, 1985). 
Serotoninergic neurones suggested to be "ratio sensors" of food induced changes in 
plasma amino acid levels (which affect cerebral tryptophan uptake and hence 
central serotonin synthesis) (Femstrom and Wurtman, 1973; Yokogoshi &
Wurtman, 1986) and therefore affect the macronutrient content of the subsequent 
meal dependant on the amount of serotonin produced.
10.1 Study F.
An Investigation into the Relationship Between Tryptophan Metabolism. 
Food Intake and Eating Behaviour During the Menstrual Cycle
10.1.1 Aims of the Study
In view of the considerable literature in support of a role for serotonin in the
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mediation of food intake, this study was undertaken to investigate the following 
aspects during the menstrual cycle. In particular (1) to confirm the relationship 
between serotonin levels with the inhibitory processes of eating ie satiation and 
satiety; (2) to examine whether altered serotonin levels result in changes in actual 
food intake, and if so, (3) to confirm the potential role of 5HT in macronutrient 
preference, specifically carbohydrate intake. In addition, this study was designed to 
to ascertain the potential regulatory affects of the kynurenergic metabolites of 
tryptophan on serotoninergic metabolism.
On the basis of the previous research the following hypotheses were proposed.
(1) That menstrual cycle alterations in serotonin concentrations affect satiation and 
satiety, with increased levels of serotonin (both absolute, and relative to 
kynurenergic pathway metabolites) being reflected in increased inhibition of eating.
(2) That reduction of serotonin levels (both absolute, and relative to kynurenergic 
pathway metabolites) leads to an increase in total food intake.
(3) That serotonin levels (both absolute, and relative to kynurenergic pathway 
metabolites) are inversely correlated to carbohydrate intake.
10.1.2 Methodology
(a) Subject sample and Study Criteria
The subjects (n=32) participating in this study were all concurrently participating in 
Study B (ie the assessment of food intake and eating behaviour during the 
menstrual cycle) and Study D (urinary levels) (ie the analysis of tryptophan 
metabolism during the menstrual cycle). Therefore, subject population details, study
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criteria, and calculation of the sampling days based on menstrual history can all be 
obtained by reference to Study B (see Chapter Eight, section 8.1.4). Informed 
consent was obtained from the subjects in accordance with the regulations of the 
Ethical Committee of RIL. All information obtained from the subjects was coded to 
ensure anonymity and confidentiality.
10.1.3 Study Design and Procedures
This study was designed to investigate the relationship between tryptophan 
metabolism and eating behaviour over two consecutive menstrual cycles on a 
repeated methods design. The relationship was investigated using the urinary data 
from Study D. Sampling days for the three phases of both cycles (ie follicular, 
luteal and premenstrual) were calculated according to retrospective analysis of their 
previous six months cycle lengths. Subjects were assessed on three days in each of 
the three phases of two cycles, making a total of 18 sampling days per subject 
(see Study B for more details).
The assessment of eating behaviour was investigated in the subject population, as 
discussed in Study B on a total of 18 sampling days during the two menstrual 
cycles. The assessment of tryptophan metabolism was additionally determined on 
each of these sampling days (see Study D), so that correlations would be 
determined between the various aspects of eating with metabolic levels. Urinary 
hormonal levels were additionally determined to accurately define the stages of the 
cycle (as described previously in Chapter Eight, section 8.4.6). Of the 32 
participating subjects, six subjects had one anovulatory cycle and therefore the data
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relating to those cycles was omitted from analysis.
10.1.4 Statistical Analysis
To determine the relationship between tryptophan metabolism and eating behaviour 
during the menstrual cycle, correlations were performed between the relevant 
variables for each seperate cycle investigated, as well as for the mean of both 
cycles; only the results from the mean of both cycles is presented here. As 
discussed in Study D, the tryptophan data did not meet the criteria for parametric 
analysis. Hence, all correlations with both actual food intake and subjective 
appetite data, were investigated using Spearman's rank correlational tests (and 
therefore regression analysis was not feasible). Significant differences were 
assumed to have occurred when p was equal to or less than 0.05.
10.2 Results for Study F /
(1) Urinary tryptophan, and tryptophan metabolites and Food Intake During the 
Menstrual Cycle
To investigate the relationship between the menstrual cycle, serotonin and eating, 
urinary metabolites of tryptophan were correlated with (a) actual food intake and
(b) percentage macronutrient intake during the phases of the menstrual cycle. 
Correlations were performed using Spearman's rank correlation test. The results are 
as follows.
(al Actual food Intake
The overall results for the correlations in the follicular, luteal and premenstrual 
stages of the menstrual cycle are found in Appendix 21, Tables 7a, 7b and 7c 
respectively. With the exception of 5HIAA, no consistent correlations were found 
between metabolite levels and calorie and macronutrient intake during the
menstrual cycle. 5HIAA however did correlate inversely with total calorific intake 
during the luteal phase of the cycle only (r=-0.377, n=32, p=0.034).
(b) Percentage Macronutrient Intake
The overall results for the correlations in the follicular, luteal and premenstrual 
stages of the menstrual cycle are found in Appendix 21, Tables 8a, 8b and 8c 
respectively. No consistent correlations were identified between any single 
tryptophan metabolite with percentage macronutrient.
(2) Urinary tryptophan, and tryptophan metabolites and Eating Behaviour During 
the Menstrual Cycle
To investigate the relationship between the menstrual cycle, serotonin and eating 
behaviour, urinary metabolites of tryptophan were correlated with (a) the stages 
involved in eating and (b) dietary restraint and cravings during the phases of the 
menstrual cycle. Correlations were performed using Spearman's rank correlation 
test. The overall results for both subjective aspects of eating behaviour during the 
follicular, luteal and premenstrual stages, are found in Appendix 21, Tables 9a, 9b, 
9c for the mean of both cycles, in Tables 10a, 10b, 10c for cycle one and 11a, l ib , 
11c for cycle two. The results are as follows.
(a) Stages Involved in Eating
No consistent relationships were identified between hunger, appetite, satiation and 
satiety with either tryptophan, serotonin or the remaining tryptophan metabolites, at 
either stage of the menstrual cycles.
Cravings
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No consistent relationships were identified between aspects of dietary restraint and 
food cravings with either tryptophan, serotonin or the remaining tryptophan 
metabolites, at either stage of the menstrual cycles.
(3) The Relationship between Urinary tryptophan metabolite ratios, tryptophan 
pathway enzyme activities and Actual and Percentage Food Intake During Two 
Consecutive Menstrual Cycles
The relationship between urinary tryptophan metabolite ratios, tryptophan pathway 
enzyme activities and actual and percentage macronutrient intake were assessed by 
Spearmans correlational tests. The correlations of these factors with the relative 
enzyme activities (ie MAO/ kynurenine hydroxylase, and MAO to kynureninase) 
could not be determined due to small case numbers. The overall results for the 
follicular, luteal and premenstrual stages are presented in Appendix 21, Tables 12 
(a,b,c), 13 (a,b,c) and 14 (a,b,c) respectively.
No consistent significant correlations between actual and percentage macronutrient 
intake with urinary tryptophan metabolite ratios, nor tryptophan pathway enzyme 
activities were identified at either stage of the menstrual cycle.
(4) The Relationship between Urinary tryptophan metabolite ratios, tryptophan 
pathway enzyme activities and Eating Behaviour During Two Consecutive 
Menstrual Cycles
The relationship between urinary tryptophan metabolite ratios, tryptophan pathway 
enzyme activities and subjective experiences of eating behaviour were assessed by 
Spearmans correlational tests. The correlations of these factors with the relative
256
enzyme activities (ie MAO/ kynurenine hydroxylase, and MAO/kynureninase) 
could not be determined due to small case numbers. The overall results for the 
follicular, luteal and premenstrual stages are presented in Appendix 21, Tables 15 
(a,b,c), 16 (a,b,c) and 17 (a,b,c) respectively.
No significant relationship was identified between tryptophan metabolite ratios, nor 
the activities of the enzymes involved in tryptophan metabolism with either 
subjective experiences of hunger, appetite, satiation and satiety. With regard to 
dietary restraint factors, the relative ratio of the serotonergic pathway to the 
kynurenine pathway [ie 5HT+5HIAA/KY+HK and, 5HT/KY+HK] correlated (albeit 
inconsistently across the two cycles) with subjective experience of overeating in the 
premenstrual stage of the cycle only ( 5HT+HIAA/KY+HK, r=0.380, n=30, 
p=0.038 ; 5HT/KY+HK, r=0.363, n=30, p=0.048).
No significant correlations were identified with food cravings and tryptophan 
metabolite ratios nor activities of the enzymes involved in tryptophan metabolism.
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10.3 Discussion of Study F
This study was designed to assess the influence of serotonin metabolism on food 
intake and eating behaviour during the menstrual cycle. With regard to the actual 
intake of food, neither absolute nor relative (to the kynurenergic pathway 
metabolites) levels of serotonin were seen to relate to the total intake of food at 
any stage of the menstrual cycle; although 5HIAA (the metabolite of serotonin) did 
correlate (r= - 0.377, p=0.034) with calorific intake (in the luteal stage of the 
menstrual cycle only). As previously discussed in Study D, serotonin breakdown is 
elevated at this stage (both 5HIAA and the activity of MAO were at their highest 
levels at this stage, although not significantly so), and suggest that the high 
progesterone levels seen at this time may activate an increased response to food 
intake mediated via serotonin catabolism. Although not significantly identified in 
Study B, food intake has been shown to increase post ovulation (eg Lyons et al, 
1989), partly as a response to increased basal metabolic rate (Solomon, Kurzer and 
Calloway, 1982), and the data from this study could therefore suggest that 
progesterone influences this actual calorific increase by increasing serotonin 
catabolism. Therefore, the hypotheses that serotonin levels directly affects total 
calorific intake was not directly supported; rather that increased serotonin 
catabolism (mediated by progesterone) does affect calorific intake.
With regard to the intake of macronutrients, the study did not support a role for 
serotonin (neither actual or relative levels; nor any other tryptophan metabolite) in 
the control of either carbohydrate, protein nor even fat intake. The hypothesis that
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serotonin specifically influences carbohydrate intake was therefore not supported; 
rather surprising in view of the significant premenstrual elevation in sugar intake 
(previously observed in Study B). However, research supporting this link between 
serotonin and macronutrient intake, employ challenge studies (eg the serotonergic 
agonist, fenfluramine eg Wurtman et al, 1985). The physiological "hormonal 
challenge" employed in this study, therefore did not identify such changes. In 
addition, other work has criticised this supposed self medication relationship; for 
example, neither Wurtman et al (1989), Rosenthal et al (1989) nor Caballero et al 
(1988) found the expected alteration in the T/LNAA ratio (necessary for increased 
serotonin synthesis) after a carbohydrate rich meal.
Previous research has identified a more convincing role for serotonin in the 
inhibitory stages of eating ie satiation and satiety, and this was the first study to 
investigate this relationship during the menstrual cycle. However, in this study 
serotonin (actual or relative; nor any other tiyptophan metabolite) did not correlate 
with either satiation and satiety scores during any stage of the menstrual cycle. 
However, a curious result was identified; a (weak) premenstrual link was identified 
between the subjective experience of overeating with an increased in both the 
relative serotonin synthesis and metabolism ie (5HT+5HIAA/KY+HK and 
5HT/KY+HK). However, as shown before this related to the subjective experience 
and not to an actual quantifiable change in food intake (food intake was highest at 
this stage although not significantly so). From previous literature it would be 
expected that increased serotonergic synthesis would result in a reduction in food
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intake, but this finding contradicts that notion. It could be hypothesised that 
women overeat premenstrually as a compensatory mechanism to elevate their 
reducing (relative) serotonin levels. However, if this were the case, it would be 
expected that women would specifically increase their carbohydrate intake at this 
time. Indeed, sugar intake did significant rise premenstrually (Study B) but no 
relationship was identified here with the appropriate serotonin ratios.
The findings from this study are not therefore supportive in a role for serotonin per 
se in either total food intake nor specific macronutrient intake, nor in the mediation 
of the inhibitory processes of food intake, either generally or as a function of the 
menstrual cycle. However, the role of progesterone on food intake does appear to 
be mediated via its influence on serotonin catabolism. Unfortunately, this supposed 
relationship could not be clarified. Of interest though, was the premenstrual link 
identified between relative serotonin and overeating which is supportive of the 
idea that serotonergic related behavioural changes may be mediated via the 
kynurenergic pathway. In view of the lack of support for the hypotheses, the final 
chapter will address the possibility of mood mediated changes in food intake during 
the menstrual cycle.
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An Investigation into the Relationship between Food Intake, Eating Behaviour and
Mood During the Menstrual cycle.
11.0 Introduction and Review of the Literature
The expression of eating behaviour and the control of food intake has been shown 
to be an interaction of biological, psychological and cultural factors (Blundell, 
1991). In the previous chapter, the role of serotonin, a neurotransmitter involved in 
the inhibition of food intake was investigated to identify its possible mediation of 
menstrual cycle related changes in feeding and eating behaviour. Therefore to 
investigate the potential role of psychological aspects, the following study was 
carried out to (1) identify if personality traits affect eating, and (2) to assess the 
relationship between mood states and eating during the cycle.
Mood states have been shown to alter during the menstrual cycle; with increased 
reporting of negative mood states in the premenstrual phase (Moos, 1968; Morse 
and Dennerstein, 1988) but more positive changes noted in the follicular or mid 
cycle phases (Gallant et al, 1991) (although most research is biased towards the 
observation of negative symptomology premenstrually). Since alteration in mood 
has been associated with the menstrual cycle, it is suggested that the changing 
levels of hormones may account for the alterations either directly (although this has 
not been supported in research studies) or indirectly (ie via the action of hormones 
on neurotransmitters eg serotonin that affect mood states). However, not all studies 
do identify significant cyclical alterations in mood (eg Abplanalp et al, 1979), and 
indeed in studies with strong methodology (ie prospective studies employing
hormonal profiling with the aim of the study concealed) the data contradict the 
widely held belief that women do have mood changes during the menstrual cycle. 
However, even if changing hormonal levels do play a role in mediating mood 
states, other factors have been identified to significantly contribute to mood 
changes eg day of the week (Rossi and Rossi, 1977) and stressful life events 
(Wilcoxon, Schrader and Sherif, 1976; Laessle et al, 1990).
The relationship between food intake and mood is relatively a new area of research 
and research data are sparse. Studies have shown that when individuals experience 
negative emotional states there can be two responses ie either the loss of appetite 
or overeating (Rosch, 1995) with breakdown of dietary restraint (reviewed by 
Ruderman, 1986). The most extensive research investigating the link is based on 
the hypothesis proposed by Wurtman et al (Femstrom and Wurtman, 1971a; 1971b, 
1972) indicating that increased carbohydrate consumption increases central 
serotonin neurotransmission, which in turn alters behaviour (eg food choice, mood 
etc reviewed by Spring et al, 1987). A further hypothesis (Wurtman and Wurtman, 
1989) was subsequently proposed that suggested some individuals (eg SAD, PMS, 
carbohydrate cravers and bulimia nervosa sufferers) specifically increase their 
carbohydrate intake to relieve depression ie they "self medicate". For example, it 
has been shown that PMS sufferers have a significant premenstrual increase in 
appetite which is associated with depression, anxiety, irritability and loneliness 
(Both Orthman et al, 1988) but carbohydrate intake at this time corresponds to a 
decrease in their depression (Wurtman et al, 1989) and anger (Sayegh et al, 1995).
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11.1 STUDY G
An investigation into the relationship between food intake, eating behaviour 
and mood during the menstrual cycle
11.1.1 Aims of the Study
This aim of this study was to investigate (1) if there is an association between trait 
anxiety and trait anger with actual food intake, or subjective experiences of eating 
during the menstrual cycle; (2) to assess cyclical changes in depression, anxiety 
and anger during the menstrual cycle; (3) to ascertain the relationship between both 
positive and negative subjective mood states with actual and subjective experiences 
of food intake during the menstrual cycle. On the basis of evidence from the 
literature, the following hypotheses were proposed.
Hypotheses
(1) That subjects with higher trait anxiety and anger scores, have increased food 
intake which is reflected in their increased hunger and appetite scores.
(2) That cyclical changes in mood occur, with a significant increase in positive 
mood in the follicular stage but increased negative mood in the luteal stage.
(3) That increased negative mood is associated with an increase in total food 
intake, specifically carbohydrate, on the basis of the "self medication" hypothesis. 
And, conversely that increased positive mood is associated with a decrease in total 
food intake.
(4) That food cravings are elevated premenstrually, and are associated with 
dysphoric mood, and finally
(5) That dietary restraint is associated with mood; increased restraint correlating 
with positive mood states but decreased restraint with negative mood states.
11.1.2 Methodology
(a) Subject population and Study Criteria
The subjects (n=32) participating in this study were all concurrently participating in 
Study B. Therefore, subject population details, study criteria, and calculation of the 
sampling days based on menstrual history can all be obtained by reference to Study 
B (see Chapter Eight). Informed consent was obtained from the subjects in 
accordance with the regulations of the Ethical Committee of RIL (Appendix 12).
All information obtained from the subjects was coded to ensure anonymity and 
confidentiality.
11.1.3 Study Design and Procedures
This study was designed to investigate the relationship between mood states and 
eating behaviour over two consecutive menstrual cycles on a repeated methods 
design. Sampling days for the three phases of both cycles (ie follicular, luteal and 
premenstrual) were calculated according to retrospective analysis of their previous 
six months cycle lengths. Subjects were assessed on three days in each of the three 
phases of two cycles, making a total of 18 sampling days per subject (see Study B 
for more details).
Prior to commencement of the study, subjects were personally interviewed to 
advise them of the procedures involved, and asked to complete two personality trait 
questionnaires ie Speilberger Trait Anger Inventory (Spielberger, 1991) and 
Spielberger Trait Anxiety Inventory (Spielberger et al, 1983) [refer to Chapter 
Seven, sections 7.4, and 7.3 respectively].
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The assessment of eating behaviour was investigated in the subject population, as 
discussed in Study B on a total of 18 sampling days during the two menstrual 
cycles. The assessment of mood states was additionally determined on each of 
these sampling days, so that correlations would be determined between the various 
aspects of eating with mood. Therefore, on each of the sampling days, the subjects 
were asked to complete the following questionnaires two hours after their evening 
meal, based on their moods at the time of completion
(1) An abridged version of the Profile of Mood State questionnaire containing only 
those items that related to anxiety/composed, depressed/elated and hostile/agreeable 
mood states.
(2) Spielberger state anxiety questionnaire
(3) Spielberger state anger questionnaire
For further information on each of these three questionnaires, refer to Chapter 
Seven, sections 7.2, 7.3 and 7.4. Urinary hormonal levels were additionally 
determined to accurately define the stages of the cycle (as described previously in 
Chapter Eight, section 8.4.6). Of the 32 participating subjects, six subjects had one 
anovulatory cycle and therefore the data relating to those cycles was omitted from 
analysis.
11.1.4 Statistical Analysis
The questionnaire data was scored by hand as discussed in Chapter Seven. With 
regard to the abridged POMS scale, for each of the mood states assessed total 
scores were obtained for (a) the positive aspect of the construct, (b) the negative
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aspect of the construct and finally (c) the averaged score (ie positive aspect score 
less the negative aspect score). For analysis of cyclical affect, the mean scores per 
mood state per phase of each cycle, were calculated. With regard to the state 
anxiety and state anger scales, a single score was obtained per sampling day; the 
mean value per phase of each cycle was then calculated prior to statistical analysis. 
The results for the mean of both cycles are presented only; however, where 
appropriate the results from the analysis of each seperate cycle are discussed.
All three questionnaires had previously been validated, and as such the use of 
parametric testing was deemed appropriate. Viewing of the data confirmed that the 
necessary criteria were met for the use of parametric tests. To determine any 
cyclical changes in affect, the data was analysed using repeated measures analysis 
of variance (ANOVA), with subsequent paired t tests to identify where cyclical 
differences occurred where appropriate. To determine the relationship between 
mood and eating behaviour, Pearsons correlational tests were performed on the 
appropriate variables (both sets of data meeting the criteria for parametric analysis). 
Where several mood variables covaried with a dietary or eating behaviour variable, 
multiple regression analysis was performed to determine the predictive value of 
their relationships. Significant differences were assumed to have occurred when p 
was equal to or less than 0.05.
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11.2 Results for Study G
The affect of (a) personality traits and (b) mood states on food intake and eating 
behaviour during the cycle are assessed in Sections A and B respectively.
11.2.1 SECTION A. The relationship between trait personality characteristics, 
eating behaviour and food intake during the menstrual cycle
Thirty three subjects completed Spielberger trait anxiety and anger questionnaires;
the mean scores are shown in Table 46 below. As expected, the mean group scores
for the personality trait scores were all within the normative range. The mean
scores were then correlated with the following aspects of food intake and eating
behaviour, previously determined for the group.
Personality Scale Subject Group 
Mean Score
Normative
scores
Trait Anxiety 35.57 (7.58) 34.79 (9.22)
Trait Anger 16.26 (5.32) 19.44 (5.11)
- Angry temperament 5.75 (1.81) 6.43 (2.55)
- Angry Reaction 8.41 (2.00) 9.78 (2.71)
- Anger In 15.84 (4.13) 15.70 (4.24)
- Anger Out 14.03 (2.92) 14.92 (4.02)
- Anger control 22.81 (5.12) 26.20 (4.26)
- Anger Expression 23.06 (7.32) 19.35 (7.36)
Table 46. Mean Trait Anxiety and Trait Anger Scores For the Subject Group (with 
Normative Mean Scores). Standard deviations in parentheses.
(I) The Relationship between Trait Anxiety. Trait Anger and Qualitative Food 
Intake During the Menstrual Cycle
(a) The relationship between trait personality characteristics and actual food intake
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(gramme weights) was assessed by Pearsons Correlation tests. The overall results 
are tabulated in the Results Appendix, Tables 18a, 18b and 18c.
No significant relationships were noted between trait anxiety levels and calorific 
nor macronutrient intake during the cycle. In addition, no relationships were 
identified between calorific or macronutrient intake with total trait anger or the 
following trait anger subscales (anger in, anger out, angry temperament, anger 
control nor anger expression) during the phases of the cycle. However, significant 
positive correlations were identified with angry reaction and fat intake; intake of fat 
positively correlated with angry reaction scores during both the luteal (r=0.509, 
n=32,p=0.003) and premenstrual phases (r=0.390, n=32, p=0.027) of the menstrual 
cycle; no relationship was identified during the follicular stages.
(b) The relationship between trait personality characteristics and the percentage 
food intake from the macronutrients was assessed by Pearsons Correlational tests. 
The results are tabulated in Appendix 21, Tables 19a, 19b and 19c. No significant 
relationship was identified between trait anxiety levels and the percentage 
macronutrient intake. However, trait anger and anger reaction scores correlated with 
percentage starch and percentage fat intake, respectively, in the premenstrual stages 
of the menstrual cycles only; no significant results being found in the follicular, nor 
luteal stages. The results are shown in Table 47.
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Anger Scores/
Percentage macronutrient intake
Trait Anger Anger Reaction
%  Starch Intake r=-0.518,n=32,p=0.002 NS
%  Fat Intake NS r=0.355,n=32,p=0.046
Table 47. Significant Correlations Between Percentage Starch and Fat Intake, with 
Trait Anger and Anger Reaction Scores During the Premenstrual Phase for the 
Mean of Both Menstrual Cycles
Higher trait anger scores related to a decrease in the percentage starch taken 
premenstrually; higher anger reaction scores with an increased percentage fat 
intake. Interestingly, these results were only identified in the premenstrual phase of 
the cycle.
(2) The Relationship between Trait Anxiety. Trait Anger and The Stages of Eating 
During the Menstrual Cycle
The relationship between trait personality characteristics and the stages involved in 
the control of eating were assessed by Spearman's Rank Correlation tests. The 
results are tabulated in Results Appendix 21, Tables 20a, 20b and 20c. No 
significant results were found linking the stages of eating with trait anxiety levels. 
However, the scores for anger expression were seen to correlate inversely with 
satiety ratings, but only during the follicular phase of the cycle only (r= -0.435, 
n=32,p=0.013).
These results indicate that the more a subject expressed anger, the more they felt 
like continuing to consume food after a period of food intake. This though was 
found in the follicular stage of the cycle only.
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(3) The Relationship between Trait Anxiety. Trait Anger. Dietary Restraint and 
Food Cravings During the Menstrual Cycle
The relationship between trait personality characteristics and dietary restraint and 
food cravings were assessed by Spearman's Rank Correlation tests. The results are 
tabulated in Appendix 21, Tables 21a, 21b and 21c. No significant correlations 
were identified between dietary restraint on food types or lack of restraint on the 
amount of food eaten with either trait anxiety, total trait anger and subtypes of the 
trait anger scales. However, trait anxiety and anger expression scores were both 
seen to correlate with dietary restraint on the amount of food eaten as shown in 
Table 48 below.
Stage of Cycle/ 
Trait Characteristics
Follicular Luteal Premenstrual
Trait Anxiety t=-0.475,n=32,p=0.008 r=-0.387,n=32,p=0.035 NS
Anger Expression r=-0.415,n=32,p=0.018 NS NS
Table 48. Significant correlations between dietary restraint on amount of food and 
Trait anxiety and Anger Expression Scores During the Menstrual cycle for the 
Mean of both Menstrual Cycles
Trait anxiety scores correlated inversely with dietary restraint scores in both the 
follicular and luteal phases of the cycle; no relationship was identified 
premenstrually. These results indicate that the more anxious the subjects, the more 
likely she is to restrain the amount of food she eats in the two phases of the cycle. 
(A lower score for dietary restraint indicating a higher degree of restraint). Anger 
expression scores also correlated with dietary restraint on the amount of food; 
however, only in the follicular stage of the cycle, indicative that increased restraint 
on the amount of food eaten in the follicular stage, the more she generally
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expresses anger.
In addition, trait anxiety score also correlated positively with food cravings, 
indicating that the more anxious the greater the tendency for food cravings. 
However, again this finding was only substantiated in the follicular stage of the 
menstrual cycle (r=0.579,n=32,p=0.001).
11.2.2 Section B. The Relationship between Food Intake. Eating Behaviour and 
Mood States
The assessment of mood on food intake and eating behaviour during the menstrual 
cycle was investigated in thirty two women. Mood states were assessed by (a) an 
abridged version of the POMS questionnaire and (b) Spielberger state anxiety and 
anger questionnaires.
(1) The Relationship between Food Intake. Eating Behaviour and Mood as assessed 
bv POMS during the menstrual cycle
(i) A verased M ood Scores.
The mean averaged mood scores for depression, hostility, anxiety and confidence 
levels for the mean of both cycles is shown in Tables 49 and can be visualised in 
Graph 6. Differences during the menstrual cycle were determined by repeated 
measures ANOVA.
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Mean Mood State N Follicular Luteal Premenstrual ANOVA(df=2)
Mean depression 32 5.53 (4.87) 4.77 (5.30) 5.45 (4.35) F=0.50 
p =0.607
Mean Hostility 32 9.47 (4.05) 8.69 (4.27) 8.49 (4.51) F=1.02
p=0.367
Mean Anxiety 32 8.23 (4.70) 6.72 (4.81) 7.41 (4.93) F=1.26
p=0.291
Mean Confidence 32 3.52 (3.88) 3.63 (4.20) 3.45 (3.49) F=0.05
p=0.952
Mean Mood (total) 32 26.72 (15.90) 23.60 (17.03) 24.81 (15.25) F=0.72
p=0.492
Table 49. Mean Mood Scores Assessed bv POMS Questionnaire for the Mean of 
Cycles One and Two. Standard deviations in parentheses.
Averaged mean mood scores during the menstrual cycle 
(Mean of cycles one and two)
Assessed by POMS
Mean score
Mood state 
cnElated/depressed 
®Agreeable/hostile 
■Composed/anxious 
EuConfidentfunconfidt mt
Follicular Luteal Premenstrual
Phase of the menstrual cycle
Graph 6. A vem zed Mean M ood Scores Putins the Menstrual Cycle (as assessed bv 
POMS).
No significant cyclical changes in the averaged mood states were noted during the 
menstrual cycle. Analysis of the results from each seperate cycle identified that the
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results for each of the mood states, except for composure/anxiety scores, did not 
follow consistent patterns throughout the two cycles. The mean scores for 
composure/anxiety however were consistently highest in the follicular stages, and 
lowest in the luteal phase.
(11 Correlations Between averaged mood states and Food Intake 
Correlations between averaged mood states and (a) actual food intake and (b)
percentage macronutrient food intake were assessed by Pearson's Correlational
tests. The overall results for each stage of the cycle are found in Appendix 21,
Tables 22a, 22b and 22c for (a) actual food intake, and Tables 23a, 23b and 23c
for (b) percentage intake.
No significant correlations between averaged mood states and total calorie intake, 
nor actual macronutrient intake were noted during the phases of the menstrual 
cycle. Correlations between the averaged mood states and percentage macronutrient 
intake showed a weak negative relationship between composed/anxiety levels and 
fat intake (r= -0.361, n=32, p=0.043), indicating that reduced anxiety levels 
correlated with lower percentage fat intake. This finding though was only 
consistent during the follicular stages of the menstrual cycle. No other correlations 
were identified between percentage macronutrient intake and averaged mood states 
during the menstrual cycle.
(21 Correlations Between Averaged Mood States and Eating Behaviour 
Correlations between averaged mood states and (a) the stages involved in eating
and (b) dietary restraint and cravings, were assessed by Spearman's rank
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correlational tests. The overall results for the follicular, luteal and premenstrual 
stages for each cycle (and the mean cycle values) are found in Appendix 21, 
Tables 24a, 24b and 24c respectively. The significant findings are as follows.
(al Stages Involved in Eating
No significant correlations were noted with any mood state and hunger or appetite 
levels. The following averaged mood states correlated with satiation and satiety as 
shown in Tables 50 and 51 below.
Satiation /Stage of cycle Elated/depressed Agreeable/Hostile Composed/Arod ous Confident/Unconfident Total Mean Score
FoUiciiar NS r=-0.384,rr=32,p=0.030 r=-0.528,n=32,p=0.002 i=-0.428,re=32,p=0.014 r=-0.4281n=32,p=0.014
Luteal NS NS r=-0.398,n=32,p=0.024 NS r=-0.399,n=32,p=0.024
Premenstrual r=-0.371,n=32,p=0.037 r=-0.388,rr=32,p=0.028 NS NS r=-0.372,n=32,p=0.036
Table 50. Significant Correlations between Satiation and Averaged Mood States 
During the Menstrual Cycle.
Satiety /Stage of cycle Hated/depressed Agreeable/Hostile Composed/Arod ous Confident/Unconfident Total Mean Score
Follicular r=0.3811n=32,p=0.031 t=0.424,n=32,p=0.016 r=0.401,n=32,p=0.022 NS r=0.424,n=32,p=0.016
Luteal 1=0.457^=32,p=0.009 1=0.434^1=32,p=0.013 r=0.500,ir=32,p=0.004 NS r=0.484,n=32,p=0.005
Premenstrual r=0.422,n=32,p=0.016 r=0.459/r=32,p=0.008 NS NS
r=0.402/r=32,p=0.023
Table 51..Signil icant Correlations between Satietv and Averaged Mood States
During the Menstrual Cycle.
The inverse correlation between these specific mood states and level of satiation
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across the cycle, indicated that the more positive the mood the greater the feeling 
of fullness (a higher score for satiation indicating the subject felt "less full"). These 
results were consistent during both the follicular and premenstrual stages but not 
during the luteal stages of the cycle.
The positive correlations found between the mood states and level of satiety 
indicated that the more positive the mood (as indicated by a higher mean score), 
the less the subject felt like eating after a meal (a high score for satiety indicating 
that the subject did not feel like eating more food). This appeared to be a relatively 
consistent finding throughout the whole cycle.
(b) Dietary restraint and food cravings
To identify any relationships between dietary restraint, cravings and the averaged 
mood scores, correlations were performed for the phases of the menstrual cycle. No 
significant findings were identified between either restraint on the amount of food 
ate, nor on excessive food intake (subjectively assessed) during the phases of the 
cycle. However significant results were obtained for restraint on food types during 
the premenstrual phases, as identified in Table 52 below.
Average mood 
state/Cyde
Elated/depressed Agreeable/Hostile Composed/anxious Confident/Unconfident Total averaged mood 
score
Mean of both cycles r=0.606,n=32,p=0.000 1=0.512,re=32,p=0.003 NS r=0.425,n=32,p=0.015 i=0.506,n=32)p=0.003
Table 52. Significant Correlations between Dietary Restraint on Food Types and 
Averaged Mood States During the Premenstrual phase
No relationship between dietary restraint for food types, with averaged mood state 
scores was noted in either the follicular nor luteal phases of the cycle. In the
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premenstrual phases, consistent positive correlations were noted indicating that the 
more elated, agreeable and overall more positive the mood, the less the subjects 
restrained themselves from eating specific food types.
In addition, significant correlations were identified between food cravings and 
averaged mood state scores during the follicular phase of the cycles. No consistent 
findings were found in the luteal, nor premenstrual stages regarding average mood 
and food cravings. The results are found in Table 53 below.
Average mood 
state/Cyde
Elated/depressed Agreeable/Hostile Composed/anxious Confident/Unconfident Total averaged mood 
score
Mean of both cydes r=-0.538,nr=32,p=0.001 i=-0.436,n=32,p=0.013 i=-0.486,n=32,p=0.005 r=-0.499,n=32,p=0.004 i=-0.589,n=32,p=0.000
Table 53. Significant Correlations between Food Cravings and Averaged Mood 
States During the Follicular Phases of the Menstrual Cvcle
The findings suggest that the more elated, agreeable, composed, confident (and
hence the more positive the overall mood state), the less the subjects craved foods
during this phase.
(ii) Positive M ood States Durins the Menstrual Cvcle
The positive aspects for each of the mood states assessed were determined during 
the menstrual cycles. Differences during the menstrual cycle were determined by 
repeated measures ANOVA. The mean scores for the mean of both cycles analysed 
are shown in Table 54. Graph 7 identifies the positive mood states for the mean of 
both cycles.
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Mean Positive Mood State N Follicular Luteal Premenstrual ANOVA (df=2)
tJation 32 13.59 (3.44) 12.99 (3.57) 13.42 (3.64) F=0.65
p=0.524
Agreeable 32 16.69 (3.38) 16.29 (3.34) 15.95 (3.57) F=1.26
p=0.290
Composed 32 16.12 (3.46) 15.20 (3.27) 15.57 (3.97) F=1.81
p=0.173
Confident 32 13.30 (3.26) 13.44 (3.58) 12.81 (3.23) F=1.13 
p=0.331
Total positive mood 32 59.71 (12.23) 57.93 (12.28) 57.65 (13.00) F=0.99
p=0.377
Table 54. Mean Positive Mood Scores for the Mean of Both Cycles During the 
Menstrual Cvcle. Standard deviation in parentheses.
Mean positive mood scores during the menstrual cycle
(Mean of cycles one and two)
Assessed by POMS
Mean score
Mood state
□Elated
■A greeable
■Composed
□Confident
Follicular Luteal Premenstrual
Phase of the menstrual cycle
Graph 7. Mean Positive Mood Scores During the Menstrual Cvcle (as assessed bv 
POMS).
No significant changes in positive mood states were noted during the menstrual 
cycle. Analysis of each seperate cycle identified that, with the exception of 
composed mood state, the remaining mood states assessed did not follow consistent
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patterns throughout the two menstrual cycles assessed. Mean scores for composure 
were however constant ie highest in the follicular stage, lowest in the luteal phase.
(1) Correlations Between Positive Mood states and Food Intake 
Correlations between positive mood states and (a) actual food intake and (b)
percentage macronutrient intake during the menstrual cycle, were assessed by
Pearsons correlational tests. The overall results for (a) actual food intake and (b)
percentage food intake are found in Appendix 21, Tables 25 (a,b,c) and Tables 26
(a,b,c) respectively.
No significant correlations between positive mood states and actual calorific and 
macronutrient intake were noted during the phases of the menstrual cycle. 
Correlations between positive mood states and percentage macronutrient intake 
showed a weak negative relationship in the follicular stage between composed 
levels and fat intake (r= -0.434, n=32,p=0.013), indicating that the less anxious the 
subject felt, the lower her percentage fat intake. This finding though was only 
consistent during the follicular stages of the menstrual cycle (and corroborated the 
finding for the averaged mood scores). No other correlations were identified 
between percentage macronutrient intake and positive mood states during the 
menstrual cycle.
(2) Correlations Between Positive mood states and Eating Behaviour 
Correlations between positive mood states and (a) the stages involved in eating and
(b) dietary restraint and cravings, were assessed by Spearmans rank correlational
tests. The overall results for the follicular, luteal and premenstrual stages for each
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cycle (and the mean cycle values) are found in Appendix 21, Tables 27 (a,b,c) 
respectively. The significant findings are as follows.
fal Stages Involved in the Control of Eating
No significant findings were found between positive mood states and hunger or 
appetite scores during the stages of the menstrual cycle. Significant correlations 
were however found between positive moods and satiation and satiety as shown 
below in Tables 55 and 56.
Positive mood state/Phase of 
cyde
Agreeable Composed Total Positive Mood
Follicular r=-0.375,m=32Jp=0.034 r=-0.439,n=32,p=0.012 r=-0.388,n=32,p=0.028
Luteal NS" r=-0.400,n=32,p=0.023 NS
Premenstrual NS NS NS
Table 55. Significant Correlations between Satiation Scores and Positive Mood 
States
The results suggest that weak negative correlations exist between positive mood 
states and satiation in the follicular and premenstrual phases of the menstrual cycle 
(mirroring the findings from the negative mood states). The negative relationships 
therefore indicate that the more positive the subjects felt in the two phases, the 
’'fuller" they felt. Multiple regression analysis, identified that positive mood states 
were not predictive of the degree of fullness in either the follicular nor the 
premenstrual stages.
Weak positive correlations between satiety and positive mood states were also
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identified in the follicular and luteal stages of the menstrual cycle; the results 
indicating that the more positive the mood, the less the desire to eat after a meal. 
Regression analysis identified that these moods (ie elated, composed and agreeable) 
were predictive of the degree of satiety (R=0.533, p=0.023) but in the luteal phase 
only.
Positive mood state/Phase of 
cyde
Elated Agreeable Composed Total Positive Mood
Follicular r=0.358,n=32,p=0.045 r=0.419,n=32,p=0.017 i=0.381^r=32,jf=0.031 i=0.362^i=32,p=0.042
Luteal r=0.468,n=32,p=0.007 NS 1=0.516^=32,p=0.002 r=0.432,n=32,p=0.013
Premenstrual NS r=0.428,n=32,p=0.015 NS NS
Table 56. Significant Correlations between Satiety Scores and Positive Mood States 
During the Menstrual cvcle.
(b) Dietary Restraint and Cravings
Correlations were performed between the positive mood states, dietary restraint and 
food cravings during the phases of the menstrual cycles investigated. No significant 
results were obtained for the subjective feeling that subjects ate greater amounts of 
food than normal, during any of the phases of the menstrual cycle. Significant 
results were found between restraint on food types, restraint on the amount eaten, 
and cravings. The results are described below.
(a) For the positive mood states, significant correlations were found between 
restraint on food types in the premenstrual phases of the cycle. The results are
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shown below in Table 57.
Positive mood 
state/Cyde
Elated Agreeable Composed Confident Total positive mood 
score
Mean of both cydes r=0.523^=32,p=0.002 r=0.542,n=32,p=0.001 NS r=0.0377,n=32,p=0.033 r=0.462,n=32,p=0.008
Table 57. Significant Correlations between Dietary Restraint on Food types and 
Positive Mood States During the Premenstrual Phase of the Menstrual Cycles
These results corroborate the findings from the averaged mood correlations, ie that
the more elated, agreeable and overall the more positive the subjects felt
premenstrually, the less they restrained their intake for food types (however,
regression analysis of the moods elated, agreeable and confident as predictors of
dietary restraint was not significant). Again, no significant findings were noted in
either the follicular or luteal phases.
(b) Significant correlations were found between positive mood states and food 
cravings during the follicular phases of the menstrual cycle. The results are shown 
in Table 58.
Positive mood 
state/Cyde
Elated Agreeable Composed Confident Total positive mood 
score
Mean of both cydes t=-0.566,n=32,p=0.001 i=-0.454^F=32,p=0.009 i=-0.536,n=32,p=0.002 r=-0.474,n=32,p=0.006 i=-0.528,n=32,p=0.002
Table 58. Significant Correlations between Food Cravings and Positive Mood 
States During the Follicular Phase of the Menstrual Cycles
These findings, ie that the more positive the mood state in the follicular phase, the
less the subjects craved specific foods, corroborated those previous findings for the
average mood states. Multiple regression analysis did identify that these positive
mood states were predictive of the cravings experienced in the follicular stage
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(R=0.600, p=0.014). No significant correlations were again noted in the luteal nor 
premenstrual phases.
(c) In addition, positive mood states (elated, r=0.407, n=32, p=0.021; and 
agreeable, r=0.403, n=32, p=0.022) were shown to be correlated with dietary 
restraint on the amount of foods eaten in the premenstrual phases only.
The findings (although weak correlations) suggest that the more elated and 
agreeable subjects felt premenstrually, the more they restrained eating larger 
amounts of foods.
(Hi) Negative M ood States During the Menstrual Cvcle
The negative aspects for each of the mood states assessed were determined during 
the menstrual cycles. Differences during the menstrual cycle were determined by 
repeated measures ANOVA. The mean scores for the mean of both cycles are 
identified in Tables 59. The scores for the mean of both cycles can be visualised in 
Graph 9.
Mean Negative Mood State N Follicular Luteal Premenstrual ANOVA (df=2)
Depression 32 8.05 (2.67) 8.22 (2.88) 7.97 (1.98) F=0.20
p=0.823
Hostile 32 16.69 (3.38) 16.29 (3.34) 15.95 (3.57) F=0.65
p=0.527
Anxious 32 7.90 (2.10) 8.48 (2.42) 8.15 (2.16) F=1.26
p=0.292
Unconfident 32 9.82 (2.28) 10.17 (2.70) 9.41 (1.97) F=1.83
0=0.170
Total negative mood 32 32.99 (7.94) 34.13 (8.96) 33.00 (7.09) F=0.60
p=0.552
Table 59. Mean Negative Mood Scores for t ie Mean of Cvcles One and Two
During the Menstrual Cvcle. Standard deviation in parentheses.
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Mean negative mood scores during the menstrual cycle
(Mean of cycles one and two)
Assessed by POMS
Mean score
Mood state 
□Depressed 
■Hostile 
■Anxious 
□Unconfident
Graph 8. Mean Positive Mood Scores Putins the Menstrual Cvcle fas assessed bv 
POMS).
No significant changes in negative mood states were found during the menstrual 
cycle phases. Analysis of the results from each cycles showed that depressed mood 
states and lack of confidence followed consistent patterns throughout the cycle; 
with highest mean scores noted in the luteal phase, lowest premenstrually. The 
other mood states did not follow any consistent pattern.
(1) Correlations Between Negative mood states and Actual Food Intake 
Correlations between negative mood states and (a) actual food intake and (b)
percentage macronutrient intake during the menstrual cycle, were assessed by
Pearsons correlational tests. The overall results for (a) actual food intake and (b)
percentage food intake are found in Appendix 21, Tables 28 (a,b,c) and Tables 29
(a,b,c) respectively. No significant correlations were identified between either
PremenstrualFollicular Luteal
Phase of the menstrual cycle
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actual calorie and macronutrient intake, and percentage macronutrient intake with 
the negative mood states, during the phases of the menstrual cycle.
(2) Correlations Between Negative mood states and Eating Behaviour 
Correlations between negative mood states and (a) the stages involved in eating and
(b) dietary restraint and cravings, were assessed by Spearman's rank correlational
tests. The overall results for the follicular, luteal and premenstrual stages for each
cycle (and the mean cycle values) are found in Appendix 21, Tables 30 (a,b,c)
respectively. The significant findings are as follows.
(al Stage Involved in the Control of Eating
No significant correlations were noted between the negative mood states and 
hunger, appetite nor levels of satiety. However, the degree of satiation did correlate 
with several negative mood states (depression, r=0.470, n=32, p=0.007; hostility, 
r=0.414, n=32, p=0.019; and total mean negative mood, r=0.398, n=32, p=0.024) 
but only in the premenstrual stage of the cycle only.
These results indicate that the more depressed, hostile and overall negative the 
subject felt premenstrually, the less full she felt. Regression analysis confirmed that 
both depression and hostility do predict the feeling of satiation premenstrually 
(R=0.451, p=0.037).
(b) Dietary Restraint and Cravings
Correlations between the negative mood states and dietary restraint and food 
cravings were performed throughout the phases of the menstrual cycles 
investigated. No consistent significant results were identified for any of the phases 
of the cycle.
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11.2.3 Section C. The Relationship between Food Intake. Eating Behaviour and 
Mood as assessed bv Spielberger State Anxiety and Anger Questionnaires 
during the menstrual cvcle
Thirty two subjects completed Spielberger State Anxiety and Anger questionnaire
during the three phases of two consecutive menstrual cycles. To assess the effects
of the menstrual cycle, the data was analysed by repeated measures ANOVA. The
results are shown in Table 60. The levels of state anxiety and anger during the
menstrual cycle can be visualised in Graph 9.
State Anger/Anxiety Scores N Follicular Luteal Premenstrual ANOVA
(df=2)
State Anger 32 11.41 (2.19) 11.26 (1.84) 11.64(1.94) X2=0-49
p=0.618
State Anxiety 32 35.72 (10.36) 37.06 (10.46) 37.70 (9.42) X2=0.92
p=0.403
Table 60. Mean State Anger and State Anxiety Scores During the Menstrual 
Cycles. Standard deviations in parentheses.
Mean state anxiety and state anger scores during the menstrual cycle
(Mean of cycles one and two)
Assessed by Spieibergers
8 Mood state-  
6 sState anxiei y
Follicular Luteal Premenstrual
Phase of the menstrual cycle
Graph 9. Mean State Anxiety and State Anger Scores During the Menstrual Cvcle 
(assessed bv STAI and STAXI respectively).
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Overall, state anger was seen to be at its lowest in the luteal phase, but maximal 
premenstrually. State anxiety levels though increased throughout the cycle, with 
maximal levels noted premenstrually. However, no significant differences were 
noted across the cycle. The mean scores for both states were then correlated with 
levels of food intake, and the data concerning eating behaviour.
(i) Correlations between state anxiety, state anger and food intake during the 
menstrual cvcle.
Mean scores for state anxiety and state anger were correlated with (a) actual calorie 
and macronutrient intake and (b) percentage macronutrient intake throughout the 
three stages of the menstrual cycle. Correlations were performed using Pearson's 
correlational tests. The overall results for the follicular, luteal and premenstrual 
stages are found in Appendix 21, Tables 31 (a,b,c) respectively. No significant 
correlations were identified between state anger, state anxiety scores and actual 
calorie and (actual and percentage) macronutrient intake during the phases of the 
menstrual cycle.
(ii) Correlations between state anxiety, state anger and eating behaviour during the 
menstrual cvcle
Mean scores for state anxiety and state anger were correlated with (a) the stages 
involved in the control of eating and (b) dietary restraint and cravings throughout 
the three phases of the cycle. Correlations were performed using Spearman's rank 
sum correlational test. The significant findings are as follows.
(a) Stages Involved in the Control of Eating
The overall results from the correlations for the follicular, luteal and premenstrual 
stages are found in Appendix 21, Tables 32 (a,b,c) respectively. Mean anxiety
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scores were found to correlate with both the inhibitory processes involved in eating 
during the follicular and luteal phases of the menstrual cycle. That is, significant 
positive correlations were found between mean state anxiety scores and the degree 
of satiation and, significant negative correlations were identified with mean state 
anxiety scores and satiety ratings. The results are found in Table 61 below. No 
significant relationship between mean state anger scores were identified with any of 
the stages involved in eating,
Phase of the cycle/ 
Inhibitory Stages of Eating
Follicular Luteal Premenstrual
Satiation r=0.422,n=31 ,p=0.018* r=0.370,n=3 l,p=0.040* NS
Satiety r=- 0.400,n=31,p =0.026* r=-0.432,n=3 l,p=0.015* NS
Table 61. Correlations between State Anxiety Scores and the Inhibitory Processes 
Involved in Eating.
(b) Dietary Restraint and Food Cravings
No consistent relationship was identified between any aspect of dietary restraint, 
nor food cravings with either state anxiety nor state anger levels during the phases 
of the menstrual cycles investigated.
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11.3 Discussion of Study G
This study was designed to assess the possible impact of personality traits and 
mood states on eating behaviour and food intake during the menstrual cycle. Trait 
anxiety and anger personality scores were assessed, and the hypotheses that those 
women with higher trait anxiety and anger would have higher total calorific intake 
(and be associated with increased scores for hunger and appetite), was not 
supported. However, certain relationships were identified. Trait anxiety scores did 
not correlate with actual food intake; however, highly anxious subject were 
suggested to crave more foods in the follicular stage (r=0.579, p=0.029) and 
additionally, to restrain the amount of food eaten in the follicular (r=-0.475, 
p=0.008) and luteal (r=-0.387, p=0.035) stages (even though no relationship was 
identified with actual intake). Trait anger though was observed to affect eating 
behaviour to a greater degree. Total trait anger scores were observed to correlate 
negatively with percentage starch intake premenstrually (r= -0.518, p=0.002). In 
addition, women who respond more angrily did increase their fat intake; with 
positive correlations observed in both the luteal (actual intake, r=0.509, p=0.003) 
and premenstrual stages [both actual (r=0.390, p=0.027) and percentage intakes 
(r=0.355, p=0.046)]. With regard to the subjective experiences of eating, 
correlations between anger expression and both satiety (r= -0.435, p=0.013) and 
dietary restraint (r= -0.415, p=0.008) were identified in the follicular stage of the 
menstrual cycle only; suggesting that those women who do express their anger feel 
less sated (and want to continue eating), but instead restrain the amount of food 
eaten.
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The assessment of mood changes on food intake and eating behaviour was 
determined. Mood changes were initially assessed, and interestingly no significant 
cyclical changes in mood states were observed (therefore rejecting hypothesis two); 
indicating that in a normal population the supposed cycle related mood changes do 
not exist. However the results confirmed those previous studies identifying that 
women felt overall more positive (being more elated, agreeable and composed) in 
the follicular stage of the cycle. However, surprisingly (compared to previous 
literature) the group felt overall more negative in their mood in the luteal stages 
(indeed depression, anxiety and lack of confidence scores rated their highest at this 
stage). This differed from previous literature that indicated a premenstrual 
exacerbation of negative mood. However (unlike the positive mood states) the 
results for the negative aspects of mood were consistent between the cycles and do 
suggest they are in support of a cyclical nature in their expression.
The hypotheses that increased negative moods were associated with increased food 
intake (particularly for carbohydrate intake) was not supported, disputing the 
suggestion that food is used to alleviate dysphoric mood. The only relationship 
identified in which mood related to alteration in diet, was observed in the follicular 
stage only; that the reduction in anxiety noted (defined by POMS) led to a 
reduction in percentage fat intake. This association though was weak (r=0.361).
Mood states were seen, though, to have a much more significant relationship to the 
subjective experiences of eating. With regard to the stages of eating, the inhibitory
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stages (ie satiation and satiety) were seen to be influenced by positive mood states 
in the follicular and luteal stages, but with negative moods in the premenstrual 
stage only. Notably, the feeling of fullness related to an overall positive mood 
(specifically agreeable and composed) in the follicular stage; and increased satiety 
(ie no desire to continue eating) with overall a more positive mood (specifically 
elation, composure and agreeability) in both the follicular and luteal stages (in the 
luteal stage these mood states were seen to be predictive of the degree of satiety, 
p=0.023).
The experience of negative mood states (specifically depression and hostility) was 
seen to inversely correpond to the degree of satiation experienced. Indeed, both 
depression and hostility were seen to predict the degree of satiation premenstrually 
(p=0.037). This relationship was only observed in the premenstrual phase and 
suggests an increased identification of negative mood (even though negative mood 
was not significantly elevated at this time) that the subjects related to in terms of 
food. However, no concomitant change in either the desire to continue eating, nor 
in actual intake was observed in this group, and suggests this may therefore be a 
socially learnt response. However, in a clinical group (eg PMS or bulimia nervosa 
sufferers) where marked changes in negative mood are apparent premenstrually, 
this may provide a possible explanation for the initiation of increased bulimic 
tendencies in response to negative mood states.
Of particular interest was the role of state anger/hostility and state anxiety in the
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mediation of eating behaviour during the menstrual cycle. Both anger and hostility 
were assessed by STAXI and POMS respectively, but each construct showed 
different (non significant) cyclical trends; with maximum state anger in the 
premenstrual stage, but maximum hostility observed in the follicular phase. 
However, the assessment of state anxiety was dually measured by STAI and the 
POMS, and therefore similar trends would have been expected. Although cross 
correlations were identified (between r=0.687 and r=0.752) between both measures 
at each stage of the cycle (indicating that both are reflective of the same measure) 
the actual trends differed; with state anxiety scores (STAI) highest in the 
premenstrual stage, but POMS anxiety scores highest in the luteal stage. A possible 
explanation for this discrepancy could be associated with the problems connected 
with self reporting; but this does question the validity of such measures for analysis 
of short term mood changes and could account for some of the contradictory cycle 
mediated findings, previously reported in the literature.
No relationship was identified between state anxiety and food intake. However, 
unlike the POMS anxiety measure, anxiety (STAI) was seen to affect the inhibitory 
eating processes in the follicular and luteal stages; with increased anxiety relating 
(albeit weak correlations) to a decrease in fullness and increased desire to continue 
eating. Interestingly, this relationship was not identified premenstrually, and could 
suggest the possibility that depression and hostility may override anxious feelings 
at that stage.
292
The affect of mood states on food cravings and dietary restraint was also 
investigated to identify the correspondance of negative mood changes with 
increased cravings and reduction in dietary restraint. However, surprisingly, both 
cravings and dietary restraint were associated with positive moods.With respect to 
cravings, the more positive the mood (overall and specifically the more elated, 
agreeable, composed and confident) the less subjects craved foods. This 
relationship was identified in the follicular stage only, and indeed the relevant 
mood states were predictive of the degree of cravings experienced (p=0.014). In 
addition, the more positive the mood (generally, and specifically the more elated, 
agreeable and confident) the less the subject restrained her intake for type of food 
premenstrually.
11.4 Overall Conclusions
The lack of significant findings in support of the hypotheses tested in this study 
was rather disappointing. As both mood states and (to the major extent) eating 
behaviour per se did not significantly alter during the menstrual cycle, the lack of 
support was not surprising. However, the lack of significant cyclical mood effects 
can be considered a positive finding; that the mood states of healthy women are not 
related to their menstrual cycles. With research studies in this field generally trying 
to confirm that (both healthy and clinical groups of) women do experience cyclical 
changes, these results oppose these strongly held beliefs.
Therefore with regard to the relationship between mood and eating behaviour, it
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appears that mood does not modulate actual food intake (except percentage fat 
intake) but is more associated with subjective experiences of eating (however, 
generally the level of correlations were rather weak). In particular, positive mood 
changes were seen to affect the inhibitory eating stages in both the follicular and 
luteal stages, but negative moods mediating the degree of satiation premenstrually. 
The results from this study therefore suggests that the impact of mood affects the 
cognitive aspects of eating, rather than its overt expression. In addition, this study 
indicates that social expectations could play a role in this relationship ie that 
premenstrually women will feel "less full" as they expect to experience negative 
mood at this time (even though no significant decrease in mood was observed 
premenstrually).
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CHAPTER TWELVE
CONCLUSIONS
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An understanding of eating control requires a multidimensional approach since 
numerous psychological, biological and cultural factors combine to influence how 
food intake is controlled. The research carried out in this thesis attempted to 
investigate the potential affect of the neurotransmitter serotonin (and the underlying 
metabolism of tryptophan) together with mood states on the mediation of food 
intake and eating behaviour during the menstrual cycle. The studies were carried 
out in women with normal eating habits and regular menstrual cycles and therefore 
provide a basis for the understanding of eating control in healthy women. However, 
it is possible to extrapolate some of the findings to those clinical conditions, ie 
carbohydrate cravers or bulimia nervosa sufferers, where eating has become 
dysregulated.
The effect of the menstrual cycle on actual food intake was investigated in this 
study, and showed that only sugar intake demonstrated a cyclical pattern, ie with a 
significantly elevated intake in the premenstrual stage of the cycle. In addition, 
total calorific intake was seen to rise to a maximum premenstrually (albeit non 
significantly) and was consistent with previous studies identifying a post ovulation 
increase. These findings could be attributable to a biological response; that the 
removal of the inhibitory effect of oestrogen, together with the high progesterone 
levels, that increase BMR, result in an increase in food intake, specifically sugar 
intake. Unfortunately, since the hormonal data could not be correlated with the 
dietary data, this could not be substantiated further.
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The post ovulation (non significant) increase in energy intake was seen to be 
attributable to a concomitant increase in percentage fat intake, indicative of the 
presence of a sensor altering the preference and choice for high fat foods. On the 
basis of previous work (although these changes in energy and percentage fat intake 
did not alter significantly during the menstrual cycle) it could be proposed that 
changing hormonal levels may mediate this percentage fat intake, with oestrogen 
having a lipolytic action, but progesterone increasing fat storage; and that to 
maintain a relative homeostatic energy balance, percentage sugar intake was 
adjusted accordingly (mirroring the intake of percentage fat).
Previous research into the neurobiological control of eating has certainly provided 
support for a role for serotonin. However, influence of the female gonadal 
hormones on serotonin metabolism has proved conflicting and as such a thorough 
investigation of tryptophan metabolism (ie its precursor) during the menstrual cycle 
was carried out. Indeed this was the first study to investigate such a range of the 
kynurenergic pathway metabolites during the cycle, and provides a useful baseline 
reference for future research. The lack of significant cyclical changes in both the 
serotoninergic pathway and kynurenergic pathway could be seen to dispute those 
studies that have previously identified a cyclical nature to serotonin metabolism; 
however, since both the urinary and saliva data exhibited extreme inter and intra 
subject variability, it could be suggested that cyclical effects may have been present 
but masked. The hypothesis that the relative changes in serotonin (mediated by the 
kynurenergic pathway metabolites) may be important in mediating behavioural
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cyclical affects generally, rather than serotonin levels per se, does though still 
warrant further investigation; since the 74% decrease in this ratio, observed from 
the luteal to premenstrual stages does suggest a potential influence on altering 
behaviours.
The role of serotonin in the mediation of eating control during the menstrual cycle 
was investigated. In the luteal stage HIAA levels did correlate with total calorific 
intake, suggesting that the high circulating levels of progesterone indirectly 
removed the inhibitory action of serotonin by its (non significant) induction of 
MAO. However, a role for serotonin in the inhibition of eating and in 
macronutrient selection was not identified, at any stage of the cycle. Instead a 
reduction in serotonin (relative to the kynurenergic pathway metabolites HK and 
KY) correlated with a premenstrual feeling of overeating. Initially, it could be 
suggested that the subjects felt they overate, as a response to the relative decrease 
in serotonin (relative to kynurenergic metabolites) levels observed premenstrually. 
However, if this were the case, then based on Wurtman's hypotheses, dietary 
patterns would alter to increase carbohydrate intake, as a compensation for this 
relative reduction in serotonin. Although sugar intake did significantly increase at 
this stage, no such correlation was identified.
This latter finding could be seen to have potential impact in the understanding of 
disturbed eating behaviour be it mild (ie dieting) or extreme (ie eating disorders). 
For example, it has been shown that women are more biologically vulnerable to
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dieting; short term dieting has been associated with a decrease in central 5HT 
function (Goodwin, Fairbum and Cowen, 1987), and a compensatory upregulation 
of 5HT2c receptors resulting in an increased desire for food intake (Cowen et al,
1995). Therefore a premenstrual relative decrease in 5HT levels could be a trigger 
for dieters breaking their diet, in response to the adaptation of the 5HT2c receptors. 
A further study to investigate if a premenstrual upregulation of these receptors does 
occur (using specific agonists) would therefore be of interest.
Premenstrual exacerbation of binging in bulimia nervosa sufferers has been 
identified (Gladis and Walsh, 1987; Price et al, 1987). Numerous reports have 
identified that bulimics have reduced serotonergic function (reviewed by Brien,
1996) that could possibly be causal in the eating disorder (ie by affecting the 
satiety cascade as the inhibition of eating is not controlled hence resulting in a 
binge) but definitely as a result of their disorder (eg the accompanying vomiting 
resulting in the loss of the post absorptive phase involved in the termination of 
eating). Therefore, the premenstrual decline in relative 5HT could mediate the 
increased binging frequency observed at this time; further studies would be 
required to investigate this.
Therefore, although the results from this thesis are not supportive for a role for 
serotonin in the inhibition of eating per se, they do suggest that the relative 
metabolism of 5HT to the kynurenergic metabolites may be more important than 
direct changes in 5HT levels, which could be of particularly relevance to other
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behavioural or psychiatric studies in which a role for serotonin has been suggested.
The lack of support for the serotonergic hypotheses suggested in this thesis, 
indicates that the menstrual cycle as an "internal challenge" on the serotonergic 
systems does not affect or mediate eating control. In addition, the results suggest 
that in those serotonergic based studies using a population of healthy women, 
menstrual cycle phase does not need accounting for; however, the determination of 
cycle phase in clinical groups may still be appropriate. The co-occurrence of 
eating problems with menstrual irregularities has been shown (eg Stewart et al, 
1990; Kriepe et al, 1989); and therefore although the data did not support any 
evidence for cyclical alterations in eating in healthy women (such as used in this 
study), this does not rule out the potential affect in clinical conditions.
Alternatively, the interaction of serotonin with the other neurotransmitters involved 
in the control of eating (ie the catecholamines dopamine, noradrenaline and 
adrenaline) may be of more importance than investigating the role of serotonin in 
isolation. However, the use of a dynamic pharmacological challenge (eg a 
tryptophan load) across the different stages of the menstrual cycle, may provide 
further insight into if and how that control is affected by changing hormonal levels. 
If such a relationship was identified, potentially it would be of immense benefit to 
use the menstrual cycle as a natural tool for manipulating dietary intake in those 
individuals who have dysregulated eating (eg those who are obese, carbohydrate 
cravers or bulimia nervosa sufferers).
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The assessment of mood states during the menstrual cycle did provide more 
support for the regulation of the subjective experiences of eating control; with 
positive moods being associated with feeling sated in both the follicular and luteal 
stages; but a premenstrual association of negative mood (specifically depressed and 
hostile mood states) with feeling less full. Food intake during the premenstrual 
phase was higher than the other stages of the cycle, but was not perceived as such 
by the subjects; this discrepancy possibly due to altered appetite perception as a 
result of depressed and hostile feelings. Of interest from the mood studies was the 
lack of significant cyclical effects on mood (either positive or negative), suggesting 
that in healthy women, mood is not associated with the menstrual cycle; a positive 
finding in view of the generally accepted negative association held in our society.
Although no significant cyclical changes in mood states were identified in these 
studies, questions regarding the assessment of short term changes in mood were 
raised. As was discussed in Chapter Eleven, daily anxiety states were investigated 
during the cycle using both the POMS and STAI, but the measures identified 
different cyclical trends. This could be explained by several arguments. Firstly, that 
the questionnaires did not measure the same construct; however both questionnaires 
are validated and have been frequently employed in menstrual cycle related studies. 
Secondly, this may have been a cause of repetitive measuring (anxious mood state 
was assessed for 18 days in total), with carryover effects and lack of commitment 
contributing to this discrepancy. However, daily diet histories were consistently 
completed by the subjects for the same length which required considerable more
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time for their completion. Alternatively, and perhaps the most likely explanation 
could be the inherent problems associated with self reporting.
Mood had no effect on actual food intake during the cycle. Therefore since both 
total energy and sugar intake (significantly so) increased premenstrually other 
psychological aspects not investigated in this study may have played a role in 
mediating these changes. One possible explanation could be that the onset of 
menstruation is perceived as an internal stress, and that food intake alters as a 
coping mechanism since there is no "flight" response. However, the assessment of 
stress (both subjective and physiological via cortisol levels) did not indicate that 
this was so. Alternatively it could be suggested that changes in food intake are 
mediated by specific primary emotions rather than the more diverse concept of 
mood, and therefore be influenced by specific emotive memories. Indeed the 
menstrual cycle does appear to affect the recall of specific emotional cued 
childhood memories (unpublished data Martin and Brien, 1996); which showed that 
premenstrually, women had an inability to retrieve personally relevant happy 
memories when cued.
What has been observed from these studies is the importance of good methodology 
when investigating menstrual cycle related phenomena. In each of the seven 
studies discussed, data was collected on a repeated measures basis, and subsequent 
analysis showed that no significant meaningful variation existed for either the 
tryptophan or mood data on a daily basis; therefore, the data does support the use
302
of a single measurement per phase of the cycle. However, the use of repeated 
measures over two or more cycles does seem to be important. With regard to both 
the mood and tryptophan data, inter cycle variability was extremely high, and as 
such disputed any possibility of cycle related phenomena at all. This suggests 
therefore that to ascertain truly cyclical effects, investigations across multiple 
consecutive cycles are required. Indeed no observations are normally made in those 
studies that do measure cyclical changes over more than one cycle, but this is 
important in view of the very nature of investigations. However the most important 
methodological control is in the correct definition of the phases of the menstrual 
cycle ie by the use of hormonal profiling. Indeed, as was shown clearly in study 
two, 10% of the data obtained had to be omitted due to six of the subjects having 
anovulatory cycles which would not have been identified if this method had not 
been used.
Several future areas of research have been highlighted on the basis of the findings 
in this thesis. In addition, the salivary assay employed to monitor tryptophan and 
tryptophan metabolites indicated that physiological levels of the metabolites were 
detectable in saliva. In view of the involvement of tryptophan in a myriad of 
physiological, behavioral and psychological aspects, this assay would be of 
immense benefit providing a potential alternative to plasma collection (saliva 
providing an insight into immediate metabolic changes). Of importance is the 
potential use of measuring the wide range of kynurenergic pathway metabolites in 
saliva. Since the kynunrenines are endogenous brain metabolites, it is suggested
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that the imbalance in the production, transport or catabolism may lead to discrete 
brain dysfunction and maybe causally related to the pathogenesis of some 
neuropsychiatric and neurodegenerative disorders. The collection of saliva is 
simple, painless, economic and sample storage and preparation easy. Although 
levels do not correlate with urinary levels, a future study to ascertain whether 
salivary levels are reflective of plasma would be imperative.
This thesis investigated eating control in healthy women during the menstrual cycle 
from a psychobiological perspective. As has been previously discussed the data 
indicates that mood is related, to a degree, to the subjective experiences of eating, 
but was not supportive of a role for the neurotransmitter serotonin in the inhibition 
of food intake. The lack of support for the hypotheses was surprising. However, the 
population employed in the study were healthy, with no known eating disorder, and 
therefore the trends identified may still hold importance to provide an insight into 
the cause or effect of severely dysregulated eating control in women.
304
REFERENCES
305
Abplanalp, JM, Donnelly, AF, Rose, RM. Psychoneuroendocrinology of the menstrual 
cycle. I. Enjoyment of daily activities and moods. Psychosomatic Medicine,41 (%), 
587-604, 1979.
Abraham, GZ, Eisner, CW, Lucas, LA. Hormonal and behavioural changes during the 
menstrual cycle. Senologia,3, 33 1978.
Abraham, SP, Beumont, PJ. How patients describe bulimia or binge eating. 
Psychological Medicine, 12, 625-35, 1982.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental 
Disorders. Washington, USA. American Psychiatric Association (Fourth Edition).
1994;
Anand, BK, Brobeck, JR. Hypothalamic control of food intake in rats and cats. Yale 
Journal o f Biological Medicine,24, 123-40, 1951.
Anden, NE, Fuxe, K, Larsson, K. Effect of large mesencephalic-diencephalic lesions 
on noradrenaline, dopamine and serotonin neurones of the central nervous system. 
Experientia,22, 842-3, 1966.
Anderson, GH, Li, ETS, Glanville, NT. Brain mechanisms and the quantitative and 
qualitative aspects of food intake. Brain Research Bulletin, 12, 167-73, 1984.
Anderson, LM, Parry Billings, M, Newsholme, EA, Fairbum, CG, Cowen, PJ. Dieting 
reduces plasma tryptophan and alters brain serotonin function in women. Psychological 
Medicine,20, 785-91, 1990.
Apter, A, van Praag, HM, Plutchik, R, Sevy, S, Korn, M, Brown, SL.
Interrelationships amongst anxiety, aggression, impulsivity and mood: a 
serotonergically linked cluster? Psychiatry Research,32, 191-9, 1990.
Asberg, M, Thoren, P, Traskman, L. 5HT depression- a biochemical subgroup within 
the affective disorders. Science,191, 478-81, 1976.
Asberg, M, Traskman, L, Thoren, P. 5HIAA in cerebrospinal fluid. A biochemical 
suicide predictor. Archives o f General Psychiatry,33, 1193-7, 1976.
Ashby, CR, Carr, LA, Cook, CL, Steptoe, MM, Franks, DD. Alterations of platelet 
serotonergic mechanisms and MAO activity in premenstrual syndrome. Biological 
Psychiatry,24, 225-33, 1988.
306
Ashley, Liardon, R, Leathwood, PD. Breakfast meal composition influences plasma 
tryptophan to large neutral amino acid ratios in healthy lean young men. Journal o f  
Neural Transmission,63, 271-83, 1985.
Ay 1 ward, M, Maddock, J. Total and free plasma tryptophan concentrations in 
rheumatoid disease. Journal o f Pharmacy and Pharmacology,25, 570-2, 1973.
Backstrom, TL, Wide, L, Sedergard, R, Carstensen, H. FSH, LH, TeBG capacity, 
estrogen and progesterone in women with premenstrual tension in the luteal phase. 
Journal o f Steroid Biochemistry,6, 473-88, 1976.
Badawy, AA. Mini Review. The functions and regulation of tryptophan pyrollase. Life 
Sciences,21, 755-68, 1977.
Bailey, J, Marshall, J. The relationship of the post ovulatory phase of the menstrual 
cycle to total cycle length. Journal o f Biosocial Sciences,2, 123-32, 1970.
Ballenger, JC, Burrows, GD, DuPont, RL, Lesser, IM, Noyes, R, Pecknold, JC, Rifkin, 
A, Swinson, RP. Alprazolam in panic disorder and agraphobia. Results from a 
multicentre trial. Archives o f General Psychiatry,45, 413-22, 1988.
Bancroft, J, Backstrom, T. Premenstrual syndrome. Clinical Endocrinology,22, 313-36, 
1985.
Bancroft, J, Cook, A, Davidson, D, Bennie, J, Goodwin, G. Blunting of 
neuroendocrine response to infusion of 1-tryptophan in women with premenstrual mood 
changes. Psychological Medicine,21, 305-12, 1991.
Bancroft, J, Cook, A, Williamson, L. Food cravings, mood and the menstrual cycle. 
Psychological Medicine, 18, 855-60, 1988.
Baran, H, Schwarcz, R. Presence of 3 hydroxy anthranilic acid in rat tissues and 
evidence for its production from anthranilic acid in the brain. Journal o f  
Neurochemistry,55, 738-44, 1990.
Barrett, JE, Vanover, KE. 5HT receptors as targets for the development of novel 
anxiolytic drugs:models, mechanisms and future directives. Psychopharmacology, 112, 
1-12, 1993.
Bear, D. Neurological perspectives on aggressive behaviour. Journal o f  
Neuropsychiatry,3(2), s3-8, 1991.
307
Beck, AT, Ward, CH, Mendelson, M, Mock, J, Erbaugh, J. An inventory for 
measuring depression. Archives o f General Psychiatry,4, 561-71, 1961.
Belmaker, RH, Wyatt, DL, Louiaux, DL. Human platelet monoamine oxidase changes 
during the menstrual cycle. Archives o f General Psychiatry,Z\, 553-6, 1974.
Bender, DA. Biochemistry of tryptophan in health and disease. Molecular Aspects of 
Medicine, 6, 101-97, 1982.
Bender, DA. Oestrogens and vitamin B6- actions and interactions. World Review o f  
Nutrition and Dietetics,51, 140-88, 1987.
Bender, DA, Laing, AE, Vale, JA, Papadaki, L, Pugh, M. Effects of oestrogen 
administration of tryptophan metabolism in rats and in menopausal women receiving 
hormone replacement therapy. Biochemical Pharmacology,32, 843-8, 1983.
Bender, DA, McCreanor, GM. The preferred route of kynurenine metabolism in the 
rat. Biochimica Biophysica A eta,717, 56-60, 1982.
Bender, DA, Wynick, D. Inhibition of kynureninase by oestrone sulphate: an 
alternative explanation for abnormal results of tryptophan load test in women receiving 
oestrogenic steroids. British Journal o f Nutrition,45, 269-75, 1981.
Berry, C, McGuire, G. Menstrual distress and acceptance of sexual role. American 
Journal o f Obstetrics and Gynaecology, 114(1), 83-7, 1972.
Beumont, PJ, Richards, DH, Gelder, MG. A study of minor psychiatric and physical 
symptoms during the menstrual cycle. British Journal o f Psychiatry, 126, 431-4, 1975.
Biegon, A. Effects of steroid hormones on the serotonergic system. Annals o f New 
York Academy o f Science,600, 427-32, 1990.
Biegon, A, Bercovitz, H, Samuel, D. 5HT receptor concentrations during the oestrous 
cycle of the rat. Brain Reseach, 187, 221-5, 1980.
Biegon, A, Essar, N, Israeli, M. Serotonin 2 receptor binding on blood platelets as a 
state dependant marker in major affective disorders. Psychopharmacology Berlin, 102, 
73-5, 1990.
Biegon, A, Fischette, CT, Rainbow, TC, McEwen, B. Serotonergic receptor modulation 
by oestrogen in discrete brain nuclei. Neuroendocrinology,35, 287-91, 1982.
308
Biegon, A, McEwan, BS. Modulation by oestradiol of 5HT1 receptors in rat brain. 
Journal o f Neuroscience,2(2), 199-205, 1982.
Bingham, SA. The dietary assessment of individuals: methods, accuracy, new 
techniques and recommendations. Nutrition Abstracts and Reviews (Series a),57(10), 
705-42, 1987.
Bingham, SA, Gill, C, Welch, A, Day, K, Cassidy, A, Khaw, KT, Sneyd, MJ, Key, JJ, 
Roe, L, Day, NE. Comparison of dietary assessment methods in nutritional 
epidemiology: weighed records versus 24 hour recall, food frequency questionnaires 
and estimated diet records. British Journal o f Nutrition,72, 619-43, 1994.
Blanchard, DC, Griebel, G, Blanchard, RJ. Gender bias in the preclinical 
pshycopharmacology of anxiety: male models for (predominantly) female disorders. 
Journal o f Psychopharmacology,9(2), 79-82, 1995.
Blaustein, JD, Wade, GN. Ovarian influences on the meal pattern of female rats. 
Physiology and Behaviour, 17, 201-8, 1976.
Blum, I, Nessiel, L, David, A, Graff, E, Harsta, A, Weissglas, L, Garbay, U, Sulkes, J, 
Yerushalmy, Y, Vered, Y. Plasma neurotransmitter profile during the different phase of 
the ovulatory cycle. Journal o f Clinical Endocrinology and Metabolism ,75, 924-9,
1992.
Blundell, JE. Serotonin and appetite. Neuropharmacology,23(12B), 1537-51, 1984.
Blundell, JE. The biology of appetite. Clinical Applied Nutrition, 1(2), 21-31, 1991.
Blundell, J.E., Burley, V., Cotton, J., et al. Dietary fat and appetite control:weak 
effects on satiation (within meals) and satiety (following meals). In Mela, D.J.eds, 
Dietary Fats 1. Determinants o f preference, selection and consumption. London:
Elseiner Applied, 1992.
Blundell, JE, Hill, AJ. Commentary. Nutrition, serotonin and appetite: case study in 
the evolution of a scientific idea. Appetite, 8, 183-94, 1987.
Blundell, JE, Hill, AJ. Serotonergic modulation of the pattern of eating and the profile 
of hunger satiety in humans. International Journal o f Obesity, ll(Suppl 3), 141-55,
1987.
Blundell, JE, Hill, AJ. Appetite control by dexfenfluramine in the treatment of obesity. 
Review o f Contemporary Pharmacotherapy,2, 79-92, 1991.
309
Blundell, J.E., Mavjee, V., Hill, A.J. Complex interactions between tryptophan and 
macronutrients on appetite, mood and performance.In Bender, D., Joseph, K., Kochen, 
P., and Steinhart, T.eds, Progress in tryptophan and serotonin research, Berlin: Walter 
de Gruyter and Company, 1987.
Blundell, JE, McArthur, RA. Investigations of food consumption using a dietary self 
selection procedure; effects of pharmacological manipulation and feeding schedules. 
British Journal o f Pharmacology,67, 436p-8p, 1979.
Blundell, JE, Rogers, PJ. Effects of anorexic drugs on food intake, food selection and 
preferences, hunger motivation and subjective experiences; pharmacological 
manipulation as a tool to investigate human feeding processes. Appetite, 1, 151-9 1986.
Bonner, AB, Brien, SB. Diurnal variations in kynurenine and neopterin 
metabolism.Proceedings of the ninth meeting ESC. Journal o f Interdiscipinary Cycle 
Research,24(4), 310-6, 1993.
Both-Orthman, B, Rubinow, DR, Hoban, MC, Malley, J, Grover, GN. Menstrual cycle 
phase related changes in appeite in patients with premenstrual syndrome and in control 
subjects. American Journal o f Psychiatry, 145, 628-31, 1988.
Bowen, DJ, Grunberg, NE. Variations in food preference and consumption across the 
menstrual cycle. Physiology and Behaviour,47, 287-91, 1990.
Braidman, LP, Rose, DP. Effects of sex hormones on 3 glucocorticoid inducible 
enzymes concerned with amino acid metabolism in the rat liver. Endocrinology, 89, 
1250 1971.
Brain, GL, Ebeit, MH, Jimerson, DC, Kleus, WJ, Bunny, WE. Aggression, suicide and 
serotonin:relationships to cerebrospinal fluid amine metabolites. American Journal o f  
Psychiatry, 139, 741-6, 1982.
Brewerton, TD, Heffeman, MM, Rosenthal, NE. Psychiatric aspects of the relationship 
between eating and mood. Nutrition Reviews,44 (Suppl), 78-88, 1986.
Brezezinski, A, Wurtman, J, Wurtman, R, Gleason, R, Greenfield, J, Nader, T. 
dFenfluramine suppresses the increased calorie and carbohydrate intake and improves 
the mood of women with premenstrual depression. Obstetrics and Gynaecology,!6, 
296-301, 1990.
Brien, S.B. The biological basis of bulimia nervosa.Bonner, A.B. and Waterhouse, 
J.eds, Addictive behaviour. Molecules to Mankind, Basingstoke: MacMillan Press Ltd, 
1996. Pp. 191 - 212.
310
Brien SB and Bonner AB. Tryptophan metabolism during the menstrual
cycle. [Unpublished] 1996;
Brin, M. Abnormal tryptophan metabolism in pregnancy and with the oral 
contraceptive pill. Specific effects on an oral contraceptive steroid on the tryptophan 
oxygenase and two aminotransferase activities in the lives of ovariectomised 
-adrenalectomised rats. American Journal o f Nutrition,24, 699-703, 1971.
Brown, G, Goodwin, F, Ballenger, J, Gouer, P, Major, L. Aggression in human 
correlates with cerebrospinal fluid metabolites. Psychiatry Research,1, 131-5, 1979.
Brown, RR, Lee, CM, Kohler, PC, Hank, JA, Storer, BE, Scondel, PM. Altered 
tryptophan and neopterin metabolism in cancer patients treated with recombinant 
interleukin2. Cancer Research,49, 4941-4, 1989.
Brownell, KD, Rodin, J. The dieting maelstrom:is it possible and advisable to lose 
weight? American Psychologist,49(9), 781-91, 1994.
Caballero, B, Finer, N, Wurtman, RJ. Plasma amino acids and insulin levels in 
obesity:response to carbohydrate intake and tryptophan supplements. Metabolism,37, 
672-6, 1988.
Cargille, CM, Ross, GT, Yoshimi, T. Daily variation in plasma follicle stimulating 
homrone, lutenising hormone and progesterone in the normal menstrual cycle. Journal 
o f Clinical Endocrinology and Metabolism,29, 12-9, 1969.
Carlsson, A, Svennerholm, L, Winblad, B. Seasonal and circadian monoamine 
variation in human brains examined post mortem. Acta Psychiatrica Scandinavia,61 
(Suppl), 75-85, 1980.
Carlsson, M, Carlsson, A. A regional study of sex differences in rat brain serotonin. 
Progress in Neuropsychopharmacology and Biological Psychiatry, 12, 719-25, 1988.
Choi, PY. The menstrual cycle and premenstrual syndrome. What is this news on the 
menstrual cycle and PMS? Social Science Medicine,41(6), 759-60, 1995.
Choi, PY, Salmon, P. Stress responsivity in excercisers and non excercisers during 
different phases of the menstrual cycle. Social Science Medicine,>41(6), 769-71, 1995.
Christensen, L. Effects of eating behaviour on mood; a review of the literature. 
International Journal o f Eating Disorders, 14(2), 171-83, 1993.
311
Christensen, L, Redig, C. Effect of meal composition on mood. Behavioural 
Neuro science, 107, 346-53, 1993.
Clare, AW. Hormones, behaviour and the menstrual cycle. Journal o f Psychosomatic 
Medicine,29(3), 225-33, 1985.
Clifford, EM, Cowen, PS, Williams, C, Walsh, AE, Fairbum, CG. Supersensitivity of 
brain serotonin 2c receptors during moderate dieting. Journal o f Psychopharmacology,9 
(Suppl)(3), A33 1995.
Cohen, IT, Sherwin, BB, Fleming, AS. Food cravings, mood and the menstrual cycle. 
Hormones and Behaviour,21, 457-70, 1987.
Cohen, R, Davis, G, Goy, R. Effects of ovarian steroids on serotonin metabolism 
within grossly dissected and microdissected brain regions of the ovariectomised rat. 
Brain Research Bulletin,7, 639-44, 1981.
Coppen, A. The biochemistry of affective disorders. British Journal o f Psychiatry, 113, 
1237-64, 1967.
Coppen, A, Swade, C, Wood, K. Platelet serotonin accumulation in depressive illness. 
Clinical Chimica Acta,87, 165-8, 1978.
Cowen, PJ, Clifford, EM, Williams, C, Walsh, A, Fairbum, CG. Why is dieting so 
difficult? Nature,376, 557 1995.
Crammer, J. Periodic psychosis associated with the menstrual cycle. British Journal o f  
Psychiatry,\ 61, 859-68, 1992.
Crowley, W, O'Donohue, T, Muth, E, Jacobowitz, D. Effects of ovarian hormones on 
levels of LH in plasma and on serotonin concentrations in discrete brain nuclei. Brain 
Research Bulletin,A, 571-4, 1979.
Curzon, G, Friedel, J, Knott, PJ. The effects of fatty acids on the binding of 
tryptophan to plasma protein. Nature,{16 March 1973) 1973.
Curzon, G, Knott, PJ. Effects on plasma and brain tryptophan in the rat of drugs and 
hormones that influence the concentration of unesterified fatty acids in plasma. British 
Journal o f Pharmacology, 50, 197-204, 1974.
Cutler, WB, Garcia, CR. The psychoneuroendocrinology of the ovulatory cycle of 
women. A review. Psychoneuroendocrinology,5, 89-111, 1980.
312
Czaja, JA. Ovarian influences on primate food intake; assessment of progesterone 
action. Physiological Behaviour,21, 923-8, 1978.
Dalvit, SP. The effect of the menstrual cycle on patterns of food intake. American 
Journal o f Clinical Nutrition,?*A, 1811-5, 1981.
Dalvit-McPhillips, SP. The effect of the human menstrual cycle on nutrient intake. 
Physiology and Behavioural, 209-12, 1983.
DaPrada, M, Cesura, AM, Launay, JM, Richards, JG. Platelets as a model for 
neurones. Experientia,44, 115-26, 1988.
Delgado, PL, Chamey, DS, Price, LH, Landis, H, Heninger, GR. Neuroendocrine and 
behavioural effects of dietaryy tryptophan restriction in healthy subjects. Life 
Sciences,45, 2323-32, 1989.
DeMeyer, MK, Shea, PA, Hendrie, H, Yoshimura, NN. Plasma tryptophan and five 
other amino acids in depressed and normal subjects. Archives o f General 
Psychiatry,38, 642-6, 1981.
Dennerstein, L, Burrows, G. Affect and the menstrual cycle. Journal o f A ffective 
Disorders,1, 77-92, 1979.
Department of Health. Dietary reference values. A guide. 1991; London: HMSO.
Diejen, JM, Heemstra, ML, Orlebeke, JF. Dietary effects on mood and performance. 
Journal o f Psychiatric Research,23, 275-83, 1989.
Dourish, CT. Multiple serotonin receptors: Opportunities for new treatments for 
obesity. Obesity Research, 3 (Suppl 4), 449S-462S, 1995.
Elliott, JM, Peters, JR, Graheme-Smith, DG. Oestrogen and progesterone change the 
binding characteristics of alpha adrenergic and serotonin receptors on rabbit platelets. 
European Journal o f Pharmacology,66, 21-30, 1980.
Eriksson, T, Voog, L, Walinder, J, Eriksson, TE. Diurnal rhythms in absolute and 
relative concentrations of large neutral amino acids in human plasma. Journal o f  
Psychiatric Research,23(3), 241-9, 1989.
Fairbum, CG, Cooper, PJ. The clinical features of bulimia nervosa. British Journal o f  
Psychiatry, 144, 238-46, 1984.
313
Feigin, RD, Klainer, AS, Beiser, WR. Factors affecting circadian periodicity of blood 
amino acids in man. Metabolism, 17(9), 764-75, 1968.
Femstrom, JD. Diet induced changes in plasma amino acid pattern: effects on the brain 
uptake of large neutral amino acid and on brain serotonin synthesis. Journal o f Neural 
Transmission,\5 (Suppl), 55-67, 1979.
Femstrom, JD. Food induced changes in brain serotonin synthesis: is there a 
relationship to appetite for specific macronutrients. Appetite,8, 163-82, 1987.
Femstrom, JD, Faller, DV. Neutral amino acids in the brain: changes in response to 
food ingestion. Journal of Neurochemistry,30, 1531-8, 1978.
Femstrom, JD, Wurtman, RJ. Brain serotonin content: increase following ingestion of 
a carbohydrate diet. Science, 174, 1023-5, 1971.
Femstrom, JD, Wurtman, RJ. Brain serotonin content: physiological dependance on 
plasma tryptophan levels. Science, 173, 149-52, 1971.
Femstrom, JD, Wurtman, RJ. Brain serotonin content: physiological regulation by 
plasma neutral amino acids. Science, 178, 414-6, 1972.
Femstrom, J.D., Wurtman, RJ. Control of brain serotonin content by dietary 
carbohydrate.Barchas, J. and Usdin, E.eds, Serotonin and behaviour, New York: 
Academic Press, 1973. Pp. 121 - 128.
Femstrom, JD, Wurtman, RJ, Hammarstrom, WB. Diurnal variations in plasma 
concentration of tryptophan, tyrosine and other neutral amino acids; effects of dietary 
protein. American Journal o f Clinical Nutrition,32, 1912-22, 1979.
Fink, G. How oestrogens keep the blues at bay. New Scientist,{\A January 1995) 1995.
Fong, A, Kretsch, MJ. Changes in dietary intake, urinary nitrogen and urinary volume 
across the menstrual cycle. American Journal o f Nutrition, 57, 43-6, 1993.
French, SA, Jeffrey, RW. Consequences of dieting to lose weight; effects on physical 
and mental health. Health Psychology, 13(3), 195-212, 1994.
Freyhan, FA. The target symptoms for treatment of depressive illness revisited. 
Comprehensive Psychiatry,20, 495-501, 1979.
Fukui, S, Schwarcz, R, Rapoport, SI, Takada, Y, Smith, QR. Blood brain barrier 
transport of kynurenines: implications for brain synthesis and metabolism. Journal o f  
Neurochemistry,56, 2007-17, 1991.
314
Fuller, R, Wong, D. Serotonin uptake and serotonin uptake inhibition. Annals o f New 
York Academy o f Sciences,600, 68-80, 1990.
Gal, EM, Armstrong, JC, Ginsberg, B. The nature of in vitro hydroxylation of 
1-tryptophan by brain tissue. Journal o f Neurochemistry, 13, 643-54, 1966.
Gal, EM, Sherman, A. Synthesis and metabolism of 1 kynurenine in the rat brain. 
Journal o f Neurochemistry,30, 607-13, 1978.
Gal, EM, Sherman, AD. IKynurenine. Its synthesis and possible regulatory function in 
the brain. Neurochemical Research,5(3), 223-40, 1980.
Galiant, MP, Bowering, J, Short, SH, Turkki, PR. Pyridoxine and magnesium states of 
women with premenstrual syndrome. Nutrition Research,7, 243-52, 1987.
Gallant, SJ, Hamiltn, J, Popiel, D, Morokoff, P, Chakraborty, P. Daily mood and 
symptoms: effects of awareness of study focus, gender, menstrual cycle phase and day 
of the week. Health Psychology, 10, 180-9, 1991.
Gannon, L. Psychological and physiological factors in the development, maintenance 
and treatment of menstrual disorders. In Haynes, S.N. and Gannon, L.eds, 
Psychosomatic disorders: A psychphysiological approach to aetiological treatment,
New York: Praeger, 1981. Pp. 79 - 132.
Gannon, L. Evidence for a psychological etiology of menstrual disorders. A critical 
review. Psychological Reports,48, 287-94, 1981.
Garattini, S, Bizzi, A, Caccia, S, Mennini, T, Samanin, R. Progress in assessing the 
role of serotonin in the control of food intake. Clinical Neuro pharmacology, 11, 508-32,
1988.
Garattini, S, Mennini, T, Samanin, R. Reduction of food intake by manipulation of 
central serotonin. Current experimental results. British Journal o f Psychiatry, 155 
(Suppl 8), 41-51, 1989.
Gessa, GL, Biggio, G, Fadda, F, Corsin, GU, Tagliamonte, A. Effect of the oral 
administration of tryptophan free amino acid mixtures on serum tryptophan, brain 
tryptophan and serotonin metabolism. Journal o f Neurochemistry,22, 869-70, 1974.
Gladis, MM, Walsh, BT. Premenstrual exaccerbation of binge eating in bulimia. 
American Journal o f Psychiatry, 144, 1592-5, 1987.
315
Goldbloom, DS, Hicks, LK, Garfinkel, PE. Platelet serotonin uptake in bulimia 
nervosa. Biological Psychiatry,28, 644-7, 1990.
Golub, S. The magnitude of premenstrual anxiety and depression. Psychosomatic 
Medicine,38, 4-14, 1976.
Golub, S. Premenstrual symptoms and premenstrual syndrome.In Golub, S.eds, 
Periods. From menarche to menopause, Newbury Park, California: Sage Publications,
1992. Pp. 191 - 198.
Goodwin, GM, Fairbum, CG, Cowen, PJ. Dieting changes serotonergic function in 
women not men: implications for the aetiology of anorexia nervosa. Psychological 
Medicine, 17, 839-42, 1987.
Green, AR, Bloomfield, MR, Woods, HF, Seed, M. Metabolism of an oral tryptophan 
load by women and evidence against the induction of tryptophan pyrollase by oral 
contraceptives. British Journal o f Clinical Pharmacology,5, 233-41, 1978.
Green, AR, Curzon, G. The effect of tryptophan metabolites on brain serotonin 
metabolism. Biochemical Pharmacology, 19, 2061-8, 1970.
Greenberg, BR. Predictors of binge eating in bulimic and non bulimic women. 
International Journal o f Eating Disorders,5, 269-84, 1986.
Greenblatt, RB, Teran, A, Barfield, WE, Bohler, CS. PMS : What is it and what it is 
not. Stress Medicine,3, 193-8, 1987.
Greengrass, DM, Tonge, S. Changes in brain monoamine concentrations during the 
oestrous cycle in the mouse; possible pharmacological implications. Journal o f  
Pharmacy and Pharmacology,23, 897-8, 1971.
Hackmann, E, Wirz Justice, A, Liechtsteiner, M. The uptake of dopamine and 
serotonin in the rat brain during progesterone decline. Psychopharmacologia (Berl),32, 
183-91, 1973.
Halbreich, U. Gonadal hormones and antihormones, serotonin and mood. 
Psychopharmacology Bulletin,26(3), 291-5, 1990.
Halbreich, U, Endicott, J, Golstein, S, Nee, J. Premenstrual changes and changes in 
gonadal hormones. A eta Psychiatrica Scandinavia,74, 576-86, 1986.
316
Halbreich, U, Tworek, H. Altered serotonergic activity in women with dysphoric 
premenstrual syndrome. International Journal o f Psychiatry in Medicine,23(1), 1-27,
1993.
Heller, A, Harvey, JA, Moore, RY. A demonstration of a fall in brain serotonin 
following CNS lesions in the rat. Biochemical Pharmacology, 11, 859-66, 1962.
Herman, C.P., Polivy, J. Restrained eating.In Stunkard, A.J.eds, Obesity, Philadelphia: 
Saunders, 1980. Pp. 208 - 225.
Heron, D, Schinitzky, M, Hershkovitz, J, Samuel, D. Lipid fluidity markedly 
modulates the binding of serotonin to mouse brain membrane. Proceedings o f National 
Academy Science USA,77, 7463-7, 1980.
Hetherington, MM, Altemus, M, Nelson, ML, Bemat, AS, Cold, PW. Eating behaviour 
in bulimia nervosa: multiple mean analyses. American Journal o f Clinical Nutrition,60, 
864-73, 1994.
Hill, AJ. Investigation of some short term influences on hunger, satiety and food 
consumption [Psychology Department]. Leeds University; 1986;
Hill, A.J., Blundell, J.E. Role of amino acids in appetite control in man.Huether,
G.eds, Amino acids in health and disease, Berlin: Springer-Verlag, 1988. Pp. 239 - 
248.
Hill, AJ, Blundell, JE. Sensitivity of the appetite control system in obese subjects to 
nutritional and serotonergic challenges. International Journal o f Obesity, 14, 219-33, 
1990.
Hindberg, I, Naesh, O. Serotonin concentrationa in plasma and variations during the 
menstrual cycle. Clinical Chemistry,38, 2087-9, 1992.
Hopkinson, G. A neurochemical theory of appeite and weight changes in depressive 
states. Acta Psychiatrica Scandinavia,64, 217-25, 1981.
Hopkinson, G, Bland, RC. Depressive syptoms in grossly obese women. Canadian 
Journal o f Psychiatry,21, 213-5, 1982.
Hoyer, D. Molecular pharmacology and biology of 5HTlc receptors. Trends in 
Pharmacological Science,9, 89-94, 1988.
Hoyer, D. Serotonin 5HT3, 5HT4 and 5HTm receptors. Neuropsychopharmacology,3, 
371-83, 1990.
317
Hoyer, D. The Serotonin receptor family: ligands, distribution and receptor effector 
coupling. In Rodgers, R.J. and Cooper, SJ.eds, 5HTla agonists, 5HTB antagonists and 
benziodiazepines: their comparative behavioural pharmacology, London: John Wiley 
and Sons, 1991.
Hoyer, D, Schoeffter, P. Serotonin receptors: subtypes and second messengers. Journal 
of Receptor Research, 11(1-4), 197-214, 1991.
Hrboticky, N, Leiter, LA, Anderson, GH. Menstrual cycle effects on the metabolism of 
tryptophan loads. American Journal o f Clinical Nutrition,50, 46-52, 1989.
Janowsky, DS, Berlens, SC, Davis, JM. Correlations between mood, weight and 
electrolytes during the menstrual cycle. A renin angiotensin -aldosterone hypothesis of 
premenstrual tension. Psychosomatic Medicine,35, 143-54, 1973.
Johnson, WG, Corrigan, SA, Lemmon, CR, Bergeron, KB, Crusco, AH. Energy 
regulation over the menstrual cycle. Physiology and Behaviour,56(3), 523-7, 1994.
Joseph, MH, Kadam, BV. Kynurenine .penetration to the brain, effect of brain 
tryptophan and serotonin metabolism and binding to plasma albumin. Proceedings of 
the British Psychological Society; 1979; 483-4
Joseph, MH, Kadam, BV, Risby, ID. Journal o f Chromatography,226, 361 1981.
Joseph, MS, Brewerton, TD, Rees, VI, Stebbins, GT. Plasma tryptophan to large 
neutral amino acid ratio and dexamethasone suppression in depression. Psychiatric 
Research, 11, 185-92, 1984.
Jouvet, M. Biogenic amines and the states of sleep. Science, 163, 32-41, 1969.
Kalin, N. The neurobiology of fear. Scientific American,May 1993, 54-60, 1993.
Karavolas, HJ, Hodges, DR, O'Brien, DJ. In vivo uptake and metabolism of (3H) 
progesterone and (3H) 5 alpha dihydroprogesterone by the rat CNS and anterior 
pituitary: tissue concentration of progesterone itseld or metabolites? Journal o f Steroid 
Biochemistry,!, 863-72, 1979.
Kaye, WH, Gwirtsman, HE, Brewerton, TD, George, DT, Wurtman, RJ. Bingeing 
behaviour and plasma amino acids: a possible involvement of brain serotonin in 
bulimia nervosa. Psychiatric Research,23, 31-4, 1988.
318
Kemnitz, JW, Gibber, JR, Lindsay, KA, Eisele, SG. Effects of ovarian hormones on 
eating behaviours, body weight and glucoregulation in rhesus monkeys. Hormones and 
Behaviour,23, 235-50, 1989.
Kennett, G.A. Mechanisms of serotonergic affect control.ln Schwarz, S.eds, 
Kynurenine and serotonin pathways, New York: Plenum Press, 1991. Pp. 231 - 243.
Kesner, JS, Knecht, EA, Krieg, EF, Barnard, G, Mikola, H, Kohen, F, Gani, M, Coley, 
J. Validations of time resolved fluroimmunoassays for urinary estrone 3 glucuronide 
and pregnanediol 3 glucuronide. Steroids,59, 205-11, 1994.
Klaiber, EL, Kobayahi, Y, Broverman, D, Hall, F. Plasma MAO activity in regularly 
menstruating women and in amenorrheic women receiving cyclic treatment with 
oestrogens and a progestin. Journal o f Clinical Endocrinology,33, 630-8, 1971.
Knaus, H. Eine neue methode zur bestimmung der ovulation-streminer. Zentrablatt fu r  
Gynakoligic,53, 2193-203, 1929.
Knight, RG, Chisholm, BJ, Paulin, JM, Waa, L, Manning, HJ. The Spielberger Anger 
Expression Scale. Some psychometric data. British Journal o f Clinical Psychology,27, 
279-81, 1988.
Koning, P, Mak, M. Problems in human aggression research. Journal o f  
Neuropsychiatry,3{2), 561-5, 1991.
Kriepe, RE, Strauss, J, Hogman, CH, Ryan, RM. Menstrual cycle abnormalities and 
subclinical eating disorders: a preliminary report. Psychosomatic Medicine,51, 81-6,
1989.
Kroner, DG, Reddon, JR. The anger expression scale and state trait anger scale. 
Stability, reliability and factor structure in an inmate sample. Criminal Justice and 
Behaviour, 19(4), 397-408, 1992.
Kushner, R, Pendarvis, L. Appetite regulation, obesity and eating disorders. Current 
Opions in Gastroenterology, 11, 179-85, 1995.
Labrum, AH. Hypothalamic, pineal and pituitary factors in premenstrual syndrome. 
Journal o f Reproductive Medicine,28, 438-45, 1983.
Ladisch, W. Influence of progesterone on serotonin metabolism: a possible causal 
factor for mood changes. Psychoneuroendocrinology,2, 257-66, 1977.
319
Ladisich, W. Effects of progesterone on regional serotonin metabolism in the rat brain. 
Neuropharmacology,13, 887-3, 1974.
Laessle, RG, Tuschl, RJ, Kotthaus, BC, Pirke, KM. Behavioural and biological 
correlates of dietary restraint in normal life. Appetite, 12, 83-94, 1989.
Laessle, RG, Tuschl, RJ, Schweiger, U, Pirke, KM. Mood changes and physical 
complaints during the normal menstrual cycle in healthy young women. 
Psychoneuroendocrinology, 15(2), 131-8, 1990.
Lai, J, Linden, W. Gender, anger expression style and opportunity for anger release 
determine cardiovascular reaction to and recovery from anger provocations. 
Psychosomatic Medicine,54, 297-310, 1992.
Le Doux, J. Emotion, memory and the brain. Scientific American,(June), 32-9, 1994.
Leibenluft, E, Fiero, P, Rubinow, DR. Effect of the menstrual cycle on dependant 
variables in mood disorder research. Archives o f General Psychiatry,51, 761-81, 1994.
Lerdo de Tejada, A, Carreno, QF, Lopez, L, Wionczek, C, Karchmen, S. Eliminacion 
urinaria de acido 5 hidroxiindol acetico durante el cicle menstrual humane.
Ginecologia Obstetrica,44, 85-91, 1978.
Lieberman, HR, Wurtman, JJ, Chew, B. Changes in mood after carbohydrate 
consumption among obese individuals. American Journal o f Clinical Nutrition,44, 
772-8, 1986.
Liebowitz, SF. Paraventricular nucleus: a primary site mediating adrenergic stimulation 
of feeding and drinking. Pharmacology, Biochemistry and Behaviour,8, 163-75, 1978.
Liebowitz, SF. The role of serotonin in eating disorders. Z)ragy,39(Suppl 3), 33-48,
1990.
Liebowitz, SF, Shor Posner, G. Brain serotonin and eating behaviour.
Appetite, 7(Suppl), 1-14, 1986.
Lissner, L, Stevens, J, Levitsky, D, Rasmussen, K, Strupp, B. Variations in energy 
intake during the menstrual cycle: implications for food intake research. American 
Journal o f Clinical Nutrition,48, 956-62, 1988.
Lorr, M, and McNair, DM. Profile of Mood States. Manual for the Bipolar Form 
(Form Bl). First. California: Educational and Industrial Testing Service; 1984;
320
Lorr, M, and McNair, DM. Profile of Mood States. Manual for the Bipolar form 
(POMS Bl). Second. California: Educational and Industrial Testing Service; 1988;
Luine, VN, McEwan, BS. Effect of oestradiol on the turnover of type A MAO. Journal 
o f Neurochemistry,28, 1221-7, 1977.
Luine, VN, Rhodes, JC. Gonadal hormone regulation of MAO and other enzymes in 
hypothalamic areas. Neuroendocrinology,36, 235-41, 1983.
Lustgaraten, JA, Wenk, RF. Simple, rapid, kinetic method for serum creatinine 
measurement. Clinical Chemistry, 18, 1419-22, 1972.
Lyons, PM, Truswell, A, Mira, M, Vizzaro, J, Abraham, S. Reduction of food intake 
in the ovulatory phase of the menstrual cycle. American Journal o f Clinical 
Nutrition,49, 1164-8, 1989.
Maes, M., Meltzer, H.Y. The serotonin hypothesis of major depression. In Bloom, F.E. 
and Kupfer, D.J.eds, Psychopharmacology :The fourth generation o f progress, New 
York: Raven Press, 1995. Pp. 933 - 944.
Malmgren, R, Collins, A, Nilsson, CG. Platelet serotonin uptake and effects of vitamin 
B6 treatment in premenstrual tension. Neuropsychobiology, 18, 83-8, 1987.
Manoucha, S, Choudhuri, G, Tansoon, BN. A study of dietary intake in pre and post 
menstrual period. Human Nutrition and Applied Nutrition,40(a), 213-6, 1986.
Marazziti, D, Macchi, E, Rotondo, A, Placidi, GF, Cassano, GB. Involvement of the 
serotonin systen in bulimia. Life Sciences,A3, 2123-6, 1988.
Martin du Pon, R, Mauron, C, Glaeser, B, Wurtman, RJ. Effect of various oral glucose 
doses on plasma neutral amino acid levels. Metabolism,31, 937-43, 1982.
Martin, C, and Brien, SB. The effect of the menstrual cycle on the recall of childhood 
memories of repressors, non repressors and "repressor polymorphs".[Unpublished]
1996;
Mason, M, Gullekson, EH. Estrogen-enzyme interactions: inhibitions and protection of 
kynurenine transaminase by the sulphate esters of diethylstilbesterol, estradiol and 
oestrone. Journal o f Biological Chemistry,235, 1312-6, 1960.
McCaffrey, TA, Czaja, JA. Diverse effects of estradiol 17 beta: Concurrent suppresion 
of appetite, blood pressure and vascular reactivity in concious unrestrained animals. 
Physiology and Behaviour,45, 649-57, 1989.
321
McClusky, S, Pearce, J, Evans, C, Jacobs, H, Lacey, JH. Polycystic ovarian syndrome 
and bulimia. Fertility and Sterility,55(2), 287-91, 1991.
McEwan, BS, Parsons, B. Gonadal steroid action on the brain; neurochemistry and 
neuropharmacology. Annual Review o f Pharmacology and Toxicology,22, 555-98, 
1982.
McGaugh, J.L. Neuromodulation and the storage of information; involvement of the 
amygdaloid complex.In Lister, R. and Weingartner, HJ.eds, Perspectived on cognitive 
neuroscience, Oxford: Oxford University Press, 1991. Pp. 279 - 298.
McMenamy, RH, Oncley, JL. The specific binding of 1 tryptophan to serum albumin. 
Journal o f Biological Chemistry,233, 1436-47, 1958.
Meltzer, H. Serotonergic dysfunction in depression. British Journal o f  
Psychiatry, 155(8), 25-31, 1989.
Metcalf, MG, Livesey, JH, Hudson, SM, Wells, EJ. The premenstrual
syndrome:moods, headaches and physical symptoms in 133 menstrual cycles. Journal
o f Psychosomatic Obstetrics and Gynaecology,8, 31-43, 1988.
Millward, DJ. A protein stat mechanism for the regulation of growth and maintenance 
of the lean body mass. Nutrition Research Review5,8, 93-120, 1995.
Mitchell, JE, Pyle, RL, Exkert, ED. Frequency and duration of binge eating episodes 
in patients with bulimia. American Journal o f Psychiatry, 138, 835-6, 1981.
Moller, SE. Serotonin, carbohydrate and atypical depression. Journal o f Pharmacology 
and Experimental Therapy,260, 16-20, 1992.
Moos, RH. The development of a menstrual distress questionnaire. Psychosomatic 
Medicine,30(6), 853-67, 1968.
Morley, D. An approach to the development of drugs for appetite disorders. 
Neuropsychobiology,21, 22-30, 1989.
Morse, CA, Dennerstein, L. The factor structure of symptom reports in PMS. Journal 
o f Psychosomatic Research,32(1), 93-8, 1988.
Munday, MR, Brush, MC, Taylor, RW. Correlations between progesterone, oestradiol 
and aldosterone levels in PMS. Clinical Endocrinology, 14, 1 1981.
322
Murphy, DL. Neuropsychiatric disorders and the multiple human brain serotonin 
receptor subtypes and subsystems. Neuropsychopharmacology,3(5), 457-71, 1990.
Murphy, D.L., Broocks, A., Aulakh, C., et al. Anxiolytic effects of drugs acting on 
serotonin receptor subtypes.In Vanhautte, P.M., Saxena, P.R., Paoletti, R., Brunello,
N., and Jackson, A.S.eds, Serotonin, cell biology to pharmacology and therapeutics, 
Dordrecht: Kleiver, 1993. Pp. 223 - 230.
Neilsen, DA, Goldman, D, Virkkunen, M, Tokola, R, Rawlings, R, Linnoila, M. 
Suicidality and 5HIAA concentrations associated with a tryptophan hydroxylase 
polymorphism. Archives o f General Psychiatry,51, 34-8, 1994.
Nelson, M, Nettleton, D. Dietary survey methods. A semi weighed technique for 
measuring dietary intake within families. Journal o f Human Nutrition,34, 325-48, 1980.
Nettleton, PA, Day, K, Nelson, M. Dietary survey methods. A comparison of nutrient 
intakes within families assessed by household measures and the semi weighed method. 
Journal o f Human Nutrition,34, 349-54, 1980.
Norton, P, Falciglia, G, Gist, D. Physiologic control of food intake by neural and 
chemical mechanisms. Journal o f American Dietetics Association,93, 450-4, 1993.
O’Keane, V, O'Hanlan, M, Webb, M, Dinan, T. dFenfluramine/prolactin response 
throughout the menstrual cycle:evidence for an oestrogen induced alteration. Clinical 
Endocrinology,34, 289-92, 1991.
O’Rourke, D, Wurtman, JJ, Wurtman, RJ, Chebli, R, Gleason, R. Treatment of 
seasonal depression with dfenfluramine. Journal o f Clinical Psychology,50, 343-7,
1989.
Odink, J, Van den Berg, H, Bruinse, HW, Van der Ploeg, H, Van Kempen, GM, 
Louwerse, ES. Circadian and circatrigintan rhytms of biogenic amines in premenstrual 
syndrome. Psychosomatic Medicine,52, 346-56, 1990.
Ogino, K. Ovulation-stermin und konzeptionstermin. Zentralblatt fu r  Gynakologie,5A, 
464-79, 1930.
Oldman, A, Walsh, A, Salkouvskis, P, Fairbum, CG, Cowen, PJ. Biochemical and 
behavioural effects of acute tryptophan depletion in abstinent bulimic subjects:a pilot 
study. Psychological Medicine,25, 995-1001, 1995.
323
Oldman, AD, Walsh, ES, Salkovskis, P, Laver, D, Co wen, PJ. Effect of acute 
tryptophan depletion on mood and appetite in healthy female volunteers. Journal o f  
Psychopharmacology,%(\), 8-13, 1994.
Olivier, B., Mos, J., Schipper, J., et al. Serotonergic involvement in aggressive 
behaviour in animals.In van Praag, H.M., Plutchik, R., and Apter, A.eds, Violence and 
suicidality'.perspectives in clinical and psychobiological research, New York: Bruner 
Mazel, 1990.
Ortiz, J, Artigas, F, Gelphi, E. Serotonergic status in human blood. Life Sciences,43, 
983-90, 1988.
Parlee, MB. Stereotypic beliefs about menstruation. Psychosomatic Medicine,35, 
229-40, 1974.
Picone, L, Kirkby, RJ. The relationship between anxiety and premenstrual syndrome. 
Psychological Reports,67, 43-8, 1990.
Pilgrim, Kamen. Science,139, 501-2, 1963.
Pirke, KM, Dogs, M, Fichter, MM, Tuschl, RJ. Gonadotrophins, oestradiol and 
progesterone during the menstrual cycle. Clinical Endocrinology,29, 265-70, 1988.
Pirke, KM, Laessle, RG, Schweiger, U, Broocks, A, Strowitzki, T, Huber, B, Tuschl, 
RJ, Middendorf, R. Dieting causes menstrual irregularities in normal weight young 
women through impairment of episodic LH secretion. Fertility and Sterility,51, 263-8, 
1989.
Pirke, KM, Schweiger, U, Lemmel, W, Krieg, JC, Berger, M. The influence of dieting 
on the menstrual cycle of healthy young women. Journal o f Clinical Endocrinology 
and Metabolism,60(4), 1174-9, 1985.
Pliner, P, Fleming, AS. Food intake, body weight and sweetness preference over the 
menstrual cycle in humans. Physiology and Behaviour,30, 663-6, 1983.
Plutchik, R. Emotions and attitudes related to being overweight. Journal o f Clinical 
Psychology,32, 21-4, 1976.
Poirier, MF, Benkelfat, C, Galzin, AM, Langer, SZ. Platelet 3H imipramine binding 
and steroid hormone serum concentrations during the menstrual cycle. 
Psychopharmacology,88, 86-9, 1986.
324
Polivy, J., Gamer, D.M., Garfinkel, P.E. Causes and consequences of the current 
preference for a thin female physique.In Herman, C.P., Zaring, M.P., and Higgins, 
E.T.eds, Physical appearance, stigma and social behaviour: the third Ontario 
symposiun in personality and social psychology, Hillsdale: Erlbaum, 1986. Pp. 89 - 
112.
Polivy, J, Herman, CP. Clinical depression and weight change: a complex relation. 
Journal o f Abnormal Psychology, 85, 338-40, 1976.
Polivy, J, Herman, CP. Dieting and bingeing. A causal analysis. American 
Psychologist,40, 193-201, 1985.
Polivy, J, Herman, CP. Diagnosis and treatment of normal eating. Journal o f  
Consulting and Clinical Psychology,55(6), 635-44, 1987.
Polivy, J, Zeitlin, SB, Herman, P, Beal, AL. Food restriction and binge eating. A study 
of former prisoners of war. Journal o f Abnormal Psychology, 103(2), 409-11, 1994.
Poison, DW, Adams, J, Wadsworth, J, Frank, S. Polycystic ovaries- a common finding 
in normal women. The Lancet,{April 16), 870-2, 1988.
Price, WA, Dimarzio, LR. Bulimia, menstruation and premenstrual syndrome:treatment 
implications. A merican Journal o f Psychiatry, 145(9), 1178-9, 1988.
Price, WA, Torem, MS, Dimarzio, LR. Premenstrual exaccerbation of bulimia. 
Psychosomatics,28(7), 378-9, 1987.
Pyle, HG, Mitchell, JE, Eckert, ED. Bulimia: a report of 34 cases. Clinical 
Psychiatry,42, 60-4, 1981.
Rapkin, AJ, Chang, LC, Reading, AE. Tryptophan loading test in premenstrual 
syndrome. Journal o f Obstetrics and Gynaecology, 10, 140-4, 1989.
Rapkin, AJ, Edelmuth, E, Chang, LC, Reading, AE, McGuire, MT. Whole blood 
serotonin in PMS. Obstetric Gynaecology,70, 533-7, 1987.
Rausch, J.L., Janowsky, D.S. Premenstrual tension:etiology.In Friedman, R.eds, 
Behaviour and the menstrual cycle, New York: Marcel Dekker Inc, 1982. Pp. 414 - 
415.
Renner, KJ, Krey, LC, Luine, V. Effect of progesterone on monoamine turnover in the 
brain of the oestrogen primed rat. Brain Research Bulletin, 19, 195-202, 1987.
325
Richards, D. Electrochemical detection of tryptophan metabolites following HPLC. 
Journal o f Chromatography, 115, 293-9, 1979.
Richardson, JTE. Questionnaire studies of paramenstrual symptoms. Psychology o f  
Women Quarterly, 14, 15-42, 1990.
Richardson, J.T.E. The menstrual cycle, cognition and paramenstrual 
symptomatology.In Richardson, J.T.E.eds, Cognition and the menstrual cycle, New 
York: Springer Verlag, 1992. Pp. 1 - 38 .
Richardson, JTE. The premenstrual syndrome; a brief history. Social Science 
Medicine,41(6), 761-7, 1995.
Rissanen, W. Food and mood: relationship between food, serotonin and affective 
disorders. Acta Psychiatrica Scandinavia,Suppl 377, 36-40, 1994.
Rogers, PJ. Food,mood and appetite. Nutrition Research Reviews,8, 243-69, 1995.
Rogers, PJ, Edwards, S, Green, M, Jas, P. Nutritional influences on mood and 
cognitive performance, the menstrual cycle, caffeine and dieting. Proceedings o f the 
Nutrition Society,51, 343-51, 1992.
Rogers, PJ, Jas, P. Menstrual cycle effects on mood, eating and food choice.
Appetite,23, 289 1994.
Rolls, ET. Central nervous mechanisms related to feeding and appetite. British Medical 
Bulletin,37(2), 131-4, 1981.
Rosch, PJ. Editorial. The stress-food-mood connection:are there stress reducing foods 
and diets. Stress Medicine, 11, 1-6, 1995.
Rose, DP, Braidman, IP. Excretion of tryptophan metabolites as affected by pregnancy, 
contraceptive steroids and steroid hormones. American Journal o f Clinical Nutrition,24, 
673-83, 1971.
Rosen, JC, Leitenberg, H, Fischer, C, Khazam, C. Binge eating episodes in bulimia 
nervosa; the amount and type of food consumed. International Journal o f Eating 
Disorders,5, 255-67, 1986.
Rosenbaum, J, Fava, M, Pava, J, McCarthy, M, Steingard, R, Bouffides, E. Anger 
correlates in unipolar depression part 2;neuroendocrine correlates and changes 
following fluoxetine treatment. American Journal o f  Psychiatry, 150(8), 1164-8, 1993.
326
Rosenthal, NE, Genhart, MJ, Caballero, B, Jacobsen, FM, Skwerer, RG, Coursey, RD, 
Rogers, S, Spring, BJ. Psychobiological effects of carbohydrate and protein rich meals 
in patients with seasonal affective disorder and normal controls. Biological 
Psychiatry,25, 1029-40, 1989.
Rosenthal, NE, Sack, DA, Gillin, C, Lewy, AJ, Goodwin, FK, Davenport, Y, Mueller, 
PJ, Newsome, DA, Wehr, TA. SAD. A description of the syndrome and preliminary 
findings with light therapy. Archives o f General Psychiatry,41, 72-80, 1984.
Rossi, AS, Rossi, PE. Body time and social time: mood patterns by menstrual cycle 
phase and day of the week. Social Science Research,6, 273-308, 1977.
Roy, A, Adinoff, B, Linnoila, M. Acting out hostility in normal volunteersrnegative 
correlation with CSF 5HIAA levels. Psychiatric Research,24, 187-94, 1988.
Roy, A, Linnoila, M. Suicidal behaviour.impulsiveness and serotonin. Acta  
Psychiatrica Scandinavia,78, 529-35, 1988.
Roy, A., Virkkunen, M., Linnoila, A. Serotonin in suicide, violence and alcoholism.In 
Coccaro, E.F. and Murphy, D.L.eds, Serotonin in major psychiatric disorders, 
Washington: APA, 1990.
Ruderman, AJ. Dietary restraint; a theoretical and empirical review. Psychological 
Bulletin,99, 247-62, 1986.
Russ, MJ, Ackerman, SH, Schwarz, M, Schundledecker, RD, Smith, GP. Plasma 
tryptophan to large neutral amino acid ratios in depressed and normal subjects. Journal 
of Affective Disorders, 19, 9-14, 1990.
Russell, G. Bulimia nervosa; an ominant variant of anorexia nervosa. Psychological 
Medicine,9(3), 429-48, 1979.
Samannin, R, Ghezzi, O, Valzelli, L, Garattini, S. The effect of selective lesioning of 
brain serotonin or catecholamine containing neurones on the anorectiv activity of 
fenfluramine and amphetamines. European Journal o f Pharmacology, 19, 318-22, 1972.
Sanders, D, Warner, P, Backstrom, T, Bancrodt, J. Mood, sexuality, hormones and the 
menstrual cycle.I. Change in mood and physical state: description of subject and 
method. Psychosomatic Medicine,45, 487-500, 1983.
Sandyk, R. Tryptophan in pschiatric disorders. A review. International Journal o f  
Neuro science, 67(1-4), 122-44, 1992.
327
Sanger, DJ. Endorphinergic mechanism in the control of food and water intake. 
Appetite Journal fo r  Intake Research,!, 193-208, 1981.
Saxena, PR. Serotonin receptors:subtypes, functional responses and therapeutic 
relevance. Pharmacology Therapy,66, 339-68, 1995.
Sayegh, R, Schiff, I, Wurtman, J, Spiers, P, McDermott, J, Wurtman, R. The effect of 
a carbohydrate rich beverage on mood, appetite and cognitive function in women with 
PMS. Obstetrics and Gynaecology, 86(4), 520-8, 1995.
Scardi, V, Iaccarino, M, Scarano, E. The action of sulphate anmd phosphate esters of 
oestrogens on the reconstitution of two pyridoxal phosphate dependent enzymes. 
Biochemical Journal,83, 413-6, 1962.
Schaetchter, JD, Wurtman, RJ. Serotonin release varied with brain tryptophan levels. 
Brain Research,532, 203-10, 1990.
Schlundt, DG, Johnson, WG, Jarrell, MP. A naturalistic functional analysis of eating 
behaviour in bulimia and obesity. Advances in Behaviour Research and Therapy, 1, 
149-62, 1985.
Schweiger, E, Broocks, A, Tuschl, BJ, Laessle, RG, Platte, P, Pirke, KM. Everyday 
eating behaviour and menstrual function in young women. Fertility and Sterility,57, 
771-5, 1992.
Schweiger, U., Laessle, R.G., Fichter, M.M., et al. Consequences of dieting at normal 
weight: implications for the understanding and treatment of bulimia.In Pirke, K.M., 
Vanereycken, W., and Ploog, D.eds, The psychology o f bulimia nervosa, Berlin: 
Springer, 1988. Pp. 74 - 82.
Seguela, P, Watkins, KC, Descarries, L. Ultrastructural relationships of serotonin axon 
terminals in the cerebral cortex of the adult rat. Journal o f Comparative 
Neurology,289(1), 129-42, 1989.
Sheehan, D, Sheehan, K. Psychiatric aspects of the oral contraceptive pill. Psychiatric 
A n n a ls ,10), 500-8, 1976.
Silverstone, T. Mood, food and serotonin. International Clinical 
Psychopharmacology,8(2), 91-4, 1993.
Silverstone, T, Goodall, E. Centrally acting anorectic drugs; a clinical perspective. 
American Journal o f Clinical Nutrition,55, 2115-45, 1992.
328
Smith, QR, Momma, S, Aoyagi, M, Rapoport, SI. Kinetics of neutral amino acid 
transport across the blood brain barrier. Journal o f Neurochemistry, 49, 1651-8, 1987.
Smith, WK. The stress analogy. Schizophrenia Bulletin, 13, 215-25, 1987.
Solomon, SJ, Kurzer, MS, Calloway, DH. Menstrual cycle and basal metabolic rate in 
women. American Journal o f Clinical Nutrition,35, 611-6, 1982.
Sommer, B. Cognitive performance and the menstrual cycle.In Richardson, J.T.E.eds, 
Cognition and the menstrual cycle, New York: Springer Verlag, 1992. Pp. 39 - 53.
Spielberger CD. State trait anger expression inventory. Revised reseach edition. 
Professional manual. Florida: Psychological Assessment Resource Inc; 1991;
Spielberger CD, Gorsuch RL, Lushene R et al. Manual for the state trait anxiety 
inventory (form Y).(Self evaluation questionnaire).. California: Consulting 
Psychologists Press Inc; 1983;
Spielberger, C.D., Johnson, E.H., Russell, S.F., et al. The experience and expression of 
anger:construction and validation of an anger expression scale.In Chesney, M.A. and 
Rosenman, R.H.eds, ^4«ger and hostility in cardiovascular and behavioural disorders, 
Washington: Hemisphere Publishing Corporation, 1985. Pp. I l l
Spring, B, Chiodo, J, Bowen, DJ. Carbohyrates, tryptophan and behaviour: a 
methodological review. Psychological Bulletin, 102(2), 234-56, 1987.
Stanley, M, Virgilio, J, Gershon, S. Tritiated imipramine binding sites are decreased in 
the frontal cortex of suicides. Science,216, 1337-9, 1982.
Steer, RA, Beck, AT, Riskino, J, Brown, C. Differentiation of depressive disorder from 
generalised anxiety by the Beck Depression Inventory. Journal o f Clinical 
Psychology,42, 475-8, 1986.
Steere, J, Cooper, PJ. The effects on eating of dietary restraint, anxiety and hunger. 
International Journal o f Eating Disorders, 13, 211-9, 1992.
Stewart, DE. Reproductive function in eating disorders. Annals o f Medicine,24,
287-91, 1992.
Stewart, DE, Robinson, E, Goldbloom, DS, Wright, C. Infertility and eating disorders. 
American Journal o f Obstetrics and Gynaecology ,\C3, 1196-9, 1990.
329
Striegel-Moore, RH, Silberstein, LR, Rodin, J. Towards an understanding of risk 
factors for bulimia. American Psychology,Al, 246-63, 1986.
Sullivan, A., Cheng, L. Appetite regulation and its modulation by drugs.In Hathcock, 
J.N. and Coon, J.eds, Nutrition and drug interrelations, New York: Academic Press, 
1978.
Swade, C, Coppen, A. Seasonal variations in biochemical factors related to depressive 
illness. Journal o f Affective Disorders,2, 249-55, 1980.
Tam, WY, Chan, MY, Lee, PH. The menstrual cycle and platelet 5HT uptake. 
Psychosomatic Medicine,Al {A), 352-62, 1985.
Tarasuk, V, Beaton, GH. Menstrual cycle patterns in energy and macronutrient intake. 
American Journal o f Clinical Nutrition,53, 442-7, 1991.
Taylor, DL, Matthews, RJ, Weinman, ML. Serotonin levels and platelet uptake during 
premenstrual tension. Neuropsychobiology, 12, 16-8, 1984.
Taylor, MW, Feng, G. The relationship between interferon gamma, indoleamine 2,3 
dioxygenase and tryptophan catabolism. The FASEB Journal, 5, 2516-22, 1991.
Thompson, SM, McMillan, BA. Test for decreased serotonin/tryptophan metabolite 
ratios in abstinent alcoholics. Alcohol,A, 1-5, 1987.
Tomelleri, R, Grunewald, KK. Menstrual cycle and food cravings in young college 
women. Journal o f American Dietetics Association, 87(3), 311-5, 1987.
Traskman, L, Asberg, M, Bertilsson, L, Sjostrand, L. Monoamine metabolites in CSF 
and suicidal behaviour. Archives o f General Psychiatry,35, 773-82, 1981.
Treolar, AE, Boynton, RE, Behn, BG, Brown, BW. Variations on the human menstrua 
cycle throughout reproductive life. International Journal o f Fertility, 12, 77-126, 1967.
Ungerstedt, U. Adipsia and aphagia after 6hydroxy dopamine induced degeneration of 
the nigrostriatal dopamine system. Acta Physiology Scandinavia,367, 95-122, 1971.
Ungerstedt, U, Ljungberg, T. Central dopamine neurones and sensory processing. 
Journal o f Psychiatric Research, 11, 149-50, 1974.
Ussher, J.M. Chapter 3.In Ussher, J.M.eds, The psychology o f the female body, 
London: Routledge, 1993. Pp. 53 - 55.
330
Valzelli, L. Reflections on experimental and human pathology of aggression. Progress 
in Neuropsychopharmacology and Biological Psychiatry,8, 311-25, 1984.
Van der Ploeg, HM. Emotional states and the premenstrual syndrome. Personal and 
Individual Difference£,8(1), 95-100, 1987.
van Kammen, DP. Serotonin, a neurotransmitter for all seasons? Biological 
Psychiatry,22(1), 1-3, 1987.
van Praag, HM. Depression, suicide and the metabolism of serotonin in the brain. 
Journal o f Affective Disorders,A, 275-90, 1982.
van Praag, HM. Cerebrospinal fluid 5HIAA and suicide in non depressed 
schizophrenics. The Lancet,II, 977-8, 1983.
van Praag, H.M. Central serotonin via the neuroendocrine window.American 
Psychiatric Associationeds, American Psychiatric Association 1986 CME syllabus,
New York: APA Press, 1986.
van Praag, HM, de Haan, S. Central serotonin metabolism and frequency of 
depression. Psychiatric Research,1, 219-24, 1979.
van Praag, HM, Lemus, C, Kahn, RS. Hormonal probes of central serotonergic 
activity: do they really exist? Biological Psychiatry,22, 86-98, 1987.
van Staveren, W, Burema, J. Symposium on "Recent studies on food intake and 
nutrient intake in Ireland". Dietary methodology: implications of errors in the 
measurements. Proceedings o f the Nutrition Society,49, 281-7, 1990.
Veeninga, AT, Westenberg, HG. Serotonergic function and late luteal phase dysphoric 
disorder. Psychopharmacology, 108, 153-8, 1992.
Vila, J, Beech, HR. Premenstrual symptamology: an interaction hypotheses. British 
Journal o f Social and Clinical Psychology, 19, 73-80, 1980.
Vliet, EL, Davis, VL. New perspectives on the relationship of hormone changes to 
affective disorders in the perimenopause. NAA Cogs Clinical Issues in Perinatal 
Womens Health Nursing,2(A), 453-71, 1991.
von Knorring, L, Oreland, L, Winblad, B. Personality traits related to MAO activity in 
platelets. Psychiatry Research, 12, 11-26, 1984.
331
Wade, GN. Gonadal hormones and behavioural regulation of body weight. Physiology 
and Behaviour,8, 523-34, 1972.
Wade, GN, Gray, JM. Gonadal influences on food intake and adiposity: a metabolic 
hypothesis. Physiology and Behaviour,22, 583-93, 1979.
Wade, GN, Gray, JM, Bartness, JJ. Gonadal influences on adiposity. International 
Journal o f Obesity,9, 83-91, 1985.
Walsh, BT, Roose, SP, Glamman, AH. Bulimia and depression. Psychosomatic 
Medicine,Al, 123-31, 1985.
Webb, P. 24 hour energy expenditure and the menstrual cycle. American Journal o f  
Clinical Nutrition,44, 614-9, 1986.
Weltzer, S, Kahn, R, Asnis, G, Kam, M, van Praag, H. Serotonin receptor sensitivity 
and aggression. Psychiatry Research, 37, 271-9, 1991.
Wilcoxon, LA, Schrader, SL, Sherif, CW. Daily self reports on activies, life events, 
mood and somatic changes during the menstrual cycle. Psychosomatic Medicine,38(6), 
399-417, 1976.
Wirz-Justice, A. Platelet research in psychiatry. Experientia,AA, 145-52, 1988.
Wirz-Justice, A, Arndt, E. Sex specific differences in chlorimipramine inhibition of 
serotonin uptake in human platelets. European Journal o f Pharmacology, AO, 21-5,
1976.
Wirz-Justice, A, Lichsteiner, A, Feer, H. Diurnal and seasonal variations in human 
platelet serotonin in man. Journal o f Neural Transmission, 41, 7-15, 1977.
Wirz-Justice, A, Puhringer, W. Seasonal incidence of an altered diurnal rhythm of 
platelet serotonin in unipolar depression. Journal o f  Neural Transmission, 42, 45-53, 
1978.
Wirz-Justice, A, Puhringer, W, Hole, G, Menzi, R. Monoamine oxidase and free 
tryptophan in human plasma. Phamiakopsychiatri Neuropsychopharmakol,%, 310-7, 
1975.
World Health Organisation Task Force on Psychosocial Research in Family Planning, 
SP, development and research training in human reproductrion. Women's bleeding 
patterns : ability to recall and predict menstrual events. Studies in Family 
Planning, 12(1), 17-27, 1981.
332
Wurtman, J. Carbohydrate cravings, mood changes and obesity. Journal o f Clinical 
Psychology,49(Suppl 8), 37-9, 1988.
Wurtman, J, Wurtman, R, Berry, E, Gleason, R, Goldberg, H, McDermott, J, Kahne,
M, Tsay, R. Dexfenfluramine, fluoxetine and weight loss among female carbohydrate 
cravers. Neuropsychopharmacology,9(3), 201-10, 1993.
Wurtman, J, Wurtman, R, Mark, S, Tsay, R, Gilbert, W, Growdon, J. dFenfluramine 
selectively suppresses carbohydrate snacking in obese subjects. International Journal o f  
Eating Disorders,4(1), 89-99, 1985.
Wurtman, JJ. The involvement of brain serotonin in excessive carbohydrate snacking 
by obese carbohydrate cravers. Journal o f American Dietetic Association, 84, 1004-7, 
1984.
Wurtman, JJ. Carbohydrate cravings. Relationship between carbohydrate intake and 
disorders of mood. Drugs,39(Suppl 13), 49-52, 1990.
Wurtman, JJ, Brezinski, A, Wurtman, RJ, Laferrere, B. Effects of nutrient intake on 
premenstrual depression. American Journal o f Obstetrical Gynaecology, 161(5),
1229-34, 1989.
Wurtman, JJ, Wurtman, RJ. Drugs that enhance central serotonergic transmission 
diminish elective carbohydrate consumption by rats. Life Sciences,24, 895-904, 1979.
Wurtman, JJ, Wurtman, RJ, Growdon, JH, Henry, P, Lipscomb, A, Zeisel, SH. 
Carbohydrate craving in obese people; suppression by treatment effecting serotonergic 
neurotransmission. International Journal o f Eating Disorders,!, 2-15, 1981.
Wurtman, JJ, Wurtman, RJ, Reynolds, S, Tsay, R, Chew, B. dFenfluramine suppresses 
snack intake among carbohydrate cravers but not among non carbohydrate cravers. 
International Journal o f Eating Disorders,6, 687-99, 1989.
Wurtman, RJ. Behavioural effects of nutrients. The Lancet,1, 145-7, 1983.
Wurtman, RJ. Dietary treatment that affects brain neurotransmitters. Effect on calories 
and nutrient intake. Annals o f Nwe York Academy o f Science,499, 179-90, 1987.
Wurtman, RJ. Nutrients affecting brain composition and behaviour. Integrative 
Psychiatry,5, 226-57, 1987.
Wurtman, RJ, Hefti, F, Melamed, E. Precursor control of neurotransmitter synthesis. 
Pharmacological Reviews,32, 315-35, 1981.
333
Wurtman, RJ, Wurtman, JJ. Do carbohydrates affect food intake via neurotransmitter 
activity? Appetite, 11 (Suppl), 42 1988.
Wurtman, RJ, Wurtman, JJ. Carbohydrates and depression. Scientific 
American,(January), 50-7, 1989.
Yokogoshi, H, Wurtman, RJ. Meal composition and plasma amino acid ratios:effects 
of various proteins or carbohydrate, and of various protein concentrations.
Metabolism,35(9), 837-42, 1986.
Young, S.N. The clinical psychopharmacology of tryptophan.ln Wurtman, R.J. and 
Wurtman, J.J.eds, Nutrition and the Brain, New York: Raven Press, 1986. Pp. 49 - 88.
Young, SN. The 1989 Borden Award Lecture. Some effects of dietary components 
(amino acids, carbohydrates, folic acid) on brain serotonin synthesis, mood and 
behaviour. Canadian Journal o f Physiological Pharmacology,69, 893-903, 1991.
Young, SN, Smith, SE, Pihl, RO, Ervin, FR. Tryptophan depletion causes a rapid 
lowering of mood in normal males. Psychopharmacology,87, 173-7, 1985.
334
BIBLIOGRAPHY
335
Baulieu, EE, Kelly, PA, Hormones: from molecules to disease. Paris: Hermann, 1990.
Beck, AT, Rush, AJ, Shaw, BF, Emery, G, Cognitive therapy o f depression. New 
York: Guildford Press, 1979.
Bender, D, Molecular aspects o f medicine. 1983.
Bonner, AB, Waterhouse, J, Addictive Behaviour. Molecules to mankind. Basingstoke: 
MacMillan Press Ltd, 1996.
Brown, TS, Wallace, PM, Physiological psychology. London: Academic Press Ltd, 
1980.
Cattell, RB, Patterns o f change: measurement in relation to state dimension, trait 
change, liability and process concept. Chicago: Rond McNally and Company, 1966.
Dana, M, Lawrence, M, Women's secret disorder. A new understanding o f bulimia 
London: Grafton Books, 1989.
Davie, K, Dickey, J, Stratford, T, Out o f focus- writings on women in the media 
London: The Women's Press, 1987.
Donovan, B, Hormones and human behaviour. The scientific basis o f psychiatry. 
Cambridge: Cambridge University Press, 1985.
Gold, JH, Severina, SK, Premenstrual dysphorias. Myths and realities. Washington: 
American Psychiatric Press Inc, 1994.
Green, B, Leake, RE, Steroid hormones- a practical approach. Oxford: IRL Press Ltd, 
1987.
Guillebaud, J, The pill. London: Oxford University Press, 1984.
Haber, B, Gabay, S, Issidorides, MR, Alivisatos, GA, Serotonin. Current aspects o f  
neurochemistry and function. New York: Plenum Press, 1981.
Hamilton, RJ, Sewell, PA, Introduction to high performance liquid chromatography. 
London: Chapman and Hall, 1982.
Hsu, LK, Eating disorders. New York: Guildford Press, 1990.
Lachelin, GC, Introduction to reproductive endocrinology. London: Butterworth 
Heinemann, 1991.
336
Lawrence, M, Fed up and hungry. Women, oppression and food. London: Women's 
Press Ltd, 1987.
Lim, CK, HPLC o f  small molecules- a practical approach. Oxford: IRL Press, 1986.
Orbach, S, Fat is a feminist issue. London: Arrow Books, 1988.
Rausch, JL, Janowsky, DS, Behaviour and the menstrual cycle. New York: Marcel 
Dekker Inc, 1982.
Richardson, JTE, Cognition and the menstrual cycle. London: Springer Verlag, 1992.
Schwarcz, R, Young, SN, Brown, RR, Kynurenine and serotonin pathways. New York: 
Plenum Press, 1991.
Schwarcz, S, International study group fo r  tryptophan research. International Sixth 
meeting -kynurenine and serotonin pathways, progress in tryptophan research. London: 
Plenum Press, 1991.
Stone, TW, Quinolinic acid and the kynurenines. Florida: CRC Press Inc, 1989. 
Vollman, RF, The menstrual cycle. Philadelphia: Saunders, 1977.
337
The Effect of the Menstrual Cycle on Eating 
Control. The Relationship of Tiyptophan 
Metabolism and Mood.
by
Sarah Brien Bsc ATT Msc
Submitted for the Degree of PhD, University of Surrey 
Addictive Behaviour Centre, Roehampton Institute, London
1996
© Sarah Brien 1996
APPENDICES
CONTENTS
Appendix
1 Methods for the Assessment of Food and 
Macronutrient intake
2 The Serotonergic Receptors Involved in Behaviour
3 The Becks Depression Inventory
4 The Abridged Profile of Mood States Questionnaire 
Used in Study G
5 Spielbergers State Anxiety Inventory
6 Spielbergers Trait Anxiety Inventory
7 Spielbergers State Anger Questionnaire
8 Spielbergers Trait Anger Questionnaire - A
9 Spielbergers Trait Anger Questionnaire - B
10 High Performance Liquid Chromatography. Theory and 
Practical Details.
11 The Analysis of Cortisol
12 Consent Form Used in Studies A to G
13 Questionnaire for the Completion of Study A
14 Subjective Appetite Questionnaire for Study A
15 Macronutrient Content of All Food Items Listed in the 
Appetite Questionnaire Checklist in Study A
16 Instructions for the Completion of the Food Diary 
in Study B
17 A Food Diary Sheet for Entering all Foods and Drinks 
Consumed in a 24 Hour Period
18 Subjective Appetite Questionnaire for Study B
19 General Daily Questionnaire for Study B
Page
’ 20 An abnormal and normal hormonal profile during 44
the menstrual cycle
21 Correlational Results Tables 45
LIST OF TABLES
Table 1 
Table 2
Page
Potential Sources of Error in the Different 6
Methods of Assessment of Dietary Intake
Molecular Weights for Tryptophan and 27
Tryptophan Metabolites
APPENDIX 1
Methods for the Assessment o f Food and Macronutrient Intake
There are 6 recognised methods used in assessing food intake. In order of accuracy 
these are; weighed method, semi weighed method, estimated weights of foods, 24 
hr recall, diet history and food frequency (all except the semi weighed method are 
reviewed by Bingham, 1987). The first three methods are actual records of food 
consumption, the remaining three attempt to assess diet by interviewing subjects 
about their food intake. Accurate results from these methods require skill from the 
observers, and commitment from the subjects since there are numerous errors 
introduced at each stage which can invalidate the assessment (that will be discussed 
later). A brief description of each of these will be discussed, with a more in depth 
description of the method to be used in this study ie the semi weighed intake 
method. When subjects are asked to keep a record of everything they eat, there is 
the problem that they may alter their diet since their awareness of what they eat 
increases. It is appreciated that there is a difference between the purpose of dietary 
experiments in experimental metabolic units and free living populations. Although 
the results from studies in metabolic units are considered more accurate that in free 
living populations, both types have their advantages and disadvantages.
(A) Weighed Method
The first method, developed approximately 40 to 50 years ago, was that of records 
of food consumption with weights of foods, known at the time as the Individual 
Method. Widdowson, assessed individual diets in children, men, women and
1
pregnant women during the 1930’s by asking subjects to weigh, describe and write 
down all items of cooked food and drink eaten in one week. Left over food was 
also weighed, and recipes for the home cooked foods were recorded. The data from 
these studies was compiled in food tables of McCance and Widdowson (1940), 
which is now the standard reference manual for determination of food composition. 
Subsequently, this method was further defined by asking subjects to weigh by 
"addition onto a plate" their food ready for eating by the cumulative method. In 
epidemiological surveys, instructions are vital and performed in the home. Again 
left over food is weighed. The problem of food being eaten away from home is 
sorted out by nutritionist buying and weighing a duplicate portion later on. In view 
of the nature of this method, it is generally used when subjects are kept in a 
metabolic unit or research unit for the duration of the study. This is considered the 
gold standard method but is obviously cumbersome, time consuming and not 
appropriate for field studies.
(B) Semi weighed food intake
This method was developed by Nelson and Nettleton (1980a) to measure food 
intake within families. Subsequently this method was adapted for individual use. 
The advantages of this method are that it is accurate, easy to record, and 
cooperation is higher than the weighed method. The basic principle of this method 
is that the whole families’ food consumption of each food is weighed, whilst the 
distribution to each family me^od is expressed in household measures. Subjects 
using this method are asked to record all foods and drinks consumed, generally
2
over a period of seven days. When at home all foods are weighed, to give accurate 
details. Commercially prepared foods such as slices of bread, meals etc are 
quantified by type and number of items eaten. However, unlike the weighed 
method, where situations make it difficult to weigh foods (eg when eating away 
from home) estimates of the food are recorded, using household measures. To 
quantify household measures, these are weighed at home. This method is obviously 
not as accurate as the weighed method, but in reality is a very useful method in 
free living subjects. Nettleton and Nelson (1980) compared the accuracy of the
semiweighed method with household measures. Significant differences were found
)
between these two methods in energy intake, fat vitamin C and dietary fibre; with
A
household measures overestimating the amount consumed. Protein, carbohydrate, 
calcium and iron did not show any difference.
(Q  Estimated weight food intake method
First described in 1942, this method records all food eaten by the individual or 
some member of the household during a seven day period. The quantity of food is 
measured as eaten from the plate using standard cups or level teaspoons or 
tablespoons as measures for the quantities consumed. The volume of the spoons is 
assessed later. For foods such as bread, meat, fruit, the amount is determined by 
three dimensional measurements. It appears that when subjects are asked to 
estimate diet intake by this method there is a huge degree of error; estimated to be 
in the region of 50% for foods and 20% for nutrients (Bingham, 1987).
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(D) The daily (24hr) recall method
This method as the name suggest, is dependant on the subject recalling all foods 
and drinks consumed within the previous 24 hours, or sometimes for longer 
periods. Dietary intake is therefore estimated, using portion sizes as a descriptive 
measure. The pitfalls of this method are obvious ie poor recall, underestimation of 
food consumed, and therefore is not an accurate nor specific method of assessing 
food intake.
(E) Diet histoiy
The subject assessed by this method is questioned about "typical" or "usual" food 
intake in a 1 - 2 hour interview, with the aim to construct a typical 7 days habitual 
eating pattern. The assessment of a diet history would seem to have an advantage 
overrecording or daily recall methods, since if it were possible to obtained an 
estimate of usual diet in one interview then the variation due to the effects of time 
would be eliminated. However, there are inherent difficulties with this method ie 
the amount of food eaten, reporting errors, coding problems and recall of how often 
different items of food are eaten. From comparative studies it appears that diet 
histories over estimate food consumption, although this can be corrected for on a 
proportional basis.
(F) Food Frequency Method
This method is the most frequently used assessment of diet, where the intake of a 
specific nutrient or food is required. Subjects are presented with a list of foods and
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are asked to say how often each is eaten per day/week/month. Therefore, this 
method is useful for the qualitative assessment of diets and not the quantitative 
assessment, and is usually performed for a 5 day (consecutive) period. Generally 
this method can be administered by the subject. Subsequent developments of this 
method have permitted the assessment of quantitative measures using models or 
photographs to assess portion sizes.
Problems of Surveys
To accurately assess dietary intake, it is necessary that the method is valid ie free 
from bias, and precise. However, in all methodology there is the opportunity for 
error which leads to a reduction in accuracy. This has been discussed in van 
Staveren and Burema (1990). Errors in the measurement of diet may be either 
random or systemic. Random errors will affect the precision of a method, and 
could theoretically be minimised by increasing the number of observations. 
Systemic, or bias, errors will though be present whatever the sample size or the 
number of observations made. The accuracy of a method therefore depends on the 
method being unbiased and precise. As discussed by Bingham, 1987. there are 
nine possible sources of errors in assessing food intake, as shown in Table 1.
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Source of Error Records with 
Weights
Records with
estimated
weights
Daily Recall Diet history & 
questionnaire
Food tables + + + +
Coding errors + + + +
Wrong weights o f food + + +
Reporting error - - + +
Variation with time + + + _
Wrong 
frequency o f  
consumption
- - - +
Change in diet ± ± - -
Sampling bias + + + +
Response bias ± ± ± ±
Table 1: Potential Sources of Error in Different Methoc s of Assessment
Intake
where + error known to be present 
- error not present 
± error may be present 
[Source: Bingham (1987)]
Generally in research papers these errors are rarely calculated. Bingham et al 
(1994) compared weighed records to 24 hr recall, a structured food frequency 
(menu) questionnaires and estimated diet records to determine which method gave 
the most accurate assessment. From this survey it appeared that food frequency 
questionnaires were not better in determining habitual diet than 24 hr recall method 
mainly because estimating frequency of food consumption was inaccurate. The 
estimated diet records though were found to be most closely associated with those 
obtained through a weighed record, with no significant differences being found in 
average food intake or nutrient intake. Coding errors arise during the coding or
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calculation and also can result from difficulties in interpretation of the dietary 
records.
In estimated weight records, it is important to calibrate the measuring devices used 
since the capacity of spoon, for example, varies considerably. In the 24 hr recall 
method there is the added problem of subjects having to remember what they ate. 
Evidence from the literature suggest that this method is particularly prone to 
reporting error, with generally a lower energy intake being reported when compared 
to the weighed method either as a result of general under reporting or else missing 
out items altogether. In addition it appears this method can result in the "flat slope 
syndrome" ie under reporting for large portions of food, but over reporting for 
small portions.
Length of Time and Time of Recording
Bingham (1987) developed criteria to ensure that valid data is obtained from 
dietary assessments, necessary to achieve a standard error of ± 10%. For energy 
intake to be assessed, a 7 day record is sufficient for an accuracy of ±10% 
standard error. For clinical work and research, it has been suggested that for 
individual assessment a 14 day record would cover most nutrient variation, and that 
the 14 days would not have to be collected on consecutive days but could be 
assessed in groups of four days so that day of the week variation can be monitored.
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Usually it is the practice to keep records, weighed or estimated for a seven day 
consecutive period, on the assumption that this is the shortest time necessary to 
cover fluctuations in dietary patterns from weekdays to weekends. Also this is 
generally the longest period which a subject can be expected to participate and 
cooperate. Individuals generally have varied intake day to day. In particular the 
variability from day to day is closely related to the nutrient being studied, and the 
degree of variation varies between individuals (Bingham, 1987). Daily variation of 
dietary intake has been shown to be greater than that between individuals, and 
result in problems analysing the data. This can be reduced by increasing the 
numbers of observations on each individual. Week to week variation has been 
shown to be less than day to day. Intake across the seasons has also been assessed. 
In industrialised countries, where seasonal food availability is minimal, as expected 
there appears to be little difference across the seasons. However, variation in 
micronutrients eg vitamin C and dietary fibre have been noted.
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APPENDIX 2
The Serotonergic Receptors Involved in Behaviour 
The following receptors have been identified within the CNS, and their function 
clarified.
(a) 5HTla Receptors
High density of these receptors are found in the brain areas that compose the 
limbic system (ie the hippocampus,amygdaloid and raphe nuclei) and as such it 
has been suggested that the effectiveness of serotonergic drugs in emotional states 
are mediated via their effects in the 5HTla receptors. Reduced density of these 
receptors in the hippocampus was shown to correspond to the loss of pyramidal 
cells in Alzheimer disease.
In addition 5HT2 receptors proliferate in the neocortex, hypothalamus and 
substantia gelatinosa in the spinal cord and suggest a possible involvement of 
serotonin in the regulation of propriorecepetion and the function of the neocortex. 
Thus the 5HT! receptors modulate a variety of functions - antihypertensive effects, 
behavioural effects (forepaw treading and flat body posture in the rat), feeding and 
sexual behaviour. Agonists of these receptors have been shown to be of potential 
use in anxiolytic and antidepressant treatment.
(b) 5HTlb and 5HTld receptors
In the brain of various mammals the 5HTlb/Id receptors (there is no evidence that
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the 5HTlb receptors exist in human brain) are localised on cells controlling the 
activity of the basal ganglia and they are characteristic of serotonin receptors (ie 
control the release of serotonin and also other transmitters).
(c) 5HTlc receptors
These receptors have been visualised using autoradiographic studies in the chorioid 
plexus of all mammalian species investigated to date (which includes human). The 
receptors are found on the epithelial cells of the chorioid plexus and are suggested 
to regulate the composition and volume of CSF. In addition they are found in 
lower densities in the limbic system and regions associated with motor behaviour. 
Administration of the serotonin agonist mCPP in humans is believed to exert its 
effect via the 5HTlc receptors and locomotor activity, feeding behaviour and 
anxiety (Kennett et al, 1988; 1989 as cited in Hoyer, 1988).
(d) 5HT2 receptors
These receptors are concentrated in the cortex and also in some parts of the limbic 
system (olfactory nuclei and basal ganglia). Decreased receptor binding has been 
demonstrated in senile dementia (Alzheimer type). The role of these receptors in 
depression, psychosis, hallucinations and sleep disturbances has been suggested. 
However antagonists for 5HT2 receptors also have high affinity for 5HTlc and 
dopamine receptors and the proposed mechanisms of effect need to be addressed.
(e) 5HT3 receptors
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These receptors are found in the entire nervous system, sympathetic and 
parasympathetic neurones (5HT3b) and sensory neurones. Highest densities of these 
receptors are found in discreet brainstem areas as identified above, especially the 
vagal nerve (5HT3a). They are also found in the cortical and limbic systems and 
exist in particularly high concentrations in the area postrema which explains the 
well known anti emetic effects of 5HT3 antagonists (believed to be mediated via 
the 5HT3c). Antagonists also have a beneficial effect in the treatment of anxiety, 
psychotic, addiction and learning deficit disorders (Hoyer, 1990).
(f) 5HT4 receptors
These receptors have been identified in the limbic system (colliculus and 
hippocampus) but their distribution is still largely unknown. No studies have 
demonstrated any behavioural or centrally mediated effects induced by 5HT4 
receptor activation.
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APPENDIX 3 
The Becks Depression Inventory
D ate:
N am e:.
O ccup ation :.
M arital S ta tu s : . 
E d u cation :____
■ A ge:. . S e x : .
T h is  q u e st io n n a ir e  c o n s is t s  o f 2 1  g r o u p s  o f  s ta te m e n ts .  A fter  r e a d in g  ea ch  g ro u p  o f s ta te m e n ts  carefu lly , 
c ir c le  th e  n u m b er  (0 , 1 , 2  or 3) n e x t  to  th e  o n e  s ta te m e n t  in  ea ch  grou p  w h ic h  b e s t  d e sc r ib e s  th e  w a y  you  
h a v e  b e e n  fe e l in g  th e  p a s t  w e e k , in c lu d in g  today. I f  s e v e r a l s ta te m e n ts  w ith in  a  g ro u p  s e e m  to app ly  eq u a lly  
w e ll, c irc le  ea ch  o n e . B e  su r e  to  rea d  a ll th e  s ta te m e n ts  in  ea ch  grou p  b efo re  m aking you r ch oice.
1 o I do not fe e l sad .
1 I fe e l sad .
2 I am  sad  a ll th e  tim e and I can 't sn a p  ou t o f it.
3 I am  so  sad  or unhap py th a t I c a n ’t s ta n d  it.
2 o I am  n ot particu larly  d iscou raged  about th e
fu tu re .
1 I fee l d iscou raged  about th e  fu tu re .
2  I fe e l I h ave  n o th in g  to look  forw ard  to.
3  I  fe e l th a t th e  fu tu re  is  h o p e le ss  and  th a t  
th in g s  can n ot im prove.
3 o I do n ot fe e l lik e  a  fa ilu re.
1 I fe e l I h ave  fa iled  m ore th a n  th e  
. average p erson .
2  A s I look  back  on m y  life , a ll I can  s e e  is  
a lo t of fa ilu res.
3  I fe e l I am  a com plete  fa ilu re  a s  a person .
4 o I g e t as m u ch  sa tis fa c tio n  ou t o f th in g s  a s  I
u sed  to.
1 I don’t en joy  th in g s  th e  w a y  I u sed  to.
2  I don’t g e t rea l sa tis fa c tio n  ou t of a n y th in g  
anym ore.
3  I am  d is sa tis fied  or bored w ith  every th in g .
5 o I don’t fe e l p articu larly  guilty .
1 . I fe e l g u ilty  a  good part o f th e  tim e.
2  I fe e l qu ite g u ilty  m o st of th e  tim e.
3  I  fe e l g u ilty  a ll of th e  tim e.
S o l  don’t fe e l I am  b e in g  p u n ish ed .
1 I fee l I m a y  be p u n ish ed .
2  I exp ect to  be p u n ish ed .
0 I fe e l I am  b ein g  p u n ish ed .
f o I d on’t fe e l d isap poin ted  in  m y se lf.
1 I am  d isappointed  in m y s e lf .
2  I am  d isg u ste d  w ith  m y se lf ,
o I h a te  m y se lf.
o o I don’t fe e l I am  an y  w o rse  than
anybody e lse .
1 I am  critica l of m y se lf  for  m y  w ea k n esse s  
or m ista k es .
2  I b lam e m y se lf  a ll th e  tim e for m y  fau lts .
3 I b lam e m y se lf for  ev ery th in g  bad  
th a t happens.
9 o I don’t h ave any  th o u g h ts  o f k illin g  m y se lf.
1 I have th o u g h ts  of k illin g  m y se lf, but I 
w ould n ot carry th em  out.
2  I w ould  lik e  to k ill m y se lf.
3  I w ould  k ill m y se lf  if  I h ad  th e  chance.
10 o I don ’t cry  an y  m ore th an  u su a l.
1 I cry  m ore now  th an  I u sed  to.
2  I cry  all th e  tim e now.
3  I u sed  to be able to cry, but now  I ca n ’t cry  
even  th o u g h  I w a n t to.
11 o I am  no m ore irrita ted  n o w  than  I ever am .
1 I g e t  annoyed or irr ita ted  m ore ea sily  th an  
I u sed  to.
2  I fe e l irrita ted  all th e  tim e now.
3  I don’t g e t  irr ita ted  a t a ll by  th e  th in g s  th a t  
u sed  to irrita te  m e.
12 o I h ave n ot lo s t  in te r e s t  in  o th er  people.
1 I am  le s s  in terested  in  o th er  people than  
I u sed  to be.
2  I have lo s t m o st of m y  in te r e s t  in  
oth er  people.
3  I have lo s t a ll of m y  in te r e s t  in  oth er  people.
13 o I m ak e d ec is ion s about a s  w e ll as
I ever could.
1 I p u t o ff m a k in g  d ec is io n s  m ore th an  
I u sed  to. "
2  I h ave grea ter  d ifficu lty  in  m a k in g  
d ecis ion s than  before.
3  I ca n ’t m ak e d ec is io n s  a t a ll anym ore.
. Subtotal P age 1 C O N TI NU ED  ON BACK
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14 o I don’t feel I look any w orse than I u sed  to.
i I am worried that I am  looking old or
unattractive.
a I fee l that there are perm anent changes  
in  m y appearance that m ake m e look  
unattractive.
3  I believe that I look ugly.
15 o I can w ork about as w ell as before.
1 It takes an  extra  effort to get started  at 
doing som eth ing.
2  I have to push  m yself very hard to do 
anything.
3  I can’t do any w ork at all.
1B o I can sleep  as w ell as usual.
1 I don’t sleep  as w ell as I u sed  to.
2  I w ake up 1 -2 hours earlier than  usual 
and find it hard to get back to sleep.
3  I w ake up several hours earlier than I 
u sed  to and cannot get back to sleep.
17 o I don’t get m ore tired than  usual.
1 I get tired more easily  than I u sed  to.
2  I get tired from  doing a lm ost anything.
3 I am  too tired to do anything.
18 o My appetite is  no w orse than usual.
1 M y appetite is  not as good as it  u sed  to be.
2  M y appetite is  m uch w orse now.
3  I have no appetite at all anym ore.
I haven ’t lo st m uch w eigh t, i f  any, lately. 
I have lo st m ore than 5 pounds.
I have lo st m ore than 10 pounds.
I have lo st m ore than 15 pounds.
I am  purposely trying to lo se  w eigh t by 
eatin g  le ss . Y es_______N o _______
20 o I  am no m ore worried about m y health  
than usual.
1 I  am  w orried about physical problem s 
such  as ach es and pains; or upset 
stom ach; or constipation.
2  I  am very worried about physical 
problem s and it's hard to th ink  of 
m uch else.
3  I  am so w orried about m y physical 
problem s th at I  cannot th in k  about 
anyth ing e lse .
21 o I have not noticed  any recent change
in m y in terest in  sex .
1 I am le s s  in terested  in  se x  than I used  
to be.
2 I am m uch le s s  in terested  in  sex  now.
3 I have lo st in terest in  sex  completely.
. Subtotal P age 2  
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APPENDIX 4
The Abridged Profile of Mood States Questionnaire Used in Study G
DAILY MOOD RATINGS
Name Date:
Below are a list o f  words that describe feelings and moods people have. Please read EVERY word carefully. Then tick one 
box that answers how you are feeling NOW. Please answer truthfully; there are no right or wrong answer.
Tick box
1 if  the statement indicates you feel not at all like this
2 if  the statement indicates you feel somewhat like this
3 if  the statement indicates you feel moderately like Ms
4 if the statement indicates you feel very much like this.
1 2 3 4 1 2 3 4
Friendly 0 0 □ 0 Timid □ 0 □ □
Nervous □ □ □ □ Furious 0 □ □ □
Lighthearted □ □ □ □ Untroubled □ □ □ □
Composed □ □ □ □ Bold □ □ □ □
Grouchy □ Q 0 □ Good natured □ D □ □
Strong □ □ 0 □ Uneasy □ 0 0 □
Downhearted □ □ □ □ Joyful 0 □ □ □
Kindly □ □ 0 □ Uncertain 0 □ □ □
Shaky □ □ □ □ Angry □ □ □ 0
Playful □ 0 □ 0 Calm □ □ 0 □
Unsure 0 □ □ □ Lonely □ □ □ □
Peaceful □ □ □ □ Forceful Q □ □ □
Powerful □ □ □ □ Tense □ □ □ □
Gloomy 0 □ D □ Cheerful □ D 0 □
Sympathetic. □ □ □ □ Inadequate □ □ □ □
Jittery □ □ □ 0 Mad □ □ □ □
Jolly □ □ □ □ Relaxed □ Q 0 □
Sad □ □ 0 □ Self assured a □ □ □
Agreeable 0 □ 0 □ Anxious □ 0 D 0
Elated □ □ □ □ Weak □ □ □ □
Serene □ □ 0 □ Annoyed □ 0 □ □
Self doubting □ □ □ □ Dejected □ □ □ □
Confident □ □ □ □ Discouraged □ □ □ a
Badtempered D 0 □ 0 Affectionate □ □ □ □
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APPENDIX 5
Spielbergers State Anxiety Inventory
A number o f statements which people have used to describe themselves are given below. Read each statement and tick tire 
box to indicate how you feel right now. There are no right or wrong answers; answer what you feel instinctively is right for 
you. Do not spend too much time on any one statement but give the answers which seem to best describe your present 
feelings.
Tick box
1 if the statement indicates you feel not at all like this
2 if the statement indicates you feel somewhat like this
3 if the statement indicates you feel moderately like this
4 if the statement indicates you feel very much like this.
I feel calm
1
□ D
2
Q
3
□
I feel secure Q 0 □ □
I am tense □ 0 □ 0
I feel strained □ □ □ □
I fee] at ease □ □ □ □
I feel upset Q D 0 □
I am presently worrying over 
possible misfortunes □ 0 □ a
I feel satisfied □ □ □ □
I feel frightened □ 0 □ □
I feel comfortable □ □ □ □
I feel self confident □ □ □ 0
I feel nervous 0 0 0 □
I am jittery □ □ □ □
I feel indecisive □ □ 0 □
I am relaxed D 0 0 D
I feel content □ □ □ □
I am worried □ □ □ □
I feel confused □ 0 □ □
I feel steady D □ □ □
I feel pleasant 0 0 0 □
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APPENDIX 6
Spielbergers Trait Anxiety Inventory
Below are a number o f statements which people have used to describe themselves. Read each 
statement and tick the appropriate box which correctly answers the statement which indicated how 
you generally feel. There are no right or wrong answers. Do not spend too much time on any one 
statement but give the answer which seems to describe best how you feel generally.
Tickbox 1 for Alm ost never 3 for Often
2 for Sometimes 4 for Alm ost always
I feel pleasant
1
□ □
2
□
3
□
I feel nervous and restless □ □ □ □
I feel satisfied with myself □ □ □ □
I wish I could be as happy as others seem to be □ □ □ □
I feel like a failure □ □ □ □
I feel rested □ □ □ □
I am "calm, cool and collected" □ □ □ □
I feel that difficulties are piling up so that I 
cannot overcome them □ □ □ □
I worry too much over something that really 
doesn't matter □ □ □ □
I am happy □ □ □ □
I have disturbing thoughts □ □ □ □
I lack self confidence □ □ □ □
I feel secure □ □ □ □
I make decisions easily □ □ □ □
I feel inadequate □ □ □ □
I am content □ □ □ □
Some unimportant thought runs through 
my mind and bothers me □ □ □ □
I take disappointments so keenly that I can't 
put them out o f my mind □ □ □ □
I am a steady person □ □ □ □
I get into a state o f tension or turmoil as I think 
over my recent concerns and interests □ □ □ □
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APPENDIX 7
Spielbergers State Anger Questionnaire
A number of statements that people use to describe themselves are given below. Read each statement and then tick the box 
which indicates how you feel right now. Remember that there are no right or wrong answers. Do not spend too much time on 
any one statement, but give the answer which seems to best describe your present feelings.
Tick box
1 if the statement indicates you feel not at all like this
2 if the statement indicates you feel somewhat like this
3 if the statement indicates you feel moderately like this
4 if the statement indicates you feel very much like this.
Statements
1 2 3 4
I am furious □ □ □ □
I feel irritated 0 □ □ □
I feel angry 0 □ D □
I feel like yelling at someone □ □ 0 □
I feel like breaking things □ □ □ 0
I am mad □ □ □ 0
I feel like banging die table □ □ □ □
I feel like hitting someone □ 0 □ D
I am burned up □ □ □ □
I feel like swearing □ □ □ □
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APPENDIX 8
Spielbergers Trait Anger Questionnaire" A
Below are a list o f statements that people use to describe themselves. Please can you read each 
statement and then fill in the box that indicates how you generally feel. There are no right or wrong 
answers. Try not to spend too much time on any one statement, but give the answer which seems to 
best describe how you generally feel.
Tickbox 1 for Almost never
2 for Sometimes
3 for Often
4 for A Imost always.
Statements
I am quick tempered
I have a fiery temper
I am a hotheaded person
I get angry when I am slowed down by 
other's mistakes
I feel annoyed when I am not given 
recognition for doing good work
I fly off the handle
When I get mad, I say nasty things
It makes me furious when I am criticise 
in front o f others
When I get frustrated, I feel like □ □ □ □
hitting someone
I feel infuriated when I do a good job □ □ □ □
and get a poor evaluation.
□ □ □ □
□ □ □ □
□ □ □ □
□ □ □ □
□ □ □ □
□ □ □ □
□ □ □ □
□ □ □ □
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APPENDIX 9
Spielbergers Trait Anger Questionnaire- B
Everyone feels angry or furious from time to time, but people differ in the ways that they react when they are angry. A 
number o f statements are listed below which people use to describe their reactions when they feel angry or furious. Read 
each statement and then fill in die box with the number which indicated how often you generally react or behave in die 
manner described when you are feeling angry or furious. There are no right or wrong answers, do not spend too much time 
on any one statement
Tick box 1 for Almost never 3 for Often
2 for Sometimes 4 for Almost always 
When angry or furious......
1 2 3
I control my temper □ 0 0 0
I express my anger □ □ □ □
I keep things in □ 0 0 □
I am patient with others □ □ □ □
I pout or sulk □ • □ 0 □
I withdraw from people a 0 0 □
I make sarcastic remarks to others □ □ 0 □
I keep my cool □ 0 □ □
I do things like slam doors □ □ □ □
I boil inside, but I don't show it □ □ □ □
I control my behaviour a a a a
I argue with others □ □ □ □
I tend to harbour grudges that I □ 0 D 0
don't tell anyone about
I strike out at whatever infuriates me 0 □ 0 0
I can stop myself from loosing my temper □ □ □ □
I am secredy quite critical of others □ □ 0 □
I am angrier than I am willing to admit □ □ □ 0
I calm down faster than most people 0 □ □ 0
I say nasty things 0 0 □ □
I try to be tolerant and understanding 0 □ □ □
I'm irritated a great deal more than 
people are aware of
0 □ □ □
I lose my temper □ □ 0 0
If someone annoys me,
I'm apt to tell him or her how I feel
□ □ □ □
I control my angry feelings 0 0 □ □
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APPENDIX 10
High Performance Liquid Chromatography. Theory and Practical 
Details
Theory of HPLC
High performance liquid chromatography (HPLC) is a chromatographic separation 
technique performed under high pressure and is an established method which can 
be used to detect biogenic amines and their metabolites within biological substrates. 
HPLC involves the separation of the components in a mixture by virtue of the 
difference in the equilibrium distribution of the components of the two phases ie a 
stationary phase (adsorbent or column packing on which the separation takes place) 
which can be a solid, liquid or ion exchange held in a column and a liquid mobile 
phase (solvent or eluent forced through the column under high pressure).
Good separation of closely related compounds can be achieved due to the 
microparticulate packing of the analytical column. A compound is characterised by 
the time it takes to migrate through the permeable solid (stationary) phase subjected 
to a flow of a liquid (mobile) phase, known as the retention time. Partition occurs 
between the hydrophobic (non polar) alkyl chains of the stationary phase and the 
relative hydrophobic (polar) eluting agent. The most polar species elute off of the 
column first. As the concentration of the organic modifier (ie methanol) is 
increased, the buffer becomes less polar and competes more effectively with the
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hydrophobic stationary phase which leads to a decrease in the retention times for 
all of the compounds. It is possible to control the retention times by altering the 
buffer pH, methanol concentration (ie organic modifier), temperature and flow rate.
The advantages of HPLC compared to other forms of chromatography are that the 
column is reusable, a much higher resolution is obtained, with increased precision, 
reduced analysis time and it can be easily automated to facilitate large scale 
analysis. Also it allows the analysis of many components in one small sample.
Practical Aspects of HPLC Relevant to the Analysis of Tryptophan and Its 
Metabolites
1. Equipment
The HPLC system consisted of a high pressure pumping system, a narrow bore 
short column packed with small particles (stationary phase), a mobile phase and an 
inline highly sensitive detector. The equipment used included :
(a) Shimadzu autoinjector SIL 6A - for sample injection
(b) Shimadzu system controller SCL 6A - for control of the system parameters
(c) Shimadzu chromatopac CR4A - for integration and analysis of data
(d) Shimadzu pump LC 6A - to maintain buffer at a set flow rate
(e) Oven set at 30Oc - for stabilising column and buffer conditions
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Tryptophan and its metabolites required different forms of detection dependant on 
their chemical structure. Electrochemical detection was used to measure tryptophan, 
serotonin, 5 hydroxy indole acetic acid, anthranilic acid and indole acetic acid 
levels (referred to as the serotonin assay); using a Shimadzu electrochemical 
detector LECD 6 A set at 90mv, with a Spherisorb analytical C l8 column ODS II 
25 cm internal diameter 4.6mm). Ultraviolet detection was used for the 
determination of the kynurenine pathway metabolites ie kynurenine, 3 hydroxy 
kynurenine, 3 hydroxy anthranilic acid, quinolinic acid and nicotinic acid (referred 
to as the kynurenine assay); using a Shimadzu UV spectrophotometric detector 
SPD-6A set at a wavelength 254 nm (set to ABS, standard response and absorption 
at 0.001) with a Spherisorb analytical C18 column ODS II 25 cm, internal diameter 
4.6mm.
2. Solvent Degassing
This was preformed to remove any air bubbles in the mobile phase which would 
interfere with detection. The solvent was degassed every day by sparging with the 
inert gas helium for 5 minutes.
3. The Stationary Phase
This consisted of a Spherisorb column containing non polar silica based packing 
material chemically bonded to C l8 hydrocarbons. A column preheater was used to 
ensure a constant temperature of 30<>c to improve repeatability of the 
chromatograms. Different separation mechanisms can be achieved by bonding
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different chemical groups to the surface of the silica particles, the most popular 
being octadecyl silica (ODS - silica) which contains C l8 alkyl groups. When 
packed into the column the minute particle size are resistant to the flow of the 
solvent so the solvent has to be pumped through the column under high pressure. 
Typically columns are 10 - 25 cm long with internal diameters of 4.6mm and are 
usually made of steel to withstand the pressure used to force the mobile phase 
through. The column size employed therefore depends upon the type of analysis 
performed. For both the serotonin and kynurenine assays the column used was a 
Spherisorb C18 ODS II 25 cm column (internal diameter 4.6mm).
4. Mobile Phase
The mobile phase has several important characteristics which include a very high 
purity, being immiscible with the stationary phase and having a low viscosity. The 
buffer solution acts as the transport fluid taking the sample through the injection 
valve to the analytical column and then onto the detector.
The mobile phases for the serotonin and kynurenine assays were similar in nature, 
the only difference being that the kynurenine assay contained no organic modifier 
(ie methanol). The serotonin assay though contains 20 % volume of methanol. The 
mobile phase for the serotonin and kynurenine assays were made up as follows
1. 13.6 g potassium dihydrogen orthophosphate and 3.722 g EDTA dissolved in 2 
litres of HPLC water.
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2. The pH adjusted to 3.2. For the kynurenine assay go to point 4.
3. For the serotonin assay only, addition of 200 ml methanol for every litre of 
buffer.
4. Filter the buffer through a Millipore 0.22 um filter.
5. Degas the buffer by sparging with helium for 5 minutes before use.
5. Sample Injector and Pump
Isocratic reversed phase HPLC was employed in the assays performed in these 
studies (ie the use of a single eluent with uniform pH, where the stationary phase is 
less polar than the mobile phase). The pump (Shimadzu LC 6A) was connected to 
the automatic sample injector (Shimadzu SIL 6A) and set to a constant flow rate of 
1.8 ml for both assays, preset with a cut out facility if  the internal pressure 
exceeded 300 kgf7cm2.
6. Detection
Electrochemical (EC), ultraviolet (UV) and fluorometric detection have been 
applied in the separation of tryptophan, its metabolites and associated metabolites. 
The metabolites detected by EC detection were tryptophan, serotonin, 5HIAA, IAA 
and AA. Those detected by UV detection were kynurenine, 3 hydroxykynurenine, 3 
hydroxy anthranilic acid, quinolinic acid and nicotinic acid,
i. Electrochemical Detection
Electrochemical detection is frequently used as it causes oxidation of only a small 
percentage of the analyte. The eluted solution passes through the detector
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(Shimadzu LECD 6A), set at an oxidising potential of 90mv connected to a 
computer integrator (Shimadzu chromatopac CR2A) for direct analysis of the 
change in electrical activity.
In order for a compound to be detected by EC detection it must have 
electrochemical activity ie the ability to accommodate the loss or addition of one or 
more electrons. Each molecule passing through the detector is oxidised as a result 
of an electrical potential applied across the electrodes of the cell. The release of 
electrons from the oxidised molecule produces a current which can be detected by 
the cell. The current produced is directly proportional to the number of electrons 
produced enabling the relative concentration of any compound to be calculated,
ii. Ultraviolet Detection
Ultraviolet detection is not frequently used as naturally occurring biogenic amines 
and their metabolites are often at the limit of detection and is not as selective a 
method for detection as EC. However this method of detection has many 
advantages such as its relative insensitivity to temperature and mobile phase flow 
changes. It also has a high sensitivity (to 1 ng of a solute) of many samples.
The eluted solution passes through the detector (Shimadzu SPD 6A), set at a 
wavelength of 254 nm connected to a computer integrator (Shimadzu chromatopac 
CR4A) for direct analysis of the change in light intensity. The radiation source 
used in the detector is a deuterium lamp. All other wavelengths than the one 
chosen for scanning, 254 nm, were filtered out to give monochromatic light at this
24
wavelength.
7. Standards and Calibration
The concentrations of the compounds separated by HPLC are typically low and 
therefore handling of the sample is important, as well as the use of standards for 
quantification.
The HPLC equipment was calibrated for both assays using 99% pure standards 
obtained from Sigma, Poole, UK. All standards were initially made up to 
concentrations of lmg/ml and aliquots immediately frozen at -75 °c for preparation 
of the standards on the day of the assay. On the day of analysis, the standards were 
further diluted (with HPLC grade water) to a final concentration of
(a) For the serotonin assay, 20ng/ml tryptophan and anthranilic acid; lOng/ml for 
serotonin and HIAA; and 30 ng/ml for IAA.
(b) For the kynurenine assay, all standards made to 500 ng/ml.
lOOpl the combined standard mixture for both assays was injected onto the column 
for calibration. The run time for the serotonin assay was 20 minutes, for the 
kynurenine assay 15 minutes. The method of calibration used was the absolute 
standard method ie calibration by calculating the concentration of the metabolites 
in the sample by reference to the areas of the eluted peaks detected. Once the 
system had been calibrated the system was then ready for the analysis of 
tryptophan levels in both urine and saliva samples.
Coefficients of variation of the two assays were determined. The inter and intra
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assay coefficients of variation for the serotonin assay was 9.75% and 7.69 % 
respectively. The inter and intra assay coefficients of variation for the kynurenine 
assay was 10.07% and 6.92% respectively
8. Sample Preparation
Urine samples, diluted 1:1 with 0.1M HC1, were defrosted. 1ml urine was 
transferred to an Eppendorf tube and centrifuged for 5 minutes at 12,000 rpm to 
remove particulate matter. 50 pi of the supernatant was extracted and transferred to 
a HPLC analysis tube containing 350pi of HPLC pure water. This was vortexed 
and put into the autosampler tray ready for analysis, with a standard rerun every 
forth sample. Details for the preparation of saliva are found in Chapter Nine, Study 
Five.
9. Data Handling
A computer integrator (Shimadzu Chromatopac CR4A) was used to calculate the 
sample metabolite concentrations, based on peak identification by the retention 
times of the metabolites. All analytical data (including the chromatograms) were 
stored on disc for subsequent retrieval, editing and analysis.
10. Analysis of the HPLC Data
The data obtained from the analyses was expressed in ng of metabolite per ml of 
saliva or urine. However, this data does not take into account the various dilution 
factors of the biological specimens during their preparation for analysis (the total
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dilution factors for urine are 1:64, and for saliva, 1:16, as shown below). Therefore 
to calculate the concentration of metabolite per ng/ml, the urinary levels are 
multiplied by 64, the salivary ones by 16. Subsequently, the data can now also be 
expressed as ng metabolite/pmol creatinine, or by nmol/pmol creatinine (see Table 
2 for molecular weights of metabolites), prior to statistical analysis.
Dilution Factors :
Urine samples were diluted 1:64, as shown below:-
(i) 5ml urine + 5ml preservative in collection tube = 1/2 dilution
(ii) 50 pi urine in 350 pi water in HPLC analysis tube = 1/8 dilution
(iii) Of the 400pl only 100 pi injected ie 1/4 of total amount in analysis tube. 
Therefore, the total Dilution Factor for urine = 16 x 4 = 64
Saliva samples were diluted 1:16, ie
(i) 100 pi of saliva diluted in 300 pi water - 1 in 4
(ii) 100 pi of saliva injected from a total of 400 pi - 1 in 4 
Therefore the Total dilution factor = 4 x 4 =  16
Metabolite Molecular Weight (g) Metabolite Molecular Weight 
(g)
Tryptophan 204.2 Kynurenine 208.2
Serotonin 387.4 3HK 224.2
5-HIAA 191.2 3 HA 153.1
AA 137.1 Quinolinic acid 167.1
IAA 175.2 Nicotinic acid 123.1
Table 2. Molecular Weights For Tryptophan and Tryptophan metabolites
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APPENDIX 11
The Analysis of Cortisol in Urine 
1. Preparing the Urine Samples for Cortisol Extraction 
NB Only glass equipment (and not plastic) was used in this extraction process.
1. All glass tubes and vials were washed in detergent and then acid (10% cone 
HC1) with a final rinse in distilled water.
2. 0.5ml of the urine sample was dispensed into glass vial with either ground glass 
stoppers or metal lined screw caps.
3. 1.0ml dichloromethane was added by glass pipette.
4. The vial contents were mixed for 10 minutes, eg. by end over end mixing or 
with a bottle roller.
5. The vial was then centrifuged at lOOOg at 4°C for 5 minutes to separate the two 
phases.
6. The aqueous (top) layer was removed using a pasteur pipette.
7. Immediately a lOOpl aliquot was taken from each organic phase (using positive 
displacement pipette, glass capillary) and placed in a clean glass tube.
8. The solvent was then evaporated in a fume cupboard and the samples were then 
ready for assaying.
2. Preparing the basic buffer solutions
a. Purified Water
Distilled water is preferred (double distilled is ideal) for the preparation of all assay 
buffers and solutions.
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Distilled water is preferred (double distilled is ideal) for the preparation of all assay 
buffers and solutions.
b. Stock Sodium Phosphate Buffer (0.5M, pH 7.4)
15.3g NaH2P 0 42H20  (AnalaR)
57.1g Na2HP04 (AnalaR)
Were dissolved in 1 litre with distilled water. This buffer can be stored at room 
temperature for up to two weeks.
c. Stock Sodium Chloride (3.0M)
175.3g NaCl (AnalaR) was dissolved in 1 litre with distilled water.This buffer can 
be stored at room temperature up to two weeks.
d. Stock Triton X-100 (10% w/v)
lO.OOg Triton X-100 (AnalaR grade or purer) was added to approximately 80ml 
distilled water and mixed by gentle rotation or stirring. The solution was then 
made up to 100.00 ml with distilled water. This buffer can be stored at 4°c for up 
to two months.
3. Procedures for Analysis
Preparation Prior to Analysis
A. Preparation of the Wash Buffer
50 ml stock sodium phosphate buffer and 50 ml stock sodium chloride buffer was 
diluted to 1 litre with double distilled water. 150 ml was removed for the 
preparation of the assay buffer. To the 850 ml left, 0.85 ml Triton X I00 was 
added. One litre of this buffer was adequate for two microtitre plates.
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B. Preparation of the Assay Buffer
This buffer is used on the day of preparation and hence was made fresh. 100 ml of 
assay buffer is adequate for TWO plates (ie 50ml for one plate) excluding the 
volume required for preparation of the standards. When standards were made fresh, 
150 ml of assay buffer is required. The assay buffer was prepared by adding 0.5g 
of sodium salicylate, and 4 ml of reconstituted EIA freeze dried protein matrix 
(obtained from NETRIA diluted with 18 ml purified water) to 100 ml of buffer (the 
150 ml extracted from the wash buffer above).
C. Reconstituting the Prepared Samples
The urine samples were reconstituted by addition of 100 pi assay buffer to the 
glass tube and left to soak for a few minutes.The samples were then vortexed to 
ensure that all cortisol present in the sample was in solution. This part of the 
extraction process introduces a dilution factor of 2. It was assumed that the 
extraction is 100% efficient.
D. Preparing Fresh Cortisol Standards
For urine samples it is important that the standard curves are sensitive enough at 
the lower concentrations to measure the exceeding low levels,
a. To one standardised vial containing cortisol (Sigma Chemical Co, UK) (which 
contains exactly 53 pg cortisol) 73 pi 100% ethanol was added accurately to the 
bottom of the vial (pipette the ethanol a couple of timed so that the air space in 
the tip and pipette is saturated with the ethanol). The vial was capped quickly to
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prevent evaporation.
b. 14.93 ml of assay buffer containing EIA protein matrix or 5% freeze dried saliva 
was then added and mixed by inversion.
c. 1.5ml of the above solution was pipetted into a clean tube and 5.8 ml assay 
buffer added, containing the EIA buffer to give the stock solution. The 
concentration o f  cortisol was now 2000 nM.
d. Serial dilutions are made to the stock solution using the assay buffer (containing 
EIA) as follows
To 0.4ml of 2000 nM, add 0.6ml assay buffer -—> cortisol = 800 nM
To 0.5ml of 800 nM, add 0.5ml assay buffer--------- > cortisol = 400 nM
To 0.5ml of 400 nM, add 0.5ml assay buffer-------> cortisol = 200 nM
To 0.5ml of 200 nM, add 0.5ml assay buffer —-----> cortisol =100 nM
To 0.5ml of 100 nM, add 0.5ml assay buffer------------- > cortisol = 50 nM
To 0.5ml of 50 nM, add 0.5ml assay buffer — -------- > cortisol = 25 nM
To 0.5ml of 25 nM, add 0.5ml assay buffer------------ > cortisol = 12.5 nM
To 0.5ml of 12.5nM, add 0.5ml assay buffer------- > cortisol = 6.25nM
To 0.5ml of 6.25 nM, add 0.5ml assay buffer > cortisol = 3.125nM
To 0.5ml of 3.125 nM add 0.5ml assay buffer------- > cortisol = 1.5625 nM
For Urine samples, the standards between 800 nM and 1.625 nM were used.
E. Preparing the HRP conjugated cortisol
The horse radish peroxidase (HRP) conjugated cortisol was obtained fresh from
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NETRIA (stored at 4 °c) and centrifuged before diluting 5 pi in 25ml with the
assay buffer/EIA protein matrix/sodium salicylate. This was adequate for one plate.
Procedures for the Assay
1. All the buffers and reagents were at room temperature before setting up the
assay.
a The number of strips required for the analysis (all standards and samples are
measured in duplicate) were obtained from the microtitre plate. (The plates 
are obtained from NETRIA and contain 12 x 8 donkey anti sheep 
immunoglobulin-sheep anti-cortisol antibody coated wells).
b. The following were added to each w e ll:
Sample/Standard 20 p 1/well
HRP-cortisol in assay buffer 200 p 1/well
c. The wells were then incubated, covered for two hours at room temperature
in the dark. The plates were gently shaken during the incubation period.
d. After incubation, the wells were aspirated and washed thoroughly with the 
wash buffer. Then the wells were tapped out firmly to dryness on absorbent 
tissue paper. This last stage is very important. The plate was now ready for 
development.
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2. Developing the Plate
This stage ie plate development takes 20 minutes. All refrigerated reagents were 
warmed to room temperature before use.
A. Fresh substrate buffer (1M sodium acetate/citrate, pH 6.2 containing 13mM 
H20 2, obtained from NETRIA) was diluted 1 in 10 ie 2.5ml stock buffer in 25ml 
double distilled water.
B. 0.25 ml of stock 3 ,35 ,5 '-tetramethylbenzidine (TMB) solution (obtained from 
NETRIA) was diluted 100 fold by addition to 25ml of fresh substrate buffer. The 
diluted TMB solution was then gently mixed by inversion.
C. Immediately, the TMB substrate solution was poured into a CLEAN reagent 
trough. 200pi of the substrate was dispensed into each well AT TIMED 
INTERVALS (eg. 5 seconds).
D. The wells were then covered and incubated for 20 minutes with shaking. A 
blue colour ( A ^  655nm,370nm) developed.
E. The enzymatic reaction was stopped by the addition of 50pl of 2.5M H2S04 
(BDH AnalaR), to each well using a multi-channel pipette. Acid addition was 
made at the same timed intervals as the addition of the TMB substrate, such that 
the time of incubation was identical for each well. The acid was added with 
sufficient force to effect instant mixing and stopping of the enzymatic reaction; the 
process was then finished by shaking the plate briefly to ensure the well contents 
are fully mixed. A yellow colour appeared (Amax 450nm).
F. The plate was then read by an Anthos microplate spectrophotometer 
preprogrammed to read at 450nm with a reference wavelength at 620 or 650 nm.
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The data was stored for subsequent retrieval. A report was produced of the 
measurement data , the standard curve and an evaluation of the coefficient of 
variation (cv) (which reflects the degree of accuracy of repetition of the samples, 
which were assayed in duplicate. An acceptable cv was 10% or less. The standard 
curve was calculated to fit based on a 4 parameter fit method. In the case of the 
occasion when the standards did not fit the model, they were rejected and the curve 
and results reevaluated.
G. Quality Control
The inter-assay and intra assay coefficients of variation were determined at 5.44% 
and 4.61%.
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APPENDIX 12
Consent Form Used in Studies A to G
CONSENT FORM
(name)
of ..................................................................................... (address)
confirm that I have received full details of the Research Study into
Eating
Control in Women from Sarah Brien. I am aware that I am under no
obligation to fully complete the study, and can leave the study with
prior
notice.
Signed
Dated
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APPENDIX 13
Questionnaire for the Completion of Study A 
CONFIDENTIAL
FORM ONE : Research Study into the link between Eating and Mood
Name
Age
Address
Weight
Please read the following statements, and answer the question at the end of the 
statements
(1) That you are aged between 20 to 40 years of age
(2) That you are not currently suffering from an eating disorder, depression or
drinking problem, and that you have never had a history of these conditions
(3) That you have no current or previous history, of any major clinical
condition
(4) That you are not currently pregnant, nor currently breastfeeding
(5) That you are not currently on a weight reducing diet, nor a specific diet for
any medical condition
(6) That you are not currently working shifts
(7) That you are free from all chronic medication (including the contraceptive
pill)
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Please answer :
I can/ can not confirm that I agree to the seven statements written above.
In addition, please answer the following questions, giving as much information as 
you can.
(1) Are you still ovulating?
(2) When was you last period ?
(3) Are your periods regular ?
If so, what is the normal length?
Please provide the dates (if you have them) for you last six months menstrual 
cycles below?
(4) If  your cycles are not regular, when did they become irregular?
(5) Have you ever been diagnosed as suffering from a gynaecological disorder? 
If so, please give details.
Are you currently taking any medication for this disorder? Please state.
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APPENDIX 14
Subjective Appetite Questionnaire for Study A
APPETITE RATING SCALES
Please answer the following questions concerning your appetite. Please tick a 
box for each question which best describes how you are feeling now. Do not 
spend too long thinking about your answers, your initial feelings will be the 
most accurate. Complete question 5 by ticking of on the checklist of foods 
presented, what you feel like eating NOW. Do NOT select items on the basis 
of choosing a meal but consider each food independently. Choose as many, or 
as few items as you wish. If there is a food item that you particularly wish to 
eat but is not listed, please note under "Others".
L How strong is your desire to eat at present?
Very
strong Strong Slight Nil□ □ □ □
□ □ □ □
□ □ □ □
□ □ □ □
2. How hungry are you now?
3. How full do you feel ?
O '
4. How mu^h food do you think you can eat now?
5. Below is a checklist consisting of 32 common food items. Please tick which 
foods you would like to eat now. You may tick as many items as you wish. 
Remember that you should NOT select items on the basis of choosing a meal but 
consider each food independently. If  there is an item of food that you feel like 
eating, but is not listed, please note under "Others".
□  white/brown roll
□  half avocado
□  lean grilled gammon
□  small green salad
□  liquorice allsorts
□  large packet o f crisps
□  portion o f cottage cheese
□  bowl o f grapes
□  baked potato
□  pot o f Greek yoghurt
□  portion o f tinned salmon
□  two sticks o f celery
□  currant bun
□  portion of Cheddar cheese
□  grilled rump steak
□  slice o f melon
□  bowl o f baked beans Others.
□  slice o f cheesecake
□  roasted chicken breast
□  two pickled onions
□  slice of jam  sponge
□  two lemon pancakes
□  dish o f prawns
□  fresh pineapple
□  bowl o f fried rice
□  fried mushrooms
□  grilled cod fillet
□  fresh strawberries
□  tinned fruit salad
□  Cadburys flake
□  lentil or chickpea dahl
□  bowl of mixed peppers
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APPENDIX 15
Macronutrient content of all food items listed in the appetite
questionnaire checklist in Study A
CATEGORY Energy (Kcal) % CHO %  Protein %  Fat
High CffWrofaft
white/brown roll 200 74.0 10.0 16.0
liquorice allsorts 175 88.2 5.0 6.3
baked potato 218 87.4 11.5 1.3
currant bun 220 67.7 22.5 9.8
bowl o f  baked beans 180 60.8 32.1 3 21
slice o f  jam  sponge 200 79.7 5.6 5.6
bowl o f  fried rice 190 58.7 12.5 1 25
tinned fruit salad 180 98.7 1.3 1.3
M ean 195.3 76.9 12.4 10.6
Std 17.23 14.17 9.41 10.09
H ich Fat 
H alf avocado 180 3.0 7.0 89.0
Large pkt crisps 200 34.7 4.7 60.6
Pot Greek Yoghurt 183 6.0 22.0 71.0
Portion Cheddar Cheese 225 0.0 25.6 74.4
Slice Cheesecake 210 21.4 4.0 74.6
Two lemon pancakes 210 3 2 9 9.8 57.3
Fried mushrooms 180 0.0 4.3 95.7
Cadburys Flake 180 42.0 6.4 51.6
M ean 196.0 17.5 10.5 71.77
Std 17.67 17.34 8.49 15.24
H ieh  Protein
Lean grilled gammon 200 0.0 50.2 49.8
Portion cottage cheese 220 8.0 56.2 34.8
Portion o f tinned salmon 185 0.0 52.4 47.6
Grilled rump steak 
R oast chicken breast 205 0.0 68.0 3 2 0
D ish o f  prawns 200 0.0 74.6 25.4
G rilled cod fillet 180 0.0 84.7 15.3
Lentil/chickpea dahl 180 0.0 87.7 12.3
180 8.7 54.9 36.6
M ean
Std 194.5 2.1 66.1 31.85
14.16 3.87 14.89 13.66
Low E nerev  
Sm all green salad 
Bowl o f  g rapes '
2  Sticks celery 
Slice o f  melon 
Tw o pickled onions 
Fresh pineapple 
Fresh strawberries 
Bow l mixed peppers
M ean
Std
6
6310
25
8
37
20
3
21.5
20.26
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APPENDIX 16
Instructions for the Completion of the Food Diarv in Study B
Keeping a Food Diary
To identify your food intake during this study, I have asked you to keep a diary of all those foods and drinks 
that you have consumed on those days of the study that you have been selected to participate. Below are a list 
of guidelines that will help you to successfully complete a diary. To enable me to identify correctly what you 
have eaten please be specific and accurate as possible, recording all food and drinks that you have consumed. 
At the end of the study, I will be able to give you a summary of your total daily calorific intake, from which 
foods you get your calories from, as well as giving more specific information of any deficiencies you may 
have for certain vitamins and minerals.
Guidelines
1. Try to fill in your diary every time you eat or drink.
2. Note the time of the meal, snack or drink in the column of the sheets provided.
3. Where possible, WEIGH in grammes, ounces or mis, all foods and drinks and record on the diary sheets. In 
situations where this is not possible (eg when eating away from home), please provide details of portion sizes 
eg teaspoon (tsp), dessertspoon (dsp), tablespoon (tbsp), cup, mug, dessert bowl, slice etc.
4. Be specific about the foods you have eaten. For example, the type of bread consumed should be described as 
either white, brown, wholemeal, granary, slimmers, grain, roll (small or large), baguette. Type of cheese; 
cheddar; low fat, vegetarian, goat cheese, cottage cheese, soft (Brie) or hard, mild, medium or mature, spreads.
5. Describe the method used to cook eg boiled, poached, fried, steamed, grilled, oven cooked. If fat has been
added, then please state the type and estimate of the amount of fat used.
6. Also on the diary please note if the food has been homeprepared (H) or purchased from a shop (S), 
restaurant (R) or takeaway (T). If the food has been made at home, please provide the recipe and/or 
constituents and the number of portions this meal provided. If the food was prepacked eg frozen lasagna, 
packet of crisps, then please keep the wrapper which gives the dietary information. (For small common items 
such as crisps and bars of chocolate, please note the manufacturers name and size; there is no need to keep 
packaging for these items).
For those items of food that you eat regularly, only provide the recipe the first time you eat it, so you can refer 
to it if you eat it on another day. However, do note the portion size on subsequent occasions when you eat it, 
especially if it has changed.
7. All drinks (including alcoholic ones) should be written down. For alcoholic drinks, please note the type, any 
mixers added, and the volume consumed.
8. In the column provided, write down any other comments such as what food was left over.
9. At the end of the day, look back through your diary to check you have included everything you have eaten
that day.
10. Make sure you have put your name, the date, the day of the week on each sheet completed.
If you need any more help, or you have run out of diaiy sheets, please do contact me either at work (081 392 
3561) or at home (081 874 5823). If I am not there, then leave a message and your telephone number so I can 
call you back.
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APPENDIX 17
A Food Diary Sheet for Entering All Food and Drinks Consumed in a
24 Hour Period
DAILY FOOD DIARY
TIME FOOD/DRINK PORTION WEIGHT COMMENTS
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APPENDIX 18
Subjective Appetite Questionnaire for Study B
Please complete the following questions around one and half hours alter your evening meal. 
Answer the question based on what you feel is the right answer - do not refer to your food diary. 
To answer the questions, please cross a vertical line on the visual analogue scale, at the place 
which best reflects your answer. For example, if  you felt you ate more food than usual, you would 
mark a line towards the right hand side o f the scale as indicated below.
Less than usual-------------------------------------------   More than usual
Questions
1. Do you feel you ate exactly what food(s) you wanted to today?
Not at all--------------------------------------------------------------------------Very much so
2. Do you feel you ate as much as you wanted to today?
Not at all--------------------------------------------------------------------------Very much so
3. Do you feel that you ate more than usual today?
Not at all--------------------------------------------------------------------------Very much so
4. Did you (or do you) crave a certain food today?
Not at all-------------------------------------------------■-------------------------Very much so
5. How strong is your desire to eat now?
Very strong--------------------------------------------------------------------------- Very weak
6. How hungiy do you feel now?
Very much-------------------------------------------------------------------------- Not at all
7. How full do you feel now?
Very full-------------------------------------------------------------------------- Not at all
8. How much food do you think you could eat now?
A large amount------------------------------------------------    None at all
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APPENDIX 19
General Daily Questionnaire for Study B
Please place a vertical line across the scale below to indicate what type o f day you have had overall 
today. The scale represents the maximum range o f feelings possible. For example, i f  you felt your 
relationship with your friends today was as normal, please make a line through the mid point o f the 
scale. However, if  you had an upsetting argument with your friends, mark the line towards the left 
hand o f the scale.
1. How much did you exercise today?
Less than norm al-------------------------------------------------------------------------- Greater than
normal
2. Did you feel stressed/hassled today?
Not at all--------------------------------------------------------------------------Very much so
3. How was your relationship with family/paitners/close friends today?
4. How did you physically feel today?
Very bad------------------------------------------------------------------------ Very good
5. Did you feel you were assertive today?
Not at all— •Very much so
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APPENDIX 20
An Abnormal and Normal Hormone Profile During the Menstrual
Cycle
Graph Show ing Abnorm al 
Horm onal levels During the M enstrual Cycle
Subject 34 
Average cycle length 36 days
■ -  crealmnie adjusted value
Day of Cycle
Graph Show ing Normal 
Horm onal levels During the M enstrual Cycle
Subject 8 
Average cycle length 30 days
3224 31 3313 22 231223 112213 211211
lE G c
P G c
ILHc
12
10
8
6
4
2
0
10 11 17 18 19 23 24 25 76 8 18 19 20 25 26 279
c creatinine adjured value
Day of Cycle 
U 4-
2-5
1.5 lE G c
P G c
ILHc
0.5
APPENDIX 21
Results Tables
The following tables identify the results from correlations between the various 
variables assessed in Chapters Eight to Eleven. All the following tables were 
analysed by Spearman's rank correlational tests, with the exception of tables IB, 19, 
22, 23, 25, 26, 28, 29 and 31 (parts a, b and c) which were analysed by Pearson’s 
correlational tests. The results presented in the following tables report subject 
numbers; in all analyses, there are two degrees of freedom. Carrying out so many 
correlational analyses may give rise to a Type I error^ ie identifying as significant 
findings, that may have arisen by chance. Therefore, caution is required in the 
interpretation of these results.
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Table la. Correlations between Actual Dietary Intake. Stress and External Factors
During the Follicular Stage of the Mean of both cycles
Other Factors/ 
Dietary Intake
Exercise Stressed/
Hassled
Relationships Physical
health
Assertiveness
KCal r=O.048
n=32
p=0.794
r=-0.165 -
n=32
p=0.368
i=-0.039
n=32
p=0.834
r=-0.086
n=32
p=0.639
r=-0.064
n=32
p=0.728
Protein (g) r=-0.025
n=32
p=0.891
r=-0.214
n=32
p=0.240
r=0.055
n=32
p=0.767
r=0.087
n=32
p=0.636
r=0.031
n=32
p=0.866
Fat (g) i=0.031
n=32
p=0.867
r=-0.122
n=32
p=0.507
r=-0.014
n=32
p=0.941
r=-0.102
n=32
p=0.577
r=0.004
n=32
p=0.981
CHO (g) r=0.074
n=32
p=0.689
r=-0.088
n=32
p=0.632
r=-0.078
n=32
p=0.671
r=-0.105
n=32
p=0.568
r=-0.128
n=32
p=0.484
Sugar(g) r=0.190
n=32
p=0.298
r=-0.087
n=32
p=0.636
r=-0.075 
n=32 ' 
p=0.683
r=-0.052
n=32
p=0.776
r=-0.143
n=32
p=0.435
Starch (g) r=-0.033
n=32
p=0.857
r=0.030
n=32
p=0.872
r=-0.154
n=32
p=0.401
r=-0.018
n=32
p=0.924
r=-0.009
n=32
p=0.959
T/LNAA r=0.062
n=32
p=0.737
i=-0.133
n=32
p=0.468
r=0253
n=32
p=0.163
r=0.060
n=32
p=0.746
r=0.362
n=32
p=0.042*
% Fat r=-0.067
n=32
p=0.717
i=0.091
n=32
p=0.622
r=-0.078
n=32
p=0.670
r=-0.085
n=32
p=0.645
r=0.005
n=32
p=0.979
% Protein r=0.078
n=32
p=0.673
r=-0.069
n=32
p=0.708
r=0.010
n=32
p=0.956
i=0.391
n=32
p=0.027
i=0.098
n=32
p=0.593
% CHO r=0.097
n=32
p=0.598
i=0.114
n=32
p=0.533
r=-0.135
n=32
p=0.463
r=0.048
n=32
p=0.796
r=0.023
n=32
p=0.903
% Sugar r=0.232
n=32
p=0.202
r=-0.046
n=32
p=0.803
r=0.045
n=32
p=0.808
r=-0.069
n=32
p=0.707
i=-0.097
n=32
p=0.597
% Starch r=-0.132
n=32
p=0.473
r=0.333
n=32
p=0.062
r=-0280
n=32
p=0.121
r=0.095
n=32
p=0.606
r=0.096
n=32
p=0.601
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Table lb. Correlations between Actual Dietary Intake. Stress and External Factors
During the Luteal Stage of the Mean of both cycles
Other Factors/ 
Dietary Intake
Exercise Stressed/
Hassled
Relationships Physical
health
Assertiveness
KCal r=0.186
n=32
p=0.308
r=-0.182
n=32
p=0.320
r=0.183
n=32
p=0.317
r=-0.118
n=32
p=0.521
r=0.222
n=32
p=0.223
Protein (g) r=0.172
n=32
p=0.348
r=-0.145
n=32
p=0.429
r=0.230
n=32
p=0.206
r=0.025
n=32
p=0.891
r=0.256
n=32
p=0.157
Fat (g) r=-0.003
n=32
p=0.987
r=-0.200
n=32
p=0.272
r=0.285
n=32
p=0.115
r=-0.178
n=32
p=0.329
r=0.157
n=32
p=0.391
CHO (g) r=0.218
n=32
p=0.231
r=-0.182
n=32
p=0.320
r=0.190
n=32
p=0.296
r=-0.006
n=32
p=0.976
r=0.128
n=32
p=0.484
Sugar(g) r=0.098
n=32
p=0.595
r=-0.044
n=32
p=0.811
r=0.U4
n=32
p=0.534
r=0.009
n=32
p=0.962
r=0.004
n=32
p=0.983
Starch (g) r=0.194
n=32
p=0.288
r=-0.219
n=32
p=0.228
r=0.100
n=32
p=0.586
r=0.015
n=32
p=0.937
r=0.248
n=32
p=0.171
T/LNAA r=0.130
n=32
p=0.476
r=0.032
n=32
p=0.862
r=0.142
n=32
p=0.437
r=0.042
n=32
p=0.820
r=0.133
n=32
p=0.467
% Fat p=-0.097
n=32
p=0.599
r=-0.325
n=32
p=0.069
r=0.140
n=32
p=0.446
r=-0.174
n=32
p=0.341
r=0.011
n=32
p=0.950
% Protein r=-0.085
n=32
p=0.642
r=0.037
n=32
p=0.842
r=0.066
n=32
p=0.718
r=0.142
n=32
p=0.440
r=0.010
n=32
p=0.959
% CHO r=0.060
n=32
p=0.744
r=0.046
n=32
p=0.805
r=-0.131
n=32
p=0.473
r=0.093
n=32
p=0.612
r=-0.054
n=32
p=0.769
% Sugar r=-0.065
n=32
p=0.723
r=0.130
n=32
p=0.477
r=-0.018
n=32
p=0.921
r=0.010
n=32
p=0.956
r=-0.191
n=32
p=0.296
% Starch r=0.131
n=32
p=0.474
r=-0.027
n=32
p=0.882
r=-0.284 
n=32 ■ 
p=0.115
r=0.061
n=32
p=0.740
r=0.095
n=32
p=0.604
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Table lc. Correlations between Actual Dietary Intake. Stress and External Factors
During the Premenstrual Stage of the Mean of both cycles
Other Factors/ 
Dietary Intake
Exercise Stressed/
Hassled
Relationships Physical
health
Assertiveness
KCal r=0.085
n=32
p=0.642
r=-0.136
n=32
p=0.460
r=0.065
n=32
p=0.726
r=0.010
n=32
p=0.957
r=-0.253
n=32
p=0.163
Protein (g) i=0.124
n=32
p=0.498
r=-0.327
n=32
p=0.068
r=0.237
n=32
p=0.191
r=0.000
n=32
p=0.998
r=-0.009
n=32
p=0.629
Fat (g) r=0.118
n=32
p=0.519
r=0.083
n=32
p=0.651
1=0.028
n=32
p=0.88I
r=-0.142
n=32
p=0.440
r=-0.278
n=32
p=0.124
CHO (g) r=0.035
n=32
p=0.850
r=-0.093
n=32
p=0.613
r=0.004
n=32
p=0.983
r=0.071
n=32
p=0.700
r=-0.154
n=32
p=0.400
Sugar(g) r=0.077
n=32
p=0.675
r=-0.092
n=32
p=0.619
r=0.099
n=32
p=0.589
r=0.127
n=32
p=0.489
r=-0.230
n=32
p=0.205
Starch (g) r=-0.010
n=32
p=0.955
r=0.030
n=32
p=0.870
r=-0.125
n=32
p=0.495
r=-0.064
n=32
p=0.729
r=-0.068
n=32
p=0.713
T/LNAA r=-0.137
n=32
p=0.454
r=-0.142
n=32
p=0.437
r=0.008
n=32
p=0.963
r=0.187
n=32
p=0.307
r=0.089
n=32
p=0.629
% Fat r=-0.031
n=32
p=0.865
r=0.256
n=32
p=0.158
r=-0.098
n=32
p=0.595
r=-0.221
n=32
p=0.225
r=-0. I l l
n=32
p=0.546
% Protein i=0.102
n=32
p=0.577
r=-0.204
n=32
p=0.264
r=0.016
n=32
p=0.933
r=-0.147
n=32
p=0.423
r=-0.015
n=32
p=0.936
% CHO i=-0.123
n=32
p=0.502
r=-0.074
n=32
p=0.686
r=-0.129
n=32
p=0.481
r=0.069
n=32
p=0.709
r=0.068
n=32
p=0.714
% Sugar i=0.032
n=32
p=0.860
r=-0.057
n=32
p=0.758
r=0.141
n=32
p=0.441
r=0.144
n=32
p=0.433
r=-0.039
n=32
p=0.832
% Starch r=-0.155
n=32
p=0.397
r=0.081
n=32
p=0.658
r=>0.359
n=32
p=0.044
r=-0.096
n=32
p=0.601
r=0.099
n=32
p=0.589
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Table 2 a. Correlations between Actual Dietary Intake. Stress and External Factors
During the Follicular Stage of Cycle One
Other Factors/ 
Dietary Intake
Exercise Stressed/
Hassled
Relationships Physical
health
Assertiveness
KCal i=0.251
n=30
p=0.181
r=-0.099
n=30
p=0.601
r=-0.019
n=30
p=0.920
i=0.126
n=30
p=0.508
r=-0.135
n=30
p=0.477
Protein (g) r=0.189
n=30
p=0.317
r=-0.142
n=30
p=0.454
r=0.161
n=30
p=0.395
i=0.167
n=30
p=0.377
r=0.059
n=30
p=0.758
Fat (g) r=0.069
n=30
p=0.717
r=-0.160
n=30
p=0.399
r=0.034
n=30
p=0.859
i=0.I67
n=30
p=0.377
r=-0.171
n=30
p=0.367
CHO (g) r=0.319
n=30
p=0.086
r=0.004
n=30
p=0.981
r=-0.095
n=30
p=0.618
r=0.049
n=30
p=0.797
r=-0.142
n=30
p=0.454
Sugar(g) r=0.356
n=30
p=0.053
r=-0.104
n=30
p=0.584
r=-0.018
n=30
p=0.925
i=0.111
n=30
p=0.558
r=-0.247
n=30
p=0.I88
Starch (g) r=0.059
n=30
p=0.759
r=0.033
n=30
p=0.862
i=-0.132
n=30
p=0.488
r=0.088
n=30
p=0.642
r=-0.031
n=30
p=0.873
T/LNAA r=0.023
n=30
p=0.906
r=-0.322
n=30
p=0.083
r=0.227
n=30
p=0.227
1=0.270
n=30
p=0.149
r=0.282
n=30
p=0.132
% Fat r=-0.32
n=30
p=0.077
r=-0.146
n=30
p=0.442
r=0.127
n=30
p=0.503
i=0.072
n=30
p=0.706
i=0.013
n=30
p=0.944
% Protein r=0.120
n=30
p=0.529
r=0.058
n=30
p=0.761
1=0.121
n=30
p=0.526
i=0.153
n=30
p=0.420
1=0.175
n=30
p=0.354
% CHO f =0.169
n=30
p=0.373
r=0.082
n=30
p=0.666
i=-0.222
n=30
p=0.239
r=-0.069
n=30
p=0.716
r=-0.029
n=30
p=0.878
% Sugar i=0.219
n=30
p=0.245
r=-0.105
n=30
p=0.581
1=0.033
n=30
p=0.863
r=0.051
n=30
p=0.790
r=-0.209 , 
n=30
p=0.268
% Starch r=-0.084
n=30
p=0.658
1=0.276
n=30
p=0.141
i=-0.341
n=30
p=0.065
r=-0.183
n=30
p=0.333
r=0.159
n=30
p=0.401
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Table 2 b. Correlations between Actual Dietary Intake. Stress and External Factors
During the Luteal Stage of Cycle One
Other Factors/ 
Dietary Intake
Exercise Stressed/
Hassled
Relationships Physical
health
Assertiveness
KCal r=0.114
n=29
p=0.556
r=-0.243
n=29
p=0.203
i=0.213
n=29
p=0.268
r=-0.017
n=29
p=0.928
r=0.051
n=29
p=0.795
Protein (g) i=0.125
n=29
p=0.520
r=-0.086
n=29
p=0.658
r=0.124
n=29
p=0.521
r=0.114
n=29
p=0.555
r=0.158
n=29
p=0.413
Fat (g) r=0.049
n=29
p=0.802
r=-0.228
n=29
p=0.234
r=0.272
n=29
p=0.153
r=-0.125
n=29
p=0.519
r=-0.002
n=29
p=0.993
CHO (g) r=0.055
n=29
p=0.777
r=-0.223
n=29
p=0.246
r=0.153
n=29
p=0.427
r=0.022
n=29
p=0.911
r=-0.050
n=29
p=0.797
Sugar(g) r=-0.118
n=29
p=0.542
r=0.003
n=29
p=0.986
r=0.120
n=29
p=0.535
r=0.137
n=29
p=0.479
r=0.089
n=29
p=0.645
Starch (g) i=0.061
n=29
p=0.753
r=-0.315
n=29
p=0.096
r=0.085
n=29
p=0.662
i=-0.026
n=29
p=0.895
r=-0.013
n=29
p=0.946
T/LNAA r=0.118
n=29
p=0.543
r=0.017
n=29
p=0.929
r=0.174
n=29
p=0.366
r=0.099
n=29
p=0.609
r=0.197
n=29
p=0.305
% Fat r=-0.327
n=30
p=0.077
r=-0.146
n=30
p=0.442
r=0.127
n=30
p=0.503
r=0.072
n=30
p=0.706
r=0.013
n=30
p=0.944
% Protein i=-0.075
n=29
p=0.699
r=0.221
n=29
p=0.249
r=-0.153
n=29
p=0.428
r=0.067
n=29
p=0.728
r=0.042
n=29
p=0.830
% CHO i0.004
n=29
p=0.984
r=-0.113
n=29
p=0.558
r=-0.089
n=29
p=0.645
r=0.100
n=29
p=0.607
r=-0.047
n=29
p=0.810
% Sugar r=-0.222
n=29
p=0248
r=0.237
n=29
p=0.217
r=-0.006
n=29
p=0.977
r=0.193
n=29
p=0.315
r=0.152
n=29
p=0.431
% Starch r=0.038
n=29
p=0.845
r=-0.272
n=29
p=0.154
r=-0.099
n=29
p=0.610
r=*0.080
n=29
p=0.682
r=-0.068
n=29
p=0.726
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Table 2 c. Correlations between Actual Dietary Intake. Stress and External Factors
During the Premenstrual Stage of Cycle One
Other Factors/ 
Dietary Intake
Exercise Stressed/
Hassled
Relationships Physical
healdi
Assertiveness
KCal r=0.I37
n=30
p=0.471
r=
n=
P=
r=0.053
n=30
p=0.780
r=-0.168
n=30
p=0.376
r=-0.317
n=30
p=0.088
Protein (g) i=0.022
n=30
p=0.908
r=-0.412
n=30
p=0.024
r=0.141
n=30
p=0.457
r=-0.028
n=30
p=0.884
r=-0.114
n=30
p=0.547
Fat (g) r=0.006
n=30
p=0.974
r=-0.111
n=30
p=0.560
1=0.031
n=30
p=0.872
r=-0.079
n=30
p=0.677
r=-0.286
n=30
p=0.126
CHO (g) i=0.053
n=30
p=0.779
r=-0.145
n=30
p=0.445
r=-0.042
n=30
p=0.827
r=-0.143
n=30
p=0.451
r=-0.248
n=30
p=0.187
Sugar (g) r=0.094
n=30
p=0.622
r=-0.073
n=30
p=0.701
r=0.118
n=30
p=0.534
r=-0.054
n=30
p=0.776
x=-0.169
n=30
p=0.372
Starch (g) r=*0.025
n=30
p=0.895
r=-0.104
n=30
p=0.586
r=-0.233
n=30
p=0216
r=-0.198
n=30
p=0.294
r=-0.059
n=30
p=0.756
T/LNAA r=0.027
n=30
p=0.890
r=-0.184
n=30
p=0.331
r=0.048
n=30
p=0.801
r=0.182
n=30
p=0.335
i=0.129
n=30
p=0.497
% Fat r=-0.145
n=30
p=0.446
r=0.071
n=30
p=0.708
r=0.040
n=30
p=0.833
r=0.022
n=30
p=0.910
i=-0.079
n=30
p=0.678
% Protein r=0.100
n=30
p=0.958
r=-0.181
n=30
p=0.338
r=0.069
n=30
p=0.717
r=0.250
n=30
p=0.182
1=0.243
n=30
p=0.196
% CHO r=-0.110
n=30
p=0.564
r=0.060
n=30
p=0.752
r=-0.195
n=30
p=0.301
r=-0.140
n=30
p=0.460
r=0.084
n=30
p=0.660
% Sugar r=-0.036
n=30
p=0.851
i=-0.050
n=30
p=0.792
r=0.045
n=30
p=0.814
r=-0.118
n=30
p=0.534
r=0.140
n=30
p=0.462
% Starch r=-0.077
n=30
p=0.685
r=0.209
n=30
p=0.268
r=-0.373
n=30
p=0.043
r=-0.053
n=30
p=0.783
r=0.077
n=30
p=0.685
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Table 3 a. Correlations between Actual Dietary Intake/Stress and External Factors
During the Follicular Stage of Cycle Two
Other Factors/ 
Dietary Intake
Exercise Stressed/
Hassled
Relationships Physical
health
Assertiveness
KCal r=0.198
n=24
p=0.353
r=-0.344
n=24
p=0.100
r=-0.049
n=24
p=0.820
r=0.090
n=24
p=0.677
r=0.146
n=24
p=0.496
Protein (g) r=0.200
n=24
p=0.349
r=-0.294
n=24
p=0.164
r=0.137
n=24
p=0.523
r=0.356
n=24
p=0.088
r=0.293
n=24
p=0.165
Fat (g) r=0.157
n=24
p=0.465
r=-0.189
n=24
p=0.377
r=-0.002
n=24
p=0.994
r=-0.056
n=24
p=0.796
r=0.042
n=24
p=0.846
CHO (g) r=0.126
n=24
p=0.558
r=-0.245
n=24
p=0.248
r=-0.030
n=24
p=0.888
r=0.160
n=24
p=0.455
r=0.145
n=24
p=0.498
Sugar (g) r=-0.057
n=24
p=0.790
r=-0.285
n=24
p=0.177
r=-0.0i3
n=24
p=0.952
r=0.044
n=24
p=0.840
r=0.031
n=24
p=0.885
Starch (g) i=0.213
n=24
p=0.318
r=-0.152
n=24
p=0.479
r=-0.113
n=24
p=0.600
r=0.178
n=24
p=0.405
i=0.177
n=24
p=0.407
T/LNAA r=-0.233
n=24
p=0.274
r=0.062
n=24
p=0.774
r=0.222
n=24
p=0.298
r=-0.124
n=24
p=0.563
r=-0.101
n=24
p=0.639
% Fat r=0.100
n=24
p=0.963
r=0.313
n=24
p=0.137
r=-0.174
n=24
p=0.416
r=-0.309
n=24
p=0.142
r=-0.219
n=24
p=0.304
% Protein r=0.114
n=24
p=0.594
r=-0.217
n=24
p=0.308
r=0.357
n=24
p=0.087
r=0.655
n=24
p=0.001***
r=0.394
n=24
p=0.056
% CHO r=0.150
n=24
p=0.483
i=0.097
n=24
p=0.652
r=-0.132
n=24
p=0.539
i=0.069
n=24
p=0.748
r=-0.011
n=24
p=0.958
% Sugar r=-0.025
n=24
p=0.907
r=-0.120
n=24
p=0.578
r=-0.061
n=24
p=0.776
r=-0.149
n=24
p=0.487
r=-0.104
n=24
p=0.629
% Starch i=0.004
n=24
p=0.984
i=0.186
n=24
p=0.384
r=0.051
n=24
p=0.813
r=0271
n=24
p=0.200
r=0.154
n=24
p=0.473
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Table 3 b. Correlations between Actual Dietary Intake. Stress and External Factors
During the Luteal Stage of Cvcle Two
Other Factors/ 
Dietary Intake
Exercise Stressed/
Hassled
Relationships Physical
health
Assertiveness
KCal r=0.114
n=27
p=0.573
r=-0.336
n=27
p=0.087
r=0.250
n=27
p=0.208
r=-0.090
n=27
p=0.656
r=0.304
n=27
p=0.123
Protein (g) r=0.123
n=27
p=0.540
r=-0.520
n=27
p=0.005**
r=0.414
n=27
p=0.032*
r=0.062
n=27
p=0.760
r=0.261
n=27
p=0.189
Fat (g) r=0.036
n=27
p=0.860
■ r=-0.295 
n=27 
p=0 136
r=0.336
n=27
p=0.087
r=-0.130
n=27
p=0.518
r=0.169
n=27
p=0.399
CHO (g) r=0.125
n=27
p=0.534
r=-0.091
n=27
p=0.651
r=0.176
n=27
p=0.381
r=-0.103
n=27
p=0.609
r=0.186
n=27
p=0.354
Sugar (g) r=-0.029
n=27
p=0.885
r=-0.010
n=27
p=0.960
r=0.069
n=27
p=0.733
r=-0.098
n=27
p=0.628
r=0.066
n=27
p=0.744
Starch (g) r=0.112
n=27
p=0.577
r=-0.092
n=27
p=0.648
r=0.167
n=27
p=0.404
r=0.030
n=27
p=0.882
r=0.239
n=27
p=0.230
T/LNAA r=0.064
n=27
p=0.750
r=0.177
n=27
p=0.379
r=-0.348
n=27
p=0.075
r=0.142
n=27
p=0.479
r=0.300
n=27
p=0.129
%  Fat r=0.101
n=27
p=0.615
r=-0.352
n=27
p=0.071
r=0.279
n=27
p=0.159
r=0.054
n=27
p=0.788
r=0.128
n=27
p=0.524
% Protein r=0.017
n=27
p=0.932
r=-0.237
n=27
p=0.234
r=0.216
n=27
p=0.279
r=0.196
n=27
p=0.328
r=0.037
n=27
p=0.856
% CHO r=0.042
n=27
p=0.836
r=0.400
n=27
p=0.039*
r=-0.158
n=27
p=0.431
r=-0.056
n=27
p=0.783
r=-0.162
n=27
p=0.418
% Sugar r=-0.037
n=27
p=0.854
r=0.360
n=27
p=0.065
r=-0.393
n=27
p=0.043*
r=-0.195
n=27
p=0.331
r=-0.049
n=27
p=0.808
% Starch r=-0.032
n=27
p=0.876
r=0.217
n=27
p=0.276
r=0.114 
n=27 • 
p =0.573
r=0.126
n=27
p=0.533
r=-0.125
n=27
p=0.535
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Table 3 c. Correlations between Actual Dietary Intake, Stress and External Factors
During the Premenstrual Stage of Cycle Two
Other Factors/ 
Dietary Intake
Exercise Stressed/
Hassled
Relationships Physical
health
Assertiveness
KCal r=0.262
n=25
p=0.206
r=-0.278
n=25
p=0.179
r=0.155
n=25
p=0.459
r=0.401
n=25
p=0.047*
r=0.109
n=25
p=0.604
Protein (g) r=0.095
n=25
p=0.650
r=-0.052
n=25
p=0.806
r=-0.044
n=25
p=0.837
r=-0.025
n=25
p=0.907
r=0.341
n=25
p=0.096
Fat (g) r=0.359
n=25
p=0.078
r=-0.167
n=25
p=0.426
r=0.034
n=25
p=0.872
r=0.152 
n=25 
p =0.470
r=-0.074
n=25
p=0.724
CHO (g) r=0.120 
n=25 
p =0.566
r=-0.122
n=25
p=0.560
r=-0.022
n=25
p=0.919
r=0.359
n=25
p=0.078
r=0.319
n=25
0=0.120
Sugar (g) r=0.315
n=25
p=0.125
r=-0.023
n=25
p=0.913
r=0.094
n=25
p=0.655
r=0.248
n=25
p=0.233
r=-0.070
n=25
p=0.738
Starch (g) . r=0.032
n=25
p=0.881
r=0.061
n=25
p=0.774
r=-0.191
n=25
p=0.361
r=0.241
n=25
p=0.246
r=0.212
n=25
p=0.310
T/LNAA r=0.016
n=25
p=0.939
r=0.006
n=25
p=0.978
r=-0.158 
n=25 
p=0.451
r=0.215
n=25
p=0.301
r=0.007
n=25
p=0.975
% Fat r=0.083
n=25
p=0.693
r=0.062
n=25
p=0.770
r=-0.144
n=25
p=0.491
r=-0.225
n=25
p=0.280
r=-0.260
n=25
p=0.209
% Protein r=0.035
n=25
p=0.867
r=0.041
n=25
p=0.846
r=-0.069
n=25
p=0.744
r=-0.324
n=25
p=0.114
r=0.084
n=25
p=0.689
% CHO r=-0.016
n=25
p=0.938
r=0.078
n=25
p=0.712
r=-0.063
n=25
p=0.765
r=0.121
n=25
p=0.564
r=0.236
n=25
p=0.256
% Sugar r=0.156
n=25
p=0.456
r=0.022
n=25
p=0.918
r=0.161
n=25
p=0.441
r=0.276
n=25
p=0.181
r=-0.110
n=25
p=0.599
% Starch r=-0.203
n=25
p=0.331
r=0.178 
n=25 
p =0.396
r=-0.311 
n=25 . 
p=0.130
r=-0.202
n=25
p=0.334
r=0.308
n=25
p=0.134
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Table 4a Correlations between actual food intake and subjective appetite ratings
in the Follicular phase for the Mean of both cycles. Standard deviations in
parentheses.
Subjective 
/  Actual
Hunger Appetite Satiation Satiety DR- food 
type
DR-
amount
Ate more
than
wanted
Cravings
KCal r=0.014
n=32
p=0.937
r=-0.130
n=32
p=0.478
r=-0.329
n=32
p=0.065
r=0.159
n=32
p=0.394
r=-0.544
n=32
p=0.767
r=-0.114
n=32
p=0.951
r=0.027
n=32
p=0.881
r=-0.044
n=32
p=0.813
Protein (g) r=0.018
n=32
p=0.924
r=-0.014
n=32
p=0.939
r=-0.516
n=32
p=0.003
r=0.201
n=32
p=0.269
r=0.080
n=32
p=0.664
r=0.024
n=32
p=0.895
r=0.040
n=32
p=0.830
r=-0.281
n=32
p=0.119
Fat (g) r=-0.177
n=32
p=0.332
r=-0.377
n=32
p=0.034
r=-0.230
n=32
p=0.205
r=0.032
n=32
p=0.862
r=-0.193
n=32
p=0.291
r=-0.146
n=32
p=0.424
r=0.049
n=32
p=0.789
r=0.188
n=32
p=0.302
CHO(g) r=-0.029
n=32
p=0.872
r=-0.079
n=32
p=0.664
r=-0.253
n=32
p=0.162
r=0.092
n=32
p=0.619
r=-0.071
n=32
p=0.698
r=-0.062
n=32
p=0.735
r=-0.001
n=32
p=0.997
r=-0.039
n=32
p=0.833
Sugar(g) r=0.144
n=32
p=0.432
r=0.094
n=32
p=0.608
r=-0.225
n=32
p=0.215
r=0.215
n=32
p=0.236
r=-0.091
n=32
p=0.624
r=-0.014
n=32
p=0.941
r=0.014
n=32
p=0.940
r=-0.139
n=32
p=0.448
Starch (g) r=-0.227
n=32
p=0.212
r=-0.129
n=32
p=0.481
r=-0.183
n=32
p=0.316
r=-0.135
n=32
p=0.462
r=0.059
n=32
p=0.747
r=-0.047
n=32
p=0.800
r=-0.047 
n=32 
p=0.7 99
r=0.035
n=32
p=0.850
T/LNAA r=-0.071
n=32
p=0.700
r=-0.166
n=32
p=0.365
r=0.286
n=32
p=0.113
r=0.048
n=32
p=0.793
r=0.113
n=32
p=0.538
r=0.094
n=32
p=0.611
r=-0.132
n=32
p=0.473
r=0.140
n=32
p=0.446
% Fat r=-0.264
n=32
p=0.144
r=-0.482
n=32
p=0.005
r=0.043
n=32
p=0.812
r=-0.202
n=32
p=0.269
r=-0.252
n=32
p=0.164
r=-0.135 
n=32 
p=0.463
r=0.113
n=32
p=0.539
r=0.425
n=32
p=0.015
% Protein r=-0.032
n=32
p=0.860
r=0.272
n=32
p=0.132
r=-0.362
n=32
p=0.042
r=0.107
n=32
p=0.562
r=0.266
n=32
p=0.141
r=0.018
n=32
p=0.922
r=0.035
n=32
p=0.848
r=-0.305
n=32
p=0.090
% CHO r=-0.032
n=32
p=0.862
r=0.183
n=32
p=0.317
r=0.051
n=32
p=0.781
r=-0.029
n=32
p=0.875
r=0.103
n=32
p=0.574
r=-0.060
n=32
p=0.745
r=-0.216
n=32
p=0.234
r=-0.149
n=32
p=0.415
% Sugar r=0.200
n=32
p=0.271
r=0.230
n=32
p=0.205
r=0.012
n=32
p=0.949
r=0.151
n=32
p=0.409
r=-0.142
n=32
p=0.439
r=-0.094
n=32
p=0.608
r=0.010
n=32
p=0.955
r=-0.126
n=32
p=0.492
% Starch r=-0.277
n=32
p=0.125
r=-0.113
n=32
p=0.538
r=0.156
n=32
p=0.393
r=-0.380
n=32
p=0.032
r=0.258
n=32
p=0.154
r=0.059
n=32
p=0.747
r=-0.169
n=32
p=0.356
r=0.081r
n=32
p=0.661
where DR- Dietary Restraint
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Table 4b Correlations between actual food intake and subjective appetite ratings
in the Luteal phase for the Mean of both cycles. Standard deviations in parentheses.
Subjective 
/ Actual
Hunger Appetite Satiation Satiety DR- food 
type
D R-
amount
Ate more
than
wanted
Cravings
KCal r=-0.004
n=32
p=0.983
r=0.158
n=32
p=0.389
r=-0.009
n=32
p=0.962
r=0.009
n=32
p=0.963
r=-0.132
n=32
p=0.472
r=-0.034
n=32
p=0.852
r=-0.036
n=32
p=0.847
r=-0.133
n=32
p=0.468
Protein (g) r=0.268
n=32
p=0.139
r=0.451
n=32
p=0.01
r=-0.330
n=32
p=0.065
r=0.241
n=32
p=0.184
r=0.012
n=32
p=0.946
r=0.235
n=32
p=0.195
r=0.122
n=32
p=0.507
r=-0.156
n=32
p=0.393
Fat (g) r=-0.022
n=32
p=0.903
x=0.0552
n=32
p=0.764
r=-0.040
n=32
p=0.828
r=0.054
n=32
p=0.769
r=-0.286
n=32
p=0.112
r=-0.134
n=32
p=0.463
r=-0.068
n=32
p=0.711
r=0.000
n=32
p=0.000
CHO (g) r=0.010
n=32
p=0.956
r=0.209
n=32
p=0.252
r=-0.059
n=32
p=0.750
r=0.047
n=32
p=0.796
r=0.051
n=32
p=0.780
r=0.063
n=32
p=0.731
r=-0.017
n=32
p=0.925
r=-0.186
n=32
p=0.309
Sugar(g) r=0.048
n=32
p=0.794
r=0.305
n=32
p=0.090
r=-0.091
n=32
p=0.619
r=0.064
n=32
p=0.729
r=0.193
n=32
p=0.289
r=0.090
n=32
p=0.623
r=-0.048
n=32
p=0.794
r=-0.217
n=32
p=0.232
Starch (g) r=-0.014
n=32
p=0.938
r=0.070
n=32
p=0.704
r=-0.030
n=32
p=0.870
i=0.041
n=32
p=0.823
r=-0.056
n=32
p=0.760
r=0.051
n=32
p=0.780
r=0.049
n=32
p=0.788
r=-0.099
n=32
p=0.589
T/LNAA r=-0.041
n=32
p=0.822
r=0.065
n=32
p=0.724
r=-0.038
n=32
p=0.836
r=0.221
n=32
p=0.225
r=0.230
n=32
p=0.205
1=0.221
n=32
p=0.225
r=-0.154
n=32
p=0.399
r=-0.142
n=32
p=0.438
% Fat r=0.043
n=32
p=0.815
r=-0.079
n=32
p=0.667
r=-0.015
n=32
p=0.935
r=0.077
n=32
p=0.675
r=-0.169
n=32
p=0.355
r=- 0.173
n=32
p=0.343
r=-0.240
n=32
p=0.186
r=0.016
n=32
p=0.931
%  Protein r=0.192
n=32
p=0.292
r=0.221
n=32
p=0.223
r=-0.388
n=32
p=O.028
r=0.168
n=32
p=0.359
r=0.059
n=32
p=0.748
r=0.222
n=32
p=0.222
r=0.410
n=32
p=0.020
r=0.076
n=32
p=0.678
% CHO r=-0.148
n=32
p=0.420
r=-0.110
n=32
p=0.550
r=0.207
n=32
p=0.255
r=-0.149 
n=32 
p =0.416
r=0.179
n=32
p=0.328
i=-0.019
n=32
p=0.918
r=-0.011
n=32
p=0.951
r=-0.055
n=32
p=0.767
% Sugar r=-0.134 .
n=32
p=0.464
r=0.097
n=32
p=0.598
r=0.042
n=32
p=0.820
r=-0.072
n=32
p=0.694
r=0.127
n=32
p=0.490
r=0.118
n=32
p=0.522
r=0.049
n=32
p=0.791
r=-0.153
n=32
p=0.402
% Starch r=-0.083
n=32
p=0.651
r=-0.231
n=32
p=0.204
r=0.210
n=32
p=0.248
r=-0.093 
n=32 . 
p=0.614
r=0.181
n=32
p=0.323
r=-0.013
n=32
p=0.943
r=0.015
n=32
p=0.936
r=0.098 
n=32 . 
p=0.593
where DR- Dietary Restraint
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Table 4c Correlations between actual food intake and subjective appetite ratings
in the Premenstrual phase for the Mean of both cycles. Standard deviations in
parentheses.
Subjective 
/ Actual
Hunger Appetite Satiation Satiny DR- food 
type
D R-
amount
Ate more
than
wanted
Cravings
KCal r=-0.128
n=32
p=0.485
r=-0.141
n=32
p=0.441
r=0.156
n=32
p=0.395
r=-0.168 :
n=32
p=0.358
r=-0.138
n=32
p=0.452
r=0.230
n=32
p=0.205
r=-0.218
n=32
p=0.231
r=0.348
n=32
p=0.051
Protein (g) r=0.341
n=32
p=0.056
r=0.291
n=32
p=0.107
r=-0.435
n=32
p=0.013
r=0.291
n=32
p=0.107
r=0.220
n=32
p=0.225
r=0.329
n=32
p=0.066
r=0.156
n=32
p=0.395
r=-0.120
n=32
p=0.515
Fat (g) r=-0.135
n=32
p=0.462
r=-0.121
n=32
p=0.510
r=0.083
n=32
p=0.651
r=-0.149
n=32
p=0.417
r=-0.215
n=32
p=0.236
r=0.030
n=32
p=0.870
r=-0.162
n=32
p=0.375
r=0.372
n=32
p=0.036
CHO (g) r=-0.177
n=32
p=0.332
r=-0.177
n=32
p=0.332
r=0.225
n=32
p=0.216
r=-0.218
n=32
p=0.230
r=-0.169
n=32
p=.357
r=0.184
n=32
p=0.314
r=-0.121
n=32
p=0.510
r=0 272
n=32
p=0.133
Sugar (g) r=-0.047
n=32
p=0.800
r=-0.052
n=32
p=0.779
r=0.073
n=32
p=0.691
r=-0.101
n-32
p=0.581
r=-0.095
n=32
p=0.605
r=0.191
n=32
p=0.296
r=-0.037
n=32
p=0.842
r=0.151
n=32
p=0.411
Starch (g) r=-0.284
n=32
p=0.115
r=-0.294
n=32
p=0.102
r=0.384
n=32
p=0.030
r=-0.325
n=32
p=0.069
r=-0.186
n=32
p=0.309
r=0.105
n=32
p=0.566
r=-0.170
n=32
p=0.353
r=0.266
n=32
p=0.141
T/LNAA r=0.275
n=32
p=0.127
r=0.120
n=32
p=0.515
r=-0.151
n=32
p=0.410
r=0.243
n=32
p=0.180
r=0.148
n=32
p=0.420
r=0.200
n=32
p=0.272
r=0.026
n=32
p=0.889
r=-0.091
n=32
p=0.621
% Fat r=-0.066
n=32
p=0.719
r=-0.022
n=32
p=0.903
r=0.065
n=32
p=0.723
r=-0.009
n=32
p=0.960
,r=-0.160
n=32
p=0.382
r=-0.141
n=32
p=0.441
r=-0.141
n=32
p=0.440
r=0.369 
n=32 
p =0.038
%  Protein r=0.388
n=32
p=0.028
r=0.398
n=32
p=0.024
r=-0.518
n=32
p=0.002
r=0.381
n=32
p=0.031
r=0.328
n=32
p=0.067
r=0.115 
n=32 
p =0.530
r=0.177
n=32
p=0.332
r=-0.416
n=32
p=0.018
% CHO r=-0.192
n=32
p=0.292
r=-0.180
n=32
p=0.325
r=0.193
n=32
p=0.289
r=-0.162
n=32
p=0.374
r=-0.025
n=32
p=0.891
r=0.052
n=32
p=0.776
r=-0.003
n=32
p=0.989
r=-0.052
n=32
p=0.778
% Sugar r=-0.006
n=32
p=0.974
r=-0.014
n=32
p=0.938
r=-0.022
n=32
p=0.903
r=-0.70
n=32
p=0.703
r=-0.028
n=32
p=0.878
r=0 078
n=32
p=0.673
r=0.055
n=32
p=0.763
r=0.037
n=32
p=0.843
%  Starch r=-0.276
n=32
p=0.126
r=-0.272
n=32
p=0.132
r=0.372
n=32
p=0.036
r=-0.217
n=32
p=0.232
r=-0.089
n=32
p=0.626
r=-0.049
n=32
p=0.792
r=-0.124
n=32
p=0.498
r=-0.114
n=32
p=0.534
where DR- Dietary Restraint
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Table 5a Correlations between actual food intake and subjective appetite ratings
in the Follicular phase od Cycle One. Standard deviations in parentheses.
Subjective 
/ Actual
Hunger Appetite Satiation Satiety DR- food 
type
D R -
amount
Ate more
than
wanted
Cravings
KCal r=-0.038
n=30
p=0.841
r=-0.066
n=30
p=0.728
r=-0.403
n=30
p=0.027
r=0.179
n=30
p=0.344
r=0.096
n=30
p=0.615
r=0.134
n=30
p=0.480
r=0.038
n=30
p=0.842
r=-0.154
n=30
p=0.416
Protein (g) r=-0.043
n=30
p=0.823
r=0.039
n=30
p=0.838
r=-0.520
n=30
p=0.003
r=0.252
n=30
p=0.180
r=0.316
n=30
p=0.089
r=0.164
n=30
p=0.386
r=-0.041
n=30
p=0.828
r=-0.423
n=30
p=0.020
Fat (g) r=-0.108
n=30
p=0.572
r=-0.216
n=30
p=0.251
r=-0.344
n=30
p=0.063
r=0.184
n=30
p=0.330
rO .011
n=30
p=0.924
r=0.041
n=30
p=0.829
r=0.051
n=30
p=0.790
r=0.013
n=30
p=0.946
CHO (g) r=0.016
n=30
p=0.933
r=0.067
n=30
p=0.724
r=-0.297
n=30
p=0.111
r=0.165
n=30
p=0.384
r=0.058
n=30
p=0.761
r=0.177
n=30
p=0.350
r=0.131
n=30
p=0.490
r=-0.073
n=30
p=0.702
Sugar (g) r=0.217
n=30
p=0.250
r=0.226
n=30
p=0.230
r=-0.309
n=30
p=0.097
r=0.259
n=30
p=0.167
r=-0.068
n=30
p=0.722
r=0.118
n=30
p=0.535
r=0.089
n=30
p=0.640
r=-0.177
n=30
p=0.349
Starch (g) r=-0.288
n=30
p=0.123
r=-0.218
n=30
p=0.248
r=-0.116
n=30
p=0.543
r=-0.086
n=30
p=0.651
r=0.067
n=30
p=0.727
r=-0.0127
n=30
p=0.947
r=0.041
n=30
p=0.828
r=0.037
n=30
p=0.848
T/LNAA r=0.406
n=30
p=0.026
r=0.225
n=30
p=0.233
r=0.013
n=30
p=0.946
r=0.257
n=30
p=0.170
r=0.274
n=30
p=0.143
r=0.325
n=30
p=0.080
r=-0.184
n=30
p=0.332
r=-0.058
n=30
p=0.761
% Fat r=-0.098
n=30
p=0.605
r=-0.392
n=30
p=0.032
r=-0.054
n=30
p=0.779
r=0.052 
n=30 
p =0.784
r=-0.088
n=30
p=0.642
r=0.063
n=30
p=0.741
r=0.121 
n=30 
p =0.525
r=0.312
n=30
p=0.093
% Protein r=-0.156
n=30
p=0.410
r=0.132
n=30
p=0.486
r=-0.370 
n=30 
p =0.044
r=0.127
n=30
p=0.504
r=0.283
n=30
p=0.130
r=-0.051
n=30
p=0.787
r=-0.074
n=30
p=0.699
r=-0.412
n=30
p=0.024
% CHO r=0.032
n=30
p=0.865
r=0.247
n=30
p=0.188
r=0.288
n=30
p=0.123
r=-0.188
n=30
p=0.319
r=-0.017
n=30
p=0.930
r=-0.041
n=30
p=0.829
r=r0.111
n=30
p=0.560
r=-0.017
n=30
p=0.930
% Sugar r=0.271
n=30
p=0.147
r=0.297.
n=30
p=0.111
r=-0.020
n=30
p=0.916
r=0.103
n=30
p=0.588
r=-0.154
n=30
p=0.418
r=-0.002
n=30
p=0.990
r=-0.031
n=30
p=0.873
r=-0.202
n=30
p=0.284
%  Starch r=-0.425
n=30
p=0.019
r=-0.241
n=30
p=0.199
r=0.453
n=30
p=0.012
r=-0.477
n=30.
p=0.008
r=0.019
n=30
p=0.920
r=-0.187
n=30
p=0.323
r=-0.132
n=30
p=0.487
r=0.328 
n=30 . 
p=0.077
where DR- Dietary Restraint
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Table 5b Correlations between actual food intake and subjective appetite ratings
in the Luteal phase of Cvcle One. Standard deviations in parentheses.
Subjective 
/ Actual
Hunger Appetite Satiation Satiety DR- food 
type
D R-
amount
Ate more
than
wanted
Cravings
KCal r=0.060
n=29
p=0.759
r=0.082
n=29
p=0.672
r=0.014
n=29
p=0.942
r=-0.018
n=29
p=0.927
r=0.003
n=29
p=0.990
r=0.098
n=29
p=0.613
r=-0.102
n=29
p=0.598
r=-0.358
n=29
p=0.056
Protein (g) r=-0.043
n=30
p=0.823
r=0.039
n=30
p=0.838
r=-0.520
n=30
p=0.003
r=0.252
n=30
p=0.180
r=0.316
n=30
p=0.089
r=0.164
n=30
p=0.386
r=-0.041
n=30
p=0.828
r=-0.423
n=30
p=0.020
Fat (g) r=-0.108
n=30
p=0.572
r=-0.216
n=30
p=0.251
r=-0.344
n=30
p=0.063
r=0.184
n=30
p=0.330
r=0.011
n=30
p=0.954
r=0.041
n=30
p=0.829
r=0.051
n=30
p=0.790
r=0.013
n=30
p=0.946
CHO (g) r=0.016
n=30
p=0.933
r=0.067
n=30
p=0.724
r=-0.297
n=30
p=0.111
r=0.165
n=30
p=0.384
r=0.058
n=30
p=0.761
r=0.177
n=30
p=0.350
r=0.131
n=30
p=0.490
r=-0.073
n=30
p=0.702
Sugar(g) r=0.217
n=30
p=0.250
r=0.226
n=30
p=0.230
r=-0.309
n=30
p=0.097
r=0.259 
n=30 
p =0.167
r=-0.068
n=30
p=0.722
r=0.118
n=30
p=0.535
r=0.089
n=30
p=0.640
r=-0.177
n=30
p=0.349
Starch (g) r=-0.288
n=30
p=0.123
r=-0.218
n=30
p=0.248
r=-0.116
n=30
p=0.543
r=-0.086
n=30
p=0.651
r=0.067
n=30
p=0.727
r=-0.013
n=30
p=0.947
r=0.041
n=30
p=0.828
r=0.037
n=30
p=0.848
T/LNAA r=0.262
n=29
p=0.169
r=0.289
n=29
p=0.128
r=-0.186
n=29
p=0.335
r=0.376
n=29
p=0.044
r=0.325
n=29
p=0.085
r=0.280
n=29
p=0.141
r=-0.062
n=29
p=0.749
r=-0.184
n=29
p=0.339
% Fat r=-0.098
n=30
p=0.605
r=-0.392
n=30
p=0.032
r=-0.054
n=30
p=0.779
r=0.052
n=30
p=0.784
r=-0.088
n=30
p=0.642
r=0.063
n=30
p=0.741
r=0.121
n=30
p=0.525
r=0.312
n=30
p=0.093
% Protein r=-0.156
n=30
p=0.410
r=0.132
n=30
p=0.486
r=-0.370
n=30
p=0.044
r=0.127
n=30
p=0.504
r=0.283
n=30
p=0.130
r=-0.051
n=30
p=0.787
r=-0.074
n=30
p=0.699
r=-0.412
n=30
p=0.024
% CHO r=0.033
n=30
p=0.865
r=0.247
n=30
p=0.188
r=0.288
n=30
p=0.123
r=-0.188
n=30
p=0.319
r=-0.017
n=30
p=0.930
r=-0.041
n=30
p=0.829
r=-0.111
n=30
p=0.560
r=-0.017
n=30
p=0.930
%  Sugar r=0.271
n=30
p=0.147
r=0.297
n=30
p=0.111
r=-0.020
n=30
p=0.916
r=0.103
n=30
p=0.588
r=-00.154
n=30
p=0.418
r=-0.002
n=30
p=0.990
r=-0.030
n=30
p=0.873
r=-0.202
n=30
p=0.284
% Starch r=-0.425
n=30
p=0.019
r=-0.241
n=30
p=0.199
r=0.453
n=30
p=0.012
r=-0.477 
n=30 .
p=0.008
r=0.019
n=30
p=0.920
r=-0.187
n=30
p=0.323
r=-0.132
n=30
p=0.487
r=0.328
n=30
p=0.077
where DR- Dietary Restraint
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Table 5c Correlations between actual food intake and subjective appetite ratings in
the Premenstrual phase of cvcle One. Standard deviations in parentheses.
Subjective 
/ Actual
Hunger Appetite Satiation Satiety DR- food 
type
DR-
amount
Ate more
than
wanted
Cravings
KCal r=0.121
n=30
p=0.525
r=0.016
n=30
p=0.934
r=-0.200
n=30
p=0.289
r=0.016
n=30
p=0.935
r=-0.015
n=30
p=0.938
r=0.331
n=30
p=0.074
r=0.155
n=30
p=0.415
r=0.168
n=30
p=0.374
Protein (g) r=-0.043
n=30
p=0.823
r=0.039
n=3Q
p=0.838
r=-0.520
n=30
p=0.003
r=0.252
n=30
p=0.180
r=0.316
n=30
p=0.089
r=0.164
n=30
p=0.386
r=-0.041
n=30
p=0.828
r=-0.423
n=30
p=0.020
Fat (g) r=-0.108
n=30
p=0.572
r=-0.216
n=30
p=0.251
r=-0.344
n=30
p=0.063
r=0.184
n=30
p=0.330
r=0.011
n=30
p=0.924
r=0.041
n=30
p=0.829
r=0.051
n=30
p=0.790
r=0.013
n=30
p=0.946
CHO (g) r=-0.129
n=30
p=0.498
r=-0.155
n=30
p=0.412
r=0.021
n=30
p=0.912
r=-0.188
n=30
p=0.320
r=-0.052
n=30
p=0.784
r=0.177
n=30
p=0.538
r=0.009
n=30
p=0.963
r=0.263
n=30
p=0.161
Sugar(g) r=-0.044
n=30
p=0.820
r=-0.142
n=30
p=0.454
r=-0.082
n=30
p=0.669
r=-0.108
n=30
p=0.569
r=-0.026
n=30
p=0.893
r=0.172
n=30
p=0.364
r=0.236
n=30
p=0.209
r=0.209
n=30
p=0.268
Starch (g) r=-0.124
n=30
p=0.516
r=-0.092
n=30
p=0.629
r=0.112
n=30
p=0.555
r=-0.225
n=30
p=0.232
r=-0.007
n=30
p=0.973
r=0.047
n=30
p=0.805
r=-0.215
n=30
p=0.253
r=0.218
n=30
p=0.248
T/LNAA r=0.059
n=30
p=0.758
r=0.034
n=30
p=0.857
r=-0.043
n=30
p=0.821
r=0.169
n=30
p=0.372
r=0.036
n=30
p=0.849
r=0.157
n=30
p=0.406
r=-0.150
n=30
p=0.428
r=0.147
n=30
p=0.439
% Fat r=0.170
n=30
p=0.370
r=0.170
n=30
p=0.368
r=-0.025
n=30
p=0.896
r=0.253
n=30
p=0.177
r=-0.247
n=30
p=0.188
r=0.069
n=30
p=0.716
r=0.014 
n=30 
p =0.940
r=0.168
n=30
p=0.374
% Protein r=0.291
n=30
p=0.118
r=0.324
n=30
p=0.081
r=-0.252
n=30
p=0.178
r=0.311
n=30
p=0.094
r=0.344
n=30
p=0.063
r=0.099
n=30
p=0.602
r=-0.030
n=30
p=0.876
r=-0.296
n=30
p=0.112
% CHO r=-0.269
n=30
p=0.150
r=-0.197
n=30
p=0.297
r=0.198
n=30
p=0.295
r=-0.276
n=30
p=0.139
r=0.115
n=30
p=0.547
r=-0.110
n=30
p=0.564
r=-0.225
n=30
p=0.231
r=0.069
n=30
p=0.719
% Sugar r=-0.290
n=30
p=0.120
r=-0.316
n=30
p =0.088
r=0.173
n=30
p=0.360
r=-0.281
n=30
p=0.133
r=0.013
n=30
p=0.945
r=-0.144
n=30
p=0.448
r=-0.066
n=30
p=0.728
r=0.144
n=30
p=0.447
%  Starch r=-0.097
n=30
p=0.611
r=0.010
n=30
p=0.960
r=0.185
n=30
p=0.327
r=-0.178
n=30
p=0.348
n=0.162
n=30
p=0.393
r=-0.011
n=30
p=0.953
r=-0.337
n=30
p=0.068
r=-0.157
n=30
p=0.407
where DR- Dietary Restraint
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Table 6a Correlations between actual food intake and subjective appetite ratings
in the Follicular phase of Cycle Two. Standard deviations in parentheses.
Subjective 
/  Actual
Hunger Appetite Satiation Satiety DR- food 
type
DR-
amount
Ate more
than
wanted
Cravings
KCal r=0.099
n=25
p=0.637
r=0.129
n=25
p=0.539
r=-0.173
n=25
p=0.407
r=0.162
n=25
p=0.440
r=0.158
n=25
p=0.451
r=0.214
n=25
p=0.304
r=-0.028
n=25
p=0.895
r=-0.306
n=25
p=0.137
Protein (g) r=0.150
n=25
p=0.474
r=0.342
n=25
p=0.094
r=-0.324
n=25
p=0.114
r=0.088
n=25
p=0.675
r=0.345
n=25
p=0.091
r=0.305
n=25
p=0.138
r=0.033
n=25
p=0.875
r=-0.400
n=25
p=0.047
Fat (g) r=-0.048
n=25
p=0.821
r=0.054
n=25
p=0.800
r=-0.034
n=25
p=0.872
r=-0.009
n=25
p=0.967
r=0.017
n=25
p=0.937
r=0.071
n=25
p=0.737
r=-0.037
n=25
p=0.862
r=-0.102
n=25
p=0.629
CHO (g) r=-0.039
n=25
p=0.855
r=0.053
n=25
p=0.801
r=-0.292
n=25
p=0.156
r=0.113
n=25
p=0.592
r=0.161 
n=25 
p =0.441
r=0.182
n=25
p=0.385
r=-0.070
n=25
p=0.739
r=-0.309
n=25
p=0.132
Sugar(g) r=-0.039
n=25
p=0.852
r=-0.106
n=25
p=0.615
r=-0.179
n=25
p=0.392
r=0.201
n=25
p=0.335
r=0.029
n=25
p=0.893
r=0.010
n=25
p=0.961
r=-0.045
n=25
p=0.831
r=-0.298
n=25
p=0.148
Starch (g) r=0.086
n=25
p=0.682
r=0.218
n=25
p=0.296
r=-0.312
n=25
p=0.129
r=0.129
n=25
p=0.540
r=0.289
n=25
p=0.161
r=0.357
n=25
p=0.080
r=-0.131
n=25
p=0.532
r=-0.329
n=25
p=0.108
T/LNAA r=-0.585
n=25
p=0.002
r=-0.609
n=25
p=0.001
r=0.373
n=25
p=0.067
r=-0.219
n=25
p=0.292
r=-0.340
n=25
p=0.097
r=-0.241
n=25
p=0.245
r=-0.057
n=25
p=0.787
r=0.353
n=25
p=0.084
% Fat r=-0.219
n=25
p=0.294
r=-0.162
n=25
p=0.439
r=0.254
n=25
p=0.221
r=-0.305
n=25
p=0.139
r=-0.313
n=25
p=0.127
r=-0.272 
n=25 
p=0.189
r=-0.104
n=25
p=0.620
r=0.291
n=25
p=0.158
%  Protein r=0.200
n=25
p=0.338
r=0.420
n=25
p=0.036
r=-0.324 
n==25 
p=0 114
r=0.056
n=25
p=0.792
r=0.433
n=25
p=0.031
r=0.249
n=25
p=0.231
r=0.295
n=25
p=0.152
r=-0.205
n=25
p=0.326
% CHO r=-0.131
n=25
p=0.532
r=-0.101
n=25
p=0.630
r=-0.167
n=25
p=0.424
r=0.057
n=25
p=0.787
r=0.075
n=25
p=0.720
r=0.089
n=25
p=0.671
r=-0.075
n=25
p=0.721
r=-0.126
n=25
p=0.549
% Sugar r=-0.034
n=25
p=0.872
r=-0.186
n=25
p=0.375
r=-0.070
n=25
p=0.741
r=0.145
n=25
p=0.491
r=-0.143
n=25
p=0.497
r=-0.163
n=25
p=0.437
r=0.035
n=25
p=0.868
r=0.055
n=25
p=0.795
% Starch r=-0.022
n=25
p=0.917
r=0.084
n=25
p=0.690
r=-0.226
n=25
p=0.278
r=0.065
n=25
p=0.456
r=0.248
n=25
p=0.232
r=0.229
n=25
p=0.272
r=-0.029
n=25
p=0.892
r=-0.173
n=25
p=0.408
where DR- Dietary Restraint
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Table 6b Correlations between actual food intake and subjective appetite ratings
in the Luteal phase of Cvcle Two. Standard deviations in parentheses.
Subjective 
/ Actual
Hunger Appetite Satiation Satiny DR- food 
type
DR-
amount
Ate more
than
wanted
Cravings
KCal r=0.152
n=27
p=0.451
r=0.204
n=27
p=0.308
r=-0.128
n=27
p=0.525
r=0.176
n=27
p=0.379
r=-0.147
n=27
p=0.466
r=-0.170
n=27
p=0.397
r=0.057
n=27
p=0.780
r=-0.096
n=27
p=0.633
Protein (g) r=0.247
n=27
p=0.215
r=0.334
n=27
p=0.089
r=-0.187
n=27
p=0.350
r=0.272
n=27
p=0.170
r=-0.144
n=27
p=0.474
r=0.017 
n=27 
p=0.931
r=-0.041
n=27
p=0.841
r=-0.275
n=27
p=0.165
Fat (g) . r=0.137
n=27
p=0.497
r=0.224
n=27
p=0.261
r=-0.193
n=27
p=0.335
r=0.206
n=27
p=0.303
r=-0.159
n=27
p=0.429
r=-0.039
n=27
p=0.847
r=-0.179
n=27
p=0.371
r=0.108
n=27
p=0.593
CHO (g) r=-0.058
n=27
p=0.773
r=0.001
n=27
p=0.996
r=0.048
n=27
p=0.813
r=-0.015
n=27
p=0.942
r=-0.013
n=27
p=0.949
r=-0.174
n=27
p=0.385
r=0.051
n=27
p=0.801
r=-0.035
n=27
p=0.861
Sugar (g) r=-0.169
n=27
p=0.401
r=-0.021
n=27
p=0.916
r=0.289 
n=27 
p=0.144
r=-0.199
n=27
p=0.320
r=-0.020
n=27
p=0.922
r=-0.281
n=27
p=0.156
r=-0.131
n=27
p=0.948
r=-0.126
n=27
p=0.532
Starch (g) r=0.109
n=27
p=0.589
r=0.017
n=27
p=0.934
I—-0.170
n=27
p=0.396
r=0.114
n=27
p=0.573
r=0.005
n=27
p=0.982
r=0.079
n=27
p=0.696
r=0.162
n=27
p=0.418
r=-0.044
n=27
p=0.826
T/LNAA r=-0.074
n=27
p=0.714
r=-0.014
n=27
p=0.945
r=-0.004
n=27
p=0.986
r=0.266
n=27
p=0.180
r=0.119
n=27
p=0.553
r=0.084
n=27
p=0.677
r=-0.026
n=27
p=0.899
r=0.180
n=27
p=0.369
% Fat r=0.127
n=27
p=0.527
r=0.088
n=27
p=0.661
r=-0.183
n=27
p=0.362
r=0.261
n=27
p=0.189
r=-0.170
n=27
p=0.396
r=-0.013
n=27
p=0.949
r=-0.378
n=27
p=0.052
r=0.134
n=27
p=0.504
%  Protein r=0.041
n=27
p=0.838
r=0.205
n=27
p=0.306
r=-0.057
n=27
p=0.776
r=0.077
n=27
p=0.702
r=-0.071
n=27
p=0.725
r=0.267
n=27
p=0.179
r=-0.054
n=27
p=0.786
r=-0.222 
n=27 
p =0.265
% CHO r=-0.271
n=27
p=0.172
r=-0.307
n=27
p=0.120
r=0.309
n=27
p=0.117
r=-0.357
n=27
p=0.068
r=0.173 
n=27 
p =0.389
r=-0.142
n=27
p=0.480
r=0.198
n=27
p=0.321
r=0.080
n=27
p=0.693
%  Sugar r=-0.203
n=27
p=0.311
r=-0.082
n=27
p=0.684
r=0.119
n=27
p=0.553
r=-0.197
n=27
p=0.324
r=0.078
n=27
p=0.699
r=-0.128
n=27
p=0.524
r=0.397
n=27
p=0.041
r=0.121
n=27
p=0.546
% Starch r=-0.054
n=27
p=0.788
r=-0.239
n=27
p=0.230
r=0.242
n=27
p=0.224
r=-0.208
n=27
p=0.299
r=0.236
n=27
p=0.236
r=0.161
n=27
p=0.422
r=0.020
n=27
p=0.922
r=-0.118 
n=27 
p =0.557
where DR- Dietary Restraint
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Table 6c Correlations between actual food intake and subjective appetite ratings in
the Premenstrual phase of cvcle Two. Standard deviations in parentheses.
Subjective 
/ Actual
Hunger Appetite Satiation Satiny DR- food 
type
DR-
amount
Ate more
than
wanted
Cravings
KCal r=0.075
n=25
p=0.722
r=0.109
n=25
p=0.604
r=-0.055
n=25
p=0.792
r=-0.080
n=25
p=0.702
r=0.312
n=25
p=0.129
r=0.319
n=25
p=0.120
r=-0.266
n=25
p=0.198
r=0.082
n=25
p=0.697
Protein (g) r=0.294
n=25
p=0.154
r=0.351
n=25
p=0.086
r=-0.396
n=25
p=0.050
r=0.302
n=25
p=0.143
r=0.284
n=25
p=0.169
r=0.261
n=25
p=0.208
r=-0.142
n=25
p=0.500
r=-0.225
n=25
p=0.279
Fat (g) r=0.006
n=25
p=0.978
r=0.177
n=25
p=0.397
r=-0.156
n=25
p=0.456
r=-0.067
n=25
p=0.751
r=0.302
n=25
p=0.143
r=0.102
n=25
p=0.628
r=-0.434
n=25
p=0.030
i=-0.003
n=25
p=0.990
CHO (g) r=0.001
n=25
p=0.996
r=-0.109
n=25
p=0.606
r=0.079
n=25
p=0.706
r=-0.149
n=25
p=0.478
r=0.082
n=25
p=0.696
r=0.167
n=25
p=0.426
r=0.083
n=25
p=0.694
r=0.132
n=25
p=0.530
Sugar(g) r=0.152
n=25
p=0.467
r=0.069
n=25
p=0.744
r=-0.072
n=25
p=0.734
r=-0.038
n=25
p=0.858
r=0.102
n=25
p=0.629
r=0.260
n=25
p=0.209
r=0.082
n=25
p=0.697
r=-0.107
n=25
p=0.610
Starch (g) r=-0.124
n=25
p=0.556
r=-0.292
n=25
p=0.156
r=0.276
n=25
p=0.182
r=-0.312 
n=25 
p=0 129
r=-0.094
n=25
p=0.655
r=0.043
n=25
p=0.839
r=0.140
n=25
p=0.506
r=0.156
n=25
p=0.456
T/LNAA r=0.056
n=25
p=0.790
r=-0.131
n=25
p=0.532
r=0.078
n=25
p=0.709
r=0.009 
n=25 
p =0.968
r=0.044
n=25
p=0.835
r=0.113
n=25
p=0.590
r=0.273
n=25
p=0.187
r=0.072
n=25
p=0.733
% Fat r=-0.094
n=25
p=0.657
r=0.083
n=25
p=0.693
r=-0.082
n=25
p=0.696
r=-0.079
n=25
p=0.709
r=0.063
n=25
p=0.765
r=-0.144
n=25
p=0.494
r=-0.318
n=25
p=0.121
r=0.074
n=25
p=0.727
% Protein r=0.252
n=25
p=0.225
r=0.331
n=25
p=0.106
r=-0.395
n=25
p=0.051
r=0.288
n=25
p=0.162
r=0.123
n=25
p=0.558
r=0.118
n=25
p=0.573
r=-0.040
n=25
p=0.851
r=-0.314
n=25
p=0.126
% CHO r=-0.169
n=25
p=0.420
r=-0.342
n=25
p=0.094
r=0.291
n=25
p=0.158
r=-0.176
n=25
p=0.399
r=-0.297
n=25
p=0.150
r=-0.117
n=25
p=0.578
r=0.413
n=25
p=0.040
r=0.099
n=25
p=0.638
% Sugar r=0.189
n=25
p=0.365
r=0.Q32
n=25
p=0.881
r=-0.065
n=25
p=0.759
r=0.030
n=25
p=0.885
r=-0.020
n=25
p=0.923
r=0.180
n=25
p=0.390
r=0.266
n=25
p=0.199
r=-0.006
n=25
p=0.978
% Starch r=-0.222
n=25
p=0.285
r=-0.381
n=25
p=0.060
r=0.386
n=25
p=0.057
r=-0.229
n=25
p=0.271
r=-0.333
n=25
p=0.104
r=-0.186
n=25
p=0.372
r=0.330
n=25
p=0.107
r=-0.020
n=25
p=0.924
where DR- Dietary Restraint
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Table 7 a. Correlations Between Tryptophan and Tryptophan Metabolites and
Actual Dietary Intake During the Follicular Phases of the Menstrual Cycle
Metabolite/ 
Actual intake (g)
TRY JHT HIAA AA IAA KY HK HA QA NA
Mean cycles 
Kcal
r=-0.156
n=32
p=0.395
r=-0.195
bf32
p=0.286
1=0.222
tr=32
p=0.223
1=0078
n=32
p=0.672
1=0.106
n=32
p=0.565
1=0272
11=32
p=0.131
1=0.193
ii=32
p=0.291
1=0.219
11=32
0=0.228
1=0.071
n=32
t>=0.700
1=0.147
if=32
u=0.424
Protein 1=0.076
0=32
p=0.681
r=-0.058
n=32
p=0.7Jl
1=0.052
n=32
p=0777
1=0330
n=32
p=0065
r=-O302
n=32
p=O093
1=0336
if=32
p=0.060
1=
11=32
p=O830
1=0106
n=32
p=0565
1=0057
n=32
p=0.729 II
S
ST
3
Fat 1=0.176
te=32
p=0.334
1=0.138
n=32
p=0.453
r=
n=32
p=0.225
1=0.091
n=32
p=0.619
1=0.016
n=32
p=0.930
1=0.193
n=32
p=0.290
1=0.093
11=32
p=0.613
1=0.263
11=32
p=0.146
1=0.149
0=32
p=0.417
1=0136
11=32
p=0.459
CHO r= 0116
n=32
p=0.528
1=0.168
n=32
p=0.359
1=0.149
n=32
p=0.417
1=0.115
n=32
p=O530
1=0.010
11=32
p=0.959
§ Jt « t
1=0266
n=32
p=0.142
1=0156
n=32
p=0.395
1=0.070
0=32
p=O702
1=0158
11=32
p=0.388
Sugar 1=0.131
tr=32
p=0408
1=0.163
n=32
p=0.372
r=-0132
n=32
p=0.472
1=0122
n=32
p=0.506
r=0.012
n=32
p=0.948
r=0.111
n=32
p=0547
1=0.267
n=32
p=0.140
1=0.117
n=32
p=0.523
1=0.126
11=32
p=0491
1=0.204
11=32
p=0.263
Starch r=0.128
n=32
p=0.484
r=0.208
n=32
p=0.253
1=0.201
n=32
p=0.269
1=0.202
n=32
p=0.267
r=O106
rr=32
p=0.562
1=0.028
n=32
p=0.879
1=0.146
11=32
[1=0.457
1=0.242
n=32
p=0182
1=0008
11=32
p=0.966
1=0.081
0=32
p=0.661
Cycle One 
Kcal
1=
n=29
p=0683
1=0.095
rr=29
p=0.626
r=O.036
n=29
p=0.855
1=0.226
n=29
p=0239
1=0.187
0=29
p=0332
1=0.064
n=30
p=OT37
1=0071
n=30
p=0711
1=0.109
n=30
p=0567
1=0106
n=30
p=0577
1=0.043
if=30
p=0821
Protein 1=0.247
n=29
p=0.197
1=0.039
n=29
p=0.839
r=0.130
n=29
p=0.501
1=0.291
tr=29
p=0.126
t=0.238
n=29
p=0.215
1=0.068
nf=30
p=0.722
1=0.120
a=30
p=0.528
1=0.057
n=30
p=0.765
1=0.073
11=30
p=O701
1=0.029
n=30
p=0.880
Fat 1=0.041
n=29
jfO.833
1=0.006
n=29
p=0976
1=0.052
n=29
p=0788
1=0.071
n=29
p=0716
1=0.025
11=29
p=0.89S
1=0038
n=30
p=0.842
1=0.024
n=30
p=0898
r=0.068
n=30
p=0.722
1=0.124
ir=30
p=0513
1=0.013
o=30
p=0945
CHO r=-0.112
n=29
p=O.S64
1=0.055
n=29
p=0.778
1=0.079
n=29
p=0.683
r=0.232
n=29
p=0.225
1=0.138
n=29
p=0.475
1=0.108
n=30
p=0.569
1=0.165
n=30
p=0.385
1=0.157
n=30
p=0.408
1=0.114
o=30
p=0.548
1=0.126
0=30
p=0.507
Sugar r=0134
if=29
p=0.488
r=0.002
n=29
p=0.992
1=0160 
n=29 
p=O407
1=0.092
n=29
p=0.637
1=0.118
n=29
p=0541
r=0128
n=30
p=0499
1=0080
11=30
p=0.675
1=0.095
n=30
p=0.619
1=0.265
0=30
p=0.157
1=0.096
0=30
p=0615
Starch 1=0.092
n=29
p=0.636
1=0.184
n=29
p=0.340
1=0098
n=29
p=0.613
1=0245
n=29
p=0.200
r=0.016
n=29
p=0.934
1=0.081
n=30
p=0.671
r=
n=30
p=0.866
1=0.231
n=30
p=0.219
1=0.118
11=30
p=OS33
1=0.090
11=30
p=0.d36
Cycle Two 
Kcal
r=-0.262
n=23
p=O.207
1=0.391
n=25
p=0.053
1=0.498
n=25
p=O011*
1=0.026
n=25
p=0.901
1=0.320
n=25
p=0.119
1=0.376
11=25
p=O.064
1=0.130
n=25
p=0.536
1=0.366
0=25
p=0.072
1=0.086
0=25
p=0.681
1=0.063
0=25
p=0.764
Protein 1=0105
n=25
p=0.619
r=0.066
n=25
p=0.753
1=0213
n=25
p=O.306
r=O036
if=25
p=0.865
r=0.379
n=25
p=0.062
1=0.381
n=25
p=0.060
1=0114
0=25
p=0.588
1=0.154
11=25
p=0.463
1=0057
n=25
p=0.788
1=0158
11=25
p=0452
Fat r=0.165
n=25
p=0.432
1=0.134
n=25
p=0.524
1=0.232
n=25
p=0.264
1=0.063
if=25
p=0.764
1=0.254
11=25
p=0.220
1=0337
n=25
p=O.099
1=0.006
11=25
p=0978
1=0.426
n=25
p=0.034*
r=
if=25
p=0.686
1=0.020
n=25
p=0.926
CHO r=0.219
n=23
p=0.294
1=0409
n=25
p=O042*
1=0.463
rr=25
p=0020*
1=0.006
n=25
p=0.976
r=
n=25
p=0.604
1=0.223
11=25
p=0.283
r= 0116
n=25
p=0.583
1=0242
n=25
p=0244
1=0.190
11=25
p=0363
1=0176
11=25
p=0.400
Sugar r=
n=25
p=0.163
1=0.445
n=25
p=0.026*
r=0.427
0=25
p=0.033*
1=0.066
n=25
p=0.754
r=0.223
n=25
p=0.285
r=0.117
n=25
p=0.578
1=0.205
11=25
p=0.327
1=0.150
11=25
p=0.475
1=0.097
11=25
p=0.645
1=0.166
11=25
[1=0.429
Starch 1=0.025
n=25
p=0.907
1=0155
n=25
p=0458
r= 0272
n=25
p=0188
1=0.029
ir=25
p=0.891
1=0098
11=25
p=0.642
1=0167
n=25
p=0.425
1=0.168
11=25
p=0421
1=0.152
11=25
p=0468
1=0417
0=25
p=0038*
1=0.125
n=25
p=0.551
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Table 7 b. Correlations Between Tryptophan and Tryptophan Metabolites and
Actual Dietary Intake During the Luteal Phases of the Menstrual
M etabolite/ 
Actual intake (g)
TRY 5HT HIAA AA IAA KY HK HA QA NA
Mean cycles 
Kcal
1=4X295
n=32
(3=0.101
1=4X274
n=32
p=0.129
[=0.377
n=32
(3=0.034*
[=0.198
13=32
p=0.277
1=0.252
13=32
p=0.164
1=0.302
13=32
p=0.093
[= 0208
13=32
[1=0.254 1 a 
a 
.
8 w 
s 1=0037
13=32
(3=0.842
1=0.250
13=32
p=0.167
Protein [=4X262
n=32
p=0.143
1=4X318
11=32
p=4X076
[=4X289
n=32
P4X109
1=0.068
0=32
(3=0.713
[=0.356
n=32
(3=0.045*
1=4X324
n=32
(3=0071
[=0.214
13=32
(1=0.240
1=0070
13=32
(3=0.705
1=0.311
13=32
(14X083
14X214
11=32
(3=0241
Fat 1=4X106
n=32
p=0.563
r=4).084
r=32
p=0.649
(=0.212
n=32
(341.245
14X228
13=32
(3=0.209
[=0.228
n=32
(3=0.209
[=0.201
11=32
(3=0.2®
r=
n=32
(1=0.754
1=0.076
13=32
(3=0.681
1=0.096
13=32
p=0.601
1=0.000
n=32
p=0.000
CHO r=4X]85
n=32
p=0.311
1=4X158
n=32
p=0.389
r=
n=32
(3=0.224
[=0.140
0=32
(3=0.444
[4X000
13=32
(3=0.998
[=0.118
13=32
(34X522
[=0003
n=32
(3=0988
[=0.127
n=32
(3=0.490
1=0.229
n=32
(3=0207
1=0254
n=32
(3=0.1®
Sugar r=*0.170
n=32
p=0.353
i=4).095
[3=32
p=0.607
[=0.182
n=32
(341.318
14X143
(3=32
p=0.435
[=0.036
(1=32
p=0.845
1=0.059
13=32
(3=0.748
1=0.063
13=32
p=0.733
1=0.124
n=32
p=0.501
1=0.227
13=32
(3=0.211
1=0.050
13=32
(3=0.786
Starch [=4X107
n=32
p=0.560
1=4X131
n=32
(34X474
[= 0194
13=32
(341.287
[=0.197
13=32
p=0.281
1=0.033
13=32
(3=0859.
[=0.144
13=32
p=0.433
1=0074
13=32
(3=0688
1=0031
n=32
[3=0.864
1=0167
n=32
(1=0362
1=0.407
13=32
(3=0.021*
Cycle One 
Kcal
r=-0.307
n=28
p = a il2
r=4).280
n=28
(3=0.149
[=4X402
n=28
p=0.034*
[=0.109
n=28
p4X581
r=
n=28
(3=0.391
[=0.278
n=29
(3=0.145
1=0.160
n=29
(3=0.409
1=0.213
13=29
(3=0.267
1=0104
13=29
(3=0592
1=0270
n=29
p=0.157
Protein r=
n=28
p=0.057
1=4X296
13=28
p=0.127
[=41.315
n=28
p=0.102
[=0.000
13=28
(3=0.999
[=0.286
n=28
p=0.140
1=0.240
13=29
(3=0.211
1=0.010
13=29
(3=0.959
1=0.224
13=29
(3=0.242
1=0.226
13=29
p=0.238
1=0.416
11=29
(3=0.025*
Fat 1=4X062
n428
p4X752
[=4X031
n=28
(34X875
[=0.236
13=28
(34X227
[4X241
n=28
(3=0.217
[=0.149
n=28
(3=0449
1=0.168
n=29
[3=0383
[=0.066
13=29
(3=0732
1=0166
13=29
p4X389
1=0.244
11=29
(1=0202
1=0249
n=29
p4X193
CHO [=4X214
ff28
[3=0274
[=0.230
n=28
p4X239
1=0.218
(3=28
(3=0.264
(=0.124
11=28
p=0.530
1=0.041
[3=28
p=0.836
[=4X330
13=29
(3=0.081
[=0.034
13=29
(3=0.863
1=0.189
13=29
(3=0.325
14X170
13=29
(3=0.378
1=0128
13=29
[3=0.508
Sugar r=-0.033
13=28
13=0.866
(=4X039
n=28
(3=4X844
[=0.026
13=28
(3=0.894
[4X070
n=28
p4X723
1=0248
n=28
(3=0.203
1=4X168
11=29
(1=0385
1=0.031
13=29
p=0.875
14X279
13=29
(1=0143
1=0180
n=29
(3=0350
1=0.116
n=29
(3=0.548
Starch 1=4X262
n=28
p=0.178
[=0.237
it=28
(3=0.225
[=0.279
13=28
p=0.151
[=0.091
n=28
p=0.644
[=4X090
13=28
[3=0.541
1=4X360
13=29
(3=0.055
1=0096
13=29
(1=0.619
[=0063
13=29
(3=0746
[=0.150
13=29
(3=0.438
1=0.116
n=29
(3=0.548
Cycle Two 
Kcal
1=4X333
n=26
p=O.097
[= 0246
tr=26
(341.226
[=0.471
n=26
(3=0.015*
[=0.074
13=26
p=0.721
[=0.378
n=26
p=O057
[=0.205
13=27
p=0.305
1=0.232
13=27
(3=0.245
1=0.314
n=27
(1=0.110
1=0.274
11=27
[3=0.166
1=4X077
13=27
(3=0.702
Protein r=-0.223
n=26
p=0.270
[=4X178
n=26
(3=0.384
1=0.307
13=26
p=0.128
[=4X025
13=26
(4X904
[=4X435
rr=26
(3=0027*
1=0180
13=27
p=0.368
1=0235
n=27
(3=0.238
1=4X263
lr=27
p=0.186
1=4X270
n=27
(3=0.173
1=0050
13=27
(3=0806
Fat [=4X186
tF=26
(3=0364
[=4X213
13=26
(341.296
1=0.159
13=26
p41.438
1=4X127
13=26
p=0.538
[=0.317
n=26
(3=0.115
1=0.151
11=27
(1=0.451
1=0.118
n=27
(3=0.558
1=0.270
13=27
(1=0173
1=0.151
13=27
(3=0.452
1=4X162
n=27
p=0.420
CHO r=4X206
n=26
p=0.314
(=4X199
n=26
P4X329
[=0.423
n=26
p4XQ31*
[4X089
n=26
p4).666
[=4X127
13=26
p=0.537
1=0.121
13=27
(3=0547
[=4X001
13=27
(14X997
1=0179
13=27
p=0.372
1=
13=27
[1=0733
1=0005
11=27
(3=0980
Sugar 1=4X108
n=26
p=O601
(=0.138
rt=26
(3=0.502
[=0.372
13=26
(3=0.062
[=0.097
n=26
p=0.638
1=
(3=26
(4X677
[=0.056
13=27
(1=0.782
[=0.173
13=27
(1=0.388
1=0.039
11=27
(3=0.846
1=0.188
13=27
p=0.347
1=4X094
n=27
p=0.640
Starch r=
n=26
[4X709
1=0.035
n=26
1)4X864
1=4X170
13=26
(3=0.407
1=0.121
d=26
(3=0555
[=0.091
(1=26
(3=0.657
[=0.002
n=27
(3=0990
1= 00®
n=27
(3=0734
1=0197
13=27
(3=0325
1=0.185
n=27
[3=0357
1=0165
13=27
(4X412
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Table 7 c. Correlations Between Tryptophan and Tryptophan Metabolites and
Actual Dietary Intake During the Premenstrual Phases of the Menstrual Cycle
M etabolite/ 
Actual intake (g)
TRY 5HT HIAA AA IAA KY HK HA QA NA
Mean cycles 
Kcal
r=0.028
ir=32
p=0.881
r=0.O41
n=32
p=0.82S
1=0.011
m=32
p=0.952
1=0.016
0=32
p=0.929
1=0.170
0=32
p=0.352
1=0.022
n=32
p=0.905
r=0.118
n=32
p=0.520
r=0.061
n=32
p=0.739
1=0.173
if=32
p=0.343
1=0.068
11=32
p=0.713
Protein r=0.120
n=32
p=0.S12
r=0174
n=32
p=0.342 II
I
&
”
S 1=0077
n=32
p=0676
1=0.081
n=32
p=0.660
1=0079
n=32
p=0667
1=0045
11=32
p=0.805
1=0.116 
0=32 
p=0526
1=0.094
0=32
p=0.608
1=0.192
11=32
p=0.293
Fat r=-0.017
n=32
p=0.925
r=0.061
n=32
p=0.739
1=0.108
n=32
p=0.557
r=0.023
n=32
p=0.899
r=0.167
n=32
p=O.360
1=0.145
0=32
p=0.428
1=0.085
n=32
p=0.643
1=0061
n=32
p=0.741
1=0.184
0=32
p=0.314
r=0176
0=32
p=0.336
CHO r=0.058
n~32
p=0.754
1=0032
n=32
p=0.864
1=0.063
n=32
p=0.730
1=0017
n=32
p=0.928 II
I 1=0.074
0=32
p=0.687
1=
0=32
p=0.755
1=0008
rr=32
p=0.966
1=0.178
n=32
p=0.329
1=0029
11=32
p=0.874
Sugar 1=0.083
n=32
p=0.654
1=0.033
n=32
p=0.848
r=
n=32
p=0867
1=0.006
n=32
p=0.973
1=0.262
n=32
p=0.148
r=0.024
n=32
p=0.896
r=0.012
ir=32
p=0.947
1=0.141
0=32
p=0.443
1=0052
n=32
p=0.780
1=0.200
11=32
p=0.272
Starch r=OOQ5
n=32
p=0979
1=0.041
11=32
pt=0.822
r=0076
n=32
p=0.681
r=0153
n=32
p=0.404
1=0.062 
n=32 
p=0735 .
1=0.048
n=32
p=0.793
1=0.031
n=32
p=0.867
1=0157
n=32
p=0.391
1=0.209
11=32
p=0252
1=0034
0=32
p=0854
Cycle One 
Kcal
r=-0.062 
n=29 
p=0749
1=0.074
n=29
p=O701
r=-0.047
n=29
p=O.810
r=-0.076
n=29
p=0.694
r=0.265
n=29
p=0.165
1=0.023
n=30
p=0.905
1=0.077
n=30
p=0687
1=0134
o=30
p=0480
r=
ir=30
p=0646
1=0.136
n=30
p=0.475
Protein 1=0.131 
n=29 
p=0.500
1=0.187
n=29
p=0.332
1=0.336
n=29
p=0.075
1=0.083
n=29
p=O670
r=
n=29
p=0.315
1=0.254
0=30
p=0.176
1=0.043
ir=30
p=0.821
1=0.088
0=30
p=0.644
1=0.078
11=30
p=0.683
1=0.203
n=30
p=0.282
Fat r=
n=29
p=0.937
1=0.003
n=29
p=0988
1=0035
n=29
p=0859
1=0.042
n=29
p=0.830
1=0.208
n=29
p=0.280
1=0.084
n=30
p=0.660
1=0269
n=30
p=0151
1=0025
n=30
p=0.893
1=0.230
0=30
p=0222
1=0.068
0=30
p=0.722
CHO r=0.171
n=29
p=0.375
r=0.068
n=29
p=0728
r=0.105
n=29
p=0.586
1=0.033
n=29
p=0.864
1=0.214
n=29
p=0.264
1=0.145
n=30
p=0.443
1=0.063
n=30
p=0741
1=0.138
n=30
p=0.467
1=0.063
tl=30
p=0.740
1=0.007
n=30
p=0.969
Sugar 1=0.089
n=29
p=0.646
1=0.100
n=29
p=0.608
t=O022 
n=29 
p=0.911
1=0.076 
n=29 
p=0696
1=0.285
0=29
p=0.134
r=O019
n=30
p=O920
1=0.099
n=30
p=0.604
1=0.076
0=29
p=0696
1=0110
n=30
p=0.562
1=0.075
n=30
p=0.693
Starch 1=0.272
n=29
p=0.154
r=0.142
n=29
p=0.461
1=0.222
n=29
p=0.248
1=0.192
n=29
p=0.319
1=0.249
0=29
p=0.192
1=0.120
a=30
p=0.529
1=0.091
n=30
p=0.634
1=0134
n=30
p=0.480
1=0.081
n~30
p=0.672
1=0.115
11=30
p=0.544
Cycle Two 
Kcal
r=*0.233
n=26
p=0252
1=0.310
n=26
p=0123
r=0.448
n=26
p=0.022*
1=0.020
n=26
p=0.922
r=0.174
0=26
p=0.396
1=0.056
0=26
p=0.784
1=0.132
n=26
p=0.522
r=0.186
n=26
p=0.363
1=0.166
0=26
p=0.417
1=0.313
0=26
p=0.119
Protein 1=0074
n=26
p=0.721
1=0.227
n=26
p=0.265
1=0454
n=26
p=0.020*
1=0.014
n=26
p=0.948
1=0.004
if=26
p=0.983
1=0.192
n=26
p=0.348
1=0301
n=26
p=0.133
1=0.270
n=26
p=0.182
1=0.037
n=26
p=0.859
1=0.027
n=26
p=0896
Fat r=-0.182 
n=26 
p=0.375
r=0.150
n=26
p=0.464
r=0.493
n=26
p=0.010*
1=0.024
n=26
p=O.908
1=0.118
n=26
p=0.567
1=0009
n=26
p=0.964
1=0.287
0=26
p=0.135
1=0.096
0=26
p=0.642
1=0.096
0=26
p=0.642
1=0.135
0=26
p=0.510
CHO 1=0.069
n=26
p=0.739
1=0.182
n=26
p=0.373
t=0.155
n=26
p=O450
r=0.081
n=26
p=0.695
1=0.055
11=26
p=0.789
1=0.029
n=26
p=0.888
1=0009 
0=26 
p=0966
1=0.192
0=26
p=0.348
1=0.109
0=26
p=0.596
1=0242
0=26
p=0.233
Sugar r=-0.118
n=26
p=0.566
1=0.132
n=26
p=0.460
1=0.025
n=26
p=0.904
1=
ir=26 
p=0.976
r=0.011
n=26
p=0.958
1=0.022
11=26
p=0.9I7
1=0.010
0=26
p=0.961
1=0.089
11=26
p=0.666
1=0.007
0=26
p=0.971
1=0.378
n=26
p=O.057
Starch 1=0.257
n=26
p=O204
1=0356
n=26
p=0.074
r=0.220
n=26
p=0.281
1=0.008
ir=26
p=0.968
1=0.158
11=26
p=0.442
1=0.184
n=26
p=0.369
1=0002
if=26
p=0.991
1=0.372
11=26
p=O062
r=
n=26
p=O680
1=0071
n=26
p=0729
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Table 8 a. Correlations between tryptophan and tryptophan metabolites and % food
intake during the Follicular phases of the Menstrual Cycle
Metabolite/
Percentage
intake
TRY 5HT HIAA AA IAA KY HK HA QA NA
Mean of cydes 
% Fat
r=0.189
n=32
p=0.301
r=-0.018
n=32
p=0.924
1=0.068
n=32
p=0.711
r=0.057
n=32
p=0.759
r=0.075
rr=32
p=0.683
1=0.140
n=32
p=0.446
r=0.016
n=32
p=0.930
r=0.201
n=32
p=0.269
r=
n=32
p=0.926
1=0.060
n=32
p=0.746
% Protein r=0.159 
n=32 
p=0.384
r=0.040
n=32
p=0.830
r=0.002
n=32
p=0.990
i=0.328
n=32
p=0.067
i=
rr=32
p=0.157
1=0.093
n=32
p=0.613
1=0.150
n=32
p=0.412
1=0.260
n=32
p=0,150
1=0.215
n=32
p=0.239
1=0.264
ii=32
p=0.145
% Carbohydrate r=
n=32
p=0.454
r=0094
n=32
p=0.611
1=0.178 
n=32 ' 
p=0.329
1=0.117
n=32
p=0.524
1=0.229
n=32
p=0.208
1=0.271
n=32
p=0.134
1=0.023
n=32
p=0.900
1=0.121
n=32
p=0.510
1=0.177
n=32
p=0.332
1=0.009
ii=32
p=0.960
% Sugar r=4). 057
n=32
p=0.756
r=-0.091
n=32
p=0.619
1=0.014
ir=32
p=0.938
1=0.235
n=32
p=0.195
1=0.075
ii=32
p=0.684
r=0.023
n=32
p=0.903
1=0.069
n=32
p=0.710
1=0.061
n=32
pF=0.741
1=0.223
nr=32
p=0.221
1=0.114
n=32
p=0.536
% Starch r=0.081
n=32
p=0.658
r=0.051
n=32
p=0.783
1=0.145
n=32
p=0.429
r=0.196
n=32
p=0.282
1=0.197
n=32
p=0781
1=0.364
n=32
p=0.041*
i=0.013
n=32
p=0.945
1=0.042
n=32
p=0.819
1=0.190
n=32
p=0.298
1=0.146
n=32
p=0.427
Cyde One 
% Fat
r=-0.031
n=29
p=0.874
r=0035
n=29
p=0.856
r=-0.I62
n=29
p=0.402
r=0.230
ir=29
p=0.231
r=0.077
rr=29
p=0.690
r=0.085
n=30
p=0.646
r=0.061
rr=30
p=O.750
r=0.012
n=30
p=0.952
1=0.005 
n=30 
p=0.97 9
1=0.042
n=30
p=0.826
% Protein 1=0.339
n=29
p=0.072
r=-0.010
rr=29
p=0.958
1=0.031
n=29
p=0.875
1=0.230
n=29
p=0.229
1=0.243
n=29
p=0.203
1=0.013 
. it=30 
p=0.948
1=0.157
n=30
p=0.407
r=0.272 
n=30 
p=0.146
r=0.056
n=30
p=0.769
1=0.122
n=30
p=OJ20
% Carbohydrate r=-0.124
n=29
p=0.523
r=-0.049
n=29
p=0.800
1=0.097
n=29
p=0.617
1=0.126
n=29
p=0.516
1=0.033
n=29
p=0.866
1=0.084
n=30
p=0.657
1=0.073
n=30
p=0.701
1=0.082
n=30
p=0.666
1=0.134
n=30
p=0.479
1=0.051
ir=30
p=0.788
% Sugar r=0.121
ir=29
p=0.531
r=-0.005
ir=20
p=0.980
1=0.179
n=29
p=0.353
1=0.027
rr=29
p=0.891
1=0.181
rr=29
p=0.347
1=0.093
n=30
p=0.626
r=0.032
if=30
p=0.868
r=0.085
n=30
p=0.656
1=0.248
n=30
p=0.186
1=0.133
ii=30
p=0.482
% Starch 1=0.051
n=29
p=0.794
r=-0.029
n=29
p=0.881
1=0.056
ir=29
p=0.774
r=0.256
n=29
p=0.180
1=0.178
n=29
p=0.355
1=0.215
n=30
p=0.254
1=0.018
rr=30
p=0.927
1=0.104
if=30
p=0.583
1=
it=30
p=.186
1=0.068
n=30
p=0.722
Cyde Two 
% Fat
1=0.066
n=25
p=0.753
1=0.172
n=25
p=O.410
1=0.062
n=25
p=0.770
r=O.090
if=25
p=0.668
r=0.038
n=2
p=0.858
t=0.042
n=25
p=0.844
r=0.121
n=25
p=0.565
r=0.221
n=25
p=0.288
1=0.041
n=25
p=0.844
1=0.093
n=25
p=0.660
% Proton r=O.240
n=25
p=0.248
1=0.396
n=25
p=0.050*
1=0.393
n=25
p=0.052
r=-0.211
n=25
p=0311
r=0.195
n=25
p=0.351
r=0.037
if=25
p=0.861
r=0.276
n=25
p=0.182
1=0.502
ir=25
p=0.010*
1=0.055
n=25
p=0.793
1=0.425
n=25
p=0.034*
% Carbohydrate 1=0.221
n=25
p=0.288
r=0.044
n=25
p=0.835
1=0.195
ir=25
p=0350
1=0.079
n=25
p=0.708
r=0.383
n=25
p=0.059
1=0.232
ir=25
p=0.264
r=
rr=25
p=0.910
1=0.142
ni=25
p=0.498
1=0.198
n=25
p=0344
i=0.132
n=25
p=0.530
% Sugar r=-0.017
n=25
p=0.937
1=0.230
n=25
p=0.269
r=
if=25
p=0.842
r=0.021
if=25
p=0.920
1=0.256-
n=25
p=0.216
1=0.122
n=25
p=0.561
1=0.237
n=25
p=0.255
1=0.214
n=25
p=0.304
i=0.128
n=25
p=0.543
1=0.211
n=25
p=0.312
Vo Starch 1=0301
rr=25
p=0.144
r=0.268
n=25
p=0.195
1=0.257
n=25
p=0.215
1=0.024
rr=25
p=0.911
r=0.313
n=25
p=0.127
1=0.231
n=25
p=0.267
r=0.089
n=25
p=0.674
1=0.237
n=25
p=0.254
1=0.138
n=25
p=0.511
1=0.053 
n=25
p=0.801
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Table 8 b. Correlations between tryptophan and tryptophan metabolites and % food
intake during the Luteal phases of the Menstrual Cycle
Metabolite/
Percentage
intake
TRY 5HT HIAA AA IAA KY HK HA QA NA
Mean of cydes 
% Fat
f=0.056 
n=32 
p=0.7 60
1=0.037
n=32
p=0.841
1=0.051
n=32
p=0.783
1=0.262
ir=32
p=0.148
1=0.179
n=32
p=0327
1=0.064
it=32
p=0.728
1=0,122
n=32
p=O.506
1=0.162
n=32
p=0.376
r=0.199
n=32
p=0.276
1=0.137
n=32
p=0.459
% Protein r=0.041
n=32
p=0.823
r=0.127
n=32
p=0.490
r=0.019
n=32
p=0.918
1=0.182
n=32
p=0.319
1=0.220
n=32
p=0.226
1=0.069
it=32
p=0.708
r=0.244
n=32
p=0.179
1=0.003
n=32
p=0.989
i=
n=32
p=0.042*
r=0.004
n=32
p=0.984
% Carbohydrate 1=0.043
n=32
p=0.817
1=0.027
n=32
p=0.883
1=0.047
n=32
p=0.800
i=0.072
n=32
p=0.696
r=
n=32
p=0.023*
1=0.180
n=32
p=0.323
1=0.115
n=32
p=0.530
1=0.138
n=32
p=0.452
1=0.436
n=32
p=0.013*
1=0.085
n=32
p=0.646
% Sugar r=
n=32
p=0.632
r=0.009
n=32
p=0.960
1=0.028
ii=32
p=0.880
1=0.129
n=32
p=0.483
r=0.306
n=32
p=0.089
1=0.051
n=32
p=0.782
1=0.207
n=32
p=0.256
i=0.162
n=32
p=0.376
1=0.246
n=32
p=0.175
1=0.013
n=32
p=0.945
% Starch r=0.031
n=32
p=0.868
1=0.066
n=32
p=0.720
1=0.049
n=32
p=0.792
r=0.023
n=32
pF=0.899
1=0.213
if=32
p=0.243
1=0.046
n=32
p=0.802
1=0.231
n=32
p=0.204
1=0.055
if=32
p=0.766
1=0.285
ir=32
p=0.114
1=0.178
n=32
p=0.331
Cyde One 
% Fat
1=0.279
n=28
p=0.151
1=0317
n=28
p=0.101
r=
if 28
p=0.616
i=0372
n=28
p=0.051
1=0.109
n=2
p=0.582
1=0.010
n=29
p=0.957
r=0.016
n=29
p=0.934
r=0.021
n=29
p=0.914
1=0.184
n=29
p=0.338
r=0.038
n=29
p=0.847
% Proton r=-0.137
rr=28
p=0.488
1=0.162
n=28
p=0.4U
1=0.098
n=28
p=0.619
r=0.250
n=28
p=0.199
r=0.115
n=28
p=0.561
1=0.025
ir=29
p=0.898
1=0.043
n=29
p=0.826
1=0.097
n=29
p=0.618
1=0.256
n=29
p=0.181
1=0.271
n=29
p=0.154
% Carbohydrate r=-0.094 
n=2 8 
p=0.635
1=0.186
n=28
p=0344
1=0.036
n=28
p=0.856
1=0.114
n=28
p=0.563
1=0.250
n=28
p=0.200
1=0.070
n=29
p=0.717
1=0.006
n=29
p=0.976
1=0.117
n=29
p=0347
1=0.414
ir=29
p=0.026*
1=0.216
n=29
p=0.260
% Sugar r=0.157
n=28
p=0.426
r=O.037
n=28
p=0.851
1=0.253
n=28
p=0.193
i=0.085
if=28
p=0.667
1=0369
n=28
p=0.053
r=0.124
n=29
p=0.523
1=0.043
n=29
p=0.824
1=0.149
ir=29
p=0.441
1=0.255
if29
p=0.181
1=0.085
ff=29
p=0.662
% Starch r=0.270
n=28
p=0.164
i=0.267
n=28
p=0.170
i=0.259
re=28
p=0.183
i=0.016
n=28
p=.935
1=0.092
n=28
p=0.641
1=0.134
n=29
p=0.488
r=O.012
ir=29
p=0.950
1=0.264
n=29
p=0.166
1=0.292
ii=29
p=0.124
1=0.123
n=29
p=0.525
Cyde Two 
% Fat
1=0.054
n=26
p=0.792
i=0.160
n=26
p=0.436
r=0.011
n=26
p=0.956
r=0.085
n=26
p=0.682
1=0.210
n=26
p=0.304
r=0.102
n=27
p=0.612
r=0.074
n=27
p=0.715
1=0.209
n=27
p=0.296
1=0.210
n=27
p=0.293
r=0.128
n=27
p=0.524
% Protein r=0.008
n=26
p=0.970
1=0.045
n=26
p=0.827
1=0.117
n=26
p=0.568
1=0.056
ii=26
p=0.785
1=0.183 
n=26 
• p=O370
1=0.032
n=27
p=0.872
1=0.009
n=27
p=0.966
1=0.117
n=27
p=0.563
r=0.096
n=27
p=0.636
1=0.036
n=27
p=0.859
% Carbohydrate r=0.090
n=26
p=0.662
1=0.034 
n=2 6 
p=0.870
r=0.040
n=26
p=0.846
r=0.071
n=26
p=0.731
i=0364
n=26
p=0.067
r=0.115
n=27
p=0.567
1=0.255
n=27
p=0.200
1=0.183
n=27
p=0362
1=0.223 
n=27 
p=0.265
1=0.238
n=27
p=0.232
% Sugar 1=0120
n=26
p=0.560
r=0.033
n=26
p=0.873
1=0.157
n=26
p=0.444
r=0.044
n=26
p=0.831
r=0.203 ‘
n=26
p=0.320
1=0.064
n=27
p=0.751
r=
n=27
p=0.506
1=0.132
n=27
pf=0.511
1=0.191
n=27
p=0.339
1=0.045
ir=27
p=0.822
% Starch z=0311
n=26
p=0.122
1=0.173
if=26
p=0.399
i=
ir=26
p=0.200
1=0.301
ii=26
p=0.135
1=0.324
n=26
p=0.106
1=0.089 
n=27
p=0.660
1=0.225
n=27
p=0.259
1=0.066
n=27
p=0.743
1=0.144
n=27
p=0.475
1=0.383
n=27
p=0.048*
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Table 8 c. Correlations between tryptophan and tryptophan metabolites and % food
intake during the Premenstrual phases of the Menstrual Cycle
Metabolite/
Percentage
intake
TRY 5HT HIAA AA IAA KY HK HA QA NA
Mean of cydes 
% Fat
r=0.179
n=32
p=0326
1=0.099
n=32
p=0.589
r=-0.249
ir=32
p=0.170
1=0.045
n=32
p=0.809
r=-0.071
n=32
p=0.700
r=0.004
n=32
p=0.984
r=0.167
n=32
p=0362
r=0.164
rt=32
p=0.370
r=0.081
n=32
p=0.660
r=0.111
n=32
p=0.544
% Protein r=0.053
n=32
p=0.772
r=0.049
n=32
p=0.791
r=0.055
rr=32
p=0.766
r=-0.230
n=32
p=0.206
r=-0.279
n=32
p=0.121
r=
n=32
p=0.847
1=0.209
n=32
p=0.252
1=0.018
n=32
p=0.923
1=0.158
n=32
p=0.389
1=0.014
n=32
p=0.938
% Carbohydrate r=0.048
n=32
p=0.794
i=
n=32
p=0.839
r=0.157
n=32
p=0.390
t=0.042
rr=32
p=0.818
r=0.148
n=32
p=0.420
r=-0.164
n=32
p=0.369
1=0.183
n=32
p=0.317
r=0.139
rt=32
p=0.449
1=0.119
n=32
p=0.516
1=0.079
n=32
p=0.668
% Sigar r=0.201
n=32
p=0.270
r=0.083
rr=32
p=0.654
r=0.135
n=32
p=0.460
r=0.036
rr=32
p=0.845
r=0.196
n=32
p=0.283
r=-0.034
ir=32
p=0.853
r=0.021
n=32
p=0.908
r=0.211
n=32
p=0.246
r=0.147
n=32
p=0.422
r=0.307
n=32
p=0.087
% Starch 1=0.065
n=32
p=0.723
r=-0.102
n=32
p=0.580
r=0.073
n=32
p=0.690
r=0.072
n=32
p=0.696
r=-0.003
n=32
p=0.986
i=-0.073
n=32
p=0.693
r=0.163
n=32
p=0.373
r=0.073
n=32
p=0.691
1=0.252
n=32
p=0.165
r=0.146
n=32
p=0.426
Cyde One 
% Fat
r=-0.238
n=29
p=0.214
l=-0.241
n=29
p=0.209
r=-0.191
n=29
p=O320
r=-0.011
n=29
p=0.955
r=-0.102
n=29
p=0.598
r=-0.186
n=30
p=0.325
r=0.422
rr=30
p=0.02Q*
1=0.005
n=30
p=0.980
r=0.027
n=30
p=0.887
1=0.178
n=30
p=0348
% Protein r=0.220
n=29
p=0.251
r=0.256
if=29
p=0.181
r=0.279
n=29
p=0.142
r=0.045
n=29
p=0.819
r=-0.128
n=29
p=0.509
r=0.251
if=30
p=0.180
r=0.037
n=30
p=0.845
1=0.005
n=30
p=0.979
1=0.036
n=30
p=0.850
1=0.164
n=30
p=0.387
% Carbohydrate r=0.296
n=29
p=0.119
t=0.201
n=29
p=0.296
r=0.264
n=29
p=0.167
r=0.258
n=29
p=0.177
r=0.166
n=29
p=0.388
r=-0.167
n=30
p=0377
r=0303
n=30
p=0.103
r=0.053
n=30
p=0.781
r=0.083
rr=30
p=0.662
1=0.090
n=30
p=0.635
% Sugar r=0.268
n=29
p=0.160
r=0.246
n=29
p=0.199
r=0.091
ir=29
p=0.638
r=0.116
n=29
p=0350
r=0.244
ir=29
p=0.202
r=-0.100
n=30
p=0.598
r=0.099
n=30
p=0.604
r=0.055
n=30
p=0.775
r=0.035
n=30
p=0.853
i=0.001
n=30
p=0.997
% Starch r=0.205
n=29
p=0.286
1=0.067
n=29
p=0.732
r=0.237
n=29
p=0.215
r=0.242
n=29
p=0.206
r=0.131
rt=29
p=0.499
r=-0.033
rr=30
p=0.864
1=0.177
n=30
p=0.350
1=0.153
rr=30
p=0.419
1=0.236
11=30
p=0.209
r=
ir=30
p=0.638
Cyde Two 
% Fat
r=-0.152
n=26
p=0.458
r=-0.256
n=26
p=0.207
r=-0.381
n=26
p=0.055
r=-0.124
n=26
p=0.547
r=-0.174
hf26
p=0394
r=-0.102
if=26
p=0.619
r=0.190
xf=26
p=0352
i=0.032
n=26
p=0.878
r=0.101
ir=26
p=0.625
1=0.014
it=26
p=0.946
°/o Protein r=-0.024
ir=26
p=0.906
r=0.034
if=26
p=0.870
r=-0.041
n=26
p=0.842
r=0.314
n=26
p=0.119
r=-0.055
n=26
pF=0.789
r=-0.212
n=26
p=0.298
r=0.164
n=26
p=0.422
r=0.041
if=26
p=0.843
1=0.088
n=26
p=0.671
1=0.185
n=26
p=0.366
% Carbohydrate 1=0.131
n=26
p=0.524
r=0.194
ir=26
p=0.342
r=0.416
n=26
p=0.035*
r=O.054
n=26
p=0.793
r=0.186
n=26
p=0.363
r=0.059
ir=26
p=0.774
1=0.166
rr=26
p=0.419
i=
ir=26
p=0.965
r=0.356
n=26
p=0.074
1=0.001 
n=2 6 
p=0.998
% Sugar r=0.187
ir=26
p=0.359
r=0329
n=26
p=0.101
r=0.414
n=26
p=0.035*
r=
n=26
p=0.679
r=0.137
n=26
p=0.506
r=0.143
n=26
p=0.487
1=0.130
rr=26
p=0.528
1=0.176
n=26
p=0.389
r=0.039
n=26
p=0.849
r=0.441
n=26
p=0.024*
% Starch r=-0.054
if=26
p=0.792
r=-0.040
n=26
p=0.847
r=0.126
n=26
p=0.541
r=0.021
rr=26
p=0.920
r=0.105
if=26
p=0.09
i=0.031
n=26
p=0.883
r=0.191
n=26
p=0351
1=0.153
if=26
p=0.455
r=0.530
n=26
p=0.005*»
1=0.357
ii=26
p=0.073
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Table 9 a. Correlations Between Tryptophan and Tryptophan Metabolites and
Subjective Appetite Ratings During the Follicular Stage of the Mean of Both
Cycles
Subjective
Appetite/
Tiyptophan
Metabolites
Hunger Appetite Satiation Satiety
Dietaiy
Restraint- food 
types
Dietaiy 
Restraint - 
Amount
Ate more than 
usual Cravings
Tiyptophan r=0.264 i=032I 1=0.333 1=0.439 r=0.287 r=0.335 1=0.094 1=0.287
n=32 ir=32 n=32 n=32 n=32 n=32 n=32 n=32
p=0.144 p=0.073 p=0.062 p=0.012 p=0.111 p=0.061 p=0.610 p=0.1Il
Serotoiin 1=0.151 1=0.232 1=0329 1=0.335 1=0.080 1=0.306 1=0.134 1=0.236
n=32 it=32 n=32 n=32 n=32 n=32 n=32 ii=32
p=0.4I0 p=0.201 p=0.208 p=0.061 p=0.662 p=0.089 p=0.466 p=0.193
5HIAA r=0.180 1=0.162 1=0.276 1=0.287 i=0.113 r=0344 1=0.130 1=0.190
ii=32 n=32 ir=32 rr=32 n=32 n=32 n=32 n=32
p=0.326 p=0.377 p=0.126 p=0.112 p=0.540 p=0.054 p=0.477 p=0.298
AA 1=0.118 1=0.083 1=0.033 r=0.244 1=0.172 r=0.221 1=0.110 r=0.093
n=32 n=32 n=32 n=32 if=32 it=32 ir=32 it=32
p=0.519 p=0.651 p=0.857 p=0.178 p=0.345 p=0.223 p=0.549 P=
IAA i=0.253 1=0.191 1=0.137 1=0.259 1=0.097 1=0.425 1=0.078 1=0.046
n=32 n=32 rt=32 n=32 n=32 n=32 n=32 n=32
p=0.163 p=0.294 p=0.454 p=0.152 p=0.599 p=0.015 p=0.671 p=0.803
KY 1=0.145 r=O.036 1=0.105 1=0.074 1=0.241 1=0.067 1=0.022 1=0.095
n=32 n=32 ir=32 n=32 n=32 n=32 n=32 n=32
p=0.430 p=0.844 p=0.567 p=0.688 p=0.183 p=0.717 p=0.906 p=O.606
HK i=O.140 1=0.067 r=0.110 1=0.006 1=0.051 1=0.003 r=0.221 r=0.197
n=32 ir=32 n=32 n=32 n=32 n=32 n=32 n=32
p=0.445 p=0.714 p=0.551 p=0.972 p=0.784 p=0.987 p=0.225 p=0.280
HA 1=0.187 1=0.175 1=0.184 1=0.309 r=0.056 1=0.096 r=0.070 r=0374
n=32 n=32 n=32 n=32 n=32 n=32 n=32 n=32
p=0305 p=0337 p=0314 p=0.085 p=0.761 p=0.603 P= p=0.129
QA 1=0.037 1=0.021 1=0.170 r=0.232 i=0.059 1=0.100 i= 0340 1=0.265
rt=32 n=32 n=32 ii=32 n=32 m=32 n=32 n=32
p=0.840 p=0.909 p=0352 p=0.202 p=0.748 p=0.586 p=0.185 p=0.143
NA 1=0.197 1=0.057 1=0.131 1=0.180 1=0.203 1=0.019 1=0.017 i=0.037
n=32 n=32 n=32 n=30 ir=32 n=32 n=32 ir=32
p=0.279 p=0.755 p=0.476 p=0.323 p=0.264 p=0.916 p=0.925 p=0.841
73
Table 9 b. Correlations Between Tryptophan and Tryptophan Metabolites and
Subjective Appetite Ratings During the Luteal Stage of the Mean of Both Cycles
Subjective
Appetite/
Tiyptophan.
Metabolites
Hunger Appetite Satiation Satiety
Dietaiy 
Restraint- food 
types
Dietaiy 
Restraint - 
Amount
Ate more than 
usual Cravings
Tiyptophan 1=0.032 r=0.030 1=0.035 1=0.013 1=0.146 1=0.124 1=0.241 r=-0.248
n=32 n=32 n=32 n=32 n=32 n=32 n=32 n=32
p=0.862 p=0.871 p=0.850 p=0.944 p=0.427 p=0.499 p=0.185 p=0.171
Serotoiin i=-0.053 1=0.026 i=0.011 1=0.023 i=0.132 1=0.049 1=0.122 r=0.120
n=32 ir=32 ir=32 if=32 n=32 if=32 it=32 n=32
p=0.773 p=0.888 p=0.954 p=0.900 p=0.470 p=0.789 P= p=0.515
5HIAA 1=0.106 1=0.156 i=0.196 r=0.217 1=0.015 1=0.272 1=0.013 1=0.157
ir=32 n=32 n=32 n=32 n=32 rr=32 n=32 n=32
p=0.565 p=0.394 p=0.283 p=0.234 p=0.935 p=0.131 p=0.943 p=0.391
AA 1=0.129 1=0.076 i=0.014 1=0.078 1=0.061 1=0.048 1=0.228 1=0.040
ir=32 n=32 n=32 n=32 rr=32 n=32 n=32 n=32
p=0.483 p=0.678 p=0.940 p=0.673 p=0.740 p=0.795 p=0.210 p=0.829
IAA i=-0.202 1=0.254 1=0.318 1=0.278 1=0.333 1=0.157 1=0.149 1=0.000
ir=32 ir=32 n=32 n=32 • n=32 n=32 if=32 if=32
p=0.268 p=0.162 p=0.076 p=0.123 p=0.062 p=0.392 p=0.416 p=0.000«*
KY 1=0.024 1=0.071 i=0.I61 1=0.130 r=0.010 1=0.051 1=0.182 r=0.392
n=32 n=32 n=32 n=32 n=32 n=32 n=32 n=32
p=0.895 p=0.698 p=0.378 p=0.477 p=0.955 P= p=0318 p=0.026*
HK r=0.107 1=0.133 1=0.036 1=0.138 1=0.206 1=0.065 1=0.137 1=0.093
n=32 n=32 n=32 if=32 n=32 ir=32 n=32 n=32
p=0.561 p=0.469 p=0.843 p=0.451 p=0.259 p=0.724 p=0.456 p=0.615
HA 1=0.158 r=0.249 r=0.253 r=0.326 1=0.067 1=0.109 1=0.004 1=0.103
ii=32 n=32 n=32 ir=32 n=32 ir=32 if=32 if=32
p=0387 p=0.169 p=0.163 P= p=0.716 p=0.552 p=0.984 p=0.574
QA r=0311 1=0.108 1=0.108 1=0.061 r=0.274 . i=0.I8I 1=0.137 1=0.144
n=32 n=32 n=32 n=32 m=32 n=32 n=32 it=32
p=0.084 p=0.558 p=0.555 p=0.738 p=0.130 p=O320 p=0.455 p=0.432
NA r=0.217 1=0.128 1=0.115 r=0.251 r=0.131 1=0.252 1=0.111 r=0.144
n=32 n=32 n=32 ir=32 n=32 n=32 n=32 n=32
p=0.233 p=0.486 p=0.532 p=0.166 P= p=0.164 p=0.546 p=0.431
74
Table 9 c. Correlations Between Tryptophan and Tryptophan Metabolites and
Subjective Appetite Ratines During the Premenstrual Stage of the Mean of Both
Cycles
Subjective
Appetite/
Tryptophan
Metabolites
Hunger Appetite Satiation Satiety
Dietaiy 
Restraint- food 
types
Dietaiy 
Restraint - 
Amount
Ate more te n  
usual Cravings
Tiyptophan 1=0.059 1=0.063 1=0.045 1=0.048 1=0.022 1=0.014 1=0.234 1=0.040
n=32 n=32 ii=32 il=32 n=32 n=32 n=32 n=32
p=0.751 p=0.732 p=0.808 p=0.793 p=0.905 p=0.940 p=0.198 p=0.828
Serotonin 1=0.112 r=0.106 1=0.117 r=0.102 1=0.013 1=0.076 1=0.239 r=0.029
ir=32 «=32 n=32 n=32 n=32 n=32 n=32 n=32
p=0.540 p=0.564 p=0.524 P= p=0.944 p=0.678 p=0.188 p=0.873
5HIAA r=0.107 1=0.066 1=0.063 r=0.119 1=0.190 1=0.092 1=0.246 1=0.063
n=32 n=32 ir=32 n=32 n=32 n=32 n=32 n=32
p=0.560 p=0.7I8 p=0.733 p=0.517 p=0.297 p=0.616 p=0.175 p=0.733
AA r=-0.003 1=0.020 i=0.I46 1=0.062 i=0.265 1=0.040 1=0.017 1=0.205
n=32 n=32 n=32 n=32 n=32 rt=32 n=32 n=32
p=0.988 p=0.915 p=0.425 p=0.735 P= p=0.829 p=0.928 p=0.260
IAA r=0.240 i=0.232 1=0.123 r=0.200 1=0.235 1=0.084 1=0.051 1=0.158
rr=32 n=32 n=32 n=32 • n=32 n=32 n=32 n=32
p=0.186 p=O.202 p=0.502 p=0.273 p=0.196 p=0.649 p=0.78I p=0.388
KY 1=0.051 1=0.073 1=0.105 1=0.115 1=0.102 1=0.042 1=0.111 1=0.218
n=32 n=32 n=32 n=32 n=32 rt=32 n=32 n=32
p=0.782 p=0.693 P= p=0.532 p=0.581 p=0.820 p=0.547 p=0.232
HK r=0.123 1=0.076 r=0.296 1=0.008 1=0.094 1=0.225 r=0.184 1=0.008
n=32 if=32 n=32 n=32 n=32 n=32 n=32 n=32
p=0.503 p=0.680 p=0.100 p=0.966 p=0.609 p=0.215 p=0.314 p=0.967
HA r=0.041 1=0.089 1=0.092 1=0.019 1=0.039 1=0.178 1=0.014 1=0.155
n=32 n=32 n=32 n=32 n=32 n=32 n=32 n=32
p=0.824 p=0.627 p=0.617 p=0.919 p=0.831 p=0.330 p=0.941 p=0397
QA i=0.295 r=-0.295 r=0.166 i=0.184 i=0.128 1=0.009 i=0.153 1=0.069
n=32 n=32 n=32 n=32 n=32 n=32 n=32 n=32
p=0.102 p=0.101 p=0364 p=0314 p=0.485 p=0.961 p=0.404 p=0.707
NA i=0.127 1=0.125 1=0.017 1=0.057 1=0.168 1=0.018 1=0.282 r=0.033
n=32 n=32 n=32 if=32 n=32 n=32 it=32 n=32
p=0.488 P= p=0.926 p=0.757 p=0359 p=0.922 p=0.118 p=0.856
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Table 10 a. Correlations Between Tryptophan and Tryptophan Metabolites and
Subjective Appetite Ratings During the Follicular Stage of the Cycle One
Subjective
Appetite/
Tiyptophan
Metabolites
Hunger Appetite Satiation Satiety
Dietaiy 
Restraint- food 
types
Dietaiy 
Restraint - 
Amount
Ate more than 
usual Cravings
Tiyptophan 1=0.121 1=0.177 1=0.126 1=0.204 1=0.270 i=0.247 1=0.014 r=0.282
n=29 n=29 n=29 n=29 n=29 n=29 n=29 if=29
p=0.532 p=0358 p=0.514 p=0.287 p=0.157 p=0.197 p=0.944 p=0.136
Serotoiin 1=0.108 i=0.I79 1=0.000 r=0.182 1=0.032 1=0.123 1=0.058 1=0.164
n=29 n=29 n=29 it=29 n=29 n=29 n=29 ir=29
p=0.576 p=0.352 p=0.999 p=0.344 p=0.870 P= p=0.766 p=0.396
5HIAA 1=0.249 1=0.140 1=0.021 1=0.115 1=0.109 1=0.194 1=0.134 r=0.081
n=29 n=29 n=29 n=29 it=29 n=29 n=29 n=29
p=0.192 p=0.469 p=0.912 p=0.553- p=0.574 p=0.314 p=0.487 p=0.675
AA 1=0.002 1=0.151 r=0.047 r=0.111 1=0.151 1=0.033 1=0.170 r=0.256
n=29 n=29 if=29 if=29 n=29 n=29 n=29 n=29
p=0.993 p=0.435 p=0.807 P= p=0.433 p=0.864 p=0.377 p=0.180
IAA 1=0.150 r=0.309 1=0.036 1=0.263 1=0.108 r=0.154 1=0.169 1=0.142
n=29 n=29 n=29 n=29 if=29 n=29 n=29 re=29
p=0.438 p=0.103 p=0.852 p=0.168‘ p=0.578 p=0.424 p=0.381 p=0.462
KY 1=0.217 1=0.127 1=0.135 1=0.151 1=0.026 1=0.207 1=0.029 1=0.109
n=30 n=30 n=30 n=30 n=30 n=30 n=30 n=30
p=0.249 p=0.503 p=0.478 p=0.427 P= p=0.273 p=0.877 p=0.567
HK 1=0.027 1=0.064 1=0.078 1=0.168 1=0.005 r=0.023 1=0.132 i= 0362
n=30 n=30 n=30 n=30 n=30 n=30 if=30 n=30
p=0.889 p=0.735 p=0.683 p=0375 p=0.978 p=0.904 p=0,488 pf=0.049*
HA i=-0.083 i=0.202 1=0.344 1=0.288 1=0.254 1=0.076 1=0.004 1=0.209
n=30 n=30 n=30 n=30 if=30 n=30 if=30 ir=30
p=0.662 p=0.285 P= p=0.123 p=0.177 p=0.692 p=0.985 p=0.269
QA 1=0.167 1=0.173 1=0.234 r=0.233 1=0.143 1=0.040 1=0348 i=0395
n=30 if=30 n=30 n=30 n=30 n=30 n=30 ir=30
p=0.377 p=0.361 p=0.213 p=0.215 p=0.451 p=0.834 p=0.060 p=O.I14
NA 1=0.149 i=0.239 1=0.013 1=0.068 i=0381 1=0.116 1=0.138 r=0.007
n=30 n=30 n=30 tt=30 n=30 ir=30 n=30 n=30
p=0.431 p=0.204 p=0.947 p=0.722 p=0.038* p=0.541 p=0.466 p=0.972
76
Table 10 b. Correlations Between Tryptophan and Tryptophan Metabolites and
Subjective Appetite Ratings During the Luteal Stage Cycle One
Subjective
Appetite/
Tiyptophan
Metabolites
Hunger Appetite Satiation Satiety
Dietaiy 
Restraint- food 
types
Dietaiy 
Restraint - 
Amount
Ate more than 
usual Cravings
Tiyptophan 1=0.076 1=0.070 r=-0.112 1=0.000 1=0.037 r=0.024 1=0.055 1=0.069
n=28 n=28 n=28 n=28 n=28 n=28 n=28 n=28
pp=0.702 p=0.723 p=0.551 p=0.999 p=0.856 p=0.904 p=0.781 p=0.727
Serotonin r=-0.095 r=0.054 r=-0.009 r=0.101 1=0.056 1=0.064 1=0.089 r=0.005
n=28 n=28 n=28 n=28 ir=28 n=28 n=28 n=28
p=0.632 p=0.786 P= p=0.611 p=0.777 p=0.917 p=0.652 pf=0.979
5HIAA 1=0.018 1=0.062 r=-0.183 1=0.198 i=0.084 1=0.021 1=0.178 1=0.073
if=28 n=28 n=28 n=28 n=28 n=28 n=28 n=28
p=0.929 p=0.752 p=0.350 p=0.311 p=0.673 p=0.917 p=0365 p=0.711
AA 1=0.248 r=-0.214 i=-0.042 1=0.063 1=0.022 1=0.049 1=0.004 1=0.066
n=28 n=28 n=28 n=28 n=28 n=28 ir=28 n=28
p=0.203 p=0.274 p=0.831 p=0.750 p=0.910 p=0.806 p=0.985 p=0.740
IAA i=-0.001 r=-0.078 r=0.120 i=0.132 1=0.265 1=0.217 1=0.131 1=0.153
n=28 n=28 n=28 n=28 n=28 n=28 rf=28 n=28
p=0.997 p=0.692 p=0.544 p=0.504 p=0.173 p=0.267 p=0.506 p=0.436
KY 1=0.152 1=0.185 r=-0.070 1=0.282 1=0.046 1=0.057 1=0.196 1=0.231
n=29 n=29 n=29 ir=29 n=29 n=29 n=29 n=29
p=0.431 P= p=0.717 p=0.138 p=0.813 p=0.771 p=0309 p=0.229
HK 1=0.273 1=0.216 r=-0.270 1=0.127 r=0.352 1=0.231 i=0.186 1=0.011
ir=29 n=29 if=29 n=29 n=29 n=29 n=29 n=29
p=0.153 p=0.261 p=0.157 p=0.512 p=0.061 p=0.228 p=0.335 p=0.954
HA 1=0.231 r=0.303 i=0386 i=0.423 i=0.110 r=0.034 1=0.070 i=0.132
n=29 n=29 n=29 n=29 n=29 n=29 n=29 n=29
p=0.228 p=0.110 p=0.038* p=0.022* p=0.570 p=0.860 p=0.718 p=0.494
QA i=-0.067 1=0.162 1=0.124 1=0.294 1=0.210 i=0374 r=0.056 1=0.113
n=29 n=29 n=2 9 n=29 n=29 if=29 n=29 n=29
p=0.731 p=0.402 p=0.521 p=0.121 p=0.274 p=0.046 p=0.772 p=0359
NA r=-0.223 1=0.122 1=0.044 1=0.172 t=0.291 i=0306 1=0.432 1=0.117
n=29 n=29 n=29 n=29 n=29 n=29 n=29 n=29
P= p=0.529 p=0.821 p=0373 p=0.126 p=0.106 p=0.019* p=0.547
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Table 10 c. Correlations Between Tryptophan and Tryptophan Metabolites and
Subjective Appetite Ratings During the Premenstrual Stage of Cycle One
Subjective
Appetite/
Tiyptophan
Metabolite*
Hunger Appetite Satiation Satiety
Dietaiy
Restraint* food 
types
Dietaiy 
Restraint - 
Amount
Ate more than 
usual Cravings
Tiyptophan 1=0.036 r=0.125 1=0.053 r=0.027 1=0.065 r=O.071 1=0.019 t=0.129
n=29 n=29 n=29 if=29 n=29 n=29 n=29 it=29
p=0.853 pO.519 p=0.784 p=0.888 p=0.739 p=0.715 p=0.923 p=0.504
Serotoiin 1=0.063 i=0.U2 1=0.161 1=0.095 1=0.013 1=0.078 1=0.134 1=0.219
if=29 if=29 n=29 n=29 n=29 n=29 n=29 n=29
p=0.745 p=0.563 p=0.404 p=0.623 p=0.945 p=0.688 p=0.487 p=0.254
5HIAA 1=0.343 1=0.362 1=0.345 r=0.284 1=0.406 1=0.254 1=0.099 1=0.051
n=29 n=29 n=29 n=29 n=29 n=29 n=29 n=29
p=0.069 p=0.053 p=0.066 p=0.135 p=0.029* p=0.183 p=0.609 p=0.795
AA r=0.031 1=0.096 1=0.035 1=0.034 1=0.350 r=O.018 1=0.365 1=0.118
it=29 n=29 ii=29 n=29 n=29 n=29 n=29 n=29
P= p=0.621 p=0.859 p=0.86I p=0.063 pO.926 p=0.052 p=0.543
IAA r=O.007 1=0.014 1=0.050 1=0.051 1=0.012 1=0.142 i=0.14 1=0.129
n=29 n=29 ir=29 n=29 n=29 n=29 ir=29 n=29
p=0.970 p=0.943 p=0.797 p=0.792 p=0.951 p=0.462 p=0.944 p=0.504
KY 1=0.119 r=0.072 1=0.143 1=0.076 r=O.044 1=0.109 1=0.142 1=0.095
if=30 n=30 n=30 if=30 if=30 n=30 ii=30 n=30
p=0.532 p=O.705 p=0.452 p=0.690 p=0.818 p=0.566 pO.455 p=0.618
HK 1=0.324 1=0.243 r=0.087 1=0.199 1=0.004 1=0.122 1=0.154 1=0.040
n=30 n=30 ir=30 ir=30 ir=30 n=30 n=30 n=30
p=0.081 p=0.195 p=0.649 p=0.293 p=0.985 p=0.521 pO.416 p=0.833
HA 1=0.196 1=0.180 1=0.132 1=0.194 1=0.144 1=0.151 1=0.147 1=0.115
n=30 ii=30 n=30 n=30 if=30 n=30 n=30 n=30
p=0.300 p=0342 p=0.487 p=0305 p=0.447 p=0.425 p=0.438 P=
QA i=-0.134 1=0.123 1=0.055 1=0.059 r=0.005 r=0.047 1=0.052 1=0.183
ir=30 n=30 n=30 n=30 n=30 n=30 n=30 n=30
p=0.482 pO.518 p=0.775 p=0.756 p=0.979 p=0.806 p=0.785 p=0.333
NA 1=0.089 1=0.081 1=0.152 i=0.089 i=0.153 1=0.104 i=0346 r=0.047
n=30 n=30 n=30 n=30 n=30 if=30 rr=30 n=30
p=0.639 p=0.670 p=0.422 p=0.640 p=0.418 p=0.586 p=0.061 p=0.807
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Table 11a.  Correlations Between Tryptophan and Tryptophan Metabolites and
Subjective Appetite Ratings During the Follicular Stage Cvcle Two
Subjective
Appetite/
Tiyptophan
Metabolitee
Hunger Appetite Satiation Satiety
Dietaiy 
Restraint- food 
types
Dietaiy 
Restraint - 
Amount
Ate more than 
usual Cravings
Tiyptophan r=0.236 r=0.447 i=0306 r=0.340 i=0378 1=0.466 r=0313 1=0.089
n=25 n=25 n=25 n=25 if=25 n=25 n=25 n=25
p=0.256 p=0.025 p=0.137 p=0.096 p=0.062 p=0.019* p=0.127 p=0.673
Serotonin r=0.255 i=OJ37 i=-0.193 1=0.237 1=0.189 1=0.191 1=0.191 1=0.099
n=25 if=25 n=25 if=25 n=25 n=25 n=25 if=25
p=0.219 P= p=0.356 p=0.254 p=0.365 p=0.361 p=0361 p=0.638
5HIAA 1=0.230 1=0.321 1=0.339 1=0.218 1=0.097 1=0.128 1=0.083 1=0.096
n=25 re=25 ir=25 n=25 n=25 n=25 n=25 n=25
p=0.269 p=0.U7 p=0.098 p=0396 p=0.646 p=0.543 p=0.693 p=0.649
AA r=-0.024 r=O.029 i=0.088 i=0.035 1=0.061 1=0.132 1=0.080 r=0.298
n=25 n=25 n=25 n=25 if=25 n=25 ir=25 n=25
p=0.908 p=0.890 p=0.676 p=0.867 p=0.773 p=0.529 p=0.704 p=0.148
IAA 1=0.052 1=0.052 1=0.281 1=0.007 1=0.094 1=0.032 1=0.128 1=0.372
n=25 n=25 n=25 n=25 if=25 ir=25 n=25 n=25
p=0.805 p=0.807 p=0.173 p=0.975 p=0.654 p=0.878 p=0.541 p=0.067
KY 1=0.182 r=0.196 r=0.176 r=0.032 1=0.117 1=0.062 r=0.255 r=0.038
n=25 ir=25 if=25 n=25 n=25 n=25 n=25 ne=25
P= p=0.347 p=0.401 p=0.881 p=0.576 p=0.768 p=0.219 p=0.858
HK r=-0.213 1=0.061 1=0.026 t=0.204 1=0.214 1=0.099 1=0.144 i=0.019
n=25 if=25 ir=25 n=25 rt=25 if=25 ir=25 n=25
p=0.307 p=0.772 p=0.904 p=0.328 p=0.305 p=0.636 p=0.494 p=0.929
HA r=0372 r=0.237 r=0.237 r=0.275 i=0.142 r=0.029 r=0.245 1=0.019
n=25 n=25 if=25 n=25 if=25 n=25 n=25 n=25
p=0.067 p=0.254 p=0.254 p=0.184 p=0.497 p=0.891 p=0.239 p=0.929
QA 1=0.024 r=0.198 r=0.290 1=0.222 1=0.251 r=0373 1=0.349 1=0.019
ir=25 n=25 if=25 n=25 n=25 if=25 n=25 n=25
p=0.909 p=0.342 p=0.159 p=0.287 p=0327 p=0.066 p=0.088 p=0.928
NA 1=0.007 1=0.018 1=0.186 i=0.I51 1=0.091 1=0.093 1=0.077 1=0.266
n=25 n=25 ii=25 n=25 n=25 n=25 n=25 n=25
p=0.973 p=0.934 p=0373 p=0.470 p=0.666 p=0.658 p=0.716 P=
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Table l i b .  Correlations Between Tryptophan and Tryptophan Metabolites and
Subjective Appetite Ratines During the Luteal Stage of Cycle Two
Subjective
Appetite/
Tryptophan.
Metabolites
Hunger Appetite Satiation Satiety
Dietary 
Restraiirt- food 
types
Dietary 
Restraint - 
Amount
Ate more than 
usual Cravings
Tryptophan r=-0.044 r=-0.134 1=0.168 r=-0.212 1=0.008 1=0.169 i=0344 1=0.229
n=26 ir=26 rr=26 n=26 n=26 n=26 n=26 n=26
p=0.832 p=0.515 p=0.412 p=0.299 p=0.968 p=0.410 p=0.086 p=0.260
Serotonin r=0.153 r=0.040 r=0.025 r=-0.029 1=0.004 1=0.079 r=0.054 1=0.138
n=26 n=26 n=26 n=26 n=26 n=26 n=26 n=26
p=0.456 p=0.845 p=0.902 p=0.888 p=0.985 p=0.701 p=0.795 p=0.502
5HIAA r=0.126 t=0.026 r=-0.082 r=0.095 1=0.072 1=0.420 1=0.084 r=0.056
n=26 n=26 n=26 rr=26 n=26 nf=26 11=26 it=26
p=0.551 p=0.898 p=0.691 p=0.644 p=0.729 p=0.033* p=0.683 p=0.784
AA r=-0.185 r=-0.291 1=0.199 r=-0.021 1=0.079 r=0.074 1=0.095 1=0.099
n=26 n=26 n=26 n=26 n=26 rr=26 n=26 n=26
p=0.366 p=0.149 p=0.330 p=0.918 p=0.702 p=0.721 p=0.644 P=
IAA r=0.291 r=-0.427 r=0.414 r=-0.413 1=0.048 r=0.037 1=0.165 1=0.337
n=26 rr=26 n=26 n=26 ir=26 n=26 n=26 n=26
p=0.150 p=0.030* p=0.036* p=0.036* p=0.815 p=0.859 p=0.420 p=0.093
KY r=-0.034 r=-0.017 r=-0.093 r=-0.021 1=0.056 r=0.085 1=0.281 1=0.358
if=27 n=27 n=27 n=27 if=27 n=27 n=27 n=27
p=0.866 p=0.932 p=0.645 p=0.917 p=0.780 p=0.673 p=0.156 p=0.067
HK r=-0.223 r=-0.179 r=0.186 r=0.033 r=0.008 1=0.079 1=0.228 1=0.052
n=27 n=27 n=27 ir=27 n=27 n=27 n=27 n=27
p=0.263 p=0.373 p=0352 p=0.871 p=0.969 p=0.695 p=0.253 p=0.796
HA r=-0.012 r=-0.009 r=-0.110 r=0.166 1=0.097 1=0.128 1=0.066 1=0.001
n=27 rr=27 n=27 if=27 nH27 n=27 n=27 ir=27
p=0.954 p=0.963 p=0.586 p=0.407 p=0.632 p=0.525 P= p=0.997
QA 1=0.431 r=-0.291 t=0.451 r=0.416 1=0.175 1=0.054 i=0.215 r=0.064
n=27 n=27 n=27 n=27 n=27 n=27 n=27 if=27
p=0.025* p=0.140 p=0.018* p=0.031* p=0.384 p=0.788 p=0.281 p=0.752
NA r=0.280 1=0.287 r=0.279 1=0.275 1=0.109 i=0.193 1=0.016 1=0.167
n=27 n=27 n=27 ir=27 n=27 if=27 n=27 if47
p=0.157 p=0.147 p=0.159 p=0.166 p=0.590 p=0.336 p=0.936 p=O.405
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Table 11c.  Correlations Between Tryptophan and Tryptophan Metabolites and
Subjective Appetite Ratines During the Premenstrual Stage of Cycle Two
Subjective
Appetite/
Tryptophan
Metabolites
Hunger Appetite Satiation Satiety
Dietary 
Restraint- food 
types
Dietary 
Restraint- 
Amount
Ate more than 
usual Cravings
Tryptophan 1=0.054 r=0.016 1=0.030 r=0.121 1=0.064 r=0.203 1=0.067 1=0.016
n=26 n=26 n=26 n=26 rt=26 rr=26 n=26 n=26
p=0.793 p=0.939 p=0.883 p=0.555 p=0.755 p=0.320 p=0.745 p=0.937
Serotonin r=-0.046 r=-0.018 1=0.123 r=0.188 i=0.022 r=0.108 1=0.007 1=0.287
ii=26 n=26 n=26 n=26 n=26 n=26 itf26 n=26
p=0.823 p=0.931 p=0.551 p=0358 p=0.917 p=0.598 P= p=0.156
5HIAA r=0.173 r=-0.283 1=0.347 1=0.067 1=0.197 r=-0.212 1=0.307 1=0.207
n=26 n=26 rr=26 n=26 n=26 n=26 n=26 n=26
p=0.397 p=0.161 p=0.082 p=0:746 p=0.334 p=0.299 p=0.127 p=0.311
AA i=-0.054 1=0.243 1=0.321 1=0.014 1=0.050 r=0.042 1=0.193 1=0.142
n=26 n=26 n=26 rr=26 n=26 n=26 n=26 ii=26
p=0.793 p=0.231 p=0.110 p=0.945 p=O.807 p=0.839 p=0344 p=0.489
IAA r=-0.236 r=-0.117 1=0.100 1=0.079 1=0.124 r=0.225 r=0.016 1=0.003
n=26 n=26 n=26 if=26 n=26 n=26 n=26 n=26
p=0.246 p=0.569 p=0.626 p=0.700 p=0.548 p=0.268 p=0.937 p=0.990
KY i=-0.171 r=-0.286 1=0.433 r=0.066 1=0.038 1=0.080 r=0.313 1=0.020
n=26 if=26 n=26 n=26 n=26 n=26 if=26 ir=26
p=0.405 p=0.157 p=0.027* p=0.748 p=0.856 P= p=0.119 p=0.923
HK i=0.096 1=0.164 r=0.318 1=0.032 1=0.027 t=0.324 1=0.284 1=0.015
n=26 n=26 n=26 n=2 6 n=26 if=26 if=26 n=26
p=0.641 p=0.424 p=0.114 p=0.876 p=0.895 p=0.107 p=0.159 p=0.941
HA r=0.190 r=0.278 r=0.166 1=0.086 1=0.027 1=0.069 1=0.235 i=0.142
nr=26 n=26 n=26 n=26 n=26 n=26 ir=26 n=26
p=0354 p=0.169 p=0.418 P= p=0.908 p=O.740 p=0.248 p=0.489
QA r=-0.409 r=-0.431 r=0.403 r=0.255 1=0.216 1=0.198 1=0.249 1=0.066
n=26 n=26 n=26 n=2 6 n=26 n=26 n=26 n=26
p=0.038* p=0.028* p=0.041* p=0.209 p=0.289 p=0.334 p=0.220 p=0.750
NA r=-0.074 r=0.006 r=0.043 i=0.088 1=0.141 1=0.039 1=0.038 1=0.168
n=26 n=26 n=26 n=26 rr=26 n=26 n=26 if=26
p=0.720 p=0.975 p=0.834 p=0.670 P= p=0.849 p=0.852 p=0.411
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Table 12 a. Correlation between actual and percentage food intake with tryptophan
metabolite ratios, and enzyme activities during the follicular phase for the mean of
both menatrual cycles
Dietary measure/ 
Metabolite ratio
Kcal Protein Fat CHO Sugar Starch % Fat %
Protein
% CHO % Sugar %
Starch
5HT + HIAA i=-0.222
n=32
p=0.223
r=0.087
n=32
p=0.636
1=0.171
ir=32
p=0350
1=0.164
n=32
p=0.370
1=0.153
it=32
p=0.405
1=0.193
n=32
p=0.290
1=0.012
n=32
p=0.949
1=0.034
n=32
p=0.855
1=0.153
n=32
p=0.405
r=0.054
n=32
p=0.770
r=0.116
n=32
p=0327
Total kyimreiine r=0.132
n=32
p=0.473
1=0.014
n=32
p=0.940
r=-0.042
n=32
p=0.819
i=0307
n=32
p=0.255
r=0.214
n=32
p=0.240
1=0.313
n=32
p=0.08I
1=0.051
n=32
p=0.73
1=0.066
n=32
p=0.720
1=0.078
ii=32
p=0.670
1=0.057
n=32
p=0.756
i=
0.149
if=32
p=0.417
5HT=HIAA/ 
Total kynurenine
r=0.032
n=32
p=0.861
r=0.044
n=32
p=0.8U
1=0.045
n=32
p=0.808
1=0.105
n=32
p=0.567
1=0.189
ir=32
p=0.301
1=0.040
n=32
p=0.828
1=0.033
n=32
p=0.858
r=0.163
n=32
p=0.372
1=0.119
n=32
p=0.516
r=0.078
n=32
p=0.670
1=0.066
n=32
p=0.718
5HT + HIAA/ 
KY+H+HA
r=0.087
n=31
p=0.641
1=0.024
ir=31
p=0.897
r=0.147
n=31
p=0.431
r=0.107
n=31
p=0.567
1=0.004
n=31
p=0.983
r=0.270
n=31
p=0.I42
1=0.204
u=31
p=0.270
1=0.254
n=31
p=0.169
1=0.066
n=31
p=0.725
1=0.192
n=31
p=0.300
r=0.207
n=31
p=0.265
5HT + HIAA/ 
KY+HK
r=0314
rr=30
p=0.091
1=0.261
n=30
p=0.164
1=0.221
n=30
p=0.242
1=0.168
n=30
p=0376
1=0.247
n=30
p=0.188'
1=0.073
n=30
p=0.701
1=0.079
n=30
p=0.678
1=0.022
n=30
p=0.908
1=0.313
n=30
p=0.092
1=0.122
if =30
p=0.522
1=0.429
n=30
p=0.018
5HT/KY+HK 1=0.307
n=30
p=0.099
1=0.247
it=30
p=0.189
1=0.180
n=30
p=0.340
1=0.187
it=30
p=0.323
i=0.301
n=30
p=0.105
r=-0.082
ir=30
p=0.666
1=0.019
ii=30
p=0.921
1=0.015
n=30
p=0.940
1=0.230
n=30
p=0.221
1=0.206
n=30
p=0.274
1=0.389
n=30
p=0.034
*
5HT + HIAA/ 
AA
1=0.172 .
n=17
p=0.510
r=0.083
n=17
p=0.751
1=0.238
n=17
p=0.358
r=0.039
n=17
p=0.881
1=0.284
n=17
p=0.269
r=0.191
n=17
p=0.462
1=0392
n=17
p=0.119
1=0.478
11=17
p=0.052
i=0314
n=17
p=0.220
1=0.064
ir=17
p=0808
1=0.336
n=17
p=0.188
5HT + HIAA/ 
IAA
r=-0.361
n=29
p=0.055
1=0.062
n=29
p=0.751
r=0.259
n=29
p=0.176
1=0.459
n=29
p=0.012
1=0.338
n=29
p=0.073
1=0.404
n=29
p=0.030
1=0.079
n=29
p=0.683
1=0.415
i i =29
p=0.025
*
1=0.019
n=29
p=0.923
1=0.186
n=29
p=0333
i=
0.033
n=29
p=0.897
KY hydroxylase 
activity
r=0.261
n=30
p=0.163
r=0.112
rr=30
p=0.557
i=0.128
n=30
p=0.501
1=0.284
n=30
p=0.128
1=0.266
11=30
p=0.155
1=0.168
ir=30
p=0.374
1=0.049
n=30
p=0.797
1=0.178
n=30
p=0.347
1=0.001
n=30
p=0.997
t=0.056
11=30
p=0.767
1=0.044
n=30
p=0.818
Kynureiinase
activity
i=0.035
rr=17
=0.895
1=0.077
n=17
p=0.769
i=0.188
n=17
p=0.469
1=0.066
ir=17
p=0.800
r=0337
n=17
p=0.186
1=0372
n=17
p=0.142
r=0.135
n=17
p=0.605
1=0.276
n=17
p=0.284
1=0.138
n=17
p=0.597
1=0.138
n=17
p=0.597
1=0.417
n=17
p=0.096
MAO activity i=
rr=32
p=0.446
1=0.001
n=32
p=0.995
r=
n=32
p=0.114
1=0.003
n=32
p=0.989
i=
n=32
p=0.706
1=0.002
if=32
p=0.990
1=0.249
ir=32
p=0.170
i=
n=32
p=0.609
1=0.246
n=32
p=0.174
i=
n=32
p=0.276
1=0.225
n=32
p=0.216
MAO activity/ 
KY hydroxylase 
activity
r=0.620
n=17
p=0.008
*•
1=0.311
ii=17
p=0.224
i=0309
,n=17
p=0.228
1=0.529
n=17
p=0.029
*
i=0358
n=17
p=0.158
1=0.495
u=]7
p=0.043
1=0.128
n=17
p=0.626
1=0.537
n=17
p=0.026
*
1=0.034
n=17
p=.896
r=0367
ii=17
p=0300
r=
0.042
n=17
p=0.874
MAO activity/
Kynureiinase
activity
r=0.119
n=8
p=0.779
1=0.143
i f =8
p=0.736
1=0.191
n=8
p=0.651
r=0.048
it=8
p=0.911
1=0.405
i f =8
p=0.320
1=0.191
n=8
p=0.651
1=0.119
n=8
p=0.779
1=0.143
n=8
p=0.736
1=0.476
n=8
p=0.233
1=0.048
ii=8
p=0.911
1=0.143 
n=8 * 
p=0.736
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Table 12 b. Correlation between actual and percentage food intake with tryptophan
metabolite ratios, and enzvme activities during the follicular phase for cycle one
Dietary measure/ 
Metabolite ratio
Kcal Proton Fat CHO Svgar Starch % Fat %
Protein
% CHO % Sugar %
Starch
5HT + HIAA r=-0.037
n=29
p=0.851
1=0.002
if=29
p=0.992
1=0.053
it=29
p=0.784
1=0.025
n=29
p=0.899
1=0.117
n=29
p=0.546
1=0.157
n=29
p=0.417
1=0.063
n=29
p=0.744
1=0.115
ir=29
p=0.553
1=0.061
n=29
p=0.755
r=0.139
17=29
p=0.471
i =
0.074
n=29
p=0.701
Total kynurerine i=-0.070
n=29
p=0.718
1=0.002
n=29
p=0.992
1=0.049
rr=29
p=0.800
1=0.091
n=29
p=0.640
1=0.080
n=29
p=0.681
i=0.207
n=29
p=0.280
1=0.210
n=29
p=0.275
1=0.013
n=29
p=0.947
1=0.167
n=29
p=0.388
1=0.126
n=29
p=0.514
i =
0.060
77=29
p=0.759
5HT=H1AA/ 
Total kynurerine
1=0.213
n=29
p=0.267
1=0.167
n=29
p=0.387
1=0.057
n=29
{7=0.770
1=0.292
n=29
{7=0.124
1=0.289
n=29
p=0.128
1=0.219
n=29
p=0.270
1=0.221
n=29
p=0.249
1=0.168
if=29
p=0384
1=0.218
n=29
p=0.257
1=0.283
17=29
p=0.137
r =
0.027
n=29
p=0.889
5HT + HIAA/ 
KY+H+HA
1=0.143
rr=26
p=0.485
1=0.003
if=26
{7=0.988
1=0.120
if=26
p=0.559
1=0.170
n=26
p=0.407
1=0.136
n=26
p=0.509
1=0.268
n=26
p=0.186
1=0.044
n=26
p=0.831
1=0.244
17=26
p=0.229
1=0.163
n=26
p=0.426
1=0.101
17=26
p=0.624
1=0.117
n=26
p=0371
5HT + HIAA/ 
KY+HK
i=-0.080
it=26 
p=0.696
1=0.077
rr=26
p=0.709
1=0.119
ir=26
p=0_564
r=0.014
rr=26
p=0.946
1=0.000
ir=26
p=0.999
1=0.048
n=26
p=0.818
1=0.219
n=26
p=0.284
1=0.170
17=26
p=0.407
1=0.331
17=26
p=0.099
1=0.060
17=26
I>=0.772
1=0.201
n=26
p=0.326
5HT/KY+HK r=-0.160
rr=26
p=0.434
1=0.207
tf=26
p=0311
i=0.065
n=26
p=0.751
i=0.084
rr=26
p=0.682
r=0.104
n=26
{7=0.612
1=0.036
n=26
p=0.862
1=0.091
n=26
p=0.657
1=0.165
n=26
p=0.420
1=0.234
ir=26
p=O.250
1=0,045
n=26
p=0.828
1=0.210
n=26
{7=0.304
5HT + H1AA/ 
AA
r=-0.786
n=7
jj=0.036
1=0.250
it=7
p=0.589
1=0.893
n=7
p=0.007
m*
1=0.857
n=7
p=0.014
*
i=0.536 
if=7
p=0.215
1=0.750
n=7
p=0.052
1=0.429
17=7
p=0337
1=0.464
17=7
p=0.294
1=0.429 
IT=7
p=0.337
r=0.072
17=7
p=0.879
i =
0.071
17=7
p=0.879
5HT + HIAA/ 
IAA
1=0.132
ir=25
p=0_528
r=0.018
rr=25
p=0.933
1=0.224
n=25
p=0.282
1=0.245
n=25
p=0.237
1=0.024
n=25
p=0.910
1=0.251
if=25
p=0.227
1=0.233
n=25
p=0.263
1=0.225
ir=25
p=0.279
1=0.130
ir=25
pf=0.536
1=0.269
n=25
p=0.194
r=-
0.118
17=25
17=0.575
KY hydroxylase 
activity
1=0.009
rf=26
p=0.965
1=0.214
n=26
p=0.293
1=0.024
n=26
p=0.908
1=0.114
it=26
p=0.58I
1=0.009
n=26
p=0.964
1=0.033
if=26
p=0.872
1=0.038
n=26
p=0.854
1=0.222
17=26
p=0.275
1=0.093
n=26
p=0.651
1=0.047
n=26
p=0.820
i =
0.055
ir=26
p=0.791
Kynureiinase
activity
1=0.138
n=13
p=0.654
1=0.420
n=13
p=0.153
r=0.297
n=13
p=324
r=0.256
rr=13
p=0398
1=0.524
17=13
p=0.066
1=0.130
17=13
p=0.672
i=0353
17=13
p=0.237
1=0.587
17=13
p=0.035
*
f=0353
17=13
p=0.237
1=0.613
17=13
p=0.026
1=0.420
17=13
p=0.153
MAO activity r=0.118
n=29
p=0.543
r=
ir=29
p=0.316
1=0.137
n=29
p=O.480
i=
re=29
p=0.275
1=0.254
n=29
p=0.183
r=
n=29
p=0.530
i=
n=29
p=0.027
1=0.073
17=29
pf=0.707
i=
17=29
p=0.073
1=0.287
n=29
{7=0.132
i=
ir=29
p=0.905
MAO activity/ 
KY hydroxylase 
activity
r=0.448
n=12
p=0.145
r=0.112
n=12
p=0.729
1=0.217
n=12
p=0.499
r=0.685
17=12
p=0.014
1=0.427
ir=12
p=0.167
1=0.483
17=12
p=0.112
1=0.098
17=12
p=0.762
1=0.504
17=12
p=0.095
1=0.245
17=12
p=0.443
i=0.224
17=12
p=0.484
1=0.140
17=12
{7=0.665
MAO activity/
Kynureiinase
activity
r=0.500
n=3
p=0.667
i=0.5 00 
n=3
p=0.667
1=1.000
ir=3
p=0.000
*#*
1=1.000
rr=3
p=0.000
**•
1=1.000
17=3
p=0.000
1=1.000
17=3
p=0.000
1=0.500
17=3
p=0.667
1=1.000
17=3
p=0.000
1=1.000
17=3
p=0.000
1=1.000
17=3
p=0.000
1=1.000
17=3
p=0.000
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Table 12 c. Correlation between actual and percentage food intake with tryptophan
metabolite ratios, and enzyme activities during the follicular phase for cycle two
Dietary measure/ 
Metabolite ratio
Kcal Protein Fat CHO Sugar Starch % Fat %
Protein
% CHO % Sugar %
Starch
5HT + HIAA 1=0.222
ir=32
p=0.223
1=0.155
n=25
p=0.458
r=-0.204
rr=25
p=0.328
r=-0.474
n=25
p=0.017
«
1=0.499
n=25
p=0.011
*
1=0.225
n=25
p=0.280
1=0.131
n=25
p=0.533
1=0.452
n=25
p=0.023
*
1=0.147
n=25
p=0.484
1=0.113
n=25
p=0.592
1=0302
n=25
p=0.124
Total kynurerine r=-0.132
n=32
p=0.473
1=0.006
n=25
p=0.977
i=-0.292
n=25
p=0.156
r=-0.349
n=25
p=0.088
r=-0.347
n=25
p=0.089
r=0.259
n=25
p=0.212
1=0.062
ir=25
p=0.767
r=0.635
n=25
p=0.001
***
1=0.084
ir=25
p=0.690
1=0.037
17=25
p=0.862
1=0.292
ir=25
p=0.156
5HT=HIAA/ 
Total kynurerine
r=0.045
n=25
p=0.829
1=0.146
rr=25
p=0.486
r=0.086
n=25
p=0.682
r=-0.145
n=25
p=0.488
r=-0.030
n=25
p=0.887
1=0.074
n=25
p=0.726
1=0.112
n=25
p=0393
1=0.154
n=25
p=0.461
1=0.109
n=25
p=0.606
1=0.019
n=25
p=0.929
r=
0.003
n=25
o=0.990
5HT + HIAA/ 
KY+H+HA
r=-0.079
n=25
p=0.709
1=0.039
n=25
p=0.855
r=0.U9
rr=25
p=0.570
r=-0.076
rr=25
p=0.718
r=-0.129
rr=25
p=0.541
1=0.090
ir=25
p=0.669
1=0.182
n=25
p=0.385
1=0.013
17=25
p=0.951
1=0.174
n=25
p=0.405
1=0.069
17=25
p=0.742
H
i
5HT + HIAA/ 
KY+HK
r=-0.497
n=23
p=0.016
r=0.388
rr=23
p=0.067
r=-0.409
rr=23
p=O.053
r=-0.368
rr=23
p=0.084
r=0.251 
ir=23 
p=0.248
1=0.201
if=23
p=0.359
1=0.103
n=23
p=0.641
1=0.328
n=23
p=0.126
1=0.379
n=23
p=0.074
1=0.199
n=23
p=0362
1=0.409
n=23
p=0.53
5HT/KY+HK r=-0.494
n=23
p=0.017
*
r=-0.360
n=23
p=0.092
r=-0.362
ir=23
p=0.090
r=-0.412
n=23
p=0.051
r=0.351
n=23
p=0.101
r=0.196
n=23
p=0.371
1=0.015
n=23
p=0.946
1=0.345
17=23
p=0.108
1=0.299
n=23
p=0.167
r=0.79
ir=23
p=0.720
1=0.381
17=23
p=0.073
5HT + HIAA/ 
AA
1=0.268
rr=15
p=0.334
r=-0.06I
n=15
p=0.830
r=-0.182
rr=15
p=0.516
1=0.204
rr=15
p=0.467
r= 037I
n=15
p=0.173
r=0.175
if=15
p=0333
1=0.046
77=15
p=0.869
i=0.4I4
17=15
p=0.125
1=0.139
17=15
p=0.621
1=0.121
17=15
p=0.666
r=0.157
if=15
p=0376
5HT + HIAA/ 
IAA
1=0.157
n=23
p=0.474
r=0.270
n=23
p=0.213
r=-0.004
rr=23
p=0.986
i=0.166
n=23
p=0.449
1=0.126
n=23
p=0.568
r=0.123
n=23
p=0378
1=0.054
rr=23
p=0.805
1=0.617
n=23
p=0.002 
**■
1=0.093
n=23
p=0.672
1=0.226
n=23
p=.299
1=0.124
ir=23
p=0373
KY hydroxylase 
activity
r=-0.233
ir=22
p=0.298
r=-0.037
n=22
p=0.871
1=0.119
n=22
p=0.599
r=-0.197
n=22
p=0.381
1=0.218
n=22
p=0331
1=0.360
n=22
p=0.100
1=0.098
n=22
p=0.666
1=0.242
n=22
p=0.277
1=0.076
n=22
p=0..738
1=0.179
n=22
p=0.425
r=0.044
n=22
p=0.846
Kynurerinase
activity
1=0.146
17=9
p=0.708
r=-0.201
n=9
p=0.604
r=-0.091
n=9
p=0.815
r=-0.055
ir=9
p=0.889
1=0.456
n=9
p=0.217
1=0.055
n=9
p=0.889
1=0.383
17=9
p=0308
r=0.256
17=9
p=0.507
i= 0310
n=9
p=0.416
1=0.128
17=9
p=0.743
r =
0.128
17=9
p=0.743
MAO activity r=
n=25
p=0.658
1=0.057
n=25
p=0.787
r=
n=25
p=0.919
1=0.089
n=25
p=0.671
r=
n=25
p=0.767
1=0.092
n=25
p=0.661
1=0.016
n=25
p=0.939
r=
n=25
p=0.170
r=0.076
n=25
p=0.717
■ r=
17=25
p=0.540
1=0.015
n=25
p=0.945
. MAO activity/ 
KY hydroxylase 
activity
r=0.738
rr=8
p=0.037
1=0.571
n=8
p=0.139
1=0.286
n=9
p=0.493
r=0.810
n=8
p=0.015
1=0.667
n=8
p=0.071
1=0.833
n=8
p=0.010
*
1=0.524
17=8
p=0.183
1=0.000
17=8
p=0.000
1=0.238
17=8
p=0.570
1=0.191
17=8
p=0.65J
i =
0.143
17=8
p=0.736
MAO activity/ 
Kynureiinase 
activity
r=-0.300
ri=5
p=0.624
r=0.200
n=5
p=0.747
r=-0.100
rr=5
p=0.873
r=0300
n=5
p=0.624
1=0.100'
n=5
p=0.873
i=0300
n=5
p=0.624
r=0.400
77=5
p=0.505
1=0.500
17=5
p=0391
1=0300
17=5
p=0.624
1=0.100
17=5
p=0.873
r=0.700
17=5
p=0.188
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Table 13 a. Correlation between actual and percentage food intake with tryptophan
metabolite ratios, and enzyme activities during the luteal phase for the mean of
both menstrual cycles
Dietary measure/ 
Metabolite ratio
Kcal Protein Fat CHO Sugar Starch % Fat %
Protein
% CHO % Sugar %
Starch
5HT + HIAA r=-0.355
n=32
p=0.046
*
1=4)310
n=32
p=0.084
1=0.154
n=32
p=0.401
r=0.198
n=32
p=0.278
1=0.142 
rr=32 
p=0.440
1=0.170
n=32
p=0.353
1=0.009
n=32
p=0.959
1=0.056
n=32
p=0.762
1=0.037
n=32
p=0.841
1=0.016
n=32
p=0.930
r =
0.063
n=32
p=0.730
Total kynurerine r=0.127
if=32
p=0.488
1=0.202
n=32
p=0.268
r=0.114
n=32
p=0.534
1=0.135
rr=32
p=0.460
r=0.127
rr=32
p=0.489
r=0.053
rr=32
p=0.774
£ 
in 
N ®
III
r=0.243
n=32
p=0.179
1=0.250
n=32
p=0.167
1=0.103
n=32
p=0.576
1=0.118
ir=32
p=0.521
5HT=HIAA/ 
Total kynurerine
i=-0.191
n=32
p=0.295
r=0.066
n=32
p=0.720
1=0.015
n=32
p=0.937
1=0.368
n=32
p=0.038
i=0.335
n=32
p=0.061
1=0.248
n=32
p=0.171
1=0.055
rr=32
p=0.767
r=0.231
rr=32
p=0.203
r=0.322
n=32
p=0.073
1=0.160
n=32
p=0.382
i=
0.221
n=32
p=0.224
5HT+HIAA/
KY+H+HA
r=0.138
n=32
p=0.453
1=0.076
n=32
p=0.678
i=0.043
n=32
p=0.816
1=0.301
rr=32
p=0.095
1=0.291
n=32
p=0.106
r=0.163
rr=32
p=0.373
1=0.039 .
n=32
p=0.834
1=0.176
n=32
p=0.335
1=0.261
n=32
p=0.149
1=0.150
n=32
p=0.412
r=
0.160 
if=32 
r>=0.383 .
5HT + HIAA/ 
KY+HK
r=0.160
rr=31
p=0.391
r=0.148
if=31
p=0.426
i=0.134
if=31
p=0.474
1=0.249
ir=31
p=0.176
i=0.263
n=31
p=0.154
1=0.182
n=31
p=0.328
1=0.140
n=3I
p=0.453
1=0.097
n=31
p=0.605
i=0.14l
n=3I
p=0.449
1=0.000
n=31
p=0.998
r=
0.058
rr=31
p=0.756
5HT/KY+HK 1=0.031
rr=31
p=0.868
1=0.017 
n=31 
p=0.930
1=0.016
n=31
p=0.931
1=0.150
n=3I
p=0.422
1=0.171
n=3I
p=0.358
r=0.063
n=31
p=0.735
r=0.055
n=31
p=0.770
i=0.165
n=31
p=0376
r=0.205
if=31
p=0.269
1=0.042
n=31
p=0.821
r =
0.102
n=31
p=0.585
5HT + HIAA/ 
AA
1=0.564
rr=32
p=0.008
r=0.369
ir=2I
p=0.100
r=0.318
n=21
p=0.160
1=0.636
r r f l
p=0.002
**
1=0.652
n=21
p=0.001
* * *
1=0.542
n=21
pp=0.011
1=0.029
rr=21
p=0.902
i=0.414
n=21
p=0.062
1=0.249
i f =21
p=0.276
r=0.255
n=21
p=0.265
r=0.005
n=21
p=0.984
5HT + HIAA/ 
IAA
r=-0.128
n=31
p=0.493
1=0.020
rr=31
p=0.916
i=0.80
n=31
p=0.668
1=0.200
n=31
p=0.282
1=0.116
n=31
p=0.535
1=0.130
n=31
p=0.485
1=0.094
rr=31
p=0.615
1=0.137
n=31
p=0.463
i=0.217
n=31
p=0.242
1=0.213
n=32
p=0.251
1=0101
n=31
p=0.590
KY hydroxylase 
activity
r=-0.327
rr=30
p=0.078
1=0.364
n=30
p=0.048
*
1=0.150
n=30
p=0.430
1=0.070
n=30
p=0.715
1=0.139
n=30
p=0.464
1=0.041
n=30
p=0.830
1=0.103
n=30
p=0.588
i=0.225
rr=30
p=0.232
1=0.184
n=30
p=0.330
1=0.172
rr=30
p=0364
1=0.284
rr=30
p=0.128
Kynureiinase
activity
1=0.178
n=17
p=0.495
1=0.076
n=17
p=0.771
1=0.114
n=17
p=0.662
1=0.064
n=17
p=0.809
r=0.079
n=17
p=0.764
1=0.064
rr=17
p=0.809
1=0.173
rr=17
p=0.507
1=0.053
n=17
p=0.839
1=0.074
n=17
p=0.779
1=0.135
n=17
p=0.607
1=0.091
re=17
p=0.727
MAO activity r=
n=32
p=0.039
r=0.263
if=32
p=0.146
r=
rr=32
p=0.232
1=0.209
n=32
p=0.251
r=
if=32
p=0.242
1=0.203
rr=32
p=0.264
1=0.123
n=32
p=0.504
r =
n=32
p=0.774
1=0.116
if=32
p=0.528
r=
n=32
p=0.680
1=0.034
n=32
p=0.855
MAO activity/ 
KY hydroxylase 
activity
i=-0.129
if =16
p=0.633
1=0.221
n=16
p=0.412
1=0.168
n=16
p=0.535
1=0.097
n=16
p=0.721
1=0.009
n=16
p=0.974
1=0.059
n=16
p=0.829
1=0.271
n=16
p=0311
1=0.212
n=16
p=0.431
1=0.279
n=16
p=0.295
1=0.362
n=16
p=0.169
r=0.015
if=16
p=0.957
MAO activity/
Kynureiinase
activity
r=-0.455
n=10
p=0.187
1=0.152 
n=10 
p=0.67 6
i=0394
n=10
p=0.260
1=0349
n=10
p=0.489
1=0.042
n=10
p=0.907
1=0.164
n=10
p=0.651
i=0370
IF=10
p=0.293
1=0.212
n=10
p=0.556
i=0.079
n=10
p=0.829
1=0.261
n=10
p=0.467
r =
0.115
ri=10
p=0.751
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Table 13 b. Correlation between actual and percentage food intake with tryptophan
metabolite ratios, and enzyme activities during the luteal phase for cycle one
Dietary measure/ 
Metabolite ratio
Kcal Protein Fat CHO Sugar Starch % Fat %
Protein
% CHO % Sugar %
Starch
5HT + HIAA r=-0.388
n=28
p=0.041
*
1=0356
n=28
p=0.063
1=0.175
n=28
p=0.373
1=0.235
n=28
p=0.228
r=0.010
ii=28
p=0.960
1=0.273
n=28
p=0.161
1=0.168
n=28
p=0.394
1=0.075
n=28
p=0.706
i=0.0/5
n=28
p=0.680
1=0.188
n=28
p=0.339
r =
0.261
n=28
p=0.180
Total kynurerine r=-0.003
n=28
p=0.989
r=0.052
n=28
p=0.795
1=0.067
n=28
p=0.734
1=0.125
it=28
p=0.527
1=0.229
n=28
p=0.242
r=0.042
n=28
p=0.831
1=0.088
n=28
p=0.657
1=0.022
n=28
p=0.912
1=0.070
n=28
p=0.725
1=0.104
n=28
p=0.598
r =
0.170
rr=28
p=0.387
5HT=HIAA/ 
Total kynurerine
r=-0.220
n=28
p=0.261
1=0.304
n=28
p=0.115
1=0.126
n=28
p=0.521
i=0.263
n=28
p=0.176
1=0.237
n=28
p=0.225
1=0.220
n=28
p=0.261
1=0.077
n=28
p=0.696
1=0.043
n=28
p=0.827
r=0.042
n=28
p=0.831
1=0.009
n=28
p=0.965
i =
0.048
ir=28
5HT + HIAA1 
KY+H+HA
i=-0.346
n=23
p=0.106
i=0.500
if=28
p=0.115
r=-0.236
n=23
p=0.278
1=0.280
rr=23
pi=0.196
1=0.238
n=23
p=0.274
t=0.244
n=23
p=0.262
1=0.130
n=23
p=0.553
1=0.237
n=23
p=0.276
r=0.071
n=23
p=0.749
r=0.050
ir=23
p=0.819
r=0.010
n=23
p=0.964
5HT + HIAA/ 
KY+HK
1=0.283
n=23
p=0.191
1=0.500
rr=23
p=0.015
*
r=0.217
n=23
p=0319
1=0.228
n=23
p=0.295
1=0.102
n=23
p=0.274
r=0.259
n=23
p=0.233
1=0.104
n=23
p=0.638
1=0.118
n=23
p=0393
r=0.033
ir=23
p=0.883
1=0.188
n=23
p=0391
i =
0.096
n=23
p=0.664
5HT/KY+HK r=-0.157
n=23
p=0.474
1=0.391
n=23
p=0.065
1=0.149
n=23
p=0.497
1=0.107
n=23
p=0.628
1=0.102
n=23
p=0.644
1=0.121
n=23
p=0.584
1=0.110
n=23
p=0.618
1=0.215
n=23
p=0.326
1=0.072
it=23
p=0.745
r=0.170
17=23
p=0.438
i=
0.012
n=23
p=0.957
5HT + HIAA/ 
AA
r=0.622
n=14
p=0.018
*
r=0.316
if =23
p=0.I42
1=0.508
if=14
p=0.064
1=0.688
rr=14
p=0.007
1=0.050
n=23
p=0.8I9
1=0.662
if=14
p=0.010
1=0.064
it=14
p=0.829
1=0.734
ir=14
p=0.003
**
r=0.165
n=14
p=0373
1=0.117
n=14
p=0.692
i =
0.530
17=14
p=0.051
5HT + HIAA/ 
IAA
r=-0.166
n=26
p=0i418
1=0.433
n=14
p=0.122
1=0.070
n=26
p=0.734
1=0.280
if=26
p=0.166
1=0.385
ii=14
p=0.175
1=0.154
if=26
p=0.454
1=0.154
n=26
p=0.452
1=0.091
h=26
p=0.660
i=0.285
ir=26
pf=0.159
i= 0288
n=26
p=0.154
i =
0.060
n=26
p=0.772
KY hydroxylase 
activity
1=0.198
n=22
p=0.376
r=0.004
ii=26
p=0.983
1=0.082
n=22
p=0.718
1=0.016
n=22
p=0.944
r=0350
n=26
p=0.079
r=O.032
n=22
p=0.887
1=0.061
n=22
p=0.786
1=0.029
n=22
p=0.900
1=0.082
n=22
p=0.718
1=0.138
n=22
p=0342
1=0.086
n=22
p=0.705
Kynrrrerinase
activity
1=0.613
n=ll
p=0.045
•
r=0.037
n=22
p=0.869
i=0358
n=ll
p=0.279
1=0326
n=ll
p=0.096
1=0.102
ir=22
p=0.652
i=0.515
n=ll
p=0.105
r=0.075
n=ll
p=0826
1=0.255
n=ll
p=0.449
1=0.098
nF=ll
p=0.774
1=0.133
17=11
p=0.697
i=
0.179
n=ll
p=0.598
MAO activity 1=0.226
n=28
p=0.249
r=0.411
n=ll
p=0.210
i=0.217
n=28
p=0.268
r=
n=28
p=0.976
1=0.451
n= ll
p=0.164
i=
n=28
•p=0.818
i=
n=28
p=0.611
1=0.020
n=28
p=0.921
r=
n=28
p=0.147
1=0.308
n=28
p=0.111
r=
11=28
p=0.784
MAO activity/ 
KY hydroxylase 
activity
1=0.383
n=9
p=0.308
r=
n=28
p=0.205
1=0.750
if=9
p=0.020
*
r=0.317
if=9
p=0.406
1=0.090
ii=28
p=0.648
1=0.283
if=9
p=0.460
r=0350
n=9
p=0.225
r=0.150
n=9
p=0.700
1=0.167
ti=9
p=0.668
1=0.067
n=9
p=0.865
1=0.333
17=9
p=0.381
MAO activity/
Kynureiinase
activity
1=0.500
rr=3
p=0.667
1=0300
n=9
p=0.433
1=0.500
ii=3
p=0.667
1=1.000
n=3
p=0.000
1=0.217
n=9
p=0.576
1=1.000
n=3
p=0.000
1=0300
n=3
p=0.667
1=0.000
17=3
p=0.000
1=0.500
17=3
p=0.667
1=0.500
17=3
p=0.667
1=
0.500
n=3
p=0.667
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Table 13 c. Correlation between actual and percentage food intake with tryptophan
metabolite ratios, and enzyme activities during the luteal phase for cycle two
Dietary measure/ 
Metabolite ratio
Kcal Protein Fat CHO Sugar Starch % Fat %
Protein
% CHO % St^ar %
Starch
5HT + HIAA 1=0.381
n=26
p=0.053
1=0.227
n=26
p=0.264
1=0.169
n=26
p=0.409
1=0.374
n=26
p=0.060
r=0.282
n=26
jrO.163
r=0.154
n=26
p=0.454
1=0.039
ir=26
p=0.851
r=0.088
ir=26
jfO.669
1=0.095
n=26
p=0.643
1=0.121
n=26
p=0.551
1=0.153
n=26
p=0.455
Total kynurerine 1=0.268
n=26
p=0.185
1=0.275
if=26
p=0.175
1=0.125
n=26
p=0.544
r=0.107
n=26
p=O.603
1=0.063
n=26
p=0.759
1=0.175
n=26
p=0.393
1=0.123
n=26
p=0.548
1=0.132
n=26
p=0.521
1=0.175
n=26
p=0393
1=0.048
n=26
p=0.818
1=0.146
n=26
p=0.476
5HT=HIAA/ 
Total kynurerine
r=-0.082 
n=2 6 
p=0.689
rO.112
n=26
p=0.587
1=0.032
n=26
p=0.877
1=0.203
n=26
p=0.321
1=0.270
n=26
p=0.183
1=0.004
n=26
p=0.985
1=0.048
n=26
p=0.815
1=0.268
n=26
p=0.186
1=0.222
n=26
p=0.276
1=0.070
n=26
p=0.734
1=0.069
it=26
p=0.736
5HT + HIAA/ 
KY+H+HA
1=0.101
n=25
p=0.632
1=0.095
n=25
p=0.650
r=O.I08
n=25
p=0.608
1=0.217
n=25
p=0.298
1=0.255
n=25
p=0.219
1=0.003
n=25
p=0.9S8
1=0.027
n=25
p=0.898
r=0.285
if=25
p=0.167
1=0.178
n=25
p=0.395
1=0.029
n=25
p=0.893
1=0.098
n=25
p=0.641
SHT + HIAA/ 
KY+HK
r=-0.309
n=23
p=0.151
1=0.161
n=23
p=0.463
1=0.206
n=23
p=0347
1=0.306
n=23
p=0.155
1=0.376
n=23
p=0.077
i=0..116
n=23
p=0.599
r=0.106
n=23
p=0.631
1=0.204
n=23
p=0350
1=0.069
n=23
p=0.754
1=0.150
n=23
p=0.495
1=0.246
n=23
p=0.259
5HT/KY+HK r=-0..1S7
n=23
p=0.474
r=O.019
n=23
p=0.932
1=0.182
n=23
p=0.406
1=0.220
n=23
jfO.312
1=0.370
n=23
p=0.083
1=0.044
n=23
p=0.844
1=0.081
n=23
p=0.713
1=0.226
n=23
p=0301
1=0.088
n=23
p=0.690
1=0.049
n=23
p=0.825
1=0.180
n=23
p=0.41
5HT+HIAA/
AA
r=-0.462
n=12
pO.131
1=0.622
n=12
p=0.031
*
1=0.203
n=12
p=0.527
1=0343
n=12
pO.276
i=0.518
i f =12
p=0.085
1=0.322
i i = 1 2
pO.308
1=0.028
n=12
p=0.931
1=0.056
n=12
p=0.862
1=0.070
n=12
pO.829
1=0.074
n=12
p=0.820
i =
0.049
n=12
p=0.880
5HT + HIAA/ 
IAA
r=-0.075
n=25
p=0.720
1=0.056
n=25
p=0.790
1=0.023
n=25
p=0.913
1=0312
n=25
p=0.310
1=0.137
n=25
p=0.514
1=0.082
ir=25
p=0.696
1=0.131
if=25
p=0.533
1=0.188
n=25
p=0.367
1=0245
if=25
p=0.239
1=0.186
n=25
p=0.375
r =
0.085
n=25
p=0.685
KY hydroxylase 
activity
r=-0.150
n=23
p=0.466
1=0.225
n=23
p=0.302
1=0.111
n=23
p=0.613
r=0.096
n=23
p=0.663
r=0375
n=23
p=0.078
1=0.120
n=23
p=0.585
1=0.161
n=23
p=0.463
1=0.047
ir=23
p=0.830
r=0325
n=23
p=0.130
1=0.246
re=23
p=0.258
1=0.164
ii=23
p=0.454
Kynureiinase
activity
r=-0.704
n=7
p=0.077
1=0.148
n=7
p=0.751
1=0.111
n=7
p=0.812
1=0393
n=7
p=0.161
1=0.852
n=7
p=0.015
r=0.259
n=7
p=0.574
1=0.111
n=7
p=0.812
1=0.812
ir=7
p=.027*
1=0.408
n=7
p=0.364
1=0.482 
n=7
p=0.274
1=0.148
n=7
p=0.751
MAO activity r=
n=26
p=0.021
1=0.381
n=26
p=0.055
r=
ir=26
p=0.446
1=0.366
n=26
p=0.066
r=
n=26
p=0.113
1=0.210
n=26
p=0.304
1=0.013
n=26
p=0.94S
1=
if=26
p=0.762
1=0.071
n=26
p=0.731
r=
if=26
p 0 5 4 2
1=0.239
n=26
p=0.240
MAO activity/ 
KY ltydroxylase 
activity
1=0.600
n=6
p=0.208
1=0.200
n=6
p=0.704
1=0.943
if=6
p=0.005
*•
1=0.486
n=6
p=0.329
1=0.086
n=6
p=0.872
r=0.257
n=6
p=0.623
1=0543
n=6
p=0.005
**
1=0.551
n=6
p=0.257
1=0.371
n=6
pO.468
1=0.486
n=6
p=0329
i =
0.543
n=6
p=0.266
MAO activity/
Kynureiinase
activity
1=0.400
n=4
p=0.600
r=0.400
n=4
p=0.600
1=0.400
n=4
p=0.600
r=1.000
n=4
p=0.000
1=0.800
n=4
p=0.200
i=1.000
n=4
p=0.000
1=0.400
n=4
p=0.600
1=0316
n=4
p=0.684
1=0.000
ir=4
pO.OOO
1=0.400
ii=4
p=0.600
i =
0.600
n=4
p=0.400
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Table 14 a. Correlation between actual and percentage food intake with tryptophan
metabolite ratios, and enzyme activities during the premenstrual phase for the mean
of both menstrual cycles
Dietary measure/ 
Metabolite ratio
Kcal Protein Fat CHO Sugar Starch % Fat %
Protrin
% CHO % Sugar %
Starch
5HT + HIAA 1=0.061
n=32
p=0.742
1=0.100
n=32
p=0.587
1=0.024
n=32
p=0.899
1=0.021
n=32
p=0.910
1=0063
n=32
p=0.732
1=0.009
n=32
p=0.962
1=0.150
n=32
p=0.414
1=0.033
n=32
p=0.859
1=0.044
n=32
p=0.813
1=0.062
n=32
p=0.736
1=0.008
i f =32
p=0.965
Total kynurerine 1=0.227
n=32
p=0.2I2
r=0.164
n=32
p=0.369
1=0.363
n=32
p=0.041
i=0.061
n=32
p=0.739
1=0.037
re=32
p=0.842
1=0.004
n=32
p=0.984
1=0.182
n=32
p=0.318
1=0.235
n=32
p=0.196
1=0.156
ir=32
p=0.395
1=0.093
n=32
p=0.614
i=
0.137
ir=32
p=0.454
5HT=HIAA/ 
Total kynurerine
r=-0.154
n=32
p=0.400
1=0.023
rt=32
p=0.900
r-0.243=
n=32
p=0.180
1=0.013
n=32
p=0.944
1=0.026
n=32
p=0.889
1=0.116
n=32
p=0.529
1=0.242
n=32
p=0.182
1=0.192
n=32
p=0.292
r=0.118
n=32
p=0.5I9 •
1=0.116
n=32
p=0.528
1=0.131
if=32
p=0.477
5HT + HIAA/ 
KY+H+HA
i=-0.032
n=31
p=0.863
r=0.073
n=31
p=0.696
1=0.102
n=31
p=0.585
1=0.004
n=31
p=0.985
1=0.068 
n=31 
p=0.7I6
1=0.111
n=31
p=0.554
1=0.074
n=31
p=0.693
1=0.117
n=31
p=0.530
i=O.0U
n=31
p=0.955
1=0.004
n=31
p=0.981
1=0.057
n=3I
n=0.760
5HT + HIAA/ 
KY+HK
r=-0.088
n=30
p=0.643
1=0.102
n=30
p=0.591
1=0.126
n=30
p=0.507
1=0.051
n=30
p=0.791
1=0.124
it=30
p=0.516
1=0.058
n=30
p=0.762
1=0.039
n=30
p=0.836
i=0.057
ii=30
p=0.763
1=0.073
n=30
p=0.701
1=0.067
n=30
p=0.723
r=0.050
n=30
p=0.793
5HT/KY+HK r=-0.044
i f =30
p=0.816
1=0.001
n=30
p=0.995
1=0.031
n=30
p=0.873
1=0.032
n=30
p=0.867
1=0.093
11=30
p=0.626
1=0.038
n=30
p=0.842
1=0.016
n=30
p=0.932
1=0.059
ir=30
p=0.755
1=0.021
n=30
p=0.914
r=0.046
n=30
p=0.811
i =
0.034
ir=30
p=0.858
5HT+ HIAA/ 
AA
r=0.089
n=23
p=0.687
r=0.013
n=23
p=0.954
1=0.134
n=23
p=0.541
1=0.018
n=23
p=0.936
1=0.028
n=23
p=0.900
1=0.077
n=23
p=0.727
1=0.238
n=23
p=0.274
1=0.438
i i =23
p=0.037
*
1=0.010
n=23
p=0.964
1=0.197
11=23
p=0.368
r =
0.115
n=23
p=0.603
5HT + HIAA/ 
IAA
i=-0.205
n=30
p=0.276
1=0.155
n=30
p=0.413
1=0.247
n=30
p=0.188
1=0.210
n=30
p=0.265
1=0.293
ir=30
p=0.117
1=0.030
n=30
p=0.875
1=0.075
n=30
p=0.695
1=0.245
n=30
p=0.192
1=0.056
n=30
p=0.768
1=0.168
n=30
p=0376
1=0.105
n=30
p=0.580
KY hydroxylase 
activity
1=0.011
n=28
p=0.956
1=0.027
n=28
p=0.893
i=0.156
n=28
p=0.427
1=0.047
n=28
p=0.814
i=0.043
n=28
p=0.829
1=0.049
ir=28
u=0.803
1=0.018
n=28
n=0.929
1=0.148
n=28
p=0.453
1=0.039
ir=28
p=0.843
1=0.043
ii=28
p=0.829
1=0.091
n=28
p=0.647
Kynureiinase
activity
1=0.143
n=20
p=0.548
1=0.045
n=20
I>=0.852
1=0.160
rr=20
p=0.501
1=0.017
n=20
p=0.944
1=0.126
n=20
p=0.597
1=0.17
n=20
p=0.456
1=0.295
n=20
p=0.207
1=0.261
11=20
p=0.266
r=0.180
n=20
p=0.448
1=0.218
n=20
p=0.355
1=0.006
n=20
p=0.979
MAO activity i=
i f =32
p=0.741
1=0.181
n=32
p=0.322
r=
n=32
p=0.113
1=0.057
n=32
p=0.757
r=
n=32
p=0.844
1=0.007
n=32
p=0.968
1=0.199
n=32
n=0.275
1=
n=32
p=0.873
1=0.249
n=32
p=0.170
i=
«=32
p=0.494
1=0.159
n=32
p=0.384
MAO activity/ 
KY hydroxylase 
activity
1=0.098
n=18
p=0.699
1=0.220
n=18
p=0.381
1=0.218
n=18
p=0.385
r=0.094
n=18
p=0.711
1=0.158
11=18
p=0.531
1=0.067
it=18
p=0.79I
1=0.046
n=18
p=0.855
1=0.115
n=18
p=0.651
1=0.018
n=18
p=0.945
1=0.172
n=18
p=0.494
i=
0.040
n=18
U=0.874
MAO activity/
Kynureiinase
activity
1=0.132
n=13
p=0.668
i=0/197
rr=I3
p=0.325
t=0.275
n=13
p=0364
1=0.352
n=13
p=0.239
1=0.308
n=13
p=0.306
1=0.363
n=13
p=0.223
1=0.517
n=13
p=0.071
1=0.093
n=13
p=0.762
i=0.29I
n=13
p=0.334
1=0.368
11=13
p=0.216
r=0.121
n=13
p=0.694
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Table 14 b. Correlation between actual and percentage food intake with tryptophan 
metabolite ratios, and enzyme activities during the premenstrual phase for cycle 
one
Dietary
measure/
Metabolite
ratio
Kcal Protein Fat CHO Sugar Starch % Fat %
Protein
% CHO % Sugar %
Starch
5HT + HIAA r=-0.121
n=29
p=0.531
r=0.205
n=29
p=0.285
1=0.015
n=29
p=0.939
r=0.010
n=29
p=0.960
r=0.038
n=29
p=0.843
1=0.106
n=29
p=0.585
1=0.227
n=29
p=0.237
1=0.325
ir=29
p=0.086
1=0.177
n=29
p=0359
1=0.159
ir=29
p=0.411
1=0.128
n=29
p=0.510
Total
kynurerine
1=0.217
n=29
p=0.258
t=0319
n=29
p=0.091
1=0.419
rr=29
p=0.024*
r=0.064
ir=29
p=0.741
r=0.052
n=29
p=0.790
1=0.016
n=29
p=0.933
1=0.195
n=29
p=0310
1=0.157
i f =29
p=0.416
1=0.281
n=29
p=0.140
1=0.168
n=29
p=0384
i=
0.099
n=29
p=0.611
5HT=HIAA/
Total
kynurerine
r=-0.168
i i =29
p=0384
1=0.118
n=29
p=0.543
1=0.266
n=29
p=0.164
f =0.187
n=29
p=0331
1=0.026
n=29
p=0.893
1=0.275
n=29
p=0.148
i=0308
n=29
p=0.104
1=0.049
n=29
p=0.802
1=0.439
re=29
p=0.017*
1=0.243
n=29
p=0.204
r=0.246
n=29
p=0.199
5HT + HIAA/ 
KY+H+HA
i=-0.054
n=26
p=0.795
r=0.039
n=26
p=0.849
r=0.020
rr=26
pf=0.922
1=0184
n=26
p=0.369
1=0.028
n=26
p=0.893
r=0307
n=26
p=0.127
1=0.100
ir=26
p=0.626
r=0.043
n=26
p=0.833
1=0.269
it=26
p=0.183
r=0.082
ir=26
p=0.689
r=0.210
n=26
p=0.304
5HT + HIAA/ 
KY+HK
r=-0.099
j j=25
p=0.640
1=0.165
n=25
p=0.429
t=0.074
n=25
p=0.726
1=0.091
ir=25
p=0.666
1=0.032
n=25
p=0.881
1=0.169
n=25
p=0.419
1=0.052
11=25
p=0.807
1=0.129
n=25
p=0.538
1=0.261
n=25
p=0.207
1=0.003
n=25
p=0.988
1=0.160
ir=25
p=0.445
5HT/KY+HK r=-0.054
n=25
p=0.798
r=0.173
n=25
p=0.408
r=0.015
n=25
p=0.945
r=0.137
n=25
p=0.514
1=0.052
i f =25
p=0.807
1=0.181
i i =25
p=0387
1=0.050
n=25
p=0.812
1=0.169
n=25
p=0.419
i=0.263
ii=25
p=0.204
1=0.077
n=25
p=0.715
1=0.102
n=25
p=0.627
5HT + HIAAI 
AA
r=-0.287
n=17
p=0.264
r=0.181
n=17
p=0.486
t=0.493
n=17
p=0.045*
r=0.142
n=17
p=0.586
1=0.137
n=17
p=0399
1=0.071
n=17
p=0.786
1=0.461
n=17
p=O.063
1=0.135
n=17
p=0.606
1=0.088
n=17
p=0.736
r=0.338
n=17
p=0.184
i =
0.042
n=17
p=0.874
5HT+HIAA/
IAA
1=0.269
n=26
p=0.184
1=0.078
n=26
p=0.704
i= 0390
n=26
p=0.151
i=0.118
n=26
p=0.566
1=0.173
rr=26
p=0.397
1=0.169
n=26
p=0.409
1=0.108
n=26
p=0.598
1=0.226
ii=26
p=0.267
1=0.047
ii=26
p=0.822
r=0.091
n=26
p=0.660
i =
0.033
i i =26
p=0.875
KY
hydroxylase
activity
r=0.269
n=21
p=0.239
1=0.135
ir=21
p=0.560
r=0.156
rr=21
p=0.500
r=0.184
n=21
p=0.426
1=0.317
n=21
p=0.162
1=0.009
n=21
p=0.969
1=0.261
n=21
p=0.254
1=0.092
ir=21
p=0..691
1=0.078
n=21
p=0.737
1=0.116
n=21
p=0.618
1=0.121
i f =21
p=0.62
Kynurerinase
activity
1=0.090
n=15
p=0.749
r=0.023
j i=15
p=0.936
r=0.049
rr=15
p=0.862
1=0.079
n=15
p=0.779
r=0.117
rt=15
p=0.679
1=0.147
n=15
p=0.602
1=0.196
n=15
p=0.484
1=0.023
it=15
p=0.936
1=0.049
ti=15
p=0.862
1=0.057
n=15
p=0.842
i=
0.041
n=15
p=0.884
MAO activity 1=0.183
n=29
p=0343
i =
n=29
p=0.792
1=0.203
n=29
p=0.291
r=
n=29
p=0.813
1=0.115
n=29
p=0.553
r=
n=29
p=0.945
i=
n=29
p=0.645
1=0.221
n=29
p=0.250
1=
n=29
p=0.542
r=0.015
n=29
p=0.939
r=
ii=29
p=0.438
MAO activity/ 
KY
hydroxylase
activity
1=0.027
n= ll
p=0.937
r=0.018
n=ll
p=0.958
r=0.100
11=11
p=0.770
1=0.218
n=ll
p=0.519
r=0.146 
n=l 1
p=0.670
i=0.036
ir=ll
p=0.915
1=0.018
ii=ll
p=0.958
1=0.100
it=ll
p=0.770
r=0.046
n=ll
p=0.894
r=O.409
i i = 1 1
p=0.212
r =
0.300
n=ll
p=0.370
MAO activity/ 
Kynurerinase 
activity
1=0300
n=9
p=0.433
r=0.433
rr=9
p=0.244
t=0.067
n=9
p=0.865
r=0.167
n=9
p=0.668
r=0.200
n=9
p=0.606
1=0.517
n=9
p=0.154
1=0.017
n=9
p=0.966
1=0.200
ii=9
p=0.606
1=0.167
n=9
p=0.667
r=0.317
n=9
p=0.406
1=0.233
n=9
p=0.546
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Table 14 c. Correlation between actual and percentage food intake with tryptophan
metabolite ratios, and enzyme activities during the premenstrual phase of cycle two
Dietary measure/ 
Metabolite ratio
Kcd Protein Fat CHO Sugar Starch % Fat %
Protein
% CHO % Sugar %
Starch
5HT + HIAA l=-0.424
n=26
p=0.031
*
1=0.398
n=26
p=0.044
*
1=0.375
n=26
p=0.059
1=0.178
if=26
p=0.384
r=0.118
n=26
p=0.566
i=0.290
ir=26
p=0.151
1=0.422
n=26
p=0.032
1=0.045
if=26
p=0.828
i=0380
ii=26
p=O.056
1=0.424
ii=26
p=0.031
1=0.098
n=26
p=0.633
Total kynurerine r=-0.195
n=26
p=0.925
1=0.176
n=26
p=0390
1=0.097
ir=26
p=0.638
i=0.087
rt=26
p=0.674
1=0.066
n=26
p=0.749
1=0.372
ii=26
p=0.062
10.112
if=26
p=0387
1=0.284
n=26
p=0.161
1=0.083
n=26
p=0.687
r-0.037
n=26
p=0.859
i=
0.143
n=26
p=0.486
5HT=HIAA/ 
Total kynurerine
1=0.126
n=26
p=0.541
1=0.048
n=26
p=0,818
1=0.180 
ir=26 
p=0.380
i=0.040
n=26
p=0.846
1=0.039
n=26
p=0.851
1=0.223
n=26
p=0.274
1=0.164
n=26
p=0.422
1=0.218
n=26
p=0.285
1=0.141
n=26
p=0.491
1=0.108
n=26
p=0.599
1=0.130
n=26
p=0.528
5HT + HIAA/ 
KY+H+HA
r=-0.022
n=25
p=0.916
1=0.068
n=25
p=0.748
1=0.159
n=25
p=0.447
1=0.141
n=25
p=0.502
1=0.138
ir=25
p=0.512
1=0.228
ir=25
p=0.274
1=0.218
n=25
p=0.296
r=0.069
n=25
p=0.742
1=0.265
ii=25
p=0.201
1=0.191
rf=25
p=0.361
1=0.186
n=25
p=0.373
5HT + HIAA/ 
KY+HK
i=-0.276
n=23
p=0.203
1=0.018
n=23
p=0.936
1=0.224
n=23
p=0.304
1=0.252
n=23
p=0.246
i=0.019
n=23
p=0.932
1= 0.211
n=23
p=0.335
i=0.067
n=23
p=0.761
1=0.238
tr=23
p=0.274
1=0.015
n=23
p=0.945
r=0.112
n=23
p=0.612
r =
0.130
n=23
ji=0.553
5HT/KY+HK r=-0.160
n=23
p=0.466
1=0.117
n=23
p=0.596
1=0.070
n=23
p=0.750
1=0.164
ir=23
p=0.455
1=0.078
n=23
p=0.723
1=0.170
if=23
p=0.438
1=0.041
n=23
p=0.854
1=0.303
n=23
p=0.159
1=0.047
it=23
p=0.833
1=0.129
ii=23
p=0.558
i=
0.189 
tp23 
p=0.388
5HT + HIAA/ 
AA
1=0.154
ir=13
p=0.616
1=0.264
n=13
p=0.384
1=0.154
n=13
p=0.616
1=0.060
n=13
p=0.845
1=0.077
n=13
p=0.803
1=0.071
n=13
p=0.817
1=0.099
ir=13
p=0.748
r=0.352
ii=13
p=0.239
1=0.082
n=13
p=0.789
1=0.198
n=13
p=0.517
1=0.176
11=13
p=0.566
5HT + HIAA/ 
IAA
r=-0.186
n=24
p=0.384
1=0.194
n=24
p=0364
i=0.311
n=24
p=0.139
1=0.037
n=24
p=0.865
1=0.098
n=24
p=0.648
1=0.150
it=24
p=0.485
1= 0.121
n=24
p=0.574
1=0.024
n=24
p=0.913
1=0.164
ii=24
p=0.444
1=0.005
n=24
p=0.981
1=0210
ir=24
p=0.325
KY hydroxylase 
activity
1=0.095
n=23
p=0.668
1=0.225
ii=23
p=0302
1=0.298
n=23
p=0.167
1=0.059
n=23
p=0.790
1=0.028
11=23
p=0.899
1=0.072
n=23
p=0.745
1=0.234
11=23
p=0.282
1=0.093
ii=23
p=0.672
1=0219
n=23
p=0.314
i = 0 .1 2 8
ir=23
p=0.561
1=0.238
n=23
p=0.274
Kynurerinase
activity
i=-0.638
n =6
p=0.173
i=0.231
it=6
p=0.618
1=0.174
n=6
p=0.742
r=0.116
11=6
p=0.827
1=0.580
n=6
p=0.228
1=0.029
n=6
p=0.957
1=0.058
n=6
p=0.9I3
1=0.551
n =6
p=0.257
1=0.029
n=6
p=0.957
1=0.058
n =6
p=0.913
1=0.232
n=6
p=0.658
MAO activity i=
ir=26
p=0.373
1=0.190
n=26
p=0351
i=
n=26
p=0.074
1=0.024
n=26
p=0.909
r=
n=26
p=0.983
1=0.084
n=26
p=0.684
1=0.247
n=26
p=0.225
r=
n=26
p=0.795
i=0329
n=26
p=0.101
i=
ii=26
p=0.345
1=0.216
ir=26
p=0.288
MAO activity/ 
KY hydroxylase 
activity
1= 0.200
ir=6
p=0.704
1=0371
ir=6
p=0.468
1=0.714
ii=6
p=0.111
1=0.543
if=6
p=0.266
1=0.429
ii=6
p=0397
1=0.886
n =6
p=0.019
1=0.600
if=6
p=0208
1=0.029
H=6
p=0.957
r=0.886
i f =6
p=0.019
*
1=0.429
11=6
p=0.397
i=0343
it=6
p=0.266
MAO activity/
Kynurerinase
activity
1=0.200
j i=4
p=0.800
1=0.600
n=4
p=0.400
1=0200
n=4
p=0.800
1=0.000
n=4
p=0.000
1=0.400
n=4
p=0.600
10.400=
n=4
p=0.600
1=0.400
n=4
p=0.600
1=0.400
n=4
p=0.600
i0.400=
11=4
p=0.600
1=0.400
ir=4
p=0.600
1=0.500
if=4
p=0.800
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Table 15 a. Correlations between subjective appetite ratings, tryptophan metabolite
ratios and tryptophan enzvme activities during the follicular phase for the mean of
both cycles
Dietaiy measure/ 
Metabolite ratio
Hunger Appetite Satiation Satiety
Dietary 
Restraint- 
food types
Dietary
Restraint-
Amount
Ate more 
than usual Cravings
5HT + HIAA r=0.143
ir=32
p=0.436
1=0.193
n=32
p=0.290
r=-0.226
n=32
p=0.213
r=0.292
n=32
p=0.105
i=0.067
n=32
p=0.715
r=0324
n=32
p=0.070
r=0.127
n=32
p=0.489
r=0.217
n=32
p=0.234
Total kynurerine r=0.212
n=32
p=0.244
r=0.099
n=32
p=0.589
1=0.259
n=32
p=0.153
i=0356
n=32
p=0.045*
r=0.003
n=32
p=0.988
r=0.163
n=32
p=0373
r=0.106
n=32
p=0.563
1=0.242
n=32
p=0.182
5HT=HIAA/ 
Total kynurerine
r=0.113
n=32
p=0.537
1=0304
n=32
p=0.264
i=-0.148
n=32
p=0.4I9
r=0.099
n=32
p=0.591
r=0.047
n=32
p=0.800
1=0.308
n=32
p=0.086
1=0.167
n=32
p=0.362
1=0.017
n=32
p=0.927
5HT + HIAA/ 
KY+H+HA
r=-0.123
n=31
p=0.5I0
r=0.023
n=31
p=0.901
r=-0.003
n=31
p=0.985
i=0.069
n=31
p=0.714
r=0.134
n=31
p=0.473
r=0.018
n=32
p=0.923
1=0.094
n=31
p=0.614
1=0.146
n=31
p=0.435
5HT + HIAA/ 
KY+HK
i=0.026
n=30
p=0.890
r=0.105
n=30
p=0.J82
r=-0.031
n=30
p=0.872
i=0.100
n=30
p=0.599
r=0.211
n=30
p=0.263
r=0.142
n=30
p=0.455
1=0.151
n=30
p=0.427
1=0.009
n=30
p=0.964
5HT/KY+HK 1=0.015 
n=30 
p=0.940
r=0.091
n?=30
p=0.634
r=-0.004
n=30
p=0.982
r=0.111
tf=30
p=0.560
r=0.195
n=30
p=0.303
1=0.154
n=30
p=0.417
1=0.090
n=30
p=0.635
1=0.011
ii=30
p=0.953
5HT + HIAA/ 
AA
1=0.218
re=17
p=0.400
i=0.578
rr=17
p=0.015*
r=-0.222
n=17
p=0.392
r=0.277
n=17
p=0.282
r=0.235
n=17
p=0.363
r=0.262
n=17
P=
r=-0.336
n=17
p=0.188
1=0.299
n=17
p=0.244
5HT + HIAA/ 
IAA
i=-0.216
n=29
p=0.260
r=-0.076
n=29
p=0.696
r=0.012
n=29
p=0.950
r=0.048
n=29
p=0.806
r=0.125
n=29
pf=0.519
1=0.019
n=29
p=0.921
1=0.215
n=29
p=0.262
1=0392
n=29
P=
KY hydroxylase 
activity
r=-0.258
n=30
p=0.169
r=-0.129
rr=30
P=
r=0.019
n=30
p=0.922
r=0.127
n=30
p=0-504
t=0.122
n=30
p=0.520
r=0.056
n=30
p=0.767
r=0.169
n=30
p=0371
1=0.078
it=30
p=0.683
Kynurerinase
activity
r=0.016
n=17
p=0.952
1=0.080
n=17
p=0.761
1=0.096
n=17
p=0.715
r=0.009
rr=17
P=
r=0.058
n=17
p=0.824
r=0.122
n=17
p=0.641
t=0.195
rr=17
p=0.453
1=0.311
n=17
p=0.225
MAO activity r=0.289
n=32
p=0.109
r=0.140
n=32
p=0.445
r=0.243
n=32
p=0.181
r=0.110
n=32
p=0.549
r=0.152
n=32
p=0.406
III
r=0.062 
n=32 
p=0.738
1=0.085
n=32
p=0.645
MAO activity/ 
KY hydroxylase 
activity
1=0.265
n=17
p=0304
r=0.005
n=17
p=0.985
r=0.085
n=17
p=0.747
r=0.077
n=17
p=0.768
1=0.105
rr=17
p=0.687
1=0.000
n=17
p=0.000
1=0.423
n=17
p=0.091
1=0.177
n=17
p=0.498
MAO activity/
Kynurerinase
activity
i=-0.310
n=8
p=0.456
r=-0.143
n=8
p=0.736
r=0.262
n=8
p=0.531
r=0.119
n=8
p=0.779
r=0.333
n=8
p=0.420
r=0.048
n=8
p=0.911
1=0.238
n=8
p=0.570
1=0.048
ir=8
p=0.911
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Table 15 b. Correlations between subjective appetite ratings, tryptophan metabolite
ratios and tryptophan enzyme activities during the follicular phase of cycle one
Dietary measure/ 
Metabolite ratio
Hunger Appetite Satiation Satiety
Dietary 
Restraint- 
food types
Dietary
Restraint-
Amount
Ate more 
than usual Cravings
5HT + HIAA 1=0.223
n=29
p=0.245
r=0.131
n=29
p=0.245
r=0.044
i f =29
p=0.821
1=0.119
n=29
P=
1=0.038
n=29
p=0.846
1=0.157
n=29
p=0.416
1=0.103
n=29
p=0.594
1=0.104
n=29
p=0.592
Total kynurerine r=0.169
n=29
p=0.381
1=0.061
n=29
p=0.752
1=0.136
n=29
p=0.483
r=0.252
n=29
p=0.188
1=0.208
n=29
p=0.278
1=0.263
n=29
p=0.168
1=0.096
n=29
p=0.621
1=0.151
n=29
p=0.434
5HT=HIAA/ 
Total kynurerine
r=-0.006
rr=29
p=0.974
r=-0.070 
n=29 . 
p=0.720
t=0.258
n=29
p=0.177
1=0.181
n=29
p=0.347
r=0.154
n=29
p=0.424
1=0.047
n=29
p=0.808
1=0.088
n=29
p=O.650
1=0.028
n=29
p=0.884
5HT + HIAA/ 
KY+H+HA
r=-0.104
ir=26
p=0.613
i=-0.235
n=26
p=0.249
r=0.362
n=26
p=0.069
1=0.293
i f =26
p=0.146
1=0.085
nf=26
p=0.682
1=0.173
n=26
p=0397
1=0.083
n=26
p=0.685
r=0.212
n=26
p=0.298
5HT + HIAA/ 
KY+HK
r=-0.063
n=26
p=0.761
r=-0.054
n=26
p=0.795
1=0.290
n=26
p=0.151
1=0.181
n=26
p=0.377
1=0.141
n=26
,p=0.491
r=0.149
n=26
p=0.468
1=0.007
n=26
p=0.974
1=0.228
n=26
p=0.263
5HT/KY+HK r=-0.200
i f =26
p=0327
r=-0.069
rr=26
p=0.736
1=0.350
n=26
p=0.079
1=0.222
rt=26
p=0.276
1=0.003
n=26
p=0.987
1=0.273
n=26
p=0.178
1=0.005
n=26
p=0.980
1=0.202
n=26
p=0.322
5HT+HIAA/
AA
r=0.107
n=7
p=0.8l!9
r=0.000
it=7
p=0.000
r=0.286
n=7
p=0.535
1=0.036
i f 7
p=0.939
1=0.054
n=7
p=0.908
1=0.214
ir=7
p=0.645
1=0.286
ir=7
p=0.535
1=0.429
it=7
p=0.337
5HT+HIAA/
IAA
1=0.152
n=25
p=0.467
r=-0.316
n=25
p=0.124
1=0.199
n=25
p=0341
1=0.317
i f =25
p=0.123
i=0.140
n=25
p=0.504
1=0.262
rt=25
p=0.207
1=0.444
ii=25
p=0.026*
1=0.001
n=25
p=0.997
KY hydroxylase 
activity
r=0.258
n=30
p=0.169
r=0.129
n=30
P=
i=O.019
n=30
p=0.922
1=0.127
n=30
p=0.504
1=0.122
n=30
p=0.520
r=0.056
it=30
p=0.767
1=0.169
ii=30
p=0.371
r=0.078
re=30
p=0.683
Kynurerinase
activity
r=-0.554
n=13
p=0.050*
1=0.245
n=13
p=0.419
r=0.199
n=13
p=0.514
1=0.082
i f =13
p=0.791
1=0398
ir=13
p=0.178
i=0.156
n=13
p=0.611
1=0.314
n=13
p=0.295
1=0.383
ii=13
p=0.196
MAO activity r=0.242
n=29
p=0.207
1=0.059
n=29
p=0.763
r=O.OI8
n=29
p=0.925
1=0.103
ir=29
p=0.595
1=0.161
n=29
p=0.403
i=0.189
n=29
P=
1=0.044
11=29
p=0.822
1=0.042
i f =29
p=0.827
MAO activity/ 
KY hydroxylase 
activity
r=0.133
n=12
p=0.681
1=0.063
n=12
p=0.846
r=0.060
n=12
p=0.854
1=0.385
n=12
p=0.217
1=0.021
rr=12
p=0.948
i=0350
n=12
p=0.265
1=0.483
i i = 1 2
p=0.111
r=0361
n=12
P=
MAO activity/ 
Kynurerinase 
activity
1=1.000
n=3
p=0.000
1=0.500
nr=3
P=
1=1.000
n=3
p=0.000
1=0.500
n=3
p=0.664
1=0.500
n=3
p=0.667
1=1.000
n=3
p=0.000
1=0.500
ir=3
p=0.667
1=0.500
n=3
p=0.667
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Table 15 c. Correlations between subjective appetite ratings, tryptophan metabolite
ratios and tryptophan enzyme activities during the follicular phase of cycle two
Dietary measure/ 
Metabolite ratio
Hunger Appetite Satiation Satiety
Dietary 
Restrairrt- 
food types
Dietary
Restraint-
Amount
Ate more 
than usual Cravings
5HT+H1AA z=0.222
n=25
p=0.285
1=0335
n=25
p=0.102
r=0.269
rr=25
p=0.194
r=0.204
n=25
p=0.329
1=0.172
n=25
p=0.412
r=0.176
n=25
p=0.399
r=-0.015
n=25
p=0.943
r=0.073
it=25
p=0.728
Total kynurerine 1=0.222
n=25
p=0.287
r=0.347
n=25
p=0.089
r=0.426
rr=25
p=0.034*
r=0.189
n=25
p=0.366
1=0.148
rr=25
p=0.481
1=0.074
n=25
P=
r=0.025
n=25
p=0.906
r=0.003
n=25
p=0.988
5HT=HIAA/ 
Total kynurerine
r=0.133
n=25
p=0.526
r=0.094
n=25
p=0.657
1=0.036
n=25
p=0.865
r=0.237
n=25
p=0.253
r=0.033
rr=25
p=0.875
r=0.167
n=25
p=0.424
r=0.055
n=25
p=0.794
r=0.064
n=25
P=
5HT+HIAA/
KY+H+HA
r=0.025
n=25
p=0.907
t=0.2l0
rr=25
P=
1=0.079
rr=25
p=0.706
t=0.185
n=25
p=0376
r=0.155
re=25
p=0.460
i=0.269
ii=25
p=0.194
1=0.231
n=25
p=0.267
1=0.192
ir=25
p=0.357
5HT + HIAA/ 
KY+HK
1=0.078
n=23
p=0.723
r=0.105
n=23
p=0.634
r=0.139
n=23
p=0.527
r=0.330
n=23
P=
r=0.347 
n=23 
. p=0.105
1=0.230
n=23
p=0.290
r=0.006
n=23
p=0.979
1=0.097
n=23
p=0.660
SHT/KY+HK r=0_060
rr=23
p=0.785
1=0.099
re=23
p=0.652
r=-0.101
n=23
p=0.645
r=0.270
n=23
p=0.2I3
r=0.333
n=23
p=0.121
1=0.176
n=23
p=0.422
1=0.056
ir=23
p=0.798
1=0.046
n=23
p=0.837
5HT + HIAA/ 
AA
i=0354
rr=15
p=0.196
r=0.483
rr=15
p=0.068
r=-0381
n=15
p=0.162
t=0.150
n=15
Pf=0.594
1=0.147
rr=15
p=0.602
1=0.218
n=15
p=0.435
1=0.432
re=15
p=0.108
1=0.335
n=15
p=0.223
5HT + HIAA/ 
IAA
r=0.090
n=23
p=0.683
r=0.27
it=23
p=0320
r=0.017
n=23
p=0.939
r=0.202
rr=23
p=0.356
r=0.225
re=23
p=0.302
i=O.I75
n=23
p=0.425
1=0.04
n=23
p=0.846
1=0.398
n=23
p=0.060
KY hydroxylase 
activity
r=-0.223
n=22
p=0318
r=-0.193
n=22
p=0.390
r=0.136
rr=22
p=0.545
r=-0358
n=22
p=0.102
r=-0.432
ir=22
p=0.045*
r=-0.353
n=22
p=0.108
1=0.003
re=22
p=0.988
1=0.140
11=22
p=0.534
Kynurerinase
activity
r=0.493
rf=9
p==0.178
r=0.201
n=9
p=0.604
r=-0.275
n=9
p=0.474
r=O.073
n=9
p=0.852
r=-0.402
n=9
p=0.284
r=-0.511
ii=9
p=0.160
r=0.365
rr=9
p=0.334
1=0.164
if=9
p=0.673
MAO activity r=0.013
n=25
p=0.951
1=0.164
n=25
p=0.435
i=0363
n=25
p=0.074
r=0.077
rt=25
p=0.713
r=0.093
n=25
p=0.659
1=0.142
n=25
p=0.498
r=0.318
rt=25
p=0.122
1=0.203
n=25
p=0331
MAO activity/ 
KY hydroxylase 
activity
r=-0.071
n=8
jf=0.867
r=0.143
rr=8
p=0.736
r=-0.503
n=8
p=0.204
r=O.071
n=8
p=0.867
1=0.143
n=8
p=0.736
r=0.167
n=8
p=0.693
r=0310
rt=8
p=0.456
1=0357
re=8
p=0385
MAO activity/ 
Kynurerinase 
activity
1=0.100
n=5
p=0.873
r=0.100
n=5
p=0.873
1=0.300
ir=5
p=0.624
r=-0.200
rr=5
p=0.747
i=-0.600
n=5
p=0.285
r=-0300
ir=8
p=0.624
r=0.300
n=5
p=0.624
1=0.200
rr=5
p=0.747
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Table 16 a. Correlations between subjective appetite ratings, tryptophan metabolite
ratios and tryptophan enzyme activities during the luteal phase for the mean of both
cycles
Dietary measure' 
Metabolite ratio
Hunger Appetite Satiation Satiety
Dietary 
Restraint- 
food types
Dietary
Restraint-
Amount
Ate more 
than usual Cravings
5HT + HIAA 1=0.052 
n=32 
p=0.776
r=0.095
rr=32
p=0.605
r=-0.125
n=32
p=0.497
r=0.153
rr=32
p=0.404
r=-0.072
rr=32
p=0.697
r=0.184
n=32
p=0.315
r=-0.107
n=32
p=0.558
r=-0.166
n=32
p=0364
Total kynurerine r=0.088
n=32
p=0.634
r=0.165
n=32
p=0.366
p=0.214
n=32
p=0.239
r=0.231
n=32
p=O.203
r=0.060
n=32
p=0.745
t=0.134
n=32
p=0.463
r=-0.129
n=32
p=0.482
r=-0.28I
n=32
p=0.119
5HT=HIAA/ 
Total kynurerine
r=-0.147
n=32
p=0.421
r=-0.139
n=32
p=0.449
1=0.194
n=32
p=0.289
r=-0.145
n=32
p=0.429
r=-0.108
n=32
p=0.557
r=0.135
n=32
p=0.460
r=0.021
n=32
p=0.911
r=0.101
rr=32
p=0.584
5HT + HIAA/ 
KY+H+HA
r=-0.241
n=32
p=0.184
r=-0.230
n=32
p=0.206
r=0.221
n=32
p=0.224
r=-0.161
n=32
p=0378
r=-0.059
n=32
p=0.748
r=0.154
n=32
p=0.400
r=0,048
rr=32
p=0.796
r=0.169
n=32
p=0.357
5HT + HIAA/ 
KY+HK
r=-0.190
n=31
p=0.306
r=-0.225
n=31
p=0.224
r=0.152
n=31
p=0.416
r=0.140
n=31
p=0.454
r=-0.083 
• rr=31 
p=0.658
r=0.204
rr=31
p=0.271
r=0089
rr=31
p=0.635
1=0.192
rr=31
p=0.302
5HT/KY+HK r=-0.152
n=31
p=0.416
r=-0.210
n=31
p=0.258
r=0.113
nr=31
p=0.544
r=-0.131
n=31
p=0.484
r=-0.139
n=31
p=0.455
1=0.071
tr=31
p=0.704
i=0.157
n=31
p=0.399
r=0.293
n=31
p=0.110
5HT+HIAA/
AA
r=-0.173 
n=21 . 
p=0.454
r=-0.098
n=21
p=0.672
r=-0.034
n=21
p=0.884
r=-0.249
n=21
p=0.276
r=-0.114
rt=21
p=0.622
r=-0.099
n=21
p=0.670
1=0.286
n=21
p=0.209
r=0.396
n=21
p=0.075
5HT + HIAA/ 
IAA
r=-0.044
n=31
p=0.814
r=O.058
n=31
p=0.758
r=0.193
n=31
p=0.298
r=0.152
71=31
p=0.415
r=0.358
n=31
p=0.048*
r=0.289
n=31
p=0.115
r=0.100
n=31
p=0394
r=-0.079
n=31
p=0.674
KY hydroxylase 
activity
1=0.112
rr=30
p=0.557
r=0.111
rr=30
p=0.561
r=-0.040
n=30
p=0.833
r=0.154
n=30
p=0.418
r=0.264
rr=30
p=0.158
r=0.043
n=30
p=0.822
r=-0.074
n=30
p=0.697
r=-0.055
rr=30
p=0.775
Kynurerinase
activity
t=-0.119
n=17
p=0.648
r=0.008
rr=17
p=0.977
1=0.028
n=17
p=0.915
r=O.208
n=17
p>=0.422
r=-0.084
rr=17
p=0.749
r=0.100
n=17
p=0.712
r=-0.036
rr=17
p=0.892
r=0.273
n=17
p=0.289
MAO activity t=0.040
n=32
p=0.830
r=0.074
n=32
p=0.688
t=-0.103
rr=32
p=0.575
r=0.176
n=32
p=0.336
r=0.048
n=32
p=0.793
r=0.261
n=32
p=0.149
r=0.120
n=32
p=0.513
r=-0.021
rr=32
p=0.908
MAO activity/ 
KY hydroxylase 
activity
r=-0.550
n=16
p=0.027*
r=-0.456
n=16
p=0.076
r=0.291
n=16
p=0.274
r=-0.188
n=16
p=0.485
r=-0.094
n=16
p=0.729
r=0.240
rr=16
p=0371
r=-0.038
rr=16
p=0.888
r=0.143
rr=16
p=0.598
MAO activity/
Kynurerinase
activity
r=0.127
n=10
p=0.726
r=0.310
n=10
p=0.383
r=-0.127
rr=10
p=0.726
r=0.115
n=10
p=0.751
r=-0.455
n=10
pf=0.187
r=-0.085
n=10
p=0.815
r=-0.079
rr=10
p=0.829
r=0.200
n=10
p=0.580
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Table 16 b. Correlations between subjective appetite ratings, tryptophan metabolite
ratios and tryptophan enzyme activities during the luteal phase of cycle one
Dietary measure/ 
Metabolite ratio Hunger Appetite Satiation Satiety
Dietary 
Restraint- 
food types
Dietary
Restraint*
Amount
Ate mote 
than usual Cravings
5HT+HIAA t=0.029
rr=28
p=0.882
r=0.070
n=28
p=0.722
r=0.096
n=28
p=0.627
r=0.145
n=28
p=0.461
t=0.010
n=28
p=0.960
r=0.043
n=28
p=0.828
r=0.022
n=28
p=0.913
1=0.011
n=28
p=0.956
Total kynurerine r=0.234
n=28
p=0.231
r=0.344
n=28
p=0.074
r=-0.386
n=28
p=0.043*
r=0.424
rr=28
p=0.025*
r=0.243
n=28
p=0.213
r=0.289 
. rr=28 
p=0.136
t=0.059
n=28
p=0.765
t=0.172
n=28
p=0.381
5HT=HIAA/ 
Total kynurerine
r=-0.212
n=28
p=0.279
r=-0.238
n=28
p=0.223
r=0.206
rr=28
p=0.293
r=0.286
n=28
p=0.140
r=-0.370
n=28
p=0.052
r=0.296
n=28
p=0.127
r=0.016
n=28
t)=0.935
r=0.226
n=28
o=0.247
SHT + H1AA/ 
KY+H+HA
r=-0.198
n=23
p=0.365
r=-0.297
n=23
p=0.169
r=0.341
tf=23
p=0.112
r=0.255
rv=23
p=0.240
r=-0.262
n=23
p=0.227
r=-0.225
rr=23
p=0.302
1=0.249
n=23
p=0.252
r=0.081
rt=23
p=0.713
5HT + HIAA/ 
KY+HK
t=0.I99
rr=23
p=0.363
r=-0.219
n=23
p=0.316
r=0.171
rr=23
p=0.435
r=-0.085
rr=23
p=0.701
r=-0.325
rt=23
p=0.131
r=0.297
n=23
p=0.169
1=0.179
n=23
p=0.415
r=0.094
n=23
p=0.670
5HT/KY+HK r=-0.260
n=23
p=0.230
r=0.2I4
n=23
p=0.328
r=0.194
n=23
p=0.375
r=0.075
n=23
p=0.735
r=-0.377
n=23
p=0.076
r=0.288
n=23
p=0.183
r=0.242
n=23
p=0.266
r=0.U3
n=23
p=0.609
5HT + H1AA/ 
AA
r=-0.462
n=14
p=0.096
r=-0.209
n=14
p=0.474
r=0.222
n=14
p=0.446
r=O.508 
n=14 
p=0.0 64
r=-0.482
rt=14
p=0.081
r=-0.490
rr=14
p=0.075
r=0.064
n=14
p=0.828
r=0.548
n=14
p=0.043*
5HT + HIAA/ 
IAA
r=-0.156
n=26
p=0.446
r=O.027
n=26
p=0.896
r=-0.120
n=26
pf=0.560
1=0.099
n=26
p=O.630
r=0.218
n=26
p=0.285
r=0.131
n=26
p=0.523
t=0.073
n=26
p=0.722
r=0.254
n=26
p=0.211
KY hydroxylase 
activity
r=0.309
n=22
p=0.161
r=0.200
n=22
p=0373
r=-0372
n=22
p=0.088
r=0.182
rr=22
p=0.418
r=0.482
n=22
p=0.023*
r=0.333
n=22
p=0.130
r=0.413
n=22
p=0.056
r=0.004
n=22
p=0.987
Kynurerinase
activity
t=0.148
n=ll
p=0.665
r=0,428
rr=ll
p=0.189
r=-0.I68
rr=ll
p=0.622
t=0.411
rr=ll
p=0.210
r=0.159
n=ll
p=0.640
r=0.275
n=Il
p=0.413
r=0.121
n=ll
p=0.722
r=0.029
n= ll
p=0.933
MAO activity r=0.030
n=28
p=0.878
r=0.012
n=28
p=0.954
r=-0.048
n=28
p=0.810
r=0.148
n=28
p=0.452
r=0.049
n=28
p=0.804
r=-0.048
n=28
p=0.808
r=0.194
n=28
p=0324
r=0.047
n=28
p=0.813
MAO activity/ 
KY hydroxylase 
activity
t=-0.410
n=9
p=0.273
r=-0.183
rr=9
p=0.637
r=0.283 
n=9 
p=0.460
r=0.000
n=9
p=0.000
r=0.611
n=9
p=0.081
r=0.417
rr=9
p=0.265
r=0.167
n=9
p=0.668
r=0.367
i f =9
p=0332
MAO activity/
Kynurerinase
activity
r=0.500
n~3
p=0.667
r=-0.500
te=3
p=0.667
r=1.000
n=3
p=0.000
r=-1.000
n=3
p=0.000
r=0.500
n=3
p=0.667
r=0.500
rr=3
p=0.667
1=0.500
n=3
p=0.667
r=1.000
n=3
p=0.000
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Table 16 c. Correlations between subjective appetite ratings, tryptophan metabolite
ratios and tryptophan enzyme activities during the luteal phase of cycle two
Dietary measure/ 
Metabolite ratio
Hunger Appetite Satiation Satiety
Dietary 
Restraint- 
food types
Dietary
Restraint-
Amount
Ate more 
than usual Cravings
5HT + HIAA 1=0.150
n=26
p=0.464
1=0.045 
n=2 6 
p=0.829
1=0.097
n=26
p=0.637
1=0.092
n=26
p=0.656
1=0.006
n=26
p=0.979
1=0.299
n=26
p=0.138
1=0.172
n=26
p=0.400
1=0.130
rr=26
p=0328
Total kynurerine r=-0.035
n=26
p=0.864
i=-0.091
n=26
p=0.659
i=0.019
n=26
p=0.926
r=0.010
i f =26
p=0.962
1=0.036
n=26
p=0.860
r=0.024
n=26
p=0.906
1=0.337
i f = 2 6
p=O.093
1=0.327
n=26
p=0.103
5HT=HIAA/ 
Tptal kynurerine
r=-0.034
rF=26
p=0.870
1=0.013 
n=26 
p=0.950
1=0.094
n=26
p=0.648
r=0.063
n=26
p=0.760
1=0.001
n=26
p=0.995
1=0.284
n=26
p=0.159
1=0.136
n=26
p=O.508
1=0.106
n=26
p=0.605
5HT + HIAA/ 
KY+H+HA
r=0.081
n=25
p=0.701
i=-0.053
ir=25
p=0.802
1=0.165
tr=25
p=0.429
1=0.124
n=25
p=0.555
1=0.015
n=25
p=0.942
1=0.284
n=25
p=0.170
i=0.185
n=25
p=0.376
1=0.095
n=25
p=0.650
5HT + HIAA/ 
KY+HK
r=-0.064
n=23
p=0.771
i=-0.156
n=23
p=0.478
1=0.102
n=23
p=0.642
1=0.015
n=23
p=0.945
1=0370
i i = 2 3
p=0.083
1=0.478
n=23
p=0.021*
1=0.255
re=23
p=0.240
r=0.154
n=23
p=0.483
5HT/KY+HK r=0.125
n=23
p=0.571
r=0.003
n=23
p=0.989
1=0.033
n=23
p=0.881
1=0.109
n=23
p=0.621
1=0.320
n=23
p=0.136
r=0.329
rt=23
p=0.126
1=0.461
ir=23
p=O.027*
i=0369
n=23
p=0.215
5HT + HIAA/ 
AA
r=0.259
n=12
p=0.417
f = 0 3 4 3
n=12
p=0.276
r=0304
ii=12
p=0.095
i=0304
n=12
p=0.095
r=0.252
i t =12
p=0.429
1=0.175
n=12
p=0387
t=0.224
n=I2
p=0.484
1=0.077
rt=12
n=0.812
5HT + HIAA/ 
IAA
r=0.088
n=25
p=0.675
1=0.194
n=25
p=03S2
r=0.173
n=25
p=0.409
1=0.190
n=25
p=0.364
1=0.114
n=25
p=0388
1=0.205
n=25
p=0326
1=0.012
n=25
p=0.956
1=0.498
n=25
p=0.011*
KY hydroxylase 
activity
r=-0.163
n=23
p=0.457
1=0.102
n=23
p=0.642
r=0.174
n=23
p=0.427
r=0.037
n=23
p=0.867
1=0.167 
n=23 
p=0.446
1=0.107
n=23
p=0.628
1=0.274
n=23
p=0.206
1=0.009
n=23
p=0.968
Kynurerinase
activity
r=-0.823
n=7
p=0.023*
1=0.741
rr=7
p=0.057
1=0.593
n=7
p=0.161
1=0.371
rr=7
p=0.413
1=0.185
n=7
p=0.691
1=0.482
n=7
p=0374
1=0.667
ii=7
p=0.102
1=0.074
n=7
p=0.875
MAO activity i=-0.081
n=26
p=0.693
1=0.142
n=26
p=0.490
1=0.021
rr=26
p=0.918
1=0.033
n=26
p=0.875
1=0.100
n=26
p=0.627
1=0.426
it=26
p=0.030*
1=0.050
i f =26
p=0.809
1=0.130
ir=26
p=0326
MAO activity/ 
KY hydroxylase 
activity
1=0.174
i f =6
p=0.742
1=0.029
n=6
p=0557
1=0.714
n=6
p=0.111
1=0.543
n=6
p=0.266
1=0.543
IF=6 
p=0.266
1=0.600
n=6
p=0.208
1=0.714
n=6
p=0.111
1=0.543
rr=6
p=0.266
MAO activity/ 
Kynurerinase 
activity
r=1.000
n=4
p=0.000
1=1.000
n=4
p=0.000
1=0.800
n=4
p=0.200
1=0.800
n=4
p=0.200
1=1.000 . 
n=4
p=0.000
i=0.800
ii=4
p=0.200
1=0.200
n=4
p=0.800
1=0.800
n=4
p=0.200
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Table 17 a. Correlations between subjective appetite ratings, tryptophan metabolite
ratios and tryptophan enzyme activities during the premenstrual phase for the mean 
• of both cycles
Dietary measure/ 
Metabolite ratio
Hunger Appetite Satiation Satiety
Dietary 
Restraint- 
food types
Dietary
Restraint-
Amount
Ate more 
than usual Cravings
5HT+HIAA r=0.092
rr=32
p=0.615
r=0.076
rr=32
p=0.680
r=-0.056
n=32
p=0.760
r=0.078
n=32
p=0.672
r=0.054
n=32
p=0.769
r=0.082
rr=32
p=0.656
r=0.231
rr=32
p=0.204
r=0.018
n=32
p=0.924
Total kynurerine r=-0.071
nf=32
p=0.698
r=-0.073
n=32
p=0.690
r=0.074
n=32
p=0.686
r=-0.U2
n=32
p=0343
r=0.052
n=32
p=0.778
r=0.152
if=32
p=0.405
r=0.031
n=32
p=0.866
r=-0.046
n=32
p=0.802
5HT=H1AA/ 
Total kynurerine
r=0.017
n=32
p=0.927
r=-0.006
n=32
p=0.976
r=-0.050
n=32
p=0.784
r=0.047 
n=32 
p=0.7 99
r=-0.090
n=32
p=0.624
t=-0.202
n=32
p=0.268
r=0.124
n=32
p=0.499
r=0.142
n=32
p=0.437
5HT + HIAA/ 
KY+H+HA
r=0.023
n=31
p=0.904
1=0.029
n=31
p=0.875
r=-0.081
n=31
p=0.665
r=0.116
n=31
p=0.534
r=0.067
n=31
p=0.719
r=0.136
n=31
p=0.467
r=O.I93
n=31
p=0.299
r=0.102
n=31
p=0.584
5HT + HIAA/ 
KY+HK
r=-0.037
n=30
p=0.846
r=-0.013
rr=30
p=0.947
r=-0.204
n=30
p=0.279
r=0.1I8
rt=30
p=0.535
r=-0.017 
n=30 . 
p=0.929
r=-0.141
n=30
p=0.457
r=0.380
n=30
p=0.038*
r=0.214
n=30
p=0.257
5HT/KY+HK r=0.007
rt=30
p=0.973
r=0.027
n=30
p=0.890
r=-0.287
n=30
p=0.124
r=0.134
n=30
p=0.482
r=-0.075
n=30
p=0.695
r=-0.I40
n=30
p=0.461
r=0.363
tr=30
p=0.048*
r=0.153
rr=30
p=0.420
5HT + HIAA/ 
AA
r=-0.206
n=23
p=0.347
t=-0.233
n=23
p=0.284
r=-0.028
n=23
p=0.900
r=0.192
n=23
p=0381
r=-0.I3G
rr=23
p=0.553
r=-0.184
n=23
p=0.401
r=-0.039
n=23
p=0.861
r=0.008
n=23
p=0.97I
5HT + HIAA/ 
IAA
r=0.181
n=30
p=0339
r=0.149
if=30
p=0.431
t=0.064
n=30
p=0.738
r=0.174
n=30
p=0.359
r=0.188
n=30
p=0.319
t=0.069
n=30
p=0.715
r=0.205
rr=30
p=0.276
r=-0.099
n=30
p=0.602
KY hydroxylase 
activity
t=0.043
rr=28
p=0.828
r=0.004
n=28
p=0.985
r=0.395
n=28
p=0.037*
r=-0.089
n=28
p=0.653
r=0.231
n=28
p=0.237
t=0.174
rr=28
p=0375
r=0.067
n=28
p=0.736
r=-0.047
rr=28
p=0.8I3
Kynurerinase
activity
r=0.006
tf=20
p=0.979
r=-0.043
n=20
p=0.857
r=-0.181
rt=20
p=0.446
r=-0.012
n=20
p=0.959
r=0.103
n=20
p=0.666
r=0.139
n=20
p=0.559
r=0.077
n=20
p=0.748
r=0.402
rr=20
p=0.079
MAO activity r=-0.096
n=32
p=0.602
r=-0.I02
n=32
p=0.578
r=0.161
n=32
p=0.378
r=-0.070
n=32
p=0.703
r=0.125
n=32
p=0.496
r=-0.046
n=32
p=0.803
1=0.046
n=32
p=0.803
r=0.262 
n=32 
p=0.I48
MAO activity/ 
KY hydroxylase 
activity
r=-0.172
n=18
p=0.494
r=*0.164
n=18
p=0315
r=0.044
n=18
p=0.861
r=-0.111
rr=18
p=0.660
r=0.389
n=18
p=0.111
r=-0.286
n=18
p=0.250
r=0.102
21=18
p=0.687
r=0.275
rr=18
p=0.270
MAO activity/
Kynurerinase
activity
r=0.280
n=13
p=0.354
r=0.412
n=13
p=0.162
r=0.154
n=I3
p=0.615
r=0.3%
n=13
p=0.181
r=0.247
rr=13
p=0.415
r=0.484
n=13
p=0.094
r=-0.088
n=13
p=0.775
r=-0.041
n=13
p=0.894
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Table 17 b. Correlations between subjective appetite ratines, tryptophan metabolite
ratios and tryptophan enzyme activities during the premenstrual phase of cycle one
Dietaiy measure/ 
Metabolite ratio
Hunger Appetite Satiation Satiety
Dietary 
Restraint- 
food types
Dietaiy
Restraint-
Amount
Ate more 
than usual Cravings
5HT + HIAA t=0.I56
n=29
p=0.420
t=0.206
n=29
p=0.285
r=0.164
n=29
p=0394
1=0.146
n=29
p=0.450
1=0.146
n=29
p=0.450
1=0.047
n=29
p=0.810
1=0.078
b=29
p=0.687
1=0.120
n=29
p=0.537
Total kynurerine r=O.202
n=29
p=0,293
1=0.177
uf29
p=0357
1=0.167
rr=29
p=0.388
r=0.159
n=29
p=0.410
1=0.011
n=29
p=0.956
1=0.134
n=29
p=0.489
1=0.028
if=29
p=0.887
1=0.106 
n=29 
p=0.585
5HT=HIAA/
Total kynurerine .
r=0.252
n=29
p=0.187
1=0.183
n=29
p=0.343
1=0.056
n=29
p=0.772
1=0.217
n=29
p=0.258
1=0.036
n=29
p=0.853
1=0.289
n=29
p=0.128
1=0.009
n=29
p=0.962
1=0.325
n=29
p=0.085
5HT + HIAA/ 
KY+H+HA
1=0.115
n=26
p=0.576
1=0.059
n=26
p=0.774
1=0.035
n=26
p=0.864
1=0.102
it=26
p=0.620
1=0.022
n=26
p=0.912
1=0.246
n=26
p=0.226
1=0.083
it=26
p=0.686
1=0.409
n=26
p=O.038*
5HT + HIAA/ 
KY+HK
r=-0.182
n=25
p=0.384
1=0.139
n=25
p=0.508
r=0.022
ir=25
p=0.919
1=0.207
n=25
p=0.322
1=0.015
n=25
p=0.945
1=0.185
n=25
p=0.377
1=0.214
n=25
p=0.304
1=0.417
n=25
p=0.038*
5HT/KY+HK r=0.246
n=25
p=0.237
1=0.211
if=25
p=0.31I
1=0.012
n=25
p=0.953
1=0.207
n=25
p=0.320
1=0.091
n=25
p=0.666
1=0.212
ir=25
p=0310
1=0.256
n=25
p=0.218
1=0.437
n=25
p=0.029*
5HT + HIAA/ 
AA
1=0.578
n=17
p=0.015*
1=0.635
n=17
p=0.006**
1=0.477
if=17
p=0.053
1=0.684
n=17
p=0.002**
1=0.306
n=17
p=0.232
1=0.453
n=17
p=0.068
1=0.114
n=17
p=0.663
1=0.265
n=17
p=0.304
5HT + HIAA/ 
IAA
r=0.187
n=26
p=036l
1=0.166
n=26
p=0.419
1=0.021
re=26
p=0.918
r=0.117
n=26
p=0.568
i=0.203
n=26
p=0321
1=0.021
n=26
p=0.919
1=0.112
re=26
p=0.587
1=0.160
if=26
p=0.435
KY hydroxylase 
activity
r=0.211
n=21
p=0359
1=0.187
rr=21
p=0.416
1=0.201
n=21
p=0.381
t=0.146
it=2l
p=0329
1=0.127
n=21
p=0.583
1=0.023
n=21
p=0.921
i=0.206
n=21
p=0371
1=0362
n=21
p=0.107
Kynurerinase
activity
1=0.045
n=15
p=0.873
1=0.028
if=15
p=0.920
1=0.034
re=15
p=0.904
1=0.019
rf=15
p=0.947
1=0.136 
n=15 
p=0.630
1=0.233
ir=15
p=0.402
1=0.151
n=15
p=0.592
1=0.297
n=15
p=0.282
MAO activity 1=0.057
n=29
p=0.768
1=0.052
n=29
p=0.791
1=0.082
n=29
p=0.671
1=0.051
n=29
p=0.794
1=0.459
ir=29
p=0.012*
1=0.159 
n=2 9 
p=0.409
1=0.155
n=29
p=0.423
1=0.157
n=29
p=0.417
MAO activity/ 
KY hydroxylase 
activity
1=0.264
ti=ll
p=0.432
1=0.205
n=Il
p=0.545
1=0.059
n=ll
p=0.863
1=0309
n=ll
p=0.355
1=0.391
IF=11
p=0.235
1=0346
n=ll
p=0.467
1=0.246
n=ll
p=0.467
1=0.427
n=ll
p=0.190
MAO activity/ 
Kynurerinase 
activity
r=0.817
ie=9
p=0.007**
1=0.795
n=9
p=0.010*
1=0.433
ie=9
p=0.244
1=0.600
n=9
p=0.088
r=0.567
it=9
p=0.112
1=0.333
n=9
p=0.381
1=0.167
n=9
p=0.668
1=0.517
rt=9
p=0.154
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Table 17 c. Correlations between subjective appetite ratings, tryptophan metabolite
ratios and tryptophan enzvme activities during the premenstrual phase for the mean
of both cycles
Dietary measure/ 
Metabolite ratio
Hunger Appetite Satiation Satiety
Dietaiy 
Restraint- 
food types
Dietaiy
Restraint-
Amount
Ate more 
than usual Cravii^s
5HT + HIAA r=0.138
n=26
p=0.503
1=0.205
ir=26
p=0316
r=0.178
n=26
p=0385
r=0.055
n=26
p=0,788
r=0.077
n=26
p=0.710
1=0.114
n=26
p=0.581
1=0.238
n=26
p=0.241
1=0.069
if=26
p=0.737
Total kynureiine r=0.060
n=26
p=0.773
1=0.087
n=26
p=0.673
r=0.045
n=26
p=0.827
r=0.045
n=26
p=0.827
1=0.051
n=26
p=0.805
1=0.079
n=26
p=0.700
r=0356
n=26
p=0.074
1=0.046
n=26
p=0.823
5HT=HIAA/ 
Total kynurerine
1=0.056
n=26
p=0.787
1=0.156
rr=26
p=0.447
1= 0.000
n=26
p=0.999
r=0.163
n=26
p=0.425
1=0.038
n=26
p=0.853
1=0.096
n=26
p=0.641
1=0.480
n=26
p=0.013*
1=0.023
ir=26
p=0.9l2
SHT+HIAA/
KY+H+HA
r=-0.133 
n=25 
p=0.527
1=0.244
n=25
p=0.240
r=0.103
n=25
p=0.624
1=0.205
n=25
p=0.326
1=0.049
n=25
p=0.817
1=0.048
n=25
p=0.821
1=0.564
n=25
p=0.003**
1=0.024
n=25
p=0.910
5HT + HIAA/ 
KY+HK
r=0.242
rf=22
p=0.278
r=0.344
n=22
p=0.117
r=0.566
n=22
p=0.006**
r=0.442
n=22
p=0.039*
1=0.137
n=22
p=0.543
r=0.142
n=22
p=0.527
1=0.612
ir=22
p=0 .002**
1=0.150
n=22
p=0.506
5HT/KY+HK t=0342
n=22
p=0.120
1=0.492
n=22
p=0.020*
1=0.712
n=22
p=0 .000**
*
1=0.537
n=22
p=0.010
1=0.276
n=22
p=0.214
1=0.188
n=22
p=0.403
1=0.441
n=22
p=0.040*
1=0.275
re=22
p=0.216
5HT + HIAA/ 
AA
r=0.476
n=12
p=0.118
i=0399
n=12
p=0.199
r=0.175
n=12
p=0.587
1=0.175
n=12
p=0.587
1=0.259
n=12
p=0.417
1=0.378
n=I2
p=0.226
1=0.245
n =12
p=0.443
1=0.133
re=12
p=0.681
5HT + H1AA/ 
IAA
r=0.235
rr=24
p=0.269
1=0.065
n=24
p=0.764
1=0.069
n=24
p=0.750
r=0.167
n=24
p=0.435
1=0.075
n=24
p=0.727
1=0.116
n=24
p=0.590
1=0.454
n=24
p=0.026*
1=0.070
n=24
p=0.744
KY hydroxylase 
activity
1=0.080
n=22
p=0.724
i=0.181
n=22
p=0.421
1=0.295
n=22
p=0.183
1=0.092
n=22
p=0.685
1=0.009
n=22
p=0.967
1=0.323
n=22
p=0.142
1=0.297
n=22
p=0.180
1=0.056
n=22
p=0.804
Kynurerinase
activity
x=0.029
i f =6
p=0S57
r=0.232
i f =6
p=0.658
r=0.696
n=6
p=0.125
1=0.232
71=6
p=0.658
r=0.232
11=6
p=0.658
1=0.551
n=6
p=0.257
1=0.319
n=6
p=0.538
r=0377
n=6
p=0.461
MAO activity r=-0.196
n=26
p=0.337
i=0319
it=26
p=0.113
1=0.499
nr=26
p=0.010*
1=0.197
n=26
p=0.336
1=0.168
n=26
p=0.413
1=0.146 
n=2 6 
p=0.476
1=0.326
n=26
p=0.104
1=0.395
it=26
p=0.046*
MAO activity/ 
KY hydroxylase 
activity
r=0.086
n=6
p=0.872
i=0.46
n=6
p=0329
r=0.486
rr=6
p=0.329
r= 0.200
rr=6
p=0.704
1=0.486 
rr=6
p=0.329
1=0.257
it=6
p=0.623
1=0.943
ti=6
p=0.005**
1=0.543
n=6
p=0.266
MAO activity/ 
Kynureiinase 
activity
r=0.800
n=4
p=0.200
r=0.400
n=4
p=0.600
r=1.000
n=4
p=0.000
r=1.000
n=4
p=0.000
1=0.400
ir=4
p=0.600
1=0.400
it=4
p=0.600
1=0.000
n=4
p=0.000
1=0.000
n=4
p=0.000
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Table 18b. Correlations between Trait Anxiety . Trait Anger and Actual Food
Intake in the Luteal Phases of the Menstrual Cycle
TtvX CfcmcUristicaf Tliit Anxiety Thit Anger Angry Angry Reaction Anger In Anger Out Anger Control Anger
Dirt»y Irtfjlce (g) (Total) Tcmpenncot Expression
M on  <£ C yd«
1*0.128 1=0.267 1*0.146 1=0.459 1=0334 1*0.114 r-0.034 1*0.119
K ot 0=30 0=32 0=32 0-32 0=32 0=32 0-32 0=32
p-0.501 p-0.140 ppO.424 p-0.008** | f0.062 pO.534 p-0.854 p-O.516
Proton * **. r-0.083 1=0268 1*0.097 r-0333 1=0399 1*0.121 1-0.018 1=0.164
ir*30 n=32 n*32 0=32 n*32 0=32 0*32 C-32
p*0.6G5 p*O.I3S p=0.597 p=0.063 p-O.024* p-0.508 p=0.924 p=0359
Fit r-0.099 r=02S3 1*0.045 1=0.509 1=0352 1=0.015 1*0.014 1=0.146
0=30 n=32 0-32 0=32 0-32 0=32 0=32 0*32
fF-0.604 p=0.116 p=0.808 p=0.0Q3** p=0.165 p-0.937 p=0.94l p-0.427
CHO r=0.U2 1-O.X4I f*0.154 1=0293 1=0306 1*0.114 1=0.048 1=0ST
IF<J0 n*32 n=32 0=32 0=32 0=32 n=32 o=22
p-0.488 p*0.443 p-0.400 jfpO.104 p-0358 p-0.535 p=0.795 p-0.840
Sugar r-0.178 1=0.184 1*0062 1=0J 17 1=0.272 1*0.203 1=0.150 1*0.032
0=30 0=32 0=32 0=32 0=32 0=32 0=32 0-32
p-0.347 p=0313 p=0.145 p=0.077 p=0.132 p=0.263 p-0.414 p-0.861
Starch p°0.005 1=0.013 1*0.045 1=0.136 1=0.066 1*0.048 1=0.080 1=0.074
0-30 0=32 n=32 0=32 o=32 0=32 n=32 0=32
p*0.980 p*0S42 p=0.808 p=0.4S7 p-0.718 p-O.794 p=0.664 p=0.687
TLA R -0JJ7n-30 1=0.017 1*0.024 1=0229 1=0.025 1*0.097 1=0.172 1=0.173
jrO.052 0=32 0=32 n=32 0=32 0-32 0=32 0=32
p*0.927 p-0.697 p=0.208 p*0.892 p-0.598 p-0347 p-0344
CydeCne
1=0.061 1=0.144 1*0.195 i=OJ52 1=0383 1*0393 1=0.096 1*0.024
K ol n-27 0=29 0=29 n-29 0=29 0-29 0=29 n-29
p*0.763 p=0.455 p=0003 P-O.061 P*0.137 p=0.124 p=0.622 p=0.902
Proton r-0.177 1=0 258 1*0039 1=0300 1=0.491 1*0355 1=0.151 1-0.033
ff-27 0=29 n=29 0-29 o*29 0-29 0=29 0=29
p-0377 p=0.177 p=0O12 p*0.114 p-0.007** jrO.059 p-0.436 p-0.567
Fit r=0.057 1=0.173 1*0.095 1=0.483 1=0345 1*0327 1=0.023 1-0.033
0-27 0=29 0*29 0=29 0=32 0-29 0=29 0=29
p=0.667 p-0-369 p=0.626 p-0.008** p-0300 p-0336 p-0.907 p-0.864
CHO r-O.OH 1=0.060 1*0.191 1=0.182 1=0.129 1*0301 1=0.114 1*0.089
0=27 0=29 o«29 0=29 n*29 0-29 0*29 0=29
p-0.947 p-0.756 p-0322 p*034J p-0.506 p-0395 p-0.555 p-0.645
Sugar 1*0.013 r=0.11S 1*0097 1*0.172 1=0.175 1*0.242 1-0.232 1-0.163
0=27 0=29 0*29 0=29 0=29 0*29 0*29 0=29
p=0.947 p=0.543 p=0.118 p=0372 p=0364 p=0303 p-0.227 p-0^98
Stanh r*0.059 1*0.075 1*0.031 1=0.061 1=0.001 1*0.10 1*0.058 1=0.001
0=27 0=29 n*29 0*29 0=29 0=29 n=29 0=29
p-0.772 p-0.699 p-0.873 p-0.753 p-0 S96 p-0.606 p-0.766 p-0.998
TLA r-0.353 1=0287 1=0.088 1*0357 1=0.061 1=0.185 1*0.054 1=0.073
n=27 0=29 n=29 0=29 n-25 0=29 tt=29 0=29
jrO.071 p-O.131 p=0.651 p=0.057 p-0.755 p=0337 p-0.781 p=0.706
CydeTwo
i=0.22S 1=0.415 1=0.043 1=0.512 1=0.468 1=0.098 1*0.116 1-0J6 8
Kcd n=25 n=27 0=27 0=27 ff-27 0*27 0=27 0=27
p-0.274 p=0.030* p=0.832 p=0.006** p*O.OI4* p=0.627 fFO.563 p-O.059
Protein 1=0.014 1*0015 1=0.154 1=0357 1=0.238 1=0.090 1*0.163 1=0.274
n=25 0*27 0=27 0=27 0=27 0=27 0=27 n=27
p-0.945 p=0081 p-0.445 p-0.068 p-0332 p-0.654 p-0.416' p-0.167
Fit 1=0.182 1*0.456 1=0.030 1=0.492 1=0382 p-0.194 1=0.055 1=0320
0=25 0=27 0=27 n=27 0=27 0=27 0=27 0-27
p=0.383 p=0.017* p=0.8S3 p=0.009+* p=0.050* p=0334 p*=0.785 p-0.104
CHO 1=0.217 1=0.199 1*0.007 1=0377 1=0340 1*0.031 1*0.092 1-0329
n=25 0=27 n=27 0=27 0=27 0-27 0=27 0=27
p=0298 p-0.319 p=0.97I p-0.162 p-0.083 p-0.879 p-0.650 p=035I
Sugv 1=0.335 f-0.179 1*0.039 1*0332 1*0369 1*0.106 1-0.081 1=0.206
0=25 0*27 0=27 0*27 0=27 H-27 0=27 0=27
p-0.102 p-0.372 p=0.846 p-0.091 p-0.059 p-0.600 p-0.690 p-0  303
SUrch 1*0.059 1=0.049 1*0.009 1*0.097 1=0.185 1*0.028 1*0.119 1=0.166
0=25 tt=27 0*27 0=27 0=27 0-27 0*27 0=27
p-0.779 p-0.807 p-0.963 p-0.631 p-0355 p-0.889 p-0.556 p-0.407
TLA r=0337 1*0.112 1*0.022 1=0.136 1=0.014 1-0.058 1*0301 1=0235
0=25 0-27 0=27 0=27 0=27 0=27 0=27 0=27
p=0.099 p*O.J77 p=0.615 p-0.498 p=0.944 p-0.772 p-0.127 p-0.239
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Table 18 c. Correlations between Trait Anxiety . Trait Anger and Actual Food
Intake in the Premenstrual Phases of the Menstrual Cycle
H d t CharacterUticaf 
Dietary Intake (g)
H ait Anxiety TtuX Anger 
(Total)
Aogiy
Tempennetf
Angry Reaction Anger In Anger Oat Anger C oord Anger
Expression
M eancf Cydea
0 .0 5 8 1-0.096 r—0.283 0 .2 6 2 0 2 3 1 1=0301 10.070 1=0.001
K ot 0=30 0-32 n-32 n-32 n-32 0=32 0-32 0=32
p-0.761 p-0.600 (0 .1 1 7 (0 .1 4 7 p-0-203 ( 0 2 6 9 (0 .7 0 5 p-0.994
Proton i O . l l * 1-0.098 1=0.253 0 .0 5 9 r-0.253 1*0.062 1=0.005 0 .1 2 1
n=30 0=32 0=32 0=32 n=32 n=32 0-32 0=32
p«0.536 (0 .5 9 4 (0 .1 6 2 p-0.750 (0 .1 6 2 (0 .7 3 5 [0 .9 7 8 p-0.508
Fat. O .G 38 O J20 1—0.122 0 .3 9 0 1=0.193 1=0.092 1*0.088 1=0.010
n»30 0-32 0-32 0-32 0*32 n-32 0-32 0=32
p-0.842 (0 .2 2 6 (0 .5 0 5 [0 .027* (0 .2 9 1 p-0.616 (0 .6 3 1 p-0.956
CHO 1=0.129 r—0.049 rO .269 r-0.117 1=0.144 1=0319 10.009 10 .0 1 3
ipOO n=32 0=32 n=32 0*32 n=32 n-32 n-32
p-0.497 p=0.790 p-0.137 [0 .5 2 4 (0 .431 (0 .2 2 8 (0 .9 6 0 [0 .9 4 6
Sugar 0 .1 6 5 1-0.025 1-0.236 r=0.171 1*0.213 1*0.172 1-0.015 0 .0 4 1
0-30 n=32 0-32 0-32 0-32 n-32 0=32 0*32
p=03S3 p-0.891 p=0.193 (0 .3 5 0 [0 .2 4 1 p-0347 pO.936 p-0.822
Starch 1-0.077 r —0.167 I-0 J 0 7 1—0.014 r-0.014 1*0.193 1=0.046 1 0 .0 3 7
0=30 n=32 n=32 n-32 n-32 n-32 n-32 0=32
p-0.685 p-0.362 p=0.256 (0 .9 4 0 p-0.938 p O J90 pO.802 p-0.842
H A 0 .3 2 7 p=0.283 1-0.113 r-0.367 r -o js o 1—0.083 1-0.008 0 .1 8 2
0=30 0=32 0-32 0=32 . 0-32 n-32 0*32 n=32
p=0.077 (0 .1 1 5 [0 .5 3 8 p=0.039* p-0.027* pO.653 p=0.966 [0 .3 2 0
CydeOoe
1-0.040 1—0.015 r—0311 '  1=0.177 r=0.284 1-0303 1=0.02 0 .0 5 6
Kcal 0=28 0-30 0-30 0*30 O-30 0=30 0*30 0=30
(0 .838 p-0.937 (0 .0 9 5 [0 .3 4 9 p=0.128 p=0.104 [0 .9 1 5 [0 .7 6 8
Proton r-0.103 1*0.020 r-0 3 9 8 1=0.006 1-0.314 1-0.126 1*0.107 n-0.203
n=25 0=00 0=30 0=30 n-30 0=30 0-30 n-30
jrO.602 p-0.917 p-0.030* P-CL973 p-0.092 (0 .5 0 8 p-0.575 [0 .2 8 3
Fit tO .031 1=0.070 X—0.103 1=0303 1=0201 1-0^05 1=0,014 0 .0 4 3
d-28 0*30 0=30 0=30 n-30 n-30 n*30 0-30.
p=0.876 (0 .7 1 3 P-0J90 (0 .1 0 4 [0 .2 8 6 (0 .2 7 7 [0 .941 p-0.820
CHO 1-0.140 r —0.076 r—0.293 0 .0 7 0 1=0.151 1=0.263 1*0.017 0 .0 1 0
d-2  5 0 OO 0=30 0-30 n-30 n-30 0-30 0-30
p=0.479 (0 .6 9 0 [0 .1 1 6 (0 .7 1 4 p=0.339 (0 .1 5 7 [0 .931 p*0360
p*0.149 1—0.024 r—0.241 1*0.101 0 2 7 7 1-0.168 1*0.115 0 .1 7 1
0*28 0=30 n-30 0=30 0=30 0*30 0=30 0=30
p-0.449 (0 .8 9 9 p=0.200 p-0.596 (0 .1 3 8 p=0-374 pO.546 p-0367
Stardt 1=0.033 1—0.142 r—0.265 0=0.014 1=0.042 r-0.244 r-0,008 1 0 .0 7 8
n-28 0=30 0=30 0=30 0*30 n*30 0=30 0-30
p-0.857 p=0.454 p-0.157 [0 .9 4 2 p-0.826 pO.193 [0 .9 6 8 p-0.683
H A 0 .1 6 7 1-0.094 1—0.068 1=0.451 0 .2 0 7 1-0.071 1 0 .1 5 5 0 .1 9 7
n-28 0=30 n-30 0=30 0*30 0*30 0*30 n*30
( 0 3 9 6 p-0.620 p-0.720 [0 .012* [0 .2 7 2 pO,708 [0 .4 1 6 p-0 .297
CydeTwo
1-0.085 0 .1 3 2 f—0.105 r=0.320 1=0.087 10.049 1 0 .0 3 2 0 .0 9 4
Kcal 0=24 0-26 0=26 0=26 0-26 0=36 n-26 n=26
( 0 6 9 5 p=0J22 p-0.610 (0 .1 1 0 [0 .6 7 3 pO.811 p*0.878 (0 .6 4 8
Protein 1-0.035 0 .1 5 2 0 .0 6 3 1=0.106 1=0.092 10.062 rO-OOl 0 .0 8 2
0=24 0=26 0=26 o=26 tt=26 0-36 0=26 n—26
p-0.799 p-0.458 p-0.759 p-0.605 p-0.656 pO.763 p-0.994 0*04589
Fat r-0.131 I-OJ15 r-0.017 1=0.521 1=0.102 1=0.206 10 .0 0 8 0 .1 5 4
0=24 n=26 0=26 0=26 n-26 n-26 0*26 0*36
(0 5 4 1 [0 .1 1 3 [0 .9 3 5 (0.006** [0 .6 2 0 [0 .3 1 4 p-0 .968 p-0.451
CHO 1-0.080 1-0.100 f-0.169 1=0.048 1-0.019 1=0.102 10 .0 5 8 0 .0 0 6
0=24 0=26 0=26 o-26 n-26 n-26 n-26 0=26
p-0.710 p-0.628 p-0.411 [0 .8 1 5 (0 .9 2 5 (0 .6 2 0 p-0.779 (0 .9 7 6
a« « r 0 .1 1 0 P—0.066 1—0.096 1—0.003 1-0074 r—0.060 1=0.083 1 0 .1 2 5
0=24 0=26 0=26 0-26 n-26 n=26 n-26 0=36
p-0.608 [0 .751 pO.642 [0 .9 8 8 p-0.719 p-0.773 pO.657 [0 .5 4 4
Starch 1*0.120 1-0.169 r—0.12S 1—0.006 r-0.018 1—0.110 10 .1 5 0 0 .0 6 3
0-24 n=26 0=26 n-26 n=26 n-26 n-26 n-26
p-0.577 (0 .4 0 8 p-0.534 p-0.977 [0 .931 p-O.592 p-0.465 p-0.761
H A 0 .3 6 0 1=0083 1=0.027 t-O.114 1-0381 10.000 1=0.014 f-0.219
0-24 n=26 0=26 0=26 0-26 0-26 0=26 0-26
(0 .0 8 4 p-0.161 p-0.895 (0 .5 7 9 p-0.055 p-1.000 p-0.948 (0 .2 8 3
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Table 19a. Correlations between Trait Anxiety. Trait Anger and Percentage Food
Intake During the Follicular Phases of the Menstrual Cycle
Trait
Characteristics/ 
% Food Intake
Trait
Anxiety
Trait Anger 
(Total)
Angiy
Temperment
Angry
Reaction
Anger In Anger Out Anger
Control
Anger
Expression
Mean of Cydes 
% Fat
r=-0.002
rr=30
p=0.991
r=0.112
n=32
p=0.540
1=0.153
«=32
p=0.403
1=0.006
ii=32
p=0.974
1=0.066
n=32
p=0.718
1=0.037
n=32
p=0.839
1=0.115
n=32
p=0.531
1=0.103
n=32
p=0.575
% Protein r=-0.083
n=30
p=0.662
1=0.095
n=32
p=0.604
1=0.098
n=32
p=0.596
i=0.U5
n=32
p=0.533
r=0.195
n=32
p=0.286
1=0.003
n=32
p=0.987
r=0.150
n=32
p=0.411
1=0.214
n=32
p=0.240
% CHO 1=0.153
n=30
p=0.418
1=0.076
n=32
p=0.678
1=0.138
n=32
p=0.451
t=0.064
ra=32
p=0.728
1=0.104
n=32
p=0.572
1=0.009
n=32
p=0.96I
r=0.150
n=32
p=0.412
r=0.160
n=32
p=0382
%Si®ar 1=0.194
n=30
p=O.303
r=0.046
n=32
p=0.801
1=0.269
n=32
p=0.136
r=0.134
n=32
p=0.466
1=0.098
n=32
p=0.S93
r=0.015
n=32
p=0.937
1=0.031
ii=32
p=0.867
1=0.040
ii=32
p=0.829
% Starch r=0.008
n=25
p=0.970
r=0.008
ir=30
p=0.967
r=-0.127
n=32
p=0.488
1=0.125
if=32
p=0.496
1=0.079
n=32
p=0.667
1=0.022
n=32
p=0.905
1=0.042
n=32
p=0.818
1=0.235
n=32
p=0.196
Cyde One 
% Fat
r=-0.043
re=28
p=0.827
1=0.123
n=30
p=0.518
1=0.250
n=30
p=0.182
i=0.021
n=30
p=0.912
1=0.177
n=30
p=0349
1=0.081
n=30
p=0.672
r=0.161
n=30
p=0.394
1=0.181
n=30
p=0.339
% Protein r=-0.021
n=28
p=0.917
1=0.087
n=30
p=0.649
1=0.051
n=30
p=0.789
1=0.311
n=30
p=0.094
1=0.220
n=30
p=0.244
i=0.027
n=30
p=0.890
1=0.217
n=30
p=0.249
r=0.265
if=30
p=0.157
% CHO 1=0.176
ii=28
p=0.369
r=-0.121
n=30
p=0.524
1=0.233
ir=30
p=0.216
1=0.009
ir=30
p=0.964
r=0.106
n=30
p=0.578
r=0.074
ii=30
p=0.697
1=0.110
ii=30
p=0.561
1=0.107
n=30
p=0.573
%Sugar r=0.189
n=28
p=0335
1=0.036
n=30
p=0.849
i=0314
n=30
p=0.091
1=0.102
n=30
p=0.592
1=0.178
n=30
p=0346
1=0.028
it=30
p=0.882
r=0.01I
n=30
p=0.956
1=0.083
it=30
p=0.661
% Starch 1=0.019
n=28
p=0.926
r=-0.151
rr=30
p=0.427
1=0.144
ir=30
p=0.447
r=0.173
n=30
p=0.360
1=0.093
ir=30
p=0.624
r=0.06S
n=30
p=0.731
1=0.168
ir=30
p=0.375
r=0.089
n=30
p=0.641
Cyde Two 
% Fat
1=0.017
n=23
p=0.938
1=0.136
n=25
p=0.516
r=0.057
n=25
p=0.788
r=0.007
it=25
p=0.975
1=0.008
n=25
p=0.971
1=0.142
n=25
p=0.5(K)
1=0.057
n=25
p=0.785
1=0.161
n=25
p=0.939
% Protein i=-0.067
n=23
p=0.763
r=0.129
n=25
p=0.538
1=0.067
n=25
p=0.751
1=0.158
ir=25
p=0.451
1=0.136
n=25
p=0.516
1=0.037
n=25
p=0.859
1=0.099
n=25
p=0.639
1=0.002
if=25
p=0.993
% CHO r=0.125
n=23
p=0371
r=-0.064
n=25
p=0.763
r=0.067
n=25
p=0.749
1=0.060
n=25
p=0.775
1=0.110
if=25
p=0.603
1=0.023
n=25
p=0.913
1=0.178
n=25
p=0.394
r=0.161
n=25
p=0.442
%Stgar 1=0.213
ir=23
p=0.329
1=0.049
n=25
p=0.815
1=0.031
n=25
p=0.882
1=0.150
n=25
p=0.474
1=0.007
n=25
p=0.973
r=0.057
ii=25
p=0.788
i=0.055
n=25
p=0.795
1=0.008
n=25
p=0.970
% Starch 1=0.004
n=23
p=0.987
1=0.056
n=25
p=0.789
r=0.027 
n=25 
p=0.899
1=0.067
n=25
p=0.751
1=0.115
n=25
p=0.585
1=0.036
n=25
p=0.863
1=0.192
n=25
p=0.357
1=0.196
ir=25
p=0348
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Table 19b. Correlations between Trait Anxiety. Trait Anger and Percentage Food
Intake in the Luteal Phases of the Menstrual Cycles
Trait
Characteristics/% 
Food Intake
Trait
Anxiety
Trait Anger 
CTotal)
Angiy
Temperment
Angry
Reaction
Anger In Anger Out Anger
Control
Anger
Expression
Mean of Cycles 
% Fat
r=0.074 
n=30 
p=0.699
1=0.018
n=32
p=0.922
r=0.161
n=32
p=0.380
1=0.190
n=32
p=0.297
1=0.138
n=32
p=0.452
1=0.093
rr=32
p=0.612
r=0.088
n=32
p=0.634
r=0.021
n=32
p=0.910
% Protein r=-0.061
n=30
p=0.751
1=0.070
n=32
p=0.704
1=0.027
n=32
p=0.885
1=0.183
n=32
p=0316
1=0.216
n=32
p=0.236
1=0.067
n=32
p=0.714
1=0.011 
ir=32 
p=0.952
1=0.087
n=32
p=0.636
% CHO r=0.136
n=30
p=0.473
1=0.122
n=32
p=0307
1=0.121
n=32
p=0.507
1=0.121
n=32
p=0.509
r=0.042
n=32
p=0.818
1=0.033
if=32
p=0.860
1=0.052
ii=32
p=0.779
r=0.014
ir=32
p=0.942
%Sugar 1=0.051
n=30
p=0.788
r=O.029
n=32
p=0.876
1=0.232
n=32
p=0.201
1=0.041
ii=32
p=0.824
1=0.014
n=32
p=0.938
1=0.044
n=32
p=0.810
1=0.125
n=32
p=0.495
r=0.113
n=32
p=0.537
% Starch f O.071 
n=30 
p=0.7 09
r=O.240
n=32
p=0.186
1=0.086
n=32
p=0.642
r=O.I59
n=32
p=0.384
1=0.138
n=32
p=0.452
1=0.017
n=32
p=0.925
1=0.157
n=32
p=0.391
1=0.025
n=32
p=0.891
Cyde One 
% Fat
1=0.003
if27
p=0.990
1=0.006
n=29
p=0.977
1=0.178
n=29
p=0.356
1=0343
n=29
p=0.069
i=O.U2
n=29
p=0.565
1=0.003
n=29
p=0.986
1=0.147
n=29
p=0.448
1=0.041
n=29
p=0.834
% Protein r=0.207 
iH 27 
p=0.300
1=0.273
n=29
p=0.152
r=0.102
n=29
p=0398
1=0.064
ir=27
p=0.743
1=0.461
n=29
p=0.012*
1=0.169
n=29
p=0.381
1=0.156
if=29
p=0.419
r=0.088
ir=29
p=0.651
% CHO r=-0.001 
n=27 
p=0.998
r=0.178
n=29
p=0355
1=0.122
n=29
p=0.528
1=0.200
rt=29
p=0.299
1=0.119
n=29
p=0.540
1=0.049
n=29
p=0.801
t=0.036
n=29
p=0.854
1=0.024
if=29
p=0.904
%Sugar 1=0.042
n=27
p=0.836
r=0.076
n=29
p=0.697
1=0.311
n=29
p=0.101
1=0.12
n=29
p=0.527
r=0.010
n=29
p=0.958
1=0.037
n=29
p=0.850
1=0.264
n=29
p=0.166
1=0.179
n=29
p=0.353
% Starch r=0.090
ii=27
p=0.655
1=0.246
n=29
p=0.199
1=0.231
n=29
p=0.229
1=0.284
n=29
p=0.136
1=0.261
n=29
p=0.172
1=0.184
ra=29
p=0339
r=0.216
ir=29
p=0.261
r=0.078
it=29
p=0.690
Cyde Two 
% Fat
1=0.012
n=25
p=0.955
1=0.217
n=27
p=0.277
r=0.026 
n=27 
p=0.900
1=0.139
n=27
p=0.489
1=0.043
n=27
p=0.830
1=0.185
n=27
p=0.355
r=0.049
n=27
n=0.809
r=0.067
n=27
o=0.740
% Protein 1=0322
n=25
p=0.117
1=0302
n=27
p=0:126
1=0.153
n=27
p=0.448
1=0.195
if=27
p=0329
r=0.284
n=27
p=0.152
1=0.036
n=27
p=0.859
1=0.121
n=27
p=0.548
1=0.084
n=27
p=0.678
% CHO i=0.177
n=25
p=0398
1=0.096
n=27
p=0.634
1=0.086
n=27
p=0.670
1=0.049
n=27
p=0.809
1=0.068
n=27
p=0.737
r=0.128
ir=27
p=0326
1=0.028
if=27
p=0.890
1=0.002
n=27
p=0.993
%Sugar 1=0.071
n=25
p=0.734
1=0.199
n=27
p=0319
1=0.002
n=27
p=0.991
1=0.114
n=27
p=0.572
1=0.005
n=27
p=0.979
1=0.115
re=27
p=0.570
r=0.129
n=27
p=0.523
1=0.036
n=27
p=0.857
% Starch r=0.158
n=25
p=0.452
1=0.150
n=27
p=0.455
1=0.187
n=27
p=0.350
1=0.060
n=27
p=0.767
1=0.044
if=27
p=0.828
1=0.203
ra=27
p=0.311
1=0.007
rt=27
p=0.971
1=0.056
ra=27
p=0.782
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Table 19c. Correlations between Trait Anxiety. Trait Anger and Percentage Food
Intakein the Premenstrual Phases of the Menstrual Cycle
Trait
Characteristics/% 
Food Intake
Trait
Anxiety
Trait Anger 
(Total)
Angry 
Tern perm exit
Angry
Reaction
Anger In Anger Out Anger
Control
Anger
Expression
Mean of Cydes 
% Fat
r=0.037
n=30
p=0.845
1=0.322
n=32
p=O.072
r=0.223
n=32
p=0720
1=0355
rt=32
p=O.046*
1=0.001
n=32
p=0.998
1=0.101
ir=32
p=0.584
r=0.147
ra=32
p=0.423
1=0.062
if=32
p=0.736
% Protein r=0.150
ir=30
p=0.428
1=0.099
n=32
p=0.590
r=0.033
n=32
p=0.859
1=0.206
n=32
p=0.258
1=0.145
ii=32
p=0.430
r=0.166
n=32
p=0.365
1=0.056
n=32
p=0.763
r=0.187
n=32
p=0.307
% CHO 1=0.129
n=30
p=0.498
1=0.324
n=32
p=0.071
i=0.097 
rt=32 
p=0.596 '
r=0.154
n=32
p=0.401
1=0.132
n=32
p=0.473
r=0.105
n=32
p=0.569
1=0.167
n=32
p=0J62
r=0.001
rr=32
p=0.998
%Sugar r=0.158
n=30
p=0.405
r=0.050
n=32
p=0.788
1=0.143
n=32
p=0.436
1=0.063
n=32
p=0.733
1=0.082
ra=32
p=0.656
1=0.059
rr=32
p=0.750
1=0.011
ir=32
p=0.953
1=0.062
n=32
p=0.736
% Starch t=0.061
n=30
p=0.747
1=0.518
n=32
p=0.002**
r=0.075
ir=32
p=0.685
1=0.327
n=32
p=0.068
1=0.323
u=32
p=0.071
1=0.133
n=32
p=0.470
1=0.262
n=32
p=0.147
r=0.052
n=32
jf O.779
Cyde One 
% Fat
1=0.046
ir=28
p=0.815
1=0.232
n=30
p=0.218
1=0355
n=30
p=0.054
1=0.279
n=30
p=0.13S
1=0.024
n=30
p=0.901
1=0.090
ir=30
p=0.637
r=0.055
n=30
p=0.773
r=0.016
n=30
p=0.933
% Protein r=-0.205
n=28
p=0.296
r=0.021
tf=30
p=0.914
x=0.098
ir=30
p=0.608
1=0.207
n=30
p=0.272
1=0.036
n=30
p=0.851
1=0.172
n=30
p=0.363
1=0.037
n=30
p=0.846
1=0.114
n=30
p=0.548
% CHO r=0.186
n=28
p=0.342
r=0.217
n=30
p=0.250
r=0.146
n=30
p=0.443
1=0.094
n=30
p=0.622
1=0.127
rr=30
p=0305
1=0.080
n=30
p=0.673
1=0.070
if=30
p=0.715
1=0.056
n=30
p=0.768
%Sugar t=0.242
n=28
p=0715
r=0.129
ir=30
p=0.496
1=0.147
n=30
p=0.438
1=0.073
n=30
p=0.702
1=0.151
ir=30
p=0.426
1=0.152
n=30
p=0.424
‘ 1=0.052 
n=30 
p=0.787
1=0.182
n=30
p=0336
% Starch r=-0.146
i f =28
p=0.459
r=0.492
n=30
p=0.006**
r=0.017
n=30
p=0.929
1=0.275
n=30
p=0.141
1=0.337
if=30
p=0.069
1=0.167
n=30
p=0.377
1=0.183
n=30
p=0.334
1=0.132
n=30
p=0.485
Cyde Two 
% Fat
r=0.133
ic=24
p=.537
1=0394
i f =26
p=0.047*
1=0.191
n=26
p=0.351
1=0.516
•n=26
p=0.007**
1=0.024
rr=26
p=0.906
r=0.268
11=26
p=0.186
1=0.130
n=26
p=0.526
1=0.014
n=26
p=0.947
% Protein r=0.024
n=24
p=0.913
1=0.204
n=26
p=0.317
r=0.148
n=26
p=0.469
1=0.153
n=26
p=0.456
1=0.325
11=26
p=0.105
1=0.086
n=26
p=0.676
1=0.041
n=26
p=0.841
1=0.259
n=26
p=0.202
% CHO 1=0.062
n=24
p=0.774
1=0.441
u=26
p=0.024*
1=0.191
ir=26
p=0351
1=0.397
n=26
p=0.045*
1=0.121
ir=26
p=0.555
1=0768
n=26
p=0.186
i=0.1I7
n=26
p=0.569
1=0.110
n=26
p=0.594
%Sugar r=0.013
n=24
p=0.951
1=0.206
n=26
p=0.313
1=0.079
n=26
p=0.703
1=0.277
n=26
p=0.171
1=0.187
n=26
p=0.362
1=0.086 
if=2 6 
p=0.676
1=0.128
n=26
p=0.534
1=0.233
n=26
p=0.252
% Starch 1=0.088
n=24
p=0.684
r=-0.458
n=26
p=0.019*
r=0.082
n=26
p=0.690
1=0.363
n=26
p=0.069
1=0.177
rr=26
p=0.387
r=0.265
ir=26
p=0.191
r= 0 .166
n=26
p=0.417
1=0.109 
n=26 
p=0.596
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Table 20a. Correlation between Trait Anxietv.Trait Anger and the Stages of Eating
in the Follicular phases of the Menstrual cycle
Trait
Characteristics/ 
Stage of Appetite
Trait
Anxiety
Trait Ariger 
CTotal)
Angty
Temperment
Angty
Reaction
Anger In Anger Out Anger
Control
Anger
Expression
Mean of cydes 
Hunger
r=-0.330
n=30
p=0.075
r=-0.234
if=32
p=0.197
r=-0.110
n=32
p=0.548
i=-0.117
n=32
p=0.524
1=0.203
n=32
p=0.266
1=0.146
n=32
p=0.424
1=0.130
it=32
p=0.480
1=0.263
n=32
p=0.145
Appetite r=-0.343
n=30
p=0.064
r=-0.248
n=32
p=0.171
r=-0.338
n=32
p=0.058
r=0.258
n=32
p=0.153
1=0.098
n=32
p=0.595
r=0.256
if=32
p=0.157
r=0.113
n=32
p=0.537
1=0.251
n=32
p=0.166
Satiation r=0.137
n=30
p=0.469
1=0.079
n=32
p=0.666
1=0.010
n=32
p=0.955
1=0.089
n=32
p=0.627
1=0.019
n=32
p=0.916
1=0.118
n=32
p=0.521
1=0.038
n=32
p=0.836
1=0.077
n=32
p=0.676
Satiety r=-0.353
n=30
p=0.056
r=-0.107
n=32
p=0.560
r=-0.204
n=32
p=0.264
1=0.046
iv=32
p=0.804
1=0.167
n=32
p=0.362
1=0.251
n=32
p=0.165
1=0.287
n=32
p=0.111
1=0.435
re=32
p=0.013*
Cyde One 
Hunger
r=-0.263
n=32
p=0.145
i=-0.339
if=28
p=0.078
i=-0.147
n=30
p=0.438
1=0.035
n=30
p=0.855
1=0.165
ir=30
p=0.383
1=0.364
n=30
p=0.048*
1=0.003
ir=30
p=0.988
r=0.214
n=30
p=0.256
Appetite r=0.264
n=28
p=0.174
r=0.295
n=30
p=0.114
r=-0317
n=30
p=0.088
1=0.103
n=30
p=.0.588
1=0.228
n=30
p=0.226
1=0.288
it=30
p=0.123
1=0.160
n=30
p=0399
1=0.383
if=30
p=0.037*
Satiation 1=0.005
n=28
p=0.978
1=0.105
n=30
p=0.583
1=0.011
ii=30
p=0.953
1=0.301
n=30
p=0.106
1=0.054
n=30
p=0.778
1=0.294
n=30
p=0.115
1=0.077
n=30
p=0.685
1=0.124
n=30
p=0314
Satiety r=0.250
n=30
p=0.200
r=-0.I53
n=30
p=0.420
i=-0.247
n=30
p=0.188
1=0.001
n=30
p=0.994
1=0.176
ii=30
p=0.352
1=0.305
n=30
p=0.101
1=0302
n=30
p=0.105
1=0.464
n=30
p=0.0!0*
Cyde Two 
Hunger
r=-0.281
n=23 
p=0.194
r=O.404
n=25
p=0.045*
1=0.126
n=25
p=0.548
1=0.247
ir=25
p=0.234
1=0.169
n=25
pf=0.420
1=0.368
n=25
pr=0.070
r=0.062
ir=25
p=0.769
1=0.296
n=25
p=0.152
Appetite r=0397
if=23
p=0.061
r=0343
n=25
p=0.093
r=-0.274
n=25
p=0.185
1=0.415
n=25
p=0.039*
i=0.U 0
n=25
p=0.600
1=0320
n=25
p=0.118
1=0.068
n=25
p=0.745
1=0.273
11=25
p=0.186
Satiation
in
r=0.220
n=25
p=0.291
r=O.083
rf=25
p=0.694
1=0.199
n=25
p=0.342
1=0.175
n=25
p=0.404
1=0.084
n=25
p=0.692
1=0.013
n=25
p=0.952
1=0.215
ii=25
p=0301
Satiety 1=0.299
n=23
p=0.166
i=-0.251
jf=25
p=0.227
i=-0.209
n=25
p=0.317
1=0.006
if=25
p=0.979
1=0.217
rr=25
p=0.297
1=0.344
11=25
p=0.092
r=0.210
n=25
p=0314
1=0.460
n=25
p=0.021*
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Table 20b. Correlation between Trait Anxietv.Trait Anger and The Stages Involved
in the Control of Eating in the Luteal phases of the Menstrual Cycle
Trait
Characteristics/ 
Stage of Appetite
Trait
Anxiety
Trait Anger 
CTotal)
Aigiy
Tempennent
Angry
Reaction
Anger In Anger Out Anger
Control
Anger
Expression
Mean of cycles 
Hunger
1=0.084
n=30
p=0.660
r=-0.194
rr=32
p=0.287
r=-0.052
n=32
p=0.778
r=0.143
rr=32
p=0.435
r=0.034
n=32
p=0.853
1=0329
n=32
p=0.066
1=0.067
n=32
p=0.716
1=0.072
n=32
p=0.695
Appetite 1=0.093
n=30
p=0.62 6
1=0.000
n=32
p=0.999
r=-0.189
nf=32
p=0.300
1=0.032
n=32
p=0.861
r=0.059
rr=32
p=0.747
i= 0330
n=32
p=O.206
1=0.133
n=32
p=0.468
1=0.144
n=32
p=0.431
Satiation 1=0.032
n=30
p=0.865
r=-0.064
n=32
p=0.727
i=0.104
n=32
p=0.572
1=0.050
ii=32
p=0.784
1=0.074
n=32
p=0.686
i=0.241
ra=32
p=0.185
1=0.242
if=32
p=0.183
r=0.202
n=32
p=0.269
Satiety r=-0.102
n=30
p=0.591
r=0.132
n=32
p=0.473
r=-0.I00
n=32
p=0.589
r=0.071
n=32
p=0.701
r=0.091
n=32
p=0.619
1=0.270
rt=32
p=0.135
r=0.126
ir=32
p=0.493
1=0.244
rt=32
p=0.179
Cyde One 
Hunger
r=-0.054
n=27
p=0.791
r=-0.176
n=29
p=0.360
r=0.061
n=29
p=0.752
r=0.045
n=29
p=0.817
1=0.153
n=29
p=0.429
1=0.086
n=29
p=0.657
r=0.046
n=29
p=0.815
1=0.087
n=29
p=0.654
Appetite 1=0.202
n=27
p=0.312
r=O.035
rr=29
p=0.856
r=-0.187
n=29
p=0331
1=0.167
n=29
p=0.386
1=0.113
n=29
p=0.560
1=0.057
ri=29
p=0.768
r=0.222
n=29
p=0.246
1=0.270
n=29
p=0.157
Satiation r=-0.113
tfQH
p=0.575
r=-0.184
n=29
p=O340
r=0.032
rr=29
p=0.870
r=0.084
n=29
p=0.666
1=0.088
n=29
p=0.651
1=0.082
n=29
p=0.673
1=0.245
n=29
p=0.200
1=0.163
n=29
p=0.397
Satiety r=-0.135
rr=27
p=0.50l
r=-0.129
n=29
p=0305
r=0.089
n=29
p=0.645
r=0.015
n=29
p=0.938
1=0.211
n=29
p=0.272
1=0.038
n=29
p=0.843
1=0.084
n=29
p=0.663
1=0.232
ir=29
p=0.226
Cyde Two 
Hunger
r=0.093
n=25
p=0.660
r=-0.159
n=27
p=0.430
r=-0.279
if=27
p=0.159
r=0.247
n=27
p=0.214
1=0.182
n=27
p=0364
1=0321
n=27
p=O.005»*
1=0.055
n=27
p=0.785
1=0334
ra=27
p=0.241
Appetite r=-0.006
n=25
p=0.977
r=-0.100
n=27
p=0.620
r=-0.155
tr=27
p=0.439
1=0.150
n=27
p=0.456
1=0.085
n=27
p=0.675
r=0327
n=27
p=0.096
1=0.019
ir=27
p=0.926
i=0.148
n=27
p=0.462
Satiation 1=0.022
n=25
p=0.916
r=0.032
n=27
p=0.876
r=0.205
n=27
p=0306 .
1=0.034
n=27
p=0.866
1=0.071
if=27
p=0.724
r=O307
n=27
p=0.119
1=0.212
n=27
pf=0.290
1=0.293
ir=27
p=0.138
Satiety r=-0.095
p=0.652
r=-0.059
n=27
p=0.769
1=0.070
ir=27
p=0.731
r=0.127
n=27
p=0329
r=0.058
n=27
p=0.773
1=0330
n=27
p=0.093
1=0.207
rt=27
p=0300
i=0353
n=27
p=0.071
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Table 20c. Correlation between Trait Anxietv.Trait Anger and The Stages Involved
in the Control of Eating during the Premenstrual phase s of the Menstrual Cycle
Trait
Characteristics/ 
Stage of Appetite
Trait
Anxiety
Trait Anger 
(Total)
Angry
Tempennent
Angiy
Reaction
Anger In Anger Out Anger
Contrd
Anger
Expression
Mean of cydes 
Hunger
1=0.124
n=30
p=0.515
r=0.037
n=32
p=0.839
1=0.008
n=32
p=0.967
1=0.182
n=32
p=0.318
1=0.165
n=32
p=0366
1=0.119
rt=32
p=0.518
1=0.030
n=32
p=0.871
r=0.099
n=32
p=0.592
Appetite 1=0.054
rt=30
p=0.779
1=0.055
n=32
p=0.766
r=0.052
n=32
p=0.779
1=0.172
it=32
p=0348
1=0.100
n=32
p=0.586
1=0.061
n=32
p=0.742
1=0.012
n=32
p=0.950
f=0.058
n=32
p=0.75I
Satiation 1=0.065
rf=30
p=0.735
1=0.178
it=32
p=0.329
1=0.046
n=32
p=0.805
r=0.200
n=32
p=0:273
1=0.133
n=32
p=0.468
1=0.095
n=32
p=0.606
1=0.199
n=32
p=0.276
1=0.066
n=32
p=0.720
Satiety r=0.098
n=30
p=0.608
1=0.005
n=32
p=0.980
1=0.003
n=32
p=0.987
1=0.170
ir=32
p=0.352
1=0.055
n=32
p=0.765
1=0.171
n=32
p=0.351
1=0.090
n=32
p=0.626
1=0.041
n=32
p=0.824
Cyde One 
Hunger
r=0.148
n=30
p=0.451
1=0.002
n=30
p=0.991
1=0.102
n=30
p=0.592
r=0.120
n=30
p=0.528
1=0.186
it=30
p=0.324
1=0.283
n=30
p=0.129
1=0.025
n=30
p=0.896
1=0.015
11=30
p=0.936
Appetite r=0.072
n=28
p=0.716
1=0.047
n=30
p=0.806
1=0.107
n=30
p=0.573
1=0.083
n=30
p=0.664
1=0.093
n=30
p=0,624
1=0.255
n=30
p=0.174
1=0.017
ir=30
p=0.930
r=0.033
ir=30
p=0.862
Satiation 1=43.037
n=28
p=0.851
1=0.036
n=30
p=0.849
1=0.120
n=30
p=0.527
1=0.002
n=30
p=0.991
1=0.033
n=30
p=0.864
1=0.310
n=30
p=0.095
i=0.148
ra=30
p=0.434
1=0.146
n=30
p=0.441
Satiety 1=0.146
re=28
p=0.458
1=0.059
n=30
p=0.756
1=0.084
n=30
p=0.659
1=0.141
n=30
p=0.458
1=0.022
n=30
p=0.909
1=0.109 
11=30 
p=0.566
i=0.U4
it=30
p=0.548
r=0.076
n=30
p=0.690
Cyde Two 
Hunger
\o 
!
S 
i~.
t
i
t
1=0.025
if=26
p=0.905
1=0.054
h=26
p=0.794
1=0.152
n=26
p=0.460
1=0.035
n=26
p=0.864
1=0.053
n=26
p=0.799
1=0.030
ir=26
p=0.884
1=0.057
n=26
p=0.781
Appetite 1=0.084
n=24
p=0.696
1=0.122
n=26
p=0.552
1=0.188
n=26
p=0.359
1=0.271
n=26
p=0.180
1=0.001
it=26
p=0.995
1=0.164
n=26
p=0.425
1=0.002
n=26
p=0.994
1=0.070
n=26
p=0.733
Satiation 1=0.236
u=24
p=0.267
i=0.292
n=26
p=0.148
1=0.115 
n=2 6 
p=0.577
r=0353
n=26
p=0.077
1=0.251
n=26
p=0.216
1=0.043
n=26
p=0.834
1=0.153
n=26
p=0.456
1=0.046
n=26
p=0.823
Satiety i=-0.009
n=24
p=0.966
1=0.151
n=26
p=0.463
1=0.080
rr=26
p=0.700
1=0.148
ir=26
p=0.469
1=0.017
n=26
p=0.936
1=0.205
n=26
p=0.315
r=0.012
n=26
p=0.953
r=-0.051
n=26
p=0.805
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Table 21a. Correlations between trait anxiety, trait anger, dietary restraint and food
cravings During the Follicular phases of the Menstrual Cycle
Trait
Characteristics/ 
Subjective 
appetite measure
Trait
Anxiety
Trait Anger 
CTotal)
Angry
Temperment
Angty
Reaction
Anger In Anger Out Anger
Control
Anger
Expression
Mean of cydes 
DR- food type r=0322
rr=30
p=0.083
1=0.267
ir=32
p=0.139
r=0.105
n=32
p=0.567
1=0.071
n=32
p=0.701
r=0.246
n=32
p=0.175
1=0318
n=32
p=0332
1=0.038
n=32
p=0.836
1=0.184
n=32
p=0.313
DR - amount of 
food
r=-0.475
n=30
p=0.008**
1=0.213
n=32
p=0.242
1=0.282
n=32
p=0.117
1=0.131
n=32
p=0.474
1=0320
ir=32
p=0.226
1=0.392
iv=32
p=0.026*
r=0.259
n=32
p=0.152
r=0.415
n=32
p=0.018*
DR - ate more 
than wanted
r=0.180
n=30
p=0.343
r=0.080
rr=32
p=0.664
r=0.022
n=32
p=0.906
1=0.012
n=32
p=0.949
1=0.068
it=32
p=0.711
r=0.181
n=32
p=0.322
r=0352
n=32
p=0.165
1=0.227
n=32
p=0.212
Cravings i=0579
n=32
p=0.001***
r=0.253
n=32
p=0.I62
1=0.102
n=2
P=0.577
r=0.227
n=32
p=0.212
r=0.158
n=32
p=0.387
1=0.136
n=32
p=0.458
r=0.099
n=32
p=0.589
r=0.097
n=32
p=0.596
Cyde One 
DR - food type 1=0.016
n=28
p=0.936
1=0.099
n=30
p=0.602
r=0.117
n=30
p=0.539
1=0.218
n=30
p=0.248
1=0.161
n=30
p=0397
1=0.098
n=30
p=0.605
1=0.097
ii=30
p=0.611
1=0.071
it=30
p=0.709
DR - amount of 
food
r=-0.144
n=28
p=0.466
1=0.041
n=30
p=0.829
r=0.017
n=30
p=0.931
1=0.044
n=30
p=0.817
1=0.231
n=30
p=0.219
i= 0388
n=30
p=0.123
i=0329
n=30
p=0.076
1=0.413
ir=30
p=0.023*
DR - ate more 
than wanted
r=0.218
if=28
p=0.265
r=0.047
n=30
p=0.804
r=0.120 
re=30 
p=0.527
1=0.073
n=30
p=0.702
1=0.213
ir=30
p=0.259
1=0332
11=30
p=0.073
1=0.125
n=30
p=0.510
r=0.105
n=30
p=0.581
Cravings r=0.414
n=28
p=0.029*
r=0.213
n=30
p=0.259
1=0.103
n=30
p=0.589
1=0.103
rr=30
p=0.588
1=0.094
n=30
p=0.623
1=0.206
n=30
p=0.275
1=0.103
n=30
p=0589
1=0.118
n=30
p=0.536
Cyde Two 
DR - Food type r=0.614
n=23
p=0.002**
1=0.236
n=25
p=0.256_
1=0323
rr=25
p=0.116
1=0.058
n=25
p=0.784
1=0.304
n=25
p=0.140
i=0337
n=25
p=0.261
1=0.153 
rr=2 5 
p=0.464
i= 0383
n=25
p=0.059
DR - amount of 
food
1=0.682
n=23
p=0.000***
r=0.363
n=25
p=O.075
11! 1=0.195ir=25p=0.350 1=0.352n=25p=0.084
1=0.297
n=25
p=0.149
1=0.101
n=25
p=0.632
r=0.408
it=25
u=0.043*
DR - ate more 
than wanted
r=0.077
n=23
p=0.727
1=0.076
n=25
p=0.718
r=0.164
n=25
p=0.432
1=0.040
n=25
p=0.849
1=0.211
n=25
p=0.312
1=0.036
n=25
p=0.866
r=0.274
n=25
p=0.184
1=0.340 
n=2 5 
p=0.097
Cravings r=0.549
n=23
p=0.007**
r=0.2 65 
n=25
p=0.200
r=0.263
rr=25
p=0.205
1=0310
n=25
p=0314
r=0.I15
n=25
p=0.583
1=0.234
n=25
p=O.260
1=0.071
ri=25
p=0.734
1=0.139
n=25
p=0.507
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Table 21b. Correlations between trait anxiety, trait anger, dietary restraint and food
cravings During the Luteal phases of the Menstrual Cycle
Trait
Characteristics/ 
Subjective 
appetite measure
Trait
Anxiety
Trait Anger 
(Jotal)
Angry
Tempennent
Angry
Reaction
Anger In Anger Out Anger
Control
Anger
Expression
Mean of cydes 
DR- food type i=0.052
n=30
p=0.783
r=0.019
n=32
p=0.917
r=0.006
n=32
p=0.975
r=0.020
n=32
p=0.913
r=-0.098
n=32
p=0.595
t=0.007 
rr=32 
p=0.969
r=0.086
n=32
p=0.641
r=O.064
n=32
p=0.729
DR - amount of 
food
r=-0387
n=30
p=0.035*
r=-0.042
n=32
p=0.819
r=-0.096
n=32
p=0.601
r=-0.244
rr=32
p=0.179
1=0.284
n=32
p=0.115
r=0.117
n=32
p=0.523
r=0.188
n=32
p=O.303
r=-.0159
n=32
p=0.384
DR - ate more 
than wanted
r=0.276
n=30
p=0.140
r=0.058
n=32
p=0.751
r=0.269
n=32
p=0.136
t=0.123
n=32
p=0.502
r=0.072
n=32
p=0.695
r=-0.051
rr=32
p=0.783
r=0.032
n=32
p=0.860
t=0.047
n=32
p=0.799
Cravings r=0.270
n=30
p=0.150
t=O.I73
n=32
p=0.344
r=0.232
rr=32
p=0.201
1=0.124
n=32
p=0.499
r=0.020
n=32
p=0513
r=0.095
rr=32
p=0.603
r=0.098
n=32
p=0.595
r=0.018
n=32
p=0.924
Cyde One 
DR - food type r=0.083
rr=27
p=0.680
r=0.281
n=29
p=0.140
r=-0,001
n=29
p=0.998
r=0.111
n=29
p=0.566
r=0.062
n=29
p=0.748
r=0.087
n=29
p=0.653
r=0.199
n=29
p=OJ01
t=O.046
n=29
p=0.814
DR - amount of 
food
r=-0.272
n=27
p=0.170
r=0.292
n=29
p=0.125
r=-0.081
rr=29
p=0.677
r=-0.155
rr=29
p=0.422
r=-0.158
n=29
p=0.414
t=0.211
n=29
p=0.272
r=0.359
n=29
p=0.056
r=-0.206
n=29
p=0.284
DR - ate more 
than wanted
r=0.236
n=27
p=0.235
r=0.293
rr=29
p=0.123
r=0.266
u=29
p=0.164
1=0.087
n=29
p=0.656
1=0.090
n=29
p=0.644
r=-0.041
n=29
p=0.834
r=0.275
n=29
p=0.148
i=-0.1I4
n=29
p=0.556
Cravings r=0.252
n=27
p=0.205
r=0.286
n=29
p=0.132
r=0.171
n=29
p=0.375
r=0.083
n=29
p=0.668
r=0.134
n=29
p=0.489
r=-0.027
n=29
p=0.891
r=0.271
n=29
p=0.156
1=0.091
rt=29
p=0.641
Cyde Two 
DR - Food type r=-0.133
n=25
p=0.528
r=-0.174
tr=27
p=0.385
1=0.007
n=27
p=0.973
r=-0.070
n=27
p=0.730
r=-0.268
n=27
p=0.177
r=-0.048
n=27
p=0.813
r=0.085
n=27
p=0.675
1=0.172
n=27
p=0.391
DR - amount of 
food
r=0.507
n=25
p=0.0I0*
r=0.403
rr=27
p=0.037*
r=-0.065
n=27
p=0.747
r=-0.328
n=27
p=0.095
r=-0.471
rr=27
p=0.013
r=0.020
n=27
p=0.923
1=0.024
n=27
p=0.905
r=O.207
n=27
p=0.299
DR - ate more 
than wanted
r=0.285
n=25
p=0.167
r=-0.iI9
n=27
p=0.555
r=0.171
n=27
p=0.393
r=0.124
n=27
p=0.537
1=0.032
n=27
p=0.873
r=0.132
n=27
p=0.513
r=O.076
n=27
p=0.706
1=0.07
rr=27
p=0.739
Cravings r=0.186
tr=27
p=0.374
r=0.018
n=27
p=0.931
r=0.327
n=27
p=0.096
r=0.085
n=27
p=0.674
t=-0.256 
n=27 
p=0.197
r=0.273
n=27
p=0.168
r=0.063
n=27
p=0.756
1=0.064
rr=27
p=0.749
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Table 21c. Correlations between trait anxiety, trait anger, dietary restraint and food
•cravings During the Premenstrual phases of the Menstrual Cycle
Trait
Characteristics/ 
Subjective 
appetite measure
Trait
Anxiety
Trait Anger 
CTotal)
Angiy
Tempennent
Angiy
Reaction
Anger In Anger Out Anger
Control
Anger
Expression
Mean of cydes 
DR- food type r=-0.077
ii=32
p=0.686
r=-0.130
n=32
p=0.478
r=0.085
n=32
p=0.642
1=0.119
n=32
p=0.515
1=0.196
n=32
p=0.282
1=0.029
n=32
p=0.875
1=0.096
n=32
p=0.600
1=0.017
n=32
p=0.927
DR - amount of 
food
r=-0.019
n=30
p=0.919
i=-0.284 
n=32 
p=0.115
1=0.193
n=32
p=0.289
1=0.058
n=32
p=0.751
1=0.060
ii=32
p=0.744
1=0.248
n=32
p=0.171
1=0.057
n=32
pf=0.756
1=0.089
n=32
p=0.628
DR - ate more 
than wanted
r=0.082
n=30
p=0.667
r=0.131
n=32
p=0.474
x=0.104
n=32
p=0.570
1=0.035
ir=32
p=0.850
r=0.118
n=32
p=0.521
1=0.147
ir=32
p=0.422
1=0.081
n=32
p=0.661
1=0.178
n=32
p=0.329
Cravings 1=0.073
n=30
p=0.703
1=0.143
n=32
p=0.436
1=0.148
n=32
p=0.419
1=0.159
if=32
p=0386
1=0.114
n=32
p=0.536
1=0.026
n=32
p=0.890
1=0.081
n=2
p=0.659
1=0.101
n=32
p=0.582
Cyde One 
DR - food type r=-0.054
n=28
p=0.787
r=-0.285
n=30
p=0.128
r=0.093
ir=30
p=0.627
1=0.184
n=30
p=0.330
1=0.051
n=30
p=0.789
1=0.087
n=30
p=0.650
1=0.305
n=30
p=0.101
1=0.102
n=30
p=0.591
DR - amount of 
food
r=0.168
tr=28
p=0.393
1=0.221
n=30
p=0.241
1=0.162
n=30
p=0.391
1=0.092
n=30
p=0.629
1=0.105
n=30
p=0380
r=0.341
ir=30
p=0.064
1=0.126
n=30
p=0.507
1=0.017
n=30
p=0.928
DR - ate more 
than wanted
r=0.207
n=28
p=0.291
1=0.083
n=30
p=0.665
1=0.064
n=30
p=0.738
r=0.127
it=30
p=O.503
i=0.294
n=30
p=0.U5
1=0.097
n=30
p=0.609
1=0.121
n=30
p=0.525
1=0.223
n=30
p=0.236
Cravings i=-0.069
rr=28
p=0.728
1=0.009
n=30
p=0.965
1=0.204
it=30
pf=0.279
1=0.259
n=30
p=0.167
1=0.022
n=30
p=0.908
1=0.122
ii=30
p=0.520
i=0.I58
n=30
p=0.404
1=0.184
n=30
p=0.330
Cyde Two 
DR - Food type r=-0.157
n=24
p=0.463
1=0.043
n=26
p=0.826
1=0.094
n=26
p=0.646
1=0.017
n=26
p=0.934
1=0.221
n=26
p=0.278
r=0.103
n=26
p=0.615
1=0.047
n=26
p=0.819
1=0.064
11=26
p=0.755
DR - amount of 
food
r=O.I98
n=24
p=0354
r=0.237
it=26
p=0.244
r=0.103
ii=26
p=0.618
1=0.114
n=26
p=0.578
1=0.224
i f =26
p=0.271
1=0.004
n=26
p=0.985
1=0.008
n=26
p=0.967
1=0.095
ir=26
0=0.645
DR - ate more 
than wanted
r=0.019
rr=24
p=0.928
1=0.067
n=26
p=0.746
1=0.020
n=26
p=0.922
1=0337
n=26
p=0.092
1=0.126
ii=26
p=0.541
1=0.150
it=26
p=0.466
1=0.012
n=26
p=0.955
1=0.035
n=26
p=0.865
Cravings r=0.175
n=24
p=0.413
1=0.214
n=26
p=0.293
1=0.049
it=26
p=0.811
1=0.047
n=26
pf=0.819
1=0.199
n=26
p=0.330
1=0.113
n=26
p=0.582
1=0.127
n=26
p=0.536
r=0.090
i f =26
p=0.663
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Table 22a. Correlations Between actual food intake and averaged mood states
during the follicular stages of the Menstrual cv cl e
Actual food intake/ 
Averaged mood states Kcal Protein (g) Fat(g)
Carbohydrat
e(g) Svgar (g) Starch (g) TLA
Mean of both cydes 
Mean Depsression
r=-0.171
n=32
p=0349
r=0.025
n=32
p=0.893
i=-0.297
n=32
p=0.099
1=0.019
rr=32
p=0.919
1=0.050
n=32
p=0.787
1=0.076
n=32
p=0.680
1=0.084
if=32
p=0.649
Mean Hostility 1=0.005
n=32
p=0.976
1=0.076
n=32
p=0.681
r=-0.142
n=32
p=0.438
1=0.147
n=32
p=0.423
1=0.167
n=32
p=0.362
1=0.036
n=32
p=0.847
1=0.253
n=32
p=0.162
Mean Anxiety r=0.013
n=32
p=0.944
r=0.156
n=32
p=0394
r=-0.213
rr=32
p=0.242
1=0.180
rt=32
p=0.324
r=0.165
n=32
p=0.367
1=0.105
ji=32
p=0.567
1=0.097
it=32
p=0.599
Mean confidence r=-0.047
n=32
p=0.799
r=0.044
n=32
p=0.812
i=-0.239
n=32
p=0.187
1=0.144
n=32
p=0.430
1=0.122
n=32
p=0.505
1=0.034
n=32
p=0.853
1=0.026
n=32
p=0.886
Mean total mood 1=0.069
n=32
p=0.708
1=0.084
if=32
p=0.647
i=-0.249
n=32
p=0.169
1=0.132
n=32
p=0.471
1=0.136
n=32
p=0.457
1=0.026
n=32
p=0.888
1=0.126
n=32
p=0.493
Cyde One 
Mean Depression t=-0.031
n=30
p=0.871
r=0.024
n=30
p=0.899
r=-0.044
n=30
p=0.818
1=0.061
if=30
p=0.751
1=0.072
n=30
p=0.704
r=-O.095
n=30
p=0.616
r=0.213
n=30
p=0.259
Mean Hostility r=0.170
rr=30
p=0.369
1=0.138
n=30
p=0.466
r=0.129
if=30
p=0.497
1=0.179
n=30
p=0345
1=0.188
n=30
p=0319
r=0.016
n=30
p=0.935
1=0.392
if=30
p=0.032*
Mean Anxiety t=0.150
n=30
p=0.429
r=0.183
n=30
p=0.333
1=0.098
if=30
p=0.607
1=0.167
n=30
p=0.377
1=0.142
n=30
p=0.453
1=0.061
n=30
p=0.747
1=0.299
n=30
p=0.108
Mean confidence r=0.027
n=30
p=0.887
i=0.034
n=30
p=0.859
r=-0.042
n=30
p=0.826
1=0.112
ir=30
p=0355
i=0.091
it=30
p=0.633
i=-0.028
n=30
p=0.882
1=0.196
m=30
p=0.298
Mean total mood r=0.077
n=30
p=0.686
1=0.100
n=30
p=0.600
r=0.029
n=30
p=0.878
1=0.134
n=30
p=0.480
1=0.126
n=30
p=0.506
1=0.015
n=30
p=0.938
1=0.286
n=30
p=0.126
Cyde Two 
Mean Depression r=0.036
n=25
p=0.865
r=0.l74
n=25
p=O.407
i=-0.174
n=25
p=C.405
r=0.218
n=25
p=0.295
1=0.244
rt=25
p=0.239
r=0.183
n=25
p=0381
r=-0.065
n=25
p=0.757
Mean Hostility- 1=0.068
n=25
p=0.747
t=0.019
ir=25
p=0.928
i=-0.224
n=25
p=0.283
1=0.172
n=25
p=0.411
1=0.235
n=25
p=0.258
1=0.122
n=25
p=0.561
1=0.092
n=25
p=0.663
Mean Anxiety 1=0.085
n=25
p=0.688
1=0.172
n=25
p=0.412
i=-0.154
n=25
p=0.461
1=0367
n=25
p=0.071 •
1=0.321
n=25
p=0.118
1=0.348
if=25
p=0.088
1=0.085
n=25
p=0.687
Mean confidence r=0.281
11=25
p=0.173
i=0334
n=25
p=0.103
1=0.017
n=25
p=0.935
1=0.456
n=25
p=0.022*
1=0.270
n=25
p=0,191
r=0.484
n=25
p=0.014*
1=0.230
n=25
p=0.268
Mean total mood r=O.073
ir=25
p=0.729
r=0.178
n=25
p=0.394
1=0.165
n=25
p=0.432
1=0.323 
ii=25 
p=0.115 .
1=0.297
rt=25
p=0.149
1=0.298
n=25
p=0.148
1=0.065
ir=25
p=0.758
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Table 22b. Correlations Between actual food intake and averaged mood states
during the Luteal stages of the Menstrual cycle.
Actual food intake/ 
Averaged mood states Kcal Protein (g) Fat (g)
Carbohydrat
efe) Sugar (g) Starch (g) TLA
Mean of both cydes 
Mean Depsression
1=0.057
n=32
p=0.756
1=0.138
n=32
p=0,452
1=0.020
n=32
p=0.916
1=0.052
n=32
p=0.777
1=0.072
n=32
p=0.696
r=0.132
n=32
p=0.471
1=0.045
if=32
p=0.807
Mean Hostility r=-0.057
n=32
p=0.758
1=0.048
n=32
p=0.793
1=0.136
n=32
p=0.458
1=0.023
n=32
p=0.900
1=0.005
n=32
p=0.977
1=0.006 
n=32 
p=0.97 5
1=0.199
it=32
p=0.275
Mean Anxiety 1=0.03
n=32
p=0.774
1=0.112
n=32
p=0.543
1=0.005
n=32
p=0.978
1=0.055
n=32
p=0.767
1=0.064
n=32
p=0.727
1=0.128
n=32
p=0.484
1=0.212
ir=32
p=0.243
Mean confidence 1=0.049
rr=32
p=0.79I
1=0.117
n=32
p=0.522
r=0.110
n=32
p=0.548
1=0.154
n=32
p=0.767
1=0.071
n=32
p=0.700
r=0.187
n=32
p=0.306
1=0.026
n=32
p=0.887
Mean total mood r=0.031
ir=32
p=0.865
r=0.092
n=32
p=0.615
1=0.068
n=32
p=0.712
1=0.154
it=32
p=0.402
1=0.022
n=32
p=0.905
1=0.126
ir=32
p=0.493
1=0.117
n=32
p=0.522
Cyde One 
Mean Depression 1=0.047
n=29
p=0.810
1=0.043
n=29
p=0.827
1=0.083
n=29
p=0.669
1=0.039
n=29
p=0.842
1=0.142
n=29
p=0.463
r=0.067
n=29
p=0.732
1=0.006
n=29
p=0.977
Mean Hostility 1=0.108
n=29
p=0.579
r=0.165
n=29
p=0.393
i=0.186
if=29
p=0335
1=0.021
n=29
p=0.913
1=0.016
n=29
p=0.936
1=0.075
ii=29
p=0.699
r=0.092
n=29
p=0.635
Mean Anxiety r=0.074
n=29
p=0.703
1=0.098
n=29
p=0.614
i=0.095
n=29
p=0.623
1=0.018
it=29
p=0.928
1=0.166
n=29
p=0389
r=0.142
n=29
pf=0.461
1=0.02
n=29
p=0.993
Mean confidence 1=0.239
n=29
p=0.212
1=0.264
n=29
p=0.166
1=0318
n=29
p=0.093
1=0.062
n=29
p=0.748
x=0.028
n=29
p=0.885
1=0.083
re=29
p=0.670
i=0.055
n=29
p=0.778
Mean total mood 1=0.138
n=29
p=0.474
1=0.166
rr=29
p=0.389
1=0.201
n=29
p=0.297
1=0.044
ii=29
p=0.822
1=0.109
n=29
p=0.572
1=0.027
n=29
p=0.890
1=0.037
ir=29
t>=0.848
Cyde Two 
Mean Depression 1=0.206
n=27
p=0.303
1=0349
n=27
p=0.075
1=0.053
n=27
p=0.791
1=0.197
ir=27
p=0.325
1=0.159
n=27
p=0.427
1=0.150
n=27
p=0.454
1=0.085
it=27
p=0.672
Mean Hostility r=0.041
if=27
p=0.840
1=0.126
n=27
p=0.533
i=0.095
n=27
p=0.639
1=0.132
n=27
p=0.511
1=0.130
n=27
p=0.517
1=0.087
n=27
p=0.667
i=OJ299
n=27
p=0.129
Mean Anxiety 1=0.203 
n=27 
p=0311
1=0.355
n=27
p=0.069
1=0.061
rr=27
p=0.763
1=0.184
n=27
p=0.3S8
1=0.215
if=27
p=0.281
1=0.081
n=27
p=0.690
1=0.218
n=27
p=0.272
Mean confidence r=0.357
if=27
p=0.067
1=0.484
n=27
p=0.011*
1=0.128
n=27
p=0.525
1=0.326 • 
n=27 
p=0.097
1=0.202
n=27
p=0313
1=0.306
n=27
p=0.121
1=0.145
n=27
p=0.469
Mean total mood 1=0.212
if=27
p=0.288
r=0.348
ir=27
p=0.075
1=0.040
if=27
p=0.845
1=0.220
n=27
p=0.271
1=0.188
n=27
p=0.348
1=0.161
ir=27
p=0.423
1=0.129
n=27
p=0.520
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Table 22c, Correlations Between actual food intake and averaged mood states
during the premenstrual stages of the Menstrual cycle
Actual food intake/ 
Averaged mood states Kcal Protein (g) Fat (g)
Carbohydrat
e(g) Sugar <g) Starch (g) TLA
Mean of both cycles 
Mean Depsression
r=O.G34
n=32
p=0.853
1=0.214
n=32
p=0.239
r=-0.194
n=32
p=0.288
1=0.054
rr=32
p=0.770
1=0.051
if=32
p=0.781
1=0.021
m=32
p=0.909
1=0.159
n=32
p=038S
Mean Hostility r=-0.003
n=32
p=0.987
r=0.247
ir=32
p=0.174
1=0.128
n=32
p=0.484
r=0.023
n=32
p=0.901
r=0.046
n=32
p=0.802
1=0.070
n=32
p=0.702
1=0.168
n=32
p=0.358
Mean Anxiety r=0.040
n=32
p=0.818
i=0394
n=32
p=0.026*
r=-0.123
rr=32
p=0302
1=0.072
n=32
p=0.697
1=0.029
n=32
p=0.874
r=0.051 
n=32 
p=0.781
1=0.041
n=32
p=0.825
Mean confidence r=-0.0S2
n=32
p=0.654
r=0.163
n=32
p=0373
r=-0.194
n=32
p=0.286
1=0.013
n=32
p=0.942
1=0.012
it=32
p=0.950
r=0.003
n=32
p=0.985
1=0.166
ir=32
p=0.363
Mean total mood r=-0.016
n=32
p=0.929
r=0.299
n=32
p=0.096
r=-0.177
«=32
p=0.331
t=0.048
n=32
p=0.793
1=0.035
n=32
p=0.849
1=0.009
if=32
p=0.959
1=0.069
n=32
p=0.707
Cyde One 
Mean Depression 1=0.080
rr=30
p=0.673
1=0.101
ii=30
p=0.597
r=-0.161
n=30
p=0.397
r=0.006
n=30
p=0.974
r=0.109
n=30
p=0.567
1=0.108
tt=30
p=0.571
1=0.164 
n=30 
p=0.388
Mean Hostility r=-0.064
n=30
p=0.737
r=0.164
n=30
p=0.387
r=-0.141
n=30
p=0.457
1=0.031
n=30
p=0.869
1=0.085
n=30
p=0.654
r=0.142
n=30
p=0.455
1=0.102
n=30
p=0.592
Mean Anxiety- r=0.101
n=30
p=0.564
r=0.327
rr=30
p=0.078
r=-0.019 
n=3 0 
p=0.922
r=0.I35
n=30
p=0.475
r=0.23 6 
n=30
p=0.210
1=0.008 
n=3 0 
p=0.966
1=0.207
n=30
p=0.273
Mean confidence r=-0.231 
n=3 0
p=0.22 0
1=0.137
n~30
p=0.470
r=0.246
n=30
p=0.190
1=0.112
n=30
p=0.557
1=0.035 
n=3 0 
p=0.854
1=0.143
n=30
p=0.453
1=0.184
if=30
p=0330
Mean total mood r=-0.060
n=30
p=0.752
1=0.145
n=30
p=0.444
r=-0.148
n=30
p=0.435
1=0.009
re=30
p=0.964
1=0.120
n=30
p=0.529
1=0.102
n=30
p=0.592
1=0.181
n=30
p=0J39
Cyde Two 
Mean Depression r=0317
n=23
p=0.122
r=0.I69
n=25
p=0.419
r=0.175
rr=25
p=0.403
r=0.259
n=25
p=0.211
r=0.220
n=25
p=0.291
r=0.109
n?=25
p=0.605
i=0.239
ii=25
p=O.250
Mean Hostility r=0.330
it=25
p=0.107
r=0.172
n=25
p=0.411
r=0.223
n=25
p=0.284
r=0.244
n=25
p=0.239
1=0.174
m=25
p=0.405
1=0.085
u=25
p=0.688
r=0.295
n=25
p=0.152
Mean Anxiety r=0316
rr=25
p=0.124
1=0.275
n=25
p=0.183
r=0.199
n=25
p=0.341
1=0.220
n=25
p=0.290
1=0.032 
n=25 
p=0.87 8
1=0.150
if=25
p=0.475
1=0.122
n=25
p=0.562
Mean confidence r=0.260
n=25
p=0.210
r=0.342
n=25
p=0.094
r=0.075
n=25
p=0.723
1=0.267 
n=25 ■ 
p=0.197
1=0.158
if<25
p=0.451
1=0.132
n=25
p=0.529
r=0.047
n=25
p=0.822
Mean total mood 1=0.351 
n=2 5 
p=0.085
1=0.267
n=25
p=0.198
r=0.197
n=25
p=0345
r=0.280
n=25
p=0.175
r=0.163
n=25
p=0.438
1=0.136
n=25
p=0.518
r=0.185
n=25
p=0.377
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Table 23 a. Correlations between Percentage food Intake and Averaged mood State
during the Follicular phases of the Menstrual Cycles
Percentage food 
intake/ Averaged 
mood states
% Fat % Protein % CHO % Sugar %starch
Mean of both cydes 
Mean Depsression
r=-0300
n=32
p=0.096
1=0.293
n=32
p=0.I04
1=0.229
n=32
p=0.207
1=0.247
n=32
p=0.173
1=0.031
it=32
p=0.867
Mean Hostility r=-0-257
n=32
p=0.155
1=0.098
n=32
p=0.592
1=0334
n=32
p=0.198
r=0317
n=32
p=0.077
i=-0.034
n=32
p=0.853
Mean Anxiety 1=0.361
xi=32
p=0.043*
1=0.244
ir=32
p=0.178
t=0303
n=32
p=0.092
i=0.248
n=32
p=0.17I
r=0.139
n=32
p=0.449
Mean confidence r=-0.271
n=32
p=0.134
1=0.181
n=32
p=0.323
1=0.178
n=32
p=0329
r=0.169
n=32
p=0.356
r=0.024
ii=32
p=0.895
Mean total mood r=0.331
n=32
p=0.064
1=0.231
n=32
p=0.203
1=0.263
n=32
p=0.145
1=0.271
n=32
p=0.134
1=0.049
n=32
p=0.792
Cyde One 
Mean Depression 1=0.106
ir=30
p=0.578
1=0.095
ii=30
p=0.618
r=0.010
ii=30
p=0.959
i=0.066
n=30
p=0.731
i=-0.149
n=30
p=0.433
Mean Hostility 1=0.101
if=30
p=0.595
r=-0.026
n=30
p=0.892
1=0.015
n=30
p=0.936
1=0.125
11=30
p=0.509
i=-0.279
n=30
p=0.136
Mean Anxiety 1=0.045
n=30
p=0.812
1=0.083
it=30
p=0.661
1=0.007
n=30
p=0.971
1=0.060
n=30
p=0.754
1=0.165
ii=30
p=0383
Mean confidence 1=0.075
n=30
p=0.694
r=0.034
ii=30
p=0.860
1=0.003
n=30
p=0.988
1=0.042
n=30
p=0.824
1=0.140
n=30
p=0.460
Mean total mood r=0.084
n=30
p=0.661
1=0.058
n=30
p=0.761
1=0.001 
n=30 
p=0.996
1=0.074 
n=30 
p=0.69 6
1=0.188
if=30
p=0319
Cyde Two 
Mean Depression r=-0.459
n=25
p=0.021*
1=0.211
n=25
p=0313
1=0.280
n=25
p=0.175
i=0330
n=25
p=0.107
1=0.167
n=25
p=0.424
Mean Hostility f =-0.409
ir=25
p=0.042*
1=0.111
ir=25
p=0.596
i=0.357
if =25
p=0.080
1=0386
n=25
p=0.057
1=0.219
n=25
p=0.292
Mean Anxiety r=-0.480
n=25
p=0.015*
r=0.092
n=25
p=0.661
r=0.420
n=25
p=0.037*
1=0.371
n=25
p=0.068
1=0.328
n=25
p=0.109
Mean confidence r=-0.396
=25
p=0.050*
1=0.140
n=25
p=0.503
1=0.204
n=25
p=0327
1=0.095
n=25
p=0.650
r=0.226 
n=25 
p=0.276
Mean total mood i=-0.491
n=25
p=0.013*
1=0.154
n=25
p=0.462
r=0363
n=25
p=0.074
1=0351
n=25
p=0.086
1=0.264 
n=25 
p=0.203
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Table 23b. Correlations between Percentage food Intake and Averaged mood State
•during the Luteal phases of the Menstrual Cycles.
Percentage food 
intake/ Averaged 
mood states
% Fat % Protein % CHO % Sugar %starch
Mean of both cydes 
Mean Depsression
r=0.059
n=32
p=0.747
1=0.137
jf=32
p=0.456
1=0.048
n=32
p=0.794
r=0.068
n=32
p=0.712
1=0.056
n=32
p=0.762
Mean Hostility r=-0.102
n=32
p=0.580
r=0.015
n=32
p=0.936
1=0.068
n=32
p=0.712
1=0.114
n=32
p=0.533
1=0.082
n=32
p=0.657
Mean Anxiety 1=0.009
n=32
p=0.963
1=0.089
n=32
p=0.629
1=0.060
n=32
p=0.744
r=0.079
ir=32
p=0.668
1=0.088
n=32
p=0.633
Mean confidence 1=0.153
n=32
p=0.403
r=0.099
n=32
p=0.591
r=0.118
nr=32
p=0.519
1=0.184
n=32
p=0.314
1=0.029
n=32
p=0.877
Mean total mood r=-0.078
ir=32
p=0.670
1=0.096
n=32
p=0.600
t=0.014
n=32
p=0.941
t=0.030
n=32
p=0.873
1=0.070
n=32
p=0.705
Cyde One 
Mean Depression i=-0.041
ir=29
p=0.832
1=0.003
n=29
p=0.989
r=0.064
n=29
p=0.740
1=0.174
n=29
p=0.366
1=0.069
n=29
p=0.720
Mean Hostility 1=0.176
n=29
p=0.361
1=0.129
n=29
p=0.504
1=0.114
n=29
p=0.555
1=0.197
n=29
p=0.305
1=0.046
n=29
p=0.813
Mean Anxiety r=0.031
n=29
p=0.874
1=0.060
n=29
p=0.757
1=0.029
it=29
p=0.880
1=0.252
n=29
p=0.187
1=0.147
n=29
p=0.448
Mean confidence r=0.162
n=29
p=0.400
1=0.112
n=29
p=0.564
1=0.192
n=29
p=0.318
1=0.365
n=29
p=0.051
r=0.003
n=29
p=0.988
Mean total mood 1=0.096
n=29
p=0.620
r=0.086
n=29
p=0.659
r=0.053
n=29
p=0.786
1=0.013
n=29
p=0.946
r=0.062
n=29
p=0.748
Cyde Two 
Mean Depression r=-0.072
rr=27
p=0.722
t=0.293
if=27
p=0.138
1=0.018
n=27
p=0.930
1=0.015
n=27
p=0.941
1=0.018
if=27
p=0.929
Mean Hostility 1=0.127
n=27
p=0.528
1=0.147
n=28
p=0.465
t=0.115
n=27
p=0.568
r=0.097
ff=27
p=0.631
1=0.056 
n=27 
p=0.782
Mean Anxiety 1=0.067
n=27
p=0.740
1=0.293
n=27
p=0.138
1=0.012
n=27
p=0.953
r=0.060
if=27
p=0.767
r=0.099
n=27
p=0.623
Mean confidence 1=0.087
n=27
p=0.665
1=0.292
n=27
p=0.140
r=0.026
n=27
p=0.896
1=0.024
rea l
p=0.905
1=0.030
n=27
p=0.882
Mean total mood 1=0.092
n=27
p=0.649
r=0.274 
n=27 
p=0.167
r=0.044
n=27
p=0.829
1=0.041
n=27
p=0.838
1=0.013
n=27
p=0.950
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Table 23 c. Correlations between Percentage food Intake and Averaged mood State
during the Premenstrual phases of the Menstrual Cycles
Percentage food 
intake/ Averaged 
mood states
% Fat % Protdn •/» CHO % Sugar %starch
Mean of both cydes 
Mean Depsression
1=0.359
n=32
p=0.043*
1=0.091
rr=32
p=0.622
1=0.257
n=32
p=0.155
1=0.120
n=32
p=0.514
1=0.152
n=32
n=0.408
Mean Hostility 1=0.253
n=32
p=0.162
1=0.131
n=32
p=0.475
1=0.122
n=32
p=0.507
1=0.059
n=32
p=0.748
1=0.050
n=32
p=0.786
Mean Anxiety 1=0.323
n=32
p=0.072
1=0.229
n=32
p=0.207
1=0.122
n=32
p=0305
1=0.011
n=32
p=0.952
1=0.103
n=32
p=0.574
Mean confidence i=-0.222
ir=32
p=0.223
1=0.090
ir=32
p=0.626
1=0.215
n=32
p=0.237
1=0.043
m=32
p=0.814
1=0.234
n=32
p=0.197
Mean total mood r=-0.332
n=32
p=0.063
1=0.159
n=32
p=0_384
1=0.198
rr=32
p=0.277
1=0.065
n=32
p=0.724
1=0.145
m=32
p=0.428
Cyde One 
Mean Depression t=-0.151
n=30
p=0.427
t=0.129
n=30
p=0.498
1=0.130
n=30
p=0.492
1=0.038
n=30
p=0.840
1=0.185
n=30
p=0.327
Mean Hostility r=-0.148
n=30
p=0.434
1=0.205
n=30
p=0.277
1=0.041
n=30
p=0.828
1=0.034
n=30
p=0.860
1=0.074
ir=30
p=0.699
Mean Anxiety r=-0.168
if=30
p=0.374
1=0.175
n=30
p=0J56
1=0.080
n=30
p=0.673
1=0.082
n=30
p=0.666
1=0.018
n=30
p=0.924
Mean confidence r=O.064 
n=30 
p=0.736
1=0.062
n=30
p=0.744
1=0.114
u=30
p=0.547
1=0.022
n=30
p=0i>06
1=0.159
ii=30
p=0.403
Mean total mood i=-0.152
it=30
p=0.424
1=0.164
n=30
p=0.386
1=0.099
n=30
p=0.601
r=0.009
n=30
p=0.962
1=0.116
n=30
p=0.542
Cyde Two 
Mean Depression r=0.152
n=25
p=0.467
r=0.101 
n=2 5 
p=0.632
1=0.048
n=25
p=0.819
1=0.160
n=25
p=0.445
1=0.176
n=25
p=0.400
Mean Hostility 1=0.051
n=25
p=0.807
1=0.080
if=25
p=0.704
1=0.004
re=25
p=0.985
1=0.086
n=25
p=0.683
1=0.204
ir=23
p=0.328
Mean Anxiety 1=0.089
n=25
p=0.672
1=0.101
n=25
p=0.631
1=0.011 
n=25 
p=0.957
1=0.119
n=25
p=0.571
1=0.068
n=25
p=0.745
Mean confidence r=0.205
n=25
p=0.326
1=0.196
n=25
p=0347
1=0.148
11=25
p==0.479
1=0.114
n=25
p=0.587
1=0.019
n=25
p=0.928
Mean total mood 1=0.137
if=25
p=0.515
r=0.024
n=25
p=0.910
1=0.044
n=25
p=0.836
r=0.061 
it=25 
p=0.773
1=0.138
11=25
p=0.512
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Table 24a. Correlations betwwen subjective appetite measures and averaged mood
stated in the Follicular Stages
Appetite/MeanMoo 
d State
Hunger Appetite Satiation Satiety DR-food 
type
D R -
amount of
food
wanted
Ate more 
than wanted
Cravings
Mean of Cycles 
Depression r=0.112
n=32
p=0.542
r=0.146
n=32
p=0.426
r=-0.300
ii=32
p=0.096
r=0.382
it=32
p=0.031*
1=0388
n=32
p=0.111
8 
J
 
til
r=-0.193
n=32
p=0.291
1=0.538
n=32
p=0.001***
Hostility r=0.185
n=32
p=0.312
1=0.158
n=32
p=0.389
r=0384
n=32
p=0.030
r=0.424
n=32
p=0.016 II
I
S
T
S 1=0.018
n=32
p=0.921
1=0.109
ij=32
p=0.551
1=0.436
n=32
p=0.013
Anxiety 1=0.155
rc=32
p=0.397
1=0.202
rr=32
p=0.267
1=0.528
n=32
p=0.002
1=0.403
n=32
p=0.022
1=0.273
n=32
p=0.130
1=0.010
n=32
p=0.956
r=O307
n=32
p=0.087
1=0.486
n=32
p=0.005
Confidence r=0.107
if=32
p=0.561
r=0.127
n=32
p=0.490
i=-0.428
n=32
p=0.014
r=0321
n=32
p=0.074
1=0.075
n=32
p=0.685
1=0.005
n=32
p=0.979
1=0.218
n=32
p=0.232
1=0.499
n=32
p=0.004
Total mean 1=0.156
n=32
p=0.393
r=0.178
ir=32
p=0.331
r=0.428
n=32
p=0.014
r=0.424
if=32
p=0.016
1=0.263
n=32
p=0.145
r=0.045
n=32
p=0.806
1=0.252
n=32
p=0.165
1=0.589
ii=32
pO.OOO
Cyde One 
Depression r=0.047
n=30
p=0.804
r=-0.112
n=30
p=0.557
1=0.113
n=30
p=0.553
1=0.100
n=30
p=0.600
1=0.056
n=30
p=0.768
1=0.038
n=30
p=0.842
r=0.366
it=30
p=0.047
1=0.236
n=30
p=O.209
Hostility 1=0.263
n=30
p=0.161
1=0.059
n=30
p=0.757
i=-0305
ir=30
p=0.102
1=0320
n=30
p=0.085
1=0.161
n=30
p=0397
1=0.176
n=30
p=0.354
1=0.233
ir=30
p=0.216
1=0355
n=30
p=0.054
Anxiety 1=0.224
n=30
p=0.234
1=0.046
n=30
p=0.808
r=0.319
n=30
p=0.086
r=0367
n=30
p=0.154
1=0.212
n=30
p=0360
r=0311
n=30
p=0363
1=0.201
n=30
p=0.287
1=0363
n=30
p=0.049
Confidence 1=0.204
n=30
p=0.279
1=0.040
ii=30
p=0.833
1=0.243
n=30
p=0.197
r=0.172
n=30
p=0365
1=0.019
if=30
p=0.920
1=0.096
n=30
p=0.614
1=0.349
n=30
p=0.059
1=0372
n=30
p=O.043
Total mean t=0.233
n=30
p=0.215
1=0.035
if=30
p=0.856
i=-0.257
n=30
p=0.170
1=0.228
re=30
p=0.225
1=0.144
n=30
p=0.447
1=0.144
re=30
p=0.449
1=0.317
ir=30
p=0.088
1=0396
n=30
p=0.030
Cyde Two 
Depression 1=0.238
n=25
p=0.252
1=0.328
n=25
p=0.109
1=0.447
n=25
p=0.025
1=0.535
n=25
p=0.006
r=0.538
ir=25
p=0.006
1=0.433
n=25
p=0.031
1=0.013
n=25
p=0.951
1=0.597
n=25
p=0.002
Hostility 1=0.204
n=25
p=.328
1=0.279
n=25
p=0.176
1=0.475
n=25
p=0.016
1=0.431
re=25
p=0.032
1=0344
11=25
p=O.093
1=0378
if=25
p=0.179
1=0.080
n=25
p=0.704
1=0.346 
ir=25 
p=0.090
Anxiety 1=0.168
n=25
p=0.423
1=0.286
n=25
p=0.I66
1=0.498
lf=25
p=0.011
r=0.494
n=25
p=0.012
1=0.511
n=25
p=0.009
r=0.465
n=25
p=0.019
1=0.129
n=25
p=0.539
1=0.498
n=25
p=0.011
Confidence 1=0356
n=25
p=0.081
i=0395
if=25
p=0.051
1=0.481
n=25
p=0.0I5
1=0.434
re=25
p=0.030
1=0.654
n=25
p=0.000
1=0.566
n=25
p=0.003
1=0.038
if=25
p=0.859
1=0.585
n=25
p=0.002
Total 1=0.174
n=25
p=0.405
1=0.299
it=25
p=0.147
1=0.491
n=25
p=0.013
1=0.458
n=25
p=0.021
1=0.549
11=25
p=0.004
1=0.454
n=25
p=0.023
1=0.008
n=25
p=0.971
1=0.516
n=25
p=0.008
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Table 24b. Correlations between subjective appetite measures and averaged mood
states during the luteal phases of the menstrual cycles
Appetite/Mean 
Mood State
Hunger Appetite Satiation Satiety DR - food 
type
D R -
amount of
food
wanted
Ate more 
than wanted
Cravings
Mean of Cycles 
Depression
1=0.176
n=32
p=0337
r=O.250
n=32
p=0.168
r=-0343
n=32
p=0.055
1=0.457 
n=32 
p=0.009
1=0.193
n=32
p=0.291
1=0.334
n=32
p=0.062
1=0.291
n=32
p=0.107
1=0.113
n=32
p=0.536
Hostility r=0.183
n=32
p=0.31S
r=0.332
n=32
p=0.063
1=0343
n=32
p=0.055
1=0.434
ji=32
p=0.013
-1=0.345
n=32
p=O.053
1=0.485
it=32
p=0.005
1=0312
ir=32
p=0.082
1=0.219
n=32
p=0.228
Anxiety 1=0.270
n=32
p=0.136
i=0348
n=32
p=0.051
1=0.398
n=32
pf=0.024
1=0.500
n=32
p=0.004
1=0.234
n=32
p=0.197
1=0367
re=32
p=0.039
1=0.197
n=32
p=0.281
1=0.073
n=32
p=0.691
Confidence r=0.113
ir=32
p=0.537
r=0.257
n=32
p=0.155
r=0.236
n=32
p=0.194
1=0.219
n=32
p=0.229
i=0.345
n=32
p=0.053
1=0.366
n=32
p=0.039
1=0.290
n=32
p=0.107
1=0.234
n=32
p=0.198
Total mean x=0.225
n=32
p=0.215
i=0359
n=32
p=0.044
r=-0399
if=32
p=0.024
1=0.484
n=32
p=0.005
1=0.249
ii=32
p=0.170
1=0.432
n=32
p=0.013
1=0.268
ii=32
p=0.138
1=0.174
it=32
p=0.341
Cyde One 
Depression 1=0.217
n=29
p=0.259
t=0.069
n=29
p=0.724
1=0.010
n=29
p=0558
1=0.199
n=29
p=0302
1=0.116
nKZ9
p=0350
1=0.223
n=29
p=0.244
x=0.127
n=29
p=0.511
i=0.I87
n=29
p=0.331
Hostility r=0.023
n=29
p=0.907
1=0.149
n=29
p=0.441
r=0.102
n=29
pf=0.598
1=0.354
n=29
p=0.060
1=0.119
n=29
p=0.538
1=0.277
n=29
p=0.146
1=0.314
it=29
p=0.097
1=0.090
ir=29
p=0.642
Anxiety r=-0.060
n=29
p=0.756
1=0.021
n=29
p=0.914
i=0.013
n=29
p=0.948
1=0.246
n=29
p=0.199
1=0.029
n=29
p=0.880
1=0.139
n=29
p=0.471
r=0.199
n=29
p=0.300
1=0.018
n=29
p=0.926
Confidence 1=0.065
ir=29
p=0.740
r=0.014
n=29
p=0.944
t=0.091 
n=2 9 
p=0.638
1=0.028
n=29
p=0.885
1=0300
n=29
p=0.114
1=0.253
n=29
p=0.186
r=0.211
n=29
p=0.271
r=0.167
rt=29
p=0.386
Total mean 1=0.032
n=29
p=0.870
1=0.074
n=29
p=0.704
1=0.026
n=29
p=0.893
1=0301
if=29
p=0.113
1=0.153
n=29
p=0.429
1=0308
n=29
p=0.105
1=0.236
11=29
p=0.219
1=0.039
n=29
p=0.840
Cyde Two 
Depression r=0.259
rr=27
p=0.193
1=0.268
n=27
p=0.176
1=0.314
it=27
p=o.m
1=0.456
n=27
p=0.017
1=0.049
n=27
p=0.809
r=0351
n=27
p=0307
1=0.214
n=27
p=0i84
1=0.430
ir=27
p=0.025
Hostility 1=0304
n=27
p=0.124
r=0.315
ir=27
p=0.110
r=0362
n=27
p=0.064
1=0.469 
n=27 
p=0.013
i=0309 
n=27 
p=0.117
r=0.419
n=27
p=0.030
1=0.050
n=27
p=0.806
1=0.232
n=27
p=0.244
Anxiety i=0314
rr=27
p=0.1U
r=0394
n=27
p=0.042
1=0340
n=27
p=0.083
r=0.450
n=27
p=0.018
1=0.192
n=27
p=0.338
1=0.266
if=27
p=0.181
i=0.020
n=27
p=0.920
1=0.224
n=27
p=0.260
Confidence 1=0.135
n=27
p=0.501
r=0.172
n=27
p=0392
1=0.206
n=27
p=0303
i=0343
n=27
p=0.080
r=0.040
n=27
p=0.84I
1=0.248
n=27
p=0.212
r=0.224
n=27
p=0.261
1=0.424
n=27
p=0.028
Total Mean r=0.297
n=27
p=0.133
r=0.328
n=27
p=0.095
1=0.372
n=27
p=0.057
1=0.481
ir=27
p=0.011
1=0.150
n=27
p=0.454
1=0.314
n=27
p=0.110
1=0.067
n=27
p=0.739
1=0.301
n=27
p=0.127
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Table 24c. Correlations between subjective appetite measures and averaged mood
states during the premenstrual stages of the menstrual cycle
Appetite/Mean 
Mood State
Hunger Appetite Satiation Satiety DR - food 
type
D R -
amount of
food
wanted
Ate more 
than wanted
Cravings
Mean of Cycles 
Depression
1=0351 1=0.286 1=0371 tO.422 rO.606 rO.453 1O .I 6O 1=0.405
n=32 n=32 ti=32 n=32 ir=32 ii=32 re=32 it=32
pO.049 p=0.113 p=0.037 pO.016 pO.OOO p0.009 pO.381 pO.021
Hostility r=0.344 1=0.274 1=0388 rO.459 10.512 10.380 10.176 1=0.292
re=32 n=32 n=32 n=32 n=32 it=32 n=32 n=32
p=0.054 p=0.130 pO.028 p0.008 p0.003 pO.032 pO.336 pO.104
Anxiety 1=0.124 1=0.052 1=0.189 rO.204 r=0.254 10.107 rO.265 1=0.080
n=32 it=32 n=32 n=32 n=32 n=32 n=32 n=32
pO 300 p=0.777 p=0300 pO.264 pO.161 pO 360 pO.143 pO.663
Confidence r=0.146 1=0.130 i=-0.291 rO.338 r=0.425 rO.166 rO.237 1=0.296
n=32 n=32 if=32 n=32 n=32 n=32 n=32 n=32
p=0.427 p=0.479 p=0.106 pO.059 pO.015 pO.364 pO.191 pO.lOO
Total mean r=0.283 1=0.206 r=-0.372 tO.402 10.506 10.294 10.228 1=0.315
n=32 n=32 n=32 if=32 n=32 ir=32 n=32 n=32
p=0.116 p=0.257 p=0.036 pO.023 p0.003 pO.102 pO.209 pO.079
Cyde One
Depression 1=0.246 1=0.164 1=0.427 rO.238 10342 rO.348 rO.163 1=0351
n=30 n=30 n=30 it=30 n=30 n=30 n=30 n=30
pO.191 p=0387 p=0.019 pO.205 p0 .0 0 2 p0.060 p 0 3 8 9 pO.057
Hostility f =0361 r=0.188 1=0.486 10.284 rO.467 10.344 rO.156 i=-0.177
ir=30 n=30 n=30 n=30 n=30 n=30 re=30 it=30
p=0.163 p=0.32I p0.006 pO.128 p0.009 pO.063 pO.411 pO.349
Anxiety 1=0.204 1=0.129 1=0.513 iO,193 10.407 10.278 10.203 1=0.134
n=30 n=30 n=30 n=30 n=30 ii=30 ir=30 ir=30
p=0.280 p=0.497 p=0.004 pO.308 pO.026 pO.138 pO.282 pO.479
Confidence i=-0.021 1=0.033 1=0.207 10.087 10.250 10.040 10.037 1=0.261
n=30 n=30 n=30 n=30 n=30 11=30 ir=30 ir=30
pf=0.9I2 p=0.864 p=0.272 pO.648 pO.182 pO.834 pO.846 pO.164
Total mean 1=0.213 1=0.146 1=0.464 10.253 10.437 10.281 10.166 1=0.266
n=30 n=30 re=30 re=30 rt=30 n=30 ir=30 n=30
p=0.259 p=0.441 p=0.010 pO.177 pO.016 pO.132 pO.380 pO.156
Cyde Two
Depression 1=0.317 1=0.264 l=-0.051 10.285 10.474 rO.505 r-0.187 1=0.174
n=26 n=26 n=26 n=26 n=26 n=26 n=26 n=26
p=0.115 p=0.193 p=0.804 pO.158 pO.014 p0.009 p 0 3 6 1 p=0396
i
Hostility 1=0.155 1=0.145 1=0.008 rO.407 10.434 10394 r-0.051 1=0.199
n=26 n=26 it=26 n=26 it=26 n=26 rt=26 n=26
p=0.449 p=0.480 p=O.970 pO.039 pO.027 pO.046 pO.806 pO.329
Anxiety 1=0.037 1=0.013 1=0.098 10.243 rO.246 rO.166 1=0.092 10.049
if=26 n=26 n=26 ir=26 n=26 n=26 n=26 ir=26
p=0.858 p=0.952 pO.635 pO.231 pO.226 pO.418 pO.653 pO.812
Confidence 1=0.069 1=0.130 1=0.048 rO.306 10.172 10.082 tO.067 1=0.094
n=26 n=26 n=26 n=26 n=26 n=26 n=26 ir=26
p=0.737 p=0.527 pO.815 pO.129 p0.400 pO.692 pO.747 pO.649
Total meod 1=0.183 1=0.173 1=0.062 rO.396 r=0.433 tO.389 1=0.107 rO .173
n=26 ir=26 n=26 n=26 n=26 n=26 n=26 n=26
p=0.371 p 0 3 9 8 p=0.763 pO.045 pO.027 p0.050 pO.603 pO.398
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Table 25a Correlations between actual food intake and positive mood states during
the Follicular phases of the Menstrual cycle
Actual food intake/ 
Positive mood states Kcal Protein (g) Fat(g)
Carbohydrat
e(g) Sugar (g) Starch (g) TLA
Mean of both cydes 
Elated
r=45.132
n=32
p=0.473
1=0.0094
n=32
p=0.608
1=45.269
n=32
p=0.137
1=0.053
it=32
p=0.724
1=0.080
n=32
p=0.665
1=45.040
n=32
p=0.828
1=0.165
n=32
p=0.368
Agreeable i=4).031
n=32
p=0.866
1=0.072
ir=32
p=0.696
1=0.186
n=32
p=0.307
1=0.120
n=32
p=0.512
1=0.169
n=32
p=0.355
1=45.014
n=32
p=0.941
1=0321
re=32
p=0.073
Composed r=-0.051
n=32
p=0.783
1=0.164
n=32
p=0371
1=45.273
n=32
p=0.131
1=0.150
n=32
p=0.414
1=0.176
n=32
p=0.336
i=0.034
n=32
p=0.852
1=0.213
ir=32
p=0.242
Confident i=-0.104
n=32
p=0.571
1=0.028
n=32
p=0.879
r=4).270
n=32
p=0.136 11
1 1=0.071
n=32
p=0.700
1=45.007
n=32
p=0.970
1=0.143
n=32
p=0.435
Total positive mood i=-0.086
if=32
p=0.64I
i=0.10I
n=32
p=O.S83
1=45.277
n=32
p=0.125
1=0.117
n=32
p=0.522
1=0.142
n=32
p=0.440
1=45.004
n=32
p=0.982
1=0.233
n=32
p=0.199
Cyde One 
Elated
1=0.027
n=30
p=0.889
1=0.085
ii=30
p=0.656
1=0.035
n=30
p=0.856
1=0.096
n=30
p=0.614
1=0.084
n=30
p=0.661
r=45.021
n=30
p=0.912
1=0.244
n=30
p=O.I94
Agreeable 1=0.122
n=30
p=0.521
1=0.130
ii=30
p=0.492
1=0.050
n=30
p=0.794
1=0.171
it=30
p=0.368
i=0.181
n=30
p=0339
1=0.015
n=30
p=0,937
1=0.451
n=30
pf=0.012*
Composed 1=0.087
n=30
pp=0.649
1=0.162
n=30
p=0.392
1=0.010
n=30
p=0.957
1=0.127
n=30
p=0.502
1=0.126
it=30
p=0.507
1=45.021
n=30
p=0.912
i=0344
ir=30
p=0.063
Confident 1=0.036
n=30
p=0.852
i=0.027
n=30
p=0.887
1=45.033
n=30
p=0.865
1=0.125
n=30
p=0.512
1=0.082
n=30
ppO.667
r=0.008
n=30
n=0.968
1=0.258
n=30
n=0.169
Total positive mood r=0.072
n=30
p=0.707
1=0.109
n=30
p=0.568
r=0.015
it=30
p=0.936
1=0.140
n=30
p=0.462
1=0.126
n=30
p=0.506
1=45.006
n=30
p=0.976
1=0.348
n=30
p=0.060
Cyde Two 
Elated
r=-0.005
n=25
p=0.981
r=0.152
n=25
p=0.468
1=45.246
n=25
p=0.236
r=0.182
n=25
p=0.384
1=0.271
n=25
p=0.190
1=0.113
n=25
p=0.592
1=0.065
n=25
p=0.759
Agreeable 1=0.010
n=25
p=0.961
r=0.099
n=25
p=0.638
1=45.204
n=25
p=0.329
1=0.192
ir=25
p=0.357
r=0.246
n=25
p=0.236
1=0.134
n=25
p=0.522
1=0.156
ir=25
p=0.458
Composed 1=0.066
if=25
p=0.753
1=0.162
n=25
p=0.439
1=45.177
ii=25
p=0396
1=0.329
n=25
p=0.109
1=0.324
n=25
p=0.114
1=0.281
11=25
p=0.174
1=0.097
n=25
p=0.644
Confident 1=0.096
n=25
p=0.650
1=0.214
n=25
p=0304
1=45.122
n=25
p=0.563
1=0.245 '
if=25
p=0.238
1=0.145
n=25
p=0.490
1=0.267
n=25
p=0.198
1=0.015
n=25
p=0.942
Total positive mood 1=0.038
n=25
p=0.857
1=0.172
n=25
p=0.4I2
1=45.215
n=25
p=0.302
1=0.270
n=25
p=0.192
1=0.285
n=25
p=0.167
1=0.223
if=25
p=0.283
r=0.095
ir=25
p=0.652
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Table 25b Correlations between actual food intake and positive mood states during
the Luteal phases of the Menstrual cycle
Actual food intake/ 
Positive mood states Kcal Protein (g) Fat (g)
Carbohydrat
e(g) Sugar (g) Starch (g) TLA
Mean of both cydes 
Hated
1=0.184
n=32
p=0.315
r=0.279
it=32
p=0.123
r=0.083
n=32
p=0.654
1=0.147
n=32
p=0.422
1=0.000
n=32
p=0.999
1=0.226
n=32
p=0.214
1=0.078
n=32
p=0.673
Agreeable 1=0.003
rr=32
p=0.989
r=0.005
n=32
p=0.979
1=0.103
n=32
p=0.574
r=0.097
n=32
p=0.598
1=0322
n=32
p=0.506
r=0.037
n=32
p=0.842
1=0321
n=32
p=0.073
Composed 1=0.105
n=32
p=0.566
r=0.233
n=32
p=0.199
r=0.001
n=32
pf=0.995
r=0.088
n=32
p=0.631
r=0.011
n=32
p=0.954
1=0.127
n=32
p=0.490
1=0.280
n=32
p=0.121
Unconfident 1=0.158
n=32
p=0389
r=0.242
ir=32
p=0.182
r=0.056
n=32
p=0.761
1=0.257
n=32
p=0.155
1=0.164
n=32
p=0369
1=0.283
it=32
p=0.116
1=0.133
u=32
p=0.469
Total positive mood 1=0.128
n=32
p=0.485
r=0.212
n=32
p=0.244
i=0.020
n=32
p=0.913
r=0.168
77=32
p=0.359
1=0.078
n=32
p=0.671
1=0.192
ii=32
p=0.292
1=0.223
n=32
p=0.220
Cyde One 
Hated
1=0.119
n=29
p=0.540
r=0.060
n=29
p=0.759
r=0.062
n=29
p=0.750
r=0.097
rr=29
p=0.618
1=0.006
it=29
p=0.974
1=0.153
ri=29
p=0.428
1=0.130
n=29
p=0.501
Agreeable r=-0.119
n=29
p=0.537
r=0.220
n=29
p=0.251
r=0.198
it=29
p=0.304
1=0.007
n=29
p=0.969
1=0.114
n=29
p=0.554
1=0.149
ii=29
p=0.440
r=0.237
n=29
p=0.216
Composed 1=0.048
n=29
p=0.806
1=0.050
n=29
p=0.798
1=0.110
n=29
p=0.570
r=0.011
n=29
p=0.955
1=0.135
it=29
p=0.486
1=0.105
ii=29
p=0.588
1=0.230
n=29
p=0.229
Unconfident 1=0.099
n=29
p=0.609
r=0.166
n=29
p=0.388
1=0.203
if=29
p=0.291
r=O.030
n=29
p=0.877
1=0.065
n=29
p=0.740
1=0.022
ir=29
p=0.910
1=0.188
n=29
p=0328
Total positive mood 1=0.052
n=29
p=0.787
1=0.130
n=29
p=O.503
r=0.151
rr=29
p=0.436
1=0.035
ir=29
p=0.856
1=0.026
n=29
p=0.892
r=0.019
ir=29
p=0.922
1=0.250
n=29
p=0.191
Cyde Two 
Hated
1=0.261
n=27
p=0.189
1=0.470
n=27
p=0.013*
r=0.12 6
rea l
p=0.532
1=0.217
rea l
p=0.277
1=0.069
n=27
p=0.732
1=0.241
n=27
p=0.227
1=0.091
rea l
p=0.651
Agreeable 1=0.135
n=27
pr0.502
1=0.252
n=27
p=0.206
r=0.019
reO.1
p=0.926
r=0.197
reO.1
p=0325
1=0.145
n=27
p=0.471
1=0.182
rea l
p=0363
1=0348
reO.1
p=0.075
Composed r=0.280
reO.1
p=0.158
r=0.453
n=27
p=0.018*
1=0.135
rea l
p=0.501
t=0.232
reO.1
p=0.245
1=0.218
ip=27
p=0.275
1=0.143
rea l
p=0.477
1=0.257
rea l
p=0.196
Unconfident r=0.411
ir=<27
p=0.033
10.599=
n=27
p=0.001*»*
r=0.161
rea l
p=0.424
1=0.388
n=27
p=0.045*
1=0.190
rea l
p=0343
1=0.413
rea l
p=0.032*
1=0.044
rea l
p=0.826
Total positive mood r=0.290 
n=27 
p=0.143
r=0.474
n=27
p=0.013*
1=0.108
rea l
p=0.591
1=0.275
rea l
p=0.166
1=0.166
n=27
p=0.407
1=0.259
real
p=0.193
1=0.200
rea l
p=0318 '
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Table 25c Correlations between actual food intake and positive mood states during
the Premenstrual phases of the Menstrual cycle
Actual food intake/ 
Positive mood states Kcal Proteiii (g) Fat (g)
Caibotydrat
e(g) Sugar (g) Starch (g) TLA
Mean of both cydes 
Bated
1=0.051
n=32
p=0.783
1=0.197
ir=32
p=0.279
1=0.084
ir=32
p=0.650
i=0.082
n=32
p=0.654
1=0.012
n=32
p=0.950
1=0.064
n=32
p=0.728
1=0327
n=32
p=0.068
Agreeable 1=0.029
n=32
p=0.875
1=0.220
n=32
p=0.227
1=0.101
if=32
p=0381
1=0.062
n=32
p=0.736
1=0.055
n=32
p=0.766
1=0.002
n=32
p=0.991
1=0.266
n=32
p=0.141
Composed 1=0.043
rr=32
p=0.816
1=0329
n=32
p=0.066
1=0.087
n=32
p=0.636
1=0.036
n=32
p=0.844
r=0.049
n=32
p=0.789
1=0.073
n=32
p=0.692
1=0.153
n=32
n=0.403
Unconfident r=-0.029
n=32
p=0.875
1=0.135
n=32
p=0.461
1=0.141
n=32
p=0.443
1=0.040
n=32
p=0.827
1=0.002
n=32
p=0591
1=0.041
ii=32
p=0.824
r=0.132
n=32
p=0.470
Total positive mood 1=0.022 
n=32 
p=0.905
1=0.240
it=32
p=0.I86
1=0.110
n=32
p=0.548
1=0.049
n=32
p=0.789
1=0.003
if=32
p=0.987
r=0.034
n=32
p=0.854
1=0.251
n=32
p=0.166
Cyde One 
Bated
r=-0.005
n=30
p=0.978
1=0.128
it=30
p=0.502
1=0.038
n=30
p=0.840
1=0.001
n=30
p=0.994
1=0.087
n=30
p=0.646
1=0.098
n=30
p=0.607
1=0.059
n=30
p=0.758
Agreeable r=O.076
n=30
p=0.689
1=0.119
n=30
p=0333
1=0.129
n=30-
p=0.496
1=0.051
n=30
p=0.789
1=0.061
n=30
p=0.750
1=0.153
n=30
p=0.419
1=0.018
n=30
p=0.925
Composed r=0.099
n=30
p=0.605
1=0330
n=30
p=0.075
1=0.010
n=30
p=0.958
1=0.054
n=30
p=0.778
1=0.179
n=30
p=0345
1=0.055
it=30
p=0.774
i=0.04I
n=30
p=0.829
Unconfident r=-0.224
n=30
p=0.234
1=0.117
n=30
p=0.538
1=0.142
n=30
p=0.453
1=0.217
n=30
p=0349
1=0.067
n=30
p=0.725
1=0.280
n=30
p=0.134
1=0.068
n=30
p=0.719
Total positive mood 1=0.069
ir=30
p=0.718
r=0.116
n=30
p=0.541
1=0.069
n=30
p=0.717
1=0.089
n=30
p=0.639
1=0.064
ji=30
p=0.738
1=0.207 
n=3 0 
p=0.272
1=0.028
ir=30
p=0.884
Cyde Two 
Bated
r=0.296
n=25
p=0.152
1=0.165
n=25
p=0.432
1=0.190
n=25
p=0.364
1=0.210
n=25
p=0.314
1=0.100
n=25
p=0.636
1=0.129
n=25
p=0.538
1=0.239
n=25
p=0349
Agreeable 1=0.311
n=25
p=0.130
1=0.203
n=25
p=0330
1=0.190
n=25
p=0363
1=0.244
n=25
p=0.239
1=0.140
n=25
p=0304
1=0.132
n=25
p=0.529
1=0.359
n=25
p=0.078
Composed 1=0.259
n=25
p=0.212
1=0.281
n=25
p=0.174
1=0.147
n=25
p=0.484
1=0.184 
n=2 5 
p=0378
1=0.058
n=25
p=0.783
1=0.204
it=25
p=0.328
1=0.167
n=25
p=0.424
Unconfident 1=0.259
ir=25
p=0.211
r=0.322
n=25
p=0.117
1=0.041
if=25
p=0.847
1=0.299 '
n=25
p=0.147
f O.139
n=25
p=0.508
r=0.240
n=25
p=0.248
1=0.144 
n=2 5 
p=0.491
Total positive mood 1=0.318
n=25
p=0.I22
1=0.271
n=25
p=0.190
1=0.165
n=25
p=0.430
1=0.260
n=25
p=0.209
1=0.086
n=25
p=0.684
1=0.197
n=25
p=0346
1=0.254
n=25
p=0.220
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Tables 26a Correlations between Percentage food intake and Postive mood states
During the Follicular phases of the Menstrual Cvcle
Perecentage food intake/ 
Positive mood states
% Fat % Protein % CHO % Sugar % Starch
Mean of both cydes
i= i= 1= r= i=
Bated n= rt= n= n= it=
P= P= P= P= P=
Agreeable 1=4.309 r=0.125 1=0247 i=0 J48 1=4.044
n=32 n=32 n=32 n=32 n=32
p=0.085 p=0.497 p=0.172 p=0.051 p=4.813
Composed 1=4.434 1=0.298 1=0.320 1=0301 r=0.111
rr=32 n=32 ii=32 n=32 m=32
p=0.013* p=0.098 p=0.074 p=O.094 p=0.545
Confident p=0.280 1=0.225 1=0.200 1=0.170 1=0.074
n=32 rr=32 n=32 n=32 n=32
p=0.120 p=0.216 p=0.272 p=0353 p=0.687
Total positive mood 1=4.380 r=0.269 1=0.293 r=0305 1=0.061
ff=32 n=32 ii=32 ir=32 n=32
p=0.032« p=0.136 p=0.104 p=0.090 p=0.741
Cyde One
1=4.159 r=0.096 1=0.040 1=0.036 r=4.069
Bated n=30 n=30 n=30 n=30 ir=30
p=O.403 p=0.614 p=0.834 p=0.851 p=0.718
Agreeable r=0.022 t=0.005 1=0.083 1=0.149 1=4.172
n=30 n=30 n=30 n=30 n=30
p=0.908 p=0.981 pf=0.665 p=0.433 p=4.362
Composed r=4.022 r=0.123 1=0.036 1=0.086 r=4.163
n=30 n=30 if=30 ir=30 n=30
p=0.909 p=0fil7 p=0.850 p=0.650 p=4.389
Confident 1=0.089 r=0.000 r=0.036 1=0.020 1=4.057
n=30 n=30 if=30 re=30 ir=30
p=0.640 p=0.999 p=0.849 p=0.916 p=0.764
Total positive mood 1=0.069 r=0.062 1=0.052 1=0.076 1=4.123
n=30 n=30 n=30 n=30 n=30
p=0.718 p=0.745 p=0.786 p=0.689 p=0316
Cyde Two
1=4.549 1=0.258 1=0.292 i=0339 1=0.178
Bated n=25 n=25 n=25 n=25 n=25
p=0.004** p=0.214 p=0.156 p=0.098 p=0.396
Agreeable 1=4.449 1=0.154 1=0.317 1=0.322 r=0.204
n=25 n=25 ir=25 n=25 ir=25
p=0.024* p=0.462 p=0.122 p=0.116 p=0.329
Composed 1=4.507 r=0.092 t=0.393 1=4.329 1=0305
n=25 n=25 ir=25 n=25 n=25
p=0.010* p=0.664 p=0.052 p=0.098 p=0.139
Confident r=4.403 r=0.244 1=0.192 1=0.043 1=0.246
re=25 n=25 rr=25 n=25 n=25
p=4.046* p=0.240 p=0.358 p=0.838 p=4.235
Total positive mood 1=4.541 1=0.204 1=0.345 i=0307 1=0.265
n=25 11=25 n=25 it=25 n=25
p=0.005*» p=0328 p=0.091 p=0.136 p=0.200
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Tables 26b Correlations between Percentage food intake and Postive mood states
During the Luteal phases of the Menstrual Cycle
Perecentage food intake/ 
Positive mood state*
% Fat % Protein % CHO % Sugar % Starch
Mean of both cyde* 
Elated
1=0.094
n=32
p=0.607
1=0.172
n=32
p=0.347
r=-0.016
n=32
p=0.930
1=0.037
ir=32
p=O.840
r=O.042
n=32
p=0.819
Agreeable r=-0.147
n=32
p=0.421
r=-0.005
n=32
p=0.980
1=0.152
n=32
p=0.408
1=0.261
n=32
p=0.149
1=0.075
n=32
p=0.684
Composed i=-0.123
rr=32
p=0.503
r=0.226
n=32
p=0.213
1=0.031
n=32
p=0.868
1=0.068
n=32
p=0.714
1=0.086
ir=32
p=0.641
Confident r=-0.256
n=32
p=0.157
1=0.134
n=32
p=0.464
r=0.197
n=32
p=0.280
1=0.242
n=32
p=0.182
r=0.044
m=32
p=0.809
Total positive mood r=-0.175
it=32
p=0339
r=0.148
n=32
p=0.419
1=0.086
rr=32
p=0.640
1=0.113
n=32
p=0.540
1=0.042
n=32
p=0.819
Cyde One 
Elated
r=-0.080
w=29
p=0.680 II
I
l
"
| 1=0.028
ii=29
p=0.887
i=-0.076
n=29
p=0.696
1=0.024
n=29
p=0.901
Agreeable i=-0.211
n=29
p=0.272
1=0.209
n=29
p=0.276
r=0.195
n=29
p=0310
1=0.469
n=29
p=0.010*
1=0.121
n=29
p=0.532
Composed 1=0 .1 1 0
n=29
p=0.572
r=0.013
n=29
p=0.946
1=0.010
rr=29
p=0.960
1=0.205
n=29
p=0.286
1=0.079
n=29
p=0.685
Confident 1=0.211
n=29
p=0.273
1=0.156
n=29
p=0.419
1=0.196
n=29
p=0.308
1=0.378
n=29
p=0.043*
1=0.035
ir=29
p=0.857
Total positive mood i=-0.201
n=29
p=0.296
r=0.151
n=29
p=0.434
1=0.126
n=29
p=0.516
1=0.214
n=29
p=0.266
1=0.023
i i =29
p=0.905
Cyde Two 
Elated
1=0.023
ir=27
p=0.908
1=0.432
n=27
p=0.025*
1=0.004
n=27
p=0.986
1=0.059
n=27
p=0.768
r=0.024
n=27
p=0.905
Agreeable i=-0.109
ir=27
p=0.588
t=0.234
n=27
p=0.240
1=0.115
11=27
p=0.568
1=0.064
n=27
p=0.750
1=0.116
n=27
p=0.565
Composed r=-0.056
n=27
p=0.780
r=0.341
n=27
p=0.082
1=0.029
n=27
p=0.884
1=0.041
re=27
p=0.838
1=0.059
n=27
p=0.770
Confident r=-0.103
n=27
p=0.609
r=O.402
ir=27
pf=0.038*
1=0.085
n=27
p=0.674
1=0.011
n=27
p=0.959
1=0.123
n=27
p=0.541
Total positive mood 1=0.077
n=27
p=0.702
1=0.377
ii=27
p=0.053
1=0.059 
n=27 
p=0.769
1=0.010
n=27
p=0.962
r=0.052
ir=27
p=0.798
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Tables 26c Correlations between Percentage food intake and Postive mood states
During the Premenstrual phases of the Menstrual Cycle
Perecentage food intake/ 
Positive mood states
% Fat % Protein % CHO % Si®ar % Starch
Mean of both cydes 
Elated
1=0.306
rt=32
p=0.088
r=0.064
n=32
p=0.727
1=0.187
if=32
p=O.305
1=0.000
ir=32
p=0.997
1=0.172
ir=32
p=0346
Agreeable r=-0.262
n=32
p=0.148
r=0.II9
n=32
p=0.516
1=0.155
n=32
p=0397
1=0.053
n=32
p=0.773
1=0.105
11=32
p=0.569
Composed r=-0.280
rv=32
p=0.121
1=0.213
n=32
p=0.242
r=0.063
n=32
p=0.734
1=0.119
n=32
p=0.518
1=0.164
n=32
p=0.370
Confident 1=0.237
it=32
p=0.192
r=0.111
n=32
p=0.546
f=0.197
n=32
p=0.279
1=0.021
ii=32
p=0.911
r=0.269
it=32
p=0.136
Total positive mood 1=0.291
if=32
p=0.I07
r=0.142
rr=32
p=0.437
1=0.152
re=32
p=0.406
1=0.044
n=32
p=0.813
1=0.195
n=32
p=0.285
Cyde One 
Elated
r=-0.055
rr=30
p=0.772
1=0.044
n=30
p=0.820
1=0.028
n=30
p=0.883
1=0.145
n=30
p=0.445
1=0.177
n=30
p=0.349
Agreeable 1=0.119
rr=30
p=0.530
1=0.148
n=30
p=0.435
1=0.042
n=30
p=0.827
1=0.054
ir=30
p=0.777
1=0.099
it=30
p=0.603
Composed 1=0.116
n=30
p=0.540
r=0.147
n=30
p=0.439
i=-0.036
n=30
p=0.852
1=0.012
n=30
p=0.949
1=0.011
11=30
p=0.953
Confident r=0.090
n=30
pO.636
1=0.054
n=30
p=0.775
r=-0.063
ir=30
p=0.742
1=0.140
n=30
p=0.462
1=0.120
it=30
p=0.528
Total positive mood r=-0.020
n=30
p=0.915
1=0.112
n=30
p=0.556
1=0.041
n=30
p=0.829
1=0.137
n=30
p=0.472
1=0.105
n=30
o=0.582
Cyde Two 
Elated
r=-0.I27
n=25
p=0.544
1=0.021
n=25
p=0.921
1=0.010 
n=25 
. p=0.964
1=0.001
n=25
p=0.997
1=0.116
n=25
p=0.582
Agreeable r=-0.100
n=25
p=0.634
1=0.052
n=26
p=0.803
1=0.033
it=25
p=0.875
1=0.045
n=25
p=0.831
1=0.122
n=25
p=0.563
Composed r=-0.140
n=25
p=O.506
1=0.271
n=25
p=0.I91
1=0.023
n=25
p=0.914
1=0.221
n=25
p=0.289
1=0.067
n=25
pO.752
Confident rO .288
n=25
p=0.162
1=0.358
n=25
p=0.079
1=0.196
n=25
p=0.347
1=0.053
n=25
p=0.803
1=0.100 
n=25 
p=0.63 6
Total positive mood r=O.I80
n=25
p=0.389
1=0.180
n=25
p=0.388
r=0.067
n=25
p=0.751
1=0.042
n=25
p=0.843
i=-0.024
n=25
pO.910
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Table 27a. Correlations between Subjective Appetite Scores and Positive Mood
States During the Follicular Stage of the Menstrual cycle
A p p e t i te /  
P o s it iv e  M o o d  
S ta te
H u n g e r A p p e t i te S a tia t io n S a tie ty D R  -  f o o d  
ty p e
D R -
a m o u n t  o f
fo o d
w a n te d
A te  m o re
th a n
w a n te d
C ra v in g s
M e a n  o f  C y c le s  
E la te d
r = 0 .1 7 2
n = 3 2
p = 0 .3 4 8
r = 0 ! l4 0
n = 3 2
p = 0 .4 4 3
r= -0 .2 9 8
n = 3 2
p = 0 .0 9 8
r = 0 .3 5 8
n = 3 2
p = 0 .0 4 5 *
r = 0 .2  9 6  
n = 3 2
p = 0 .1 0 0
r= 0 .0 4 2
n = 3 2
p 0 .8 2 1
r = -0 .1 37
n = 3 2
p = 0 .4 5 3
r = -0 .5 6 6
n = 3 2
p = 0 .0 0 1 * *
A g re e a b le r= 0 .2 0 4
n = 3 2
p = 0 .2 6 2
1 = 0 .1 4 2
n = 3 2
p = 0 .4 3 9
r= -0 .3 7 5  
n = 3 2  
p = 0 .0  3 4
r = 0 .4 1 9
n = 3 2
p = 0 .0 1 7
1 = 0 .2 2 8
n = 3 2
p = 0 .2 1 0
r= 0 .0 7 8  
n = 3 2  
p—0.670
r = - 0 .1 11
n = 3 2
p = 0 .5 4 5
x = -0 .4 5 4
n = 3 2
p = 0 .0 0 9
C o m p o s e d 1 = 0 .1 8 1
n = 3 2
p = 0 .3 2 2
r= 0 .2 5 2  
n = 3 2  
p = 0 .1 6 5
i= - 0 .4 3 9
n = 3 2
p = 0 .0 1 2
r= 0 .3 8 1
n = 3 2
p = 0 .0 3 1
r = 0 .2 1 2
n = 3 2
p = 0 .2 4 4
r= -0 .0 2 7
n = 3 2
p = 0 .8 8 3
r= -0 .3 5 4
n = 3 2
p = 0 .0 4 7
r= -0 .5 3 6
n = 3 2
p = 0 .0 0 2
C o n f id e n t r= 0 .1 7 7
n = 3 2
p = 0 .3 3 3
r= 0 .1 3 4
n = 3 2
p = 0 .4 6 6
r= -0 .3 5 5
n = 3 2
p = 0 .0 4 6
r = 0 .2 3 0
n = 3 2
p = 0 .2 0 6
1 = 0 .0 4 8
n = 3 2
p = 0 .7 9 5
r= -0 .0 0 8
n = 3 2
p = 0 .9 6 5
r = - 0 .2 1 5
n = 3 2
p = 0 .2 3 7
r = -0 .4 7 4
n = 3 2
p = 0 .0 0 6
T o ta l  p o s it iv e  
m e a n
r= 0 .1 7 7
n = 3 2
p = 0 .3 3 1
r= 0 .1 6 6
n = 3 2
p = 0 .3 6 5
r= -0 .3 8 8
n = 3 2
p = 0 .0 2 8
r= 0 .3 6 2
n = 3 2
p = 0 .0 4 2
r= 0 .1 8 9
n = 3 2
p = 0 .3 0 0
r= 0 .0 0 5
n = 3 2
p = 0 .9 7 8
r = -0 .2 1 9
n = 3 2
p = 0 .2 2 8
r= -0 .5 2 8
n = 3 2
p = 0 .0 0 2
C y c le  O n e  
E la te d
r= 0 .1 1 9
n = 3 0
p = 0 .S 3 1
r = -0 .0 8 9
n = 3 0
p = 0 .6 3 9
r= -0 .1 4 5
n = 3 0
p = 0 .4 4 5
r = 0 .0 9 9
n = 3 0
p = 0 .6 0 1
r= 0 .1 5 1
n = 3 0
p = 0 .4 2 6
r= 0 .0 8 4
n = 3 0
p = 0 .6 5 9
r = -0 .2 4 8
n = 3 0
p = 0 .1 8 6
r= -0 .2 6 8
n = 3 0
p = 0 .1 5 2
A g re e a b le r= 0 .3 6 5
n = 3 0
p = 0 .0 4 7
r = 0 .1 6 9
n = 3 0
p = 0 .3 7 1
r= -0 .3 0 1
n = 3 0
p = 0 .1 0 7
r= 0 .3 4 2
n = 3 0
p = 0 .0 6 4
r = 0 .2 5 6
n = 3 0
p = 0 .1 7 1
r = 0 .2 1 0  
n = 3 0
p = 0 .2 6 6
r= -0 .2 2 0
n = 3 0
p = 0 .2 4 3
r= -0 .3 9 1
n = 3 0
p = 0 .0 3 2
C o m p o s e d 1 = 0 .2 6 9
n = 3 0
p = 0 .1 5 0
r= 0 .0 6 7
n = 3 0
p = 0 .7 2 5
r= -0 .3 1 0
n = 3 0
p = 0 .0 9 5
r= 0 .2 7 7
n = 3 0
p = 0 .1 3 8
r = 0 .1 6 0
n = 3 0
p = 0 .4 0 0
r= 0 .1 6 8
n = 3 0
p = 0 .3 7 4
r= -0 .2 8 2
n = 3 0
p = 0 .1 3 1
r= -0 .4 1 3
n = 3 0
p = 0 .0 2 3
C o n f id e n t r= 0 .2 1 8
n = 3 0
p = 0 .2 4 7
r= 0 .0 2 1
n = 3 0
p = 0 .9 1 2
i= -0 .2 5 8  
n = 3 0  
p = 0 .1 6 9
r= 0 .0 9 7
n = 3 0
p = 0 .6 1 2
r= 0 .0 4 7
n = 3 0
p = 0 .8 0 6
r = 0 .1 1 3
n = 3 0
p = 0 .5 5 1
r= -0 .3 1 3
n = 3 0
p = 0 .0 9 2
r= - 0 .4 1 2
n = 3 0
p = 0 .0 2 4
T o ta l  p o s it iv e  
m e a n
r = 0 .2 7 9
n = 3 0
p = 0 .1 3 6
r= 0 .0 8 0
n = 3 0
p = 0 .6 7 5
r= -0 .3 0 1
n = 3 0
p = 0 .1 0 7
r= 0 .2 4 6
n = 3 0
p = 0 .1 9 1
r= 0 .1 4 7
n = 3 0
p = 0 .4 3 9
r= 0 .1 2 4
n = 3 0
p = 0 .5 1 5
r= -0 .2 5 0
n = 3 0
p = 0 .1 8 4
r= -0 .4 3 5
n = 3 0
p = 0 .0 1 6
C y c le  T w o  
E la te d
r = 0 .1 5 I
n = 2 5
p = 0 .4 7 3
r= 0 .2 8 0
n = 2 5
p = 0 .1 7 6
r= -0 .3 7 5
n = 2 5
p = 0 .0 6 5
r= 0 .4 4 1
n = 2 5
p = 0 .0 2 7
r= 0 .4 3 1
n = 2 5
p = 0 .0 3 1
r= 0 .3 6 4
n = 2 5
p = 0 .0 7 4
i= -0 .0 2 1
n = 2 5
p = 0 .9 2 1
r= -0 .6 0 4
n = 2 5
p = 0 .0 0 1
A g re e a b le r= 0 .0 7 7
n = 2 5
p = 0 .7 1 3
r= 0 .1 7 6
n = 2 S
p = 0 .4 0 1
r= -0 .4 3 1
n = 2 5
p = 0 .0 3 2
r= 0 .4 1 8
n = 2 5
p = 0 .0 3 7
r= 0 .3 6 6
n = 2 5
p = 0 .0 7 2
1 = 0 .2 9 2
n = 2 5
p = 0 .1 5 7
i= 0 .0 2 9
n = 2 5
p = 0 .8 8 9
r= -0 .3 9 7
n = 2 5
p = 0 .0 4 9
C o m p o s e d r= 0 .1 4 4
n = 2 5
p = 0 .4 9 2
1 = 0 .2 3 0
n = 2 5
p = 0 .2 6 9
r= -0 .3 8 4
n = 2 5
p = 0 .0 5 8
r= 0 .4 3 2
n = 2 5
p = 0 .0 3 1
r= 0 .3 7 4
n = 2 5
p = 0 .0 6 5
r= 0 .3 6 8
n = 2 5
p = 0 .0 7 0
r= -0 .2 8 3
n = 2 5
p = 0 .1 7 1
r= -0 .5 1 6
n = 2 5
p = 0 .0 0 8
C o n f id e n t r = 0 .1 3 9
n = 2 5
p = 0 .5 0 9
r= 0 .1 6 5
n = 2 5
p = 0 .4 3 1
r= -0 .3 4 9
n = 2 5
p = 0 .0 8 8
r = 0 .1 9 8
n = 2 5
p = 0 .3 4 2
r= 0 .3 5 3
n = 2 5
p = 0 .0 8 4
r= 0 .2 7 3
n = 2 5
p = 0 .1 8 7
r= -0 .1 2 6
n = 2 5
p = 0 .5 4 7
r= -0 .3 7 8
n = 2 5
p = 0 .0 6 3
T o ta l  p o s it iv e  
m e a n
i= 0 .0 7 9
n = 2 5
p = 0 .7 0 8
r= 0 .1 6 9
n = 2 5
p = 0 .4 1 9
r= -0 .3 8 5
n = 2 5
p = 0 .0 5 7
r= 0 .3 9 2
n = 2 5
p = 0 .0 5 3
r= 0 .4 3 2
n = 2 5
p = 0 .0 3 1
r= 0 .3 4 9
n = 2 5
p = 0 .0 8 7
r= -0 .0 7 5
n = 2 5
p = 0 .7 2 3
r = - 0 .5 1 5  
n = 2 5
p = 0 .0 0 6
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Table 27b. Correlations between Subjective Appetite Scores and Positive Mood
States During the Luteal Stage of the Menstrual Cycle
A p p e t i te /  
P o s itiv e  M o o d  
S ta te
H u n g e r A p p e t i te S a tia tio n S a tie ty D R  -  f o o d  
ty p e
D R -
a m o u n t  o f
fo o d
w a n te d
A te  m o re
th a n
w a n te d
C ra v in g s
M e a n  o f  C y c le s  
E la te d
r= 0 .2 1 4
n = 3 2
p = 0 .2 4 0
r= 0 .2 8 0
n = 3 2
p = 0 .1 2 1
r= -0 .2  6 6
n = 3 2
p = 0 .1 4 1
r= 0 .4 6 8
n = 3 2
p = 0 .0 0 7
r= 0 .1 5 9
n = 3 2
p = 0 .3 8 4
r= 0 .2 8 7
n = 3 2
p = 0 .1 1 2
r= -0 .2 8 8
n = 3 2
p=o.m
x = -0 .0 8 3
n = 3 2
p = 0 .6 5 3
A g re e a b le r= 0 .1 7 0
n = 3 2
p = 0 .3 5 2
r= 0 .3 2 2
n = 3 2
p = 0 .0 7 2
r= -0 .2 3 8
n = 3 2
p = 0 .1 9 0
r= 0 .3 3 3
n = 3 2
p = 0 .0 6 3
r= 0 .3 4 4
n = 3 2
p = 0 .0 5 4
r= 0 .4 2 8  
n = 3 2  
p = 0 .0 1 5
r= -0 .2 7 3
n = 3 2
p = 0 .1 3 0
i= - 0 .1 7 9
n = 3 2
p = 0 .3 2 7
C o m p o s e d r= 0 .3 0 9
n = 3 2
p = 0 .0 8 5
r= 0 .4 2 7  
n = 3 2  
p = 0 .0 1 5
r= -0 .4 0 0
n = 3 2
p = 0 .0 2 3
r= 0 .5 1 6
n = 3 2
p = 0 .0 0 2
i= 0 .2 4 9  
n = 3 2  
p = 0 .1 6 9
r= 0 .3 4 0
n = 3 2
p = 0 .0 5 7
r= -0 .1 6 1
n = 3 2
p = 0 .3 7 8
r= -0 .0 0 4
n = 3 2
p = 0 .9 8 2
C o n f id e n t r= 0 .1 6 1
n = 3 2
p = 0 .3 7 8
r= 0 .3 2 6
n = 3 2
p = 0 .0 6 9
r= -0 .2 3 3
n = 3 2
p = 0 .1 9 9
r= 0 .2 9 2  
n = 3 2  
p = 0 .1 0 5
r= 0 .2 5 9
n = 3 2
p = 0 .1 5 3
r= 0 .3 2 7
n = 3 2
p = 0 .0 6 8
r= -0 .2 6 3  
n = 3 2  
p = 0 .1 4 6
r= -0 .2 6 3  
n = 3 2  
p = 0 .1 4 6
T o ta l  p o s it iv e  
m e a n
r= 0 .2 1 7
n = 3 2
p = 0 .2 3 2
r= 0 .3 5 4
n = 3 2
p = 0 .0 4 7
r= -0 .2 9 8
n = 3 2
p = 0 .0 9 8
r= 0 .4 3 2
n = 3 2
p = 0 .0 1 3
r= 0 .2 7 5
n = 3 2
p = 0 .1 2 8
r= 0 .3 7 1
n = 3 2
p = 0 .0 3 7
i= -0 .2 7 7
n = 3 2
p = 0 .1 2 5
r= - 0 .1 6 5
n = 3 2
p = 0 .3 6 7
C y c le  O n e  
E la te d
i= - 0 .1 3 8
n = 2 9
p = 0 .4 7 6
r= 0 .0  0 9
n = 2 9
p = 0 .9 6 5
r= -0 .0 4 9
n = 2 9
p = 0 .8 0 0
r= 0 .2 9 7
n = 2 9
p = 0 .1 1 8
r= 0 .2 3 0
n = 2 9
p = 0 .2 3 0
r= 0 .2 9 1
n = 2 9
p = 0 .1 2 6
r= -0 .1 2 7
n = 2 9
p = 0 .5 1 2
r= 0 .1 4 5
n = 2 9
p = 0 .4 5 5
A g re e a b le r= -0 .0 6 4
n = 2 9
p = 0 .7 4 3
r= 0 .0 3 3
n = 2 9
p = 0 .8 6 7
r= 0 .0 7 1
n = 2 9
p = 0 .7 1 3
r= 0 .2 1 7
n = 2 9
p = 0 .2 5 8
r= 0 .2 1 4
n = 2 9
p = 0 .2 6 5
r= 0 .2 7 3
n = 2 9
p = 0 .1 5 2
r= -0 .2 6 8
n = 2 9
p = 0 .1 6 0
r= -0 .1 1 7
n = 2 9
p = 0 .5 4 5
C o m p o s e d r= 0 .1 6 3
n = 2 9
p = 0 .3 9 9
r= 0 .2 6 1
n = 2 9
p = 0 .1 7 2
r= -0 .2 0 1
n = 2 9
p = 0 .2 9 6
r= 0 .4 8 1  
n = 2  9
p = 0 .0 0 8
r= 0 .1 0 6
n = 2 9
p = 0 .5 8 3
r= 0 .2 9 8  
n = 2 9  
p = 0 .1 17
r= -0 .2 2 6
n = 2 9
p = 0 .2 4 0
r= -0 .0 2 7
n = 2 9
p = 0 .8 9 0
C o n f id e n t r= -0 .0 2 4
n = 2 9
p = 0 .9 0 1
r= 0 .0 8 7
n = 2 9
p = 0 .6 5 4
r= -0 .0 6 9
n = 2 9
p = 0 .7 2 1
r= 0 .1 4 5
n = 2 9
p = 0 .4 5 3
r= 0 .3  4 4  
n = 2  9
p = 0 .0 6 8
r= 0 .3 0 6
n = 2 9
p = 0 .1 0 7
r= -0 .1 8 4
n = 2 9
p = 0 .3 3 9
i= - 0 .1 1 0
n = 2 9
p = 0 .5 6 9
T o ta l  p o s it iv e  
m e a n
r= 0 .0 2 9
n = 2 9
p = 0 .8 8 3
r= 0 .1 2 3
n = 2 9
p = 0 .5 2 5
r= -0 .0 4 1
n = 2 9
p = 0 .8 3 4
r= 0 .2 8 4
n = 2 9
p = 0 .1 3 5
i= 0 .3 5 5
n = 2 9
p = 0 .0 5 9
r= 0 .3 6 4
n = 2 9
p = 0 .0 5 2
r = -0 .2 1 7
n = 2 9
p = 0 .2 5 9
r= -0 .0 6 5  
n = 2  9  
p = 0 .7 3 8
C y c le  T w o  
E la te d
r= 0 .2 9 3
n = 2 7
p = 0 .1 3 8
r= 0 .3 0 3
n = 2 7
p = 0 .1 2 5
r= -0 .2 3 3
n = 2 7
p = 0 .2 4 3
r= 0 .3 8 2
n = 2 7
p = 0 .0 4 9
r= 0 .0 3 5
n = 2 7
p = 0 .8 6 4
r= 0 .2 1 8
n = 2 7
p = 0 .2 7 4
r= -0 .2 7 0
n = 2 7
p = 0 .1 7 3
r= * 0 .3 9 6
n = 2 7
p = 0 .0 4 1
A g re e a b le r= 0 .4 5 3
n = 2 7
p = 0 .0 1 8
r= 0 .4 7 5
n = 2 7
p = 0 .0 1 2
r= -0 .4 0 5
n = 2 7
p = 0 .0 3 6
r= 0 .5 3 3  
n = 2 7  
p = 0 .0 0 4  '
1 = 0 .2 8 0  
n = 2 7  
p = 0 .1 57
r= 0 .3 8 4
n = 2 7
p = 0 .0 4 8
r= 0 .0 1 7
n = 2 7
p = 0 .9 3 4
i= -0 .2 5 3
n = 2 7
p = 0 .2 0 3
C o m p o s e d r= 0 .3 5 2
n = 2 7
p = 0 .0 7 1
1 = 0 .4 5 3
n = 2 7
p = 0 .0 1 8
r= -0 .3 2 2
n = 2 7
p = 0 .1 0 2
r= 0 .4 1 1
n = 2 7
p = 0 .0 3 3
r= 0 .1 3 6
n = 2 7
p = 0 .4 9 9
r= 0 .1 6 6
n = 2 7
p = 0 .4 0 9
r= 0 .0 1 3
n = 2 7
p = 0 .9 4 8
r= -0 .2 6 5
n = 2 7
p = 0 .1 8 1
C o n f id e n t r= 0 .2 4 2
n = 2 7
p = 0 .2 2 4
r= 0 .3 1 9
n = 2 7
p = 0 .1 0 5
r= -0 .2 1 4
n = 2 7
p = 0 .2 8 3
r= 0 .3 5 1
n = 2 7
p = 0 .0 7 3
r= -0 .0 4 3
n = 2 7
p = 0 .8 3 3
r= 0 .1 7 9
n = 2 7
p = 0 .3 7 1
r = - 0 .2 0 7
n = 2 7
p = 0 .3 0 1
r= -0 .4 6 1
n = 2 7
p = 0 .0 1 5
T o ta l  p o s it iv e  
m e a n
r= 0 .2 9 2
n = 2 7
p = 0 .1 3 9
r= 0 .3 5 7
n = 2 7
p = 0 .0 6 8
r= -0 .2 5 8  
n = 2 7  
p = 0 .1 94
r= 0 .4 1 0
n = 2 7
p = 0 .0 3 3
r= 0 .0 9 4
n = 2 7
p = 0 .6 4 0
r= 0 .2 1 9
n = 2 7
p = 0 .2 7 2
r= - 0 .1 27
n = 2 7
p = 0 .5 2 7
r= -0 .3 8 2
n = 2 7
p = 0 .0 4 9
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Table 27c. Correlation between♦ Subjective Appetite Scores and Positive Mood
States During the Premenstrual Stages of the Menstrual cycle
A p p e t i te /  
P o s it iv e  M o o d  
S ta te
H u n g e r A p p e t i te S a tia t io n S a tie ty D R  -  f o o d  
ty p e
D R  -
a m o u n t  o f
f o o d
w a n te d
A te  m o re
th a n
w a n te d
C ra v in g s
M e a n  o f  C y c le s  
E la te d
r = 0 .2 8 0
n = 3 2
p = 0 .1 2 1
r= 0 .1 7 4
n = 3 2
p = 0 .3 4 1
r= -0 .1 9 9
n = 3 2
p = 0 .2 7 6
1 = 0 .2 7 9
n = 3 2
p = 0 .1 2 3
r= 0 .5 2 3
n = 3 2
p = 0 .0 0 2
r= 0 .4 0 7
n = 3 2
p = 0 .0 2 1
r= 0 .1 1 5
n = 3 2
p = 0 .5 3 1
r= -0 .3 7 2
n = 3 2
p = 0 .0 3 6
A g re e a b le r= 0 .3 5 6
n = 3 2
p = 0 .0 4 6
r= 0 .2 6 1
n = 3 2
p = 0 .1 5 0
r= -0 .3 1 9  
n = 3 2  
p = 0 .0 7  5
r= 0 .4 2 8  
n = 3 2  
p = 0 .0 1 5
r= 0 .5 4 2
n = 3 2
p = 0 .0 0 1
i= 0 .4 0 3
n = 3 2
p = 0 .0 2 2
r= 0 .1 6 4
n = 3 2
p = 0 .3 6 9
r= -0 .3 2 2
n = 3 2
p = 0 .0 7 2
C o m p o s e d r= 0 .1 2 8
n = 3 2
p = 0 .4 8 6
r= 0 .0 1 9
n = 3 2
p = 0 .9 2 0
r = -0 .0 7 2  
n = 3 2  
p =0.695
r= 0 .1 3 0
n = 3 2
p = 0 .4 7 8
r= 0 .2 6 2
n = 3 2
p = 0 .1 4 7
r= 0 .1 6 0
n = 3 2
p = 0 .3 8 2
r= 0 .1 7 2
n = 3 2
p = 0 .3 4 7
r= -0 .1 3 3  
n = 3 2  ' 
p = 0 .4 6 9
C o n f id e n t r = 0 .1 9 2
n = 3 2
p = 0 .2 9 4
r= 0 .1 2 1
n = 3 2
p = 0 .5 0 9
r = - 0 .1 3 7
n = 3 2
p = 0 .4 5 5
r= 0 .2 8 3
n = 3 2
p = 0 .1 1 7
r= 0 .3 7 7
n = 3 2
p = 0 .0 3 3
r = 0 .1 8 I
n = 3 2
p = 0 .3 2 0
r = 0 .2 2 5
n = 3 2
p = 0 .2 1 5
r= -0 .3 2 2
n = 3 2
p = 0 .0 7 2
T o ta l  p o s it iv e  
m e a n
r = 0 .2 5 7
n = 3 2
p = 0 .1 5 5
r= 0 .1 5 0
n = 3 2
p = 0 .4 1 3
r= -0 .1 6 6
n = 3 2
p = 0 .3 6 3
r= 0 .2 9 4  
n = 3 2  
p = 0 .1 0 3
r= 0 .4 6 2
n = 3 2
p = 0 .0 0 8
r= 0 .3 1 7
n = 3 2
p = 0 .0 7 7
r= 0 .1 6 7
n = 3 2
p = 0 .3 6 1
r= -0 .3 0 5
n = 3 2
p = 0 .0 8 9
C y c le  O n e  
E la te d
r = 0 .2 9 9
n = 3 0
p = 0 .1 0 8
r= 0 .1 9 2
n = 3 0
p = 0 .3 1 0
r= -0 .3 9 1
n = 3 0
p = 0 .0 3 2
r= 0 .2 3 9
n = 3 0
p = 0 .2 0 4
r= 0 .5 3 2
n = 3 0
p = 0 .0 0 3
r= 0 .4 3 3  
n = 3 0  
p = 0 .0 1 7
r= 0 .1 7 9
n = 3 0
p = 0 .3 4 4
r= -0 .4 3 7
n = 3 0
p = 0 .0 1 6
A g re e a b le r= 0 .2 7 7  
n = 3 0  
p = 0 .1 3 9
r = 0 .1 9 6
n = 3 0
p = 0 .3 0 6
r= -0 .4 6 1
n = 3 0
p = 0 .0 1 0*
i= 0 .3 1 0  
n = 3 0  
p = 0 .0 9 6
r= 0 .4 8 5
n = 3 0
p = 0 .0 0 7
r= 0 .3 6 7
n = 3 0
p = 0 .0 4 6
r = 0 .1 2 8
n = 3 0
p = 0 .5 0 0
r= -0 .2 8 0
n = 3 0
p = 0 .1 3 5
C o m p o s e d r= 0 .2 0 3
n = 3 0
p = 0 .2 8 2
r= 0 .1 0 3
n = 3 0
p = 0 .5 8 8
r = -0 .4 3 3  
n = 3 0  
p = 0 .0 1 7
i= 0 .1 8 3
n = 3 0
p = 0 .3 3 2
r = 0 .4 2 9
n = 3 0
p = 0 .0 1 8
r= 0 .3 2 6
n = 3 0
p = 0 .0 7 9
r = 0 .2 1 1
n = 3 0
p = 0 .2 6 4
r= -0 .2 0 1
n = 3 0
p = 0 .2 8 6
C o n f id e n t r= 0 .0 9 8
n = 3 0
p = 0 .6 0 8
r= 0 .0 5 4  
n = 3 0  
p = 0 .7 7  9
r= -0 .1 7 9
n = 3 0
p = 0 .3 4 5
r= 0 .1 8 6
n = 3 0
p = 0 .3 2 4
r= 0 .2 8 2
n = 3 0
p = 0 .1 3 1
r = 0 .2 0 3
n = 3 0
p = 0 .2 8 2
r = 0 .0 6 5
n = 3 0
p = 0 .7 3 5
r= -0 .3 9 3
n = 3 0
p = 0 .0 3 2
T o ta l  p o s it iv e  
m e a n
r = 0 .2 5 6  
n = 3 0  
p = 0 .1 6 9
r= 0 .1 7 4
n = 3 0
p = 0 .3 5 8
r= -0 .3 7 9
n = 3 0
p = 0 .0 3 9
r= 0 .2 7 4
n = 3 0
p = 0 .1 4 3
r= 0 .4 4 7
n = 3 0
p = 0 .0 1 3
r= 0 .3 6 4
n = 3 0
p = 0 .0 4 8
r= 0 .1 4 6
n = 3 0
p = 0 .4 4 2
r= -0 .3 5 7
n = 3 0
p = 0 .0 5 3
C y c le  T w o  
E la te d
r= 0 .3 2 1
n = 2 6
p = 0 .1 1 0
r= 0 .1 8 2
n = 2 6
p = 0 .3 7 2
r= -0 .0 1 9
n = 2 6
p = 0 .9 2 5
r= 0 .2 1 1
n = 2 6
p = 0 .3 0 2
r= 0 .3 6 4
n = 2 6
p = 0 .0 6 7
r= 0 .4 1 2
n = 2 6
p = 0 .0 3 7
r = - 0 .1 6 8
n = 2 6
p = 0 .4 1 3
r= -0 .0 7 2  
n = 2 6  
p = 0 .7 2 7
A g re e a b le r = 0 .1 6 9
n = 2 6
p = 0 .4 0 9
r= 0 .1 0 4  
n = 2 6
p = 0 .6 1 2
r= 0 .0 0 3
n = 2 6
p = 0 .9 8 8
r= 0 .3 2 9
n = 2 6
p = 0 .1 0 1  '
r = 0 .3 7 0
n = 2 6
p = 0 .0 6 3
r= 0 .3 3 5
n = 2 6
p = 0 .0 9 5
r = - 0 .0 1 7
n = 2 6
p = 0 .9 3 5
r= -0 .0 6 8
n = 2 6
p = 0 .7 4 2
C o m p o s e d r= -0 .0 2 3  
n = 2 6  
p = 0 .9 1 1
r= -0 .0 2 5
n = 2 6
p = 0 .9 0 4
r= 0 .0 9 5  
n = 2 6  
p = 0 .6 4 4
r= 0 .1 4 2
n = 2 6
p = 0 .4 9 0
r= 0 .1 7 4
n = 2 6
p = 0 .3 9 6
r= 0 .1 6 9
n = 2 6
p = 0 .4 0 8
r = -0 .1 8 6
n = 2 6
p = 0 .3 6 2
r= 0 .1 3 9
n = 2 6
p = 0 .4 9 9
C o n f id e n t r= - 0 .0 4 2
n = 2 6
p = 0 .8 3 7
r= -0 .0 9 1  
n = 2  6  
p = 0 .6 5 9
r= 0 .0 7 4  
n = 2 6  
p = 0 .7 1 9
1 = 0 .1 9 8
n = 2 6
p = 0 .3 3 2
r= 0 .1 4 2
n = 2 6
p = 0 .4 8 8
r= 0 .1 0 4
n = 2 6
p = 0 .6 1 2
r= 0 .0 0 5
n = 2 6
p = 0 .9 8 1
r= 0 .0 5 6
n = 2 6
p = 0 .7 8 7
T o ta l  p o s it iv e  
m e a n
r = 0 .1 5 2
n = 2 6
p = 0 .4 5 8
r= 0 .0 2 5
n = 2 6
p = 0 .9 0 4
r= 0 .0 6 4  
n = 2  6  
p = 0 .4 5 6
r= 0 .2 2 5
n = 2 6
p = 0 .2 6 9
r= 0 .2 9 3
n = 2 6
p = 0 .1 4 7
r = 0 .3 1 6
n = 2 6
p = 0 .1 1 5
r= -0 .0 8 8
n = 2 6
p = 0 .6 6 8
r= 0 .0 4 5
n = 2 6
p = 0 .8 2 9
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Table 28a. Correlations between Actual Food intake and Negative Mood states
during the Follicular phases of the Menstrual Cycle
Actual food intake/ 
Negative mood states Kcal Protein (g) Fat (g)
Caibohydrat
efe) Stgar(g) Starch(g) TLA
Mean of both cydes 
Depressed
r=0.143
n=32
p=0.436
r=0.076
n=32
p=0.678
r=0.196
rr=32
p=0.284
1=0.034
n=32
p=0.853
r=0.012
n=32
p=0.948
1=0.087
n=32
p=0.636
1=0.060
ir=32
p=0.146
Hostile 1=0.054
n=32
p=0.770
1=0.042
n=32
p=0.820
r=0.035
n=32
p=0.851
1=0.123
n=32
p=0.503
1=0.068
n=32
p=0.714
1=0.124
ir=32
p=0.500
1=0.038
if=32
p=0.838
Anxious r=-0.055 
n=32 
p=0.766
i=-0.076
n=32
p=0.678
1=0.027
n=32
p=0.886
r=0.158
n=32
p=0.389
r=0.078
ir=32
p=0.673
1=0.182
n=32
p=0.319
i=0.133
n=32
p=0.468
Unconfident r=0.061
n=32
p=0.742
1=0.036
n=32
p=0.846
1=0.020
n=32
p=0.914
1=0.104
n=32
p=0.571
r=O.088
n=32
p=0.632
1=0.053
n=32
p=0.772
1=0.156
n=32
p=0.393
Total negative mood r=0.006
n=32
p=0.975
1=0.013
n=32
p=0.944
1=0.072
n=32
p=0.697
r=0.084
n=32
p=0.649
1=0.055
n=32
p=0.766
1=0.058
n=32
p=0.752
r=0.107
ir=32
p=0.559
Cyde One 
depressed
1=0.083
n=30
p=0.664
1=0.052
n=30
p=0.786
i=0.113
n=30
p=0.551
1=0.001
n=30
p=0.995
1=0.033
n=30
p=0.863
1=0.141
ir=30
p=0.457
1=0.098
n=30
p=0.606
Hostile 1=0.166
n=30
p=0.380
r=0.081
n=30
p=0.672
r=0.200
tr=30
p=0.288
1=0.101
n=30
p=0.597
1=0.104
n=30
p=0.586
1=0.008
n=30
p=0.965
r=O.088
n=30
p=0.645
Anxious r=0.195
n=30
p=0.303
r=0.165
n=30
p=0.383
1=0.186
n=30
p=0.326
1=0.178
n=30
p=0.348
r=0.129
n=30
p=0.498
1=0.152
n=30
p=0.422
1=0.169
ri=30
p=0.372
Unconfident 1=0.007
n=30
p=0.970
1=0.030
n=30
p=0.873
1=0.055 
rr=30 
p=0.772
1=0.040
n=30
p=0.835
1=0.056
ii=30
p=O.770
1=0.071
re=30
p=0.711
1=0.027
n=30
p=0.889
Total negative mood i=-0.056
n=30
p=0.770
r=0.052
n=30
p=0.783
1=0.036
n=30
p=0.849
1=0.078
n=30
p=0.681
1=0.081
n=30
p=0.671
1=0.021
ir=30
p=0.912
1=0.102
n=30
p=0.590
Cyde Two 
Depressed
i=-0.]05
n=25
p=0.619
i=O.I43
n=25
p=0.496
1=0.048
n=25
p=0.820
r=0.198
n=25
p=0342
1=0.084
n=25
p=0.691
1=0.248
if=25
p=0.231
1=0.303
n=25
p=0.140
Hostile 1=0.151
n=25
p=0.471
1=0.144
n=25
p=0.491
1=0.168
ir=25
p=0.424
1=0.060
n=25
p=0.777
1=0.115
re=25
p=0.585
1=0.047
n=25
p=0.823
1=0.071
n=25
p=0.734
Anxious r=-0.079
ir=25
p=0.708
1=0.101
n=25
p=0.631
1=0.033
n=25
PfO .877
r=0.272
ir=25
p=0.188
1=0.152
n=25
p=0.469
r=0.328
n=25
p=O.109
1=0.421
n=25
p=0.036*
Unconfident r=-0.315
n=25
p=0.126
r=0.215 
n=25 
p=0.2 99
r=0.242
if=25
p=0.243
1=0330
n=25
p=0.108
1=0.187
n=25
p=0.372
i=0342
n=25
p=0.094
1=0.404
ir=25
p=0.045*
Total negative mood r=-0.103
n=25
p=0.625
1=0.093
n=25
p=0.660
1=0.028
n=25
p=0.894
1=0.252
rt=25
p=0.225
1=0.157
n=25
p=0.453
1=0.283
if=25
p=0.171
1=0.350
n=25
p=k).086
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Table 28b. Correlations between Actual Food intake and Negative Mood states
during the Luteal phases of the Menstrual Cycle
Actual food intake/ 
Negative mood states Kcal Protein (g) Fat (g)
Cafbohydrat
e(g) Sugar (g) Starch (g) TLA
Mean of both cydes 
Depressed
r=0.122
n=32
p=0.506
i=0.091
n=32
p=0.620
1=0.138
n=32
p=0.451
1=0.086
n=32
p=0.639
1=0.132
re=32
p=0.470
1=0.036
ir=32
p=0.844
r=0.013
n=32
p=0.943
Hostile 1=0.109
n=32
p=0.552
1=0.078
n=32
p=0.672
1=0.102
n=32
p=0.578
i=0.101
n=32
p=0.582
1=0.177
n=32
p=0.332
1=0.040
it=32
p=0.826
1=0.104
n=32
p=0.572
Anxious 1=0.038
n=32
p=0.836
1=0.094
n=32
p=0.608
1=0.012
ir=32
p=0.947
1=0.011
n=32
'p=0.951
1=0.115
n=32
p=0.532
1=0.085
n=32
p=0.645
1=0.044
n=32
p=0.811
Unconfident 1=0.095
if=32
p=0.606
1=0.060
n=32
p=0.746
1=0.066
n=32
p=0.718
i=0.091
i i =32
p=0.621
1=0.121
n=32
p=0.509
1=0.069 
rt=32 
p=0.709
1=0.149
n=32
p=0.415
Total negative mood r=0.116
j f =32
p=0.528
r=0.115
n=32
p=0.530
1=0.102
rf=32
p=0.580
1=0.086
n=32
p=0.640
1=0.149
n=32
p=0.417
1=0.024
i i =32
p=0.896
1=0.083
n=32
p=0.653
Cyde One 
depressed
1=0.200
n=29
p=0.298
r=0.133
n=29
p=0.492
1=0.204
n=29
p=0.289
1=0.164
h =29
p=0395
1=0.248
n=29
p=0.195
1=0.042
n=29
p=0.827
1=0.142
n=29
p=0.463
Hostile 1=0.009
n=29
p=0.964
i=-0.070
n=29
p=0.720
1=0.001 
• n=29 
p=0.997
1=0.022
n=29
p=0.909
1=0.143
n=29
p=0.461
1=0.101
n=29
p=0.604
1=0.206
11=29
p=0.285
Anxious 1=0.085
n=29
p=0.662
1=0.127
n=29
p=0.512
1=0.055
n=29
p=0.778
1=0.022
n=29
p=0.910
1=0.163
n=29
p=0.399
1=0.149
n=29
p=0.440
1=0.246
r r f9
p=0.198
Unconfident r=0.196
n=29
p=0.309
1=0.083
ir=29
p=0.668
1=0.209
n=29
p=0.278
1=0.157
n=29
p=0.416
1=0.108
n=29
p=0.579
1=0.189
n=29
p=0.326
1=0.011
n=29
p=0.955
Total negative mood 1=0.168
n=29
p=0.384
1=0.125
n=29
p=0.517
1=0.158
n=29
p=0.413
1=0.112
n=29
p=0.562
1=0.210
n=29
p=0.274
1=0.023
ir=29
p=0.907
1=0.225
n=29
p=0.242
Cyde Two 
Depressed
r=-0.105
n=25
p=0.619
r=-0.056
re=27
p=0.780
r=0.064
n=27
p=0.753
1=0.097
n=27
p=0.632
i=0.221
n=27
p=0.267
1=0.027
n=29
p=0.897
r=-0.046
n=27
p=0.820
Hostile i=0.151
n=25
p=0.471
1=0.102
n=27
p=0.614
1=0.171
n=27
p=0.395
1=0.010
n=27
p=0.959
1=0.065
rt=27
p=0.746
1=0.086
rt=27
p=0.668
i=0.115
n=27
p=0.568
Anxious 1=0.079
n=25
p=0.708
r=0.098
n=27
p=0.626
1=0.069
n=27
p=0.732
r=0.055
i f =27
p=0.785
1=0.143
re=27
p=0.477
1=0.038 
n=27 
p=0.852
1=0.094
n=27
p=0.641
Unconfident r=-0.315
n=25
p=0.126
1=0.058
ir=27
p=0.775
i=0.012
n=27
p=0.953
1=0.060 '
n=27
p=0.765
1=0.107
n=27
p=0.594
1=0.012
11=27
p=0.954
r=0.328
rt=27
p=0.095
Total negative mood i=-0.103
n=25
p=0.625
1=0.035
n=27
p=0.864
1=0.074
n=27
p=0.712
1=0.057
n=27
p=0.778
1=0.148
n=27
p=0.463
r=0.042
n=27
p=0.837
1=0.021
n=27
p=0.916
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Table 28c. Correlations between Actual Food intake and Negative Mood states
during the Premenstrual phases of the Menstrual Cycle
Actual food intake/ 
Negative mood states Kcal Protein (g) Fat (g)
Carbohydrat
e(g) Sugar (g) Starch (g) TLA
Mean of both cydes 
Depressed
r=0.168
n=32
p=0359
1=0.107
n=32
p=0.558
1=0.272
n=32
p=0.132
1=0.033
n=32
p=0.856
1=0.091
15=32
p=0.621
1=0.164
n=32
p=0.371
1=0.252
n=32
p=0.164
Hostile 1=0.071
n=32
p=0.701
1=0.198
n=32
p=0.277
1=0.132
n=32
p=0.471
1=0.072
n=32
p=0.695
1=0.007
n=32
p=0.969
r=0.188
it=32
p=0.304
1=0.116
n=32
p=0.526
Anxious i=-0.013
n=32
p=0.945
1=0.294
ii=32
p=0.102
r=0.120
n=32
p=0.515
r=0.097
it=32
p=0.599
1=0.156
n=32
p=0.393
1=0.016
if=32
p=0.931
1=0.194
n=32
p=0.288
Unconfident 1=0.122
n=32
p=0.505
1=0.030
ir=32
p=0.871
r=0.113
15=32
p=0.538
1=0.080
n=32
p=0.662
1=0.048
15=32
p=0.796
1=0.111
15=32
p=0.546
1=0.485
n=32
p=0.005**
Total negative mood 1=0.094
n=32
p=0.610
1=0.174
n=32
p=0.341
r=0.175
n=32
p=0339
r=0.019
re=32
p=0.918
1=0.062
15=32
p=0.738
1=0.125
15=32
p=0.495
r=0.291
nf=32
p=0.106
Cyde One 
depressed
1=0.162
n=30
p=0.392
1=0.009
n=30
p=0.961
1=0.279
n=30
p=0.135
1=0.0156
15=30
p=0.935
1=0.091
15=30
p=0.632
1=0.072
n=30
p=0.705
1=0.441
15=30
p=O.015*
Hostile 1=0.018
n=30
p=0.927
1=0.204
n=30
p=0.279
1=0.120
n=30
p=0.526
1=0.019
15=30
p=0.920
1=0.109
15=30
p=0.567
r=0.073
ii=30
p=0.702
r=0.243
ir=30
p=0.196
Anxious r=0.090
n=30
pf=0.636
1=0.214
n=30
p=0.257
1=0.050
15=30
p=0.794
1=0.204
15=30
p=0.281
1=0.237
n=30
p=0.208
1=0.092
15=30
p=0.628
r=OJ62
15=30
p=0.050*
Unconfident 1=0.120
n=30
p=0.527
r=0.106
n=30
p=0.576
1=0.200
15=30
p=0291
1=0.038
15=30
p=0.840
1=0.018
15=30
p=0.926
r=0.027
it=30
p=0.888
1=0.441
15=30
p=0.015*
Total negative mood r=0.053
n=30
p=0.783
r=0.092
ii=30
p=0.627
1=0.176
15=30
p=0.353
1=0.085
n=30
p=0.656
1=0.133
is=30
p=0.483
1=0.001
n=30
p=0.995
1=0,413
n=30
p=0.023*
Cyde Two 
Depressed
1=0.129
if=25
p=0.539
1=0.051
15=25
p=0.810
1=0.000
n=25
p=0.998
1=0.188
n=25
p=0367
1=0.366
n=25
p=0.072
1=0.030
15=25
p=0.889
1=0.052
15=25
p=0.803
Hostile 1=0.195
15=25
p=0.349
1=0.003
15=25
p=0.987
1=0.184
n=25
p=0.380
1=0.108
n=25
p=0.609
1=0.164
15=25
p=0.434
1=0.085
re=25
p=0.687
1=0.036
n=25
p=0.866
Anxious r=0.228
n=25
p=0.273
1=0.090
15=25
p=0.667
1=0.174
ii=25
p=0.405
1=0.152
n=25
p=0.468
1=0.187
15=25
p=0.370
1=0.049
n=25
p=0.815
1=0.043
ir=25
p=0.837
Unconfident 1=0.012
n=25
p=0.954
r=0.0I8
15=25
p=0.931
1=0.045
n=25
p=0.831
r=0.063 .
n=25
p=0.764
1=0.031
n=25
p=0.884
1=0.193
«=25
p=0.355
1=0.329
15=25
p=0.109
Total negative mood 1=0.146
rt=25
p=0.486
r=0.047
it=25
p=0.823
r=0.111
15=25
p=0.598
1=0.102
n=25
p=0.629
1=0.199
n=25
p=0340
1=0.101
15=25
p=0.632
1=0.109
n=25
p=0.605
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Table 29a. Correlations between perecentase food intake and Negative Mood States
During the Follicular Stases of the Menstrual cycle
Percentage food intake/ 
Negative mood states
% Fat % Protein % CHO % Sugar % Starch
Mean of both cydes 
Depressed
1=0.118
ir=32
p=0.521
r=0.113
n=32
p=0.537
r=0.068
n=32
p=0.712
1=0.103
n=32
p=0.576
r=0.034
n=32
p=0.856
Hostile r=-0.000
n=32
p=0.998
1=0.015
rr=32
p=0.937
1=0.073
n=32
p=0.693
1=0.072
n=32
p=0.696
1=0.006
ir=32
p=0.975
Anxious 1=0.089
n=32
p=0.629
r=0.051 
n=32 
p=0.781
r=0.152
n=32
p=0.406
1=0.058
n=32
p=0.754
r=0.131
n=32
,p=0.477
Unconfident 1=0.051
n=32
p=0.781
r=0.004
n=32
p=0.985
r=0.003
n=32
p=0.986
1=0.031
n=32
p=0.866
1=0.073
n=32
p=0.690
Total negative mood 1=0.078
re=32
p=0.673
r=0.048
n=32
p=0.795
1=0.076
rt=32
p=0.679
1=0.073
n=32
p=0.693
1=0.003
n=32
p=0.985
Cyde One 
depressed
i=-0.008
n=30
p=0.968
r=0.058
n=30
p=0.761
1=0.027
ir=30
p=0.887
r=0.073
n=30
p=0.700
f =0.180
n=30
p=0.341
Hostile
g 
8
■
o
''!
I
l
l
1=0.066
n=30
p=0.731
r=0.178 
n=3 0 
p=0.347
r=0.020
n=30
p=0.917
1=0.320
if=30
p=0.085
Anxious i=-0.121
n=30
p=0.525
r=0.012
n=30
p=0.950
r=0.032
rr=30
p=0.867
1=0.011
n=30
p=0.956
1=0.127
n=30
p=0.504
Unconfident r=0.008
n=30
p=0.967
r=0.079 
n=30
p=0.680
r=0.054
n=30
p=0.778
1=0.052
n=30
p=0.783
1=0.187
n=30
p=0.323
Total negative mood 1=0.072
ir=30
p=0.704
1=0.032
n=30
p=0.867
r=0.065
n=30
p=0.734
r=0.045
n=30
p=0.814
1=0.203
n=30
p=0.281
Cyde Two 
Depressed
1=0.077
n=25
p=0.716
r=0.023
ir=25
p=0.912
r=0.134
n=25
p=0.525
i=0.171
n=25
p=0.414
1=0.074
n=25
p=0.724
Hostile 1=0.158
n=25
p=0.450
1=0.019
rr=25
p=0.930
r=0.282
n=25
p=O.I72
1=0.346
n=25
p=0.091
r=0.157
n=25
p=0.455
Anxious 1=0.191
n=25
p=0.361
1=0.039
n=25
p=0.852
t=0.282
n=25
p=.0.173
1=0.263
n=25
p=0.203
1=0.227 
n=25 
p=0.276
Unconfident 1=0.019
n=25
p=0.927
1=0.146 
n—25 
p=0.485
i=0.0U 
n=25 
p=0.959
r=0.059 
n=25 
p=0.779
1=0.057
n=26
p=0.785
Total negative mood 1=0.118
n=25
p=0.576
1=0.031
n=25
p=0.881
1=0.199
n=25
p=0.340
1=0.245
n=25
p=0.239
1=0.115
n=25
p=0.584
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Table 29b. Correlations between percentage food intake and Negative Mood States
During the Luteal Stages of the Menstrual cycle
Percentage food intake/ 
Negative mood states
% Fat % Protein % CHO % Sugar % Starch
Mean of both cycles 
Depressed
r=0.007
n=32
p=0.968
r=-0.038
n=32
p=0.835
r=0.068
n=32
p=0.710
t=0.079 
n=32
p=0.666
1=0.051
rr=32
p=0.783
Hostile r=-0.033
n=32
p=0.858
r=-0.044
n=32
p=0.813
r=0.107
n=32
p=0.558
i=0.183
n=32
p=0317
1=0.050
n=32
p=0.786
Anxious r=-0.183
n=32
p=0.317
r=0.130
n=32
p=0.480
1=0.078
n=32
p=0.673
1=0.067
n=32
p=0.715
1=0.056
ir=32
p=0.761
Unconfident r=-0.093
n=32
p=0.612
r=-0.049
n=32
p=0.79I
i=0.10I
n=32
p=0.581
1=0.166
n=32
p=0.363
r=0.039
rr=32
p=0.834
Total negative mood r=-0.091
n=32
p=0.622
1=0.020
n=32
p=0.915
1=0.092
n=32
p=0.616
1=0.098
n=32
p=0.593
r=0.075
n=32
p=0.685
Cyde One 
depressed
r=-0.0U
n=29
p=0.954
1=0.086
re=29
p=0.659
r=0.082
n=29
p=0.674
1=0.219
n=29
p=0.253
1=0.093
n=29
p=0.630
Hostile r=-0.034
n=29
p=0.861
1=0.111
n=29
p=0.567
t=0.111
n=29
p=0_568
1=0.380
n=29
p=0.042*
1=0.103
re=29
p=0.595
Anxious 1=0.178
n=29
p=0.357
i=0.126
n=29
p=0J14
1=0.045
n=29
p=0.817
r=0.246
n=29
p=0.198
i=0.187
n=29
p=0.330
Unconfident 1=0.038
n=29
p=0.843
r=0.168
n=29
p=0.385
1=0.043
n=29
p=0.826
1=0.046
n=29
p=0.815
1=0.065
if =29
p=0.739
Total negative mood 1=0.072
n=29
p=0.711
r=0.032
n=29
p=0.870
1=0.057
n=29
p=0.770
1=0.222
n=29
p=0.246
1=0.129
n=29
p=0.505
Cyde Two 
Depressed
r=0.110
n=27
p=0.584
1=0.002
n=27
p=0.993
r=0.040
n=27
p=0.843
1=0.109
rr=27
p=0.587
1=0.068
n=27
p=0.736
Hostile 1=0.106
n=27
p=0.600
r=0.034
n=27
p=0.8 68
r=0.069
n=27
p=0.734
i=0.12I
n=27
pf=0.549
tu
Anxious i=0.061
rr=27
p=0.761
r=0.129
n=27
p=0.521
1=0.018
n=27
p=0.929
1=0.068
n=27
p=0.734
1=0.127
n=27
p=0.528
Unconfident r=0.017
n=27
p=0.933
r=0.021
if=27
p=0.916
r=0.069
n=27
p=0.731
r=0:030 
n=27
p=0.882
1=0.115
ir=27
p=0.568
Total negative mood r=0.078
re=27
p=0.698
r=0.021
n=27
p=0.916
1=0.004
n=27
p=0.983
r=0.071
n=27
p=0.725
r=0.101
n=27
p=0.617
134
Table 29c. Correlations between percentage food intake arid Negative Mood States
During the Premenstrual Stages of the Menstrual cycle
Percentage food intake/ 
Negative mood states
% Fat % Protein % CHO % Sugar % Starch
Mean of both cydes 
Depressed
r=0.22 6
n=32
p=0.214
1=0.081
n=32
p=0.660
r=0.221
n=32
p=0.224
1=0.261
is=32
p=0.149
1=0.016
15=32
p=0.930
Hostile i=0.127
rt=32
p=0.490
1=0.101
n=32
p=0.584
r=0.003
n=32
p=0.987
1=0.047
n=32
p=0.799
r=0.090
15=32
p=0.626
Anxious 1=0.219
n=32
p=0.228
r=0.129
n=32
pf=0.480
r=0.164
n=32
p=0.371
1=0.240
15=32
p=0.185
1=0.064
n=32
p=0.730
Unconfident r=-0.028
n=32
p=0.879
r=0.030
n=32
p=0.873
1=0.031
n=32
p=0.867
1=0.058
15=32
jfO.751
1=0.017
n=32
p=0.926
Total negative mood 1=0.152
n=32
p=O.407
1=0.077
n=32
p=0.675
1=0.120
n=32
p=0.515
r=0.173
n=32
p=0.343
1=0.040
15=32
p=0.826
Cyde One 
depressed
1=0.231
re=30
p=0.219
r=0.204
np30
p=0.280
1=0.232
n=30
p=0.218
1=0.151
15=30
p=0.427
1=0.110
n=30
p=0.564
Hostile 1=0.161
n=30
p=0.396
i=0.257
n=30
p=0.171
1=0.028
n=30
p=0.885
1=0.019
n=30
p=0.919
i=0.003
15=30
p=0.989
Anxious 1=0.182
n=30
p=0337
1=0.155
n=30
p=0.415
1=0.212
n=30
p=0.261
1=0.179
«=30
p=0.344
1=0.027
15=30
p=0.886
Unconfident r=0.154
n=30
p=0.415
1=0.046
15=30
p=0.811
1=0.211
n=30
p=0.264
r=0.140
15=30
p=0.461
r=0.085
15=30
p=0.657
Total negative mood t=0.203
ir=30
p=0.283
1=0.180
n=30
p=0.340
r=0.196
n=30
p=0.299
1=0.142
15=30
p=0.455
1=0.062
n=30
p=0.746
Cyde Two 
Depressed
1=0.101
n=25
p=0.633
r=0.233
n=25
p=0.262
1=0.113
n=25
p=0.592
1=0.456
n=25
p=0.022*
1=0.199
n=25
p=0.341
Hostile r=-0.102
n=25
p=0.627
i=0376
n=25
p=0.064
1=0.097
n=25
p=0.644
r=0.143
n=25
p=0.495
1=0303
n=25
p=0.142
Anxious r=-0.065
n=25
p=0.757
1=0.292
n=25
p=0.157
1=0.070
re=25
p=0.739
1=0.154
n=25
p=0.462
1=0.288
n=25
p=0.163
Unconfident r=-0.149
n=25
p=0.478
r=0.303
n=25
p=0.141
1=0.079
n=25
p=0.706
r=0.114
n=25
p=0.588
1=0.203
n=25
p=0.331
Total negative mood r=0.064
rr=25
p=0.763
r=0.329
n=25
p=O.109
1=0.040
n=25
p=0.850
1=0.231
if=25
p=0.26 6
1=0.272
n=25
p=0.188
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Table 30a. Correlaions betwwen Negative Mood States and Subjective Appetite
Rating During the Follicular Stages of the Menstrual Cycle
A p p e t i te /  
N e g a tiv e  M o o d  
S ta te
H u n g e r A p p e t i te S a tia t io n S a tie ty D R  -  f o o d  
ty p e
D R -
a m o u n t  o f
fo o d
w a n te d
A te  m o re
th a n
w a n te d
C ra v in g s
M e a n  o f  C y c le s  
D e p re s s e d r= 0 .2 3 6
n = 3 2
p = 0 .1 9 4
r= 0 .0 0 5
n = 3 2
p = 0 .9 7 8
r= 0 .1 2 8
n = 3 2
p = 0 .4 8 7
r= -0 .0 8 8
n = 3 2
p = 0 .6 3 4
r= -0 .0 5 4
n = 3 2
p = 0 .7 6 7
r= 0 .2 5 5  
n = 3 2  
p = 0 .1 5 9
r = 0 .2 4 3
n = 3 2
p = 0 .1 8 0
r = 0 .0 8 6
n = 3 2
p = 0 .6 4 1
H o s ti le r = 0 . l5 3
n = 3 2
p = 0 .4 0 4
r = 0 .0 2 8
n = 3 2
p = 0 .8 8 0
r= 0 .1 9 8
n = 3 2
p = 0 .2 7 7
i= -0 .1 0 9
n = 3 2
p = 0 .5 5 1
r = 0 .1 2 2
n = 3 2
p = 0 .5 0 6
r = 0 .2 5 2
n = 3 2
p = 0 .1 6 4
r = -0 .0 3 3
n = 3 2
p = 0 .8 5 8
r= -0 .0 7 0
n = 3 2
p = 0 .7 1 6
A n x ie o u s r= 0 .1 7 9
n = 3 2
p = 0 .9 2 3
r= -0 .0 7 2
n = 3 2
p = 0 .6 9 7
r = 0 .3 3 9
n = 3 2
p = 0 .0 5 8
r= -0 .2 0 0
n = 3 2
p = 0 .2 7 2
r= -0 .2 2 0
n = 3 2
p = 0 .2 2 5
r= 0 .0 3 2
n = 3 2
p = 0 .8 6 3
i= 0 .1 4 5
n = 3 2
p = 0 .4 2 7
r= 0 ,0 2 2
n = 3 2
p = 0 .9 0 4
U n c o n f id e n t r= 0 .1 1 3
n = 3 2
p = 0 .5 3 9
r= -0 .0 9 4
n = 3 2
p = 0 .6 0 8
r= 0 .0 4 0
n = 3 2
p = 0 .8 2 7
r= -0 .0 5 9
n = 3 2
p = 0 .7 4 8
r = -0 .0 1 0
n = 3 2
p = 0 .9 5 6
r= 0 .1 1 5
n = 3 2
p = 0 .5 3 2
r= - 0 .0 1 9
n = 3 2
p = 0 .9 1 8
r = -0 .0 2 0
n = 3 2
p = 0 .9 1 3
T o ta l  n e g a tiv e  
m e a n
r= 0 .1 5 2
n = 3 2
p = 0 .4 0 7
r= -0 .0 4 9
n = 3 2
p = 0 .7 9 1
1 = 0 .1 5 5
n = 3 2
p = 0 .3 9 7
r= -0 .0 9 6
n = 3 2
p = 0 .6 0 2
r= -0 .0 7 I
n = 3 2
p = 0 .6 9 8
r= 0 .1 6 8
n = 3 2
p = 0 .3 5 8
r= 0 .1 0 9
n = 3 2
p = 0 .5 5 4
r = - 0 .0 1 3
n = 3 2
p = 0 .9 4 2
C y c le  O n e  
D e p re s s e d r= 0 .2 0 7
n = 3 0
p = 0 .2 7 4
r= 0 .2 4 3
n = 3 0
p = 0 .1 9 6
r= -0 .2 0 1
n = 3 0
p = 0 .2 8 8
r= 0 .1 4 7
n = 3 0
p = 0 .4 3 9
1 = 0 .1 67
n = 3 0
p = 0 .3 7 8
1=0.261
n = 3 0
p = 0 .1 5 4
r= 0 .3 9 6
n = 3 0
p = 0 .0 3 0
i= -0 .0 6 1
n = 3 0
p = 0 .7 4 9
H o s ti le r= 0 .0 8 7
n = 3 0
p = 0 .6 4 7
1= 0 .2 1 1
n = 3 0
p = 0 .2 6 2
r= 0 .1 1 3  
n = 3 0  
p = 0 .5 5 3
r= -0 .0 7 8
n = 3 0
p = 0 .6 8 4
r= 0 .0 4 2
n = 3 0
p = 0 .8 2 7
r= 0 .0 4 2
n = 3 0
p = 0 .8 2 6
1=0.096 
n = 3  0  
p = 0 .6 1 4
r= 0 .0 6 4
n = 3 0
p = 0 .7 3 8
A n x ie o u s r= 0 .0 9 4
n = 3 0
p = 0 .6 2 0
r = 0 .0 3 3
n = 3 0
p = 0 .8 6 4
r= 0 .1 6 6
n = 3 0
p = 0 .3 8 2
r= -0 .1 3 1
n = 3 0
p = 0 .4 9 2
i= -0 .0 8 3
n = 3 0
p = 0 .6 6 2
r= 0 .0 1 5
n = 3 0
p = 0 .9 4 0
r= 0 .1 0 0
n = 3 0
p = 0 .5 9 7
1=0.019 
n = 3  0  
p = 0 .6 7 8
U n c o n f id e n t r= 0 .1 1 2
n = 3 0
p = 0 .5 5 4
1 = 0 .0 2 7
n = 3 0
p = 0 .8 8 9
r= -0 .0 7 5
n = 3 0
p = 0 .9 6 5
r= 0 .0 3 2
n = 3 0
p = 0 .8 6 8
r= 0 .0 7 2
n = 3 0
p = 0 .7 0 4
i= 0 .1 2 5  
n = 3 0  
p = 0 .5 1 1
r= 0 .1 3 1
n = 3 0
p = 0 .4 9 1
r = 0 .0 4 6
n = 3 0
p = 0 .8 0 8
T o ta l  n e g a tiv e  
m e a n
r= 0 .1 4 6  
n = 3 0  
p = 0 .4 4 3
r= 0 .1 3 1
n = 3 0
p = 0 .4 9 0
r= -0 .0 7 0
n = 3 0
p = 0 .7 1 3
r= 0 .0 4 9
n = 3 0
p = 0 .7 9 5
r= -0 .0 2 6
n = 3 0
p = 0 .8 9 2
r= 0 .0 6 1
n = 3 0
p = 0 .7 4 9
r = 0 .2 0 0
n = 3 0
p = 0 .2 9 0
r = 0 .0 2 0
n = 3 0
p = 0 .9 1 9
C y c le  T w o  
D e p re s s e d
r = -0 .1 87
n = 2 5
p = 0 .3 7 0
r= -0 .2 8 2
n = 2 5
p = 0 .1 7 1
r= 0 .3 9 1
n = 2 5
p = 0 .0 5 3
r= -0 .3 6 3
n = 2 5
p = 0 .0 7 4
r= -0 .4 4 7
n = 2 5
p = 0 .0 2 5
r= -0 .3 1 5
n = 2 5
p = 0 .1 2 5
r= -0 .1 0 8
n = 2 5
p = 0 .6 0 7
1=0.201 
n=2 5  
p = 0 .3 2 1
H o s ti le i= -0 .3 2 4
n = 2 5
p = 0 .1 1 5
r= -0 .3 4 6
n = 2 5
p = 0 .0 9 0
r= 0 .3 6 1
n = 2 5
p = 0 .0 7 6
r= -0 .2 2 4
n = 2 5
p = 0 .2 8 2
r= -0 .0 7 8
n = 2 5
p = 0 .7 1 4
r= 0 .0 1 2
n = 2 5
p = 0 .9 5 4
r= -0 .2 4 6
n = 2 5
p = 0 .2 3 7
r= -0 .0 6 9
n = 2 5
p = 0 .7 4 4
A n x ie o u s r= -0 .2 0 2
n = 2 5
p = 0 .3 3 2
r= -0 .3 3 5
n = 2 5
p = 0 .1 0 1
r= 0 .4 9 4
n = 2 5
p = 0 .0 1 2
r= -0 .4 2 1
n = 2 5
p = 0 .0 3 6
r= -0 .6 2 7
n = 2 5
p = 0 .0 0 1
r= -0 .5 3 2
n = 2 5
p = 0 .0 0 6
r= -0 .1 7 8
n = 2 5
p = 0 .3 9 6
r= 0 .2 5 4
n = 2 5
p = 0 .2 2 0
U n c o n f id e n t r= -0 .1 5 9
n = 2 5
p = 0 .4 4 7
r= -0 .2 1 4
n = 2 5
p = 0 .3 0 3
r= 0 .1 9 8
n = 2 5
p = 0 .3 4 3
r= -0 .1 8 2
n = 2 5
p = 0 .3 8 3
r= -0 .2 6 0
n = 2 5
p = 0 .2 0 9
r= -0 .2 8 5
n = 2 5
p = 0 .1 6 8
r= -0 .0 9 1
n = 2 5
p = 0 .6 6 7
r = - 0 .0 1 1
n = 2 5
p = 0 .9 6 0
T o ta l  n e g a tiv e  
m e a n
r= -0 .2 8 8
n = 2 5
p = 0 .1 6 3
r= -0 .3 3 6
n = 2 5
p = 0 .1 0 1
r= 0 .4 5 8
n = 2 5
p = 0 .0 2 1
r= -0 .3 7 1
n = 2 5
p = 0 .0 6 8
r= -0 .4 3 2
n = 2 5
p = 0 .0 3 1
r= -0 .3 2 4  
n = 2 5  
p = 0 .1 15
r= -0 .2 6 2
n = 2 5
p = 0 .2 0 5
r = 0 .0 7 9
n = 2 5
p = 0 .7 0 8
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Table 30b. Correlaions betwwen Negative Mood States and Subjective Appetite
Rating During the Luteal Stages of the Menstrual Cycle
A p p e t i te /  
N e g a t iv e  M o o d  
S ta te
H u n g e r A p p e t i te S a tia t io n S a tie ty D R  -  f o o d  
ty p e
D R  -
a m o u n t  o f
f o o d
w a n te d
A te  m o re
th a n
w a n te d
C ra v in g s
M e a n  o f  C y c le s  
D e p re s s e d
r= 0 .0 4 3
n = 3 2
p = 0 .8 1 5
r0 = 0 .0 3 7
n = 3 2
p = 0 .8 4 2
r = 0 .1 6 9
n = 3 2
p = 0 .3 5 4
r= -0 .1 5 1
n = 3 2
p = 0 .4 0 8
r = -0 .2 0 9
n = 3 2
p = 0 .2 5 1
r = -0 .1 8 2
n = 3 2
p = 0 .3 1 9
r= 0 .1 9 1
n = 3 2
p = 0 .2 9 6
1 = 0 .0 4 4
n = 3 2
p = 0 .8 1 2
H o s ti le i= 0 .1 0 1
n = 3 2
p = 0 .5 8 3
r= 0 .0 3 4
n = 3 2
p = 0 .8 5 5
r= 0 .2 0 2
n = 3 2
p = 0 .2 6 8
r = -0 .1 8 6
n = 3 2
p = 0 .3 0 8
r= 0 .0 1 7
n = 3 2
p = 0 .9 2 7
i= -0 .0 6 6
n = 3 2
p = 0 .7 1 9
r= 0 .1 4 2
n = 3 2
p = 0 .4 3 9
i= -0 .1 9 1
n = 3 2
p = 0 .2 9 6
A n x ie o u s r= 0 .0 4 7
n = 3 2
p = 0 .7 9 9
r= 0 .0 2 6  
n = 3 2  
p = 0 .8 8 9
r= 0 .1 5 0
n = 3 2
p = 0 .4 1 2
r= -0 .1 8 4
n = 3 2
p = 0 .3 1 5
r = 0 .0 2 4
n = 3 2
p = 0 .8 9 7
r= -0 .1 1 2
n = 3 2
p = 0 .5 4 2
r = 0 .1 7 3
n = 3 2
p = 0 .3 4 4
r = 0 .0 5 2
n = 3 2
p = 0 .7 7 6
U n c o n f id e n t r = -0 .0 4 8
n = 3 2
p = 0 .7 9 6
r= -0 .0 7 1
n = 3 2
p = 0 .6 9 9
r = 0 .1 9 9
n = 3 2
p = 0 .2 7 4
r= -0 .0 6 3
n = 3 2
p = 0 .7 3 3
r= -0 .2 1 2
n = 3 2
p = 0 .2 4 4
r= -0 .1 3 1
n = 3 2
p = 0 .4 7 4
r = 0 .0 1 8
n = 3 2
p = 0 .9 2 1
r = 0 .0 6 9  
n = 3 2  
p = 0 .7  0 9
T o ta l  n e g a tiv e  
m e a n
r= 0 .0 9 0
n = 3 2
p = 0 .6 2 3
r= 0 .0 3 9
n = 3 2
p = 0 .8 3 3
r= 0 .1 9 3
n = 3 2
p = 0 .2 9 0
r= -0 .1 1 0
n = 3 2
p = 0 .5 5 1
r= -0 .0 5 2  
n = 3 2  
p = 0 .7 7  9
r= -0 .0 6 1
n = 3 2
p = 0 .7 4 2
r= 0 .1 7 9
n = 3 2
p = 0 .3 2 8
r= 0 .0 9 1
n = 3 2
p = 0 .6 2 0
C y c le  O n e  
D e p re s s e d
r= -0 .2 2  9
n = 2 9
p = 0 .2 3 2
r= 0 .1 8 9
n = 2 9
p = 0 .3 2 5
i= - 0 .0 6 9
n = 2 9
p = 0 .7 2 4
r= -0 .0 2 0
n = 2 9
p = 0 .9 2 0
i= -0 .0 0 5
n = 2 9
p = 0 .9 8 0
r= -0 .0 4 2
n = 2 9
p = 0 .8 3 0
r = 0 .1 7 8
n = 2 9
p = 0 .3 5 6
r= -0 .0 0 3
n = 2 9
p = 0 .9 8 7
H o s ti le r= 0 .1 8 6
n = 2 9
p = 0 .3 3 3
r= 0 .0 4 4
n = 2 9
p = 0 .8 2 2
r= 0 .0 9 3
n = 2 9
p = 0 .6 3 1
r= -0 .1 2 5  
n = 2  9  
p = 0 .5 1 9
r= 0 .1 8 5
n = 2 9
p = 0 .3 3 8
r= 0 .0 6 0
n = 2 9
p = 0 .7 5 7
r= 0 .0 3 1
n = 2 9
p = 0 .8 7 2
r= -0 .2 8 2
n = 2 9
p = 0 .1 3 8
A n x ie o u s r= 0 .2 4 9  
n = 2 9  
p = 0 .1 9 3
r= 0 .2 0 9
n = 2 9
p = 0 .2 7 6
r= -0 .2 2 4
n = 2 9
p = 0 .2 4 3
r = 0 .0 4 0
n = 2 9
p = 0 .8 3 7
i= 0 .1 5 2
n = 2 9
p = 0 .4 3 2
r= -0 .0 0 1
n = 2 9
p = 0 .9 9 8
r= 0 .1 3 3
n = 2 9
p = 0 .4 9 2
r = 0 .0 4 5
n = 2 9
p = 0 .9 0 3
U n c o n f id e n t r = 0 .1 1 6
n = 2 9
p = 0 .1 9 3
r= 0 .0 4 6
n = 2 9
p = 0 .8 1 4
r= 0 .0 5 1  
n = 2  9  
p = 0 .7 9 2
r= 0 .1 0 8
n = 2 9
p = 0 .5 7 7
r= -0 .0 5 0
n = 2 9
p = 0 .7 9 6
r= - 0 .0 2 6
n = 2 9
p = 0 .8 9 5
r = -0 .0 8 6
n = 2 9
p = 0 .6 5 8
r = 0 .0 2 4
n = 2 9
p = 0 .9 0 3
T o ta l  n e g a t iv e  
m e a n
r= 0 .2 4 9  
n = 2 9  
p = 0 .1 9 3
r= 0 .1 4 5
n = 2 9
p = 0 .4 5 3
r= -0 .1 0 5
n = 2 9
p = 0 .5 8 6
r= 0 .0 3 3
n = 2 9
p = 0 .8 6 4
r = 0 .1 2 5
n = 2 9
p = 0 .5 2 0
i= 0 .0 2 3
n = 2 9
p = 0 .9 0 7
r= 0 .1 4 6
n = 2 9
p = 0 .4 4 9
1 = 0 .0 7 0
n = 2 9
p = 0 .7 1 7
C y c le  T w o  
D e p re s s e d
r= -0 .0 5 4
n = 2 7
p = 0 .7 8 8
r= -0 .0 5 7
n = 2 7
p = 0 .7 7 8
r= 0 .2 4 4
n = 2 7
p = 0 .2 2 0
r= -0 .2 9 4
n = 2 7
p = 0 .1 3 6
r = -0 .2 6 5
n = 2 7
p = 0 .1 8 1
i= -0 .3 2 3
n = 2 7
p = 0 .1 0 0
r= 0 .0 5 6
n = 2 7
p = 0 .7 8 3
r= 0 .2 1 8
n = 2 7
p = 0 .2 7 6
H o s ti le r= 0 .1 0 7
n = 2 7
p = 0 .5 9 4
r= 0 .1 1 0
n = 2 7
p = 0 .5 8 4
r = 0 .1 15
n = 2 7
p = 0 .5 6 9
r = -0 .1 9 4
n = 2 7
p = 0 .3 3 1
r= -0 .2 5 1
n = 2 7
p = 0 .2 0 7
r= -0 .2 8 2  
n = 2 7  
p = 0 .1 5 3
r= 0 .0 3 1
n = 2 7
p = 0 .8 7 8
r= 0 .1 5 3
n = 2 7
p = 0 .4 4 5
A n x io u s r= -0 .1 3 1
n = 2 7
p = 0 .5 1 6
r = - 0 .1 11
n = 2 7
p = 0 .5 8 1
r= 0 .3 1 3
n = 2 7
p = 0 .1 1 2
r= -0 .3 4 8
n = 2 7
p = 0 .0 7 6
r = -0 .2 1 3
n = 2 7
p = 0 .2 8 7
r = -0 .2 2 6
n = 2 7
p = 0 .2 5 6
r= 0 .0 1 4
n = 2 7
p = 0 .9 4 6
r= 0 .0 7 3
n = 2 7
p = 0 .7 1 9
U n c o n f id e n t r= -0 .0 1 2
n = 2 7
p = 0 .9 5 3
i= 0 .0 4 2
n = 2 7
p = 0 .8 3 5
r = 0 .2 2 4
n = 2 7
p = 0 .2 6 1
r = -0 .1 4 5
n = 2 7
p = 0 .4 7 1
r = -
0 .2 8 9
n = 2 7
p = 0 .1 4 4
r = -0 .2 6 0
n = 2 7
p = 0 .1 9 1
r= -0 .0 3 4
n = 2 7
p = 0 .8 6 8
r= 0 .1 4 2
n = 2 7
p = 0 .4 8 0
T o ta l  n e g a tiv e  
m e a n
r= -0 .0 3 3
n = 2 7
p = 0 .8 6 9
r = 0 .0 1 3
n = 2 7
p = 0 .9 4 8
r= 0 .2 4 8
n = 2 7
p = 0 .2 1 2
r= -0 .2 6 0
n = 2 7
p = 0 .1 9 1
r= -0 .2 6 1
n = 2 7
p = 0 .1 8 9
r = -0 .2 7 2  
n = 27  
p = 0 .1 7 0
r= 0 .0 2 9
n = 2 7
p = 0 .8 8 4
r= 0 .1 4 6
n = 2 7
p = 0 .4 6 8
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Table 30c. Correlaions betwwen Negative Mood States and Subjective Appetite
Rating During the Premenstrual Stages of the Menstrual Cycle
A p p e t i te /  
N e g a tiv e  
M o o d  S ta te
H u n g e r A p p e t i te S a tia t io n S a tie ty D R  -  fo o d  
ty p e
D R -
a m o im t o f
fo o d
w a n te d
A te  m o re
th a n
w a n te d
C ra v in g s
M e a n  o f  C y c le s  
D e p re ss e d
i= -0 .1 9 8
n = 3 2
p = 0 .2 7 7
r= -0 .2 5 6
n = 3 2
p = 0 .1 5 8
r= 0 .4 7  0
n = 3 2
p = 0 .0 0 7
r= -0 .3 6 7
n = 3 2
p = 0 .0 3 9
i= -0 .3 9 0
n = 3 2
p = 0 .0 2 7
r= -0 .2 1 0
n = 3 2
p = 0 .2 5 0
r= -0 .0 5 6
n = 3 2
p = 0 .7 6 3
r= 0 .2 5 8
n = 3 2
p = 0 .1 5 3
H o s ti le r = -0 .1 9 6
n = 3 2
p = 0 .2 8 3
r= -0 .2 4 1
n = 3 2
p = 0 .1 8 4
r= 0 .4 1 4
n = 3 2
p = 0 .0 1 9
r= -0 .3 1 4
n = 3 2
p = 0 .0 8 0
r= -0 .3 5 9
n = 3 2
p = 0 .0 4 4
r= -0 .1 9 6
n = 3 2
p = 0 .2 8 3
r= - 0 .0 1 2
n = 3 2
p = 0 .9 4 8
r= 0 .2 0 2
n = 3 2
p = 0 .2 6 8
A n x ie o u s r= -0 .1 0 1
n = 3 2
p = 0 .5 8 1
r = -0 .1 2 6
n = 3 2
p = 0 .4 9 3
r= 0 .3 2 4
n = 3 2
p = 0 .0 7 0
r= -0 .2 3 0
n = 3 2
p = 0 .2 0 5
r= -0 .1 6 8
n = 3 2
p = 0 .3 5 8
r= -0 .0 1 3
n = 3 2
p = 0 .9 4 6
r = - 0 .1 6 9
n = 3 2
p = 0 .3 5 6
1= 0 .0 31
n = 3 2
p = 0 .8 6 4
U n c o n f id e n t r= 0 .1 4 7
n = 3 2
p = 0 .4 2 1
r= 0 .0 6 0  
n = 3 2  
p = 0 .7  4 4
r= 0 .2 2 5
n = 3 2
p = 0 .2 1 6
r= -0 .0 3 4
n = 3 2
p = 0 .8 5 4
r= 0 .0 0 3
n = 3 2
p = 0 .9 8 9
r= 0 .1 9 0
n = 3 2
p = 0 .2 9 9
r= -0 .1 0 5
n = 3 2
p = 0 .5 6 7
r= -0 .0 3 4
n = 3 2
p = 0 .8 5 4
T o ta l  n e g a tiv e  
m e a n
r= -0 .0 8 0
n = 3 2
p = 0 .6 6 2
r= -0 .1 4 6
n = 3 2
p = 0 .4 2 4
r= 0 .3 9 8
n = 3 2
p = 0 .0 2 4
r= -0 .2 4 3
n = 3 2
p = 0 .1 8 0
r= -0 .2 1 7
n = 3 2
p = 0 .2 3 4
r= -0 .0 5 7
n = 3 2
p = 0 .7 5 7
r= -0 .0 8 6
n = 3 2
p = 0 .6 3 8
r= 0 .1 1 1
n = 3 2
p = 0 .5 4 5
C y c le  O n e  
D e p re ss e d
r= -0 .1 S 2
n = 3 0
p = 0 .4 2 3
r= -0 .1 6 9
n = 3 0
p = 0 .3 7 2
r= 0 .4 7 2
n = 3 0
p = 0 .0 0 8
r= -0 .2 5 0
n = 3 0
p = 0 .1 8 3
r= -0 .1 9 4
n = 3 0
p = 0 .3 0 5
r = -0 .1 0 0
n = 3 0
p = 0 .6 0 0
i= - 0 .1 1 6
n = 3 0
p = 0 .5 4 1
r= 0 .1 5 1
n = 3 0
p = 0 .4 2 5
H o s ti le r= -0 .2 0 8
n = 3 0
p = 0 .2 7 0
r= -0 .1 8 7
n = 3 0
p = 0 .3 2 2
r= 0 .4 8 7
n = 3 0
p = 0 .0 0 6
r= -0 .1 7 4
n = 3 0
p = 0 .3 5 8
r= -0 .3 5 2
n = 3 0
p = 0 .0 5 6
r= -0 .2 5 4
n = 3 0
p = 0 .1 7 6
r= -0 .1 2 7
n = 3 0
p = 0 .5 0 4
1 = 0 .0 6 2
n = 3 0
p = 0 .7 4 5
A n x ie o u s r= -0 .1 6 2
n = 3 0
p = 0 .3 9 3
r = -0 .1 4 9
n = 3 0
p = 0 .4 3 3
r= 0 .4 9 4
n = 2 5
p = 0 .0 1 2
r= -0 .1 5 0  
n = 3  0  
p = 0 .4 2 7
r= -0 .1 8 5
n = 3 0
p = 0 .3 2 7
r= - 0 .1 1 7
n = 3 0
p = 0 .5 3 8
r= -0 .2 5 4
n = 3 0
p = 0 .1 7 5
r= -0 .0 7 8
n = 3 0
p = 0 .6 8 1
U n c o n f id e n t r= 0 .2 4 9
n = 3 0
p = 0 .1 8 5
r= 0 .2 1 2
n = 3 0
p = 0 .2 6 2
r= 0 .1 9 8
n = 2 5
p = 0 .3 4 3
r= 0 .2 1 0  
n = 3 0
p = 0 .2 6 6
r= 0 .1 3 0
n = 3 0
p = 0 .4 9 3
r = 0 .3 7 0
n = 3 0
p = 0 .0 4 4
i= - 0 .0 0 4
n = 3 0
p = 0 .9 8 4
r= -0 .2 0 2
n = 3 0
p = 0 .2 8 4
T o ta l  n e g a tiv e  
m e a n
r= -0 .0 7 3
n = 3 0
p = 0 .7 0 2
r= -0 .0 8 8
n = 3 0
p = 0 .6 4 3
r= 0 .4 5 8
n = 2 5
p = 0 .0 2 1
r= -0 .0 9 4
n = 3 0
p = 0 .6 2 1
r= -0 .1 6 4
n = 3 0
p = 0 .3 8 7
r= - 0 .0 1 7
n = 3 0
p = 0 .9 2 8
r= -0 .1 1 2
n = 3 0
p = 0 .5 5 7
i= - 0 .0 4 4
n = 3 0
p = 0 .8 1 8
C y c le  T w o  
D e p re ss e d
r= -0 .0 8 2  
n = 2  6  
p = 0 .6 9 2
i= -0 .1 4 0
n = 2 6
p = 0 .4 9 4
r= 0 .1 3 4
n = 2 6
p = 0 .5 1 5
r= -0 .3 7 0
n = 2 6
p = 0 .0 6 3
r= -0 .2 3 5
n = 2 6
p = 0 .2 4 9
r= -0 .1 6 8  
n = 2 6  
p = 0 .4 1 1
r= -0 .1 0 3
n = 2 6
p = 0 .6 1 7
r= 0 .1 5 4
n = 2 6
p = 0 .4 5 3
H o s ti le 1 = 0 .0 7 0  
n = 2  6  
p = 0 .7 3 4
r= -0 .0 0 3
n = 2 6
p = 0 .9 8 1
r= -0 .0 5 5
n = 2 6
p = 0 .7 8 9
r= -0 .2 8 4
n = 2 6
p = 0 .1 5 9
r= -0 .2 1 9
n = 2 6
p = 0 .2 8 3
r= -0 .2 3 4
n = 2 6
p = 0 .2 4 9
r= 0 .1 0 9
n = 2 6
p = 0 .5 9 7
r= 0 .2 2 5
n = 2 6
p = 0 .2 6 9
A n x ie o u s r= -0 .0 1 2  
n = 2  6  
p = 0 .9 5 3
r= 0 .0 0 5
n = 2 6
p = 0 .9 8 1
i= -0 .0 2 9
n = 2 6
p = 0 .8 8 8
r= -0 .4 0 8
n = 2 6
p = 0 .0 3 9
r= 0 .2 0 9  
n = 2  6  
p = 0 .3 0 5
r= - 0 .1 2 2
n = 2 6
p = 0 .5 5 2
r= -0 .0 2 5
n = 2 6
p = 0 .9 0 4
1 = 0 .0 9 4
n = 2 6
p = 0 .6 4 8
U n c o n f id e n t r= 0 .1 3 4  
n = 2  6  
p = 0 .5 1 4
r= 0 .0 8 6
n = 2 6
p = 0 .6 7 5
i= 0 .0 7 7  
n = 2  6 
p = 0 .7 0 8
r= -0 .1 6 4  
n = 2  6  
p = 0 .4 2 3
r= -0 .2 8 9
n = 2 7
p = 0 .1 4 4
r= 0 .1 6 7
n = 2 6
p = 0 .4 1 4
r= -0 .2 1 5
n = 2 6
p = 0 .2 9 2
r= 0 .1 1 8
n = 2 6
p = 0 .5 6 5
T o ta l  n e g a tiv e  
m e a n
r= 0 .0 0 0
n = 2 6
p = 0 .9 9 9
r = - 0 .0 1 2
n = 2 6
p = 0 .9 5 5
r= 0 .0 7 0
n = 2 6
p = 0 .7 3 3
r= -0 .3 5 7
n = 2 6
p = 0 .0 7 3
r= -0 .2 6 1
n = 2 7
p = 0 .1 8 9
r= - 0 .0 8 4
n = 2 6
p = 0 .6 8 3
r= -0 .0 2 9
n = 2 6
p = 0 .8 8 8
r = 0 .1 5 0
n = 2 6
p = 0 .4 6 4
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Table 31a. Correlations between (a* actual food intake and (b) percentage food
intake and state anxiety and state anger During the Follicular phases of the
Menstrual Cycle
(a)
Actual food intake/ 
Sate anxiety, Anger Kcal Protein (g) Fat (g)
Caibohydrat
e(g) Stgar (g) Starch (g) TLA
Mean of both cyde 
State Anxiety
r=0.022
n=31
p=0.906
r=0.134
r r f l
p=0.472
1=0.137
n=31
p=0.463
r=0.129
ir=31
p=0.490
1=0.137
n=31
p=0.464
1=0.034
n=31
p=0.854
r=0.179
ir=31
p=0335
State Anger r=-0.263
n=32
p=0.146
r=0.219
n=32
p=0.229
r=O.303
ir=32
p=0.092
1=0.157
n=32
p=0.392
1=0.031
n=32
p=0.868
1=0.213
n=32
p=0.243
1=0.072
n=32
p=0.696
Cyde One 
State anxiety
r=-0.115
if=29
p=0.552
r=0.186
n=29
p=0.335
r=0.063
rr=29
p=0.744
r=0.137
n=29
p=0.478
1=0.140
n=29
p=0.468
r=0.014
n=29
p=0.945
r=0.279
n=29
p=0.143
State Anger r=0.204
n=30
p=0.280
r=0.153
n=30
p=0.421
1=0.299
n=30
p=0.108
1=0.097
n=30
p=0.610
1=0.070
n=30
p=0.715
r=0.078 
n=3 0
p=0.681
1=0.115
n=30
p=0.547
Cyde Two 
State Anxiety
r=o.m
rf=24
p=0.423
r=-0.236
ir=24
p=0.267
1=0.063 
ii=24 
p=0.7 69
1=0343
n=24
p=0.101
r=0316
ir=24
p=0.132
1=0.304
n=24
p=0.149
r=0.053
n=24
p=0.806
State Anger r=-0.212
n=25
p=0.308
r=-0.159
n=25
p=0.447
1=0.183
n=25
p=0.382
1=0.261
n=25
p=0.208
1=0.157 
if=25 
p=0.453
r=0.267
ir=25
p=0.198
1=0.233
n=25
p=0.262
(b)
% food intake/
State anxiety, Anger
% Fat %  Protein % CHO %  Sugar % Stardh
Mean of both cycle 
State Anxiety
r=0.252
n=31
p=0.171
r=-0.161
n=31
p=0.388
r=-0.145
n=31
p=0.435
r=-0.190
n=31
p=0.307
r=0.032
n=31
p=0.865
State Anger r=-0.195
n=32
p=0.284
r=0.036 
n=32 
p=0.844
r=0.151
n=32
p=0.409
r=0.090
n=32
p=0.625
r=0.154
n=32
p=0.400
Cycle One 
State anxiety
r=-0.037
n=29
p=0.850
r=-0.128
n=29
p=0.508
r=-0.003
n=29
p=0.988
r=-0.119
n=29
p=0.539
r=0.301
n=30
p=0.106
State Anger r=-0.286
n=30
p=0.126
r=0.016
n=30
p=0.934
r=0.228
n=30
p=0.226
r=0.041 
n=30 
p=0.831
r=0.069
n=29
p=0.720
Cycle Two 
State Anxiety
r=0.423
n=24
p=0.040*
r=-0.073
n=24
p=0.736
r=-0.250
n=24
p=0.239
r=-0.301
n=24
p=0.152
r=-0.132
n=24
p=0.540
State Anger r=-0.016
n=25
p=0.938
r=0.163
n=25
p=0.436
r=-0.073
n=25
p=0.727
r=-0.176
n=25
p=0.401
r=0.034
n=25
p=0.873
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Table 31b. Correlations between (a) actual food intake and fb) percentage food
intake and state anxiety and state anger During the Luteal phases of the Menstrual
Cycle
(a)
Actual food intake/ 
Sate anxiety, Anger Kcal Protein (g) Fat (g)
Caibohydrat
e(g) Sugar (g) Starch (g) TLA
Mean of both cyde 
State Anxiety
r=-0.020
n=31
p=0.916
i=-0.062
ii=31
p=0.739
1=0.042
n=31
p=0.822
r=0.049
re=31
p=0.795
r=0.070
n=31
p=0.707
r=0.136
n=31
p=0.467
r=-0.174
n=31
p=0.348
State Anger r=0.134
n=32
p=0.464
1=0.176
n=32
p=0.336
1=0.151 
n=32 
p=0.409
1=0.052
n=32
p=0.777
1=0.111
ir=32
p=0.544
r=O.023
n=32
p=0.903
1=0.022
n=32
p=0.907
Cyde One 
State anxiety
r=0.109
n=28
p=0.58I
1=0.120
te=28
p=C.542
1=0.155
n=28
p=0.432
r=0.041
n=28
p=0.835
1=0.164
n=28
p=0.406
1=0.093
ir=28
p=0.639
1=0.091
rr=28
p=0.645
State Anger r=0.149
ii=29
p=0.442
1=0.128
n=29
p=0.507
r=0.137
n=29
p=0.478
r=0.138
n=29
p=0.476
r=0.009
n=29
p=0.961
1=0.246
n=29
p=0.199
r=0.148
ir=29
p=0.443
Cyde Two 
State Anxiety
1=0.168
ir=26
p=0.412
r=0.291
n=26
p=0.149
1=0.035
n=26
p=0.867
1=0.155 
n=2 6 
p=0.449
1=0.093
n=26
p=0.652
r=0.150
n=26
p=0.464
1=0.147
n=26
p=0.473
State Anger 1=0.463
xi=27
p=0.015* in §r 
§ 1=0.516
re=27
p=0.006**
1=0.181
n=27
p=0.367
r=0.026
n=27
p=0.782
1=0.198
nK27
p=0J22
r=0.140
n=27
p=0.486
(b)
% food intake/ 
State anxiety, Anger
% Fat % Protein % CHO % Sugar % Starch
Mean of both cycle 
State Anxiety
r=0.003
n=31
p=0.987
r=-0.046
n=31
p=0.805
r=0.008
n=31
p=0.964
r=0.053
n=31
p=0.778
r=0.012
n=31
p=0.948
State Anger r=-0.010 
n=32 
p =0.957
r=0.083
n=32
p=0.651
r=-0.026
n=32
p=0.888
r=0.120
n=32
p=0.514
r=-0.081
n=32
p=0.660
Cycle One 
State anxiety
r=0.027
n=28
p=0.891
r=0.070
n=28
p=0.723
r=-0.015
n=28
p=0.938
r=0.141
n=28
p=0.474
r=-0.115
n=28
p=0.561
State Anger r=-0.033
n=29
p=0.863
r=0.006
n=29
p=0.977
r=-0.009
n=29
p=0.965
r=0.305
n=29
p=0.107
r=-0.162
n=29
p=0.400
Cycle Two 
State Anxiety
r=0.072
n=26
p=0.725
r=-0.242 
n=2 6 
p=0.233
r=-0.017
n=26
p=0.934
r=0.007
n=26
p=0.973
r=-0.031 
n=26
p=0.882
State Anger r=0.233 
n=27 
p =0.243
r=-0.052
n=27
p=0.796
r=-0.172
n=27
p=0.392
r=-0.339
n=27
p=0.083
r=0.058
n=27
p=0.774
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Table 31c. Correlations between fa) actual food intake and (b) percentage food
intake and state anxiety and state anger During the Premenstrual phases of the
Menstrual Cycle
(a)
Actual food intake/ 
Sate anxiety, Anger Kcal Protein (g) Fat (g)
Carbohydrat
e(g) Sugar (g) Starch (g) TLA
Mean of both cyde 
State Anxiety
r=-0.050
n=31
p=0.790
r=-0.290
n=31
p=0.113
1=0.086
n=31
p=0.648
r=-0.074
n=31
p=0.695
1=0.077
n=31
p=0.681
i=0.005
ir=31
p=0.978
r=0.076
ir=31
p=0.6S3
State Anger r=-0.041
n=32
p=0.822
r=-0.057
n=32
p=0.757
r=0.046
n=32
p=0.804
1=0.099
n=32
p=0.590
r=0.101
rr=32
p=0.584
1=0.055
n=32
p=0.764
r=0.351
n=32
p=0.049*
Cyde One 
State anxiety
1=0.004
n=29
p=0.984
r=-0.172
n=29
p=0.373
i=0.127
n=29
p=0.511
1=0.078
n=29
p=0.686
i=0.I82
n=29
p=0.344
1=0.018
n=29
p=0.926
1=0.336
n=29
p=0.075
State Anger r=0.084
n=30
p=0.660
r=0.023
n=30
p=0.904
r=0.165
n=30
p=0.383
1=0.044
n=30
jj=0.818
r=0.019
rt=30
p=0.923
1=0.045
n=30
p=0.812
i=0.508
rt=30
p=0.004**
Cyde Two 
State Anxiety
r=-0.335
if=24
p=0.110
r=-0.321
n=24
p=0.126
i=-0.222
ir=24
p=0.297
1=0.226
ir=24
p=0.289
1=0.132
n=24
p=0.538
1=0.033
n=24
p=0.880
1=0.237
n=24
p=0.265
State Anger r=0.178
n=25
p=0.395
r=0.064
n=25
p=0.761
r=O.099
n=25
p=0.637
1=0.195
n=25
p=0.351
1=0.192
n=25
p=0_358
1=0.058
if=25
p=0.784
1=0.146
n=25
p=0.486
(b)
% food intake/ % Fat % Protein % CHO % Sugar % Starch
State anxiety, Anger
Mean of both cycle
r=0.239 r=-0.068 r=-0.111 r=-0.043 r=-0.07 6
State Anxiety n=31 n=31 n=31 n=31 n=31
p=0.196 p=0.718 p=0.553 p=0.818 p=0.686
State Anger r=0.135 r=0.058 r=-0.133 r=-0.124 r=-0.033
n=32 n=32 n=32 n=32 n=32
p=0.461 p=0.755 p=0.467 p=0.498 p=0.859
Cycle One
r=0.200 r=-0.120 r=-0.145 r=-0.032 r=-0.192
State anxiety n=29 n=29 n=29 n=29 n=29
p=0.298 p=0.534 p=0.452 p=0.870 p=0.319
State Anger r=0.150 r=-0.128 r=-0.179 r=-0.030 r=-0.173
n=30 n=30 n=30 n=30 n=30
p=0.428 p=0.500 p=0.345 p=0.876 p=0.360
Cycle Two
r=0.079 r=0.028 r=0.017 r=-0,040 r=0.204
State Anxiety n=24 n=24 n=24 n=24 n=24
p=0.714 p=0.896 p=0.939 p=0.855 p=0.340
State Anger r=0.085 r=0.402 r=-0.108 r=-0.227 r=0.1I5
n=25 n=25 n=25 n=25 n=25
p=0.687 p=0.046* p=0.607 p=0.276 p=0.585
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Table 32 a. Correlations Between Subjective Appetite Measures and State Anxiety
and State Anger During the Follicular Stages of the Menstrual Cycles
State Anx/Ang 
Appetite Ratings
Mean of Two Cydes
State Anxiety State Anger
Cyde One
State Anxiety State Anger
Cyde Two
State Anxiety State Anger
Hunger r=0.050 r=0.113 r=-0.185 1=0.080 r=0.221 1=0.034
rr=31 n=32 n=29 n=30 n=24 ii=25
p=0.393 p=0.539 p=0.337 p=0.676 p=0.30I p=0.871
Appetite r=-0.088 r=0.150 x=-0.035 1=0.003 i= 0330 1=0.141
n=3I n=32 n=29 n=30 rr=24 n=25
p=O,640 p=0.413 p=0.857 p=0.987 p=0.116 p=0.503
Satiation 1=0.422 1=0.254 1=0.157 r=0.221 1=0.449 i=0.248
n=31 n=32 n=29 n=30 n=24 n=25
p=0.018* p=0.160 p=0.415 p=0.241 p=0.028* p=0.232
Satiety 1=0.400 1=0.194 1=0.214 1=0.277 1=0.522 r=0.281
n=3t rr=32 n=29 n=30 n=24 n=25
p=0.026* p=0.288 p=0.264 p=0.138 p=0.009*« p=O.I73
DR - food type r=0.295 r=0.174 1=0.192 1=0.095 1=0.704 1=0.278
rt=31 n=32 n=29 n=30 n=24 ir=25
p=0.108 p=0.342 p=0.318 p=0.616 p=0.000 *** p=0.178
DR - amount of i=-0.034 i=-0.001 1=0.114 1=0.069 1=0.584 1=0.256
food wanted n=3I n=32 n=29 n=30 n=24 if=25
p=0.856 p=0.996 p=0.556 p=0.716 p=0.003 p=0.216
Ate more than 1=0.354 1=0.127 1=0.403 p=0.142 1=0.001 1=0.055
wanted n=31 n=32 n=29 n=30 if=24 n=25
p=0.051 p=0.488 p=0.030* p=0.453 p=0.998 p=0.793
Cravings r=0.518 r=0.157 i=0348 1=0.130 r=0.542 1=0.127
if=31 n=32 n=29 n=30 n=24 ra=25
p=0.003** p=0.392 p=0.064 p=0.495 p=0.006 p=0.547
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Table 32 b. Correlations Between Subjective Appetite Measures and State Anxiety
and State Anger During the Luteal Stases of the Menstrual Cycles
State Anx/Ar® 
Appetite Ratings
Mean of Two Cydes
State Anxiety State Anger
Cyde One
State Anxiety State Anger
Cyde Two
State Anxiety State Anger
Hunger r=-0.210 1=0.046 1=0.030 1=0.054 t=0.346 1=0.001
n=31 tr=32 n=28 n=29 n=26 n=27
p=0.257 p=0.804 p=0.878 p=0.783 p=0.083 p=0.997
Appetite r=-0.259 r=0.086 r=-0.015 r=0.063 1=0359 1=0.064
n=31 n=32 n=28 n=29 n=26 re=27
p=0.160 p=0.640 p=0.939 p=0.746 p=0.071 p=0.753
Satiation 1=0.370 1=0.129 r=0.071 r=-0.064 1=0.395 r=0.226
n=31 n=32 n=28 ir=29 n=26 n=27
p=0.040* p=0.482 p=0.721 p=0.742 p=0.046* p=0.258
Satiety r=-0.432 r=0.176 i=-0.261 r=-0.044 r=0.458 1=0.246
n=31 n=32 n=28 n=29 n=26 ir=27
p=0.015* p=0.336 p=0.180 p=0.819 p=0.019* p=0.217
DR - food type r=-0.261 r=0.034 r=-0.095 r=0.235 r=0.282 r=0.438
n=31 n=32 n=28 ir=29 if=26 n=27
p=0.156 p=0.854 p=0.631 p=0.219 p=0.162 pf=0.022
DR * amount of r=0.295 1=0.051 r=-0.163 r=0.125 1=0.379 1=0.406
food wanted n=3I n=32 n=28 n=29 n=26 n=27
p=0.107 p=0.781 p=0.407 p=0.520 p=0.056 p=0.035*
Ate more than r=0.206 r=0.051 r=0.267 1=0.153 r=0.001 1=0.168
wanted n=31 n=32 n=28 n=29 n=26 n=27
p=0.267 p=0.782 p=0.170 p=0.428 p=0.998 p=0.403
Craving3 r=0.099 r=-0.076 1=0.134 1=0.026 1=0.176 1=0.148
n=31 n=32 n=28 n=29 rt=26 n=27
p=0.595 p=0.680 p=0.497 p=0.892 p=0391 p=0.46 2
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Table 32c. Correlations Between Subjective Appetite Measures and State Anxiety
and State Anger During the Premenstrual Stages of the Menstrual Cycles
State Anx/Ang 
Appetite Ratings
Mean of Two Cydes
State Anxiety State Anger
Cyde One
State Anxiety State Anger
Cyde Two
State Anxiety State Anger
Hunger r=-0.117 r=-0.029 r=-0.115 r=0.010 r=-0.116 r=-0.002
n=31 it=32 n=29 rt=30 n=25 n=26
p=0.529 p=0.876 p=0.554 p=0.960 p=0.580 p=0.993
Appetite r=-O.OS8 r=0.150 r=-0.035 r=0.003 r=-0.330 r=-0.141
n=3l n=32 n=29 n=30 n=24 rf=25
p=0.640 p=0.413 p=0.857 p=0.987 p=0.116 p=0.503
Satiation 1=0.240 r=0.105 1=0.443 r=0.289 r=0.017 i=-0.186
n=31 n=32 n=29 n=30 rr=25 n=26
p=0.194 p=0.567 p=0.016* p=0.121 p=0.936 pf=0.362
Satiety r=-0.227 r=-0.088 r=-0.121 i=-0.022 r=-0.435 r=-0.257
n=31 n=32 n=29 n=30 ir=25 n=26
p=0.221 p=0.633 p=0.531 p=0.910 p=0.030* p=0.205
DR - food type r=-0.383 r=-0.285 r=-0.366 i=4)J28 r=-0.487 r=-0.327
n=31 n=32 n=29 n=30 n=25 n=26
p=0.034* p=0.114 p=0.051 p=0.077 p=0.014* p=0.103
DR - amount of i=-0.205 i=-0.216 i=-0.206 r=-0.156 i=-0.379 i=-0.406
food wanted n=31 n=32 n=29 n=30 n=26 ir=27
p=0.268 p=0.234 p=0.285 p=0.410 p=0.056 p=0.035
Ate more than r=-0.159 1=0.043 r=0.145 r=-0.052 r=0.051 1=0.047
wanted n=31 n=32 n=29 nr=30 n=25 n=26
p=0.392 p=0.813 p=0.452 p=0.783 p=0.807 p=0.821
Cravings i=O.I47 1=0.081 r=0.070 r=0.013 r=0.170 1=0.039
n=31 n=32 ir=29 b=30 n=25 n=26
p=0.429 p=0.659 p=0.719 p=0.945 p=0.415 p=0.849
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